Citrus Sinensis ID: 021127
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.776 | 0.630 | 0.388 | 6e-44 | |
| P18161 | 1155 | Dual specificity protein | yes | no | 0.728 | 0.2 | 0.349 | 4e-28 | |
| Q54L00 | 650 | Probable LIM domain-conta | no | no | 0.684 | 0.333 | 0.342 | 5e-28 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.694 | 0.240 | 0.320 | 6e-28 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.712 | 0.169 | 0.344 | 8e-28 | |
| P41243 | 467 | Megakaryocyte-associated | yes | no | 0.772 | 0.524 | 0.294 | 2e-27 | |
| Q54XQ2 | 1125 | RGS domain-containing ser | no | no | 0.690 | 0.194 | 0.339 | 4e-27 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.678 | 0.253 | 0.312 | 7e-27 | |
| Q66HA1 | 850 | Mitogen-activated protein | no | no | 0.678 | 0.252 | 0.308 | 7e-27 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.678 | 0.252 | 0.308 | 8e-27 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 177 bits (450), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 110/283 (38%), Positives = 152/283 (53%), Gaps = 37/283 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIV----HKGETPEEIAKKESRFAR 73
+W D LF+G + GAH+++Y G YK + VA+K+V HK ET AK E +F
Sbjct: 78 EWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETR---AKLEQQFKS 134
Query: 74 EVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
EVA+LSR+ H N+V+FI ACK+P V I+TE +S G LR YL P L + + AL
Sbjct: 135 EVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLAL 194
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192
DI+R ME LHS G+IHRDLK NLLL ++++ +K+ADFG + E+ GTYRWM
Sbjct: 195 DISRGMEYLHSQGVIHRDLKSNNLLLNDEMR-VKVADFGTSCLETQCREAKGNMGTYRWM 253
Query: 193 APEL------------YS--------TVTLR--QG-----EKKHYNHKNVRPS-AENVPE 224
APE+ YS T L QG KN RP +
Sbjct: 254 APEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQP 313
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 267
L+ ++ CW E+P+ RP+F+ I+ +L Y + P+ H
Sbjct: 314 ALAHLIKRCWSENPSKRPDFSNIVAVLEKYDECVKEGLPLTSH 356
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 4e-28, Method: Composition-based stats.
Identities = 95/272 (34%), Positives = 138/272 (50%), Gaps = 41/272 (15%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ +++ID + ++GEGA ++V+EG +K VAIK + E+ + RF REV
Sbjct: 843 EREYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQF---KERFIREV 899
Query: 76 AMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDV----CVAIGFA 131
L + H+N+V FIGAC +P I+TE ++GG+L L N V + + A
Sbjct: 900 QNLKKGNHQNIVMFIGACYKPA-CIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMA 958
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
D+A + LHS I+HRDL +N+LL E L IK++DFGL+RE+S MT G
Sbjct: 959 TDMALGLLHLHSITIVHRDLTSQNILLDE-LGNIKISDFGLSREKSREGSMTMTNGGICN 1017
Query: 190 -RWMAPEL---------------YSTVT--LRQGEKKHYNHKNVRPSAE--------NVP 223
RW PEL +S V + GE + + SA+ +P
Sbjct: 1018 PRWRPPELTKNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIP 1077
Query: 224 E----ELSIILTSCWKEDPNARPNFTQIIQML 251
E EL ++LT CW+ DPN RP FT I+ L
Sbjct: 1078 EYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54L00|LIMKA_DICDI Probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001 OS=Dictyostelium discoideum GN=DDB_G0287001 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (314), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 87/254 (34%), Positives = 126/254 (49%), Gaps = 37/254 (14%)
Query: 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNL 86
G I GA KVY+G YK + VAIK+ + E F REV ++S + H N
Sbjct: 389 GDVIASGASGKVYKGIYKGRDVAIKVY----SSENFCFNIEEFDREVTIMSLIDSDHPNF 444
Query: 87 VKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+F GA K+ + V+EL+ G+LR LL+ + + L + A DIA AM+ LHS
Sbjct: 445 TRFYGANKQNKKYLFHVSELVKSGSLRDLLLD-KEKPLAYFTQLSIASDIANAMKHLHSI 503
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS------ 198
G+IHRDLK N+L+TED T K+ DFG +R L + MT GT +M+PEL+
Sbjct: 504 GVIHRDLKSLNVLITEDF-TAKVIDFGTSRNVDLAKQMTLNLGTSCYMSPELFKGNGYDE 562
Query: 199 ------------TVTLRQGEKKHYNH--------KNVRPSA-ENVPEELSIILTSCWKED 237
+ R+ ++ N K RP+ + P E S ++ +CW +
Sbjct: 563 TCDVYAFGIVLWEIIARKEPYENINSWSIPVLVAKGERPTIPADCPSEYSKLIKACWTDK 622
Query: 238 PNARPNFTQIIQML 251
P RP+F +I L
Sbjct: 623 PKKRPSFKEICDTL 636
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 125 bits (313), Expect = 6e-28, Method: Compositional matrix adjust.
Identities = 81/253 (32%), Positives = 134/253 (52%), Gaps = 33/253 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+ ++GEG VY+G ++ +VAIK + E +E F +E+ +LSR++H N+V
Sbjct: 664 ISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEE--FRKELTILSRLRHPNIV 721
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ AC P + +TE L GG+L L + + + +++ + A+ IA+ M LH G+
Sbjct: 722 LLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK-MNMQLYKKLAIQIAQGMNYLHLSGV 780
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL---------- 196
IHRD+K NLLL E + +K+ DFGL++ +S + MT G+ WM+PEL
Sbjct: 781 IHRDIKSLNLLLDEHMN-VKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDYTEKV 839
Query: 197 ----YSTVT--LRQGEKKH-----------YNHKNVRPSAENV-PEELSIILTSCWKEDP 238
+ + L GE + K++RP N P +LS ++ +CW +DP
Sbjct: 840 DVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDP 899
Query: 239 NARPNFTQIIQML 251
RP+FT+I+ +L
Sbjct: 900 LKRPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (312), Expect = 8e-28, Method: Composition-based stats.
Identities = 94/273 (34%), Positives = 136/273 (49%), Gaps = 47/273 (17%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVH--KGETPEEIAKKESRFAREVAM 77
+I+ + + IG+G +KV +G +K + VA+K ++ K + EE+ ++ F EV +
Sbjct: 1067 MINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQE---FKAEVEL 1123
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR------CLDVCVAIGFA 131
L +QH NLV G P M IV E L G L + L++ +P LD + + A
Sbjct: 1124 LGSLQHPNLVTCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIA 1181
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
DIAR M+ LH+ IIHRDLK NLL+ + IK+AD G+ARE S T+ MT GT W
Sbjct: 1182 FDIARGMQHLHTRNIIHRDLKSSNLLMDKHF-NIKIADLGIARETSFTQTMTT-IGTVAW 1239
Query: 192 MAPEL--------------YSTV--TLRQGEKKHYN-----------HKNVRPS-AENVP 223
APE+ Y+ V L GE+ + K +RP +N
Sbjct: 1240 TAPEILRHESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCD 1299
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256
++ CW EDPN RP+F +I NYL+
Sbjct: 1300 PNWKKLVVWCWSEDPNKRPSFEEIT----NYLT 1328
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P41243|MATK_RAT Megakaryocyte-associated tyrosine-protein kinase OS=Rattus norvegicus GN=Matk PE=2 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (307), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 83/282 (29%), Positives = 135/282 (47%), Gaps = 37/282 (13%)
Query: 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKES 69
A+E A WL+D +HL +G +IGEG V +G+Y Q VA+K + T +
Sbjct: 178 AEEELAKAGWLLDLQHLTLGAQIGEGEFGAVLQGEYLGQKVAVKNIKCDVTAQA------ 231
Query: 70 RFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
F E A+++++QHRNLV+ +G + IV E +S G L +L + +
Sbjct: 232 -FLDETAVMTKLQHRNLVRLLGVILHHGLYIVMEHVSKGNLVNFLRTRGRALVSTSQLLQ 290
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
FAL +A ME L S ++HRDL N+L++EDL K++DFGLA+ E L + + +
Sbjct: 291 FALHVAEGMEYLESKKLVHRDLAARNILVSEDL-VAKVSDFGLAKAE-LRKGLDSSRLPV 348
Query: 190 RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVRPSAE---------N 221
+W APE L+ + + + K V + E +
Sbjct: 349 KWTAPEALKNGRFSSKSDVWSFGVLLWEVFSYGRAPYPKMSLKEVSEAVEKGYRMEPPDS 408
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 263
P + ++ SCW+ +P+ RP F +I++ L L ++ P
Sbjct: 409 CPGPVHTLMGSCWEAEPSRRPPFRKIVEKLGRELRSVGVAAP 450
|
Could play a significant role in the signal transduction of hematopoietic cells. May regulate tyrosine kinase activity of SRC-family members in brain. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54XQ2|RCKA_DICDI RGS domain-containing serine/threonine-protein kinase A OS=Dictyostelium discoideum GN=rckA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 122 bits (306), Expect = 4e-27, Method: Compositional matrix adjust.
Identities = 88/259 (33%), Positives = 130/259 (50%), Gaps = 40/259 (15%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRNLVKFI 90
I G+ +VY G+YK + VAIK++ PE + + F REVA++S +H NL + +
Sbjct: 848 IASGSSGRVYNGQYKGKDVAIKVL----GPEVCVHFDLNEFKREVALMSIFKHDNLARCL 903
Query: 91 GACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
GA + + +TE G+L YL + R + + FAL IAR M LHS IIHR
Sbjct: 904 GAGQYDDKYFHLTEYCHNGSLFSYLRDQR-NNISFGQRLHFALGIARGMRYLHSMSIIHR 962
Query: 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQ----- 204
DLK N+LLT+ LK IK+ DFG +R + MT GT WMAPE++++ T
Sbjct: 963 DLKSMNILLTKRLK-IKIVDFGTSRVANKYN-MTTHVGTQAWMAPEIFTSRTYTNKVDVY 1020
Query: 205 ----------GEKKHYNH-----------KNVRPS-AENVPEELSIILTSCWKEDPNARP 242
K Y+ K RP +++ +S I+ CW++ P+ RP
Sbjct: 1021 SYAIILFEIFTRKSAYDENANINIPNMVMKGERPELPKDMQTSISNIIKKCWQQKPSNRP 1080
Query: 243 NFTQIIQMLLNYLSAIAPP 261
+F +I+ YL +I P
Sbjct: 1081 SFIKIVA----YLESIIYP 1095
|
Serine/threonine kinase involved in negative regulation of chemotaxis. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 81/259 (31%), Positives = 122/259 (47%), Gaps = 44/259 (16%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 123 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 181
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 182 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 238
Query: 148 HRDLKPENLLL-----TEDL--KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL ++D+ KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 239 HRDLKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 297
Query: 201 TLRQGEKKH-------------------------YN---HKNVRPSAENVPEELSIILTS 232
T +G Y +K P PE + ++
Sbjct: 298 TFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFAQLMAD 357
Query: 233 CWKEDPNARPNFTQIIQML 251
CW +DP+ RP+F I+Q L
Sbjct: 358 CWAQDPHRRPDFASILQQL 376
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 80/259 (30%), Positives = 120/259 (46%), Gaps = 44/259 (16%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 182
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 183 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 239
Query: 148 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 240 HRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 298
Query: 201 TLRQGEKKH-------------------------YN---HKNVRPSAENVPEELSIILTS 232
T +G Y +K P PE + ++
Sbjct: 299 TFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFAQLMAD 358
Query: 233 CWKEDPNARPNFTQIIQML 251
CW +DP+ RP+F I+Q L
Sbjct: 359 CWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 121 bits (303), Expect = 8e-27, Method: Compositional matrix adjust.
Identities = 80/259 (30%), Positives = 120/259 (46%), Gaps = 44/259 (16%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KVY G ++ + VA+K + + E+I+ +E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ-DPDEDISVTAESVRQEARLFAMLAHPNIIALKA 182
Query: 92 AC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---II 147
C +EP + +V E +GG L + L R + V + +A+ IAR M LH +I
Sbjct: 183 VCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPVI 239
Query: 148 HRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
HRDLK N+LL + + KT+K+ DFGLARE T M+A GTY WMAPE+
Sbjct: 240 HRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKAS 298
Query: 201 TLRQGEK-------------------------KHYN---HKNVRPSAENVPEELSIILTS 232
T +G Y +K P PE + ++
Sbjct: 299 TFSKGSDVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLTLPIPSTCPEPFAQLMAD 358
Query: 233 CWKEDPNARPNFTQIIQML 251
CW +DP+ RP+F I+Q L
Sbjct: 359 CWAQDPHRRPDFASILQQL 377
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | ||||||
| 255540509 | 351 | protein kinase atn1, putative [Ricinus c | 0.996 | 0.900 | 0.792 | 1e-160 | |
| 449440628 | 353 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.898 | 0.776 | 1e-157 | |
| 225456892 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.900 | 0.767 | 1e-157 | |
| 356516635 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.900 | 0.764 | 1e-154 | |
| 224140853 | 351 | predicted protein [Populus trichocarpa] | 0.996 | 0.900 | 0.755 | 1e-153 | |
| 363808050 | 352 | uncharacterized protein LOC100804884 [Gl | 1.0 | 0.900 | 0.752 | 1e-152 | |
| 224055579 | 351 | predicted protein [Populus trichocarpa] | 0.996 | 0.900 | 0.744 | 1e-151 | |
| 357461809 | 352 | Serine/threonine protein kinase TNNI3K [ | 1.0 | 0.900 | 0.744 | 1e-150 | |
| 225452312 | 352 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.900 | 0.738 | 1e-150 | |
| 255560936 | 353 | protein kinase atn1, putative [Ricinus c | 1.0 | 0.898 | 0.736 | 1e-149 |
| >gi|255540509|ref|XP_002511319.1| protein kinase atn1, putative [Ricinus communis] gi|223550434|gb|EEF51921.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1466), Expect = e-160, Method: Compositional matrix adjust.
Identities = 279/352 (79%), Positives = 296/352 (84%), Gaps = 36/352 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES +RFY DE+KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVA+KIVHKGET
Sbjct: 1 MESGNRFYSPDEVKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAVKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEI+K+E+RFAREVAMLSRVQH+NLVKF+GACKEPVMVIVTELLSGGTLRKYLLNMRPR
Sbjct: 61 PEEISKREARFAREVAMLSRVQHKNLVKFVGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CL+ VAIGFALDIARAMECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLTE
Sbjct: 121 CLETRVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAE++PEELSIILTSCWKEDPN RPNF+QII MLLN+L+ IAPPEP I
Sbjct: 241 AAYAAAFKNVRPSAEDLPEELSIILTSCWKEDPNTRPNFSQIIHMLLNHLAVIAPPEPAI 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
PHRIF SENT LPPESPGTSSLM V D GETPKAKM ++PK LFFCF CY
Sbjct: 301 PHRIFTSENTFLPPESPGTSSLMAVH-DTGETPKAKMENQPKGLFFCFKQCY 351
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440628|ref|XP_004138086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449524138|ref|XP_004169080.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 274/353 (77%), Positives = 294/353 (83%), Gaps = 36/353 (10%)
Query: 1 MESRSRFYLA-DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE 59
ME+ SRFY A DE +L+AKWL+DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE
Sbjct: 1 MEAGSRFYSATDEFRLEAKWLVDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE 60
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRP 119
T +E+AKKE+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRP
Sbjct: 61 TVDEVAKKEARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRP 120
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179
RCLD VA+GFALDIARAMECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLT
Sbjct: 121 RCLDTRVAVGFALDIARAMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLT 180
Query: 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------------------------- 212
EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH
Sbjct: 181 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNL 240
Query: 213 --------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 264
KNVRPSAEN+PEEL+IILTSCW+ED NARPNF+QIIQMLLNYL I+PPEP+
Sbjct: 241 QAAYAAAFKNVRPSAENLPEELAIILTSCWQEDANARPNFSQIIQMLLNYLYTISPPEPV 300
Query: 265 IPHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
IP RIF SENT+ PPESPGTSSLM VRDD G+TPKAKM + P+ FFC N CY
Sbjct: 301 IPSRIFTSENTVFPPESPGTSSLMAVRDDSGDTPKAKMENNPRGCFFCSNDCY 353
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456892|ref|XP_002280504.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|147839295|emb|CAN63533.1| hypothetical protein VITISV_011081 [Vitis vinifera] gi|297733702|emb|CBI14949.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 559 bits (1440), Expect = e-157, Method: Compositional matrix adjust.
Identities = 270/352 (76%), Positives = 289/352 (82%), Gaps = 35/352 (9%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES +RFY DE LD KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ VAIKIVH+GET
Sbjct: 1 MESGNRFYSVDEFHLDPKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQNVAIKIVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEI K+E+RFAREV+MLSRVQH+NL KFIG CKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 61 PEEITKREARFAREVSMLSRVQHKNLAKFIGVCKEPVMVIVTELLLGGTLRKYLLNMRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD +A+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KL DFGLAREESLTE
Sbjct: 121 CLDARIAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLVDFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLR GEKKHYN+
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNNKVDAYSFAIVLWELLHNKLPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAEN+PEEL+IILTSCWKEDPNARPNF+QI+QMLL+YLS I+PPEP I
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAIILTSCWKEDPNARPNFSQIVQMLLHYLSTISPPEPAI 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P R+F SENTILPPESPGTSSLM VRDD GETPK KM +KPK FFCFN CY
Sbjct: 301 PSRVFASENTILPPESPGTSSLMAVRDDSGETPKVKMENKPKGFFFCFNQCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516635|ref|XP_003526999.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 269/352 (76%), Positives = 288/352 (81%), Gaps = 35/352 (9%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES FY DE +LD KWLIDPKHLFVGP+IGEGAHAKVYEGKYKNQTVAIKIVHKGET
Sbjct: 1 MESGDMFYSVDEFRLDPKWLIDPKHLFVGPQIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+IAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYL +MRP+
Sbjct: 61 TEDIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLFSMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIGFALDIARAMECLHSHGIIHRDLKP+NLLLTED KT+KLADFGLAREESLTE
Sbjct: 121 CLDRHVAIGFALDIARAMECLHSHGIIHRDLKPDNLLLTEDQKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAEN+PEEL++ILTSCW+EDPNARPNFTQIIQMLLNYL +APPEPMI
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAVILTSCWQEDPNARPNFTQIIQMLLNYLYTVAPPEPMI 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P RIF+SENT+LPPESPGTSSLM RDD G+TP+AK KP CF+ CY
Sbjct: 301 PSRIFSSENTVLPPESPGTSSLMAKRDDTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140853|ref|XP_002323793.1| predicted protein [Populus trichocarpa] gi|222866795|gb|EEF03926.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-153, Method: Compositional matrix adjust.
Identities = 266/352 (75%), Positives = 293/352 (83%), Gaps = 36/352 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY ++E LDAKWLIDPK LFVGP+IGEGAHAKVYEGKYKNQ VAIKIVH GET
Sbjct: 1 MGSSNGFY-SEEFDLDAKWLIDPKLLFVGPKIGEGAHAKVYEGKYKNQIVAIKIVHGGET 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 60 PEEIAKREARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPR 119
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 120 CLDMRLAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 179
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLR GEKKHYNH
Sbjct: 180 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 239
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAEN+PE+L++I+TSCWKEDPNARPNF+QIIQMLL+YLS I+ P+P+I
Sbjct: 240 AAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPKPVI 299
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P RIF SEN +LPPESPGTSSLM VRDD+GETP+ ++ DKPKS FFCFN CY
Sbjct: 300 PARIFTSENAVLPPESPGTSSLMAVRDDLGETPRTQIEDKPKSFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808050|ref|NP_001241956.1| uncharacterized protein LOC100804884 [Glycine max] gi|255636187|gb|ACU18435.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-152, Method: Compositional matrix adjust.
Identities = 265/352 (75%), Positives = 284/352 (80%), Gaps = 35/352 (9%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES RFY DE +LD KWLIDP HLFVGP+IGEGAHAKVYEGKYKNQTVA KIVHKGET
Sbjct: 1 MESGGRFYSVDEFRLDPKWLIDPNHLFVGPQIGEGAHAKVYEGKYKNQTVAFKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+IAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLL+MRP+
Sbjct: 61 TEDIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLSMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIG+ALDIARAMECLHSHGIIHRDLKP+NLLLTED KT+KL DFGLAREESLTE
Sbjct: 121 CLDRHVAIGYALDIARAMECLHSHGIIHRDLKPDNLLLTEDQKTVKLVDFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELLHNKVPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAEN+PEEL++ILTSCW+ED NARPNFTQIIQMLLNYL +APPEPM
Sbjct: 241 AAYAAAFKNVRPSAENLPEELAVILTSCWQEDSNARPNFTQIIQMLLNYLYTVAPPEPMT 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P RIFNSENT+LPPESPGTSSLM RD G+TP+AK KP CF+ CY
Sbjct: 301 PSRIFNSENTVLPPESPGTSSLMAKRDGTGDTPRAKDEIKPNGFLCCFSQCY 352
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055579|ref|XP_002298549.1| predicted protein [Populus trichocarpa] gi|222845807|gb|EEE83354.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 262/352 (74%), Positives = 287/352 (81%), Gaps = 36/352 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY + E LDAKWL+DPK LFVGP+IGEGAHAKVYEGKYKNQ VAIKIVH GET
Sbjct: 1 MGSSNVFY-SGEFNLDAKWLVDPKLLFVGPKIGEGAHAKVYEGKYKNQNVAIKIVHGGET 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+++RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLNMRPR
Sbjct: 60 PEEIAKRQARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNMRPR 119
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CL++ VA GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 120 CLEMRVAFGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 179
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLR GEKKHYNH
Sbjct: 180 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 239
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSAEN+PE+L++I+TSCWKEDPNARPNF+QIIQMLL+YLS I+ PEP I
Sbjct: 240 AAYAAAFKNVRPSAENLPEDLALIVTSCWKEDPNARPNFSQIIQMLLHYLSTISAPEPAI 299
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P RIF SEN + PPESPGTSSLM VRDD GETP+ ++ DKP+ FFCFN CY
Sbjct: 300 PARIFTSENAVFPPESPGTSSLMAVRDDSGETPRTQIEDKPRGFFFCFNQCY 351
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461809|ref|XP_003601186.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] gi|355490234|gb|AES71437.1| Serine/threonine protein kinase TNNI3K [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1387), Expect = e-150, Method: Compositional matrix adjust.
Identities = 262/352 (74%), Positives = 283/352 (80%), Gaps = 35/352 (9%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
MES RFY DE LD KWL+DPKHL+VGPRIGEGAHAKVYEGKYKNQ VAIKIVHKGET
Sbjct: 1 MESGGRFYSVDEFNLDPKWLVDPKHLYVGPRIGEGAHAKVYEGKYKNQIVAIKIVHKGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
EEIAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRP+
Sbjct: 61 TEEIAKREDRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VAIGFALDI+RAMECLHSHGIIHRDLKP+NLLLTED T+KLADFGLAREESLTE
Sbjct: 121 CLDTHVAIGFALDISRAMECLHSHGIIHRDLKPDNLLLTEDHGTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVFWELLHNKVPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRP+A+++PEEL++ILTSCW+ED NARPNFTQIIQMLLNYL ++PP P I
Sbjct: 241 AAYAAAFKNVRPNADHLPEELAVILTSCWQEDANARPNFTQIIQMLLNYLYTVSPPTPAI 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P RIF SENT+LPPESPGTSSLM RDD G+TP+ K KP CF+ CY
Sbjct: 301 PSRIFTSENTLLPPESPGTSSLMAKRDDTGDTPRVKDEIKPNGFLCCFSQCY 352
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452312|ref|XP_002272486.1| PREDICTED: serine/threonine-protein kinase HT1 [Vitis vinifera] gi|296087594|emb|CBI34850.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/352 (73%), Positives = 285/352 (80%), Gaps = 35/352 (9%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY ++E LDAKWL+DPK LFVGPRIGEGAHAKVYEGKYKNQ VAIKIVH+GET
Sbjct: 1 MGSGNGFYESEEFNLDAKWLVDPKLLFVGPRIGEGAHAKVYEGKYKNQNVAIKIVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RPR
Sbjct: 61 PEEIAKREGRFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
CLD VA+GFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 121 CLDTKVAVGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLR GEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELVHNKLPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KN+RPSAE++PE+L++I+TSCWKEDPN RPNF+QIIQMLL+YLS I+PPEPM+
Sbjct: 241 AAYAAAFKNMRPSAEDLPEDLALIVTSCWKEDPNTRPNFSQIIQMLLHYLSTISPPEPMV 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGDKPKSLFFCFNLCY 317
P R+F SEN +LPPESPGTSSLM VRD GETPK M P+ F CFN CY
Sbjct: 301 PPRVFTSENAVLPPESPGTSSLMAVRDGSGETPKTSMETNPRGCFSCFNHCY 352
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560936|ref|XP_002521481.1| protein kinase atn1, putative [Ricinus communis] gi|223539380|gb|EEF40971.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1375), Expect = e-149, Method: Compositional matrix adjust.
Identities = 260/353 (73%), Positives = 288/353 (81%), Gaps = 36/353 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + + E LDAKWLIDPK L VGP+IGEGAHAKVYEGKYKN+ VAIK+VH+GET
Sbjct: 1 MGSTDNGFYSGEFNLDAKWLIDPKLLLVGPKIGEGAHAKVYEGKYKNRIVAIKVVHRGET 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+E+RFAREVAMLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RPR
Sbjct: 61 PEEIAKREARFAREVAMLSRVQHKNLVKFIGACKEPVMVIVTELLLGGTLRKYLLNLRPR 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
L++ VAIGFALDIARAMECLHSHGIIHRDLKPENL+LT D KT+KLADFGLAREESLTE
Sbjct: 121 SLELHVAIGFALDIARAMECLHSHGIIHRDLKPENLILTADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------------- 212
MMTAETGTYRWMAPELYSTVTLR GEKKHYNH
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQ 240
Query: 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265
KNVRPSA+++PEE+++I+TSCW+EDPNARPNFTQIIQMLL +LS I+PPEP+I
Sbjct: 241 AAYAAAFKNVRPSADDLPEEMAMIVTSCWQEDPNARPNFTQIIQMLLRFLSTISPPEPVI 300
Query: 266 PHRIFNSENTILPPESPGTSSLMTVRDDIGETPKAKMGD-KPKSLFFCFNLCY 317
P RIF SEN +LPPESPGTSSLM VRDD GETPK+KM D KP+ FFCFN CY
Sbjct: 301 PARIFTSENAVLPPESPGTSSLMAVRDDSGETPKSKMEDNKPRGFFFCFNQCY 353
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 317 | ||||||
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.630 | 0.578 | 0.875 | 5.3e-132 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.671 | 0.598 | 0.816 | 2.2e-122 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.671 | 0.603 | 0.807 | 4.5e-122 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.769 | 0.732 | 0.6 | 5.7e-75 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.624 | 0.488 | 0.525 | 2.3e-64 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.634 | 0.533 | 0.532 | 4.2e-59 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.561 | 0.433 | 0.486 | 1.4e-48 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.561 | 0.432 | 0.469 | 4.2e-47 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.552 | 0.333 | 0.433 | 4.7e-44 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.561 | 0.374 | 0.407 | 1.3e-38 |
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 5.3e-132, Sum P(2) = 5.3e-132
Identities = 175/200 (87%), Positives = 187/200 (93%)
Query: 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR 73
+++ KW IDP+ LFVGP+IGEGAHAKVYEGKYKNQTVAIKIVH+GETPEEIAK++SRF R
Sbjct: 8 RMEPKWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFLR 67
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
EV MLSRVQH+NLVKFIGACKEPVMVIVTELL GGTLRKYLLN+RP CL+ VAIGFALD
Sbjct: 68 EVEMLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALD 127
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
IAR MECLHSHGIIHRDLKPENLLLT D KT+KLADFGLAREESLTEMMTAETGTYRWMA
Sbjct: 128 IARGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMA 187
Query: 194 PELYSTVTLRQGEKKHYNHK 213
PELYSTVTLR GEKKHYNHK
Sbjct: 188 PELYSTVTLRLGEKKHYNHK 207
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 2.2e-122, Sum P(2) = 2.2e-122
Identities = 174/213 (81%), Positives = 200/213 (93%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S S FY +E +LD KWL+DP+HLFVGP+IGEGAHAKVYEGKY+NQTVAIKI+ +GE+
Sbjct: 1 MGSASGFYSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGES 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+++RFARE+AMLS+VQH+NLVKFIGACKEP+MVIVTELL GGTLRKYL+++RP+
Sbjct: 61 PEEIAKRDNRFAREIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPK 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
LD+ +A+GFALDIARAMECLHSHGIIHRDLKPENL+L+ D KT+KLADFGLAREESLTE
Sbjct: 121 RLDIRLAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 4.5e-122, Sum P(2) = 4.5e-122
Identities = 172/213 (80%), Positives = 197/213 (92%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M S + FY + +LD KW++DP+HLFVGP+IGEGAHAK+YEGKYKN+TVAIKIV +GE+
Sbjct: 1 MGSVTGFYSNEVFELDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGES 60
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
PEEIAK+ESRFAREV+MLSRVQH+NLVKFIGACKEP+MVIVTELL GGTLRKYL+++RP
Sbjct: 61 PEEIAKRESRFAREVSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPG 120
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
LD+ VA+G+ALDIARAMECLHSHG+IHRDLKPE+L+LT D KT+KLADFGLAREESLTE
Sbjct: 121 SLDIRVAVGYALDIARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTE 180
Query: 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
MMTAETGTYRWMAPELYSTVTLR GEKKHYNHK
Sbjct: 181 MMTAETGTYRWMAPELYSTVTLRHGEKKHYNHK 213
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 5.7e-75, P = 5.7e-75
Identities = 153/255 (60%), Positives = 193/255 (75%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFARE 74
++ L+DPK LF+G +IGEGAH KVY+G+Y Q VAIK+V++G P++ + ESRF RE
Sbjct: 7 IEESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSLESRFVRE 66
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
V M+SRVQH NLVKFIGACK+P+MVIVTELL G +LRKYL ++RP+ L + +A+ FALDI
Sbjct: 67 VNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDI 126
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
ARA+ CLH++GIIHRDLKP+NLLLTE+ K++KLADFGLAREES+TEMMTAETGTYRWMAP
Sbjct: 127 ARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAP 186
Query: 195 ELYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254
ELYSTVTLRQGEKKHYN+K +V I+L W+ N P F + + Y
Sbjct: 187 ELYSTVTLRQGEKKHYNNK------VDV-YSFGIVL---WELLTNRMP-FEGMSNLQAAY 235
Query: 255 LSAIAPPEPMIPHRI 269
+A P++P I
Sbjct: 236 AAAFKQERPVMPEGI 250
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 2.3e-64, Sum P(2) = 2.3e-64
Identities = 105/200 (52%), Positives = 146/200 (73%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAR 73
++ + L+D K + +G IGEG+ + VY G ++ V++KI T ++ +F R
Sbjct: 60 INTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIEQRKKFQR 119
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
EV +LS+ +H N+V+FIGAC EP ++I+TEL+ G TL+K++L++RP+ LD+ ++I FALD
Sbjct: 120 EVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALD 179
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
IAR ME L+++GIIHRDLKP N+LLT D K +KLADFGLAREE+ MT E GTYRWMA
Sbjct: 180 IARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREET-KGFMTFEAGTYRWMA 238
Query: 194 PELYSTVTLRQGEKKHYNHK 213
PEL+S TL GEKKHY+HK
Sbjct: 239 PELFSYDTLEIGEKKHYDHK 258
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 4.2e-59, Sum P(2) = 4.2e-59
Identities = 108/203 (53%), Positives = 149/203 (73%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESR 70
+ + + L++PK + G IGEG ++ VY+G+ KN VA+KIV G+T + + +
Sbjct: 34 DFNISRELLLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQQ 93
Query: 71 FAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
F +EV +LS ++H N+V+F+GAC EP ++IVTEL+ GGTL++++LN RP LD+ V++ F
Sbjct: 94 FQKEVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSF 153
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
ALDI+RAME LHS GIIHRDL P N+L+T D+K +KLADFGLARE++L M T E GTYR
Sbjct: 154 ALDISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGM-TCEAGTYR 212
Query: 191 WMAPELYSTVTLRQGEKKHYNHK 213
WMAPE+ S LR GEKKHY+ K
Sbjct: 213 WMAPEVCSREPLRIGEKKHYDQK 235
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.4e-48, Sum P(2) = 1.4e-48
Identities = 88/181 (48%), Positives = 127/181 (70%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE-TPEEIAKKESRFAREVA 76
+W ID + L +GP +GA K+Y+G Y + VAIKI+ + E +PE+ E +F +EV+
Sbjct: 122 EWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVS 181
Query: 77 MLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
ML+ ++H N+V+FIGAC++P V IVTE GG++R++L + R + + +A+ ALD+A
Sbjct: 182 MLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 241
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
R M +H IHRDLK +NLL++ D K+IK+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 242 RGMAYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 196 L 196
+
Sbjct: 301 M 301
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 429 (156.1 bits), Expect = 4.2e-47, Sum P(2) = 4.2e-47
Identities = 85/181 (46%), Positives = 125/181 (69%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET-PEEIAKKESRFAREVA 76
+W ID + L +GP +GA K+Y G Y + VAIK++ + ++ PE+ E +F +EV+
Sbjct: 123 EWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVS 182
Query: 77 MLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
ML+ ++H N+V+FIGAC +P V IVTE GG++R++L + R + + +A+ ALD+A
Sbjct: 183 MLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVA 242
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
R M +H IHRDLK +NLL++ D ++IK+ADFG+AR E TE MT ETGTYRWMAPE
Sbjct: 243 RGMAYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 196 L 196
+
Sbjct: 302 M 302
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 392 (143.0 bits), Expect = 4.7e-44, Sum P(2) = 4.7e-44
Identities = 78/180 (43%), Positives = 119/180 (66%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI---AKKESRFAREVAM 77
+D LF G + G ++++Y GKY+++ VA+K++ + + A+ E +F +EV +
Sbjct: 202 VDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTL 261
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
LSR+ H N++KF+GA K+P V ++T+ L G+LR +L R L + I FA+DIAR
Sbjct: 262 LSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIAR 321
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
ME +HS IIHRDLKPEN+L+ E+ +K+ADFG+A EE +M+ + GTYRWMAPE+
Sbjct: 322 GMEYIHSRRIIHRDLKPENVLIDEEFH-LKIADFGIACEEEYCDMLADDPGTYRWMAPEM 380
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 359 (131.4 bits), Expect = 1.3e-38, Sum P(2) = 1.3e-38
Identities = 75/184 (40%), Positives = 111/184 (60%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI---AKKESRFAREVA 76
LID L G R G ++++Y G+Y+ + VA+KI+ E ++I A+ E F E
Sbjct: 155 LIDVSKLSYGDRFAHGKYSQIYHGEYEGKAVALKIITAPEDSDDIFLGARLEKEFIVEAT 214
Query: 77 MLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+LSR+ H N+VKF+G I+TE + G+LR YL + + L + I F LDIA+
Sbjct: 215 LLSRLSHPNVVKFVGV--NTGNCIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAK 272
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
ME +HS I+H+DLKPEN+L+ D +K+ADFG+A EE +++ GTYRWMAPE+
Sbjct: 273 GMEYIHSREIVHQDLKPENVLIDNDFH-LKIADFGIACEEEYCDVLGDNIGTYRWMAPEV 331
Query: 197 YSTV 200
+
Sbjct: 332 LKRI 335
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00015979001 | SubName- Full=Putative uncharacterized protein (Chromosome chr17 scaffold_12, whole genome shotgun sequence); (352 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 317 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-60 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-60 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-33 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-32 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-29 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-21 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-10 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-05 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 1e-60
Identities = 85/258 (32%), Positives = 129/258 (50%), Gaps = 44/258 (17%)
Query: 32 IGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+G K VA+K + + + ++I + F RE ++ ++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE----FLREARIMRKLDHPN 62
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+VK +G C +EP+M IV E + GG L YL RP+ L + + FAL IAR ME L S
Sbjct: 63 IVKLLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPE-----L 196
IHRDL N L+ E+ +K++DFGL+R+ + + G RWMAPE
Sbjct: 122 KNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 197 YST--------VTL----RQGEKKHYNHKNV-----------RPSAENVPEELSIILTSC 233
+++ V L GE+ + N P N P EL ++ C
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQC 240
Query: 234 WKEDPNARPNFTQIIQML 251
W EDP RP F++++++L
Sbjct: 241 WAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 5e-60
Identities = 83/259 (32%), Positives = 128/259 (49%), Gaps = 47/259 (18%)
Query: 32 IGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+GK K VA+K + + + ++I + F RE ++ ++ H N
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE----FLREARIMRKLDHPN 62
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLH 142
+VK +G C +E + IV E + GG L YL RP+ + ++ + FAL IAR ME L
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIARGMEYLE 119
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG--TYRWMAPE----- 195
S IHRDL N L+ E+ +K++DFGL+R+ + G RWMAPE
Sbjct: 120 SKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 196 LYST--------VTL----RQGEKKHYNHKNVR-----------PSAENVPEELSIILTS 232
+++ V L GE+ + N P N P EL ++
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQ 238
Query: 233 CWKEDPNARPNFTQIIQML 251
CW EDP RP F++++++L
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 3e-55
Identities = 80/259 (30%), Positives = 125/259 (48%), Gaps = 46/259 (17%)
Query: 32 IGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEGA +VY+G K VA+K + +G + EE + F E +++ ++ H N
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKKLSHPN 62
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+V+ +G C EP+ IVTE + GG L +L L + + AL IA+ ME L S
Sbjct: 63 IVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPEL---- 196
+HRDL N L+TE+L +K++DFGL+R+ + G +WMAPE
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 197 -YST--------VTL----RQGEKKHYNHKNVR-----------PSAENVPEELSIILTS 232
+++ V L GE+ + N P EN P+EL ++
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQ 239
Query: 233 CWKEDPNARPNFTQIIQML 251
CW DP RP F+++++ L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 6e-54
Identities = 76/252 (30%), Positives = 112/252 (44%), Gaps = 40/252 (15%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ KVY + K + VAIK++ K ++I K R RE+ +L +++H N+V+
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
++ + +V E GG L L L A + I A+E LHS GI+H
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL-----YST---- 199
RDLKPEN+LL ED +KLADFGLAR+ E +T GT +MAPE+ Y
Sbjct: 121 RDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 200 ----VTL-----------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDP 238
V L +K P ++ E ++ +DP
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDP 239
Query: 239 NARPNFTQIIQM 250
R + +Q
Sbjct: 240 EKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-53
Identities = 82/265 (30%), Positives = 127/265 (47%), Gaps = 51/265 (19%)
Query: 32 IGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+GEGA +VY+GK K VA+K + + + EE F +E ++ ++ H N+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----FLKEARVMKKLGHPNV 58
Query: 87 VKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARA 137
V+ +G C +EP+ +V E + GG L YL RP L + + FA+ IA+
Sbjct: 59 VRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAP 194
ME L S +HRDL N L+ ED +K++DFGL+R+ + +TG RWMAP
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 195 E-----LYST--------VTL--------------RQGEKKHYNHKNVRPSA-ENVPEEL 226
E ++++ V L E Y K R E P+EL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236
Query: 227 SIILTSCWKEDPNARPNFTQIIQML 251
++ SCW+ DP RP F+++++ L
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-53
Identities = 74/235 (31%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG VY + K + VAIKI+ K E+ + RE+ +L ++ H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
G + E + +V E GG+L+ L L + L I +E LHS+GIIH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RDLKPEN+LL D +KLADFGL++ S ++ GT +MAPE+ K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GK 168
Query: 208 KHYNHK-----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+Y+ K + EL ++ ++DP RP+ +I++ L
Sbjct: 169 GYYSEKSDIWSLGVILYEL--------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-48
Identities = 84/260 (32%), Positives = 125/260 (48%), Gaps = 44/260 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ ++G G+ VY+ K+K + VA+KI+ K E +KK+ RE+ +L R+ H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPN 59
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V+ I A ++ + +V E GG L YL R L A AL I R +E LHS+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPE-------- 195
GIIHRDLKPEN+LL E+ +K+ADFGLA++ + +T GT +MAPE
Sbjct: 118 GIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 196 ------------LYSTVTLR---QGEK-----------KHYNHKNVRPSAENVPEELSII 229
LY +T + GE + P + EE +
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 230 LTSCWKEDPNARPNFTQIIQ 249
+ C +DP+ RP +I+Q
Sbjct: 237 IKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 58/178 (32%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
G +G G+ VY K+ + +A+K V E + ++ RE+ +LS +QH N+
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 87 VKFIGAC--KEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
V++ G+ +E + I E +SGG+L LL + L V + I + LHS
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGK-LPEPVIRKYTRQILEGLAYLHS 119
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPELYS 198
+GI+HRD+K N+L+ D +KLADFG A+ E GT WMAPE+
Sbjct: 120 NGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 84/268 (31%), Positives = 127/268 (47%), Gaps = 50/268 (18%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W I+ K L +G IG+G V G Y+ Q VA+K + ++ + F E +++
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL------KDDSTAAQAFLAEASVM 54
Query: 79 SRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA---IGFALD 133
+ ++H NLV+ +G P+ IVTE ++ G+L YL R R V +GFALD
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALD 110
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RW 191
+ ME L +HRDL N+L++EDL K++DFGLA+E S + ++G +W
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ----DSGKLPVKW 165
Query: 192 MAPE-----LYST--------VTL------------RQGEKKHYNH--KNVR-PSAENVP 223
APE +ST + L R K H K R + E P
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCP 225
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQML 251
E+ ++ CW+ DP RP F Q+ + L
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 62/170 (36%), Positives = 99/170 (58%), Gaps = 14/170 (8%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G +VY+ ++K + VAIK++ E +K+ + E+ +L + +H N+VK
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVI-----KLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 89 FIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHG 145
+ G+ K+ + IV E SGG+L+ LL + L I + ++ + +E LHS+G
Sbjct: 62 YYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTES-QIAYVCKELLKGLEYLHSNG 118
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
IIHRD+K N+LLT D + +KL DFGL+ + S T+ GT WMAPE
Sbjct: 119 IIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 81/256 (31%), Positives = 120/256 (46%), Gaps = 43/256 (16%)
Query: 31 RIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+IG+G VY+G K T VA+K P+ K F +E +L + H N+VK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK----FLQEAEILKQYDHPNIVKL 57
Query: 90 IGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
IG C K+P+ IV EL+ GG+L +L + R L V + +LD A ME L S I
Sbjct: 58 IGVCVQKQPIY-IVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCI 115
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT----YRWMAPE-------- 195
HRDL N L+ E+ +K++DFG++REE + T G +W APE
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 196 -----------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPEELSIILTSCWK 235
L+ T +L +++ R P+ + PEE+ ++ CW
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233
Query: 236 EDPNARPNFTQIIQML 251
DP RP+F++I L
Sbjct: 234 YDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-32
Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 44/264 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
WL++ + L +G IGEG V +G+Y Q VA+K + T + F E A++
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA-------FLEETAVM 53
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+++ H+NLV+ +G + IV EL+S G L +L + V + F+LD+A M
Sbjct: 54 TKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPEL 196
E L S ++HRDL N+L++ED K++DFGLAR S M + +W APE
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGS----MGVDNSKLPVKWTAPEA 168
Query: 197 -----------------------------YSTVTLRQGEKKHYNHKNVRPSAENVPEELS 227
Y ++L++ ++ + P E P ++
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP-PEGCPADVY 227
Query: 228 IILTSCWKEDPNARPNFTQIIQML 251
+++TSCW+ +P RP+F ++ + L
Sbjct: 228 VLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 83/302 (27%), Positives = 131/302 (43%), Gaps = 77/302 (25%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIA 65
L LD +W + L +G +GEGA +V + + + TVA+K++ T +++
Sbjct: 1 LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL- 59
Query: 66 KKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR-- 120
S E+ M+ + +H+N++ +G C + P+ V+V E + G LR +L RP
Sbjct: 60 ---SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGE 115
Query: 121 --CLDVCVAIG----------FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
D FA +AR ME L S IHRDL N+L+TED +K+A
Sbjct: 116 YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIA 174
Query: 169 DFGLAREESLTEMMTAETG---TYRWMAPE-------------------LYSTVT----- 201
DFGLAR+ + T +WMAPE L+ T
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
Query: 202 ------------LRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
L++G ++ +P N +EL ++ CW E P+ RP F Q+++
Sbjct: 235 YPGIPVEELFKLLKEG------YRMEKPQ--NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
Query: 250 ML 251
L
Sbjct: 287 DL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 82/270 (30%), Positives = 124/270 (45%), Gaps = 52/270 (19%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDP L +G G V+ GK++ + VAIK++ +G E+ F E ++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED------DFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALD 133
++ H NLV+ G C K+ + IVTE ++ G L YL + + LD+C D
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC------SD 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L S+G IHRDL N L+ ED +K++DFGLAR L + T+ GT +
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLAR-YVLDDQYTSSQGTKFPVK 166
Query: 191 WMAPEL-----YSTVT-----------LRQGEKKHYNHKNVRPSAENV------------ 222
W PE+ +S+ + + K Y + E+V
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA 226
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252
P E+ I+ SCW E P RP F +++ L
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 75/266 (28%), Positives = 115/266 (43%), Gaps = 52/266 (19%)
Query: 31 RIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G G V +G Y K VA+K + E IA + F RE ++++++ H
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK----QEHIAAGKKEFLREASVMAQLDHPC 57
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--IGFALDIARAMECLHS 143
+V+ IG CK +++V EL G L KYL R ++ V+ A +A M L S
Sbjct: 58 IVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES 113
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL---TEMMTAETG---TYRWMAPE-- 195
+HRDL N+LL K++DFG++R +L ++ A T +W APE
Sbjct: 114 KHFVHRDLAARNVLLVNR-HQAKISDFGMSR--ALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 196 ---LYST--------VTLRQ----GEKKHYNHKNVR-----------PSAENVPEELSII 229
+S+ VTL + G K + K P E P+E+ I
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI 230
Query: 230 LTSCWKEDPNARPNFTQIIQMLLNYL 255
+ SCWK P RP F+++
Sbjct: 231 MLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-30
Identities = 61/181 (33%), Positives = 96/181 (53%), Gaps = 13/181 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNL 86
+ ++GEG+ +VY + + VA+K++ K + K+ RF RE+ +L+ + H N+
Sbjct: 4 ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNI 60
Query: 87 VKFIGACKEP-VMVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHSH 144
VK ++ + +V E + GG+L L R L A+ I A+E LHS
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPELY 197
GIIHRD+KPEN+LL D + +KL DFGLA+ S+ + + GT +MAPE+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 198 S 198
Sbjct: 181 L 181
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 79/255 (30%), Positives = 117/255 (45%), Gaps = 40/255 (15%)
Query: 23 PKHLF-VGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
P+ F + ++G G +V+EG +KN+ VAIKI+ + K+ F +EV L R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-----DDLLKQQDFQKEVQALKR 58
Query: 81 VQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++H++L+ C EPV I+TEL+ G+L +L + + L V I A +A M
Sbjct: 59 LRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-YRWMAPE-- 195
L IHRDL N+L+ EDL K+ADFGLAR ++++ Y+W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 196 -----------------LYSTVTLRQGEKKHYNHKNV---------RPSAENVPEELSII 229
LY T Q N+ V P P+E+ I
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236
Query: 230 LTSCWKEDPNARPNF 244
+ CW +P RP+F
Sbjct: 237 MLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 63/282 (22%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEG-----KYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
IDP ++ + IG G +V G K VAIK + G + K+ F E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEA 56
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++ + H N+++ G PVM I+TE + G+L K+L + V +G
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFLRENDGK-FTVGQLVGMLRG 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---- 189
IA M+ L +HRDL N+L+ +L K++DFGL+R +E TY
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSE------ATYTTKG 167
Query: 190 -----RWMAPELYSTVTLRQ--------------------GEKKHYNHKNVR-------- 216
RW APE + R+ GE+ +++ N
Sbjct: 168 GKIPIRWTAPE---AIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG 224
Query: 217 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
P + P L ++ CW++D N RP F+QI+ L +
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 72/285 (25%), Positives = 124/285 (43%), Gaps = 58/285 (20%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG K VAIK V++ + E + F
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE----F 56
Query: 72 AREVAMLSRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--- 126
E +++ ++V+ +G +P +V++ EL++ G L+ YL + RP +
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGP 115
Query: 127 -----AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
I A +IA M L + +HRDL N ++ EDL T+K+ DFG+ R+ T+
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDY 174
Query: 182 MTAETGTY---RWMAPE-------------------LYSTVTLRQGEKKHYNHKNV---- 215
RWMAPE L+ TL + + +++ V
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234
Query: 216 -------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
P EN P++L ++ CW+ +P RP F +I+ L +
Sbjct: 235 IDGGHLDLP--ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 56/276 (20%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W ++ + + ++G G + +VYEG +K + TVA+K T +E + F +E A
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAA 54
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++H NLV+ +G C +EP I+TE ++ G L YL + ++ V + A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT------- 188
AME L IHRDL N L+ E+ +K+ADFGL+R +MT +T T
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSR------LMTGDTYTAHAGAKF 167
Query: 189 -YRWMAPE-----------------------------LYSTVTLRQ-GEKKHYNHKNVRP 217
+W APE Y + L Q E ++ RP
Sbjct: 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERP 227
Query: 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
E P ++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 79/260 (30%), Positives = 117/260 (45%), Gaps = 43/260 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W ID + + ++G G +V+EG + N T VA+K + G P++ F E
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD-------FLAEAQ 53
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ +++H L++ C +EP+ IVTEL+ G+L +YL R L + I A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
A M L + IHRDL N+L+ E+ K+ADFGLAR +E + E +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 193 APE-------------------LYSTVT--------LRQGEKKHYNHKNVR-PSAENVPE 224
APE L VT + E + R P P+
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231
Query: 225 ELSIILTSCWKEDPNARPNF 244
EL I+ CWKEDP+ RP F
Sbjct: 232 ELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-29
Identities = 74/258 (28%), Positives = 111/258 (43%), Gaps = 47/258 (18%)
Query: 32 IGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IGEG VY+G Y + VA+K +P + +E +F +E ++ + H ++
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP---SVRE-KFLQEAYIMRQFDHPHI 69
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
VK IG E + IV EL G LR YL + LD+ I ++ ++ A+ L S
Sbjct: 70 VKLIGVITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESKRF 128
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPELYSTVTLRQ 204
+HRD+ N+L++ +KL DFGL+R A G +WMAPE ++ R+
Sbjct: 129 VHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE---SINFRR 184
Query: 205 --------------------GEKKHYNHKNVR-----------PSAENVPEELSIILTSC 233
G K KN P N P L ++T C
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 244
Query: 234 WKEDPNARPNFTQIIQML 251
W DP+ RP FT++ L
Sbjct: 245 WAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 66/259 (25%), Positives = 113/259 (43%), Gaps = 51/259 (19%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVH-KGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ KVY K + +K + + +E ++++ EV +L ++ H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE--REDAL--NEVKILKKLNHPNIIK 63
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRC--------LDVCVAIGFALDIARAME 139
+ + +E + IV E GG L + + + LD V + AL
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK------ 117
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE--- 195
LHS I+HRD+KP+N+ LT + +KL DFG+++ S ++ GT +++PE
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQ 176
Query: 196 ----------------LYSTVTLR---QGEKKH---YN--HKNVRPSAENVPEELSIILT 231
LY TL+ +GE P EL +++
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236
Query: 232 SCWKEDPNARPNFTQIIQM 250
S ++DP RP+ QI+Q
Sbjct: 237 SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-28
Identities = 81/259 (31%), Positives = 119/259 (45%), Gaps = 46/259 (17%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG G +V+ G+ + N VA+K + P+ AK F +E +L + H N+V+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK----FLQEARILKQYSHPNIVR 57
Query: 89 FIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
IG C K+P+ IV EL+ GG +L PR L V I + A ME L S
Sbjct: 58 LIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHC 115
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR-----WMAPEL----- 196
IHRDL N L+TE +K++DFG++REE + + A TG + W APE
Sbjct: 116 IHRDLAARNCLVTEK-NVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 197 YST----------------------VTLRQGEKKHYNHKNVR-PSAENVPEELSIILTSC 233
YS+ L + + + VR P E P+ + ++ C
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC 232
Query: 234 WKEDPNARPNFTQIIQMLL 252
W+ DP RP+F+ + Q L
Sbjct: 233 WEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-28
Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 59/274 (21%)
Query: 32 IGEGAHAKVYEGKYKN--------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+G GA +VYEG + VA+K + KG T +E + F +E ++S H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE----FLKEAHLMSNFNH 58
Query: 84 RNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIAR 136
N+VK +G C EP +I+ EL+ GG L YL + R P L + + LD+A+
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFGLAREESLTEMMTAETG---TY 189
L IHRDL N L++E + +K+ DFGLAR+ ++ E
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 190 RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSA 219
RWMAPE ++ +TL G++ + N
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTL--GQQPYPALNNQEVLQHVTAGGRLQKP 235
Query: 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
EN P+++ ++T+CW +DP+ RP F +I ++L N
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 82/266 (30%), Positives = 119/266 (44%), Gaps = 55/266 (20%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W I + L + ++G G +V+ G + T VA+K + G +PE F +E
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-------FLQEAQ 53
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ +++H LV+ C +EP+ IVTE +S G+L +L + + L + + A I
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRW 191
A M L S IHRDL N+L+ E+L K+ADFGLAR E TA G +W
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDE-YTAREGAKFPIKW 170
Query: 192 MAPE-------------------LYSTVT--------------LRQGEKKHYNHKNVRPS 218
APE L VT L Q E+ ++ RP
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---GYRMPRPP 227
Query: 219 AENVPEELSIILTSCWKEDPNARPNF 244
N PEEL ++ CW +DP RP F
Sbjct: 228 --NCPEELYDLMLQCWDKDPEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 79/266 (29%), Positives = 114/266 (42%), Gaps = 52/266 (19%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDPK L +G G V GK++ Q VAIK++ +G E+ F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAIGFALD 133
++ H LV+ G C K+ + IVTE +S G L YL R L++C D
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------D 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ M L S IHRDL N L+ + +K++DFGL+R L + T+ G+ R
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSR-YVLDDEYTSSVGSKFPVR 166
Query: 191 WMAPE--LYSTVTLRQG--------------EKKHYNHKNVRPSAENV------------ 222
W PE LYS + + K Y N + E V
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226
Query: 223 PEELSIILTSCWKEDPNARPNFTQII 248
E++ I+ SCW E RP F Q++
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 80/275 (29%), Positives = 114/275 (41%), Gaps = 64/275 (23%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ G+ + + VA+K + K + A+K+ F RE +L+ QH
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASND-ARKD--FEREAELLTNFQHE 68
Query: 85 NLVKFIGACKE---PVMVIVTELLSGGTLRKYL----------LNMRPRC--LDVCVAIG 129
N+VKF G C E P+MV E + G L K+L + L + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVF--EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A+ IA M L S +HRDL N L+ DL +K+ DFG++R+ T+ T
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 190 ---RWMAPE--LYSTVTLRQ---------------GEKKHYNHKN-------------VR 216
RWM PE +Y T G++ Y N R
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
Query: 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
P P E+ I+ CWK DP R N I + L
Sbjct: 246 P--RTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 63/171 (36%), Positives = 91/171 (53%), Gaps = 13/171 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G+ KV + K + A+K++ K + I +KE E +LSR+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK---IIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + +V E GG L +L + A +A +I A+E LHS GII
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+RDLKPEN+LL D IKL DFGLA+E S +E T GT ++APE+
Sbjct: 116 YRDLKPENILLDAD-GHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 78/269 (28%), Positives = 115/269 (42%), Gaps = 58/269 (21%)
Query: 32 IGEGAHAKVYEG-------KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KVY+G + +VAIK + + P K + F +E ++S +QH
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----KVQQEFRQEAELMSDLQHP 68
Query: 85 NLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIG 129
N+V +G C KE ++ E L+ G L ++L+ P LD +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
A+ IA ME L SH +HRDL N L+ E L T+K++DFGL+R+ + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 187 GTYRWMAPE--LYSTVTLRQ---------------GEKKHYNHKN-----------VRPS 218
RWM PE LY T G + +Y N + P
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPC 247
Query: 219 AENVPEELSIILTSCWKEDPNARPNFTQI 247
E+ P + ++ CW E P RP F I
Sbjct: 248 PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 28/214 (13%)
Query: 10 ADELKLDAKWLI---DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE 63
+ELK K ++ DP+ L+ +IGEGA +VY+ + + VAIK + +
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK---- 56
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCL 122
+ + E+ ++ +H N+V + + + +V E + GG+L ++ +
Sbjct: 57 --QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRM 113
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180
+ ++ + +E LHS +IHRD+K +N+LL++D ++KLADFG A + LT+
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQ--LTKEK 170
Query: 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
+ GT WMAPE+ +K Y K
Sbjct: 171 SKRNSVVGTPYWMAPEVIK--------RKDYGPK 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 11/174 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ RIGEGAH V++ K + +TVA+K V I + RE+ L QH
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ---ALREIKALQACQHPY 60
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VK + V+V E + L + L + R L + + + + +H++
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPEL 196
GI+HRDLKP NLL++ D +K+ADFGLAR E + + + T + APEL
Sbjct: 119 GIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 28 VGPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G IG GA VY+G VAIK + + EE K +E+ +L ++H N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK---SIMQEIDLLKNLKHPN 60
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VK+IG+ + + I+ E G+LR+ ++ + VA+ + + + + LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAV-YVYQVLQGLAYLHEQ 118
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPE-------- 195
G+IHRD+K N+L T+D +KLADFG+A + +++ + GT WMAPE
Sbjct: 119 GVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 196 -------LYSTVT-LRQGEKKHYN-------HKNVR----PSAENVPEELSIILTSCWKE 236
L TV L G +Y+ + V+ P E + EL L C+++
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237
Query: 237 DPNARPN 243
DPN RP
Sbjct: 238 DPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 44/265 (16%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W ++ K L + IG+G V G Y+ VA+K + T + F E +++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEASVM 53
Query: 79 SRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++++H NLV+ +G E + IVTE ++ G+L YL + L + F+LD+
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
AME L ++ +HRDL N+L++ED K++DFGL +E S T+ +TG +W AP
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAP 168
Query: 195 E-------------------LYSTVTLRQGEKKHYNHKNVRPSAEN---------VPEEL 226
E L+ + + K+V P E P +
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 227 SIILTSCWKEDPNARPNFTQIIQML 251
++ CW D RP+F Q+ + L
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 67/277 (24%), Positives = 107/277 (38%), Gaps = 77/277 (27%)
Query: 31 RIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++G+G+ V G++ VA+K + ++++ F +E A++ + H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCL----KSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLH 142
L++ G +++VTEL G+L L +R L + +A+ IA M L
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR----------WM 192
S IHRDL N+LL D +K+ DFGL R E Y W
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWC 167
Query: 193 APELYST-------------VTL------------------------RQGEKKHYNHKNV 215
APE T VTL ++GE+
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE------ 221
Query: 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252
RP E P+++ ++ CW +P RP F + + L
Sbjct: 222 RP--EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 46/281 (16%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE----GKYKNQTVAIKIVHKGETPEEIAKK 67
+L D KW +L G +G GA KV E G K+ +K+ K P + +
Sbjct: 23 QLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSD-AVMKVAVKMLKPTAHSSE 81
Query: 68 ESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
E+ ++S + H N+V +GAC P++VI TE G L +L R L +
Sbjct: 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTL 140
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
+ F+ +A+ M L S IHRDL N+LLT K +K+ DFGLAR+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVV 199
Query: 185 ETGTY---RWMAPE-----LYST------------------VTLRQG---EKKHYN---- 211
+ +WMAPE +Y+ G + K Y
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 212 -HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
++ +P E+ P E+ I+ +CW DP RP F QI+Q++
Sbjct: 260 GYRMAQP--EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-25
Identities = 85/304 (27%), Positives = 133/304 (43%), Gaps = 67/304 (22%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPE 62
EL D +W + L +G +GEG +V E + VA+K++ T +
Sbjct: 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK 65
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP 119
++ S E+ M+ + +H+N++ +GAC + P+ VIV E S G LR+YL RP
Sbjct: 66 DL----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRP 120
Query: 120 RCLDVCV--------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ C + A +AR ME L S IHRDL N+L+TED +
Sbjct: 121 PGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVM 179
Query: 166 KLADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY----------- 210
K+ADFGLAR+ + T +WMAPE L+ + Q + +
Sbjct: 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239
Query: 211 ------------------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252
H+ +PS N EL +++ CW P+ RP F Q+++ L
Sbjct: 240 GSPYPGVPVEELFKLLKEGHRMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 253 NYLS 256
L+
Sbjct: 298 RILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 62/181 (34%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++GEG + VY+ K + VA+K + + + EE + RE+++L ++H N+VK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTA--LREISLLKELKHPNIVK 62
Query: 89 FIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L+KYL + RP L + + R + HSH I+
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL 120
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGT--YRWMAPEL------YS 198
HRDLKP+N+L+ D +KLADFGLAR + T E T YR APE+ YS
Sbjct: 121 HRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEILLGSKHYS 177
Query: 199 T 199
T
Sbjct: 178 T 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 92/336 (27%), Positives = 145/336 (43%), Gaps = 74/336 (22%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPEE 63
L D KW + L +G +GEG +V + K TVA+K++ T ++
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR 120
+ S E+ M+ + +H+N++ +GAC + P+ V+V E S G LR+YL RP
Sbjct: 61 L----SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPP 115
Query: 121 CLDVCV--------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
+D + A +AR ME L S IHRDL N+L+TED +K
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMK 174
Query: 167 LADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY------------ 210
+ADFGLAR+ + T +WMAPE L+ V Q + +
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234
Query: 211 -----------------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
H+ +P+ N EL +I+ CW P+ RP F Q+++ L
Sbjct: 235 SPYPGIPVEELFKLLKEGHRMDKPA--NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292
Query: 254 YLSAIAPPEPM---IPHRIFNSENTILPPESPGTSS 286
L+ + E + +P ++ P+SP + S
Sbjct: 293 VLTVTSTDEYLDLSVPFEQYSPGC----PDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 61/171 (35%), Positives = 87/171 (50%), Gaps = 12/171 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VAIK + E I K RE+ +L + H N++K
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKELNHPNIIK 62
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + +V E + L K L+ R R L + + + + + HSHGI+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYK-LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-APEL 196
HRDLKPENLL+ + +KLADFGLAR S T T RW APEL
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPEL 169
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 73/278 (26%)
Query: 32 IGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV +Y VA+K + E+ S F RE+ +L + H N
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQ---HRSDFEREIEILRTLDHEN 67
Query: 86 LVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+VK+ G C++P + ++ E L G+LR YL R + +++ + F+ I + M+ L
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLG 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY----------RWM 192
S IHRDL N+L+ + +K++DFGLA+ ++ + Y W
Sbjct: 127 SQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIFWY 179
Query: 193 APELYST-------------VTL-----------------------RQGEKKHYN----- 211
APE T VTL QG+
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 212 HKNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQII 248
+ R P + P+E+ ++ CW+ +P RP+F +I
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 64/189 (33%), Positives = 98/189 (51%), Gaps = 24/189 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ +VY+ K NQ VAIK++ E +EI +E+ LS+ + + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED----IQQEIQFLSQCRSPYITK 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGI 146
+ G+ K + I+ E GG+ L +P LD I F L ++ +E LH G
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDE-TYIAFILREVLLGLEYLHEEGK 119
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ 204
IHRD+K N+LL+E+ +KLADFG++ + + T M T GT WMAPE+ ++Q
Sbjct: 120 IHRDIKAANILLSEE-GDVKLADFGVSGQLTST-MSKRNTFVGTPFWMAPEV-----IKQ 172
Query: 205 GEKKHYNHK 213
Y+ K
Sbjct: 173 SG---YDEK 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-24
Identities = 78/267 (29%), Positives = 120/267 (44%), Gaps = 41/267 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W + + L + ++G G +V+ G Y T VAIK + +G E F E +
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA------FLAEANL 54
Query: 78 LSRVQHRNLVK-FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ ++QH LV+ + +EP+ I+TE + G+L +L L + I A IA
Sbjct: 55 MKQLQHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
M + IHRDL+ N+L++E L K+ADFGLAR E E + +W AP
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 195 EL--YSTVTLRQG---------EKKHY---------NHKNVR--------PSAENVPEEL 226
E Y T T++ E Y N + ++ P +N PEEL
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232
Query: 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253
++ CWKE P RP F + ++ +L
Sbjct: 233 YELMRLCWKEKPEERPTF-EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-24
Identities = 85/306 (27%), Positives = 132/306 (43%), Gaps = 67/306 (21%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY---------KNQTVAIKIVHKGETPEE 63
L LD KW L +G +GEG +V + + TVA+K++ T ++
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPR 120
+A S E+ ++ + +H+N++ +G C + P+ VIV E + G LR++L RP
Sbjct: 61 LADLIS----EMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPP 115
Query: 121 CLDVCVAI--------------GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
D I A +AR ME L S IHRDL N+L+TED +K
Sbjct: 116 GPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED-NVMK 174
Query: 167 LADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYN----------- 211
+ADFGLAR + + +WMAPE L+ V Q + +
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
Query: 212 ------------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
H+ +PS N EL +++ CW P RP F Q+++ L
Sbjct: 235 SPYPGIPVEELFKLLREGHRMDKPS--NCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292
Query: 254 YLSAIA 259
L+A++
Sbjct: 293 VLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 62/189 (32%), Positives = 93/189 (49%), Gaps = 27/189 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
I +GA+ +V+ K K AIK++ K + + + R++ LS+ Q +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
F G + +V E L GG L L N+ LD VA + +I A+E LHS+G
Sbjct: 59 YYSFQGKKN---LYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG 113
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE---------TGTYRWMAPEL 196
IIHRDLKP+N+L+ + +KL DFGL++ + + GT ++APE
Sbjct: 114 IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE- 171
Query: 197 YSTVTLRQG 205
V L QG
Sbjct: 172 ---VILGQG 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG+GA KV + + + A+K ++K + + K R E +L + H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC---VEKGSVRNVLNERRILQELNHPFLVN 64
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E M +V +LL GG LR +L + +I A+E LHS GII
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK--FSEEQVKFWICEIVLALEYLHSKGII 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
HRD+KP+N+LL E + + DF +A + + + T+ +GT +MAPE+
Sbjct: 123 HRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 63/188 (33%), Positives = 95/188 (50%), Gaps = 25/188 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG++ VY+ +K Q VAIK+V E +EI K E+++L + +VK+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-------EISILKQCDSPYIVKY 63
Query: 90 IGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGII 147
G+ K + IV E G++ ++ + + L I L + +E LHS+ I
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTE-EEIAAILYQTLKGLEYLHSNKKI 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+K N+LL E+ KLADFG++ + + T M T GT WMAPE V G
Sbjct: 122 HRDIKAGNILLNEE-GQAKLADFGVSGQLTDT-MAKRNTVIGTPFWMAPE----VIQEIG 175
Query: 206 EKKHYNHK 213
YN+K
Sbjct: 176 ----YNNK 179
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-23
Identities = 71/251 (28%), Positives = 120/251 (47%), Gaps = 44/251 (17%)
Query: 32 IGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
+G+G +V++G K++T VA+K K + P+E+ + +F E +L + H N+VK I
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTC-KEDLPQEL---KIKFLSEARILKQYDHPNIVKLI 58
Query: 91 GAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
G C ++P+ IV EL+ GG +L + L + FALD A M L S IH
Sbjct: 59 GVCTQRQPIY-IVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG----TYRWMAPE--------- 195
RDL N L+ E+ +K++DFG++R+E + + + +G +W APE
Sbjct: 117 RDLAARNCLVGEN-NVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 196 ----------LYSTVTL--------RQGEKKHYNHKNVRPSA-ENVPEELSIILTSCWKE 236
L+ T +L + + K R S + P+++ ++ CW
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233
Query: 237 DPNARPNFTQI 247
P RP F+++
Sbjct: 234 KPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-23
Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 45/274 (16%)
Query: 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQH 83
L +G +GEG V EG+ + +K+ K + E F E A + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 84 RNLVKFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFAL 132
N++K IG C E P +++ + G L +LL R P L + + F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAETGTY 189
DIA ME L + IHRDL N +L ED+ T+ +ADFGL+++
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 190 RWMAPE-----LYST--------VTLRQ----------GEKKH--YN---HKNVRPSAEN 221
+W+A E +Y++ VT+ + G + H Y+ H N E+
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
+EL ++ SCW+ DP RP FT++ ++L N L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 7e-23
Identities = 75/268 (27%), Positives = 118/268 (44%), Gaps = 39/268 (14%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + + + ++G G +V+ G Y N T VA+K + G + F E +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA------FLEEANL 54
Query: 78 LSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ +QH LV+ KE + I+TE ++ G+L +L + + + I F+ IA
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAP 194
M + IHRDL+ N+L++E L K+ADFGLAR E E + +W AP
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 195 E-------------------LYSTVTLRQGEKKHYNHKNV---------RPSAENVPEEL 226
E LY VT + ++ +V P EN P+EL
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDEL 233
Query: 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254
I+ +CWKE RP F + +L ++
Sbjct: 234 YDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 8e-23
Identities = 66/207 (31%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84
G IGEG+ + V K K N+ AIKI+ K + +E KK E +L+R+ H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE--KKVKYVKIEKEVLTRLNGHP 62
Query: 85 NLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
++K ++ V+ E G L +Y+ LD +A +I A+E
Sbjct: 63 GIIKLYYTFQDEENLYFVL----EYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALE 116
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
LHS GIIHRDLKPEN+LL +D IK+ DFG A+ + G T
Sbjct: 117 YLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDA---------T 166
Query: 200 VTLRQGEKKHYNHKNVRPSAENVPEEL 226
Q EK + +AE V EL
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPEL 193
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 70/281 (24%), Positives = 118/281 (41%), Gaps = 58/281 (20%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ + + +G GA +VYEG Y+ + + + E+ E + ES F E
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEA 60
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPR-----CLDVCVAI 128
++S+ H+N+V+ IG + P I+ EL++GG L+ +L RPR L + +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL 119
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLTE------ 180
A D+A+ + L + IHRD+ N LLT + K+ADFG+AR+
Sbjct: 120 FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 181 --MMTAETGTYRWMAPE-----LYSTVT------------LRQGEKKHYNHKNVR----- 216
M+ +WM PE ++++ T G + N
Sbjct: 180 RAMLPI-----KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
Query: 217 ------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ P + I+T CW+ P RPNF I++ +
Sbjct: 235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 15/173 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEGA+ V + + K + VAIK + E E++ K REV +L +++H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHENIVN 64
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + + +V E + L LL P L + + +A+ HSH II
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM-APEL 196
HRD+KPEN+L++E +KL DFG AR +L + Y RW APEL
Sbjct: 123 HRDIKPENILVSESG-VLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 73/269 (27%), Positives = 116/269 (43%), Gaps = 52/269 (19%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
I P L + IG G V+ G + + VAIK + +G EE F E ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE------DFIEEAQVMM 54
Query: 80 RVQHRNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ H LV+ G C E + +V E + G L YL R + +G LD+ M
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE 195
L S +IHRDL N L+ E+ + +K++DFG+ R L + T+ TGT +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE 171
Query: 196 L-----YSTVT------------LRQGEKKHYNHKNVRPSAENVPEELSI---------- 228
+ YS+ + +G+ + N N V E ++
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAGFRLYKPRLA 226
Query: 229 ------ILTSCWKEDPNARPNFTQIIQML 251
++ CWKE P RP+F+ ++ L
Sbjct: 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 60/177 (33%), Positives = 89/177 (50%), Gaps = 20/177 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IGEG + KVY+ ++K Q VAIKI+ E EE K+E R+ + H N+ F
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATF 68
Query: 90 IGA-------CKEPVMVIVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIARAME 139
GA + + +V EL GG+ L K L R + +A + R +
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-ILRETLRGLA 127
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPE 195
LH + +IHRD+K +N+LLT++ + +KL DFG++ + T GT WMAPE
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 76/269 (28%), Positives = 120/269 (44%), Gaps = 42/269 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGE-TPEEIAKKESRFAREVA 76
W I + L + ++G G +V+ G + T VA+K + G +PE F E
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-------FLEEAQ 53
Query: 77 MLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++ +++H LV+ E + IVTE +S G+L +L + R L + + A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMA 193
M + IHRDL+ N+L+ + L K+ADFGLAR E TA G +W A
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNE-YTARQGAKFPIKWTA 171
Query: 194 PE--LYSTVTLR---------------QGEKKH--YNHKNV---------RPSAENVPEE 225
PE LY T++ +G + N++ V P ++ P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231
Query: 226 LSIILTSCWKEDPNARPNFTQIIQMLLNY 254
L ++ CWK+DP RP F + L +Y
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 73/267 (27%), Positives = 115/267 (43%), Gaps = 38/267 (14%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G+G +V+ G + T VAIK + G E F +E +
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA------FLQEAQI 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +++H LV E + IVTE + G+L +L + L + + A IA
Sbjct: 55 MKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + IHRDL+ N+L+ ++L K+ADFGLAR E + + +W APE
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 196 --LYSTVTLR---------------QGEKKHYNHKNVR-----------PSAENVPEELS 227
LY T++ +G + N P + PE L
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233
Query: 228 IILTSCWKEDPNARPNFTQIIQMLLNY 254
++ CWK+DP+ RP F I L +Y
Sbjct: 234 ELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 59/190 (31%), Positives = 93/190 (48%), Gaps = 19/190 (10%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIK---IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
G +G G+ VYEG A+K + G+T +E K+ +E+A+LS++QH
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQ---LEQEIALLSKLQH 61
Query: 84 RNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+V+++G + E + I EL+ GG+L K L V + I +E LH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLH 119
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
+HRD+K N+L+ + +KLADFG+A++ + G+ WMAPE V
Sbjct: 120 DRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----VIA 174
Query: 203 RQGEKKHYNH 212
+QG Y
Sbjct: 175 QQGG---YGL 181
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 82/299 (27%), Positives = 131/299 (43%), Gaps = 67/299 (22%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVY---------EGKYKNQTVAIKIVHKGETPE 62
EL D +W L +G +GEG +V + + TVA+K++ T +
Sbjct: 3 ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC + P+ VIV E S G LR+YL RP
Sbjct: 63 DLSD----LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRP 117
Query: 120 RCLDVCVAIGFALD--------------IARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ I D +AR ME L S IHRDL N+L+TE+ +
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN-NVM 176
Query: 166 KLADFGLAREESLTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHY----------- 210
K+ADFGLAR+ + + T +WMAPE L+ V Q + +
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236
Query: 211 ------------------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
H+ +P+ N EL +++ CW P+ RP F Q+++ L
Sbjct: 237 GSPYPGIPVEELFKLLKEGHRMDKPA--NCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 65/188 (34%), Positives = 91/188 (48%), Gaps = 34/188 (18%)
Query: 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRF-----------AREVAM 77
G +IG G KVY A+ + +T E +A KE R A E+ +
Sbjct: 5 GNKIGGGTFGKVY--------TAVNL----DTGELMAVKEIRIQDNDPKTIKEIADEMKV 52
Query: 78 LSRVQHRNLVKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
L ++H NLVK+ G +E V I E SGGTL + L + R LD V + L +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVY-IFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLL 109
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-----REESLTEMMTAETGTYR 190
+ LHSHGI+HRD+KP N+ L IKL DFG A ++ E + + GT
Sbjct: 110 EGLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 191 WMAPELYS 198
+MAPE+ +
Sbjct: 169 YMAPEVIT 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ VY+ ++K + A+K +H E + RE+ L + +VK
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE----FRKQLLRELKTLRSCESPYVVKC 64
Query: 90 IGA-CKEPVMVIVTELLSGGTL---RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-H 144
GA KE + IV E + GG+L K + + L A I + ++ LH+
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYLHTKR 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE 195
IIHRD+KP NLL+ +K+ADFG+++ E +L + T GT +M+PE
Sbjct: 120 HIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 72/286 (25%)
Query: 26 LFVGPRIGEGAHAKVYE-------GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
L +G +GEG KV + G+ TVA+K++ + + E+ S F +L
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LL 57
Query: 79 SRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRP----------------- 119
+V H +++K GAC P+++IV E G+LR +L R
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 120 -----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
R L + I FA I+R M+ L ++HRDL N+L+ E + +K++DFGL+R
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG-RKMKISDFGLSR 175
Query: 175 ---EESLTEMMTAETGTYRWMAPE-------------------LYSTVTLRQ------GE 206
EE + +WMA E L+ VTL
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 207 KKHYN-----HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQI 247
++ +N ++ RP EN EE+ ++ +CWK++P+ RP F I
Sbjct: 236 ERLFNLLKTGYRMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 8e-22
Identities = 59/175 (33%), Positives = 94/175 (53%), Gaps = 21/175 (12%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNL 86
IG GA+ VY GK+ + VA+KI++ +TP++ S REVA+LS+++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDD---DVSDIQREVALLSQLRQSQPPNI 64
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD---VCVAIGFALDIARAMECLH 142
K+ G+ K P + I+ E GG++R M+ + + V I L A++ +H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTL---MKAGPIAEKYISVIIREVL---VALKYIH 118
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPEL 196
G+IHRD+K N+L+T +KL DFG+A + + GT WMAPE+
Sbjct: 119 KVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 66/280 (23%)
Query: 32 IGEGAHAKVYEGK------YKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
IG+GA +V++ + Y+ T VA+K++ + + A ++ F RE A+++ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS----ADMQADFQREAALMAEFDHP 68
Query: 85 NLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC------------------LDV 124
N+VK +G C +P M ++ E ++ G L ++L + PR L +
Sbjct: 69 NIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 125 CVAI--GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
A +A M L +HRDL N L+ E++ +K+ADFGL+R +
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 186
Query: 183 TAETGTY---RWMAPE--LYSTVTLRQ---------------GEKKHYN--HK------- 213
A RWM PE Y+ T G + +Y H+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246
Query: 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
NV +N P EL ++ CW + P+ RP+F I ++L
Sbjct: 247 DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 75/265 (28%), Positives = 113/265 (42%), Gaps = 63/265 (23%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+GA KVY+ ++K + A KI+ EE+ F E+ +LS +H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EEL----EDFMVEIDILSECKHPNIVGL 67
Query: 90 IGA-CKEPVMVIVTELLSGGTLRKYLLNM---------RPRCLDVCVAIGFALDIARAME 139
A E + I+ E GG L +L + R C + A+ F
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF--------- 118
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYS 198
LHSH +IHRDLK N+LLT D +KLADFG+ A+ +S + GT WMAPE+ +
Sbjct: 119 -LHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 199 TVT---------------------LRQGEKKHYNHKNVR----------PSAENV---PE 224
T L Q E H+ +R P+ +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQ 249
+ L SC +DP+ RP ++++
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 62/180 (34%), Positives = 91/180 (50%), Gaps = 24/180 (13%)
Query: 31 RIGEGAHAKVYEGKYKNQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN 85
IGEGA+ VY+ + N VA+K V + E I RE+A+L +++ H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEHPN 62
Query: 86 LVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ + C +E + +V E + L YL L + R ++
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPE 195
LHSH I+HRDLKP+N+L+T D +K+ADFGLAR E +LT ++ T YR APE
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVV--TLWYR--APE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-21
Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 38/269 (14%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G+G +V+ G + T VAIK + G E F +E +
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQV 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +++H LV+ E + IVTE +S G+L +L + L + + A IA
Sbjct: 55 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + +HRDL+ N+L+ E+L K+ADFGLAR E + + +W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 196 --LYSTVTLR---------------QGEKKHYNHKNVR-----------PSAENVPEELS 227
LY T++ +G + N P PE L
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 233
Query: 228 IILTSCWKEDPNARPNFTQIIQMLLNYLS 256
++ CW+++P RP F + L +Y +
Sbjct: 234 DLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 8e-21
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 15/170 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G V + ++ + +A+K + + RE+ +L + +V F
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ----KQILRELDILHKCNSPYIVGF 64
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHS-HGI 146
GA + I E + GG+L K L ++ R + I A + + + LH H I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHEKHKI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPE 195
IHRD+KP N+L+ IKL DFG++ + L + GT +MAPE
Sbjct: 123 IHRDVKPSNILVNS-RGQIKLCDFGVSGQ--LVNSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-21
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 57/269 (21%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+G G +V+ K K V +K + K T +E + E F RE+ M ++ H+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--TKDENLQSE--FRRELDMFRKLSHK 68
Query: 85 NLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDV---------CVAIGFALD 133
N+V+ +G C EP ++ E G L+++L + + + VA+
Sbjct: 69 NVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL--CTQ 125
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE--MMTAETGTYRW 191
IA M+ L + +HRDL N L++ + +K++ L+++ +E + RW
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 192 MAPE-----LYST--------VTL----RQGEKKHYNHKNVR------------PSAENV 222
+APE +ST V + QGE Y + P E
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251
P L ++T CW +P RP+F++++ L
Sbjct: 245 PSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 8e-21
Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 25/193 (12%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA A VY N+ VAIK + + + E R +EV +S+ H N+VK+
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV--DELR--KEVQAMSQCNHPNVVKY 64
Query: 90 IGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSHGII 147
+ + +V LSGG+L + + PR I L ++ + +E LHS+G I
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET-------GTYRWMAPELYSTV 200
HRD+K N+LL ED ++K+ADFG++ SL + GT WMAPE+
Sbjct: 125 HRDIKAGNILLGED-GSVKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVME-- 179
Query: 201 TLRQGEKKHYNHK 213
+ Y+ K
Sbjct: 180 -----QVHGYDFK 187
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-21
Identities = 67/287 (23%), Positives = 119/287 (41%), Gaps = 58/287 (20%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFARE 74
I + + + EG +++ G K + V +K V + ++ +E
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT----LLLQE 58
Query: 75 VAMLSRVQHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR------PRCLDVC 125
+L + H+N++ + C E P V+ ++ G L+ +L R P+ L
Sbjct: 59 SCLLYGLSHQNILPILHVCIEDGEPPFVLYP-YMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE------ESLT 179
+ A+ IA M LH G+IH+D+ N ++ E+L+ +K+ D L+R+ L
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALSRDLFPMDYHCLG 176
Query: 180 EMMTAETGTYRWMAPE-----LYST--------------VTLRQG--------EKKHYNH 212
+ E +WMA E YS+ +TL Q E Y
Sbjct: 177 D---NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233
Query: 213 KNVR-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258
R N P+EL ++ CW DP RP+F+Q++Q L ++ + +
Sbjct: 234 DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 55/171 (32%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIA--KKESRFAREVAMLSRVQHRNLV 87
+G G+ +V ++K + A+KI+ K +I K+ E +L ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSK----AKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 88 KFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
G+ ++ + +V E + GG L +L + VA +A + A+E LHS I
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLA-REESLTEMMTAETGTYRWMAPEL 196
++RDLKPENLLL D IK+ DFG A R + T + GT ++APE+
Sbjct: 123 VYRDLKPENLLLDSD-GYIKITDFGFAKRVKGRTYTL---CGTPEYLAPEI 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 58/269 (21%)
Query: 32 IGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GE A K+Y+G Q VAIK + P++ + F +E ++++ + H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE----FQQEASLMAELHHPN 68
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC---------------LDVCVAIG 129
+V +G +E + ++ E L+ G L ++L+ P LD +
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A+ IA ME L SH +H+DL N+L+ E L +K++D GL+RE + + +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYYRVQPKSL 187
Query: 190 ---RWMAPEL-----YST--------VTLRQ----GEKKHYNHKN------VR-----PS 218
RWM PE +S+ V L + G + +Y N VR P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 247
Query: 219 AENVPEELSIILTSCWKEDPNARPNFTQI 247
+E+ P + ++T CW+E P+ RP F I
Sbjct: 248 SEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 62/264 (23%), Positives = 115/264 (43%), Gaps = 63/264 (23%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + + VAIK++ + +P+ A KE E +++ V H +
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPK--ANKE--ILDEAYVMASVDHPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+V+ +G C + ++T+L+ G L Y+ N + + + + + IA+ M L
Sbjct: 71 VVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 146 IIHRDLKPENLLLTEDLKT---IKLADFGLARE-ESLTEMMTAETGTY--RWMAPELYST 199
++HRDL N+L +KT +K+ DFGLA+ + + AE G +WMA E
Sbjct: 130 LVHRDLAARNVL----VKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE---- 181
Query: 200 VTLRQGEKKHYN-------------------HKNVRPSAENVPE---------------- 224
++ H + ++ + A +P+
Sbjct: 182 -SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLLEKGERLPQPPICTI 238
Query: 225 ELSIILTSCWKEDPNARPNFTQII 248
++ ++L CW D +RP F ++I
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 46/266 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
I+P L +G G V+ GK++ Q VAIK +++G A E F E ++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG------AMSEEDFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ H LV+ G C ++ + IVTE + G L YL + + L + + D+ M
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE 195
E L + IHRDL N L++ +K++DFG+ R L + T+ +G +W PE
Sbjct: 114 EYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPE 171
Query: 196 L-----YSTVT------------LRQGEKKHYNHKNV-------------RPSAENVPEE 225
+ YS+ + +G+ N RP
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKL--ASMT 229
Query: 226 LSIILTSCWKEDPNARPNFTQIIQML 251
+ ++ SCW E P RP F ++++ +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-20
Identities = 74/272 (27%), Positives = 114/272 (41%), Gaps = 48/272 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G+ K VAIK + G T K+ F E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT----EKQRRDFLSEA 56
Query: 76 AMLSRVQHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++ + H N++ G + PVM I+TE + G L +L V +G
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL-RQNDGQFTVIQLVGMLRG 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETG--- 187
IA M+ L +HRDL N+L+ +L K++DFGL+R +++ T+ G
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 188 TYRWMAPEL--------------YSTVT---LRQGEKKHYNHKNVR-----------PSA 219
RW APE Y V + GE+ +++ N P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233
Query: 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ P L ++ CW++D NARP F QI+ L
Sbjct: 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 7e-20
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 48/271 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G+ K VAIK + G T K+ F E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT----EKQRRDFLSEA 56
Query: 76 AMLSRVQHRNLVKFIGA---CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+++ + H N++ G K PVM IVTE + G+L +L + V +G
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLR 113
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGT-- 188
IA M+ L G +HRDL N+L+ +L K++DFGL+R E+ T G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172
Query: 189 YRWMAPEL--------------YSTV---TLRQGEKKHYNHKNVR-----------PSAE 220
RW APE Y V + GE+ ++ N P+
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPM 232
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ P L ++ CW++D N RP F QI+ +L
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-20
Identities = 62/175 (35%), Positives = 91/175 (52%), Gaps = 13/175 (7%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA--REVAMLSRVQHR 84
G ++GEG +A VY+ + K + VAIK + GE + AK F RE+ +L ++H
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQELKHP 62
Query: 85 NLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
N++ + + + +V E + L K + + + + L R +E LHS
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHS 120
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM-APEL 196
+ I+HRDLKP NLL+ D +KLADFGLAR S MT + T RW APEL
Sbjct: 121 NWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPEL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 70/305 (22%), Positives = 119/305 (39%), Gaps = 88/305 (28%)
Query: 24 KHLFVGPRIGEGAHAKVY----------------EGKYKNQT--VAIKIVHKGETPEEIA 65
+ L ++GEG +V+ E + VA+K++ + A
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN--A 62
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYL---------L 115
+++ F +EV +LSR+ N+ + +G C +P + ++ E + G L ++L L
Sbjct: 63 RED--FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 116 NMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ L + A IA M L S +HRDL N L+ ++ TIK+ADFG++R
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY-TIKIADFGMSRN 179
Query: 176 ESLTEMMTAETGTY-----------RWMAPEL-----YST--------VTLRQ----GEK 207
+ Y RWMA E ++T VTL + +
Sbjct: 180 --------LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 208 KHYNH-------KNVR------------PSAENVPEELSIILTSCWKEDPNARPNFTQII 248
+ Y H +N P N P+++ ++ CW+ D RP F +I
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291
Query: 249 QMLLN 253
L
Sbjct: 292 LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 63/180 (35%), Positives = 99/180 (55%), Gaps = 16/180 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+G+ K Q VA+K + + E+ EE S RE+++L +QH N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEE--GVPSTAIREISLLKELQHPNIVC 63
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGI 146
+E + ++ E LS L+KYL ++ + +D + + I + + HS +
Sbjct: 64 LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------YST 199
+HRDLKP+NLL+ ++ IKLADFGLAR + + T E T + APE+ YST
Sbjct: 123 LHRDLKPQNLLI-DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 59/169 (34%), Positives = 87/169 (51%), Gaps = 10/169 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG++ V + K+K Q VAIK + E + + K RE+ ML +++H NLV
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA---MREIRMLKQLRHENLVNL 65
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
I + + + +V E + L L P LD + I R +E HSH IIH
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPEL 196
RD+KPEN+L+++ +KL DFG AR + E+ T T + APEL
Sbjct: 124 RDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 50/259 (19%)
Query: 32 IGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IG+G VY G + A+K +++ EE+ + F +E ++ H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ----FLKEGIIMKDFSHPNV 58
Query: 87 VKFIGAC--KEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH 142
+ +G C E ++V + G LR ++ + P D+ IGF L +A+ ME L
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYLA 115
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-----YRWMAPELY 197
S +HRDL N +L E T+K+ADFGLAR+ E + T +WMA E
Sbjct: 116 SKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 198 STVT-----------------LRQG----------EKKHYNHKNVR-PSAENVPEELSII 229
T + +G + Y + R E P+ L +
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEV 234
Query: 230 LTSCWKEDPNARPNFTQII 248
+ SCW P RP F++++
Sbjct: 235 MLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-19
Identities = 64/244 (26%), Positives = 116/244 (47%), Gaps = 24/244 (9%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IGEG+ K+Y K K+ + I T + +KE+ +EV +L++++H N+V F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66
Query: 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150
+ +E + IV E GG L K + R + + + I+ ++ +H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 151 LKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 209
+K +N+ L+++ KL DFG+AR+ E+ GT +++PE+ + +
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC--------QNRP 178
Query: 210 YNHKNVRPSAENVPEEL-------------SIILTSCWKEDPNARPNFTQIIQMLLNYLS 256
YN+K S V EL ++L C PNF++ ++ L++ L
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238
Query: 257 AIAP 260
++P
Sbjct: 239 KVSP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-19
Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 47/258 (18%)
Query: 32 IGEGAH--AKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+G+GA A +Y + V K V+ E KE R A E+ +LS +QH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE----KERRDALNEIVILSLLQHPNIIA 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + ++I E +GGTL ++ + + + + + + I A+ +H GI+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE---------- 195
HRD+K N+ LT+ IKL DFG+++ +E AET GT +M+PE
Sbjct: 124 HRDIKTLNIFLTKA-GLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 196 ---------LYSTVTLRQGEKKHYNHKN--------VRPSAENVPE----ELSIILTSCW 234
LY +TL K+ ++ N V+ + V EL ++ S
Sbjct: 182 SDIWALGCVLYELLTL----KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237
Query: 235 KEDPNARPNFTQIIQMLL 252
++DP RP +++ L
Sbjct: 238 QQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 72/267 (26%), Positives = 111/267 (41%), Gaps = 38/267 (14%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + L + ++G G +V+ Y T VA+K + G + F E +
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANV 54
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +QH LVK + + I+TE ++ G+L +L + + I F+ IA
Sbjct: 55 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY--RWMAPE 195
M + IHRDL+ N+L++ L K+ADFGLAR E E + +W APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 196 L--YSTVTLRQ---------------GEKKHYNHKNVR-----------PSAENVPEELS 227
+ + T++ G + N P EN PEEL
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233
Query: 228 IILTSCWKEDPNARPNFTQIIQMLLNY 254
I+ CWK P RP F I +L ++
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 67/280 (23%)
Query: 32 IGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV Y + VA+K + + + S + +E+ +L + H N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN----TSGWKKEINILKTLYHEN 67
Query: 86 LVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECL 141
+VK+ G C E + ++ E + G+LR YL P+ L++ + FA I M L
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPE- 195
HS IHRDL N+LL D + +K+ DFGLA+ E ++ + W A E
Sbjct: 124 HSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVEC 181
Query: 196 ------------------LYSTVT------------LRQGEKKHYNHKNVR--------- 216
LY +T K VR
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 217 --PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254
P +N P+E+ I++ +CW+ + RP F +I +L
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 2e-18
Identities = 60/180 (33%), Positives = 86/180 (47%), Gaps = 25/180 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA+ V K + VAIK + AK R RE+ +L ++H N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK---RILREIKLLRHLRHENIIGL 64
Query: 90 IGACKEPV------MVIVTELLSGGT-LRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ + P + IVTEL+ T L K + + +P D F I R ++ LH
Sbjct: 65 LDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQY--FLYQILRGLKYLH 120
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT--YRWMAPEL 196
S +IHRDLKP N+L+ + +K+ DFGLAR +E +T T YR APEL
Sbjct: 121 SANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--APEL 177
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 68/290 (23%), Positives = 127/290 (43%), Gaps = 72/290 (24%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG ++ VA+K V++ + E F
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE----RIEF 56
Query: 72 AREVAMLSRVQHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLD------ 123
E +++ ++V+ +G +P +V++ EL++ G L+ YL ++RP +
Sbjct: 57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPP 115
Query: 124 --VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
+ I A +IA M L++ +HRDL N ++ D T+K+ DFG+ R+
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD------ 168
Query: 182 MTAETGTYR----------WMAPE-------------------LYSTVTLRQGEKKHYNH 212
ET YR WMAPE L+ +L + + ++
Sbjct: 169 -IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 213 KNV-----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ V +P +N PE ++ ++ CW+ +P RP F +I+ +L
Sbjct: 228 EQVLKFVMDGGYLDQP--DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 44/269 (16%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
I P H+ IG G +V+ G K VAIK + G T K+ F E
Sbjct: 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT----EKQRQDFLSEA 57
Query: 76 AMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+++ + H N+++ G K +I+TE + G L KYL + +G I
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGI 116
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETG---TYR 190
A M+ L +HRDL N+L+ +L+ K++DFGL+R E E +G R
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLEC-KVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 191 WMAPEL--YSTVT---------------LRQGEKKHY---NHKNVR--------PSAENV 222
W APE Y T + GE+ ++ NH+ ++ P+ +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251
P + ++ CW++D RP F I+ +L
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + N+T+A+K + + E + S RE+++L +QH N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP---STAIREISLLKEMQHGNIVR 65
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
E + +V E L L+K++ + + + + I R + HSH ++
Sbjct: 66 LQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------YST 199
HRDLKP+NLL+ +KLADFGLAR + T E T + APE+ YST
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 45/254 (17%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G++ VY+ K NQ A+K V G + ++E E+ +L+ V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ--KEREDAV-NEIRILASVNHPNIISY 64
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHS 143
F+ K + IV E G L K + + + + + + R ++ LH
Sbjct: 65 KEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AETGTYRWMAPE------- 195
I+HRDLK N+LL + +K+ D G+++ L + M + GT +MAPE
Sbjct: 122 QKILHRDLKSANILLVAN-DLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 196 ------------LYSTVTLR---QGEK-KHYNHKNVRPSAENVP----EELSIILTSCWK 235
LY T + + +K R +P ++L + S +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238
Query: 236 EDPNARPNFTQIIQ 249
P RPN +I+
Sbjct: 239 VKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 59/178 (33%), Positives = 90/178 (50%), Gaps = 29/178 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV--HKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
RIG G + VY+ + + VAIK++ G+ E I + E++ML +H N+
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ-------EISMLKECRHPNI 62
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIAR----AMEC 140
V + G+ + + IV E GG+L+ Y + P ++ +A + R +
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP-LSELQIAY-----VCRETLKGLAY 116
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMAPE 195
LH G IHRD+K N+LLTED +KLADFG++ + LT + GT WMAPE
Sbjct: 117 LHETGKIHRDIKGANILLTED-GDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-18
Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 29 GPRIGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82
G +G+GA +VY G+ +A+K V E K+ + E+ +L +Q
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H +V++ G ++ + I E + GG+++ L L V + I +E L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYL 120
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE----ESLTEMMTAETGTYRWMAPELY 197
HS+ I+HRD+K N +L + +KL DFG ++ S M + TGT WM+PE+
Sbjct: 121 HSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 198 S 198
S
Sbjct: 180 S 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-18
Identities = 63/256 (24%), Positives = 108/256 (42%), Gaps = 51/256 (19%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G GA V+ K + V IK + E++ K E A+ E +L + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQI----PVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ ++ ++IV E GGTL +Y+ LD + F + I A+ +H+ I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
HRDLK +N+LL + +K+ DFG+++ S GT +++PEL E
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EG 175
Query: 208 KHYNHKN-----------------------------------VRPSAENVPEELSIILTS 232
K YN K+ P ++ +L ++ S
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 233 CWKEDPNARPNFTQII 248
DP+ RP +QI+
Sbjct: 236 MLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-18
Identities = 63/181 (34%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 22 DPKHLFVGPR-IGEGAHAKVY--EGKYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY N+ VAIK + + G+ E K +EV
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVRF 68
Query: 78 LSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
L +++H N +++ G C +E +V E G ++ +P AI
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI--CHGAL 125
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ + LHSH IHRD+K N+LLTE T+KLADFG A SL + GT WMAPE
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSA---SLVSPANSFVGTPYWMAPE 181
Query: 196 L 196
+
Sbjct: 182 V 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-18
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + + VA+K V + E + S RE+ +L ++H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVR 63
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + +V E L+KY + +D + F + + + HSH ++
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPE------LYST 199
HRDLKP+NLL+ ++ +KLADFGLAR + +AE T + P+ LYST
Sbjct: 122 HRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 74/260 (28%), Positives = 124/260 (47%), Gaps = 40/260 (15%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF +IG+G+ +V++G + VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + K+ G+ K+ + I+ E L GG+ L P LD +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 197 ----------------YSTVTLRQGEKKHYN----------HKNVRPSAE-NVPEELSII 229
+ + L +GE H KN P+ E N + L
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 232
Query: 230 LTSCWKEDPNARPNFTQIIQ 249
+ +C ++P+ RP ++++
Sbjct: 233 VEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-17
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 55/273 (20%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGE--TPEEIAKKESRFAREVAMLSR 80
+G +G+G V E + K+ Q VA+K++ K + + +I F RE A +
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDI----EEFLREAACMKE 57
Query: 81 VQHRNLVKFIGAC-------KEPVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIG 129
H N++K IG + P+ +++ + G L +LL R P L + +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
F +DIA ME L S IHRDL N +L E++ T+ +ADFGL+++ A
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 187 GTYRWMAPE-----LYST--------VTL----RQGEKKH--------YNH---KNVRPS 218
+W+A E +Y+T VT+ +G+ + YN+ N
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236
Query: 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ E++ ++ CW +P RP+F + L
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 69/250 (27%), Positives = 101/250 (40%), Gaps = 59/250 (23%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC---KEPVMVIVTELLS 106
VA+K + T E + F RE+ +L +QH N+VK+ G C + +V E L
Sbjct: 36 VAVKKLQHS-TAEHLRD----FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
G+LR YL R R D + +A I + ME L S +HRDL N+L+ E +K
Sbjct: 91 YGSLRDYLQKHRERL-DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV-ESENRVK 148
Query: 167 LADFGLAR-----EESLTEMMTAETGTYRWMAPE-------------------LY----- 197
+ DFGL + +E E+ + W APE LY
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-WYAPESLTESKFSVASDVWSFGVVLYELFTY 207
Query: 198 -------STVTLRQ-GEKKHYN----------HKNVR-PSAENVPEELSIILTSCWKEDP 238
+R G K N R P+ P E+ I+ CW DP
Sbjct: 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267
Query: 239 NARPNFTQII 248
+ RP+F+++
Sbjct: 268 SQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 35/195 (17%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIK-IVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
++G+G VY + K + VAIK + K + EE REV L ++ H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNI 60
Query: 87 VKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
VK KE V E + G L + + + + + V I + + +
Sbjct: 61 VKL----KEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ES---LTEMMTAETGTYRWMAPELY 197
H HG HRDLKPENLL++ +K+ADFGLARE S T+ ++ T YR APE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVS--TRWYR--APE-- 168
Query: 198 STVTLRQGEKKHYNH 212
+ LR Y+
Sbjct: 169 --ILLRST---SYSS 178
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 40/260 (15%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF RIG+G+ +VY+G + VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + ++ G+ K + I+ E L GG+ L +P L+ +I +
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 197 ----------------YSTVTLRQGEKKHYN----------HKNVRPSAE-NVPEELSII 229
+ + L +GE + + KN P+ E +
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEF 232
Query: 230 LTSCWKEDPNARPNFTQIIQ 249
+ +C +DP RP ++++
Sbjct: 233 VEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 15/179 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + E + S RE+++L + H N+VK
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVK 63
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L L+K++ + + + + + + + HSH ++
Sbjct: 64 LLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------YST 199
HRDLKP+NLL+ + IKLADFGLAR + T E T + APE+ YST
Sbjct: 123 HRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 72/287 (25%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRF 71
W + + + + +G+G+ VYEG K VAIK V++ + E F
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE----RIEF 56
Query: 72 AREVAMLSRVQHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--- 126
E +++ ++V+ +G + P +VI+ EL++ G L+ YL ++RP + V
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 127 -----AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
I A +IA M L+++ +HRDL N ++ ED T+K+ DFG+ R+
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRD------ 168
Query: 182 MTAETGTY----------RWMAPE-------------------LYSTVTLRQGEKKHYNH 212
ET Y RWM+PE L+ TL + + ++
Sbjct: 169 -IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227
Query: 213 KNV-----------RPSAENVPEELSIILTSCWKEDPNARPNFTQII 248
+ V +P +N P+ L ++ CW+ +P RP+F +II
Sbjct: 228 EQVLRFVMEGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-17
Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 16/151 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVH---KGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A VY+G+ + + VA+K +H + TP S RE++++ ++H N
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-------STAIREISLMKELKHEN 59
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYL-LNMRPRCLDVCVAIGFALDIARAMECLHS 143
+V+ E +++V E + L+KY+ + LD F + + + H
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ ++HRDLKP+NLL+ + +KLADFGLAR
Sbjct: 119 NRVLHRDLKPQNLLINKR-GELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 8e-17
Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 21/195 (10%)
Query: 15 LDAKWLIDPKHLF-VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRF 71
+D L DP +F + +G G + +VY+G++ Q AIK++ E EE K E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE--- 62
Query: 72 AREVAMLSRV-QHRNLVKFIGAC--KEPV-----MVIVTELLSGGTLRKYLLNMRPRCL- 122
+ ML + HRN+ + GA K P + +V E G++ + N + L
Sbjct: 63 ---INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEM 181
+ +A +I R + LH+H +IHRD+K +N+LLTE+ + +KL DFG+ A+ +
Sbjct: 120 EDWIAY-ICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGR 177
Query: 182 MTAETGTYRWMAPEL 196
GT WMAPE+
Sbjct: 178 RNTFIGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 59/179 (32%), Positives = 94/179 (52%), Gaps = 15/179 (8%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + + ET +E S RE+++L + H N+V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDE--GVPSTAIREISLLKELNHPNIVR 62
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ E + +V E L L+KY+ + LD + + + + + HSH ++
Sbjct: 63 LLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------YST 199
HRDLKP+NLL+ + +KLADFGLAR + T E T + APE+ YST
Sbjct: 122 HRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 29 GPRIGEGAHAKVYEG-KYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNL 86
G +G+GA+ VY G + Q +A+K V + A+KE EV +L ++H N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 87 VKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V+++G C + + I E + GG++ L P L V + I + LH++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLARE-------ESLTEMMTAETGTYRWMAPEL 196
++HRD+K N++L + IKL DFG AR + + M+ + GT WMAPE+
Sbjct: 123 VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-16
Identities = 74/273 (27%), Positives = 114/273 (41%), Gaps = 50/273 (18%)
Query: 32 IGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+GEGA KV+ + N Q + V + + A+K+ F RE +L+ +QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--FHREAELLTNLQHEHIV 70
Query: 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-----------LDVCVAIGFALDIA 135
KF G C E +++V E + G L K+L P L + A IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM 192
M L S +HRDL N L+ E+L +K+ DFG++R+ T+ T RWM
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 193 APE--LYSTVTLRQ---------------GEKKHYNHKN-----------VRPSAENVPE 224
PE +Y T G++ Y N V P+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK 249
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
E+ ++ CW+ +P+ R N +I +L N A
Sbjct: 250 EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 66/256 (25%), Positives = 117/256 (45%), Gaps = 41/256 (16%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G + VY+ + VA+K V E + AK +E+ +L ++ H N++K
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
++ + + + IV EL G L + + + + R + + + + A+E +HS
Sbjct: 67 YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE-------- 195
I+HRD+KP N+ +T +KL D GL R S ++ A + GT +M+PE
Sbjct: 127 IMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 196 -----------LYSTVTLR---QGEK-------KHYNHKNVRP-SAENVPEELSIILTSC 233
LY L+ G+K K + P A++ EEL +++ C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRC 244
Query: 234 WKEDPNARPNFTQIIQ 249
DP RP+ + ++Q
Sbjct: 245 INPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 74/251 (29%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 31 RIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+IGEG+ K K K Q V +I +P+E ++ESR +EVA+LS ++H N+V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE--REESR--KEVAVLSNMKHPNIV 62
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
++ + +E + IV + GG L K + R + + + I A++ +H I
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE---------- 195
+HRD+K +N+ LT+D TIKL DFG+AR S E+ GT +++PE
Sbjct: 123 LHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181
Query: 196 ---------LYSTVTLRQ----GEKKHYNHKNVRPSAENVP----EELSIILTSCWKEDP 238
LY TL+ G K+ K +R S V +L +++ +K +P
Sbjct: 182 SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNP 241
Query: 239 NARPNFTQIIQ 249
RP+ I++
Sbjct: 242 RDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 61/174 (35%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G GA V + Q VAIK + K + +AK R RE+ +L ++H N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK---RTYRELKLLKHLRHENIISL 74
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
FI ++ + VTELL GT LL RP L+ F I R ++ +HS G
Sbjct: 75 SDIFISPLED--IYFVTELL--GTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSAG 128
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
++HRDLKP N+L+ E+ +K+ DFGLAR + MT T + APE+ T
Sbjct: 129 VVHRDLKPSNILINENCD-LKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLT 179
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIK-IVHKGETP--EEIAKKESRFAREVAMLSRVQHRN 85
+IGEG++ V++ + + Q VAIK V + P ++IA RE+ ML +++H N
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA------LREIRMLKQLKHPN 61
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV I + + +V E L + L PR + + +A+ H H
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APEL 196
IHRD+KPEN+L+T+ IKL DFG AR + + RW APEL
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 78/286 (27%)
Query: 31 RIGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRN 85
+IGEG+ V + Q VA+K + ++ K++ R EV ++ QH N
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQ-VAVKKM-------DLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 86 LVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARA 137
+V+ + +V +V E L GG L + + R + VC+A+ +A
Sbjct: 78 IVEMYSS----YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAV------LKA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG--------LAREESLTEMMTAETGTY 189
+ LH+ G+IHRD+K +++LLT D +KL+DFG + R +SL GT
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSL-------VGTP 179
Query: 190 RWMAPEL-----YST-----------VTLRQGEKKHYNH------KNVRPS-------AE 220
WMAPE+ Y T + + GE ++N K +R +
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH 239
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
V L L DP R +++ +L+ PP ++P
Sbjct: 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH--PFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLV 87
+G+G +V + K + A K + K + + K+ E E +L +V R +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK----KRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 88 KFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
A + + +V L++GG L+ ++ N+ AI +A I +E LH I
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
++RDLKPEN+LL +D ++++D GLA E + + GT +MAPE+
Sbjct: 117 VYRDLKPENVLL-DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 51/267 (19%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRNLVKF 89
IGEG +V + + K + + K E +K + R FA E+ +L ++ H N++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG--------------FALDI 134
+GAC+ + + E G L +L R D AI FA D+
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T RWMA
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192
Query: 195 E-------------------LYSTVTL-----------RQGEKKHYNHKNVRPSAENVPE 224
E L+ V+L EK ++ +P N +
Sbjct: 193 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL--NCDD 250
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQML 251
E+ ++ CW+E P RP+F QI+ L
Sbjct: 251 EVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 70/264 (26%), Positives = 110/264 (41%), Gaps = 62/264 (23%)
Query: 32 IGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ + N VA+K + + E A+++ F RE +L+ +QH+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQD--FQREAELLTVLQHQ 67
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRC-------------LDVCVAIGF 130
++V+F G C E +++V E + G L ++L + P L + +
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY- 189
A IA M L S +HRDL N L+ + L +K+ DFG++R+ T+ T
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 190 --RWMAPE--LYSTVTLRQ---------------GEKKHYNHKNV-------------RP 217
RWM PE LY T G++ Y N RP
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP 246
Query: 218 SAENVPEELSIILTSCWKEDPNAR 241
P E+ I+ CW+ +P R
Sbjct: 247 RT--CPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 58/269 (21%)
Query: 32 IGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GE KVY+G + Q VAIK + + E +E F E M SR+QH
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL---KDKAEGPLRE-EFKHEAMMRSRLQHP 68
Query: 85 NLVKFIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPR--------------CLDVCVAIG 129
N+V +G KE + ++ S L ++L+ P L+ +
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE---ESLTEMMTAET 186
IA ME L SH ++H+DL N+L+ + L +K++D GL RE ++M
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSL 187
Query: 187 GTYRWMAPE--LYSTVTL--------------------------RQGEKKHYNHKNVRPS 218
RWM+PE +Y ++ Q + ++ V P
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 219 AENVPEELSIILTSCWKEDPNARPNFTQI 247
++ P + ++ CW E P+ RP F I
Sbjct: 248 PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 54/172 (31%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
R+GEGA V + + KN A+K + P+ + K+ RE+ + + +VK
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQ---ILRELEINKSCKSPYIVK 63
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVC--VAIGFALDIARAMECLHS 143
+ GA + + I E GG+L ++ R + V A + + + LHS
Sbjct: 64 YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
IIHRD+KP N+LLT +KL DFG++ E + T TGT +MAPE
Sbjct: 124 RKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNSLAGTF-TGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-16
Identities = 61/180 (33%), Positives = 94/180 (52%), Gaps = 13/180 (7%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF RIG+G+ +V++G Q VAIKI+ E +EI + +E+ +L
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
S+ + K+ G+ K + I+ E L GG+ L R D +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
++ LHS IHRD+K N+LL+E +KLADFG+A + + T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 12/169 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA-KKESRFAREVAMLSRVQHRNLVK 88
+G G +V+ + + A+K++ PE I K+E E +L V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + ++ E + GG L YL N + +A +I A+E LHS I+
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+RDLKPEN+LL ++ IKL DFG A++ L + GT ++APE+
Sbjct: 124 YRDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEV 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 48 QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI--GACKEPVMVIVTELL 105
VAIK++ + + PEE + +RF RE A+ +R+ H N+V + G ++ V E +
Sbjct: 4 HEVAIKLL-RTDAPEE-EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL--TEDLK 163
G TLR+ L L L + A+ C H+ GI+HRDLKP+N+++ T
Sbjct: 62 PGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 164 TIKLADFGLAR-----EESLTEMMTAET---GTYRWMAPE 195
K+ DFG+ ++ +T T GT + APE
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHRNLV 87
+G+G + VY + + V I I +EI +++SR+ + E+A+ S ++HRN+V
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAI-------KEIPERDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 88 KFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-ALDIARAMECLHSHG 145
+++G+ E I E + GG+L L + D I F I ++ LH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMAPEL 196
I+HRD+K +N+L+ +K++DFG LA TE TGT ++MAPE+
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV 180
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LV 87
+IGEG + KVY+ + KN + VA+K E I RE+++L + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQMLSESIYIV 64
Query: 88 KFIGA------CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAM 138
+ + +P + +V E L L+K++ + R L F + + +
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL- 196
H HG++HRDLKP+NLL+ + +K+AD GL R S+ + T E T + APE+
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183
Query: 197 -----YST 199
YST
Sbjct: 184 LGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 60/268 (22%), Positives = 108/268 (40%), Gaps = 56/268 (20%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG+G+ V + + K+ + + K + G E K++ + EV +L ++H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAM-ECLH 142
+ + + IV E GG L + + + + ++ + A+ EC H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC-H 122
Query: 143 -----SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE 195
+ ++HRDLKP N+ L + +KL DFGLA+ + A+T GT +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 196 -------------------LYSTVTLR---QGEKKHYNHK---------NVRPSAENVPE 224
+Y L N R
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFTA----RNQLQLASKIKEGKFRRIPYRYSS 236
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQMLL 252
EL+ ++ S DP+ RP+ +++Q+ L
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 45/189 (23%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---IAKKESRFAREVAMLSRVQHRN 85
+IGEG + +VY+ + K + VA+K + + E +E I RE+ +L +++H N
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPIT-----AIREIKLLQKLRHPN 59
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYL-----------LNMRPRCLDVCVAI-GFALD 133
+V+ IVT G Y+ L P I +
Sbjct: 60 IVRLKE--------IVTSKGKGSI---YMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQ 108
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE------TG 187
+ ++ LHS+GI+HRD+K N+L+ D +KLADFGLAR T+ +A+ T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLAR--PYTKRNSADYTNRVITL 165
Query: 188 TYRWMAPEL 196
YR PEL
Sbjct: 166 WYR--PPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 90/353 (25%), Positives = 136/353 (38%), Gaps = 122/353 (34%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE------GKYKNQ-TVAIKIVHKGETPEEI 64
+L + KW +L G +G GA KV E GK N VA+K++ +E
Sbjct: 26 QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE- 84
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACKE--PVMVIVTELLSGGTL----------- 110
+E+ + E+ +LS + QH+N+V +GAC PV+VI TE G L
Sbjct: 85 --REALMS-ELKILSHLGQHKNIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRKKAETF 140
Query: 111 -----------------------RKYL--------------LNMRP-------------- 119
+KY+ + MRP
Sbjct: 141 LNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE 200
Query: 120 ------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
LD+ + F+ +A+ M+ L S IHRD+ N+LLT D + K+ DFGLA
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLA 259
Query: 174 REESLTEMMTAETGTYR----WMAPE-------------------LYSTVTLRQG----- 205
R + + + G R WMAPE L+ +L +
Sbjct: 260 R-DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
Query: 206 --EKKHYN-----HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
K Y ++ RP + P E+ I+ CW +P RP F+QI Q++
Sbjct: 319 LVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 25/186 (13%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESR-------FAREVAMLS 79
G IG G+ VY G + +A+K V E P A + R ARE+A+L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQV---ELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 80 RVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+QH N+V+++G+ + I E + GG++ LLN + V F I + +
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLVR-NFVRQILKGL 119
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR-------- 190
LH+ GIIHRD+K N+L+ ++ IK++DFG++++ + T T R
Sbjct: 120 NYLHNRGIIHRDIKGANILV-DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVF 177
Query: 191 WMAPEL 196
WMAPE+
Sbjct: 178 WMAPEV 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 63/275 (22%)
Query: 32 IGEGAHAKVYEGKYKNQT-------VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+GEGA KV+ + N + VA+K + + P A+K+ F RE +L+ +QH
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKD--FQREAELLTNLQHE 67
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKY----------LLNMRPRC----LDVCVAIG 129
++VKF G C + +++V E + G L K+ L++ +PR L + +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
A IA M L S +HRDL N L+ +L +K+ DFG++R+ T+ T
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 190 ---RWMAPE--LYSTVTLRQ---------------GEKKHYNHKNV-------------R 216
RWM PE +Y T G++ + N R
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER 246
Query: 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
P P+E+ I+ CW+ +P R N +I ++L
Sbjct: 247 PRV--CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 4e-15
Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 21/190 (11%)
Query: 20 LIDPKHLF-VGPRIGEGAHAKVYEGKY--KNQTVAIKIVH-KGETPEEIAKKESRFAREV 75
L DP +F + +G G + +VY+G++ Q AIK++ G+ EEI + E+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-------EI 53
Query: 76 AMLSRV-QHRNLVKFIGAC--KEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
ML + HRN+ + GA K P + +V E G++ + N + L
Sbjct: 54 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 113
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAET 186
+I R + LH H +IHRD+K +N+LLTE+ + +KL DFG+ A+ +
Sbjct: 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTVGRRNTFI 172
Query: 187 GTYRWMAPEL 196
GT WMAPE+
Sbjct: 173 GTPYWMAPEV 182
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 76/277 (27%), Positives = 112/277 (40%), Gaps = 59/277 (21%)
Query: 32 IGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRN 85
IGEG +V K AIK++ E ++ + R FA E+ +L ++ H N
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-----EFASENDHRDFAGELEVLCKLGHHPN 64
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGF 130
++ +GAC+ + I E G L +L R D A + F
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
A D+A M+ L IHRDL N+L+ E+L + K+ADFGL+R E + T R
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS-KIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 191 WMAPEL--YSTVTLRQG----------------------------EKKHYNHKNVRPSAE 220
WMA E YS T + EK ++ +P
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP--R 241
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
N +E+ ++ CW++ P RP F QI L L A
Sbjct: 242 NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 31 RIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++GEG++A VY+G + Q VA+K++ +T E + RE ++L ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTA---IREASLLKGLKHANIVL 67
Query: 89 F--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
I KE + + + + L +Y++ P L F + R + +H I
Sbjct: 68 LHDIIHTKETLTFVFEYMHT--DLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------YST 199
+HRDLKP+NLL++ L +KLADFGLAR +S+ ++ ++E T + P++ YS+
Sbjct: 125 LHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 200 -----------VTLRQGEKKHYNHKNVRPSAENVPEELSIILT 231
+ + QG+ P +V E+L I T
Sbjct: 184 ALDIWGAGCIFIEMLQGQP-------AFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 56/279 (20%)
Query: 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHR 84
L +G +GEG V EG+ +K+ K + E F E + H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 85 NLVKFIGACKE-------PVMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALD 133
N+++ IG C + P V++ + G L +LL R P+ L + + F D
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA---------REESLTEMMTA 184
IA ME L S IHRDL N +L E++ + +ADFGL+ R+ + +M
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKM--- 176
Query: 185 ETGTYRWMAPE-----LYST--------VTL----RQGEKKH--------YNHKNVRPSA 219
+W+A E +Y+T VT+ +G+ + Y++
Sbjct: 177 ---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233
Query: 220 ENVPEELSII---LTSCWKEDPNARPNFTQIIQMLLNYL 255
+ P+ L + ++SCW +P RP+F + L L
Sbjct: 234 KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 61/177 (34%), Positives = 93/177 (52%), Gaps = 17/177 (9%)
Query: 32 IGEGAHAKVYEGK-YKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN 85
IGEGA+ KV++ + KN + VA+K V + +T EE + REVA+L ++ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST--IREVAVLRHLETFEHPN 65
Query: 86 LVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ C +E + +V E + L YL + + + R ++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T + APE+
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 59/185 (31%), Positives = 87/185 (47%), Gaps = 17/185 (9%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+D K++ + P IG GA+ V K N+ VAIK + AK R RE+ +L
Sbjct: 3 VDTKYVPIKP-IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK---RTLREIKLL 58
Query: 79 SRVQHRNLVKFIGACKEPVM------VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ H N++ P IV EL+ L + + + + D C F
Sbjct: 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQY--FLY 115
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRW 191
+ R ++ +HS ++HRDLKP NLLL + +K+ DFGLAR S + MT T +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVTRWY 174
Query: 192 MAPEL 196
APEL
Sbjct: 175 RAPEL 179
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 60/176 (34%), Positives = 91/176 (51%), Gaps = 16/176 (9%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNL 86
IG GA+ VY+ + + VA+K V + +T E+ + REVA+L R++ H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLST--VREVALLKRLEAFDHPNI 64
Query: 87 VKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
V+ + C +E + +V E + LR YL + P L R ++
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
LH++ I+HRDLKPEN+L+T +KLADFGLAR S +T T + APE+
Sbjct: 124 LHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 22/186 (11%)
Query: 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAR--------EVAML 78
G IG+G + +VY + +A+K V E P IA + + E+ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQV---ELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 79 SRVQHRNLVKFIG-ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ H N+V+++G E + I E + GG++ L + + F +
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQVLEG 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE----SLTEMMTAETGTYRWMA 193
+ LHS GI+HRDLK +NLL+ D K++DFG++++ + M+ + G+ WMA
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMA 178
Query: 194 PELYST 199
PE+ +
Sbjct: 179 PEVIHS 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 62/193 (32%), Positives = 96/193 (49%), Gaps = 27/193 (13%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAIK ++ + P KKE E+ ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP----KKE-LIINEILVM 70
Query: 79 SRVQHRNLVKFIGA---CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
+H N+V ++ + E + +V E L+GG+L + C+D +
Sbjct: 71 RENKHPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECL 125
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRW 191
+A+E LHS+ +IHRD+K +N+LL D ++KL DFG + E+S M GT W
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYW 181
Query: 192 MAPELYSTVTLRQ 204
MAPE+ VT +
Sbjct: 182 MAPEV---VTRKA 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 14/136 (10%)
Query: 70 RFAREVAMLSRVQHRNLVKFIGACKEPV------MVIVTELLSGGTLRKYLLNMRPRCLD 123
R RE+ ML +H N++ + + P + +VTEL+ L K +++ +P D
Sbjct: 45 RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD 103
Query: 124 -VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180
V V F I R ++ LHS GI+HRD+KP NLL+ + +K+ DFGLAR E E
Sbjct: 104 HVKV---FLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESK 159
Query: 181 MMTAETGTYRWMAPEL 196
MT E T + APE+
Sbjct: 160 HMTQEVVTQYYRAPEI 175
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 60/180 (33%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 22 DPKHLFVG-PRIGEGAHAKVY--EGKYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ +FVG IG G+ VY + N+ VA+K + + G+ E K +EV
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---KWQDIIKEVKF 74
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L +++H N +++ G KE +V E G LL + + L +
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LLTE +KLADFG A S + + GT WMAPE+
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SKSSPANSFVGTPYWMAPEV 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-14
Identities = 56/259 (21%), Positives = 103/259 (39%), Gaps = 53/259 (20%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G+ V++ K + A+K + + + ++ E +L+++ +++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQI---DLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + + IV E G L K L R R L F + I + LHS I+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+K NL L +K+ D G+A+ S A T GT +++PEL
Sbjct: 124 HRDIKSLNLFLDAYDN-VKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELC-------- 173
Query: 206 EKKHYNHKN-----------------------------------VRPSAENVPEELSIIL 230
E K YN K+ P ++ ++L+ ++
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233
Query: 231 TSCWKEDPNARPNFTQIIQ 249
C +D RP+ Q+++
Sbjct: 234 DQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 3e-14
Identities = 61/180 (33%), Positives = 87/180 (48%), Gaps = 14/180 (7%)
Query: 22 DPKHLFVGPR-IGEGAHAKVYEGK--YKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY + N+ VAIK + + G+ E K +EV
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---KWQDIIKEVKF 78
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L R++H N +++ G +E +V E G LL + + L +
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LLTE +KLADFG A S+ + GT WMAPE+
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSA---SIASPANSFVGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 16/194 (8%)
Query: 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQH 83
+ FV +G+G++ +V +++T + V K +++E + A +E +LS+++H
Sbjct: 2 YCFVRV-VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58
Query: 84 RNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N+V + + + + ++ IV GG L L + + L + + + IA A++ L
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTV 200
H I+HRDLK +N+ LT IK+ D G+AR E+ +M + GT +M+PEL+S
Sbjct: 119 HEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN- 176
Query: 201 TLRQGEKKHYNHKN 214
K YN+K+
Sbjct: 177 -------KPYNYKS 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 8/146 (5%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G +V+ K + A+K++ K E + K R E +L+ + H L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR--NKVKRVLTEQEILATLDHPFLPTL 66
Query: 90 IGACKEPVMVI-VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + V + GG L + LL +P +CL VA +A ++ A+E LH GI+
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLA 173
+RDLKPEN+LL E I L+DF L+
Sbjct: 126 YRDLKPENILLHES-GHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 64/271 (23%), Positives = 112/271 (41%), Gaps = 62/271 (22%)
Query: 29 GPRIGEGAHAKVYEGK-YKNQTV-AIKIV--------HKGETPEEIAKKESRFAREVAML 78
G ++G GA + Y+ + K T+ A+K V + E E + K E+ ++
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRK-------EIRLM 57
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+R+ H ++++ +GA C++ + E ++GG++ L V I + + R
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRG 115
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-----TGTYRWM 192
+ LH + IIHRD+K NLL+ + +++ADFG A + E GT +M
Sbjct: 116 LSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 193 APEL---------------------YSTVTLRQGEKKHYNH---------KNVRPSAENV 222
APE+ +T +KH NH PS +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS---I 232
Query: 223 PEELSI----ILTSCWKEDPNARPNFTQIIQ 249
PE LS + C + P RP ++++
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 6e-14
Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 47/280 (16%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ ++ + P K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
+E LHS+ +IHRD+K +N+LL D ++KL DFG + + + + GT WMAPE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 197 YS----------------TVTLRQGEKKHYNHKNVR----------PSAENVPEELSII- 229
+ + + +GE + N +R P +N PE+LS I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-PEKLSAIF 246
Query: 230 ---LTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
L C D R + +++Q +L P + P
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 46/132 (34%), Positives = 73/132 (55%), Gaps = 2/132 (1%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K E+ E +L +V R +V A + + + +V L++GG L+ ++ NM D
Sbjct: 42 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH I++RDLKPEN+LL +D I+++D GLA E E +
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILL-DDYGHIRISDLGLAVEIPEGETIRG 160
Query: 185 ETGTYRWMAPEL 196
GT +MAPE+
Sbjct: 161 RVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 18/191 (9%)
Query: 21 IDPKHLF-VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
+DP ++ + +G+GA KVY+ K K +T A+ ET E ++ + E+ +L+
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSE--EELEDYMVEIEILA 64
Query: 80 RVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNM-----RPRCLDVCVAIGFALD 133
H +VK +GA + + I+ E GG + +L + P+ +C
Sbjct: 65 TCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC------RQ 118
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWM 192
+ A++ LHS IIHRDLK N+LLT D IKLADFG++ + T + + GT WM
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177
Query: 193 APELYSTVTLR 203
APE+ T++
Sbjct: 178 APEVVMCETMK 188
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 63/274 (22%)
Query: 32 IGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+GEG KV EG + VA+K + IA +E+ +L + H N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD----LKKEIEILRNLYHEN 67
Query: 86 LVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+VK+ G C E + ++ E L G+L++YL + + +++ + +A+ I + M+ L
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLG 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWMAPE-- 195
S +HRDL N+L+ E +K+ DFGL + +E T ++ + W APE
Sbjct: 127 SRQYVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF-WYAPECL 184
Query: 196 -----------------LYSTVTL-----------------RQGEKKHYNHKNV------ 215
LY +T G+ V
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
P N PEE+ ++ CW+ P+ R F +I+
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 7e-14
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 43/253 (16%)
Query: 32 IGEGAHAKVY------EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY EG+ VAIKI+++ P K F E +++ + H +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP----KANVEFMDEALIMASMDHPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
LV+ +G C P + +VT+L+ G L Y+ + + + + + + IA+ M L
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTY--RWMAPEL--YSTV 200
++HRDL N+L+ +K+ DFGLAR E + A+ G +WMA E Y
Sbjct: 130 LVHRDLAARNVLVKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 201 T--------------LRQGEKKHYNHKNVR------PSAENVPE------ELSIILTSCW 234
T L K Y+ R E +P+ ++ +++ CW
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCW 248
Query: 235 KEDPNARPNFTQI 247
D ++RP F ++
Sbjct: 249 MIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 36/99 (36%), Positives = 60/99 (60%), Gaps = 1/99 (1%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ +V L++GG L+ ++ N+ R L++ I ++ I + LHS I++RD+KPEN+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 158 LTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
L +D +L+D GLA E + +T GT +MAPE+
Sbjct: 128 L-DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEI 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 60/175 (34%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESR---FAREVAMLSRVQHRNL 86
IG+G+ KV K+K A+K++ K + I KK+ + A +L V+H L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK----KAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 87 V----KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
V F A K + V + ++GG L +L R R A +A +IA A+ LH
Sbjct: 59 VGLHYSFQTADK---LYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLH 113
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
S II+RDLKPEN+LL + + L DFGL +E T+ GT ++APE+
Sbjct: 114 SLNIIYRDLKPENILL-DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 64/190 (33%), Positives = 87/190 (45%), Gaps = 33/190 (17%)
Query: 28 VGPR------IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
VGPR IGEGA+ V +K VAIK + P E R RE+ +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS----PFEHQTFCQRTLREIKILR 58
Query: 80 RVQHRNLVKFIGACKEPV------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
R +H N++ + + P + IV EL+ + L+ + D F
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYK--LIKTQHLSNDHIQY--FLYQ 114
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAR----EESLTEMMTAETG 187
I R ++ +HS ++HRDLKP NLLL DL K+ DFGLAR E T +T
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDL---KICDFGLARIADPEHDHTGFLTEYVA 171
Query: 188 TYRWM-APEL 196
T RW APE+
Sbjct: 172 T-RWYRAPEI 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 73/267 (27%), Positives = 109/267 (40%), Gaps = 59/267 (22%)
Query: 32 IGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIAKKESR-FAREVAMLSRV-QHRN 85
IGEG +V + + K AIK + E +K + R FA E+ +L ++ H N
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--------------IGF 130
++ +GAC+ + + E G L +L R D A + F
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
A D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + + T R
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 191 WMAPEL--YSTVTLRQG----------------------------EKKHYNHKNVRPSAE 220
WMA E YS T EK ++ +P
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP--L 234
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQI 247
N +E+ ++ CW+E P RP+F QI
Sbjct: 235 NCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 13/173 (7%)
Query: 32 IGEGAHAKVYE-----GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G + KV++ G + A+K++ K K + E +L V+H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFI 62
Query: 87 VKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V I A + + ++ E LSGG L +L R A + +I+ A+E LH G
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
II+RDLKPEN+LL +KL DFGL + ES+ E T GT +MAPE+
Sbjct: 121 IIYRDLKPENILLDAQ-GHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEI 171
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 57/171 (33%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLV 87
IG+G+ KV K K A+K++ K + KKE A +L ++H LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI---LKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ + + V + ++GG L +L R RC A +A ++A A+ LHS I
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
I+RDLKPEN+LL + L DFGL +E E T+ GT ++APE+
Sbjct: 118 IYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 22/157 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-----REVAMLSRVQH 83
++GEG++A VY+G+ K Q VA+K EI + A RE ++L ++H
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALK---------EIRLEHEEGAPFTAIREASLLKDLKH 62
Query: 84 RNLVKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N+V I K+ + +V E L L++Y+ + L + F + R +
Sbjct: 63 ANIVTLHDIIHTKK-TLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYC 119
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178
H ++HRDLKP+NLL++E +KLADFGLAR +S+
Sbjct: 120 HQRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 55/281 (19%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA V+ Q VAIK ++ + P K+ E+ ++
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-----KKELIINEILVM 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++ N+V F+ + + +V E L+GG+L + C+D + +A
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMA 193
+E LH++ +IHRD+K +N+LL D ++KL DFG + E+S M GT WMA
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMA 183
Query: 194 PELYS----------------TVTLRQGEKKHYNHKNVR----------PSAENVPEELS 227
PE+ + + + +GE + N +R P +N PE+LS
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PEKLS 242
Query: 228 II----LTSCWKEDPNARPNFTQIIQ----MLLNYLSAIAP 260
I L C + D R + +++Q L LS++ P
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 61/198 (30%), Positives = 88/198 (44%), Gaps = 52/198 (26%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHR 84
RI EG + VY + K + VA+K + ++ K++ F RE+ +L ++QH
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLREINILLKLQHP 64
Query: 85 NLVKFIGACKEPVM-------VIVTELLSGGTLRKYLLNMRPR-------CLDVCVAIGF 130
N+V KE V+ +V E + L+ + M+ CL
Sbjct: 65 NIVTV----KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCL-------- 111
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT- 188
L + + LH + I+HRDLK NLLL +K+ DFGLARE S + T T
Sbjct: 112 MLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTL 170
Query: 189 -YRWMAPEL------YST 199
YR APEL YST
Sbjct: 171 WYR--APELLLGAKEYST 186
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 55/281 (19%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAIK ++ + P K+ E+ ++
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-----KKELIINEILVM 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREESLTEMMTAETGTYRWMA 193
++ LHS+ +IHRD+K +N+LL D ++KL DFG + E+S M GT WMA
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMA 183
Query: 194 PELYS----------------TVTLRQGEKKHYNHKNVR----------PSAENVPEELS 227
PE+ + + + +GE + N +R P +N PE LS
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN-PERLS 242
Query: 228 II----LTSCWKEDPNARPNFTQIIQ----MLLNYLSAIAP 260
+ L C + D + R + +++Q L LS++ P
Sbjct: 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 31 RIGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLV 87
IG GA +V+ K Q A+K++ K + I + + R E +L+ +V
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM---IKRNQIAHVRAERDILADADSPWIV 64
Query: 88 KFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
K + + E + +V E + GG L L+ A + ++ A++ +H G
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGF 122
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLA 173
IHRD+KP+N+L+ D IKLADFGL
Sbjct: 123 IHRDIKPDNILIDAD-GHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 57/180 (31%), Positives = 85/180 (47%), Gaps = 14/180 (7%)
Query: 22 DPKHLFVGPR-IGEGAHAKVYEGK--YKNQTVAIK-IVHKGETPEEIAKKESRFAREVAM 77
DP+ LF R IG G+ VY + ++ VAIK + + G+ E K +EV
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---KWQDIIKEVRF 68
Query: 78 LSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L +++H N +++ G +E +V E G LL + + L +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+ LHSH +IHRD+K N+LL+E +KL DFG A S+ GT WMAPE+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA---SIMAPANXFVGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 60/178 (33%), Positives = 82/178 (46%), Gaps = 24/178 (13%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIGEG + VY + + VA+K V + I RE+ +L ++H N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIVE 70
Query: 89 FIGACKEPVMVIVTELLSG---------GTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
KE V+V + L L L NM P L + R ++
Sbjct: 71 L----KE---VVVGKHLDSIFLVMEYCEQDLASLLDNM-PTPFSESQVKCLMLQLLRGLQ 122
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPEL 196
LH + IIHRDLK NLLLT D +K+ADFGLAR + MT + T + APEL
Sbjct: 123 YLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPEL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 58/176 (32%), Positives = 76/176 (43%), Gaps = 24/176 (13%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA V Q VAIK K P + R RE+ ++ V H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC--- 140
+ T S + L M ++C I LD R M C
Sbjct: 81 LNV--------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 141 -LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 63/265 (23%), Positives = 115/265 (43%), Gaps = 65/265 (24%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + + VAIK + + +P+ A KE E +++ V + +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKE--ILDEAYVMASVDNPH 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMEC 140
+ + +G C + ++T+L+ G L Y+ + L+ CV IA+ M
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNY 124
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---------RW 191
L ++HRDL N+L+ + + +K+ DFGLA+ ++ A+ Y +W
Sbjct: 125 LEERRLVHRDLAARNVLV-KTPQHVKITDFGLAK------LLGADEKEYHAEGGKVPIKW 177
Query: 192 MAPE--LYSTVT--------------LRQGEKKHYNH------KNVRPSAENVPE----- 224
MA E L+ T L K Y+ ++ E +P+
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 237
Query: 225 -ELSIILTSCWKEDPNARPNFTQII 248
++ +I+ CW D ++RP F ++I
Sbjct: 238 IDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 8/146 (5%)
Query: 32 IGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
I GA KVY G+ KN + A+K+V K + + + + R+ LS+ +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF--IVHL 69
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + V +V E L GG + K LL++ D +A+ + ++A A++ LH HGIIH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDV-KSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAR 174
RDLKP+N+L++ + IKL DFGL++
Sbjct: 128 RDLKPDNMLISNE-GHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 55/181 (30%), Positives = 92/181 (50%), Gaps = 15/181 (8%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+P+H + + R+G G + VY+ + + + A+KI+ K E ++ S +E+ M+
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDF----SLIQQEIFMV 60
Query: 79 SRVQHRNLVKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+H N+V + G+ +E + I E GG+L+ P L + +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQ 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPE 195
+ LHS G +HRD+K N+LLT D +KLADFG+A + + T + GT WMAPE
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176
Query: 196 L 196
+
Sbjct: 177 V 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 60/279 (21%), Positives = 111/279 (39%), Gaps = 82/279 (29%)
Query: 32 IGEGAHAKVYEGKYKNQT------------VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
+G+G +Y+G + Q+ V +K++ F +++S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL------AFFETASLMS 56
Query: 80 RVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI----A 135
++ H++LVK G C ++V E + G L +L + V++ + LD+ A
Sbjct: 57 QLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLA 111
Query: 136 RAMECLHSHGIIHRDLKPENLLLT-EDLKT-----IKLADFGLAREESLTEMMTAETGTY 189
A+ L ++H ++ +N+L+ L IKL+D G+ +T +
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREE 163
Query: 190 R-----WMAPELY-----------------STV------------TLRQGEKKH-YNHKN 214
R W+APE +T+ TL EK+ Y ++
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223
Query: 215 VRPSAENVPE--ELSIILTSCWKEDPNARPNFTQIIQML 251
P +P+ EL+ ++ CW DP RP+F I++ L
Sbjct: 224 RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 14/180 (7%)
Query: 29 GPRIGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
G +G+GA +V Y+ + A ++ E+PE +K+ S E+ +L +QH
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE-TSKEVSALECEIQLLKNLQHER 65
Query: 86 LVKFIGACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+V++ G + E + I E + GG+++ L L V + I M LH
Sbjct: 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH 123
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWMAPELYS 198
S+ I+HRD+K N +L + +KL DFG ++ M + + TGT WM+PE+ S
Sbjct: 124 SNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 2/132 (1%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K E+ E +L +V R +V A + + + +V +++GG L+ ++ NM D
Sbjct: 42 KGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
AI +A ++ +E L I++RDLKPEN+LL +D I+++D GLA + E +
Sbjct: 102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILL-DDRGHIRISDLGLAVQIPEGETVRG 160
Query: 185 ETGTYRWMAPEL 196
GT +MAPE+
Sbjct: 161 RVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 52/186 (27%), Positives = 91/186 (48%), Gaps = 14/186 (7%)
Query: 23 PKHLFVGPRIGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
P + +G +G+GA +VY + +A+K V E +K+ + E+ +L
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 81 VQHRNLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ H +V++ G ++P + I E + GG+++ L + L V + I
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEG 118
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRWM 192
+ LHS+ I+HRD+K N +L + + +KL DFG ++ S T M + TGT WM
Sbjct: 119 VSYLHSNMIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWM 176
Query: 193 APELYS 198
+PE+ S
Sbjct: 177 SPEVIS 182
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 35/163 (21%)
Query: 122 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
LD + F+ +A+ M L S IHRDL N+LLT + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIR-NDS 268
Query: 182 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYN-----------------------HK 213
G R WMAPE +++ V + + Y +K
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 214 NVRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
++ S E P E+ I+ SCW DP RP F QI+Q++
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 60/182 (32%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G+ KV+ G Q A+K++ K + R E +L+ V H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFI 60
Query: 87 VKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECLHSH 144
VK A + E + ++ + L GG L + + + F L ++A A++ LHS
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLR 203
GII+RDLKPEN+LL E+ IKL DFGL++E E GT +MAPE V R
Sbjct: 118 GIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE----VVNR 172
Query: 204 QG 205
+G
Sbjct: 173 RG 174
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 60/191 (31%), Positives = 96/191 (50%), Gaps = 24/191 (12%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+GA KVY+ + K V A K++ ++ EE+ + E+ +L+ H N+VK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT-KSEEELED----YMVEIDILASCDHPNIVKL 67
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHS 143
+ A E + I+ E +GG + +L + P+ VC A+ LH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCK------QTLEALNYLHE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTL 202
+ IIHRDLK N+L T D IKLADFG++ + + T + + GT WMAPE+ V
Sbjct: 122 NKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VMC 177
Query: 203 RQGEKKHYNHK 213
+ + Y++K
Sbjct: 178 ETSKDRPYDYK 188
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 42/132 (31%), Positives = 72/132 (54%), Gaps = 2/132 (1%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K ES E +L +V + +V A + + + +V +++GG L+ ++ NM +
Sbjct: 42 KGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH ++RDLKPEN+LL +D I+++D GLA + E +
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILL-DDYGHIRISDLGLAVKIPEGESIRG 160
Query: 185 ETGTYRWMAPEL 196
GT +MAPE+
Sbjct: 161 RVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIK-IVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV- 87
IG GA+ V + VAIK I H + P +AK R RE+ +L +H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPT-LAK---RTLRELKILRHFKHDNIIA 68
Query: 88 -KFIGACKEPVM--VIVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHS 143
+ I V V L L + + +P + + F + R ++ +HS
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY---FLYQLLRGLKYIHS 125
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAETGTYRWM-APEL 196
+IHRDLKP NLL+ ED +++ DFG+AR MT T RW APEL
Sbjct: 126 ANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRAPEL 182
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 31 RIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG G ++VY + VA+K V E + A+++ +E+ +L ++ H N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDC--VKEIDLLKQLNHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
++ + ++ + IV EL G L + + + R + + + + A+E +HS
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPE 195
++HRD+KP N+ +T +KL D GL R S T + GT +M+PE
Sbjct: 127 VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 54/274 (19%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K + ++ K++ R EV ++ QH N+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM-------DLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLH 142
V+ + + +V E L GG L + + R + VC+A+ +A+ LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAV------LKALSVLH 133
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYS--- 198
+ G+IHRD+K +++LLT D + +KL+DFG A+ + GT WMAPEL S
Sbjct: 134 AQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 199 -------------TVTLRQGEKKHYNH----------KNVRPSAEN---VPEELSIILTS 232
+ + GE ++N N+ P +N V L L
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR 252
Query: 233 CWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
DP R ++++ +L+ PP ++P
Sbjct: 253 LLVRDPAQRATAAELLKH--PFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 55/180 (30%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 32 IGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G KV G+ Y V +K + + +E + +F E +QH NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE----QMKFLEEAQPYRSLQHSNLL 58
Query: 88 KFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCL---DVCVAIGFALDIARAMECLHS 143
+ +G C E ++V E G L+ YL + R L D A +IA + LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTV 200
+ IH DL N LLT DL T+K+ D+GL+ + + + RW+APEL V
Sbjct: 119 NNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 67/270 (24%), Positives = 119/270 (44%), Gaps = 60/270 (22%)
Query: 32 IGEGAHAKVYEGKYKNQT---VAIK--IVHKGETPEEIAKKESRFAREVAMLS----RVQ 82
+G GA VY+ + KN +A+K VH ++ +++ V+ ++ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALD 133
H N+V++ E + IV +L+ G L ++ +++ R ++ V + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL- 126
Query: 134 IARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192
LH I+HRDL P N++L ED K + + DFGLA+++ +T+ GT +
Sbjct: 127 -----RYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 193 APE-------------------LYSTVTLRQGEKKHYNH-------KNVRPSAENVPE-- 224
PE LY TL + Y+ K V E +PE
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTL---QPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 225 ---ELSIILTSCWKEDPNARPNFTQIIQML 251
+++ ++TSC D ARP+ Q+ M+
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 10/169 (5%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
++G+G + +V+ K K+ + VA+K + K + + E +L+ + LVK
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKK-SLLFK-LNEVRHVLTERDILTTTKSEWLVK 65
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ A ++ + + E + GG R L N+ L A + ++ A++ LH G I
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYI 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
HRDLKPEN L+ IKL DFGL++ + + G+ +MAPE+
Sbjct: 124 HRDLKPENFLIDAS-GHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEV 169
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 68/261 (26%), Positives = 103/261 (39%), Gaps = 66/261 (25%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGG 108
VA+KI+ P+ + F +EV +LSR++ N+++ +G C E + ++TE + G
Sbjct: 49 VAVKILR----PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104
Query: 109 TLRKYL--------------LNMRPRCLDVC---VAIGFALDIARAMECLHSHGIIHRDL 151
L ++L CL + AL IA M+ L S +HRDL
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPEL------------ 196
N L+ E+L TIK+ADFG++R + + RWMA E
Sbjct: 165 ATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 197 ------------------YSTVTLRQ-----GEKKHYNHKNV---RPSAENVPEELSIIL 230
Y +T Q GE + V RP P+ L ++
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPP--CPQGLYELM 281
Query: 231 TSCWKEDPNARPNFTQIIQML 251
CW D RP+F+ I L
Sbjct: 282 LQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 30/182 (16%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEE-------IAKKESRFARE----VAML 78
+G+G+ KV E K ++ A+K++ K ++ K+ A + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
S Q ++ + F V E ++GG L ++ R D A +A +I +
Sbjct: 63 SCFQTKDRLFF-----------VMEYVNGGDLMFHIQ--RSGRFDEPRARFYAAEIVLGL 109
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+ LH GII+RDLK +N+LL + IK+ADFG+ + E + +T T GT ++APE+
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEI 167
Query: 197 YS 198
S
Sbjct: 168 LS 169
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A V++G+ K VA+K + H+ P REV++L ++H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP-------CTAIREVSLLKNLKHAN 64
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V E + +V E L L++YL N V I F + R + H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL------Y 197
I+HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P++ Y
Sbjct: 123 KILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 198 STVTLRQGEK-KHYNHKNVRP--SAENVPEELSIIL 230
ST G Y RP V EEL +I
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 16/170 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA--REVAMLSRVQHRNL 86
++GEG++A VY+GK K + VA+K++ E ++ + F RE ++L ++H N+
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQE------EEGTPFTAIREASLLKGLKHANI 65
Query: 87 VKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
V I KE + ++ + + L +Y+ + P L F + R + +H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHT--DLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
I+HRDLKP+NLL++ D +KLADFGLAR +S+ + W P
Sbjct: 123 YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 45/127 (35%), Positives = 67/127 (52%), Gaps = 23/127 (18%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ +V E + GG L N+ +D+ + FA + A+E LH++GI+HRDLKP+NLL
Sbjct: 76 LCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFA-ETVLALEYLHNYGIVHRDLKPDNLL 133
Query: 158 LTEDLKTIKLADFGLAR---------------EESLTEMMTAET-GTYRWMAPELYSTVT 201
+T + IKL DFGL++ E+ E + + GT ++APE V
Sbjct: 134 ITS-MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE----VI 188
Query: 202 LRQGEKK 208
LRQG K
Sbjct: 189 LRQGYGK 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 43/132 (32%), Positives = 72/132 (54%), Gaps = 2/132 (1%)
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
K ES E +L +V R +V A + + + +V L++GG L+ ++ +M +
Sbjct: 42 KGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE 101
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184
A+ +A +I +E LH I++RDLKPEN+LL +D I+++D GLA + +
Sbjct: 102 GRAVFYAAEICCGLEDLHQERIVYRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKG 160
Query: 185 ETGTYRWMAPEL 196
GT +MAPE+
Sbjct: 161 RVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGG 108
VAI + G + K+ F E L + H N+V+ G + M+IVTE +S G
Sbjct: 36 VAIHTLRAGCS----DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91
Query: 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
L +L + L +G +A M+ L G +H+ L +L+ DL K++
Sbjct: 92 ALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKIS 149
Query: 169 DFGLAREESLTEMMTAETG--TYRWMAPEL-----YSTVT------------LRQGEKKH 209
F +E+ + T +G W APE +S+ + + GE+ +
Sbjct: 150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
Query: 210 YN--HKNV---------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
++ ++V P+ N P L ++ CW+++ RP F+QI +L
Sbjct: 210 WDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 39/256 (15%)
Query: 31 RIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG G ++VY VA+K V + + AK + +E+ +L ++ H N++K
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIK 66
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHG 145
+ + ++ + IV EL G L + + + + R + + + + A+E +HS
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPE--------- 195
++HRD+KP N+ +T +KL D GL R S T + GT +M+PE
Sbjct: 127 VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNF 185
Query: 196 ----------LYSTVTLRQ---GEK-------KHYNHKNVRP-SAENVPEELSIILTSCW 234
LY L+ G+K K + P +++ EEL ++ C
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245
Query: 235 KEDPNARPNFTQIIQM 250
DP RP+ T + +
Sbjct: 246 NPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 40/184 (21%)
Query: 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
T R L+N P L +GF+ +A ME L S +HRDL N+L+ E K +K
Sbjct: 222 ERTRRDTLINESP-ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG-KLVK 279
Query: 167 LADFGLAREESLTEMMTAETGTY---RWMAPE-----LYSTVT----------------- 201
+ DFGLAR+ ++ T+ +WMAPE LY+T++
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 202 -----LRQGEKKHYN-----HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
L E + YN ++ +P+ + +E+ I+ CW+E RP+F+Q++ ++
Sbjct: 340 TPYPELPMNE-QFYNAIKRGYRMAKPA--HASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396
Query: 252 LNYL 255
+ L
Sbjct: 397 GDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 31/68 (45%), Positives = 41/68 (60%), Gaps = 9/68 (13%)
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------EESLTEMMTAETGTY 189
+A++ +HS +IHRDLKP N+LL D +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 190 RWM-APEL 196
RW APE+
Sbjct: 176 RWYRAPEI 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 12/170 (7%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG G + VY+ + N + AIK++ K E E+ A + +E+ M+ +H N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQ----QEIIMMKDCKHSNIVA 70
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ G+ + + I E GG+L+ P L + + + + LHS G +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPEL 196
HRD+K N+LLT++ +KLADFG++ + + T + GT WMAPE+
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 37/206 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFA------ 72
I +++ G +GEG + KV + + VAIK V E ++ K
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 73 ---REVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDV---C 125
RE+ +++ ++H N++ + + + +V ++++ L+K +++ + R + C
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC 123
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----------- 174
+ L I + LH +HRDL P N+ + K+ADFGLAR
Sbjct: 124 IL----LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTL 178
Query: 175 ----EESLTEMMTAETGTYRWMAPEL 196
E MT++ T + APEL
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPEL 204
|
Length = 335 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 14/169 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLV 87
I +GA VY K + AIK++ K + IAK + A M+ + + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM---IAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 88 K-FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
K + + + +V E L+GG + + L A + ++ +E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
IHRD+KPENLL+ + +KL DFGL+R GT ++APE
Sbjct: 119 IHRDIKPENLLIDQT-GHLKLTDFGLSR---NGLENKKFVGTPDYLAPE 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 52/191 (27%), Positives = 82/191 (42%), Gaps = 8/191 (4%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KV G+ ++V K ++ F +EV + H N+++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 92 ACKEPV-MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGII 147
C E + ++V E G L+ YL + R + V A ++A + LH I
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTY--RWMAPELYSTVTLRQ 204
H DL N LT DL ++K+ D+GLA E+ + +T + RW+APEL
Sbjct: 123 HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDL 181
Query: 205 GEKKHYNHKNV 215
K N+
Sbjct: 182 LPKDQTKKSNI 192
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 35/163 (21%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 233
Query: 188 TYR----WMAPE-----LYST------------------------VTLRQGEKKHYNHKN 214
R WMAPE +Y+T V + + +
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT 293
Query: 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ E E+ I+ CW +P RP F++++++L + L
Sbjct: 294 RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 57/179 (31%), Positives = 90/179 (50%), Gaps = 29/179 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A VY+G+ K + VA+K + H+ P REV++L ++H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP-------CTAIREVSLLKDLKHAN 65
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYL------LNMRPRCLDVCVAIGFALDIARAM 138
+V E + +V E L L++YL +NM L F + R +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKL-------FLFQLLRGL 117
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL 196
H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P++
Sbjct: 118 NYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 35/161 (21%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +AR ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 234
Query: 188 TYR----WMAPE-----LYST------------------------VTLRQGEKKHYNHKN 214
+ R WMAPE +Y+T V + + +
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294
Query: 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
+ EN E+ I+ +CW+ DP RP F+ ++++L + L
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 50/152 (32%), Positives = 68/152 (44%), Gaps = 19/152 (12%)
Query: 55 VHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYL 114
V K P + R RE+ +L V H+N++ + + T S +
Sbjct: 51 VKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN--------VFTPQKSLEEFQDVY 102
Query: 115 LNMRPRCLDVCVAIGFALDIAR------AMEC----LHSHGIIHRDLKPENLLLTEDLKT 164
L M ++C I LD R M C LHS GIIHRDLKP N+++ D T
Sbjct: 103 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-T 161
Query: 165 IKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+K+ DFGLAR MMT T + APE+
Sbjct: 162 LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +G G+ +V K+K + AIK + K E + K+ A+E ++L + H
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPF 79
Query: 86 LVKFI-GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V + E + + E + GG L +L DV A + ++ A E LHS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV--AKFYHAELVLAFEYLHSK 137
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
II+RDLKPENLLL +K+ DFG A++ + + GT ++APE+
Sbjct: 138 DIIYRDLKPENLLLDNK-GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV 186
|
Length = 329 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W + ++ + P +G GA+ +V + VAIK K P + A R RE+
Sbjct: 11 WEVPDRYQNLSP-VGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELR 66
Query: 77 MLSRVQHRNLVKFIGACKEPV-------MVIVTELLSGGTLRKYLLNMRPRCLD---VCV 126
+L + H N++ + + +VT L+ G L ++ + L +
Sbjct: 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNI---VKCQKLSDDHIQF 122
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186
+ I R ++ +HS GIIHRDLKP N+ + ED + +K+ DFGLAR + MT
Sbjct: 123 LV---YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLAR--HTDDEMTGYV 176
Query: 187 GTYRW-MAPE 195
T RW APE
Sbjct: 177 AT-RWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 59/172 (34%), Positives = 89/172 (51%), Gaps = 14/172 (8%)
Query: 32 IGEGAHAKVYEGKYKNQTV--AIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-- 87
IG+G+ KV ++K + A+K++ K ++ +K R V +L V+H LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 61
Query: 88 --KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
F A K + V + ++GG L +L R RC A +A +IA A+ LHS
Sbjct: 62 HFSFQTADK---LYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
I++RDLKPEN+LL + I L DFGL +E T+ GT ++APE+
Sbjct: 117 IVYRDLKPENILL-DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 40/162 (24%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ F +AR ME L S +HRDL N+LL + K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGS 298
Query: 188 TY---RWMAPE-----LYSTV------------------TLRQG---EKKHYN-----HK 213
T+ +WMAPE LY+T+ T G + YN ++
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358
Query: 214 NVRPSAENVPEELSIILTSCWKEDPNARPNF---TQIIQMLL 252
+P ++ +E+ I+ CW +P RP+F + I++ LL
Sbjct: 359 MAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 60/259 (23%), Positives = 105/259 (40%), Gaps = 42/259 (16%)
Query: 32 IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+G G V +G YK +TVA+KI+ K + + K E RE ++ ++ + +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDE--LLREANVMQQLDNPYIV 59
Query: 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ IG C+ ++V EL G L K+L + + + ++ M+ L +
Sbjct: 60 RMIGICEAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPEL-----YS 198
HRDL N+LL K++DFGL++ +E+ + T +W APE +S
Sbjct: 118 HRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 199 TVT----------------------LRQGEKKHYNHKNVRPSA-ENVPEELSIILTSCWK 235
+ + ++ E R + P E+ ++ CW
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT 236
Query: 236 EDPNARPNFTQIIQMLLNY 254
+ RP F + L NY
Sbjct: 237 YGVDERPGFAVVELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEGA+ V + ++K + VAIK E EE+ KE+ RE+ ML ++ N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV--KETTL-RELKMLRTLKQENIVEL 65
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
A + + +V E + L LL P + + + +A+ H + I+H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWM-APEL 196
RD+KPENLL++ + +KL DFG AR +L+E A Y RW +PEL
Sbjct: 124 RDIKPENLLISHN-DVLKLCDFGFAR--NLSEGSNANYTEYVATRWYRSPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 80/265 (30%)
Query: 50 VAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELL 105
VA+K++ E A K +R F +E+ ++SR++ N+++ + C +P+ +I TE +
Sbjct: 49 VAVKML------REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYM 101
Query: 106 SGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 156
G L ++L P + I A IA M+ L S +HRDL N
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161
Query: 157 LLTEDLKTIKLADFGLAREESLTEMMTAETGTY-----------RWMAPE---------- 195
L+ ++ TIK+ADFG++R +G Y RWM+ E
Sbjct: 162 LVGKNY-TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212
Query: 196 ---------LYSTVTLRQGEKKHYNHKNVRPSAENV-------------------PEELS 227
L+ +TL +++ Y+ + EN P+ L
Sbjct: 213 SDVWAFGVTLWEILTL--CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY 270
Query: 228 IILTSCWKEDPNARPNFTQIIQMLL 252
++ SCW+ + RP+F +I LL
Sbjct: 271 KLMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 10/180 (5%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
IG G KV + T ++V K +K+++ F ++ +QH N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 92 ACKEPV-MVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIH 148
C E + ++V E G L+ YL + R + + A +IA + +H H +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLH 122
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPELYSTVTLRQG 205
DL N LT DL T+K+ D+G+ + + E RW+APEL V G
Sbjct: 123 SDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL---VGEFHG 178
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 52/197 (26%)
Query: 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHR 84
+IG+G +V++ ++K Q VA+K V +KE F RE+ +L ++H
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN------EKEG-FPITALREIKILQLLKHE 71
Query: 85 NLVKFIGACKEPVMVIVTELLSGGTLRK--YLLNMRPRCLDVC----------VAIGFAL 132
N+V I C+ T+ + YL+ + C + F L
Sbjct: 72 NVVNLIEICR-------TKATPYNRYKGSFYLV------FEFCEHDLAGLLSNKNVKFTL 118
Query: 133 -DIARAMECL-------HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180
+I + M+ L H + I+HRD+K N+L+T+D +KLADFGLAR SL++
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 181 -MMTAETGTYRWMAPEL 196
T T + PEL
Sbjct: 178 NRYTNRVVTLWYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G+ KV E K N+ AIK + K E+ + + R V L+ +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
F + + V E L+GG L ++ + D A +A +I ++ LH GII+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTVTLRQGEK 207
RDLK +N+LL +D IK+ADFG+ +E E + GT ++APE+ +G+K
Sbjct: 120 RDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK 172
Query: 208 KHYNH 212
YN
Sbjct: 173 --YNE 175
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 56/177 (31%), Positives = 78/177 (44%), Gaps = 24/177 (13%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA V + VAIK K P + R RE+ ++ V H+N++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC--- 140
+ + T S + + M ++C I LD R M C
Sbjct: 89 LN--------VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 141 -LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE+
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 23/177 (12%)
Query: 31 RIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K + ++ K++ R EV ++ H N+
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM-------DLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLH 142
V + + +V E L GG L + + R + VC L + RA+ LH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVC------LSVLRALSYLH 135
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGL-AREESLTEMMTAETGTYRWMAPELYS 198
+ G+IHRD+K +++LLT D + IKL+DFG A+ + GT WMAPE+ S
Sbjct: 136 NQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 27/179 (15%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
RIG GA VY+ ++ + A+K+++ G + + ++ RE+ +L V H N+VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIY-GNHEDTVRRQ---ICREIEILRDVNHPNVVK 136
Query: 89 FIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
C + + ++ E + GG+L + DV A I + LH
Sbjct: 137 ----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHR 186
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---TAETGTYRWMAPELYST 199
I+HRD+KP NLL+ K +K+ADFG++R L + M + GT +M+PE +T
Sbjct: 187 RHIVHRDIKPSNLLI-NSAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT 242
|
Length = 353 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 58/176 (32%), Positives = 79/176 (44%), Gaps = 26/176 (14%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V + K KN+T A+K V K E ++ E +L H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET--GQQEHIFSEKEILEECNHPFIVKL 58
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMEC 140
K+ + ++ E GG L L R R L F AR A E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---RDRGL-------FDEYTARFYIACVVLAFEY 108
Query: 141 LHSHGIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPE 195
LH+ GII+RDLKPENLLL D +KL DFG A++ + GT ++APE
Sbjct: 109 LHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 25/180 (13%)
Query: 31 RIGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESR--FAREVAMLSRVQHRNL 86
+IGEG+ V K+ + VA+K++ ++ K++ R EV ++ QH+N+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM-------DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 87 VKFIGA--CKEPVMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECL 141
V+ + E + V++ E L GG L + R + VC ++ +A+ L
Sbjct: 81 VEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTRLNEEQIATVCESV------LQALCYL 133
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELYSTV 200
HS G+IHRD+K +++LLT D + +KL+DFG + S + GT WMAPE+ S
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE----EIAKKESRFAREVAMLSRVQHRN 85
+G G KV +YK + AIK + KG+ E E R E A + +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIF-ETA--NSERHPF 63
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV + V V E +GG L ++++ A+ +A + ++ LH +
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLHEN 120
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
I++RDLK +NLLL + +K+ADFGL +E T+ GT ++APE+
Sbjct: 121 KIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 40 VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV 99
VY+ + K VAIK++ E+ + E RE ++ ++ + +V+ IG C+ ++
Sbjct: 15 VYKMRKKQIDVAIKVLKNEN--EKSVRDE--MMREAEIMHQLDNPYIVRMIGVCEAEALM 70
Query: 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159
+V E+ SGG L K+L + + V + ++ M+ L +HRDL N+LL
Sbjct: 71 LVMEMASGGPLNKFLSGKKDE-ITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129
Query: 160 EDLKTIKLADFGLAR----EESLTEMMTAETGTYRWMAPE--LYSTVTLRQ--------- 204
K++DFGL++ ++S + +A +W APE + + R
Sbjct: 130 NQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
Query: 205 ------GEKKH----------YNHKNVR---PSAENVPEELSIILTSCWKEDPNARPNFT 245
G+K + + + R P+ P E+ ++ CW RPNF
Sbjct: 189 WEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAE--CPPEMYALMKDCWIYKWEDRPNFA 246
Query: 246 QIIQMLLNY 254
++ + + Y
Sbjct: 247 KVEERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 58/178 (32%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG GA V Y+ ++ VAIK K P + R RE+ ++ V H+N++
Sbjct: 25 IGSGAQGIVCAAYDAVL-DRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR------AMEC-- 140
+ + T S + L M ++C I LD R M C
Sbjct: 81 LLN--------VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 141 --LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
LHS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 17/133 (12%)
Query: 74 EVAMLSRVQHRNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNM--------RPRCLDV 124
E +L++V R +V A + + +V +++GG LR ++ N+ PR
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR---- 98
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT- 183
A + I +E LH II+RDLKPEN+LL D ++++D GLA E + T
Sbjct: 99 --ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTK 155
Query: 184 AETGTYRWMAPEL 196
GT +MAPEL
Sbjct: 156 GYAGTPGFMAPEL 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 8/169 (4%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ KV K K + A+K++ K +K R V +L V+H LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + V + ++GG L +L R R A +A +IA A+ LHS I++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPEL 196
RDLKPEN+LL + + L DFGL +E + ++ T GT ++APE+
Sbjct: 120 RDLKPENILL-DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 32 IGEGAHAKVYEGKYKNQT---VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V YKN+ VAIK K + ++ K+ E +L+ + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ--KQVDHVFSERKILNYINHPFCVN 95
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
G+ K E + +V E + GG +L R + V +A I E L S I+
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPELYSTV 200
+RDLKPENLLL +D IK+ DFG A+ + + T GT ++APE+ V
Sbjct: 154 YRDLKPENLLLDKD-GFIKMTDFGFAK---VVDTRTYTLCGTPEYIAPEILLNV 203
|
Length = 340 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 26/177 (14%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA+ V K + VAIK + + E AK R RE+ +L +QH N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAK---RAYRELTLLKHMQHENVIGL 79
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD----------IARAME 139
+ + T +SG + + L M D+ +G L + ++
Sbjct: 80 LD--------VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+HS GIIHRDLKP NL + ED + +K+ DFGLAR MT T + APE+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVTRWYRAPEV 185
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 35/261 (13%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYKNQT---VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
P + +G +G GA +VY Y T +A+K V +E +K+ + E+ +L
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLC-YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK 59
Query: 80 RVQHRNLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++H +V++ G ++P + I E + GG+++ L L V + I +
Sbjct: 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQ 117
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----MTAETGTYRWM 192
+ LHS+ I+HRD+K N +L + +KL DFG ++ M + + TGT WM
Sbjct: 118 GVSYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 193 APELYSTVTLRQGEKKHYNHK-NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+PE+ S GE Y K +V A V E L+ +P + + M
Sbjct: 177 SPEVIS------GEG--YGRKADVWSVACTVVEMLT------------EKPPWAEYEAMA 216
Query: 252 LNYLSAIAPPEPMIPHRIFNS 272
+ A P +PM+P + ++
Sbjct: 217 AIFKIATQPTKPMLPDGVSDA 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 31/180 (17%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV---HKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++GEG +A V++G+ K VA+K + H+ P REV++L ++H N
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP-------CTAIREVSLLKDLKHAN 65
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG-------FALDIARA 137
+V + + +V E L L++Y+ D C I F I R
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYM--------DDCGNIMSMHNVKIFLYQILRG 116
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPEL 196
+ H ++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ + E T + P++
Sbjct: 117 LAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 60/266 (22%), Positives = 115/266 (43%), Gaps = 45/266 (16%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
++ L +G G V++G + + +IKI +T ++ + +++ ML+
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 80 --RVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ H +V+ +G C + +VT+L G+L ++ R LD + + + IA+
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKG 121
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA-------REESLTEMMTAETGTYR 190
M L H ++HR+L N+LL D +++ADFG+A ++ +E T +
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IK 176
Query: 191 WMAPE--LYSTVTLRQGEKKHYN-------------HKNVRPS--------AENVPE--- 224
WMA E L+ T Q + Y + +RP E + +
Sbjct: 177 WMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI 235
Query: 225 ---ELSIILTSCWKEDPNARPNFTQI 247
++ +++ CW D N RP F ++
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 32 IGEGAHAKVYE--GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G + KVY+ K A+KI+ +E + E + + H N+VKF
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKF 84
Query: 90 IGA------CKEPVMVIVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
G + +V EL +GG+ L K LL R LD + ++
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQH 143
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPEL 196
LH++ IIHRD+K N+LLT + +KL DFG++ + + T + GT WMAPE+
Sbjct: 144 LHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 199
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 43/254 (16%)
Query: 32 IGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA VY+G + VAIK++ + +P+ A KE E +++ V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKE--ILDEAYVMAGVGSPY 70
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ + +G C + +VT+L+ G L Y+ + R + + + + IA+ M L
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG---TYRWMAPE--LYSTV 200
++HRDL N+L+ + +K+ DFGLAR + E G +WMA E L+
Sbjct: 130 LVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 201 T--------------LRQGEKKHYNHKNVR------------PSAENVPEELSIILTSCW 234
T L K Y+ R P ++ +I+ CW
Sbjct: 189 THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCW 248
Query: 235 KEDPNARPNFTQII 248
D RP F +++
Sbjct: 249 MIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 58/177 (32%)
Query: 32 IGEGAHAKVYEGKYKNQTV----AIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNL 86
IG G + +VY+ K KN AIK K + +E S+ A RE+A+L ++H N+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIK---KFKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCL---------DVCVAIGF-----AL 132
V L + L + + D+ I F +
Sbjct: 65 VS---------------------LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV 103
Query: 133 DIARAM------------ECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAR 174
I +M LHS+ ++HRDLKP N+L+ + +K+ D GLAR
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 8/169 (4%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K + A+K++ K ++ + + + + L+R H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ P + V E ++GG L ++ + R D A +A +I A+ LH GII+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
RDLK +N+LL + KLADFG+ +E T+ GT ++APE+
Sbjct: 120 RDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 58/176 (32%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNL 86
+G+G KV + K + A+KI+ K E I K+ EVA SRV
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKK----EVIIAKD-----EVAHTLTESRVLQNTR 53
Query: 87 VKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
F+ A K + V E +GG L +L R R A + +I A+ L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALGYL 111
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTAETGTYRWMAPEL 196
HS +++RDLK ENL+L +D IK+ DFGL +E S M GT ++APE+
Sbjct: 112 HSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 32/194 (16%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIK------IVHKGETPEEIAKKESRFAREVAMLSR 80
+G GA+ KV+ G + A+K IV K +T E +R R+V L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH-----TRTERQV--LEA 60
Query: 81 VQHRN-LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARA 137
V+ LV A + + + ++ + ++GG L +L +V V I +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA---EIVLA 117
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE 195
++ LH GII+RD+K EN+LL + + L DFGL++E E A + GT +MAPE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 196 LYSTVTLRQGEKKH 209
+ +R G H
Sbjct: 177 V-----IRGGSGGH 185
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 55/253 (21%), Positives = 99/253 (39%), Gaps = 55/253 (21%)
Query: 50 VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGG 108
VA+K++ + + F +E+ ++SR+++ N+++ +G C + + ++TE + G
Sbjct: 47 VAVKMLR----ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102
Query: 109 TLRKYLLNMRPR----------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158
L ++L + + + A+ IA M+ L S +HRDL N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 159 TEDLKTIKLADFGLAREESLTEMMTAETGTY---RWMAPEL------------------- 196
TIK+ADFG++R + + RWMA E
Sbjct: 163 GNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 197 -----------YSTVTLRQ-----GEKKHYNHKNVRPSAENV-PEELSIILTSCWKEDPN 239
YS ++ Q GE + + S + P + ++ CW D
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281
Query: 240 ARPNFTQIIQMLL 252
RP F +I L
Sbjct: 282 DRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 43/152 (28%), Positives = 64/152 (42%), Gaps = 22/152 (14%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I GA A++Y G + IK + K E+ ++ R RE ++SR + V
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVN 62
Query: 89 FIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
V IV E + G L+ + + L++ IG + + LH
Sbjct: 63 ----VPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRL--VGK----LH 112
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
S GIIH DL N++L+ I L DFGLA
Sbjct: 113 SAGIIHGDLTTSNMILSGG--KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 8/169 (4%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV E K ++ AIK++ K ++ + + + L+ +H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + V E ++GG L + R R D + +A ++ A+ LH HG+I+
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVIY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
RDLK +N+LL + KLADFG+ +E L + T GT ++APE+
Sbjct: 120 RDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 60/249 (24%), Positives = 117/249 (46%), Gaps = 38/249 (15%)
Query: 32 IGEGA--HAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ A + + +Q A+K + ++ + ++SR +E +L++++H N+V F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSR--KEAVLLAKMKHPNIVAF 63
Query: 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + + IV E GG L + + R + + + + + ++ +H ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE----------- 195
RD+K +N+ LT++ K +KL DFG AR + + A T GT ++ PE
Sbjct: 124 RDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIWENMPYNNKS 181
Query: 196 --------LYSTVTLRQ----GEKKHYNHKNVRPSAENVPE----ELSIILTSCWKEDPN 239
LY TL+ K+ K + S + +P EL ++ +K +P
Sbjct: 182 DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPR 241
Query: 240 ARPNFTQII 248
+RP+ T I+
Sbjct: 242 SRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 23/178 (12%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIK------IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
IG+G+ KV + + ++ + A+K IV + E +A E +L++V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA--------ERTVLAQVNC 52
Query: 84 RNLV--KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+V KF E + +V ++GG L +L R D+ A + ++ A+E L
Sbjct: 53 PFIVPLKFSFQSPEK-LYLVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENL 109
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPELYS 198
H +I+RDLKPEN+LL + I L DFGL + + GT ++APEL
Sbjct: 110 HKFNVIYRDLKPENILL-DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 21/178 (11%)
Query: 32 IGEGAHAKVYE--GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G + KV++ K A+KI+ +E + E + ++ H N+VKF
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80
Query: 90 IGAC-KEPV-----MVIVTELLSGGT---LRKYLLNMRPRCLDVCVAIGFALDIA-RAME 139
G K+ V + +V EL +GG+ L K L R + +A + L A ++
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA--YILHEALMGLQ 138
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-MTAETGTYRWMAPEL 196
LH + IHRD+K N+LLT + +KL DFG++ + + T + GT WMAPE+
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 52/169 (30%), Positives = 87/169 (51%), Gaps = 8/169 (4%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK- 88
+G+G+ KV+ + K NQ AIK + K + + + + V L+ +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHL 61
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + V E L+GG L ++ + D+ A +A +I ++ LHS GI++
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
RDLK +N+LL D IK+ADFG+ +E L + T GT ++APE+
Sbjct: 120 RDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 32/182 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G +VY+ + K + A+K++ K +EI K +EVA + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK----KEIVAK-----KEVA--HTIGERNILVR 49
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ P +V +VT+ +SGG L +L + A + ++
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVL 107
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
A+E LH + I++RDLKPEN+LL I L DFGL++ LT+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 195 EL 196
E+
Sbjct: 166 EV 167
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 37/156 (23%), Positives = 59/156 (37%), Gaps = 17/156 (10%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I +GA A +Y + +K + K E+ +K R RE +L++ V
Sbjct: 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVP 62
Query: 89 --FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ +IV E + G L+ L D+ +G + + LH GI
Sbjct: 63 VPIVYDVDPDNGLIVMEYIEGELLKDAL---EEARPDLLREVG--RLVGK----LHKAGI 113
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
+H DL N++L+ I DFGL E
Sbjct: 114 VHGDLTTSNIILSGG--RIYFIDFGLGEFSDEVEDK 147
|
Length = 204 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 57/187 (30%), Positives = 96/187 (51%), Gaps = 18/187 (9%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRN 85
+G GA+ KV+ G + A+K++ K ++ E +R R+V R Q
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 66
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A + + + ++ + ++GG L +L + R R + V I ++ +I A+E LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQI-YSGEIVLALEHLHKL 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPELYSTVTL 202
GII+RD+K EN+LL + + L DFGL++E E E + GT +MAP++ +
Sbjct: 125 GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI-----V 178
Query: 203 RQGEKKH 209
R G+ H
Sbjct: 179 RGGDGGH 185
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 25/177 (14%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V Y+ + + Q VA+K K P + R RE+ +L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR-QKVAVK---KLSRPFQSLIHARRTYRELRLLKHMKHENVIG 78
Query: 89 FIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVC-VAIGFAL-DIARAME 139
+ + +VT L+ LN +C + + F + + R ++
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLMGAD------LNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+HS GIIHRDLKP N+ + ED + +++ DFGLAR+ + MT T + APE+
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQAD--DEMTGYVATRWYRAPEI 186
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 51/171 (29%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +A+ ME L S IHRDL N+LL+E+ +K+ DFGLAR + + G
Sbjct: 182 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR-DIYKDPDYVRKG 239
Query: 188 TYR----WMAPE-----LYSTVT--------------------------------LRQGE 206
R WMAPE +Y+ + L++G
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 299
Query: 207 KKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ +R PE +L CW +P+ RP F+++++ L N L A
Sbjct: 300 R-------MRAPDYTTPEMYQTML-DCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 20/187 (10%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W + ++ + P +G GA+ V + +T V K P + R RE+ +L
Sbjct: 13 WEVPERYQNLSP-VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 79 SRVQHRNLVKFIGACKEPV-------MVIVTELLSGGTLRKYLLNMRPRCLDVCV-AIGF 130
++H N++ + + +VT L+ LN +C + + F
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD------LNNIVKCQKLTDDHVQF 124
Query: 131 AL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+ I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTD--DEMTGYVATR 181
Query: 190 RWMAPEL 196
+ APE+
Sbjct: 182 WYRAPEI 188
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 38/188 (20%)
Query: 32 IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
+G+GA+ V + +TVAIK + + + +AK R RE+ +L + H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAK---RALRELKLLRHFRGHKNI 64
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI------------GFALDI 134
M IV G + L D+ I F I
Sbjct: 65 TCLYD------MDIVFP----GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTY 189
++ +HS ++HRDLKP NLL+ D + +K+ DFGLAR MT T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVAT- 172
Query: 190 RWM-APEL 196
RW APE+
Sbjct: 173 RWYRAPEI 180
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 18/173 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKG-ETPEEIAKKESRFAREVAMLSRVQ-HRNL 86
+IGEG ++V + + + + AIK + K ++ E++ RE+ L R+ H N+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-----LREIQALRRLSPHPNI 60
Query: 87 VKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ I + + +V EL+ L + + R R L + + ++++ +H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APE 195
+GI HRD+KPEN+L+ +D +KLADFG R T T RW APE
Sbjct: 119 NGIFHRDIKPENILIKDD--ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 9/174 (5%)
Query: 32 IGEG--AHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V K A+K++ K + + S F E +LS + +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ--ETVSFFEEERDILSISNSPWIPQL 66
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
A ++ + +V E GG L LLN D +A + ++ A+ +H G +H
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPELYSTV 200
RD+KPEN+L+ + IKLADFG A + +M+ ++ GT ++APE+ +T+
Sbjct: 126 RDIKPENVLI-DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V ++K + A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A + + + +V E + GG L + N DV A + ++ A++ +HS G
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
+IHRD+KP+N+LL + +KLADFG + T M+ +T GT +++PE+ +
Sbjct: 163 LIHRDVKPDNMLL-DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS---- 217
Query: 204 QGEKKHY 210
QG +Y
Sbjct: 218 QGGDGYY 224
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 30/180 (16%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG-----------ETPEEIAKKESRFAREVAML 78
IG G++AKV + K + A+K++ K +T + + + S V +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
S Q E + V E +SGG L ++ R R L A ++ +I+ A+
Sbjct: 63 SCFQ-----------TESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLAL 109
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
LH GII+RDLK +N+LL + IKL D+G+ + E + T T GT ++APE+
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 21/118 (17%)
Query: 73 REVAMLSRVQHRNLVKFIGA-----------CKEPVMV----IVTELLSGGTLRKYLLNM 117
RE+ ++ R+ H N+VK + IV E + L +L
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLAN-VLEQ 108
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAR 174
P L A F + R ++ +HS ++HRDLKP N+ + TEDL +K+ DFGLAR
Sbjct: 109 GP--LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 29/154 (18%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEEIAKK--ESRFAREVAMLSRVQHRNLVK 88
I +GA A +Y G + IK V K E+ ++ R E +LSR + V
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVN 60
Query: 89 FIGACKEPV--------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
PV IV E + G L+ + ++ IG + +
Sbjct: 61 ------TPVVYDVDPDNKTIVMEYIEGKPLKDV---IEEGNDELLREIGRL--VGK---- 105
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
LH GI+H DL N+++ +D + L DFGL +
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 58/177 (32%), Positives = 86/177 (48%), Gaps = 25/177 (14%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNL 86
+G+G KV K + A+KI+ K E I K+ EVA SRV
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKD-----EVAHTVTESRVLQNTR 53
Query: 87 VKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
F+ A K + V E +GG L +L R R A + +I A+E L
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYL 111
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
HS +++RD+K ENL+L +D IK+ DFGL + E +++ T +T GT ++APE+
Sbjct: 112 HSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 13/174 (7%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRN 85
+G GA+ KV+ G + A+K++ K ++ E +R R V R Q
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSPF 66
Query: 86 LVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A + E + ++ + +SGG + +L R + V ++ +I A+E LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRF-YSGEIILALEHLHKL 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPEL 196
GI++RD+K EN+LL + + L DFGL++E E + GT +MAPE+
Sbjct: 125 GIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 36/100 (36%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ V E L+GG L + + + R D+ A +A +I ++ LHS GII+RDLK +N++
Sbjct: 71 LFFVMEFLNGGDL-MFHIQDKGR-FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 158 LTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPEL 196
L D IK+ADFG+ +E + + GT ++APE+
Sbjct: 129 LDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVK 88
IG GA V + +K +A+K + K++ R ++ ++ R +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRS----TVDEKEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 89 FIGAC-KEPVMVIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSH 144
F GA +E I EL +S KY+ + + + A+ +A+ L
Sbjct: 68 FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 145 GIIHRDLKPENLLLTEDLK-TIKLADFGLA--REESLTEMMTAETGTYRWMAPE 195
IIHRD+KP N+LL D IKL DFG++ +S+ + T + G +MAPE
Sbjct: 128 KIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 12/179 (6%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ + L +G G V + K+ +A K+VH G + RE+ ++
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIM 57
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ +V F GA E + + E + G+L + P +++ I A+ +
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKI--AVAVVEG 115
Query: 138 MECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ L++ H I+HRD+KP N+L+ IKL DFG++ E + + GT +M+PE
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-GELINSIADTFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 57/172 (33%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKE-SRFAREVAMLSRVQHRNL-- 86
+G+G KV K + A+KI+ K IAK E + E +L +H L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVI---IAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+K+ K+ + V E ++GG L +L R R + +I A++ LHS I
Sbjct: 60 LKYSFQTKDR-LCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
++RDLK ENL+L +D IK+ DFGL + E +T+ T +T GT ++APE+
Sbjct: 117 VYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 16/173 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG--ETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G++AKV + K +Q A+K+V K E+I ++ E + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQT----EKHVFEQASSNPFL 58
Query: 88 KFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ +C + +V E ++GG L ++ R R L A +A +I A+ LH G
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
II+RDLK +N+LL D IKL D+G+ + E L T T GT ++APE+
Sbjct: 117 IIYRDLKLDNVLLDAD-GHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V ++K Q A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM---IKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A ++ + +V E + GG L + N D+ A + ++ A++ +HS G
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
IHRD+KP+N+LL + +KLADFG + M+ +T GT +++PE V
Sbjct: 163 FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLKS 217
Query: 204 QGEKKHY 210
QG +Y
Sbjct: 218 QGGDGYY 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 30/73 (41%), Positives = 47/73 (64%), Gaps = 4/73 (5%)
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ + E++ T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCK-ENIFGGKTTR 159
Query: 186 T--GTYRWMAPEL 196
T GT ++APE+
Sbjct: 160 TFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 69/284 (24%), Positives = 108/284 (38%), Gaps = 62/284 (21%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G +VY ++ VA+K + + + + KK RF RE + + + H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK--RFLREAKIAADLIHPGIVPV 67
Query: 90 IGACKEPVMVIVT-ELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDI----ARAME 139
C + V T + G TL+ L ++ + L ++G L I +E
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 140 CLHSHGIIHRDLKPENLLL---------------TEDLKTIKLADFGLAREESLTEMMTA 184
+HS G++HRDLKP+N+LL + L+ L D + MT
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 185 E---TGTYRWMAPE-------------------LYSTVTLR------QGEKKHYNHKNVR 216
GT +MAPE LY +TL +G K Y +
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILS 247
Query: 217 PSA----ENVPEELSIILTSCWKEDPNAR-PNFTQIIQMLLNYL 255
P +P LS I DP R + ++ Q L +L
Sbjct: 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 51/175 (29%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA+ V + VAIK +++ E AK R RE+ +L ++H N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMKHENVIGL 79
Query: 90 IGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIARAMECL 141
+ + + +V + GT L+ D I F + + + ++ +
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSED---RIQFLVYQMLKGLKYI 134
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + APE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD--SEMTGYVVTRWYRAPEV 186
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 17/165 (10%)
Query: 35 GAHAKVYEGKYKNQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92
G+ +V+ Q V +KI KG T E +L V H ++++
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKIGQKGTT-----------LIEAMLLQNVNHPSVIRMKDT 125
Query: 93 -CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151
+ +V S L YL R R L + A+ I + LH+ IIHRD+
Sbjct: 126 LVSGAITCMVLPHYSS-DLYTYL-TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDV 183
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
K EN+ + D+ + + D G A+ + GT APE+
Sbjct: 184 KTENIFI-NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEV 227
|
Length = 357 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG GA +V K + A+K++ K E I + +S F E +++ +V+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCV--AIGFALDIARAMECLHSHG 145
A ++ + +V E + GG L + N DV A + ++ A++ +HS G
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMG 162
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLR 203
IHRD+KP+N+LL + +KLADFG + + M+ +T GT +++PE+ +
Sbjct: 163 FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---- 217
Query: 204 QGEKKHY 210
QG +Y
Sbjct: 218 QGGDGYY 224
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV E K ++ AIKI+ K ++ + + + V L+ +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRV--LALQDKPPFLTQ 65
Query: 90 IGACKEPV--MVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHS 143
+ +C + V + V E ++GG L ++ + P+ A+ +A +I+ + LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ------AVFYAAEISVGLFFLHR 119
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
GII+RDLK +N++L + IK+ADFG+ + E + + +T T GT ++APE+
Sbjct: 120 RGIIYRDLKLDNVMLDSE-GHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 47/160 (29%)
Query: 131 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAETG 187
A+ I +A+E LHS +IHRD+KP N+L+ + + +KL DFG++ L + + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGY--LVDSVAKTIDAG 165
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHKN--------------------------------V 215
+MAPE + + +K Y+ K+ V
Sbjct: 166 CKPYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221
Query: 216 RPSAENVPEE-----LSIILTSCWKEDPNARPNFTQIIQM 250
+ +P E + C K++ RPN+ +++Q
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 51/263 (19%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-----FAREVAMLSRVQHRNL 86
+G+G K+++G + ++ HK E ++ K R F +M+S++ H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGEL-HKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 87 VKFIGAC---KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
V G C E +M V E + G+L Y L +++ + A +A A+ L
Sbjct: 62 VLNYGVCVCGDESIM--VQEYVKFGSLDTY-LKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 144 HGIIHRDLKPENLLLT--EDLKT-----IKLADFG-----LARE-----------ESLTE 180
G+ H ++ +N+LL ED KT IKL+D G L +E E +
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIEN 178
Query: 181 MMTAETGTYRW----MAPELYSTVTL------RQGEKKHYNHKNVRPSAENVPE--ELSI 228
+W E++S Q + + Y ++ P P+ EL+
Sbjct: 179 PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLP----APKWTELAN 234
Query: 229 ILTSCWKEDPNARPNFTQIIQML 251
++ C +P+ RP+F II+ L
Sbjct: 235 LINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 53/185 (28%), Positives = 92/185 (49%), Gaps = 27/185 (14%)
Query: 46 KNQTVAIKIVHKGETPEE--IAK-------KESRFAR-EVAMLSRVQHRNLVKFIGACK- 94
+N T A + +G P+E +AK +++ +AR E+ L+ H +VK K
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 95 EPVMVIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151
+ ++++ E SGG L K + L + V + F I A++ +HS ++HRDL
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLF-YQIVLALDEVHSRKMMHRDL 195
Query: 152 KPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKK 208
K N+ L IKL DFG +++ S + ++ ++ GT ++APEL+ E+K
Sbjct: 196 KSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW--------ERK 246
Query: 209 HYNHK 213
Y+ K
Sbjct: 247 RYSKK 251
|
Length = 478 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 46/190 (24%), Positives = 77/190 (40%), Gaps = 41/190 (21%)
Query: 8 YLADELKLDAKWLIDPKHLFVGPR---IGEGAHAKVYEGKYKNQTVAIKI-VHKGETPEE 63
+ DE+ + W+ + + IG+GA A + +G+Y + IK V KG E
Sbjct: 316 FRTDEV--EVTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPE 373
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----PV--------MVIVTELLSGGTL 110
+ ++ L + R + + + PV IV E + GG
Sbjct: 374 LDER----------LRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYI-GGKD 422
Query: 111 RKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
K +L P ++ +G +A+ LH GI+H DL N ++ +D + L DF
Sbjct: 423 LKDVLEGNP---ELVRKVG--EIVAK----LHKAGIVHGDLTTSNFIVRDD--RLYLIDF 471
Query: 171 GLAREESLTE 180
GL + L E
Sbjct: 472 GLGKYSDLIE 481
|
Length = 535 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 14/172 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKG--ETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IG G++AKV + K + A+K+V K E+I ++ E + + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQT----EKHVFEQASNHPFL 58
Query: 88 KFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ +C E + V E ++GG L ++ R R L A ++ +I+ A+ LH G
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE-TGTYRWMAPEL 196
II+RDLK +N+LL + IKL D+G+ +E T+ GT ++APE+
Sbjct: 117 IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 13 LKLDA-KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES 69
L +D K+ D L IG G +VY+ ++K +A+K + + EE K
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRI 60
Query: 70 RFAREVAMLSRVQHRNLVKFIGAC-----KEPVMVIVTELLSG--GTLRKYLLNMRPRCL 122
+V + S + +I C + + I EL+S L K + P +
Sbjct: 61 LMDLDVVLKS-----HDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDI 115
Query: 123 --DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
+ VAI AL + HG+IHRD+KP N+LL + +KL DFG++ L +
Sbjct: 116 LGKMTVAIVKALHYLK-----EKHGVIHRDVKPSNILL-DASGNVKLCDFGISGR--LVD 167
Query: 181 MM--TAETGTYRWMAPE 195
T G +MAPE
Sbjct: 168 SKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 17/143 (11%)
Query: 35 GAHAKVY----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
G+ +V+ G + + V +K V G+TP RE+ +L + HR ++ I
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG----------REIDILKTISHRAIINLI 152
Query: 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150
A + V + L Y+ P L+ + I L A+ LH GIIHRD
Sbjct: 153 HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL--LEALAYLHGRGIIHRD 210
Query: 151 LKPENLLLTEDLKTIKLADFGLA 173
+K EN+ L E + L DFG A
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAA 232
|
Length = 392 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 31/165 (18%)
Query: 28 VGPRIGEGAHAKVYEGKY-KNQT-VAIK--IVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+ ++GEG +VY+ + K VA+K ++H + I RE+ +L +++H
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA-----LREIKILKKLKH 66
Query: 84 RNLVKFI---------GACKEPVMVIVTEL----LSGGTLRKYLLNMRPRC-LDVCVAIG 129
N+V I K + +VT LSG LL P L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG------LLE-NPSVKLTESQIKC 119
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ L + + LH + I+HRD+K N+L+ ++ +K+ADFGLAR
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILI-DNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 45/167 (26%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 32 IGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G VY+ + + +A+K++ T E + + E+ +L + ++ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----LQKQIMSELEILYKCDSPYIIGF 64
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
GA E + I TE + GG+L Y R + V A+ + + + L S I+H
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
RD+KP N+L+ +KL DFG++ + + + GT +MAPE
Sbjct: 119 RDVKPSNMLVNTR-GQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 29/77 (37%), Positives = 41/77 (53%), Gaps = 17/77 (22%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT- 188
F + RA++ +H+ + HRDLKP+N+L D K +K+ DFGLAR + +T T
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLAR------VAFNDTPTA 160
Query: 189 --------YRWM-APEL 196
RW APEL
Sbjct: 161 IFWTDYVATRWYRAPEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+K + K E E+ R R++ L+ + +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVVKL 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + ++ E L GG + L M+ + + A++ +H G IH
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGL 172
RD+KP+NLLL IKL+DFGL
Sbjct: 125 RDIKPDNLLLDAK-GHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 29/71 (40%), Positives = 45/71 (63%), Gaps = 2/71 (2%)
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE- 185
A+ +A +IA + LHS GII+RDLK +N++L + IK+ADFG+ +E + T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTF 161
Query: 186 TGTYRWMAPEL 196
GT ++APE+
Sbjct: 162 CGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 25/67 (37%), Positives = 39/67 (58%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
++ + RA+ +HS I HRDLKP+NLL+ + T+KL DFG A+ + + +
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 190 RWMAPEL 196
+ APEL
Sbjct: 235 FYRAPEL 241
|
Length = 440 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 1e-06
Identities = 20/55 (36%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
LH H IIH D+K EN+L I L D+GL + GT + +PE
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
I A++ LHS GI+HRD+KP+N++ +E + K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+KI+ K + E+ R R++ L +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI--LVEADSLWVVKM 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + + ++ E L GG + L M+ L + + A++ +H G IH
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA-ETGTYRWMAPELYSTVTL----- 202
RD+KP+NLLL + +KL+DFGL T + A T YR + L S T
Sbjct: 125 RDIKPDNLLL-DSKGHVKLSDFGLC-----TGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 203 -RQGEKKHYNHKNVRPSAENVPEELS--IILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
R+ E N + + S P+ ++ + + + + + + + +ML+ Y +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 260 PPEPMIPHRIFN-SENTILPPESP 282
++ N E I PPE P
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 25/67 (37%), Positives = 43/67 (64%), Gaps = 2/67 (2%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 190 RWMAPEL 196
+MAPE+
Sbjct: 160 GYMAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 28/82 (34%), Positives = 41/82 (50%), Gaps = 19/82 (23%)
Query: 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR--------AMECLHSHGIIHRDL 151
++ E L GG L L+ F+ D+ R A+E +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDT----------FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 152 KPENLLLTEDLKTIKLADFGLA 173
KP+N+L+ IKL+DFGL+
Sbjct: 128 KPDNILIDRG-GHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 24/51 (47%), Positives = 31/51 (60%), Gaps = 9/51 (17%)
Query: 130 FALDIAR--------AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172
F D+AR A+E +H G IHRD+KP+N+L+ D IKL DFGL
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENL 156
+ V E +GG L +L R R A + +I A++ LHS +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 157 LLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+L +D IK+ DFGL + E + + T +T GT ++APE+
Sbjct: 128 MLDKD-GHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMA 193
A+ +HS +IHRD+K N+LL + +KL DFG ++ + T ++ GT ++A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 194 PE-------------------LYSTVTLRQ---GEKKH-YNHKNVR----PSAENVPEEL 226
PE LY +TL++ GE HK + P ++ E+
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEM 273
Query: 227 SIILTSCWKEDPNARPNFTQIIQM 250
I+T+ DP RP+ ++++ M
Sbjct: 274 QEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 45/257 (17%)
Query: 31 RIGEGAHAKVY-----EGKYKNQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHR 84
R+G+G+ VY + + + +K + GE P E + +E +LS++ H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHP 62
Query: 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECL 141
+VKF + E I+TE G L L ++ + L + + + + +
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-EESLTEMMTAETGTYRWMAPE----- 195
H I+HRDLK +N+ L +L +K+ DFG++R ++ T TGT +M+PE
Sbjct: 123 HQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 196 --------------LYSTVTLRQGEKKHYNHKNV--------RPS-AENVPEELSIILTS 232
LY L + N +V PS E +L+ I+ S
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS 239
Query: 233 CWKEDPNARPNFTQIIQ 249
+DP+ RP+ +I++
Sbjct: 240 MLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA---REVAMLSRVQHRNL 86
+G+G + VY+ ++ T+A+K + + ES+F E+ +L + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPYI 61
Query: 87 VKFIGA-CKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HS 143
V F GA E + + E + G+L K Y + + V + + ++ L
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLA--REESLTEMMTAETGTYRWMAPE 195
H IIHRD+KP N+L+ + +KL DFG++ SL + G +MAPE
Sbjct: 122 HNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAK---TNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 25/67 (37%), Positives = 43/67 (64%), Gaps = 2/67 (2%)
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
+A +I +E +H+ +++RDLKP N+LL E ++++D GLA + S + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 190 RWMAPEL 196
+MAPE+
Sbjct: 160 GYMAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 23/51 (45%), Positives = 31/51 (60%), Gaps = 1/51 (1%)
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
D+ V G + + LH GI+HRD+KPENLL+T D +K+ DFG A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 32 IGEGAHAKV--YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V + K A+KI+ K + E+ R R++ L +VK
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI--LVEADGAWVVKM 66
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ ++ + ++ E L GG + L M+ L + + A++ +H G IH
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 149 RDLKPENLLLTEDLKTIKLADFGL 172
RD+KP+NLLL + +KL+DFGL
Sbjct: 125 RDIKPDNLLL-DAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 2e-05
Identities = 39/166 (23%), Positives = 62/166 (37%), Gaps = 38/166 (22%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHK-GETPEEIAKK---------------ESR 70
+G +IG G + VY + VA+K H+ G T K+ SR
Sbjct: 19 LGNQIGVGKESDVYLALDPDGNPVALKF-HRLGRTSFRKVKRKRDYLGDRKHASWLYLSR 77
Query: 71 FA--REVAMLSRVQHRNLVKFIGACKEPV----MVIVTELLSGGTLRKYLLNMRPRCLDV 124
A +E A L + +P+ +V E + G L + + P
Sbjct: 78 LAAQKEFAALKALYEEG-----FPVPKPIDWNRHAVVMEYIDGVELYRVRVLEDPE---- 128
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
+I + + HGIIH DL N+L+ +D K I + D+
Sbjct: 129 ----EVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK-IYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 6/125 (4%)
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
RE+ +L +V F GA + + I E + GG+L + L + ++ + A
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111
Query: 132 LDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
+ R + L H I+HRD+KP N+L+ IKL DFG++ + + M + GT
Sbjct: 112 --VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRS 167
Query: 191 WMAPE 195
+M+PE
Sbjct: 168 YMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 33/151 (21%), Positives = 57/151 (37%), Gaps = 25/151 (16%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL---- 86
+ G +VY K++ +KI E K + REVA+L + + L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKINPSRE-------KGADREREVAILQLLARKGLPVPK 57
Query: 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-- 144
V G + ++ E + G TL + + A +A + LH
Sbjct: 58 VLASGE-SDGWSYLLMEWIEGETLDEVSEEEKED---------IAEQLAELLAKLHQLPL 107
Query: 145 -GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ H DL P N+L+ + K + + D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDG-KILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 28/77 (36%), Positives = 42/77 (54%), Gaps = 7/77 (9%)
Query: 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155
+ V + + GG + L+ M P L A + ++ A+E +H G IHRD+KP+N
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIAELTLAIESVHKMGFIHRDIKPDN 131
Query: 156 LLLTEDLKTIKLADFGL 172
+L+ D IKL DFGL
Sbjct: 132 ILIDLD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 21/52 (40%), Positives = 32/52 (61%), Gaps = 2/52 (3%)
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 119 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 7/169 (4%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG GA +V K K+ + A+KI++K E + R R V + Q + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
E + +V + GG L L R L +A + ++ A+ +H +HR
Sbjct: 69 -AFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHR 126
Query: 150 DLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPEL 196
D+KP+N+LL + I+LADFG L + T + GT +++PE+
Sbjct: 127 DIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 3/75 (4%)
Query: 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157
+ V + + GG + L+ M D+ A + ++ A+E +H G IHRD+KP+N+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 158 LTEDLKTIKLADFGL 172
+ D IKL DFGL
Sbjct: 134 IDRD-GHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 16/112 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYE----GKYKN---QTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA KV + G K+ +TVA+K++ +G T E
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE----YKA 56
Query: 71 FAREVAMLSRV-QHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR 118
E+ +L + H N+V +GAC + P+MVIV E G L YL + R
Sbjct: 57 LMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 30/140 (21%), Positives = 59/140 (42%), Gaps = 12/140 (8%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK-- 88
I E +Y+G + N+ V I+ K + K E+ L R+ N++K
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKK---FHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 89 --FIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SH 144
I + P + ++ E + G LR+ L + + L + A+D + + L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 145 GIIHRDLKPENLLLTEDLKT 164
+++L + L+TE+ K
Sbjct: 143 NKPYKNLTSVSFLVTENYKL 162
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 11/171 (6%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG GA +V K KN Q A+KI++K E + + E+ F E +L R +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEM---LKRAETACFREERDVLVNGDRRWITN 65
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + E + +V + GG L L R L +A + ++ A++ +H G +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPEL 196
HRD+KP+N+LL ++ I+LADFG L T GT +++PE+
Sbjct: 125 HRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 48/171 (28%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 32 IGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESR-FAREVAMLSRVQHRNLVK 88
IG GA +V K KN + A+KI++K E + + E+ F E +L ++ +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDNQWITT 65
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V + GG L L R L +A + ++ A++ +H +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFG--LAREESLTEMMTAETGTYRWMAPEL 196
HRD+KP+N+L+ + I+LADFG L E T + GT +++PE+
Sbjct: 125 HRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 31/162 (19%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IGEG + +VY+ + K + VA+K V E RE+ +L ++ HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA---IREIKILRQLNHRNIVN- 70
Query: 90 IGACKEPVMVIVTELLSGGTLRK-----YLL--NMRPRCLDVCVA--IGFALD-IARAME 139
+ IVT+ +K YL+ M + + + + F+ D I M+
Sbjct: 71 -------LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 140 CL-------HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
L H +HRD+K N+LL + IKLADFGLAR
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLAR 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 37/155 (23%), Positives = 56/155 (36%), Gaps = 25/155 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVA--------ML 78
VG IG G A VY + + VA+KI ++ +K R L
Sbjct: 1 VGGPIGTGKEADVYLALDGDGEPVAVKI-YRTGRTSFKKRKRYRTGDYRFGRKKSNWRYL 59
Query: 79 SRV----QHRNLVKFIGA---CKEPVM----VIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
SR+ + RNL + A +P+ V+V E + G + L D
Sbjct: 60 SRLWAEKEFRNLKRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLED---P 116
Query: 128 IGFALDIARAMECL-HSHGIIHRDLKPENLLLTED 161
I M L G++H DL N+L+ +
Sbjct: 117 EELYDQILELMRKLYREAGLVHGDLSEYNILVDDG 151
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 5/61 (8%)
Query: 115 LNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGL 172
L R R L + A + A++ +H GIIHRD+K EN+L+ ED I L DFG
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGA 306
Query: 173 A 173
A
Sbjct: 307 A 307
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 50/221 (22%)
Query: 71 FAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
F +++S+V H +L G C + ++V E + G L L + R + V I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKIT 121
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFG-----LAREESL 178
A +A A+ L ++H ++ +N+LL IKL+D G L+REE +
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV 181
Query: 179 TEMMTAETGTYRWMAPELYSTV--------------TLRQ--------------GEKKHY 210
+ W+APE TL + EK+ +
Sbjct: 182 ERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 211 NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
K R + E L+ +++ C +P RP+F I++ L
Sbjct: 234 YEKKHRLPEPSCKE-LATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 47/203 (23%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAI---KIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
+IG G +V+ K+K I ++G E +S+ EV ++ ++H+N+V
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE----KSQLVIEVNVMRELKHKNIV 75
Query: 88 KFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAI--GFALDIARAMECLH 142
++I + I+ E G L + + +C + I +DI R + LH
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNI----QKCYKMFGKIEEHAIVDITRQL--LH 129
Query: 143 S-------------HGIIHRDLKPENLLLTEDLKTI----------------KLADFGLA 173
+ ++HRDLKP+N+ L+ ++ I K+ DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 174 REESLTEMMTAETGTYRWMAPEL 196
+ + M + GT + +PEL
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPEL 212
|
Length = 1021 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLH 142
L K+I E + +V + GG L ++ LN+ C+ +A ++ A++ LH
Sbjct: 50 LHKYI--VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR-----WAAEMVVALDALH 102
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
GI+ RDL P N+LL +D I+L F E
Sbjct: 103 REGIVCRDLNPNNILL-DDRGHIQLTYFSRWSE 134
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 23/172 (13%)
Query: 39 KVYEGKYKNQTVAIKIVHKGETPEEIAKK----------ESRFAREVAMLSRVQHRNLVK 88
K+ E N V K+ HK + +A+K ++ RE+ +L +V
Sbjct: 9 KISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMR--PRCL--DVCVAIGFALDIARAMECLHS 143
F GA + + I E + GG+L + L P + V +A+ L R
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-----EK 122
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
H I+HRD+KP N+L+ IKL DFG++ + + M + GT +M+PE
Sbjct: 123 HKIMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 16/112 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGK-------YKNQTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E
Sbjct: 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRA 56
Query: 71 FAREVAMLSRV-QHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMR 118
E+ +L + H N+V +GAC + P+MVIV E G L YL + R
Sbjct: 57 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 22/134 (16%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91
I G Y+GK + + +EI S + E+A + ++QH N+VK IG
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVV-------KEINDVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 92 ACK-EPVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSH--- 144
C+ E ++ E + G L + L N+ R R +AIG IA+A+ LH
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRR----KIAIG----IAKALRFLHCRCSP 802
Query: 145 GIIHRDLKPENLLL 158
++ +L PE +++
Sbjct: 803 AVVVGNLSPEKIII 816
|
Length = 968 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 73/274 (26%)
Query: 32 IGEGAHAKVYEGKYKNQT--------------VAIKIVHKGETPEEIAKKESRFAREVAM 77
+G G ++Y G + V +K++ +A F +M
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA-----FFETASM 57
Query: 78 LSRVQHRNLVKFIGACKEPVM-VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF--ALDI 134
+ +V H+++V G C V ++V E + G L L M + + F A +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQL 114
Query: 135 ARAMECLHSHGIIHRDLKPENLLL------TEDLKTIKLADFG-----LAREESLTEMMT 183
A A+ L ++H ++ +N+LL E IKL+D G L+R+E + +
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI-- 172
Query: 184 AETGTYRWMAPELYST--------------VTLRQ--------------GEKKHYNHKNV 215
W+APE TL + EK+ +
Sbjct: 173 ------PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226
Query: 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
+ +EL+ ++T C DPN RP F I++
Sbjct: 227 MLVTPSC-KELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 29/167 (17%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-------SRFAREVAMLS 79
+ G ++G G + VY+ K K+ G+ +E A K+ RE+A+L
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKD----------GKDEKEYALKQIEGTGISMSACREIALLR 53
Query: 80 RVQHRNLVK----FIGACKEPVMVIVTELLSG-----GTLRKYLLNMRPRCLDVCVAIGF 130
++H N++ F+ V ++ R N +P L +
Sbjct: 54 ELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 174
I + LH++ ++HRDLKP N+L+ + +K+AD G AR
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKK 67
+L D++W L +G +G GA KV EG ++Q V +K+ K P + +
Sbjct: 25 QLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPV-MKVAVKMLKPTARSSE 83
Query: 68 ESRFAREVAMLSRV-QHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR 118
+ E+ +++ + H N+V +GAC K + I+TE G L YL R
Sbjct: 84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNR 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 29/167 (17%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKE-------SRFAREVAMLS 79
+ G ++G G + VY+ K K+ G+ + A K+ RE+A+L
Sbjct: 4 YEGCKVGRGTYGHVYKAKRKD----------GKDDRDYALKQIEGTGISMSACREIALLR 53
Query: 80 RVQHRNLVK----FIGACKEPVMVIVTELLSG-----GTLRKYLLNMRPRCLDVCVAIGF 130
++H N++ F+ V ++ R N +P L +
Sbjct: 54 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 174
I + LH++ ++HRDLKP N+L+ + +K+AD G AR
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 19/54 (35%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
R + +C + + RA++ LH + IIHRD+K EN+ + + L DFG A
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 15/117 (12%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYE----GKYKNQ---TVAIKIVHKGETPEEI 64
+L D KW L G +G GA KV E G +K+ TVA+K++ P
Sbjct: 23 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKML----KPSAH 78
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMR 118
+ E+ +LS + H N+V +GAC P +VI TE G L +L R
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI-TEYCCYGDLLNFLRRKR 134
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.82 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.62 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.54 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.53 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.48 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.17 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.02 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.86 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.85 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.72 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.66 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.41 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.28 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.2 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.14 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.03 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.9 | |
| PLN02236 | 344 | choline kinase | 97.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.42 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.38 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.34 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.23 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.93 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.76 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.75 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.69 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.65 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.24 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.21 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 96.04 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=335.00 Aligned_cols=229 Identities=26% Similarity=0.355 Sum_probs=192.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH--HHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
.+.|.+.+.||+|+||.|-+|..+ ++.||||++.+....... ......+.+|+++|++|+|||||++++++... .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467889999999999999999775 899999999886654422 11233467999999999999999999999876 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~ 175 (317)
.||||||++||+|.+++-.++- +.+..-..+++|++.|+.|||++||+||||||+|||+..+ .-.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 7999999999999999987665 8888889999999999999999999999999999999865 23689999999999
Q ss_pred cccccccccccCccceeccccccccc--ccccccccccCC--------------------------------CCCCCCCC
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK--------------------------------NVRPSAEN 221 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~--------------------------------~~~~~~~~ 221 (317)
......+.+.|||+.|.|||++.+.. ......+.|+.+ ...+....
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 88888899999999999999987643 233345566554 11123456
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++++..+||.+||..||++|||++++++|-|-
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 78899999999999999999999999999653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=336.04 Aligned_cols=243 Identities=41% Similarity=0.708 Sum_probs=204.8
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEECCeE-EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
....|.|+..++.+.+.||+|+||+||+|.+.|+. ||||++......... ++.|.+|+.+|.+++|||||+++|+|
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34679999999999999999999999999999888 999999876655432 67899999999999999999999999
Q ss_pred ecC--ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEeeCCCCceEEccc
Q 021127 94 KEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 94 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
.++ ...+||||+++|+|.+++.......+++..++.|+.||++||.|||+++ ||||||||+|||++.+.-++||+||
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 877 4899999999999999998854455999999999999999999999999 9999999999999998228999999
Q ss_pred Ccccccccc-cccccccCccceecccccccc-cccccccccccCC----------------------------CCC-CCC
Q 021127 171 GLAREESLT-EMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK----------------------------NVR-PSA 219 (317)
Q Consensus 171 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~----------------------------~~~-~~~ 219 (317)
|+++..... ...+...||+.|||||++.+. ...+...+.|+.+ ..+ ..+
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 999866543 333446899999999999953 2222223333322 222 335
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..++..+..||..||..||..||++.+++..|+.+......
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 66899999999999999999999999999999988775544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=339.86 Aligned_cols=221 Identities=29% Similarity=0.445 Sum_probs=192.5
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|..++.||+|||.+||++++ +|+.||+|++++..... ...++++.+||+++++|+|||||+++++|++. .+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 5799999999999999999988 39999999999865544 35567899999999999999999999999987 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
|.|+|..++|..+++.++. ++|.++..+++||+.||.|||+++|+|||||.+|+|++.++ .+||+|||+|..... .
T Consensus 96 vLELC~~~sL~el~Krrk~--ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKP--LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCCccHHHHHHhcCC--CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCcc
Confidence 9999999999999986555 99999999999999999999999999999999999999995 899999999987654 3
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
+...+.||||.|+|||++.. .-..-..++|+.+ ..-..|..++.+.++||.+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 67788999999999999873 2233344555544 2233466889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
+|+.||.+|||+++|+.+
T Consensus 252 lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HhcCCcccCCCHHHHhcC
Confidence 999999999999999988
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=321.03 Aligned_cols=225 Identities=26% Similarity=0.394 Sum_probs=190.7
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..|...+++.++.||+|..|+||+++++ ++.+|+|++...... ...+++.+|+++++..+|||||++||.|..+
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~----~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP----ALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH----HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 3455568889999999999999999986 899999999554442 3466799999999999999999999998754
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...|+||||++|+|.+++...+. +++...-.|+.+|++||.|||+ .+||||||||+|||++.. |.+||||||.+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS 226 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVS 226 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEecccccc
Confidence 39999999999999999987644 9999999999999999999996 899999999999999998 89999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------------------------------CCCC-CCC
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRP-SAE 220 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~-~~~ 220 (317)
...... ...+.+||..|||||-+.+..+.-. .++|+.+ ...| .|.
T Consensus 227 ~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 227 GILVNS-IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred HHhhhh-hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 976655 6678899999999999888655443 4444443 1111 244
Q ss_pred C-ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 221 N-VPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 221 ~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+ +++++++||..||++||.+||++.|+++|-+
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 4 8899999999999999999999999999844
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=313.68 Aligned_cols=225 Identities=30% Similarity=0.404 Sum_probs=191.6
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+.+++|++.++||+|+||+||.++.. ++.+|+|++++...-.. +..+...+|..+|.+++||+||+++..|+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~--~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK--KEVRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh--hhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 577899999999999999999998764 89999999998765442 3456788999999999999999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc-
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE- 175 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~- 175 (317)
.+|+|+||+.||.|..+|++.+. +++..+..++..|+.||.|||++|||||||||+|||++.+ |.++|+|||+++.
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhc
Confidence 89999999999999999997655 9999999999999999999999999999999999999999 8999999999994
Q ss_pred cccccccccccCccceecccccccccccccccccccCC---------------------------CCCCC-CCCChHHHH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS-AENVPEELS 227 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~~l~ 227 (317)
......+.+.|||+.|||||++.+..+. ...+||+.+ ...+. +..++.+.+
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred ccCCCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 4444566778999999999999886443 344555544 11123 344899999
Q ss_pred HHHHHhhhcCCCCCC----CHHHHHHH
Q 021127 228 IILTSCWKEDPNARP----NFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rp----s~~~~~~~ 250 (317)
+++.++|..||++|. ++.+|.+|
T Consensus 255 dll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 255 DLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 999999999999995 56666655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=327.04 Aligned_cols=240 Identities=30% Similarity=0.562 Sum_probs=203.5
Q ss_pred ccceec-CCceeecCCceeecceeccccceEEEEeEECCe-EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 10 ADELKL-DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 10 ~~~~~~-~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
|+.... ...|+|+++.+.+++.||+|.||.||.|.+++. .||+|.+....... ..|.+|+.+|++|+|+|||
T Consensus 191 p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~------~~f~~Ea~iMk~L~H~~lV 264 (468)
T KOG0197|consen 191 PQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP------EAFLREAQIMKKLRHEKLV 264 (468)
T ss_pred CCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh------hHHHHHHHHHHhCcccCeE
Confidence 444444 678999999999999999999999999999976 89999998765432 3588999999999999999
Q ss_pred eEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+++|+|.++ .++||||||+.|+|.++|+......+...+.+.|+.|||+||+||+++++|||||.++||||+++ ..+|
T Consensus 265 ~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vK 343 (468)
T KOG0197|consen 265 KLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVK 343 (468)
T ss_pred EEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEE
Confidence 999999875 69999999999999999998555669999999999999999999999999999999999999999 6999
Q ss_pred EcccCccccccccccccc--ccCccceecccccccccccccccccccCC-----------------------------CC
Q 021127 167 LADFGLAREESLTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NV 215 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~ 215 (317)
|+|||+|+.......... ..-...|.|||++....+.... ++|+.+ ..
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kS-DVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR 422 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKS-DVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR 422 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCCccccc-ceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc
Confidence 999999995443332222 2235789999998775544433 333333 45
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+.|..+|+++.++|..||+.+|++|||++.+...++++...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 677999999999999999999999999999999998887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=312.65 Aligned_cols=221 Identities=29% Similarity=0.445 Sum_probs=185.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|.+.++||.|+||+||+|+++ +..||||.+.+..... +..+.+..|+.+|+.++|||||++++++..+ .+|+
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~---k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK---KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH---HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 68999999999999999999986 8899999998765322 3455678999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-C----CceEEcccCcccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-L----KTIKLADFGLARE 175 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~----~~~kl~Dfg~a~~ 175 (317)
|||||.||+|.+|++..+. +++..+..++.||+.||++||+++||||||||+||||+.. . -.+||+|||+|+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999998765 9999999999999999999999999999999999999864 1 2589999999999
Q ss_pred cccccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
........+.||++.|||||++....++...+ .|+.+ .....+..++..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAKAD-LWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAKAD-LWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccchhh-HHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence 88888888899999999999997655554433 33322 111123345566
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+|+...++.+|.+|.+..+.+.+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhh
Confidence 7789999999999999988877655
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=314.05 Aligned_cols=225 Identities=28% Similarity=0.388 Sum_probs=189.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 96 (317)
.+.-++|.+.++||.|.||.||+|+.. +..||||.+++....-+ +..=++|+..|++|+ |||||+|.+++.++
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e----e~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH----HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 344578999999999999999999875 88999999987654321 233478999999998 99999999998654
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
.+++||||| ..+|+++++.+ .+.+++.++..|+.||+.||+|+|.+|+.|||+||+|||+..+ ..+||+|||+|+
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLAR 158 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAR 158 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEeccccccc
Confidence 799999999 67999999886 6679999999999999999999999999999999999999966 489999999999
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
........+..+.|.+|+|||++..-.+.....+.|..+
T Consensus 159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 887777778889999999999987755555555544433
Q ss_pred -----------CCC-----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -----------NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -----------~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
... ....+.+.+..++|.+|+.+||.+|||+.+++++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000 01234678999999999999999999999999983
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=308.46 Aligned_cols=230 Identities=27% Similarity=0.417 Sum_probs=195.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 96 (317)
...+.|.+++.||+|+||+|+.|.+. ++.||+|++.+.............+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45579999999999999999999875 899999987765222110122334668999999998 99999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++|||||.||+|.+++.+.+. +.+..+..+++|+++|++|||++||+||||||+|||++.+.+.+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 79999999999999999998443 9999999999999999999999999999999999999987458999999999977
Q ss_pred -ccccccccccCccceeccccccccc-ccccccccccCC---------------------------CCCCCCCCC-hHHH
Q 021127 177 -SLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK---------------------------NVRPSAENV-PEEL 226 (317)
Q Consensus 177 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~---------------------------~~~~~~~~~-~~~l 226 (317)
.......+.+||+.|+|||++.+.. +.....+.|+.+ .....+..+ +.++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 4556778889999999999999977 777777888766 112235566 9999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.|+.+||..||.+|+++.+++.+-|
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChh
Confidence 99999999999999999999996644
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.37 Aligned_cols=226 Identities=27% Similarity=0.469 Sum_probs=186.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee--ecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~-~ 97 (317)
..++..++.||+|+||.||++.+. +...|||.+....... .+.+.+|+.+|.+++|||||+++|.. .+. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 567889999999999999999886 6999999988764322 44578999999999999999999973 343 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++.|||+++|+|.+++.+.+. .+++..+..++.||++||+|||++|||||||||+|||++...+.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 8999999999999999998775 599999999999999999999999999999999999999832689999999998655
Q ss_pred c----ccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCCh
Q 021127 178 L----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~ 223 (317)
. ........||+.|||||++..........++|+.+ .....+..++
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls 249 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLS 249 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccC
Confidence 2 22234568999999999998522221233333332 1234467789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+.++|+..|++.||++|||++++++|..-.
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 9999999999999999999999999986543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=293.59 Aligned_cols=221 Identities=28% Similarity=0.373 Sum_probs=182.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|+.+.++|+|+||.||+++++ |+.||||.+......... .+-.++|+++|++++|+|+|.|+.+|... ..++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V---kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV---KKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH---HHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 46888899999999999999885 999999999766554332 23467999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
|+|||+. ++.+-|+.. +..++.+.+..|+.|++.|+.|+|++++|||||||+||||+.+ +.+||||||+|+... ..
T Consensus 79 VFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 79 VFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPG 155 (396)
T ss_pred Eeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCc
Confidence 9999965 555556553 3349999999999999999999999999999999999999999 799999999999776 66
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
...+..+.|.+|.|||++.+........++|..+
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 7778888999999999988855555555555443
Q ss_pred --CCCCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --NVRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...|. -+.++..+.+|+..||+.||++|++.++++.|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111 12445678999999999999999999999865
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=293.31 Aligned_cols=226 Identities=26% Similarity=0.434 Sum_probs=184.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee-e-ecC-c
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-C-KEP-V 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~-~~~-~ 97 (317)
..+|+++++||.|+||+||++... |..||.|.+...... .+.++....|+.+|++|+|||||+++++ + .++ .
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md---~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD---AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc---HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 357999999999999999998774 899999999865543 3667789999999999999999999984 3 344 4
Q ss_pred eEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCcEEeeCCCCceEEcccC
Q 021127 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHS--HG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~--~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++||||+|..|+|.+.++..+ .+.+++..+|+++.|++.||..+|+ .. |+||||||.||||+.+ |.+||+|||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfG 173 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFG 173 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccch
Confidence 899999999999999997543 4569999999999999999999999 45 9999999999999998 799999999
Q ss_pred cccccccc-cccccccCccceecccccccccccccccccccCC----------------------------CCCCCC-CC
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSA-EN 221 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~-~~ 221 (317)
+++..+.. ....+.+|||.||+||.+.+..+....+ +|+.+ ...+.| ..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSD-iWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSD-IWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchh-HHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 99976543 4456678999999999987755444332 23222 223334 57
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++..+..||..|+..||+.||+.-.+++-+..
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 78999999999999999999996555554443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=308.48 Aligned_cols=236 Identities=33% Similarity=0.626 Sum_probs=196.1
Q ss_pred CCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...|+|.++++.++..||+|.||+||+|+|.| .||||++.......+ ..+.|.+|+..+++-+|.||+-++|+|..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~---qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPE---QLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHH---HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 37899999999999999999999999999986 689999998776653 56679999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+...||+.+|+|.+|+.+|+..+.+ |+..+.+.|++||+.|+.|||.++|||||||..|||+.++ +.|||+|||++..
T Consensus 460 p~~AIiTqwCeGsSLY~hlHv~etk-fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPLAIITQWCEGSSLYTHLHVQETK-FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATV 537 (678)
T ss_pred CceeeeehhccCchhhhhccchhhh-hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceee
Confidence 8889999999999999999876543 9999999999999999999999999999999999999998 7999999999975
Q ss_pred ccccc---ccccccCccceeccccccccccc--ccccccccCC----------------------------CCCC----C
Q 021127 176 ESLTE---MMTAETGTYRWMAPELYSTVTLR--QGEKKHYNHK----------------------------NVRP----S 218 (317)
Q Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~~----------------------------~~~~----~ 218 (317)
..... ......|...|||||++...... ....++|..+ ...+ .
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhh
Confidence 43321 12334578899999998753211 1112222221 1111 1
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+++.++++|+..||..++++||.+.+|+..|+.++..
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 346788999999999999999999999999998888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.13 Aligned_cols=225 Identities=30% Similarity=0.397 Sum_probs=189.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
...+.+|.+++.||.|+|++|++|+.. ++.||||++.+...-.+ +...-+..|-+.|.+| .||.|++|+..|++.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike--~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKE--KKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhh--cccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 445689999999999999999999875 89999999987665442 3345577899999999 899999999999876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+|+|+||+++|+|.++|.+.+. |++.....++.+|+.||+|||++|||||||||+|||++.| +.+||+|||.|+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeecccccc
Confidence 89999999999999999998765 9999999999999999999999999999999999999999 6999999999985
Q ss_pred cccccc--------------cccccCccceecccccccccccccccccccCC---------------------------C
Q 021127 176 ESLTEM--------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N 214 (317)
Q Consensus 176 ~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~ 214 (317)
.+.... ...++||-.|++||++.......+.+- |..+ .
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi-WAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL-WALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccch-HHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 432111 145789999999999887544443332 2222 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++++++.+++||.++|..||.+|+|+.+|.+|
T Consensus 303 ~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 234478899999999999999999999999999887
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=298.74 Aligned_cols=239 Identities=30% Similarity=0.538 Sum_probs=196.8
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC---C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
+.|++..+++.+.++||+|+||.||+|+.. + ..||||........ ...+...|++|+++++.++|||||++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~--~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL--TKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc--cHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 479999999999999999999999999875 1 23899988752211 135577899999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
|++... .+++|||+|.||+|.++|++.+. .++..+.+.++.+++.||+|||++++|||||.++|+|++.+ +.+||+|
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISD 305 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISD 305 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCc
Confidence 998655 79999999999999999998765 49999999999999999999999999999999999999997 5789999
Q ss_pred cCcccccccccccc-cccCccceecccccccccccccccccccCC------------------------------CCCCC
Q 021127 170 FGLAREESLTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS 218 (317)
Q Consensus 170 fg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 218 (317)
||+++......... ...-...|+|||.+... ..+...++|..+ ...+.
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 99998654222222 22356799999998876 333344444433 23444
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
+...|.++..++.+||..+|++||++.++.+.++.+.....+
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 667789999999999999999999999999999998876554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=294.82 Aligned_cols=224 Identities=24% Similarity=0.365 Sum_probs=198.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|++.+.||+|.||+|-+|... |+.||||.+++....++ ...-.+.+||+++..|+||||+.+|.+|+.. ...|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde--qDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE--QDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH--HHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 68999999999999999999774 99999999998776553 3455688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||..+|.|++++...+. +++..+..++.||.+|+.|+|.++++|||||.+|||+|.| +.+||+|||++.......
T Consensus 131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence 9999999999999998766 9999999999999999999999999999999999999999 789999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCC--------CC------------------CCCCCChHHHHHHHHHhh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------VR------------------PSAENVPEELSIILTSCW 234 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~~------------------~~~~~~~~~l~~li~~cl 234 (317)
...++||++-|.+||++.+..+.....+.|+.+. .+ -..+.-|....-||+.||
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWML 287 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHH
Confidence 8899999999999999999888877777776551 01 112345677889999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
..||++|.|+.+|..|.|
T Consensus 288 mVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWW 305 (668)
T ss_pred hcCcccchhHHHHhhhhe
Confidence 999999999999999977
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=298.60 Aligned_cols=232 Identities=28% Similarity=0.373 Sum_probs=186.3
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH---------HHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---------IAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
..-++|++.+.||+|.||.|-+|++. ++.||||++.+...... .....+++.+||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999986 89999999986543211 00113478899999999999999999
Q ss_pred EeeeecC---ceEEEEEccCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 90 IGACKEP---VMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 90 ~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~-l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+.+..+. .+|||+|||..|.+...=. ... +++.+++.|+.+++.||+|||.+|||||||||+|+||+.+ |++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcE
Confidence 9999764 7999999999888654222 223 8999999999999999999999999999999999999999 899
Q ss_pred EEcccCccccc------ccccccccccCccceeccccccc---ccccccccccccCC-----------------------
Q 021127 166 KLADFGLAREE------SLTEMMTAETGTYRWMAPELYST---VTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~------~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~~~~~----------------------- 213 (317)
||+|||.+... +........+|||.|+|||.+.+ ..+.....++|..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999754 22223344689999999999887 33444555666655
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
...|..+.+.+.+++||.++|.+||++|.++.+|..|.|-...
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1122334567899999999999999999999999999775443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=308.34 Aligned_cols=224 Identities=27% Similarity=0.410 Sum_probs=201.3
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+-|++++-||.|+.|.|-+|++ +|+.+|||++.+..... ......+.+||-+|+.+.||||+++|+++.+. ++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 4578999999999999999988 49999999998763211 13345688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|.||++||.|.+++...++ +++.++..++.||+.|+.|+|..+|+||||||+|+|++.. +.+||+|||+|.......
T Consensus 90 vlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence 9999999999999997666 9999999999999999999999999999999999999988 469999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
...+.||++.|.|||++.+..+.....++|+.+ .....|..++.+.++|+.+|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 888999999999999999999999999999876 23345788999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|..||+.|.|+++|++|.+
T Consensus 247 l~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPF 265 (786)
T ss_pred hccCccccccHHHHhhCch
Confidence 9999999999999999955
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=273.85 Aligned_cols=227 Identities=24% Similarity=0.348 Sum_probs=183.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
.+|...++||+|.||.||+|+++ |+.||||.++.....+.. ....++||..|+.++|+||+.++++|.. +.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi---~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI---NRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc---cHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 57888999999999999999986 899999999887654322 2246899999999999999999999965 48999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+||+ ..+|...+++.. ..++..++..|+.+++.||+|||++.|+||||||.|+||+.+ |.+||+|||+|+......
T Consensus 79 VfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCC
Confidence 99999 579999998744 459999999999999999999999999999999999999999 899999999999765443
Q ss_pred -ccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
.....+-|..|.|||++-+........+.|+.+
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 334447899999999876644333333333322
Q ss_pred ---CCCC------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---NVRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---~~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
...| .-...+.++.+|+.+||..||.+|+++.|++++ .++...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~ 287 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSL 287 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcC
Confidence 0000 122346778999999999999999999999988 445443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=299.25 Aligned_cols=233 Identities=30% Similarity=0.557 Sum_probs=184.0
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
+|.|+.++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+.++..+ +||||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~niv~~ 76 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA----SEHKALMSELKILIHIGNHLNVVNL 76 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch----HHHHHHHHHHHHHHHhccCcceeeE
Confidence 48899999999999999999999999742 467999998754432 2245688999999999 89999999
Q ss_pred EeeeecC--ceEEEEEccCCCCHHHHHHhcC-------------------------------------------------
Q 021127 90 IGACKEP--VMVIVTELLSGGTLRKYLLNMR------------------------------------------------- 118 (317)
Q Consensus 90 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------- 118 (317)
++++... .+++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 77 LGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred EeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 9988643 6899999999999999997532
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---cccc
Q 021127 119 -----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTA 184 (317)
Q Consensus 119 -----------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 184 (317)
...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...... ....
T Consensus 157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccC
Confidence 1247888999999999999999999999999999999999988 689999999997542211 1122
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..++..|+|||++.+..... ..++|+.+ .....+..++..+.+|+.+||
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CCCCccccCcHHhhcCCCCc-ccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 34567899999876533221 12222111 111224567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHhhh
Q 021127 235 KEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+.||.+|||+.++++.|+.++.
T Consensus 315 ~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 315 QGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=289.40 Aligned_cols=234 Identities=25% Similarity=0.441 Sum_probs=194.8
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
.......|-+.++.|++...||.|..++||+|+.. +..||||++........ ...+.+|+..+..++||||+++
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~----ld~l~kE~~~msl~~HPNIv~~ 89 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND----LDALRKEVQTMSLIDHPNIVTY 89 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh----HHHHHHHHHHhhhcCCCCcceE
Confidence 33445578899999999999999999999999885 89999999988776553 3458899999999999999999
Q ss_pred Eeeee-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 90 IGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 90 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
+.+|. +..+|+||.||.+|++.+.+....+..+++..+..|+++++.||.|||++|.||||||+.||||+.+ |.|||+
T Consensus 90 ~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLa 168 (516)
T KOG0582|consen 90 HCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLA 168 (516)
T ss_pred EEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEc
Confidence 99886 5589999999999999999998877779999999999999999999999999999999999999999 899999
Q ss_pred ccCccccc-cccccc----ccccCccceecccc-cccccccccccccccCC---------------------------CC
Q 021127 169 DFGLAREE-SLTEMM----TAETGTYRWMAPEL-YSTVTLRQGEKKHYNHK---------------------------NV 215 (317)
Q Consensus 169 Dfg~a~~~-~~~~~~----~~~~gt~~y~aPE~-~~~~~~~~~~~~~~~~~---------------------------~~ 215 (317)
|||.+-.. ...... .+.+||++|||||+ .....-...+.++|+.+ +.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99986532 211111 55689999999999 44444455556666554 11
Q ss_pred CCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.|. ...++..++.++..||+.||.+|||+.+++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 110 12356789999999999999999999999886
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=295.22 Aligned_cols=225 Identities=25% Similarity=0.349 Sum_probs=186.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+.-++|++++.||+|+||.||+|+.+ |..+|+|++++..... ..+.+.++.|-++|...++++||+|+..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~--~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK--KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh--hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 456689999999999999999999764 9999999999876544 34566788999999999999999999999987
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+||||||++||++..+|..... |++..+..++.+++.|+..||+.|+|||||||+|+|||.. |.+||+|||++...
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchh
Confidence 89999999999999999987655 9999999999999999999999999999999999999999 89999999998521
Q ss_pred cc----------------------cccc--------------------------ccccCccceecccccccccccccccc
Q 021127 177 SL----------------------TEMM--------------------------TAETGTYRWMAPELYSTVTLRQGEKK 208 (317)
Q Consensus 177 ~~----------------------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~ 208 (317)
.. .... ...+|||.|||||++.+..+.. ..+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~-~cD 370 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK-ECD 370 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc-ccc
Confidence 00 0000 1225999999999999876433 334
Q ss_pred cccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHHH
Q 021127 209 HYNHK-------------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQML 251 (317)
Q Consensus 209 ~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~l 251 (317)
||+.+ ...|....++.+.++||.+||. ||+.|. +++||-+|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 44443 2334455678999999999999 999996 477887763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.45 Aligned_cols=222 Identities=24% Similarity=0.323 Sum_probs=182.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
-+.|+.+++||+|.||.||+|++. |+.||+|.++.......... -..+||.+|++|+||||++|.+...+ +.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~---t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPI---TAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchH---HHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 357888999999999999999985 88999999987764443222 36789999999999999999998754 48
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|+|||+ -+|.-++.... -.|++.++..|+.|++.||+|||++||+|||||.+|||||.+ |.+||+|||+|++..
T Consensus 193 iYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeecc
Confidence 999999995 58988887643 239999999999999999999999999999999999999998 899999999999654
Q ss_pred ccc--ccccccCccceecccccccccccccccccccCC---------------------------------------CCC
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------NVR 216 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 216 (317)
... ..+..+-|++|.|||++.+..-.....+.|+.+ ...
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 332 456678899999999988755555444444433 000
Q ss_pred C-----------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 P-----------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ~-----------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
| ....++....+|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 123467888999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.77 Aligned_cols=217 Identities=27% Similarity=0.436 Sum_probs=185.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l 100 (317)
..|....+||+|+.|.||.|+.. ++.||||.+....... .+.+++|+.+|+..+|+|||++++.+. ...+|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 56788899999999999999875 7889999998877644 446889999999999999999999775 458999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||++||+|.+.+.... +++.++..|+.+++.||+|||.+||+|||||.+|||++.+ |.+||+|||++......
T Consensus 348 VMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeecccccc
Confidence 999999999999998754 9999999999999999999999999999999999999999 78999999999865443
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
....+.+||++|||||++....+.... ++|+.+ .....++.++..+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KV-DIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKV-DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccc-cchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 355677999999999998764444332 233332 2233467889999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||+.|+++|+++.++|+|
T Consensus 503 L~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcC
Confidence 999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=292.65 Aligned_cols=225 Identities=34% Similarity=0.548 Sum_probs=174.7
Q ss_pred CceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC--ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~l 100 (317)
++|.-.++||+|+||.||+|...+ ..||||.+....... ..+|.+|+.++.+++|||+|+|+|+|.+. ..+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 456666899999999999999985 899999887665431 23499999999999999999999999865 3899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|+||+++|+|.++|.......++|..+++|+.++|.||+|||+.. ||||||||+|||+|++ ..+||+|||+|+...
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence 999999999999998755326999999999999999999999864 9999999999999998 589999999997665
Q ss_pred c-ccccccc-cCccceecccccccccccccccccccCC---------------------------------------CCC
Q 021127 178 L-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------NVR 216 (317)
Q Consensus 178 ~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------~~~ 216 (317)
. ....... .||.+|+|||++....... ..++|+.+ ...
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~-KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD 307 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYASTGKLTE-KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD 307 (361)
T ss_pred ccccceeeecCCCCccCChhhhccCCcCc-ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence 4 3333333 8999999999875421111 11111111 001
Q ss_pred CC-C-CCCh--H---HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 217 PS-A-ENVP--E---ELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 217 ~~-~-~~~~--~---~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
+. . ...+ . .+..+..+|++.+|.+||+|.++++.|....
T Consensus 308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 11 1 2222 2 2566778999999999999999998885443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=275.03 Aligned_cols=220 Identities=27% Similarity=0.335 Sum_probs=186.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.+.||.|+||+|.+++.+ +..+|+|++.+...-. .++.+...+|.++|+.+.||+++++++.+.+. .+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk--lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK--LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH--HHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 356889999999999999999886 8999999998766543 46677889999999999999999999999876 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||.+||.|..++++.+. +++..+..++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc
Confidence 99999999999999998665 9999999999999999999999999999999999999999 89999999999976543
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
+.+.||||.|+|||++........ .+||..+ .....|..++.++++|+..
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 567899999999999887554433 3344333 1223467788999999999
Q ss_pred hhhcCCCCC-----CCHHHHHHH
Q 021127 233 CWKEDPNAR-----PNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~R-----ps~~~~~~~ 250 (317)
+|+.|-.+| ....+|..|
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H 297 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNH 297 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccC
Confidence 999999999 344555554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=278.35 Aligned_cols=226 Identities=27% Similarity=0.338 Sum_probs=184.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|+.+++|++|.||.||+|+++ ++.||+|.++-....+... ---++||.+|.+++|||||.+-.+... +.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP---ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP---ITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc---chhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 57889999999999999999986 8999999998654332211 135789999999999999999988754 369
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+|||||+ -+|..++...+ +++...++..++.|+++||+|||.+.|+|||||++|+|++.. |.+||+|||+|+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGS 229 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcC
Confidence 99999994 69999998865 459999999999999999999999999999999999999998 8999999999997654
Q ss_pred c-cccccccCccceecccccccccccccccccccCC--------------------------------------------
Q 021127 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------------- 213 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------------- 213 (317)
. ...+..+-|+.|.|||++.+....+...+.|+.+
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 3456667899999999988765555555555433
Q ss_pred -------------CCCC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 -------------NVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------------~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+. ....+++.-.+|+..+|..||.+|.|+.+.++| .++..
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e 366 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRE 366 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--ccccc
Confidence 0000 011256888999999999999999999999998 55554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.17 Aligned_cols=222 Identities=24% Similarity=0.309 Sum_probs=182.0
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||+|++. ++.||||++....... ......+.+|+.++++++||||+++++++.++ ..
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK--MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 3478999999999999999999885 7899999997543211 23345688999999999999999999998765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence 999999999999999987544 8999999999999999999999999999999999999988 7999999999986533
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. .....||+.|+|||++.+.... ...++|+.+ .....+..++..+++|+.
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 171 R--TFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVK 247 (329)
T ss_pred C--cceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHH
Confidence 2 2345799999999998765432 334444433 111224457889999999
Q ss_pred HhhhcCCCCCCC-----HHHHHHHH
Q 021127 232 SCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 232 ~cl~~~p~~Rps-----~~~~~~~l 251 (317)
+||+.||.+||+ +++++.|.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 999999999986 78888773
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=296.96 Aligned_cols=226 Identities=30% Similarity=0.532 Sum_probs=194.7
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+-++.|+|+.+.+.-++-||+|+.|.||+|+..++.||||.++.-. ..+|+-|++|+|+||+.+.|+|
T Consensus 114 qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 114 QQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh------------hhhHHHHHhccCcceeeEeeee
Confidence 4467899999999999999999999999999999999999875321 2367889999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+. .++||||||..|-|+..|+.... ++......|..+||.|+.|||.+.|||||||.-||||..+ ..+||+|||.
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGT 258 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGT 258 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccc
Confidence 875 89999999999999999997555 8999999999999999999999999999999999999988 5899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccc-------------------------cccCC---CCCCCCCCChH
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK-------------------------HYNHK---NVRPSAENVPE 224 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-------------------------~~~~~---~~~~~~~~~~~ 224 (317)
++........-.++||..|||||++.........+. +|..+ ...+.|..+|+
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~ 338 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPD 338 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCch
Confidence 997666566667899999999999987554433221 12222 23566889999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
-++-||++||+..|..||++.+++.||+-.
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 999999999999999999999999998754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.43 Aligned_cols=246 Identities=31% Similarity=0.486 Sum_probs=194.1
Q ss_pred CCCccccccceecCCceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHH
Q 021127 3 SRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREV 75 (317)
Q Consensus 3 ~~s~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~ 75 (317)
++=.++.|..+..+..|.++.++|++.+.||+|+||.||+|++ ++..||||++...... .....+.+|+
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei 89 (375)
T cd05104 14 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL----TEREALMSEL 89 (375)
T ss_pred ceEEEecCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc----HHHHHHHHHH
Confidence 3445778889999999999999999999999999999999864 2568999998754432 2245688999
Q ss_pred HHHHhc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------------------
Q 021127 76 AMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------------------- 119 (317)
Q Consensus 76 ~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------- 119 (317)
.++..+ +||||+++++++.++ ..++|||||++|+|.+++.....
T Consensus 90 ~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (375)
T cd05104 90 KVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYM 169 (375)
T ss_pred HHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhh
Confidence 999999 899999999999765 88999999999999999975321
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 120 ---------------------------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 120 ---------------------------------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~ 249 (375)
T cd05104 170 DMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH 249 (375)
T ss_pred hcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC
Confidence 13788899999999999999999999999999999999998
Q ss_pred CCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC------------------------
Q 021127 161 DLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 250 ~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~ 327 (375)
T cd05104 250 G-RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY 327 (375)
T ss_pred C-CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCC-CCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH
Confidence 7 6899999999975432211 11223466899999876533221 12222111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+...+.++++|+.+||+.||++||++.++++.|++.
T Consensus 328 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 01122345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=287.81 Aligned_cols=223 Identities=24% Similarity=0.381 Sum_probs=194.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c-eE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V-MV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~-~~ 99 (317)
++|..++++|+|+||.+++.+++ +..+|+|.+......+ ..++...+|+.++.+++|||||.+.+.|.++ . .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~---~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE---PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc---hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 68999999999999999988776 7889999998766544 2334678899999999999999999998654 5 89
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+||+||+|.+.+...+...++++.++.|+.|++.|+.|||+++|+|||||+.|||++.+ +.+||+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence 99999999999999998777779999999999999999999999999999999999999999 68899999999987766
Q ss_pred c-ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. ...+..||+.||.||++.+..+....+.|.... ...|.+..++.+++.+|.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 5 667789999999999999988776554432221 235667888999999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
.||..+|+.||++.+++.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=290.30 Aligned_cols=222 Identities=23% Similarity=0.316 Sum_probs=175.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|++++.||+|+||+||+|++. ++.||||++....... ......+.+|+.+++.++|+||+++++++.+. .+++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~l 78 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN--RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEE
Confidence 36889999999999999999885 7899999997644322 23345788999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccc
Confidence 9999999999999986544 8999999999999999999999999999999999999988 79999999997532100
Q ss_pred -----------------------------------------------cccccccCccceecccccccccccccccccccC
Q 021127 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 180 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
......+||+.|+|||++.+.... ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSl 234 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSV 234 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-Cccceeeh
Confidence 001234699999999998764432 33444443
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHH--hhhcCCCCCCCHHHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTS--CWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~--cl~~~p~~Rps~~~~~~~l 251 (317)
+ ...+....++.++.+||.+ |+..+|..||++.++++|-
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 3 0111223578899999998 5556666799999999884
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=280.55 Aligned_cols=223 Identities=24% Similarity=0.332 Sum_probs=180.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.+.||+|+||.||++.+. ++.||+|.+....... ......+.+|+.++.+++|+||+++++++.+. ..++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh--hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 4788899999999999999874 8999999987654322 12344678999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++|+|..++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCe
Confidence 999999999988876554458999999999999999999999999999999999999988 6899999999986543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....||..|+|||++.+..+.. ..++|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTF-SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCc-ccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 34557899999999987644332 23333322 01112346788999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~l 251 (317)
.+||+.||.+||+ +++++++-
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 9999999999997 88888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.09 Aligned_cols=219 Identities=31% Similarity=0.456 Sum_probs=187.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|+.+ .+.||+|.+.+....+ +....+.+|++++++++|||||.++++|+.. ++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~---k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE---KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch---HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 57889999999999999999876 7899999998876554 4455688999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|.|||.| +|..+|...+. ++++.+..++.+++.||.|||+++|+|||+||.|||+..+ +.+|+||||+|+.....
T Consensus 79 Vte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc
Confidence 9999966 99999987665 9999999999999999999999999999999999999998 79999999999976544
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
...+...|||.|||||++.+..+....+- |+.+ .....+.+.+..+.+|+..
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDl-WslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDL-WSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhH-HHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 34456679999999999987655443332 2222 2233466889999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
.|..||.+|.++.+++.|
T Consensus 234 LL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhhcChhhcccHHHHhcC
Confidence 999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=279.83 Aligned_cols=235 Identities=20% Similarity=0.264 Sum_probs=190.0
Q ss_pred ecCCceeecCCceeec--ceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 14 KLDAKWLIDPKHLFVG--PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~--~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
.+++.+.|+++++... ..||+|++|.||+|.++++.||||.+....... ......+.+|+.++.+++||||++++|
T Consensus 8 ~~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 8 YINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH--KVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred hcCcceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccccc--HHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3566778888888887 779999999999999999999999997654322 233456889999999999999999999
Q ss_pred eeec-----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCce
Q 021127 92 ACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 92 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~ 165 (317)
++.+ ...++||||+++|+|.+++..... +++...+.++.|++.||.|||+. +++||||||+||+++.+ +.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCC--CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcE
Confidence 9865 268899999999999999987543 89999999999999999999985 99999999999999998 799
Q ss_pred EEcccCcccccccccccccccCccceecccccccc-cccccccccccCC-----------------------------CC
Q 021127 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK-----------------------------NV 215 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~-----------------------------~~ 215 (317)
||+|||+++...... ....|+..|+|||++.+. .......++|+.+ ..
T Consensus 163 kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~ 240 (283)
T PHA02988 163 KIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS 240 (283)
T ss_pred EEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999997543322 234688999999998652 1122233333322 11
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.+.+..++.++.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 2224467899999999999999999999999999988764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=267.13 Aligned_cols=225 Identities=23% Similarity=0.342 Sum_probs=191.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+++.||+|-||.||.|+.+ +-.||+|++.+..... .....++.+|+++-..|+||||+++|++|.+. ..|+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~--~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK--TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH--hcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 67999999999999999999886 6779999998766433 34456788999999999999999999999876 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
++||...|+|++.|.......+++.....++.|++.||.|+|.++||||||||+|+|++.. +.+||+|||-+...+ ..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-CC
Confidence 9999999999999997666679999999999999999999999999999999999999998 799999999998665 34
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
...+.|||..|.+||+..+...+...+.| ..+ .....|..++...+++|.+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w-~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLW-SLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRL 256 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHH-HHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHH
Confidence 45678999999999998775443332221 111 12234678999999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~ 253 (317)
+..+|.+|....|+++|.|-
T Consensus 257 l~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred hccCccccccHHHHhhhHHH
Confidence 99999999999999999663
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.50 Aligned_cols=215 Identities=26% Similarity=0.314 Sum_probs=175.0
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. ++.||||++....... .....++.+|+.++++++||||+++++++.++ ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA--KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 46999999999999875 8899999997543221 23345678899999999999999999998765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~ 185 (317)
+++|.+++...+. +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... ........
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSRERV--FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccce
Confidence 9999999986544 8999999999999999999999999999999999999988 789999999987532 22233445
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+||.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred ecCccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 799999999998764433 234444433 1112245678999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021127 239 NARP-----NFTQIIQM 250 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~ 250 (317)
++|| ++.++++|
T Consensus 235 ~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 235 KQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9999 79999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=290.84 Aligned_cols=243 Identities=29% Similarity=0.495 Sum_probs=191.1
Q ss_pred cccccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHH
Q 021127 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (317)
|..+..+.....|.++.++|++.+.||+|+||.||+|.+. +..||||++....... ....+.+|+.+++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~il~ 96 (374)
T cd05106 21 FIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD----EREALMSELKILS 96 (374)
T ss_pred eeCCccccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH----HHHHHHHHHHHHH
Confidence 5556667778899999999999999999999999998752 3579999997654432 2456889999999
Q ss_pred hc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC---------------------------------------
Q 021127 80 RV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR--------------------------------------- 118 (317)
Q Consensus 80 ~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------------------------------------- 118 (317)
.+ +|+||+++++++.+. ..++||||+++|+|.+++....
T Consensus 97 ~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (374)
T cd05106 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176 (374)
T ss_pred hhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccc
Confidence 99 899999999998765 8999999999999999986432
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 119 -----------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 119 -----------------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
...+++..++.|+.||+.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~D 255 (374)
T cd05106 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICD 255 (374)
T ss_pred ccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEee
Confidence 1237888999999999999999999999999999999999987 6899999
Q ss_pred cCcccccccccc---cccccCccceecccccccccccccccccccCC------------------------------CCC
Q 021127 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVR 216 (317)
Q Consensus 170 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~ 216 (317)
||+++....... .....++..|+|||++....+.. ..++|+.+ ...
T Consensus 256 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~ 334 (374)
T cd05106 256 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334 (374)
T ss_pred ceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence 999975432211 11223566899999875433221 12222211 011
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
..+..++.++.+++.+||+.||.+||++.++++.|++++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 123456889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.03 Aligned_cols=236 Identities=30% Similarity=0.512 Sum_probs=198.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
...|.+.++++.+.||+|+||+||+|+.. ...||||.++..... ..+++|.+|++++..++|||||+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~----~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN----QARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH----HHHHHHHHHHHHHHhccCCCeEEEE
Confidence 56799999999999999999999999874 467999999876653 3577899999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLL 157 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nil 157 (317)
|+|.++ ..++|+|||..|+|.+||+...+ ..++..+.+.|+.|||.||.||-++.+|||||..+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 999766 89999999999999999986542 22889999999999999999999999999999999999
Q ss_pred eeCCCCceEEcccCcccccccccccccc---cCccceecccccccccccccccc-----------------cccC-----
Q 021127 158 LTEDLKTIKLADFGLAREESLTEMMTAE---TGTYRWMAPELYSTVTLRQGEKK-----------------HYNH----- 212 (317)
Q Consensus 158 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~~-----------------~~~~----- 212 (317)
|.++ -.|||+|||+++.....+..... .-..+||+||.+....+....+. ++..
T Consensus 636 Vge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 636 VGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 9999 48999999999976555444332 34679999998776544433222 2211
Q ss_pred ------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 ------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 ------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+...+.|+++|.+++.||..||+.+|.+||++.||-..|.++....
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1446678999999999999999999999999999999999887543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.96 Aligned_cols=226 Identities=27% Similarity=0.463 Sum_probs=176.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (317)
+..++|++.++||+|+||.||++.+. +..||+|++...... ....+|.+|+.++.+++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~ 77 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK----NARNDFLKEVKILSRLK 77 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH----HHHHHHHHHHHHHhhcC
Confidence 45678999999999999999999752 346999998765432 23557899999999999
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP-----------------RCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
||||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999998754 78999999999999999865321 2367888999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC--------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
||+||||||+|||++.+ +.+||+|||+++...... ......++..|+|||++....... ..++|+.+
T Consensus 158 ~ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT-ASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc-hhhhHHHHHHHHHHHH
Confidence 99999999999999988 789999999997543221 122334578899999875433221 12222211
Q ss_pred -----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----------------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+|+.+||+.||.+|||+.++.+.|+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 001123456889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.00 Aligned_cols=239 Identities=28% Similarity=0.498 Sum_probs=189.0
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-C
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-H 83 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 83 (317)
.+..+++|.++.++|+++++||+|+||.||+|.+. +..||||++...... ...+.+.+|+.+++++. |
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~~Ei~~l~~l~~H 100 (400)
T cd05105 25 QLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS----SEKQALMSELKIMTHLGPH 100 (400)
T ss_pred cCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh----HHHHHHHHHHHHHHhcCCC
Confidence 35566899999999999999999999999999863 246999999765432 23456899999999995 9
Q ss_pred CCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC--------------------------------------------
Q 021127 84 RNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR-------------------------------------------- 118 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------- 118 (317)
|||+++++++.+. ..++|||||++|+|.+++....
T Consensus 101 pnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (400)
T cd05105 101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDM 180 (400)
T ss_pred CCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccc
Confidence 9999999999765 8999999999999999986532
Q ss_pred --------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 021127 119 --------------------------------------------------PRCLDVCVAIGFALDIARAMECLHSHGIIH 148 (317)
Q Consensus 119 --------------------------------------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH 148 (317)
...+++..++.++.|++.||+|||+++|+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 260 (400)
T cd05105 181 KQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVH 260 (400)
T ss_pred ccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 123788889999999999999999999999
Q ss_pred cCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC------------
Q 021127 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------ 213 (317)
Q Consensus 149 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------ 213 (317)
|||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 261 ~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwSlGvil~ellt~g~~ 338 (400)
T cd05105 261 RDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGT 338 (400)
T ss_pred CCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCC
Confidence 9999999999988 689999999997543221 112234678899999876532221 12222211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
...+.+..++.++.+++.+||+.||++||++.++.+.|..++.
T Consensus 339 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 339 PYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1122345678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=284.07 Aligned_cols=223 Identities=25% Similarity=0.287 Sum_probs=178.1
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.++||+|+||.||+++. +++.||+|++.+..... .......+..|+.++..+ +|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ-KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 588999999999999999876 37889999987533211 123345678899999999 599999999988755 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence 8999999999999999976544 8999999999999999999999999999999999999988 799999999997532
Q ss_pred cc--cccccccCccceecccccccccccccccccccCCC-------------------------------CCCCCCCChH
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------VRPSAENVPE 224 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 224 (317)
.. .......||+.|+|||++.+........++|+.+. ..+.+..++.
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP 236 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 22 12234579999999999876443334455555440 0112345778
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
.+.+++.+||+.||++|| ++++++++.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 899999999999999999 788888873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.59 Aligned_cols=222 Identities=25% Similarity=0.402 Sum_probs=186.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
.....|...+.||+|+||.||+|.+. ++.||+|++......++ ..++.+|+.++.+++++||.++|+.+..+ .
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de----Iediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE----IEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchh----hHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 34467788899999999999999886 88999999998776543 45688999999999999999999988655 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|++||||.||++.+.++.... +++..+..++.+++.||.|||+++.+|||||+.||++..+ |.+||+|||++-...
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLT 162 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeee
Confidence 9999999999999999986443 5888899999999999999999999999999999999998 899999999998665
Q ss_pred cc-cccccccCccceecccccccccccccccccccCC---------------------------CCCCC-CCCChHHHHH
Q 021127 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS-AENVPEELSI 228 (317)
Q Consensus 178 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~-~~~~~~~l~~ 228 (317)
.. ....+++||+.|||||++.. .....+.++|+.+ ...|. ...++..+++
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kE 241 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKE 241 (467)
T ss_pred chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHH
Confidence 44 33377899999999999984 3444555566554 11111 3367889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||..||+.||+.||++.++++|
T Consensus 242 FV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhhh
Confidence 9999999999999999999886
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=280.31 Aligned_cols=223 Identities=24% Similarity=0.306 Sum_probs=178.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||++++. ++.||||++....... ......+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLA--QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 47899999999999999999875 8899999998643211 23455688899999999999999999988765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK 156 (330)
T ss_pred EECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence 999999999999998752 249999999999999999999999999999999999999988 799999999997543322
Q ss_pred c--cccccCccceeccccccccc-----ccccccccccCCC-------------------------------CCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHKN-------------------------------VRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~~-------------------------------~~~~~~~~ 222 (317)
. .....||+.|+|||++.... ......++|+.+. ..+....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 1 22346899999999986421 1122334444330 01122357
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.++.+|+..||. +|.+||+++++++|-
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 8899999999998 999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.32 Aligned_cols=234 Identities=30% Similarity=0.546 Sum_probs=197.0
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC----C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK----N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~----~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.++.++++.+.+.++||.|.||.||+|.++ | -.||||.-+.....+. .+.|+.|..+++.++||||++|+
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~----tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD----TEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh----HHHHHHHHHHHHhCCCcchhhee
Confidence 378899999999999999999999999885 2 3588998777665543 56799999999999999999999
Q ss_pred eeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
|+|.+...|||||+++-|.|..||+.++.. ++......++.||+.||+|||++++|||||..+|||+.+. ..+||+||
T Consensus 458 Gv~~e~P~WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDF 535 (974)
T KOG4257|consen 458 GVCVEQPMWIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADF 535 (974)
T ss_pred eeeeccceeEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeeccc
Confidence 999999999999999999999999986644 9999999999999999999999999999999999999988 68999999
Q ss_pred Cccccccccccccccc--Cccceecccccccccccc-----------------ccccc-----------ccCCCCCCCCC
Q 021127 171 GLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQ-----------------GEKKH-----------YNHKNVRPSAE 220 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~-----------------~~~~~-----------~~~~~~~~~~~ 220 (317)
|+++............ -...|||||-+.-..+.. +..++ ...+...|.|+
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP 615 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence 9999776655444434 357899999654322211 11111 22335677899
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
++|+.+..|+.+||..+|.+||.+.++...|.+++.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999999888776
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=285.88 Aligned_cols=221 Identities=25% Similarity=0.370 Sum_probs=179.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|++. ++.||||++....... ......+.+|++++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 47999999999999999999986 8999999997543211 12345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccC
Confidence 999999999999998763 39999999999999999999999999999999999999998 799999999997543322
Q ss_pred ------------------------------ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 181 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
......||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCC
Confidence 22344689999999998765332 223333332
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC-HHHHHHHH
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPN-FTQIIQML 251 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~~~~~l 251 (317)
...+....++.++.+||.+||. ||.+||+ +.+++++.
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1112223468999999999997 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=283.20 Aligned_cols=221 Identities=23% Similarity=0.302 Sum_probs=180.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... .+....+.+|+.++++++||||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR--LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 47899999999999999999886 8899999987543221 23355688999999999999999999988765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC-
Confidence 9999999999999987554 8999999999999999999999999999999999999988 79999999999855322
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....|++.|+|||++.+.... ...++|+.+ .....+..++..+++|+.+|
T Consensus 155 -~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 155 -TWTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred -cccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHH
Confidence 2345789999999988764432 223333322 11123456788999999999
Q ss_pred hhcCCCCCCC-----HHHHHHHHH
Q 021127 234 WKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps-----~~~~~~~l~ 252 (317)
|+.||.+||+ ++++++|.+
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCcc
Confidence 9999999995 899988743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.85 Aligned_cols=215 Identities=27% Similarity=0.339 Sum_probs=168.5
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||+||+|.+. ++.||||++....... ......+..|.. +++.++||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK--KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 46899999999999985 8899999997543221 122234555555 45778999999999988765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCcccc
Confidence 99999999976543 8999999999999999999999999999999999999988 799999999987432 2223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++..+.++|.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred ccCChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5799999999998765433 334455443 011223467889999999999999
Q ss_pred CCCCCCHH----HHHHH
Q 021127 238 PNARPNFT----QIIQM 250 (317)
Q Consensus 238 p~~Rps~~----~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 235 RTKRLGAKDDFLEIKNH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 99999884 66654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=280.60 Aligned_cols=215 Identities=26% Similarity=0.327 Sum_probs=173.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. +..||+|++....... ......+.+|+.+++.++||||+++++++... ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 46899999999999875 7899999997643211 23345678899999999999999999988765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-ccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 185 (317)
+|+|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccc
Confidence 9999998876543 8999999999999999999999999999999999999988 7899999999875322 2222345
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
.||+.|+|||++.+.... ...+.|+.+ .....+..++.++.++|.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred cCCcCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence 789999999998764432 223334332 1112345778999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 021127 239 NARP-----NFTQIIQM 250 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~ 250 (317)
.+|| ++.+++++
T Consensus 235 ~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 235 KQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 9998 89999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=293.09 Aligned_cols=234 Identities=29% Similarity=0.507 Sum_probs=198.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+|++..+.|.++||.|.||.|++|+.+ ...||||.++.... .+++.+|+.|+.|+.++.||||++|.|+.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt----ekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT----EKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc----HHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 4688999999999999999999999885 46799999998766 35688899999999999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
... ...||.|||++|+|+.||+++..+ ++..+...++++|+.|++||-+.|+|||||.+.|||++.+ -.+|++|||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGL 777 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGL 777 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccc
Confidence 776 678899999999999999987655 9999999999999999999999999999999999999999 5999999999
Q ss_pred cccccccc--ccccccC--ccceeccccccccccccc-----------------ccccccCC-----------CCCCCCC
Q 021127 173 AREESLTE--MMTAETG--TYRWMAPELYSTVTLRQG-----------------EKKHYNHK-----------NVRPSAE 220 (317)
Q Consensus 173 a~~~~~~~--~~~~~~g--t~~y~aPE~~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~ 220 (317)
++...... ..++..| ..+|.|||.+.-..+.+. .+++|+.. ...|.|.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 99653322 2222233 478999998765443332 23333322 4567788
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
++|..|.+||..||++|-..||++.+|+..|+++++..
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999998753
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=279.20 Aligned_cols=216 Identities=25% Similarity=0.315 Sum_probs=174.7
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++++. ++.||||++....... ......+.+|+.+++.++||||+++++++.+. ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999875 7899999997643221 23345688999999999999999999998765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAE 185 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~ 185 (317)
+|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........
T Consensus 79 ~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccc
Confidence 9999998876543 8999999999999999999999999999999999999988 789999999987532 22223345
Q ss_pred cCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCC
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDP 238 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p 238 (317)
+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+|+.+||+.||
T Consensus 156 ~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred cCCcCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 799999999998764432 233444433 1112345678899999999999999
Q ss_pred CCCC-----CHHHHHHHH
Q 021127 239 NARP-----NFTQIIQML 251 (317)
Q Consensus 239 ~~Rp-----s~~~~~~~l 251 (317)
.+|| ++.+++++.
T Consensus 235 ~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 235 NKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHcCCCCCCCHHHHhcCC
Confidence 9997 899998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.14 Aligned_cols=221 Identities=28% Similarity=0.353 Sum_probs=182.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
+..|...+.||.|+||.|+.+.++ ++.||||.+...-.. ....++..+|+.+|+.++|+||+.+++++.-
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~---~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN---QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc---hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 345666899999999999999886 899999998743322 2335578999999999999999999998743
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
..+|+|+|+| +.+|.+.++.... ++.+.+..++.|++.||+|+|+.+|+||||||+|++++.+ ..+||+|||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEecccccee
Confidence 2689999999 7899999987554 9999999999999999999999999999999999999999 689999999999
Q ss_pred cccc---ccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 175 EESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 175 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
..+. ....+..+.|.+|.|||++....-.....+.|+.+
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 7653 44556678899999999987655555555555544
Q ss_pred ---------------CC--CC---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------------NV--RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------------~~--~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.. .+ .-++.++...+|+.+||..||.+|+|++|+++|
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 00 123667889999999999999999999999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.64 Aligned_cols=210 Identities=26% Similarity=0.315 Sum_probs=165.2
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||+|++.+..... ......+..|.. +++.++||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK--KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7899999987643221 122334555554 57788999999999988765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
++++|..++..... +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.. ........
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQRERC--FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCcccc
Confidence 99999998876443 8999999999999999999999999999999999999988 79999999998753 22223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..+. ...++|+.+ .....+...+..+.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred ccCCcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5789999999998764433 334555444 111224466788999999999999
Q ss_pred CCCCCCHH
Q 021127 238 PNARPNFT 245 (317)
Q Consensus 238 p~~Rps~~ 245 (317)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (321)
T cd05603 235 QRRRLGAK 242 (321)
T ss_pred HhhcCCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.20 Aligned_cols=216 Identities=24% Similarity=0.337 Sum_probs=180.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---C---
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P--- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~--- 96 (317)
.|.-.+++|+|+||.||+|... ++.||||..-...... -+|+.+|+.+.|||||+|.-+|.. .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 5777899999999999999875 7899999876544321 258999999999999999988742 2
Q ss_pred ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...+||||++ .+|.++++.. .+..++...+.-+.+||++||+|||+.||+||||||.|+|+|.+.|.+||||||.|+
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 4568999995 6999999853 223488888999999999999999999999999999999999998999999999999
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
.....+...+...|..|+|||++.+........+.|+.+
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 887777667778899999999988877766666666655
Q ss_pred ---------C------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------N------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ........+++..+|+.++|+.+|.+|.++.+++.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 001234568899999999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=292.69 Aligned_cols=238 Identities=23% Similarity=0.378 Sum_probs=191.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 93 (317)
..+.|...++++.+.|.+|||+.||+|.+. +..||+|++...+ ....+.+.+||++|+.|. |+|||.+++..
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-----e~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-----EEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-----HHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 478899999999999999999999999987 4899999987663 244567899999999995 99999999932
Q ss_pred -e-----c--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCC
Q 021127 94 -K-----E--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 94 -~-----~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~ 163 (317)
. . -+++|+||||.||.|-+++..+....|++.++++|+.|+++|+++||... |||||||-+||||..+ +
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g 183 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-G 183 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-C
Confidence 1 1 26899999999999999999877777999999999999999999999997 9999999999999998 7
Q ss_pred ceEEcccCccccccccc-cc---------ccccCccceeccccccc---cccccc------------------------c
Q 021127 164 TIKLADFGLAREESLTE-MM---------TAETGTYRWMAPELYST---VTLRQG------------------------E 206 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~-~~---------~~~~gt~~y~aPE~~~~---~~~~~~------------------------~ 206 (317)
..||||||.|+..-... .. -...-|+.|+|||++.- ..+... .
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 99999999997322111 10 11236899999997542 222222 2
Q ss_pred cccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 207 KKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..+.......|..+.++..+.+||+.||+.||.+||++.+++..+..+.....+
T Consensus 264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 222222234455578999999999999999999999999999998887765444
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=284.99 Aligned_cols=222 Identities=23% Similarity=0.312 Sum_probs=175.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||||++....... ......+.+|++++++++|+||+++++.+.++ .+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM--RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh--hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 47999999999999999999875 7899999986532211 12345678899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCccccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999988 79999999997421100
Q ss_pred -------------------------------------------cccccccCccceecccccccccccccccccccCC---
Q 021127 180 -------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--- 213 (317)
Q Consensus 180 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--- 213 (317)
......+||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil 234 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVIL 234 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeecccee
Confidence 001124699999999998664432 233444333
Q ss_pred ----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHHHH
Q 021127 214 ----------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQMLL 252 (317)
Q Consensus 214 ----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~l~ 252 (317)
...+....++.++.++|.+|+ .+|.+|+ ++.++++|-+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 011122357889999999976 5999999 8999998833
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=282.55 Aligned_cols=220 Identities=25% Similarity=0.345 Sum_probs=179.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|++. ++.||||++....... ......+.+|++++..++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 47999999999999999999885 7899999997643221 23345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--
Confidence 9999999999999976544 8999999999999999999999999999999999999988 7999999999975433
Q ss_pred ccccccCccceecccccccccccccccccccCCC-------------------------------CCCCC----CCChHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------VRPSA----ENVPEE 225 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~----~~~~~~ 225 (317)
......||+.|+|||++.+.... ...++|+.+. ..+.. ..++.+
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred ccCCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 23445799999999998765332 2333443330 00111 145889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||..+|.+||++.+++++.
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 99999999999999999999999884
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=272.44 Aligned_cols=228 Identities=25% Similarity=0.454 Sum_probs=181.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|+.++|++.+.||+|+||.||+|.+. +..||+|.++..... .....+.+|+.++++++||||+++++++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 77 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD----KQRRGFLAEALTLGQFDHSNIVRLEGVITR 77 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH----HHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence 67789999999999999999999763 568999998865442 234568899999999999999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~ 155 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQ 155 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCcccc
Confidence 4 8999999999999999997643 348999999999999999999999999999999999999988 689999999876
Q ss_pred cccccccc--ccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCCChH
Q 021127 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~~~~ 224 (317)
........ ....++..|+|||++.+..... +..+++.. ....+.+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN 235 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 53322111 1234567899999875432211 11111110 112234567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+.+++.+||+.+|.+||+++++++.|.++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=283.40 Aligned_cols=228 Identities=24% Similarity=0.309 Sum_probs=185.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.....+..++|++.+.||+|+||.||+|.+. +..||+|++....... ......+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK--QKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 3456678889999999999999999999864 3689999987543211 2334568899999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.+. ..++||||+++|+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG 176 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFG 176 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCC
Confidence 9765 79999999999999999986554 8999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChH
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPE 224 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~ 224 (317)
++...... .....||+.|+|||++.+.... ...++|+.+ .....+..++.
T Consensus 177 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 253 (340)
T PTZ00426 177 FAKVVDTR--TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDN 253 (340)
T ss_pred CCeecCCC--cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 99865322 2345799999999998764332 334444433 11122456788
Q ss_pred HHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
.+.++|.+||+.||++|+ +++++++|.
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 999999999999999995 899998873
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.23 Aligned_cols=235 Identities=31% Similarity=0.540 Sum_probs=195.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC---C----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK---N----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~---~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.+.+++.++.+.||+|.||.||.|... + ..||||.+.+..+.. ...+|++|..+++.++|||||+++|+
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~----~~~~Fl~Ea~~m~~f~HpNiv~liGv 763 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ----EVSDFLKEALLMSKFDHPNIVSLIGV 763 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH----HHHHHHHHHHHHhcCCCcceeeEEEe
Confidence 466899999999999999999999874 3 348999998776643 36679999999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
|.+. ..+|++|||+||+|..||++.+ ...++..+.+.++.|||.|+.||+++++|||||.++|+|++.. ..+|
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VK 842 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVK 842 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEE
Confidence 9765 7899999999999999999863 3359999999999999999999999999999999999999998 6999
Q ss_pred EcccCccccccccccc-ccc--cCccceecccccccccccccccccccCC-----------------------------C
Q 021127 167 LADFGLAREESLTEMM-TAE--TGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N 214 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~-~~~--~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~ 214 (317)
|+|||+|+........ ... .-...|||||.+.+..+.. ..++|+.+ .
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts-kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS-KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhccccc-ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999954333222 111 2357899999998744443 33344433 4
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
..+.|..+|+.++++|.+||+.+|++||++..|++.+.+......+
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 5566889999999999999999999999999999988887765544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=283.72 Aligned_cols=221 Identities=23% Similarity=0.317 Sum_probs=176.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||||++....... ......+.+|+.++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 47899999999999999999885 7899999997643221 23345678899999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 79 v~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceeccccc
Confidence 9999999999999986543 9999999999999999999999999999999999999988 799999999986432110
Q ss_pred ---------------------------------------ccccccCccceecccccccccccccccccccCC--------
Q 021127 181 ---------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 181 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
.....+||+.|+|||++....+. ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~ 234 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLV 234 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhc
Confidence 01123689999999988664432 233444433
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHHH
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQML 251 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~l 251 (317)
...+....+++++.+||.+|+. +|.+|++ +.+++++-
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 0011123468899999999996 9999997 99998874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=279.79 Aligned_cols=218 Identities=27% Similarity=0.349 Sum_probs=174.1
Q ss_pred cceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
.++||+|+||.||+++. .++.||||++........ ......+.+|+.+++.++||||+++++++..+ ..++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh-hhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 36799999999999875 378899999975432111 22345678899999999999999999988754 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-ccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~ 181 (317)
||+++++|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus 80 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence 99999999999976544 8899999999999999999999999999999999999988 7999999999874322 222
Q ss_pred cccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.....||+.|+|||++.+.... ...++|+.+ .....+..++..+.++|.+||
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 235 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL 235 (323)
T ss_pred ccccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 3345799999999998764432 334444433 111234567889999999999
Q ss_pred hcCCCCCC-----CHHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~l 251 (317)
+.+|++|| ++.+++++-
T Consensus 236 ~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 236 KRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ccCHhHcCCCCCCCHHHHhcCC
Confidence 99999999 899988873
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=281.82 Aligned_cols=226 Identities=29% Similarity=0.406 Sum_probs=189.9
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-c
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-V 97 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~ 97 (317)
....|++.+.||.|.||.||++..+ |+.+|+|++.+...... .....+.+|+.+|+++. |||||.+++++.+. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3468999999999999999999885 89999999987765432 23457889999999998 99999999999876 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC---CceEEcccCccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAR 174 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~---~~~kl~Dfg~a~ 174 (317)
+++|||+|.||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.... +.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999999876 299999999999999999999999999999999999997542 379999999999
Q ss_pred ccccccccccccCccceeccccccccccccccc----------------ccccCC--------------CCCCCCCCChH
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEK----------------KHYNHK--------------NVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~----------------~~~~~~--------------~~~~~~~~~~~ 224 (317)
...........+||+.|+|||++....+....+ +++... ...+..+.++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 877766778889999999999988543333222 111111 12334567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.++++|+.|+..||.+|+|+.++++|.|
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 9999999999999999999999999844
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=281.90 Aligned_cols=228 Identities=23% Similarity=0.321 Sum_probs=182.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK--RSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45567789999999999999999999885 7899999997532211 1223457789999999999999999998876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~ 190 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 190 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEecccee
Confidence 5 799999999999999998753 28899999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-----------------------------C--CCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-----------------------------N--VRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-----------------------------~--~~~~ 218 (317)
...... .....+||+.|+|||++.+.. ......++|+.+ . ..+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (370)
T cd05596 191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD 270 (370)
T ss_pred eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCC
Confidence 543322 223457999999999876532 122334444433 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 251 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l 251 (317)
...++.++.+||.+||+.+|.+ |++++++++|.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 2357899999999999999988 99999999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=269.16 Aligned_cols=228 Identities=28% Similarity=0.498 Sum_probs=183.9
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|.|+.++|++.++||+|+||.||+|... +..||+|.+..... ..+.+.+|+.++++++|+||+++++.+.+.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM------SVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch------hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 7889999999999999999999999876 67799998765332 234688999999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..+++|||+++++|.+++.......+++..++.++.|++.||+|||+++++||||||+||+++.+ +.++|+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVI 153 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceec
Confidence 78999999999999999976555568999999999999999999999999999999999999988 78999999999754
Q ss_pred ccccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
..... .....++..|+|||++....... ..++|+.+ ...+....++.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCCh-hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 33221 12234567899999875433221 12222211 112234467889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+.+++.+||..+|++||+++++++.|+++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=269.84 Aligned_cols=229 Identities=28% Similarity=0.507 Sum_probs=184.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.|+.++|++.++||+|+||.||+|.+. +..||+|.+...... ..++.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP 74 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC------HHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence 6788899999999999999999999886 457999998754332 235889999999999999999999987778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.......+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||.+....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~ 153 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIE 153 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecc
Confidence 8999999999999999986544458999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... ....++..|+|||+..+..... ..+.|+.+ ...+.+..++..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 232 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHH
Confidence 32211 1234567899999865432211 11111100 1122345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.+++.+||+.+|++||++.++++.|++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.29 Aligned_cols=230 Identities=25% Similarity=0.310 Sum_probs=189.8
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..-.+...+++++++||.|.-|+||+++.. +..+|+|++.+..... .+...+...|.+||+.++||.++.||..++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~--rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS--RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh--hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 345677788999999999999999999987 4899999998876544 456677888999999999999999999998
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.+ ..++|||||+||+|....+.+..+.+++..+..++..|+-||+|||-.|||+|||||+||||.++ |.+.|+||.++
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS 226 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLS 226 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeecccc
Confidence 65 88999999999999999999888899999999999999999999999999999999999999999 89999999987
Q ss_pred cccc----------------------------------c-c----------------------cccccccCccceecccc
Q 021127 174 REES----------------------------------L-T----------------------EMMTAETGTYRWMAPEL 196 (317)
Q Consensus 174 ~~~~----------------------------------~-~----------------------~~~~~~~gt~~y~aPE~ 196 (317)
.... . . ......+||..|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 3100 0 0 01123469999999999
Q ss_pred cccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC----
Q 021127 197 YSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---- 243 (317)
Q Consensus 197 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---- 243 (317)
+.+..-.. ..+||..+ ...+....++..+++||+++|.+||.+|..
T Consensus 307 I~G~GHgs-AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 307 IRGEGHGS-AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred eecCCCCc-hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 98744332 34444433 112223366789999999999999999987
Q ss_pred HHHHHHH
Q 021127 244 FTQIIQM 250 (317)
Q Consensus 244 ~~~~~~~ 250 (317)
+.||-+|
T Consensus 386 A~eIK~H 392 (459)
T KOG0610|consen 386 AAEIKRH 392 (459)
T ss_pred hHHhhcC
Confidence 8888877
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.01 Aligned_cols=215 Identities=27% Similarity=0.363 Sum_probs=171.3
Q ss_pred cceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
++.||+|+||.||+++. +++.||+|++...... .....++.+|++++++++||||+++++++.++ ..++||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh---hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 36799999999999875 3789999999764322 12334577899999999999999999998765 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~ 181 (317)
||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...... ..
T Consensus 78 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence 99999999999976443 8999999999999999999999999999999999999988 78999999999754333 22
Q ss_pred cccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.....|++.|+|||++.+.... ...+.|+.+ .....+..++..+.+|+.+||
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred eecccCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3345789999999998764332 234444433 111224567889999999999
Q ss_pred hcCCCCCCCH-----HHHHHH
Q 021127 235 KEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rps~-----~~~~~~ 250 (317)
+.||.+||++ .+++.+
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCC
Confidence 9999999994 455544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.31 Aligned_cols=221 Identities=26% Similarity=0.379 Sum_probs=172.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.++||.|+||.||+|.+. ++.||+|++....... ....+.+|+.++++++||||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 467999999999999999999875 7899999987543221 123567899999999999999999998755 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 80 LVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 9999996 59999887643 337899999999999999999999999999999999999988 78999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........++|+.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 2223456899999999875422111112222111
Q ss_pred ---CCCC---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---NVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+ ....++.++.+|+.+||+.||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 012457789999999999999999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=281.86 Aligned_cols=220 Identities=22% Similarity=0.317 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.++||+|+||.||+|++. ++.||||++....... ......+.+|++++++++|+||+++++.+.++ ..++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~l 78 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 78 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh--HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEE
Confidence 36889999999999999999885 7899999987543221 23455788999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCccccccc
Confidence 9999999999999976543 8999999999999999999999999999999999999988 79999999997521100
Q ss_pred -----------------------------------------------cccccccCccceecccccccccccccccccccC
Q 021127 180 -----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 180 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
......+||+.|+|||++.+..+. ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSl 234 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSV 234 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEec
Confidence 001224689999999998765433 23444443
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
+ ...+....+++++.++|.+|+ .+|.+|++ ++++++|
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 3 011223457889999998876 49999987 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=267.00 Aligned_cols=226 Identities=26% Similarity=0.354 Sum_probs=185.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
..++|++.+.||+|.|+.|+++.+. |+.+|+|++....... ..-+++.+|+++-+.|+||||++|.+...+ +..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~---~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc---ccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3478999999999999999998764 8999999887544332 234568899999999999999999998865 589
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 176 (317)
|+|+|++.|++|..-|-.+.- +++..+-.++.||+++|.|+|.+||||||+||.|+++.+. ..-+||+|||+|...
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~--ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEEecccchHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999887765533 8899999999999999999999999999999999999642 246899999999988
Q ss_pred ccccccccccCccceeccccccccccccc----------------ccccccCC--------------CCCCCCCCChHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQG----------------EKKHYNHK--------------NVRPSAENVPEEL 226 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~----------------~~~~~~~~--------------~~~~~~~~~~~~l 226 (317)
+.........|||.|||||++....+... ..++|... ...+..++++++.
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 76666777889999999999876444322 22222211 1223467899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++|+++||..||.+|.|+.|+++|-|
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCch
Confidence 99999999999999999999998865
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=280.11 Aligned_cols=221 Identities=23% Similarity=0.321 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.++||+|+||.||++.+. ++.||||++.+..... ......+.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK--KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 47899999999999999999875 8899999987543211 23345688999999999999999999999865 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeeccccccccccc
Confidence 9999999999999986543 8999999999999999999999999999999999999988 799999999985211000
Q ss_pred ------------------------------------------------ccccccCccceecccccccccccccccccccC
Q 021127 181 ------------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH 212 (317)
Q Consensus 181 ------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 212 (317)
.....+||+.|+|||++.+..+. ...++|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSl 234 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSL 234 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEec
Confidence 00124689999999998654432 23344433
Q ss_pred C-------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCC---CCHHHHHHHH
Q 021127 213 K-------------------------------NVRPSAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 251 (317)
Q Consensus 213 ~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~R---ps~~~~~~~l 251 (317)
+ ...+....++.++.+||.+||. +|.+| +++.+++++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 3 0011122467899999999997 77765 5999999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=275.70 Aligned_cols=216 Identities=26% Similarity=0.319 Sum_probs=173.9
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+.||+|+||.||++.+. ++.||+|++....... .....++.+|++++..++||||+++++++... ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46899999999999874 8899999997643221 22345678899999999999999999988765 8999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
+|+|..++..... +++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCccccc
Confidence 9999998876543 8999999999999999999997 799999999999999988 799999999987432 2222334
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+.... ...++|+.+ .....+..++.++.+|+.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred ccCCcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 5799999999998765433 334444443 011124567889999999999999
Q ss_pred CCCCC-----CHHHHHHHH
Q 021127 238 PNARP-----NFTQIIQML 251 (317)
Q Consensus 238 p~~Rp-----s~~~~~~~l 251 (317)
|.+|+ ++.++++|.
T Consensus 235 P~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred HHHhCCCCCCCHHHHhcCC
Confidence 99996 899999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.70 Aligned_cols=221 Identities=23% Similarity=0.334 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||+||++.+. ++.||||++.+..... ......+.+|+.++.+++|+||+++++.+.+. ..++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE--KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH--hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 47899999999999999999875 7899999997543221 23345678899999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCcccccccc
Confidence 9999999999999986543 9999999999999999999999999999999999999988 799999999987432110
Q ss_pred ------------------------------------ccccccCccceecccccccccccccccccccCC-----------
Q 021127 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 181 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------- 213 (317)
.....+||+.|+|||++.+.... ...++|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCC
Confidence 01234799999999998664332 233344332
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWK--EDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~--~~p~~Rps~~~~~~~ 250 (317)
...+....++.++.+++.+++. .++..||+++++++|
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 0011123467889999988554 233456899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=286.48 Aligned_cols=218 Identities=26% Similarity=0.375 Sum_probs=183.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
-|.=++.||.|+||.||-|++. .+.||||.+....... ...-++++.|++.|++++|||+|.+-|++... ..|+|
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs--~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccccc--HHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 4556788999999999999885 7889999987655433 35567899999999999999999999999654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||| -|+-.+.+.-.+ +++.+..+..|+.+.+.||+|||+.+.||||||+.|||++.. |.|||+|||.|.....
T Consensus 105 MEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCc---
Confidence 9999 678888887644 349999999999999999999999999999999999999998 8999999999986553
Q ss_pred cccccCccceecccccccc--cccccccccccCC---------------------------CCCC--CCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK---------------------------NVRP--SAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~---------------------------~~~~--~~~~~~~~l~~li 230 (317)
.++++|||+|||||++..+ ....+..++|+.+ +..| ....++..+++|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 3578999999999998754 3456777788776 1111 1345688999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
..||+.-|.+|||.++++.|
T Consensus 259 d~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHhhCcccCCcHHHHhhc
Confidence 99999999999999998776
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.96 Aligned_cols=223 Identities=21% Similarity=0.363 Sum_probs=178.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.+.||+|+||.||++++. +..||+|++...... ....++.+|++++++++||||+++++++.++ .
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 45689999999999999999999986 788999998765432 2345689999999999999999999998654 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+++++|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 154 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCcccccc
Confidence 9999999999999999986544 89999999999999999999986 69999999999999988 78999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-------------------------------------------
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------- 213 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------- 213 (317)
... ......|++.|+|||++.+..... ..++|+.+
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 322 233457899999999876532211 11111111
Q ss_pred ------------------------------CCCC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ------------------------------NVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ------------------------------~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+ ....++.++++||.+||+.||++|||+.+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 01236788999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.83 Aligned_cols=211 Identities=27% Similarity=0.343 Sum_probs=165.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||+|++....... ......+..|.. +++.++|+||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh--hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 46999999999999885 6789999997543211 122233444444 56778999999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|.+++..... +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCccc
Confidence 99999999986543 8899999999999999999999999999999999999988 789999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+.. ..++|+.+ ........++..+.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred ccCCccccCHHHHcCCCCCC-ccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence 57999999999987654432 34445443 111224467899999999999999
Q ss_pred CCCCCCHHH
Q 021127 238 PNARPNFTQ 246 (317)
Q Consensus 238 p~~Rps~~~ 246 (317)
|.+||++.+
T Consensus 235 p~~R~~~~~ 243 (325)
T cd05602 235 RTKRLGAKD 243 (325)
T ss_pred HHHCCCCCC
Confidence 999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.24 Aligned_cols=228 Identities=28% Similarity=0.528 Sum_probs=183.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
|.++..+|.+.++||+|+||.||+|.+. +..||+|.+..... ....+.+|++++++++|+||+++++++.+.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch------HHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 6788899999999999999999999875 78899999875432 234588999999999999999999998654
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~ 153 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRL 153 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccc
Confidence 88999999999999999987655568999999999999999999999999999999999999988 7899999999976
Q ss_pred cccccccc--cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 176 ESLTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
........ ...++..|+|||.+.+..... ..++|+.+ .....+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP 232 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence 54332211 123456799999875432211 11111111 11233567789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++.+++.+||+.||++||++.++++.|+.+
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.88 Aligned_cols=213 Identities=24% Similarity=0.331 Sum_probs=171.7
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||.||++++. ++.||+|++....... ......+.+|+.++++++||||+++++++.+. ..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS--RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 699999999999885 7889999987542211 23345678899999999999999999988765 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cccccccccC
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTAETG 187 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~g 187 (317)
+|.+++...+. +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++... ........+|
T Consensus 79 ~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccC
Confidence 99999986543 8999999999999999999999999999999999999988 789999999997532 2223344579
Q ss_pred ccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
|+.|+|||++.+.... ...+.|+.+ .....+..++.++.+++.+||+.||.+
T Consensus 156 t~~y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 234 (312)
T cd05585 156 TPEYLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR 234 (312)
T ss_pred CcccCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence 9999999998765433 234444433 111234567889999999999999999
Q ss_pred CCC---HHHHHHH
Q 021127 241 RPN---FTQIIQM 250 (317)
Q Consensus 241 Rps---~~~~~~~ 250 (317)
||+ +.+++.|
T Consensus 235 R~~~~~~~e~l~h 247 (312)
T cd05585 235 RLGYNGAQEIKNH 247 (312)
T ss_pred cCCCCCHHHHHcC
Confidence 975 6777766
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.70 Aligned_cols=219 Identities=22% Similarity=0.331 Sum_probs=172.6
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH---HhcCCCCeeeEEeeeecC-ceE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~-~~~ 99 (317)
|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|++++ +.++||||+++++++.++ ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA--RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 678999999999999999885 7899999997543211 12234566666655 566899999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-c
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-L 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~ 178 (317)
+||||+++++|..++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++... .
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCC
Confidence 99999999999988864 239999999999999999999999999999999999999998 799999999987432 2
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.......+|++.|+|||++.+.... ...++|+.+ .....+..++..+.++|.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 233 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR 233 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2233456799999999998764432 233444432 111234567899999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHHH
Q 021127 232 SCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 232 ~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
+||+.||.+|| ++.+++++.
T Consensus 234 ~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 234 RLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 99999999999 577887763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=281.51 Aligned_cols=241 Identities=27% Similarity=0.494 Sum_probs=188.8
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.+.....+..|.++.++|.+.++||+|+||.||+|++. +..||||++....... ....+.+|+.++.++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~----~~~~~~~E~~~l~~l 97 (401)
T cd05107 22 DPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS----EKQALMSELKIMSHL 97 (401)
T ss_pred CCCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh----HHHHHHHHHHHHHhc
Confidence 34445666789999999999999999999999999864 3679999997654322 234688999999999
Q ss_pred C-CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------------------------
Q 021127 82 Q-HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------------------------- 119 (317)
Q Consensus 82 ~-h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------- 119 (317)
. ||||+++++++... ..++||||+.+|+|.+++...+.
T Consensus 98 ~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (401)
T cd05107 98 GPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177 (401)
T ss_pred CCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcc
Confidence 7 99999999999764 88999999999999999975321
Q ss_pred --------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 021127 120 --------------------------------------------------------RCLDVCVAIGFALDIARAMECLHS 143 (317)
Q Consensus 120 --------------------------------------------------------~~l~~~~~~~i~~~i~~~L~~lH~ 143 (317)
..+++..++.++.|++.||+|||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~ 257 (401)
T cd05107 178 YMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS 257 (401)
T ss_pred ccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 136777889999999999999999
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-------
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------- 213 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------- 213 (317)
++++||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++....... ..++|+.+
T Consensus 258 ~~ivHrdlkp~NiLl~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~e~l 335 (401)
T cd05107 258 KNCVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLWEIF 335 (401)
T ss_pred CCcCcccCCcceEEEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHHHHH
Confidence 999999999999999987 689999999997532211 112235678899999876432211 11111100
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+.+..++.++.+|+.+||+.+|.+||+++++++.|++++
T Consensus 336 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111234467889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=276.75 Aligned_cols=215 Identities=27% Similarity=0.349 Sum_probs=168.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|..++..+ +||||+++++++..+ ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE--DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7889999998643211 12233455667777654 899999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
++|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.... ......
T Consensus 79 ~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccc
Confidence 99999999976544 8999999999999999999999999999999999999988 7899999999975322 223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred ccCCccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5799999999998765433 334444433 111224567889999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 P~~R~~~~~~l~~h 248 (316)
T cd05592 235 PTKRLGVDGDIRQH 248 (316)
T ss_pred HHHcCCChHHHHcC
Confidence 99999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=271.95 Aligned_cols=222 Identities=26% Similarity=0.341 Sum_probs=179.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.++||+|+||.||++.+. ++.||||++....... ......+.+|+.++++++|+||+++++++.++ ..++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh--hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 4888999999999999999875 7899999987644322 12345678899999999999999999998654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++|+|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence 999999999998876554559999999999999999999999999999999999999988 7899999999976543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|++.|+|||++.+..... ..++|+.+ .....+..++..+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~-~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCc-cccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 34457899999999986543322 23333322 00112345788999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHHH
Q 021127 231 TSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
.+||+.||.+|| ++++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 88898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=277.52 Aligned_cols=215 Identities=25% Similarity=0.320 Sum_probs=171.9
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||+||++++. ++.||||++.+..... ......+..|+.++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ--DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 46999999999999885 7899999998643221 12344567888888887 799999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|..++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccc
Confidence 99999999876544 9999999999999999999999999999999999999998 799999999987422 1222234
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+|++.|+|||++.+..... ..+.|+.+ .....+..++.++.+||.+||+.|
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~-~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred eecCccccCHHHhcCCCCCc-chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence 56899999999987654432 23333322 111224567899999999999999
Q ss_pred CCCCCCH-----HHHHHH
Q 021127 238 PNARPNF-----TQIIQM 250 (317)
Q Consensus 238 p~~Rps~-----~~~~~~ 250 (317)
|.+||++ .+++++
T Consensus 235 P~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 9999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=278.21 Aligned_cols=233 Identities=30% Similarity=0.536 Sum_probs=182.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
.|.++.++|++.+.||+|+||.||+|... ++.||+|++....... ....+..|+.++.++ +|+||+++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~----~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS----EYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH----HHHHHHHHHHHHHhhccCcchhhe
Confidence 48999999999999999999999998643 4689999987544322 234578899999999 89999999
Q ss_pred Eeeeec--CceEEEEEccCCCCHHHHHHhcCC------------------------------------------------
Q 021127 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMRP------------------------------------------------ 119 (317)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------ 119 (317)
++++.. ...+++|||+++++|.+++.....
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998854 478899999999999999864321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccc
Q 021127 120 -----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAE 185 (317)
Q Consensus 120 -----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 185 (317)
..+++..+..++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++....... .....
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCC
Confidence 247899999999999999999999999999999999999987 689999999998543221 11223
Q ss_pred cCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
.++..|+|||++.+...... .++|+.+ .....+...+.++.+++.+||+
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred CCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHcc
Confidence 45678999998755322211 1111110 1111234567889999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhh
Q 021127 236 EDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+|++||++.+++++|.+++.
T Consensus 315 ~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 315 NNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.96 Aligned_cols=224 Identities=23% Similarity=0.359 Sum_probs=184.8
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
.+.-++|.++++||+|+||+|+++..+ ++.+|||++++...-.. ...+..+.|.+++... +||.+++++.+|+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~--d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR--DEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc--ccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 456689999999999999999999886 78999999998765432 3345577788888776 699999999999876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++|+||||+.||++..+.+ ...+++..+..|+..|+.||.|||++||||||||.+|||+|.+ |.+||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccc
Confidence 8999999999999444333 2339999999999999999999999999999999999999999 8999999999995
Q ss_pred c-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
. .....+++.||||.|||||++.+..+... .+||..+ .....|..++.+..
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI 596 (694)
T ss_pred cCCCCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence 4 35567788999999999999988666554 3445443 11233667899999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHHH
Q 021127 228 IILTSCWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~-----~~~~~~ 250 (317)
++|+++|..||++|..+ ++|.+|
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~h 624 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKH 624 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhC
Confidence 99999999999999765 555554
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.78 Aligned_cols=227 Identities=28% Similarity=0.502 Sum_probs=182.9
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.+..++|++.++||+|+||.||+|... +..||+|.+...... ...+.+|+.++++++|+|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVSEEP 74 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEECCCC
Confidence 7788899999999999999999999876 677999998764432 235889999999999999999999988778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeecc
Confidence 8999999999999999987555558999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... ....++..|+|||++.+..... ..+.|+.+ ...+.+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 32211 1223456899999865422111 11111110 1222355678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+|+.+||..+|.+|||++++.+.|++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=274.24 Aligned_cols=230 Identities=22% Similarity=0.436 Sum_probs=182.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+...+|++.+.||+|+||.||+|.+. +. .||+|++...... ....++.+|+.+++.++||||++++|++.
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP----KANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 55678999999999999999999863 33 4899998754332 23456889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~ 157 (316)
T cd05108 80 TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (316)
T ss_pred CCCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccc
Confidence 888899999999999999998644 238899999999999999999999999999999999999988 689999999998
Q ss_pred cccccccc---ccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
........ ....++..|+|||++....... ..++|+. ....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 236 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence 65432221 1223467899999875533221 1111111 1122334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.+|.+||++.+++..+..+...
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 78999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.31 Aligned_cols=223 Identities=29% Similarity=0.390 Sum_probs=180.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecC---
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEP--- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~--- 96 (317)
...|...++||+|.||+||+|+.. |+.||+|.++.....+. .-....+|+.+++.++|+| |++|++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG---~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG---VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC---CCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 456788889999999999999885 89999999987654221 1123578999999999999 99999998542
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
..++|+||+ ..+|..++..... ..++...+..++.||+.||+|||+++|+||||||.||+|+++ |.+||+||
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADF 164 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeecc
Confidence 588999999 6799999988663 358888999999999999999999999999999999999998 89999999
Q ss_pred Ccccccc-cccccccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 171 GLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 171 g~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
|+|+... .....+..++|..|.|||++.+........+.|+.+
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999655 334466778999999999988865555555555433
Q ss_pred --------------CCCCCC-------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --------------NVRPSA-------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --------------~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....+ +....+..+++..||+.+|.+|.|++.+++|
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000001 1223478999999999999999999999987
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=279.03 Aligned_cols=229 Identities=23% Similarity=0.321 Sum_probs=180.6
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 45567789999999999999999999885 7899999987532211 1234457889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~ 190 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCM 190 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccce
Confidence 5 799999999999999999753 28899999999999999999999999999999999999988 799999999998
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-----------------------------C--CCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-----------------------------N--VRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-----------------------------~--~~~~ 218 (317)
...... .....+||+.|+|||++.+.. ......++|+.+ . ..+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 270 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE 270 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC
Confidence 643222 123457999999999986532 122334445433 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l~ 252 (317)
...++..+++++..||..++.+ |+++.++++|-+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 271 DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 2346888999999999855543 889999999843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=268.07 Aligned_cols=235 Identities=32% Similarity=0.572 Sum_probs=187.2
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCe
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNL 86 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 86 (317)
++..|.++.++|++.+.||+|+||.||++.+. ...+|+|.+...... +....+.+|+.++.++ +|+||
T Consensus 3 ~~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~i 78 (293)
T cd05053 3 LDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGKHKNI 78 (293)
T ss_pred CCcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH----HHHHHHHHHHHHHHhhcCCCCe
Confidence 46789999999999999999999999999864 367999998765432 2345688999999999 89999
Q ss_pred eeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021127 87 VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151 (317)
Q Consensus 87 v~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl 151 (317)
+++++++.++ ..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+++|+||||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999998755 8999999999999999997532 235899999999999999999999999999999
Q ss_pred CCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC---------------
Q 021127 152 KPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------- 213 (317)
Q Consensus 152 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------- 213 (317)
||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 159 kp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 159 AARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred ceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc-ccceeehhhHHHHHhcCCCCCCC
Confidence 9999999988 7999999999985433211 12223567899999876533322 22333322
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.....+...+..+.+|+.+||..||.+|||+.++++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 011224456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=274.61 Aligned_cols=221 Identities=25% Similarity=0.343 Sum_probs=172.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.++||+|+||.||+|++. ++.||||++....... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 468999999999999999999985 7899999987544321 123467899999999999999999998765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 80 lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP 156 (303)
T ss_pred EEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence 999999 578888887643 348999999999999999999999999999999999999988 78999999998743322
Q ss_pred -cccccccCccceecccccccccccccccccccCC--------CCC----------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------------------- 216 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------------------- 216 (317)
.......+++.|+|||++.+........++|+.+ ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 2223456899999999875432222222222211 000
Q ss_pred ---C------C---------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ---P------S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ---~------~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ . ...++..+.+|+.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0 01234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=260.97 Aligned_cols=227 Identities=22% Similarity=0.318 Sum_probs=187.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCC---hHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
..|.-.+.||.|..+.|-++.++ +..+|+|++..... .+...+.++.-.+|+.+|+++ .||+|+++.++++.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56777889999999999987664 78899998875432 222344555677899999998 799999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++|+|.|+.|.|.++|...-. ++++....|+.|+++|+.|||.++||||||||+|||++++ .++||+|||+++..
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeecc
Confidence 78999999999999999987554 9999999999999999999999999999999999999999 48999999999999
Q ss_pred ccccccccccCccceeccccccccc-----ccccccccccCC-------------------------------CCCCCCC
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHK-------------------------------NVRPSAE 220 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~-------------------------------~~~~~~~ 220 (317)
..+......||||+|+|||.+...- ......+.|..+ -..+...
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 8888888899999999999865321 112222333222 1234456
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++...++||.+||+.||.+|.|++|+++|-+-
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 789999999999999999999999999998543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.69 Aligned_cols=215 Identities=27% Similarity=0.328 Sum_probs=167.8
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|.. +++.++||||+++++++..+ ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN--RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 46899999999999875 8899999997643221 122334555655 46778999999999988754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCccc
Confidence 99999998876544 8999999999999999999999999999999999999988 799999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCCC---------------------------CCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKN---------------------------VRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+. ...++|+.+. ........+..+.+++.+||+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred ccCChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence 5799999999998765443 2344454430 11123457788999999999999
Q ss_pred CCCCCCHH----HHHHH
Q 021127 238 PNARPNFT----QIIQM 250 (317)
Q Consensus 238 p~~Rps~~----~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 235 RQRRLGAKEDFLEIQEH 251 (325)
T ss_pred HHhcCCCCCCHHHHhcC
Confidence 99999875 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.99 Aligned_cols=227 Identities=30% Similarity=0.513 Sum_probs=184.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|.|..++|++.++||+|+||.||+|... ++.||+|.+...... ..++.+|+.++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS------PEAFLAEANLMKQLQHPRLVRLYAVVTQEP 74 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc------HHHHHHHHHHHHhcCCcCeeeEEEEEccCC
Confidence 7789999999999999999999999875 688999998765432 235889999999999999999999987778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecC
Confidence 9999999999999999976555568999999999999999999999999999999999999988 689999999997544
Q ss_pred cccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
.... .....++..|+|||++....... ..+.|+.+ ...+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCc-ccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2221 12234567899999875433221 11111111 1122345677899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.+|++||++++++..|++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=270.15 Aligned_cols=243 Identities=31% Similarity=0.548 Sum_probs=190.2
Q ss_pred ccceecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh
Q 021127 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80 (317)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 80 (317)
+.+...+..|.+..++|.+.+.||+|+||.||++++. ...+|+|.+...... .....+.+|+.++..
T Consensus 4 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~ 79 (307)
T cd05098 4 EYELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE----KDLSDLISEMEMMKM 79 (307)
T ss_pred cccCCCCCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh----HHHHHHHHHHHHHHH
Confidence 3445557789999999999999999999999999763 246999998764332 224468889999999
Q ss_pred c-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 81 V-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 81 l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
+ +|+||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++
T Consensus 80 l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 159 (307)
T cd05098 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK 159 (307)
T ss_pred hcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 799999999998754 89999999999999999976432 2488999999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------- 213 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------- 213 (317)
|++||||||+||+++.+ +.+||+|||+++....... .....+++.|+|||++.+..... ..++|+.+
T Consensus 160 gi~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~ 237 (307)
T cd05098 160 KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFT 237 (307)
T ss_pred CcccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc-HHHHHHHHHHHHHHHc
Confidence 99999999999999988 7899999999875432211 11223457899999875432211 11111111
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+|+.+||..+|.+||++.++++.|.+++...
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 238 LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred CCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 112234567889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=264.14 Aligned_cols=225 Identities=32% Similarity=0.591 Sum_probs=184.2
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 97 (317)
|.++.++|++.+.||.|+||.||+|...++.||||.+..... ...++.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP 74 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC
Confidence 567889999999999999999999999999999999875543 24568899999999999999999999874 48
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||.++...
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~ 153 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEAS 153 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccc
Confidence 9999999999999999987664469999999999999999999999999999999999999988 689999999998653
Q ss_pred cccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
... ....++..|+|||.+.+..... ..+.|+.+ .....+..++..+.+
T Consensus 154 ~~~--~~~~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 154 QGQ--DSGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred ccc--ccCCCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 221 1334567899999875432211 11111110 011224467899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
++.+||..+|.+||++.++++.|..
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHHHhc
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=279.46 Aligned_cols=220 Identities=25% Similarity=0.382 Sum_probs=174.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
...++|++.++||+|+||.||+|++. ++.||||++...... .....+.+|+++++.++|+||+++++++.+. .
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH----HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 34567889999999999999999885 789999998755432 2345688999999999999999999998755 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.... ..++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 147 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILA 219 (353)
T ss_pred EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecc
Confidence 99999999999986532 25678888999999999999999999999999999999988 799999999997543
Q ss_pred cc-cccccccCccceeccccccccc----ccccccccccCC-------------------------------CCCCCCCC
Q 021127 178 LT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-------------------------------NVRPSAEN 221 (317)
Q Consensus 178 ~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-------------------------------~~~~~~~~ 221 (317)
.. .......||..|+|||++.... ......++|+.+ .....+..
T Consensus 220 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 22 2223457899999999874321 111123333322 01112446
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.++.+||.+||+.||++||++.++++|-
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 788999999999999999999999999983
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=268.48 Aligned_cols=219 Identities=34% Similarity=0.620 Sum_probs=169.2
Q ss_pred eecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 27 FVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
.+.+.||.|.||.||+|.+. +..|+||.+...... .....+.+|++.+++++||||++++|++.+ +..+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE----EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH----HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc----ccceeeeeccccccccccccccccccccccccccc
Confidence 57789999999999999887 688999999654332 235679999999999999999999999985 4799
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++|+|.++|.......+++..++.|+.||+.||.|||+++++|+||+++||+++.+ +.+||+|||++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999999999998745559999999999999999999999999999999999999998 69999999999865221
Q ss_pred ---cccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCCChHHHH
Q 021127 180 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAENVPEELS 227 (317)
Q Consensus 180 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~ 227 (317)
.......+...|+|||.+...... ...+.|+ .....+.+..++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHH
Confidence 122333467889999986553211 1111111 1122334567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++|.+||..||++||++.++++.|
T Consensus 236 ~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 236 SLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999865
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=270.49 Aligned_cols=221 Identities=28% Similarity=0.390 Sum_probs=171.0
Q ss_pred CceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeee---
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK--- 94 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 94 (317)
++|++.+.||+|+||.||+|++. ++.||||.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 47999999999999999999873 67899999876543221 122355677766665 6999999999874
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+...++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg 155 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFG 155 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEcccc
Confidence 236899999995 699999987655568999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------CC--------------------------C-
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV--------------------------R- 216 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~--------------------------~- 216 (317)
+++............|++.|+|||++.+..... ..+.|+.+ .. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCC-ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 998654444444567899999999875533221 22222211 00 0
Q ss_pred -------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0012467788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=264.16 Aligned_cols=227 Identities=28% Similarity=0.504 Sum_probs=180.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|++++|++.+.||+|+||.||+|.+. ...||||.+...... .....|.+|+.++++++|+||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD----KQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh----HHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 46788999999999999999999874 357999998765432 234568899999999999999999998865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++..... .+++..++.++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~ 154 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhh
Confidence 4 78999999999999999976443 48999999999999999999999999999999999999988 689999999998
Q ss_pred cccc-ccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 175 EESL-TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 175 ~~~~-~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
.... ... .....++..|+|||.+.+..... ..+.|+.+ ...+.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDC 233 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCcc-ccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6531 111 11223467899999876532211 11111110 112334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+..+.+++.+||+.+|++||++.+++++|.++
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 89999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=270.75 Aligned_cols=220 Identities=25% Similarity=0.307 Sum_probs=172.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+++++ ++.||||++....... .....+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE---EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc---cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 47999999999999999999986 7889999997654322 2344678899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.+..+.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 78 VFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccc
Confidence 99999887666544332 348999999999999999999999999999999999999988 789999999998643221
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------CC-----------------------------------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------------- 215 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------------- 215 (317)
......|++.|+|||++.+.... ...+.|+.+ ..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22334689999999987654332 222333211 00
Q ss_pred -----CCC-----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----RPS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----~~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+. ...++.++.+|+.+||+.||++|||++++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 11357789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.70 Aligned_cols=224 Identities=29% Similarity=0.540 Sum_probs=181.8
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-c-C
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-E-P 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~-~ 96 (317)
|.++..+|++.+.||+|+||.||++...+..||+|.+..... ...+.+|+.++++++|+|++++++++. + +
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch-------HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 678889999999999999999999999999999999864432 335889999999999999999999763 3 4
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++..
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~ 152 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 152 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceec
Confidence 78999999999999999987665568999999999999999999999999999999999999988 79999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+..++..+.
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 153 SSTQ--DTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred cccC--CCCccceeecCHHHHccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 3221 2334567899999876533221 12222211 01112346788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++.+||+.+|++|||+.++++.|+.
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=250.54 Aligned_cols=234 Identities=21% Similarity=0.300 Sum_probs=189.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+....|+.++|.+.++||.|||+.||+++. ++..+|+|.+..... +.++..++|++..++++||||++++++.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-----~~~e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-----EDIEEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-----HHHHHHHHHHHHHHhhCCcchHHHHHHH
Confidence 567789999999999999999999999875 588999999987663 3356689999999999999999999876
Q ss_pred e----c--CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCC
Q 021127 94 K----E--PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 94 ~----~--~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~ 163 (317)
. + ...|++++|...|+|.+.+...+ +..+++.+++.|+.+|++||++||+.. ++||||||.||++..+ +
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~ 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-G 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-C
Confidence 2 1 26999999999999999997643 345999999999999999999999998 9999999999999987 6
Q ss_pred ceEEcccCcccccccccc----------cccccCccceeccccccccc--ccccccccccCC------------------
Q 021127 164 TIKLADFGLAREESLTEM----------MTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK------------------ 213 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~------------------ 213 (317)
.++|.|||.++.....-. ......|..|.|||++.-.. .-....++|+.+
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 999999999874332111 12234689999999875321 122233344333
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...|....+++.+.++|+.||+.||.+||++.+++..++++.
T Consensus 247 ~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 223444568999999999999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=268.87 Aligned_cols=228 Identities=32% Similarity=0.570 Sum_probs=180.7
Q ss_pred ecCCceeecceeccccceEEEEeEECC-------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++.++|++.+.||+|+||.||+|...+ ..||+|.+...... .....+.+|+.++.+++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP----KVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH----HHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 445689999999999999999998642 56999998755432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 754 78999999999999999976421 348899999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.++|+|||++....... ......+++.|+|||.+.+..... ..++|+.+
T Consensus 158 ~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 158 GEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT-ESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 988 689999999987542221 123345678899999875433221 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+..+|.++.+|+.+||+.||.+||++.+++++|+++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 12233567889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=269.35 Aligned_cols=239 Identities=31% Similarity=0.549 Sum_probs=188.1
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-C
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (317)
+.....|.+...+|.+.+.||+|+||.||++++. +..||+|.+...... ....++.+|+.++..+ +
T Consensus 4 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred cccCCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch----HHHHHHHHHHHHHHhhcc
Confidence 4445679999999999999999999999999741 357999988754322 2345688999999999 8
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
||||+++++++... ..++||||+++++|.+++..... ..+++.+++.++.||+.||+|||++|++
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~giv 159 (304)
T cd05101 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI 159 (304)
T ss_pred CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCee
Confidence 99999999998755 78999999999999999976432 2478889999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------- 213 (317)
||||||+||+++.+ +.+||+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 160 H~dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 160 HRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred ecccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc-hhhHHHHHHHHHHHHcCCC
Confidence 99999999999988 789999999998553321 122234567899999875532211 12222211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+|+.+||+.+|.+||++.++++.|.+++..
T Consensus 238 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 238 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11122456788999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=266.61 Aligned_cols=228 Identities=27% Similarity=0.520 Sum_probs=179.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.+..++|++.+.||+|+||.||+|.+. +..||||.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 6788899999999999999999998764 367999998654332 23446889999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~- 155 (277)
T cd05062 77 VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-
Confidence 98765 88999999999999999976332 236788899999999999999999999999999999999988
Q ss_pred CceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------------------------
Q 021127 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+.++|+|||++........ .....++..|+|||++.+..... ..++|+.+
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 6899999999874432211 11234577899999876532211 11222111
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 112234567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=264.06 Aligned_cols=228 Identities=29% Similarity=0.495 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|++..++|.+.+.||+|++|.||++.+. +..+|+|.+...... ...+.+|+.++++++|+|++++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM------PEAFLQEAQIMKKLRHDKLVPLYAVVSEEP 74 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 6788889999999999999999999886 457999987654321 245888999999999999999999988778
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~ 153 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIE 153 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEcc
Confidence 8999999999999999987555558999999999999999999999999999999999999988 689999999997543
Q ss_pred ccccc--ccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCCChHHHH
Q 021127 178 LTEMM--TAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAENVPEELS 227 (317)
Q Consensus 178 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~~~~~l~ 227 (317)
..... ....++..|+|||...+..... +..++... ....+.+...+..+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 22211 1224567899999765321110 11111000 011223456789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+++.+||+.||.+||+++++++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=273.71 Aligned_cols=220 Identities=23% Similarity=0.282 Sum_probs=174.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~l 100 (317)
+|++.+.||+|+||.||+|.+. ++.||||++.+..... ......+..|++++..+.| ++|+++++++.+. ..++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 5889999999999999999886 6789999997643211 1234567889999999966 4688888888654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
||||+++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence 9999999999999976544 8999999999999999999999999999999999999988 789999999987432 22
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~ 234 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (324)
T ss_pred CceeeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 223345799999999998765433 223444332 1112245678899999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||..||.+|++. ++++++
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999986 566665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=263.39 Aligned_cols=225 Identities=24% Similarity=0.401 Sum_probs=181.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
+++|.+.+.||+|++|.||++.+. ++.||+|.+...............+.+|+.++++++||||+++++++.++ ..+
T Consensus 1 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CCcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 367999999999999999999764 79999999886554333334456788999999999999999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence 99999999999999986544 8999999999999999999999999999999999999988 78999999998754322
Q ss_pred ccc----ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 180 EMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 180 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
... ....++..|+|||++.+.... ...+.|+.+ .....+..++..+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence 111 234578899999987664321 122222211 1122345678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+++.+||..+|.+|||+.+++++.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCC
Confidence 9999999999999999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=273.59 Aligned_cols=215 Identities=26% Similarity=0.348 Sum_probs=171.8
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||||+++...... ......+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND--DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 46899999999999885 7899999998653322 12344678899999888 799999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
++|+|..++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.. ........
T Consensus 79 ~~g~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQRQRK--LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccc
Confidence 99999998876543 9999999999999999999999999999999999999988 78999999998742 22223345
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~ 228 (317)
.+||+.|+|||++.+..... ..++|+.+ .....+..++.++.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCC-ccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 67999999999987643322 23333322 011224567888999
Q ss_pred HHHHhhhcCCCCCCC------HHHHHHH
Q 021127 229 ILTSCWKEDPNARPN------FTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps------~~~~~~~ 250 (317)
++.+||+.||.+|++ ++++++|
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 6788776
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=274.33 Aligned_cols=215 Identities=25% Similarity=0.348 Sum_probs=168.6
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||+|++....... ......+..|..++... +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI--DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 46999999999999885 7899999997643211 12233466777777754 899999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
.+|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.... ......
T Consensus 79 ~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceec
Confidence 99999999876543 8999999999999999999999999999999999999988 7899999999874321 222344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
.+||+.|+|||++.+..+. ...++|+.+ .....+..++.++++++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred cCCCcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence 5789999999998765433 233444433 011124457889999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. ++++|
T Consensus 235 P~~R~~~~~~~~~h 248 (316)
T cd05620 235 PTRRLGVVGNIRGH 248 (316)
T ss_pred HHHcCCChHHHHcC
Confidence 99999984 66655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=275.55 Aligned_cols=219 Identities=24% Similarity=0.305 Sum_probs=171.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------C
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------P 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~ 96 (317)
+|++.++||+|+||.||+|.+. ++.||||.+....... ....++.+|+.++++++||||+++++++.. .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV---SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc---hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5899999999999999999875 7899999987532221 223468899999999999999999998742 2
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+ +++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccc
Confidence 479999999 5799999876544 8999999999999999999999999999999999999988 79999999999753
Q ss_pred cccc----ccccccCccceecccccccc-cccccccccccCC--------CCC---------------------------
Q 021127 177 SLTE----MMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK--------NVR--------------------------- 216 (317)
Q Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~--------~~~--------------------------- 216 (317)
.... ......||+.|+|||++.+. .......++|+.+ ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 12345789999999987542 1112222333221 000
Q ss_pred ------------------C-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ------------------P-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ------------------~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||++|||+.+++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 012456778999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=262.27 Aligned_cols=222 Identities=26% Similarity=0.503 Sum_probs=175.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++++|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+.++++++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 46788999999999999999999886 568999987654322 23588899999999999999999998755 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.+||+|||+++....
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCC
Confidence 999999999999999875432 38999999999999999999999999999999999999988 6899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 231 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccch-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 2211 1223566899999876432111 11111110 11122445678899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|.+||++.++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=268.56 Aligned_cols=238 Identities=30% Similarity=0.564 Sum_probs=187.8
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCC
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHR 84 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 84 (317)
.+..|.++.++|.+.++||+|+||.||+++.. ...+|+|.+...... .....+.+|+.+++++ +||
T Consensus 3 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~ 78 (314)
T cd05099 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD----KDLADLISEMELMKLIGKHK 78 (314)
T ss_pred CcccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh----HHHHHHHHHHHHHHhccCCC
Confidence 57789999999999999999999999998752 457999998755432 2245688999999999 699
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHR 149 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~ 149 (317)
||+++++++.+. ..++||||+++|+|.+++..... ..+++..+..++.|++.||.|||++|++||
T Consensus 79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999998754 78999999999999999976431 348899999999999999999999999999
Q ss_pred CCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-------------
Q 021127 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------- 213 (317)
Q Consensus 150 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------- 213 (317)
||||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 159 dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 159 DLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred cccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc-cchhhHHHHHHHHHHhCCCCC
Confidence 999999999988 6899999999975432211 12223456899999875532221 22222211
Q ss_pred ----------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ----------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+++.+||+.+|++||++.++++.|+++....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 237 YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111224566789999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=264.81 Aligned_cols=228 Identities=28% Similarity=0.506 Sum_probs=181.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.|+.++|++.+.||+|+||.||+|.+. +..||+|.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM----RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH----HHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 7789999999999999999999998875 267999998655432 22456889999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++++||||||+||+++.+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~- 155 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED- 155 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-
Confidence 98755 89999999999999999975332 236888999999999999999999999999999999999998
Q ss_pred CceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC--------------------------
Q 021127 163 KTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+.+||+|||+++...... ......++..|+|||.+....... ..+.|+.+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCc-ccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 799999999987543221 122334678899999875433221 12222211
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 122235567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=275.91 Aligned_cols=229 Identities=22% Similarity=0.321 Sum_probs=181.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...+..++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~--~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45677799999999999999999999886 7899999987533211 1234457889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~ 190 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 190 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCcee
Confidence 5 799999999999999998753 28899999999999999999999999999999999999988 799999999997
Q ss_pred cccccc--ccccccCccceeccccccccc---ccccccccccCC-------------------------------CCCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVT---LRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
...... .....+||+.|+|||++.... ......++|+.+ ...+.
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 553322 223457999999999986532 122344455443 01122
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l~ 252 (317)
...++..++++|..||..++.+ |+++.++++|.+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 3367899999999999844433 789999998853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.79 Aligned_cols=215 Identities=26% Similarity=0.348 Sum_probs=170.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.++.++ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc--hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 46999999999999885 7899999998653222 12344577888888776 899999999998754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccc
Confidence 99999998876543 9999999999999999999999999999999999999988 799999999987432 2222344
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~l~~ 228 (317)
..||+.|+|||++.+..... ..++|+.+ .....+..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCC-ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 57999999999987643322 23333322 011124567788999
Q ss_pred HHHHhhhcCCCCCCC------HHHHHHH
Q 021127 229 ILTSCWKEDPNARPN------FTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps------~~~~~~~ 250 (317)
++.+||+.||.+||+ +.++++|
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999998 4677766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=280.19 Aligned_cols=214 Identities=25% Similarity=0.438 Sum_probs=179.4
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
+||+|.||+||.|++. ...+|||.++...+.. .+.+.+||.++++|+|.|||+++|.+.++ .+-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-----~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-----VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchh-----hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 5899999999999886 5678999998766533 55688999999999999999999999765 78899999999
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-cccccccc
Q 021127 108 GTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEMMTA 184 (317)
Q Consensus 108 g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~~~~ 184 (317)
|+|..+|+...+ ++ ++.+.-.+.+||++||.|||++.|||||||-+|+||+...|.+||+|||.++.. .....+.+
T Consensus 657 GSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999999987443 35 788888999999999999999999999999999999987789999999999854 44456677
Q ss_pred ccCccceeccccccccccc-ccccccccCC------------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 185 ETGTYRWMAPELYSTVTLR-QGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
+.||+.|||||++....-. ....++|+.+ ...+.|..++.+.+.+|.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 8999999999998764322 2233444433 23455778889999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~ 250 (317)
+.+||.+||++.++++-
T Consensus 816 Fepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cCCCcccCccHHHhccC
Confidence 99999999999999863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=272.54 Aligned_cols=171 Identities=25% Similarity=0.392 Sum_probs=146.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.++||+|+||.||++.+. +..+|+|.+...... .....+.+|++++++++|+||+++++++.++ .
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence 55689999999999999999999886 788999988765432 2345688999999999999999999998755 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+++++|.+++...+. +++..+..++.|++.||.|||++ +++||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~ 154 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQL 154 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhh
Confidence 9999999999999999986544 89999999999999999999985 79999999999999988 68999999998754
Q ss_pred ccccccccccCccceeccccccc
Q 021127 177 SLTEMMTAETGTYRWMAPELYST 199 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~ 199 (317)
... ......|+..|+|||++.+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcC
Confidence 322 2234568999999998765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=268.92 Aligned_cols=238 Identities=32% Similarity=0.559 Sum_probs=186.7
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCC
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRN 85 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n 85 (317)
+.+|++...+|++.+.||+|+||.||++.+. +..||+|.+...... .....+.+|+.+++++ +|+|
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~ 79 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD----KDLSDLVSEMEMMKMIGKHKN 79 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH----HHHHHHHHHHHHHHhhcCCCC
Confidence 4689999999999999999999999999752 236899988754332 2345688999999999 8999
Q ss_pred eeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021127 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRD 150 (317)
Q Consensus 86 iv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~D 150 (317)
|+++++++.+. ..+++|||+++|+|.+++..... ..+++..++.++.|++.||+|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 99999998755 78999999999999999976421 2378889999999999999999999999999
Q ss_pred CCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC--------------
Q 021127 151 LKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------- 213 (317)
Q Consensus 151 lkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------- 213 (317)
|||+||+++.+ +.+||+|||+++....... .....++..|+|||++.+...... .++|+.+
T Consensus 160 lkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 160 LAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCC
Confidence 99999999988 6899999999975432211 122234568999998755332211 1222111
Q ss_pred ---------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 214 ---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 214 ---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
.....+..++.++.+++.+||+.+|.+||++.++++.|+++.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1122345667899999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.57 Aligned_cols=215 Identities=21% Similarity=0.316 Sum_probs=169.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+...+|++.++||+|+||.||++.+. ++.||||.... ..+.+|+.++++++||||+++++++..+ .
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 45578999999999999999999885 78999996432 2367899999999999999999998754 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|+|++ +++|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPV 233 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccc
Confidence 89999999 5799998876543 8999999999999999999999999999999999999988 789999999997432
Q ss_pred cc--cccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.. .......||+.|+|||++.+..+.. ..++|+.+
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGP-AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 21 2223457999999999876532211 11111111
Q ss_pred --------------------CC----CCC---CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 --------------------NV----RPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 --------------------~~----~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.. .+. ...++.++.+||.+||+.||.+|||+.+++++-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 00 000 013466889999999999999999999999873
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=283.48 Aligned_cols=222 Identities=24% Similarity=0.334 Sum_probs=171.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 95 (317)
...++|++.++||+|+||.||+|.+. ++.||||.+..... ...+|+.+++.++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~ 133 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECF 133 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeeccc
Confidence 34568999999999999999999874 78999998864332 13469999999999999999887632
Q ss_pred -----C-ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 96 -----P-VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 96 -----~-~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
. .+++||||++ ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||
T Consensus 134 ~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 134 KKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceee
Confidence 1 4678999996 5787777532 23458999999999999999999999999999999999999976457999
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC--------CC------------------------
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------ 215 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------ 215 (317)
+|||+++............||+.|+|||++.+........++|+.+ ..
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999998654444444567899999999876532222222222221 00
Q ss_pred ------------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 ------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 ------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+...+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0012345788999999999999999999999998843
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=261.92 Aligned_cols=227 Identities=30% Similarity=0.510 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|+++.++|++.+.||+|++|.||+|.+. ++.||||.+...... .+.+.+|+.++++++|+||+++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc------HHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 6788899999999999999999999875 678999998754321 33588899999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 153 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVI 153 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEc
Confidence 78999999999999999987654558999999999999999999999999999999999999988 68999999999865
Q ss_pred cccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
...... .....+..|+|||++.+...... .+.|+.+ ...+.+..++..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKE 232 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 422111 11123457999998654322111 1111100 112234567899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+.+++.+||+.+|.+||++.++.+.|++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=274.14 Aligned_cols=234 Identities=29% Similarity=0.538 Sum_probs=181.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
.|.+..++|++.+.||+|+||.||+|.+ .++.||||+++...... ....+.+|+.++.++ +|+||+++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH----HHHHHHHHHHHHHhccCCccHhhh
Confidence 4888999999999999999999999974 26789999997654322 234688899999999 78999999
Q ss_pred Eeeeec--CceEEEEEccCCCCHHHHHHhcC-------------------------------------------------
Q 021127 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMR------------------------------------------------- 118 (317)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------- 118 (317)
++++.. ...++||||+++|+|.+++....
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 998754 36889999999999999987532
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 119 ----------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 119 ----------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
...+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcch
Confidence 1236788889999999999999999999999999999999988 689999999987542211
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......++..|+|||++.+..+.. ..++|+.+ .....+...+.++.++
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 111223567899999875432211 11111100 1112234467789999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+||+.||.+||++.+++++|+.++..
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=268.48 Aligned_cols=216 Identities=25% Similarity=0.321 Sum_probs=172.2
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|.+++..+ +||||+++++++.++ ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ--DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 46999999999999886 6899999987643211 12344577888888876 899999999999765 799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++++|..++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.... .......
T Consensus 79 ~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccc
Confidence 99999999876544 8999999999999999999999999999999999999988 799999999987432 2222344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..... ..++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred cccCccccCHHHHcCCCCCC-ccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence 57899999999987644332 34444433 011123456889999999999999
Q ss_pred CCCCC-------CHHHHHHHH
Q 021127 238 PNARP-------NFTQIIQML 251 (317)
Q Consensus 238 p~~Rp-------s~~~~~~~l 251 (317)
|++|| ++.+++++.
T Consensus 235 p~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcCC
Confidence 99999 888888773
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.50 Aligned_cols=220 Identities=23% Similarity=0.290 Sum_probs=175.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~l 100 (317)
+|.+.+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ .|++|+++++++.+. ..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 5889999999999999999886 6789999998643221 12334567788888777 689999999988765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
||||+++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 79 v~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCC
Confidence 9999999999999876544 8999999999999999999999999999999999999998 7999999999975322 2
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 234 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG 234 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 223445799999999998765443 334455443 1112245678999999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||+.||.+|++. .+++++
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcC
Confidence 999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=284.12 Aligned_cols=221 Identities=21% Similarity=0.332 Sum_probs=175.9
Q ss_pred CCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
...|.+.+.||+|+||.||+|... ++.||+|.+..... .....+.+|+.+++.++||||+++++++..+ ..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-----RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 345999999999999999999764 57789987654332 2334577899999999999999999998754 89
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~ 219 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceec
Confidence 9999999999999988643 22348999999999999999999999999999999999999988 79999999999854
Q ss_pred cccc---ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHH
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~ 225 (317)
.... .....+||+.|+|||++.+..+.. ..++|+.+ ...+.+..++.+
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 3221 233456999999999876643322 12222211 122334567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.++|.+||+.||++||++.+++.+
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999998764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=265.18 Aligned_cols=228 Identities=31% Similarity=0.548 Sum_probs=183.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
|+....+|++.++||.|+||.||+|.+. +..+|+|++..... .....+.+|+.+++.++|+||+++++++.+.
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-----hhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3455678999999999999999999886 68899999876543 2234588899999999999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~ 154 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLI 154 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhc
Confidence 78999999999999999987665668999999999999999999999999999999999999988 68999999999754
Q ss_pred ccccc-cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 177 SLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 177 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
..... .....++..|+|||++....... ..++|..+ ...+.+..++..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFST-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI 233 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHH
Confidence 32211 12334567899999875432211 11111110 1223356778999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.||.+|||+.++++.|+.
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=269.07 Aligned_cols=215 Identities=25% Similarity=0.319 Sum_probs=168.5
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
||+|+||+||+|++. ++.||||++....... ......+..|..++... .||||+++++++.+. ..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA--KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh--hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 799999999999885 7899999987543221 12233456677777665 699999999998765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccC
Confidence 99999999876543 8999999999999999999999999999999999999988 789999999987532 2223345
Q ss_pred ccCccceecccccccccccccccccccCCC----------------------------CCCCCCCChHHHHHHHHHhhhc
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKN----------------------------VRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~ 236 (317)
.+||+.|+|||++.+........+.|+.+. .......++.++.+++.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 679999999999865433334455555441 0111234688999999999999
Q ss_pred CCCCCC----CHHHHHHHH
Q 021127 237 DPNARP----NFTQIIQML 251 (317)
Q Consensus 237 ~p~~Rp----s~~~~~~~l 251 (317)
||.+|| ++.+++++.
T Consensus 236 ~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CHHHCCCCCCCHHHHhcCc
Confidence 999998 677887763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.61 Aligned_cols=240 Identities=30% Similarity=0.506 Sum_probs=187.7
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.+.....+..|.+..++|.+.+.||+|+||.||++.+. +..||||.+...... .....+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l 95 (302)
T cd05055 20 DPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS----SEREALMSELKIMSHL 95 (302)
T ss_pred CcccccccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh----HHHHHHHHHHHHHHhc
Confidence 33444556678899999999999999999999998751 457999998765432 2245688999999999
Q ss_pred -CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 82 -QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 82 -~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
+|+||+++++++... ..++||||+.+++|.+++.......+++.++..++.|++.||+|||+++++|+||||+||+++
T Consensus 96 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~ 175 (302)
T cd05055 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT 175 (302)
T ss_pred cCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc
Confidence 899999999998754 799999999999999999865544589999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.++|+|||+++...... ......++..|+|||++.+..... ..++|+.+
T Consensus 176 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~t~g~~p~~~~~~~~~~ 253 (302)
T cd05055 176 HG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253 (302)
T ss_pred CC-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCc-HhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence 87 689999999997543221 112234567899999865432211 11111100
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.....+...+..+.+++.+||+.+|++|||+.++++.|.++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01122345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.92 Aligned_cols=225 Identities=24% Similarity=0.367 Sum_probs=198.2
Q ss_pred CceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+=|.+.+-||+|-|..|-+|++ +|..||||++.+...... ....+.+|++.++.++|||||+||.+.... .+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~---st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL---STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh---hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 4578899999999999999877 599999999998776542 234578999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+|+-.+|+|++||.+...+ +.++.+.+++.||+.|+.|+|+..+|||||||+|+.+-+..|-+||+|||++.......
T Consensus 95 iLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999999875543 99999999999999999999999999999999999988777899999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCCC---------------------------CCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------RPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~c 233 (317)
...+.||++.|.|||++.+..++....++|+.+.. ...|..++.+.++||..|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sM 253 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSM 253 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHH
Confidence 88899999999999999999999888888876611 112566789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|..||.+|.+.++|...-|
T Consensus 254 LvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 254 LVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred HhcCchhhccHHHHhcccc
Confidence 9999999999999987743
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=272.48 Aligned_cols=215 Identities=25% Similarity=0.350 Sum_probs=171.0
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ--DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh--ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 46899999999999885 7899999987543211 12344577888888876 799999999998765 799999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|.+++..... +++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++... .......
T Consensus 79 ~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccc
Confidence 99999999876544 9999999999999999999999999999999999999988 799999999987532 2223344
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred cccCccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence 5799999999998764432 233444433 111224457889999999999999
Q ss_pred CCCCCCH------HHHHHH
Q 021127 238 PNARPNF------TQIIQM 250 (317)
Q Consensus 238 p~~Rps~------~~~~~~ 250 (317)
|.+||++ +++++|
T Consensus 235 P~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHCCCCCCCCCHHHHHcC
Confidence 9999998 666665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=283.74 Aligned_cols=226 Identities=23% Similarity=0.374 Sum_probs=181.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
....++|++.+.||+|+||+||++++. ++.||||++....... ....++.+|+..+..++|+||+++++.+...
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~---~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 345689999999999999999999874 8999999997655432 3345688999999999999999998776321
Q ss_pred --------ceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 97 --------VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 97 --------~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vk 183 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVK 183 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEE
Confidence 3689999999999999997532 2358999999999999999999999999999999999999988 7899
Q ss_pred EcccCcccccccc---cccccccCccceecccccccccccccccccccCC----------------------------CC
Q 021127 167 LADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NV 215 (317)
Q Consensus 167 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~ 215 (317)
|+|||+++..... ......+||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~-k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK-KADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999999754321 2233457999999999987643321 22222211 12
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+..++.++.+++.+||+.||.+||++.+++++
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 23456788999999999999999999999999876
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=263.36 Aligned_cols=227 Identities=28% Similarity=0.511 Sum_probs=178.5
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+-.+|++.++||+|+||.||+|.+ .+..||+|.+...... .....+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 78 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP----QQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH----HHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence 447899999999999999999975 2578999998754432 234568899999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMR---------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
. ..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||++|++||||||+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 4 7899999999999999986322 12378899999999999999999999999999999999999
Q ss_pred CCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.+||+|||+++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 159 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 88 689999999997542221 122334567899999876433211 11222111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+++.+||+.||++||++.+++++|..|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 237 EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 11233556789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=267.05 Aligned_cols=215 Identities=26% Similarity=0.328 Sum_probs=171.4
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+++.. ++.||+|++....... ......+.+|+.++.++ +|+||+++++++.+. .+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD--DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 46999999999999875 7899999998654322 23345678899999888 699999999998755 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-ccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~~~~~~ 184 (317)
++|+|..++...+. +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++... .......
T Consensus 79 ~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceec
Confidence 99999998876544 9999999999999999999999999999999999999988 789999999987432 2223345
Q ss_pred ccCccceecccccccccccccccccccCC----------------------------------CCCCCCCCChHHHHHHH
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~l~~li 230 (317)
.+||+.|+|||++.+.... ...++|+.+ .....+..++..+.+++
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 6799999999998764432 223333322 01123456778899999
Q ss_pred HHhhhcCCCCCCCH------HHHHHH
Q 021127 231 TSCWKEDPNARPNF------TQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~------~~~~~~ 250 (317)
.+||+.||.+|+++ .++++|
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999984 577766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=264.22 Aligned_cols=231 Identities=26% Similarity=0.523 Sum_probs=180.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
|.++.++|++.++||+|+||.||+|..+ +..||+|.+...... .....+.+|+.+++.++|+||+++++
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL----RERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH----HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 7899999999999999999999998653 357999988654432 22345788999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRP--------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
++.++ ..++||||+++|+|.+++..... ..++...+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~- 155 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD- 155 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-
Confidence 88655 78999999999999999975331 235677889999999999999999999999999999999988
Q ss_pred CceEEcccCcccccccccc---cccccCccceecccccccccccccccccccC---------------------------
Q 021127 163 KTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------------------------- 212 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--------------------------- 212 (317)
+.++|+|||+++....... .....++..|+|||.+.+..... ..+.|+.
T Consensus 156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCCh-HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7899999999875432211 12224567899999876432211 1111110
Q ss_pred --CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 213 --KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 213 --~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
......+...+..+.+++.+||+.||.+|||+.++++.+.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0112234566889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=265.32 Aligned_cols=214 Identities=26% Similarity=0.345 Sum_probs=169.0
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||.||+++.. ++.||+|.+....... ......+..|++++++++||||+++++++.++ ..++||||++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 699999999999875 8999999986533211 11233456799999999999999999988765 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|..++.......+++..++.++.|++.||+|||+.|++||||||+||+++.+ +.++|+|||++.............|+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCC
Confidence 99998876655568999999999999999999999999999999999999988 68999999998765443333445789
Q ss_pred cceecccccccccccccccccccCC--------------------------------CCCCCCCCChHHHHHHHHHhhhc
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~l~~li~~cl~~ 236 (317)
..|+|||++.+.... ...+.|+.+ ........++.++.+|+.+||+.
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999987664422 222333222 00011235788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 021127 237 DPNARPNFTQIIQ 249 (317)
Q Consensus 237 ~p~~Rps~~~~~~ 249 (317)
||.+||++.++++
T Consensus 237 ~P~~R~~~~~~~~ 249 (277)
T cd05607 237 KPEDRLGSREKND 249 (277)
T ss_pred CHhhCCCCccchh
Confidence 9999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=256.88 Aligned_cols=220 Identities=22% Similarity=0.385 Sum_probs=177.9
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|+||.||++.+. ++.+|+|.++..... ...+.+.+|+.+++.++|+||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch----HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 5889999999999999999875 889999998754432 2345678899999999999999999998755 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+...... .
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence 999999999999876555568999999999999999999999999999999999999988 78999999998754322 2
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+.+..++..+.+|+.+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccccCCccccCHHHHccCCcCc-hhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 223456888999999876543222 22223222 1222345678889999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.||++||++.+++..
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=259.63 Aligned_cols=217 Identities=24% Similarity=0.460 Sum_probs=172.5
Q ss_pred eeccccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEccC
Q 021127 31 RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
+||+|+||.||+|.+ ++..+|+|++....... .....+.+|+.+++.+.|+||+++++++.+...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP---ALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH---HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 689999999999965 36889999987554322 34567899999999999999999999998778899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc----c
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~ 182 (317)
+++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++........ .
T Consensus 79 ~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeec
Confidence 9999999976443 8999999999999999999999999999999999999988 6899999999975432211 1
Q ss_pred ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
....++..|+|||.+....... ..++|+.+ ...+.+..++.++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2223457899999865422111 11111100 11234567889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHh
Q 021127 234 WKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~~ 254 (317)
|+.||++||++++|.+.|++.
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hccCchhCcCHHHHHHHHhcc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=262.22 Aligned_cols=230 Identities=23% Similarity=0.444 Sum_probs=181.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+...+|++.++||+|+||+||+|++. +. .||+|++...... .....+.+|+.++..+.|+||+++++++.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP----KANKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH----HHHHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 55688999999999999999999863 33 5899998765443 23456889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~ 157 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLAR 157 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCcee
Confidence 888899999999999999997643 348999999999999999999999999999999999999887 689999999998
Q ss_pred cccccccc---ccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
........ ....++..|+|||.+.+..... ..++|+. ....+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTH-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPIC 236 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccC
Confidence 55432211 1223467899999875432211 1111111 1122334567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.||++||++.++++.+.++...
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 88999999999999999999999999988777543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.56 Aligned_cols=223 Identities=32% Similarity=0.600 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
|.+..++|++.+.||+|+||.||++..+++.||+|.+..... ...+.+|+.++++++|+|++++++++.....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT-------AQAFLEETAVMTKLHHKNLVRLLGVILHNGL 73 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcch-------HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCc
Confidence 567778999999999999999999998899999999865432 2358899999999999999999999987788
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSM 152 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceeccc
Confidence 999999999999999987655558999999999999999999999999999999999999988 6899999999875432
Q ss_pred ccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
. ......+..|+|||.+.+..... ..+.|+.+ .....+..++..+.++
T Consensus 153 ~--~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 153 G--VDNSKLPVKWTAPEALKHKKFSS-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred c--CCCCCCCceecCHHHhccCCcCc-hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 2 12233456899999875432211 11111111 1112245678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.+||+.+|++||+++++++.|+
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHHHc
Confidence 99999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=258.16 Aligned_cols=227 Identities=29% Similarity=0.497 Sum_probs=182.7
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
|+|..++|++.++||+|+||.||++.+. +..+|+|.+..... ....+.+|+.++++++|+||+++++.+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVTKEP 74 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh------HHHHHHHHHHHHHhcCCCCcceEEEEEcCCC
Confidence 7899999999999999999999999875 56799998765321 2346889999999999999999999988888
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||.+....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~ 153 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIE 153 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeecc
Confidence 8999999999999999987555558899999999999999999999999999999999999988 799999999987543
Q ss_pred cccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
.... .....++..|+|||++....... ..+.|+.+ ...+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCc-cccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHH
Confidence 2211 11223567799999875432211 12222211 1112345677899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=260.17 Aligned_cols=222 Identities=29% Similarity=0.500 Sum_probs=175.4
Q ss_pred ecCCceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++++|.+.+.||+|+||.||+|.+.+ ..+|||.+...... ...+.+|+.++.+++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 467889999999999999999998874 46999988754322 23588999999999999999999998755 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+.+++|.+++..... .+++..++.++.||+.||+|||++|++|+||||+||+++.+ +.+||+|||.++....
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCC
Confidence 999999999999999976443 48999999999999999999999999999999999999988 6899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||++.+..... ..+.|+.+ .....+...+..++
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSS-KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 2211 1223567899999876432211 11111110 11122445678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|.+||++.++++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=264.00 Aligned_cols=232 Identities=28% Similarity=0.462 Sum_probs=179.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce--EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
+..++|++.+.||+|+||.||+|.+. +. .+|+|.+...... .....+.+|++++.++ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH----HHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 45578999999999999999999874 33 4677776543322 2345688899999999 89999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 4 89999999999999999975431 24789999999999999999999999999999999999998
Q ss_pred CCCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC---------------------------
Q 021127 161 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------- 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------- 213 (317)
+ +.+||+|||++.............++..|+|||++.+.... ...++|+.+
T Consensus 160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 160 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred C-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 8 68999999998643222112222346679999987553322 223333322
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+..++.++.+|+.+||+.+|++||+++++++.+..++...
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 011123456789999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.05 Aligned_cols=229 Identities=21% Similarity=0.394 Sum_probs=178.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+..++|++.+.||+|+||.||+|.+. ++ .+++|.+...... ....++..|+..+.+++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR----QTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch----HHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 44578899999999999999999873 43 4788877543321 22346778888999999999999999988
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+...++++||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~ 157 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVAD 157 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccce
Confidence 778889999999999999997643 348999999999999999999999999999999999999988 689999999997
Q ss_pred cccccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 175 EESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
...... ......++..|+|||.+.+..... ..+.|+.+ ...+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC 236 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence 543221 122334677899999875432211 11111111 112224456
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+.++.+++.+||..||.+|||+.++++.|..+.+
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 7789999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=260.10 Aligned_cols=227 Identities=26% Similarity=0.430 Sum_probs=179.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|+||.||+|++. ++.||||.+....... .+....+.+|+.+++.++||||+++++++.+ +..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD--AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC--HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 57999999999999999999874 8999999887543322 2345568899999999999999999998865 48899
Q ss_pred EEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+||+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceeccc
Confidence 999999999999886432 2348899999999999999999999999999999999999988 6899999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCC-CCCChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS-AENVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~-~~~~~~~l 226 (317)
.. ......+++.|+|||.+.+..... ..+.|+.+ ...+. ...++..+
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCc-hhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 22 122346888999999876533221 12222211 00111 23566889
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||+.+|++||++.++++.++.+
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.23 Aligned_cols=224 Identities=24% Similarity=0.326 Sum_probs=178.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|++.+.||+|+||.||++.+. ++.||||.+....... ......+.+|+.++++++|+||+++++.+.+. ..++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc--hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 3678889999999999999885 7899999987654322 12334577899999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcc
Confidence 999999999999876555569999999999999999999999999999999999999988 6899999999875543333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|+..|+|||++.+..... ..+.|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 33457899999999986543322 22333221 00112345778899999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~l~ 252 (317)
.+||+.||++||| +.++++|-+
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChh
Confidence 9999999999999 889988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=261.54 Aligned_cols=222 Identities=24% Similarity=0.361 Sum_probs=174.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||+|++. ++.||+|++....... ...+.+|+.++++++|+||+++++++... ..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-----FSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch-----HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 3468999999999999999999874 7899999987543322 23577899999999999999999998654 88
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecc
Confidence 999999999999999876543 8999999999999999999999999999999999999988 6899999999975432
Q ss_pred cc-ccccccCccceeccccccccc--ccccccccccCC----------------------------C-CC---CCCCCCh
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK----------------------------N-VR---PSAENVP 223 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~----------------------------~-~~---~~~~~~~ 223 (317)
.. ......|+..|+|||.+.... ......+.|+.+ . .. .....++
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence 21 223346889999999874211 011112222111 0 00 1123467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.+++.+||..+|++||+++++++++
T Consensus 239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 239 STFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 8999999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=258.64 Aligned_cols=227 Identities=30% Similarity=0.526 Sum_probs=183.1
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-C
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-P 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 96 (317)
|.++.++|++.++||+|+||.||+|.+. ++.||||.+...... ...+.+|+.++++++|+||+++++++.+ .
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS------PEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC------HHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 6789999999999999999999999876 578999998754432 2358899999999999999999999876 5
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++...
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~ 153 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLI 153 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceec
Confidence 89999999999999999987655569999999999999999999999999999999999999998 79999999998754
Q ss_pred ccccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 177 SLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
..... .....++..|+|||.+.+..... ..+.|+.+ ...+.+...+.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTI-KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEE 232 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 32211 11223456899999876532221 11111100 122335567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+.+++.+||+.+|.+||+++++++.|+.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=262.77 Aligned_cols=225 Identities=26% Similarity=0.471 Sum_probs=177.9
Q ss_pred cCCceeecceeccccceEEEEeEECC------------------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYKN------------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~------------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 83 (317)
..++|++.++||+|+||.||++.+.+ ..||+|.+...... .....+.+|++++++++|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~~ 78 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD----NAREDFLKEVKILSRLSD 78 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH----HHHHHHHHHHHHHHhcCC
Confidence 45789999999999999999987642 46899998866543 335578899999999999
Q ss_pred CCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 84 RNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 84 ~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
+||+++++++.. +..+++||++++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 999999999876 489999999999999999976541 2489999999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
+||+++.+ +.++|+|||+++...... ......++..|+|||++.+.... ...++|+.+
T Consensus 159 ~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999998 799999999987543221 12233467789999986542211 111222111
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 011223456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=262.15 Aligned_cols=215 Identities=24% Similarity=0.316 Sum_probs=169.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||+||++.+. ++.||+|.+....... ......+..|+++++.++|+||+++.+++... ..++||||+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh--hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 699999999999875 7899999987643322 12335678899999999999999999988655 799999999999
Q ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cccccc
Q 021127 109 TLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAE 185 (317)
Q Consensus 109 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 185 (317)
+|..++... ....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++...... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCcccccc
Confidence 999887542 22358999999999999999999999999999999999999987 78999999999754322 222334
Q ss_pred cCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
.||+.|+|||++.+..... ..+.|+.+ .....+..++..+.+++.+||
T Consensus 158 ~g~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCCcCccCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 6899999999987643322 22222211 011123457889999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~ 250 (317)
+.||++|| +++++++|
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcC
Confidence 99999999 77888877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=262.42 Aligned_cols=230 Identities=29% Similarity=0.502 Sum_probs=181.9
Q ss_pred ecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|...+|.+.+.||+|+||.||++.. ++..+|+|.+..... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-----NARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 5678899999999999999999974 145689998865432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
.+. ..++||||+++++|.+++...+. ..+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 754 89999999999999999975431 248999999999999999999999999999999999999988
Q ss_pred CCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-------------------------
Q 021127 162 LKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------- 213 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------- 213 (317)
+.+||+|||+++....... .....++..|+|||++.+..... ..++|+.+
T Consensus 157 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 157 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred -CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7899999999975432211 12234577899999876532221 11111111
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 235 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11223446788999999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=265.48 Aligned_cols=224 Identities=23% Similarity=0.315 Sum_probs=173.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+++.. ++.||||++.+..... ......+.+|+.++..++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK--RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 47999999999999999999885 7899999987532211 12345678899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG 156 (331)
T ss_pred EEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence 999999999999997633 238999999999999999999999999999999999999988 789999999987543222
Q ss_pred c--cccccCccceecccccccc----cccccccccccCC--------------------------------CCCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK--------------------------------NVRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~--------------------------------~~~~~~~~~ 222 (317)
. .....||+.|+|||++... .......++|+.+ ...+....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 1 1234689999999998632 1122233444433 001112346
Q ss_pred hHHHHHHHHHhhhcCCC--CCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPN--ARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~--~Rps~~~~~~~l 251 (317)
+..+++++.+||..++. .|+++.++++|-
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 88999999998865443 378999999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=272.45 Aligned_cols=240 Identities=26% Similarity=0.406 Sum_probs=197.0
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
...+-+....-+++++...+.++||+|-||.|.++...+ ..||||.++...... .+..|.+|+++|.+|+||||+
T Consensus 523 ~~~~~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~----~r~~F~kEIkiLsqLkhPNIv 598 (807)
T KOG1094|consen 523 PPGVGKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN----ARNDFLKEIKILSRLKHPNIV 598 (807)
T ss_pred CcccccCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh----HHHHHHHHHHHHhccCCCCee
Confidence 334455666678999999999999999999999999885 999999998766533 367899999999999999999
Q ss_pred eEEeeee-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+|+|+|. ++.+++|+||+++|+|.+|+.++....+.-.....|+.||++||+||.+.++|||||.+.|+|++.+ .++|
T Consensus 599 eLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iK 677 (807)
T KOG1094|consen 599 ELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIK 677 (807)
T ss_pred EEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEE
Confidence 9999996 4589999999999999999998765445666778899999999999999999999999999999999 5899
Q ss_pred EcccCccccccccccc---ccccCccceecccccccccccccccccccCC------------------------------
Q 021127 167 LADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------ 213 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------ 213 (317)
|+|||+++........ ...+-...|||||.+....+....+.| ..+
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvW-afgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVW-AFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhh-hhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 9999999965444332 233567899999987654444332221 111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.|.-+|..+.++|.+||..|-.+||+++++-.+|.+.
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 23445778899999999999999999999999998887654
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=259.06 Aligned_cols=230 Identities=30% Similarity=0.519 Sum_probs=183.5
Q ss_pred eecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
.+...+|.+.++||+|+||.||+|.+.+ ..||||........ ...+.+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP----SVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH----HHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 4677889999999999999999998642 46899988655432 23457899999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+...++||||+++++|.+++..... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~ 155 (270)
T cd05056 78 ENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSR 155 (270)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceee
Confidence 8888999999999999999976433 48999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCCh
Q 021127 175 EESLTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 223 (317)
........ ....++..|+|||.+...... ...+.|+.+ ...+.+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCP 234 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 54333211 122345689999986543221 111111100 1223356778
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
..+.+++.+||..+|.+|||+.++++.|.++..
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=264.53 Aligned_cols=228 Identities=27% Similarity=0.455 Sum_probs=178.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|+..+|.+.+.||+|+||.||+|.+. +..||||++...... .....+.+|+.++..++||||+++++++
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 77 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG----PLREEFKHEAMMRSRLQHPNIVCLLGVV 77 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 44567889999999999999999863 477999998755432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 764 7899999999999999985321 1247888999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.+||+|||+++....... .....+++.|+|||++....... ..++|+.+
T Consensus 158 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 FDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI-DSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred cCC-CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 988 6899999999875432211 12334578899999875432211 12222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+|+.+||+.+|.+||+++++++.|+.+
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 236 IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 12233567889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=272.68 Aligned_cols=224 Identities=29% Similarity=0.375 Sum_probs=195.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
..|.+.+.||+|.|+.|.+|++. +..||||.+.+..... ..++.+.+|++++..++|||||+++.+... ..+|+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~---~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP---SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh---HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 67899999999999999999885 8999999998876544 345568899999999999999999999974 58999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+|.+.+++.+.+. ..+..+..++.|+.+|++|||+++|||||||++||||+.++ .+||+|||++.......
T Consensus 133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeecccc
Confidence 9999999999999998765 77789999999999999999999999999999999999995 69999999999888888
Q ss_pred ccccccCccceecccccccccccccccccccCCCC---------------------------CCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------RPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~c 233 (317)
...+.+|++.|.|||++.+..+.....+.|..+.. ...+.-++.+..++|+++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~ 289 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF 289 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence 88889999999999999998877777777765511 111334467899999999
Q ss_pred hhcCCCCCCCHHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~ 253 (317)
|..+|.+|++.+++..+-|.
T Consensus 290 lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 290 LVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred hccCccccCCHHHhhhhccc
Confidence 99999999999999887664
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=265.79 Aligned_cols=215 Identities=27% Similarity=0.352 Sum_probs=168.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|++. ++.||||++....... ......+..|..++.. ++||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 46999999999999886 6889999998643211 1223346677788876 4999999999998765 889999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-cccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~~~~~~ 184 (317)
++|+|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..... ......
T Consensus 79 ~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceee
Confidence 99999999986543 8999999999999999999999999999999999999988 6899999999874321 122334
Q ss_pred ccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..||+.|+|||++.+..+. ...+.|+.+ .....+..++.++++++.+||+.|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred ecCCccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence 5789999999998764432 223333322 011123457888999999999999
Q ss_pred CCCCCCHH-HHHHH
Q 021127 238 PNARPNFT-QIIQM 250 (317)
Q Consensus 238 p~~Rps~~-~~~~~ 250 (317)
|.+||++. +++++
T Consensus 235 P~~R~~~~~~l~~h 248 (316)
T cd05619 235 PERRLGVKGDIRQH 248 (316)
T ss_pred HhhcCCChHHHHcC
Confidence 99999996 67665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=260.31 Aligned_cols=226 Identities=25% Similarity=0.485 Sum_probs=179.1
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+...|++.++||+|+||.||++++ .+..||+|.+...... .....+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG----NHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH----HHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345678999999999999999874 3678999998754332 234568899999999999999999998864
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~ 155 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGL 155 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcc
Confidence 36899999999999999997643 248999999999999999999999999999999999999988 6899999999
Q ss_pred cccccccc----ccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 173 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCc-cccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 97543221 112345677899999876533221 22333222
Q ss_pred --------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 --------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++..+.+|+.+||+.||.+||++.++++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11122456788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=270.57 Aligned_cols=221 Identities=25% Similarity=0.321 Sum_probs=172.7
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
..++|++.+.||+|+||.||++.+. ++.||||++....... ....++.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ---THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch---hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 3478999999999999999999875 7899999987653322 2344678999999999999999999988532
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCC
Confidence 4799999995 567766642 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CC-----------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------- 215 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------- 215 (317)
++............||+.|+|||++.+..... ..+.|+.+ ..
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 97654443444567899999999886643322 12222211 00
Q ss_pred -----------C---------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -----------R---------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -----------~---------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
. ......+..+++||.+||+.||++|||+.|+++|.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0 001123567899999999999999999999999844
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.48 Aligned_cols=222 Identities=32% Similarity=0.561 Sum_probs=175.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++.+|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|+++++.++|+||+++++++.+. ..
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 46678999999999999999999886 567999998754332 23578899999999999999999998654 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLD 152 (256)
T ss_pred EEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccc
Confidence 999999999999999976443 48999999999999999999999999999999999999988 7899999999875432
Q ss_pred cccc--ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
.... ....++..|+|||.+.+..... ..+.|+.+ .....+..++.++.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVY 231 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 2111 1122345799999876533221 11111110 11223456789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.+|++|||+.++++.|
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.21 Aligned_cols=222 Identities=24% Similarity=0.362 Sum_probs=172.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.++||+|+||.||+|++. ++.||+|.+....... ....+.+|+.++++++|+||+++++++..+ ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 367999999999999999999875 7889999987654322 123467899999999999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVP 157 (309)
T ss_pred EEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCC
Confidence 9999996 58888887643 338899999999999999999999999999999999999988 78999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........+.|+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2223346789999999875422111112222111
Q ss_pred -------CC-----CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -------NV-----RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -------~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.. ......++.++.+||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00 001124678899999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=256.67 Aligned_cols=217 Identities=24% Similarity=0.498 Sum_probs=171.1
Q ss_pred eeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEccC
Q 021127 31 RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
.||+|+||.||+|.+. +..||+|++...... .....+.+|+.++++++|+||+++++++.....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~----~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK----SVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh----HHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCC
Confidence 3899999999999764 456999998765432 23456889999999999999999999998778999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc----c
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM----M 182 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~----~ 182 (317)
+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++........ .
T Consensus 78 ~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 GGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceecc
Confidence 999999997533 348999999999999999999999999999999999999988 6899999999874432211 1
Q ss_pred ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
....++..|+|||++....... ..+.|+.+ .....+...+.++.+++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 1123357899999875433211 11222111 11223456789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHHHh
Q 021127 234 WKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~~~ 254 (317)
|..+|++||++.++.+.|+.+
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=271.00 Aligned_cols=220 Identities=23% Similarity=0.347 Sum_probs=173.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++... ++.||||++....... ......+.+|+.++..++|+||+++++.+.+. ..++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh--hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 46889999999999999999885 7899999997533211 23355688899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++..... +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCccccccc
Confidence 9999999999999986544 8999999999999999999999999999999999999988 799999999986432110
Q ss_pred ------------------------------------ccccccCccceecccccccccccccccccccCCC----------
Q 021127 181 ------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN---------- 214 (317)
Q Consensus 181 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~---------- 214 (317)
.....+||+.|+|||++.+.... ...++|+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCC
Confidence 01134699999999998764433 2344444330
Q ss_pred ---------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 215 ---------------------VRPSAENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 215 ---------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
..+....++.++++||.+|+. ||.+|++ +.++++|
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 001112367889999999774 9999984 7788877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=255.95 Aligned_cols=221 Identities=22% Similarity=0.361 Sum_probs=179.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||+|++|.||++.+. ++.|++|.+....... .....+.+|++++++++||||+++++++.+. ..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR---REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH---HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 4788999999999999999885 7899999987654332 3355688999999999999999999998754 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence 999999999999987644569999999999999999999999999999999999999988 689999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNE-KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 223446889999999877644322 22333221 1112233678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 236 CLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HccCCcccCcCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=262.56 Aligned_cols=219 Identities=32% Similarity=0.523 Sum_probs=174.3
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~ 102 (317)
|++.+.||+|+||+||++++. ++.||+|++........ ......+|+.++++++|+||+++++++.+ ...++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE---EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH---HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc---ccchhhhhhhccccccccccccccccccccccccccc
Confidence 789999999999999999997 67899999988765432 22234569999999999999999999975 4889999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc-ccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE-SLTEM 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~-~~~~~ 181 (317)
|++.+++|.+++..... +++..++.++.|++.||++||++|++|+||||+||+++.+ +.++|+|||.+... .....
T Consensus 78 ~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSE
T ss_pred ccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 99999999999985444 9999999999999999999999999999999999999987 78999999999752 33334
Q ss_pred cccccCccceecccccccccccccccccccCC--------C--------------------------CCCCCCCChHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------VRPSAENVPEELS 227 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------~~~~~~~~~~~l~ 227 (317)
.....++..|+|||++..........+.|+.+ . ........+..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR 234 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence 45567899999999987222222222222211 0 0001112247899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++.+||+.||++||++.+++++
T Consensus 235 ~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 235 DLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=255.90 Aligned_cols=216 Identities=31% Similarity=0.553 Sum_probs=169.1
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
++||+|+||.||+|.+. ++.||+|.+...... .....+.+|++++++++|+||+++++++... ..++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP----DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 46899999999999874 888999987654332 2345688999999999999999999998755 7899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc---
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--- 183 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--- 183 (317)
+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++..........
T Consensus 77 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCC
Confidence 999999997643 348999999999999999999999999999999999999988 689999999987543221111
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
....+..|+|||.+.+..... ..+.|+.+ ...+.+..++..+.+|+.+||
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSS-ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CCCCceeecCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHc
Confidence 112345799999875432211 11111111 112334567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
+.+|++|||+.++++.|.
T Consensus 234 ~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 234 EYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCChhhCcCHHHHHHHHh
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.46 Aligned_cols=221 Identities=28% Similarity=0.433 Sum_probs=180.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ecCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~l 100 (317)
+.|.|+..||.|+||.||+|..+ +-..|-|++..... ....+|+-||++|..+.||+||+|++.| .++.+||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkse-----EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-----EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccch-----hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence 34566777999999999999876 55568888865543 3366799999999999999999999854 6789999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-cc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-LT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-~~ 179 (317)
+.|||.||-.+..+-..+ ..+++.++.-+++|++.||.|||+++|||||||+.|||++-+ |.++|+|||.+-... ..
T Consensus 107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTR 184 (1187)
T ss_pred EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHH
Confidence 999999999999887754 349999999999999999999999999999999999999999 799999999975432 22
Q ss_pred cccccccCccceeccccccccccccc----ccccccCC------------------------------CCCCCCCCChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQG----EKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~----~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
....++.|||+|||||+....++... ..++|+.+ .....|..++..
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 34466789999999999765444332 33455544 111225667889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||..||..||++.++++|-
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 99999999999999999999999873
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=259.90 Aligned_cols=225 Identities=28% Similarity=0.521 Sum_probs=175.4
Q ss_pred cCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+..+|++.+.||+|+||.||++.. ++..||||.+..... .....+.+|++++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-----EHLRDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 456899999999999999999874 367899999875432 234568899999999999999999998642
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~ 154 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGL 154 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcc
Confidence 368999999999999999976432 38999999999999999999999999999999999999988 6899999999
Q ss_pred ccccccccc----cccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 173 AREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 173 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
+........ .....++..|+|||++.+..... ..++|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 985432211 11123445699999875432111 11111111
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+|+.+||..+|++|||+.++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=275.45 Aligned_cols=232 Identities=31% Similarity=0.562 Sum_probs=195.3
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+.|++++.++...++||-|.||.||.|.|+ .-.||||.++.... ....|+.|..+++.+.|||+|+|+|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM------eveEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch------hHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 589999999999999999999999999998 68899999875543 2457999999999999999999999996
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+..+|||+|||..|+|.+||+.....-++.-..+.++.||.+|++||..+++|||||.+.|+|+.++ ..+||+|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchh
Confidence 5589999999999999999998766668888899999999999999999999999999999999999 69999999999
Q ss_pred cccccccccccccC---ccceeccccccccccccccccccc-----------------------------CCCCCCCCCC
Q 021127 174 REESLTEMMTAETG---TYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 221 (317)
+....... +...| .+.|.|||-+.-..+.... +.|. .+..+..+++
T Consensus 413 RlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKS-DVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 413 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred hhhcCCce-ecccCccCcccccCcccccccccccch-hhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCC
Confidence 97654432 22223 5789999976543332222 1121 1234556889
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+|+.+++||+.||+++|.+||++.++-+.++.++..
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 999999999999999999999999999998877653
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=257.57 Aligned_cols=227 Identities=28% Similarity=0.498 Sum_probs=178.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|++.+|++.+.||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46788999999999999999999863 347999998754432 234568899999999999999999999865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~ 154 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccc
Confidence 4 8899999999999999997643 348999999999999999999999999999999999999988 689999999997
Q ss_pred ccccccc----cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 175 EESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
....... .....++..|+|||.+.+..... ..+.|+.+ ...+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD 233 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCc-hhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCC
Confidence 5432211 11122356899999876532211 11111110 11233446
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++..+.+++.+||+.+|.+||++.++++.|.+.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.40 Aligned_cols=223 Identities=21% Similarity=0.286 Sum_probs=173.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+++++ ++.||+|++.+..... ......+.+|+.++..++|+||+++++++.+. ..++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH--hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 47899999999999999999886 6889999986532211 12234578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence 9999999999999986432 38999999999999999999999999999999999999988 789999999987532221
Q ss_pred --ccccccCccceecccccccc----cccccccccccCC-----------------------------C---CCCCCCCC
Q 021127 181 --MMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK-----------------------------N---VRPSAENV 222 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~-----------------------------~---~~~~~~~~ 222 (317)
......||+.|+|||++... .......++|+.+ . .......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 12235799999999998632 1122334444433 0 01112357
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNA--RPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~--Rps~~~~~~~ 250 (317)
+.++++|+.+|+..++.. |+++.++++|
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 889999999988654444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=260.69 Aligned_cols=231 Identities=29% Similarity=0.462 Sum_probs=178.8
Q ss_pred CceeecceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
++|++.+.||+|+||.||+|... + ..+++|.++..... ...+.+.+|+.++.++ +||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE----NDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH----HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 68999999999999999999875 3 34788887643322 2245688999999999 799999999998754 7
Q ss_pred eEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 98 MVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-L 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-C
Confidence 899999999999999997532 1248899999999999999999999999999999999999988 6
Q ss_pred ceEEcccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------C
Q 021127 164 TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N 214 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~ 214 (317)
.+||+|||++..............+..|+|||++....... ..++|+.+ .
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 89999999986432221112223356799999876533221 12222211 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
....+..++..+.+|+.+||+.+|.+||+++++++.|..+......
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1122446788999999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=261.03 Aligned_cols=222 Identities=24% Similarity=0.322 Sum_probs=176.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|+..+.||+|+||+||++.+. ++.||+|.+....... ......+.+|+++++.++|+||+++.+.+..+ ..++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK--RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh--hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 3678899999999999999885 7899999987643322 12234578899999999999999999887654 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCc
Confidence 999999999998876555569999999999999999999999999999999999999988 6899999999875443333
Q ss_pred cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li 230 (317)
.....|+..|+|||++.+..... ..+.|+.+ .....+..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTL-SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 34457899999999986543322 22333221 01112345788899999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
..||+.||++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 7787776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=256.15 Aligned_cols=222 Identities=25% Similarity=0.371 Sum_probs=181.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
+|++.+.||+|++|.||++... ++.+|||.+....... .....+.+|++++++++|+||+++++.+.. +..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK---DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc---HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 5889999999999999998874 7899999998654332 234568899999999999999999998865 479999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.......+++..+..++.+++.||+|||++|++|+||+|+||+++.+.+.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999998765555899999999999999999999999999999999999987645789999999986554433
Q ss_pred cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....++..|+|||.+.+.... ...+.|+.+ ...+.+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 236 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236 (256)
T ss_pred ccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHH
Confidence 3445688999999988654322 222333221 11223456788999999999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~ 250 (317)
|+.+|.+|||+.+++++
T Consensus 237 l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 237 LNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ccCChhhCCCHHHHhhC
Confidence 99999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=258.22 Aligned_cols=222 Identities=29% Similarity=0.495 Sum_probs=173.9
Q ss_pred Cce-eecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-
Q 021127 24 KHL-FVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 95 (317)
++| ++.+.||+|+||+||++.. .+..||+|++...... .....+.+|++++++++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ----QNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 344 8999999999999988653 3678999998765432 234568899999999999999999998753
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...++||||+++++|.+++... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccc
Confidence 2589999999999999999763 29999999999999999999999999999999999999988 68999999999
Q ss_pred cccccccc----cccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 174 REESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
+....... .....++..|+|||.+....... ..++|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY-ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCc-ccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 75433211 12234567799999875432211 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+++.+||+.+|++|||++++++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 01112445678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=262.27 Aligned_cols=224 Identities=21% Similarity=0.280 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++++. ++.||+|++.+..... ......+.+|+.++..++|+||+++++++.+. ..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 47999999999999999999885 7889999987532211 22344578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 79 v~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence 999999999999998643 238999999999999999999999999999999999999988 789999999997543322
Q ss_pred c--cccccCccceeccccccccc----ccccccccccCC-----------------------------C---CCCCCCCC
Q 021127 181 M--MTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------N---VRPSAENV 222 (317)
Q Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~---~~~~~~~~ 222 (317)
. .....||+.|+|||++.+.. ......++|+.+ . .......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 1 12356999999999886521 112233444433 0 00112346
Q ss_pred hHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNA--RPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~--Rps~~~~~~~l 251 (317)
+.++++++.+||..++.+ |++++++++|.
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 889999999999866544 46899998873
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=260.57 Aligned_cols=226 Identities=30% Similarity=0.518 Sum_probs=179.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+..++|.+.+.||+|+||.||+|.+. ++.||||.+...... .....+.+|++++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN----DARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH----HHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 34578999999999999999999763 468999998765442 2345789999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
... ..++||||+++++|.+++...+. ..+++..+..++.|++.||+|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 765 89999999999999999976431 34789999999999999999999999999999999999998
Q ss_pred CCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC------------------------
Q 021127 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
+ +.+||+|||+++...... ......+++.|+|||++.+..... ..++|+.+
T Consensus 158 ~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 158 D-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred C-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcch-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 8 799999999987532221 112334578899999876543322 12222111
Q ss_pred -----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=287.41 Aligned_cols=227 Identities=21% Similarity=0.340 Sum_probs=178.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 95 (317)
+..++|++.++||.|+||+||++++. +..||+|++....... .....+..|+.++++++||||+++++++.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e---~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH---HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 44478999999999999999999886 7889999987654433 234568899999999999999999998743
Q ss_pred CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCcEEeeCC-----
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-------GIIHRDLKPENLLLTED----- 161 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~-------~ivH~Dlkp~Nill~~~----- 161 (317)
..+||||||+++++|.++|.... ...+++..++.|+.||+.||+|||+. +||||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 36899999999999999997632 23499999999999999999999984 49999999999999642
Q ss_pred -----------CCceEEcccCcccccccccccccccCccceeccccccccc-ccccccccccCC----------------
Q 021127 162 -----------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK---------------- 213 (317)
Q Consensus 162 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~---------------- 213 (317)
...+||+|||++.............||+.|+|||++.+.. ......++|+.+
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 1348999999998655444444567999999999875421 122223333322
Q ss_pred ------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.........+.++.+||..||..+|.+||++.+++.+
T Consensus 247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 0111123567899999999999999999999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=262.49 Aligned_cols=220 Identities=29% Similarity=0.390 Sum_probs=169.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec----
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE---- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 95 (317)
+|++.+.||+|+||.||+|++. ++.||+|.+........ ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG---LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC---CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 5889999999999999999885 78999999876432221 112245566666554 79999999998753
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...++||||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLA 155 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCcc
Confidence 25799999996 589999877555558999999999999999999999999999999999999988 78999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CC------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------ 215 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------ 215 (317)
+............|+..|+|||++.+.... ...++|+.+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 865444333445689999999987653322 122222211 00
Q ss_pred ----------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+++.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00012467788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=256.24 Aligned_cols=227 Identities=28% Similarity=0.476 Sum_probs=177.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|+...|++.+.||+|+||.||+|.+. + ..||||++...... .....|..|+.+++.++||||+++++++.+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE----KQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred CChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 34577999999999999999999875 2 36999998765432 234568999999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~ 154 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 154 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccc
Confidence 5 7899999999999999997643 348999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc---cccc---CccceecccccccccccccccccccCC-----------------------------CCCCCC
Q 021127 175 EESLTEMM---TAET---GTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSA 219 (317)
Q Consensus 175 ~~~~~~~~---~~~~---gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 219 (317)
........ .... .+..|+|||.+....... ..++|+.+ ...+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 233 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccc-hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence 54322111 1111 245799999876533221 12222211 112334
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 56788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=261.73 Aligned_cols=226 Identities=24% Similarity=0.428 Sum_probs=175.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC----------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK----------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 84 (317)
+...+|++.++||+|+||.||++.+. ...||+|.+...... .....|.+|++++++++|+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~ei~~l~~l~h~ 77 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK----TARNDFLKEIKIMSRLKNP 77 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCC
Confidence 45578999999999999999998753 235899998765432 2345689999999999999
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP----------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
||+++++++... ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999998654 88999999999999999965321 1368889999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
+||+++.+ +.+||+|||++........ .....++..|+|||++...... ...++|+.+
T Consensus 158 ~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999987 6899999999875432211 1223456789999986543221 111222111
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+...|..+.+|+.+||+.||++||+++++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 001123456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.06 Aligned_cols=222 Identities=25% Similarity=0.392 Sum_probs=179.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||.|+||.||.++.. ++.+++|.+....... ....++.+|+.++++++|+||+++++++.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch---hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 5899999999999998887764 7889999987654332 2345688999999999999999999998765 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 999999999999987644558999999999999999999999999999999999999988 689999999997543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCC-cchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence 223456899999999876543221 12222211 1222345678899999999
Q ss_pred hhhcCCCCCCCHHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~l 251 (317)
||+.+|.+||++.++++++
T Consensus 236 ~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HcccCcccCCCHHHHhhCc
Confidence 9999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.20 Aligned_cols=230 Identities=28% Similarity=0.488 Sum_probs=180.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+...+|.+.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-----AARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-----HHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 34578999999999999999999752 45688888764332 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL 158 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill 158 (317)
.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 765 78999999999999999975431 238899999999999999999999999999999999999
Q ss_pred eCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC----------------------
Q 021127 159 TEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 159 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
+.+ +.++|+|||+++...... ......++..|+|||++.+..... ..+.|+.+
T Consensus 157 ~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 157 GAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred ccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 988 699999999997543321 122345678899999876533221 11222111
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+...|..+.+++.+||+.+|.+||++.++++.|.++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11122445688999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.71 Aligned_cols=172 Identities=30% Similarity=0.372 Sum_probs=147.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-C-----CCeeeEEeeee-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-H-----RNLVKFIGACK-E 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~-~ 95 (317)
+|.+.+.||+|+||.|.+|.+. ++.||||+++.... ...+-..|+.+|..|+ | -|+|+++++|. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR------FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH------HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 8899999999999999999885 89999999987643 3345677999999996 3 58999999996 4
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~ 174 (317)
++.+||+|.+ +.+|+++|+.++..+++...+..|+.||+.||.+||+.||||+||||+||||.. +...+||+|||.++
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 5999999999 789999999998888999999999999999999999999999999999999973 33579999999999
Q ss_pred ccccccccccccCccceeccccccccccccc
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQG 205 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 205 (317)
.....-. +.+.+..|.|||++.+..+...
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILGlpY~~~ 368 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILGLPYDTA 368 (586)
T ss_pred ccCCcce--eeeeccccccchhhccCCCCCc
Confidence 7654432 5677899999999887554443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=273.23 Aligned_cols=221 Identities=27% Similarity=0.332 Sum_probs=173.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 96 (317)
+|++.+.||+|+||.||++.+. ++.||||.+....... ....++.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL---VSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch---HHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 4788999999999999999874 8999999986543222 2345688999999999999999999998643
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+.+.... .+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++..
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~ 153 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVE 153 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeec
Confidence 5899999995 68888886544 39999999999999999999999999999999999999988 79999999999754
Q ss_pred ccc--cccccccCccceecccccccccccccccccccCC--------CC-------------------------------
Q 021127 177 SLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------- 215 (317)
Q Consensus 177 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------- 215 (317)
... .......+++.|+|||++.+........++|+.+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 322 1223346789999999876533222233333322 00
Q ss_pred -------------C-------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -------------R-------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -------------~-------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
. ......+.++.+||.+||+.||.+|||+.+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 0 112345778999999999999999999999998844
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=258.62 Aligned_cols=226 Identities=28% Similarity=0.523 Sum_probs=176.5
Q ss_pred ceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+|++.+.||+|+||.||+|... ...+++|.+....... ...++.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS----ELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH----HHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788999999999999999864 2568999887654432 245688999999999999999999988654
Q ss_pred ceEEEEEccCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 97 VMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 7899999999999999986532 124789999999999999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC------------------
Q 021127 155 NLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------ 213 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------ 213 (317)
||+++.+ +.+||+|||+++....... .....++..|+|||.+.+..... ..+.|+.+
T Consensus 157 nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 157 NVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred eEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch-HhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999988 6899999999975422211 12234567899999765422111 11111110
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.....+..++.++.+++.+||+.+|.+||++.++++.|++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1122355678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.24 Aligned_cols=226 Identities=28% Similarity=0.394 Sum_probs=179.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+..+.+.|++.++||.|+||.||+|++. +..||+|.+..... .....+.+|+.+++.++|+||+++++.+..
T Consensus 6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-----EELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 45566688999999999999999999885 78999999876432 234568889999999999999999998764
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+..++||||+++++|..++.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 158 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSA 158 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccce
Confidence 48999999999999998876533 348999999999999999999999999999999999999987 789999999986
Q ss_pred ccccc-cccccccCccceecccccccccc----cccccccccCC------------------------------CCCCCC
Q 021127 175 EESLT-EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK------------------------------NVRPSA 219 (317)
Q Consensus 175 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~------------------------------~~~~~~ 219 (317)
..... .......+++.|+|||++.+... .....++|+.+ .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 159 KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred eccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 43222 12234467889999998853221 11223333322 001123
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++.++.+++.+||+.||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 4567889999999999999999999999886
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=270.43 Aligned_cols=166 Identities=23% Similarity=0.332 Sum_probs=139.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+...+|++.+.||+|+||.||+|++. ++.||+|+..... ...|+.++++++|+||+++++++.+. .
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----------TLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----------cHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 34457999999999999999999986 6789999854332 34689999999999999999998765 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|||++ .++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 132 TCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPV 208 (357)
T ss_pred eEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccc
Confidence 89999999 578998887643 348999999999999999999999999999999999999988 689999999997544
Q ss_pred cccccccccCccceecccccccc
Q 021127 178 LTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
.........||..|+|||++.+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~ 231 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARD 231 (357)
T ss_pred cCcccccccccccccCCeecCCC
Confidence 33333455789999999987653
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=256.03 Aligned_cols=232 Identities=23% Similarity=0.435 Sum_probs=182.9
Q ss_pred eecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.|+.++|++.+.||+|+||.||+|.+. +..|++|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE----IQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 367889999999999999999999875 478999988754332 3356688999999999999999999987
Q ss_pred ec--CceEEEEEccCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 94 KE--PVMVIVTELLSGGTLRKYLLNMRP------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 94 ~~--~~~~lv~e~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
.+ ...+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~ 156 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQV 156 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcE
Confidence 54 478999999999999999976432 348999999999999999999999999999999999999988 689
Q ss_pred EEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------
Q 021127 166 KLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------- 213 (317)
||+|||+++....... .....++..|+|||++.+..... ..+.|+.+
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSS-ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCc-hhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999999975432211 12234567899999875432211 11222111
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++.++.+++.+||..||++|||+.++++.|.++...
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11122345688999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=260.25 Aligned_cols=217 Identities=24% Similarity=0.356 Sum_probs=180.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~l 100 (317)
+-|.++.+||+|+||.||+|.++ |+.+|||.++.... .+.+..|+.+++++..|+||++||.+. ...+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-------LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-------LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-------HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 45678999999999999999775 89999999987654 446899999999999999999999765 458999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||..|+..+.++.+. +.+++..+..++...+.||+|||...-||||||+.|||++.+ |.+||+|||.|-.....
T Consensus 106 VMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTM 183 (502)
T ss_pred ehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhH
Confidence 999999999999988644 459999999999999999999999999999999999999998 79999999999765433
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCC---CCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVR---PSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~l~~l 229 (317)
...++..||+.|||||++....+....+ +|+.+ +.. ..|...+.++.++
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~AD-IWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKAD-IWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhh-HhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence 2345668999999999987655443322 22221 111 1245567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++||..+|++|-|+.++++|
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999999887
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=253.07 Aligned_cols=217 Identities=29% Similarity=0.509 Sum_probs=173.3
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 104 (317)
++||+|+||.||+|.+. +..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 47999999999999764 267999998766543 234568899999999999999999999987789999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc--
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-- 182 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~-- 182 (317)
+++++|.+++.... .+++..++.++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccc
Confidence 99999999998755 38999999999999999999999999999999999999988 68999999999854322211
Q ss_pred --ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHH
Q 021127 183 --TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 183 --~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
....++..|+|||.+.+..... ..+.|+.+ ...+.+..++..+++++.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCc-cchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1122356799999875433221 11221111 112335567899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHh
Q 021127 232 SCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+||..+|.+||++.++++.|.+.
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.97 Aligned_cols=221 Identities=24% Similarity=0.402 Sum_probs=177.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--CceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--PVMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~l 100 (317)
+|++.+.||.|++|.||++.+. ++.||+|.+....... .....+.+|++++++++|+|++++++.+.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR---RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH---HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 5899999999999999999875 6889999987644322 234457889999999999999999988753 36889
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++.......+++.+++.++.+++.||++||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQC 156 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccC
Confidence 9999999999999987555568999999999999999999999999999999999999988 78999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.......+++.|+|||++.+...... .++|+.+ .....+..++..+.+++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 22234468899999998765433221 2222211 111234567789999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.||++||++.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 236 TMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHhccCcccCCCHHHHhcC
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=257.64 Aligned_cols=221 Identities=24% Similarity=0.389 Sum_probs=174.7
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
+.++|.+.++||+|+||.||+|.+. ++.||+|+++..... ....+.+|+.+++.++||||+++++.+.. +..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence 3468999999999999999999874 789999998765432 13357789999999999999999998865 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++...+. +++..++.++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITA 158 (267)
T ss_pred EEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccC
Confidence 999999999999999876554 8999999999999999999999999999999999999988 6899999999875432
Q ss_pred c-cccccccCccceeccccccc--ccccccccccccCC----------------------------CCC-C---CCCCCh
Q 021127 179 T-EMMTAETGTYRWMAPELYST--VTLRQGEKKHYNHK----------------------------NVR-P---SAENVP 223 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~~----------------------------~~~-~---~~~~~~ 223 (317)
. .......|+..|+|||++.. ........+.|+.+ ... + ....++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06645 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238 (267)
T ss_pred cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence 2 12234468999999998642 11111222333211 000 0 012467
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|++||++++++++
T Consensus 239 ~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 239 NSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=265.04 Aligned_cols=220 Identities=22% Similarity=0.285 Sum_probs=172.6
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~l 100 (317)
+|.+.+.||+|+||.||+|.++ ++.||||++.+..... ......+..|..++..+. |++|+++++++.+. ..++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ--DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 4678899999999999999885 7899999987643211 123445778888888885 57788899888754 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++|+|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 v~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCC
Confidence 9999999999999976544 9999999999999999999999999999999999999988 78999999998753222
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.......||+.|+|||++.+.... ...++|+.+ .....+..++.++.+++.+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 234 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 222345689999999998764432 334444433 1112245678899999999
Q ss_pred hhhcCCCCCCCH-----HHHHHH
Q 021127 233 CWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~-----~~~~~~ 250 (317)
||+.+|.+|++. .++.+|
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcC
Confidence 999999999975 455554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.18 Aligned_cols=227 Identities=25% Similarity=0.420 Sum_probs=179.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.+|||.+......+ .....++.+|+.+++.++|+||+++++++.++ ..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh--HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 47889999999999999999864 8899999887644322 23456788999999999999999999988654 8899
Q ss_pred EEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
+|||+++++|.+++... ....+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhcccc
Confidence 99999999999998742 22348999999999999999999999999999999999999988 7899999999875432
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCC-CCCCCChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVR-PSAENVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~-~~~~~~~~~l 226 (317)
.. ......++..|+|||.+.+..... ..+.|+.+ ... .....++..+
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccc-hhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 22 223346889999999875532221 11222111 001 1123577899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||+.||.+|||+.+|++.+.++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 9999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=285.18 Aligned_cols=230 Identities=24% Similarity=0.322 Sum_probs=178.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|.+. ++.||||++....... .....++.+|++++++++||||+++++++.++ ..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~--e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN--PLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC--HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 68999999999999999999885 7899999987644322 23456799999999999999999999998765 8899
Q ss_pred EEEccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 101 VTELLSGGTLRKYLLNMR---------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
||||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEecC
Confidence 999999999999986421 1235677889999999999999999999999999999999988 789999999
Q ss_pred cccccccc-------------------cccccccCccceecccccccccccccccccccCC-------------------
Q 021127 172 LAREESLT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------- 213 (317)
Q Consensus 172 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------- 213 (317)
+++..... ......+||+.|+|||++.+..... ..++|+.+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99754110 0011246899999999876543321 22222211
Q ss_pred -------C----CCCCCCCChHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhhhc
Q 021127 214 -------N----VRPSAENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -------~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp-s~~~~~~~l~~~~~~ 257 (317)
. .......+|..+.+++.+||+.||++|| +++++++.|..++..
T Consensus 238 ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0001235778899999999999999996 567777888877654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=267.13 Aligned_cols=219 Identities=23% Similarity=0.287 Sum_probs=172.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
+++|++.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.++++++|+||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL---IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh---HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 578999999999999999999875 7889999987543221 234457789999999999999999988742
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~ 165 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLA 165 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccc
Confidence 2478999988 88998877642 39999999999999999999999999999999999999988 78999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CCCCC---------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRPS--------------------------- 218 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~~--------------------------- 218 (317)
+..... .....||+.|+|||++.+........++|+.+ ...+.
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 865432 23457899999999986533333333444322 00000
Q ss_pred -----------------------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 -----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 -----------------------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....++.+.+|+.+||+.||.+|||+.++++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 012345678999999999999999999999883
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=253.81 Aligned_cols=223 Identities=26% Similarity=0.454 Sum_probs=179.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|+..+.||+|++|.||+|... ++.|++|.+..........+....+.+|+.+++.++|+||+++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999885 78999999876553322234456788999999999999999999998765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++..... +++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence 999999999999986543 8999999999999999999999999999999999999988 6899999999876544333
Q ss_pred cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....++..|+|||.+..........+.|+.+ .....+..++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34556889999999875533112222222211 1112245678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++.+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 238 CLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HhhcCcccCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=258.77 Aligned_cols=226 Identities=28% Similarity=0.493 Sum_probs=177.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++.++|++.+.||+|+||.||++.+. +..||+|++...... .....+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~ei~~l~~l~h~~iv~~~~~~ 77 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDHPNIVKLLGVC 77 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH----HHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence 45678999999999999999999863 578999998765432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP--------------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
.++ ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 765 78999999999999999975321 237888999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------- 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------- 213 (317)
|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+..... ..++|+.+
T Consensus 158 p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc-hhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999988 7899999999875432211 12223466799999865432211 11222111
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++.++.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 236 MAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 112234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=254.57 Aligned_cols=230 Identities=24% Similarity=0.464 Sum_probs=182.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--C----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--N----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
++...+|++.+.||+|+||.||+|.+. + ..+|+|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP----KANKEILDEAYVMASVDHPHVVRLLGIC 78 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 356688999999999999999999864 2 36899988766542 3345688999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.....++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 79 ~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~ 156 (279)
T cd05057 79 LSSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLA 156 (279)
T ss_pred ecCceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCccc
Confidence 88889999999999999999987543 38999999999999999999999999999999999999987 68999999999
Q ss_pred ccccccccc---ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 174 REESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
+........ ....++..|+|||.+....... ..+.|+.+ ...+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCc-hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 854322211 1122356899999765422111 11111111 11233445
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+..+.+++.+||..+|.+||++.++++.|..+.+
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 67889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=258.77 Aligned_cols=221 Identities=29% Similarity=0.405 Sum_probs=172.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|++. ++.||||.+....... .....+.+|+.++++++||||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC---CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 5889999999999999999885 7899999987543221 1234577899999999999999999998754 89999
Q ss_pred EEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||++ ++|.+++..... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 99996 689988875432 458999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------C-------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------- 214 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------- 214 (317)
.......+++.|+|||++.+........+.|+.+ .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 1223345788999999875432222222222211 0
Q ss_pred -----------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 -----------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 -----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++.++.++|.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000123467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=269.02 Aligned_cols=220 Identities=25% Similarity=0.317 Sum_probs=172.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||++.+. ++.||||.+....... ....++.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh---HHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4578999999999999999999875 8899999987654332 234567889999999999999999998743
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcc
Confidence 24799999995 577777653 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCCC--------------------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN-------------------------------------- 214 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-------------------------------------- 214 (317)
++............||..|+|||++.+..+.. ..+.|+.+.
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98655444445567899999999876533221 111111110
Q ss_pred -------------------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 -------------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 -------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
........+..+++||.+||+.||++|||+.+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000112356789999999999999999999999883
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.74 Aligned_cols=225 Identities=27% Similarity=0.472 Sum_probs=176.8
Q ss_pred ecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|+..+|.+.++||+|+||.||++.. ++..+|+|.+..... .....+.+|+++++.++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-----SARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-----HHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 4567899999999999999999864 256789998765432 2345689999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
.++ ..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 765 78999999999999999976432 2488999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
.+ +.+||+|||++........ .....+++.|+|||.+.+...... .+.|+.+
T Consensus 157 ~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 157 QG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 87 6899999999874432211 122235678999998765332211 1111111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+|+.+||+.||.+||++.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 112224567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.39 Aligned_cols=219 Identities=25% Similarity=0.318 Sum_probs=178.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.||+|++....... .+....+.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 47999999999999999999885 7899999987543222 23456788999999999999999999998765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC-
Confidence 9999999999999987543 8999999999999999999999999999999999999988 78999999999865433
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....+++.|+|||.+.+.... ...+.|+.+ .....+..++..+++++.+|
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHH
Confidence 3345688999999987654322 122222221 11223456788999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 021127 234 WKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rp-----s~~~~~~~ 250 (317)
|..||.+|+ ++++++++
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcC
Confidence 999999998 88888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=253.14 Aligned_cols=224 Identities=30% Similarity=0.507 Sum_probs=175.0
Q ss_pred eeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
|++.+.||+|+||.||+|... +..||||.+....... .....+.+|+..++.++|+||+++++++.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY---SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 568899999999999999864 3679999987644332 2345688999999999999999999987432
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..++||||+++++|..++.... ...+++..++.++.|++.||+|||+++++||||||+||+++++ +.+||+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECC
Confidence 3789999999999999986432 2358999999999999999999999999999999999999988 6899999
Q ss_pred cCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------CCCC
Q 021127 170 FGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 170 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
||+++....... .....++..|+|||.+.+..... ..++|+.+ ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999985432211 11223467899999875433222 22222211 1122
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+..++.++.+++.+||+.||.+||++.++++.|.++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3456788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=253.94 Aligned_cols=212 Identities=22% Similarity=0.377 Sum_probs=163.6
Q ss_pred ceeccccceEEEEeEEC--------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 30 PRIGEGAHAKVYEGKYK--------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+.||+|+||.||+|+.. ...|++|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-----DISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 46899999999999752 23588998765322 234468889999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc-------eEE
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-------IKL 167 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~-------~kl 167 (317)
+ ..++||||+++++|..++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +. +++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~~~~~~~~~l 153 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLARE-GIDGECGPFIKL 153 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecC-CccCCCCceeEe
Confidence 5 7899999999999999887543 338999999999999999999999999999999999999865 33 899
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC---------C------------------CCCCCC
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------N------------------VRPSAE 220 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~------------------~~~~~~ 220 (317)
+|||++...... ....++..|+|||.+..........++|+.+ . ......
T Consensus 154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd05077 154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230 (262)
T ss_pred CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCC
Confidence 999998654322 2345788999999876432222223333322 0 001122
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.++.+||.+||+.||.+||++.+|++.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=267.20 Aligned_cols=220 Identities=26% Similarity=0.328 Sum_probs=172.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||++.+. ++.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc---hhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 3578999999999999999999875 7889999987643322 224467889999999999999999998742
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCC
Confidence 25799999995 578777753 28899999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CC-----------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------- 215 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------- 215 (317)
++............||..|+|||++.+..+.. ..+.|+.+ ..
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 98655444445567899999999876533222 12222211 00
Q ss_pred -----------CC---------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 -----------RP---------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 -----------~~---------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+ .....+..+++||.+||+.||.+|||+.++++|-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 0111245789999999999999999999999883
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=252.11 Aligned_cols=227 Identities=26% Similarity=0.439 Sum_probs=180.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|... ++.||+|.++...... .....++.+|++++++++|+||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD--AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc--hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999885 8899999987543322 13355788999999999999999999988654 8899
Q ss_pred EEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
||||+++++|.+++.... ...+++..++.++.+++.||+|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeeccC
Confidence 999999999999987532 2348999999999999999999999999999999999999988 6899999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCC-CChHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAE-NVPEEL 226 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~-~~~~~l 226 (317)
.. ......++..|+|||.+.+..... ..+.|+.+ ...+.+. .++..+
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCc-hhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 21 223346888999999875533221 11222111 1111222 567799
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+++.+||..+|.+||++.++++.+..+
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.51 Aligned_cols=221 Identities=26% Similarity=0.419 Sum_probs=175.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
.+.|++.+.||+|+||.||+|.+. ++.||+|++...... ...+..|+.++.++ +|+||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 357899999999999999999875 789999998765422 23577899999998 79999999998853
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||+|+||+++.+ +.++|+|||+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~ 157 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGV 157 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCC
Confidence 358999999999999999987555568999999999999999999999999999999999999988 6899999999
Q ss_pred ccccccc-cccccccCccceeccccccccc----ccccccccccCC-----------------------------CCCCC
Q 021127 173 AREESLT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------NVRPS 218 (317)
Q Consensus 173 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~~~~~ 218 (317)
+...... .......|+..|+|||++.... ......+.|+.+ .....
T Consensus 158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06637 158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237 (272)
T ss_pred ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCC
Confidence 8754322 2223456899999999875321 111223333322 01111
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...++.++.+|+.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 33567899999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=252.46 Aligned_cols=216 Identities=34% Similarity=0.634 Sum_probs=175.0
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 103 (317)
+.||+|+||.||+|.+. +..|++|.+....... ....+.+|++.+..++|+||+++++++.+. ..++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE----ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh----HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46899999999999886 6789999988665432 345688999999999999999999998764 8999999
Q ss_pred ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 104 LLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
|+++++|.+++.... ...+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccccccccc
Confidence 999999999998752 2449999999999999999999999999999999999999998 79999999999865
Q ss_pred cccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.... ......++..|+|||.+...... ...+.|+.+ .....+..++.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 4331 22334578899999987653211 111222111 12233566789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.+++.+||+.+|.+|||+.+++++|
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=254.96 Aligned_cols=221 Identities=27% Similarity=0.385 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+-|++.+.||+|+||.||++.+. +..+++|.+..... .....+.+|+.+++.++|+||+++++.+... ..++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 34678899999999999999886 67889998865432 2345688899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|..++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccc
Confidence 999999999998876532 348999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccc----cccccccccccCC------------------------------CCCCCCCCChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
.......++..|+|||++... .......++|+.+ .....+..++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHH
Confidence 222345688999999987421 1111223333322 011224457889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.++|.+||+.||.+||++.+++++.
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCC
Confidence 99999999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=254.24 Aligned_cols=224 Identities=27% Similarity=0.477 Sum_probs=172.1
Q ss_pred eeecceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
|.+.++||+|+||.||+|.+. + ..||+|.+....... .....+.+|+.+++.++|+||+++++.+.+
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR---SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 357789999999999999875 2 368999887654322 234568899999999999999999997632
Q ss_pred -CceEEEEEccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
...+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.+||+||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df 156 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADF 156 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCC
Confidence 2468999999999999988532 22348999999999999999999999999999999999999988 68999999
Q ss_pred Ccccccccccc---cccccCccceecccccccccccccccccccC-----------------------------CCCCCC
Q 021127 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 218 (317)
|+++....... .....+++.|+|||.+....... ..++|+. ....+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ 235 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcCh-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99986433221 12224567899999876432211 1111110 011233
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=255.18 Aligned_cols=227 Identities=29% Similarity=0.514 Sum_probs=175.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+..++|++.+.||+|++|.||+|.+. +..||+|.+...... .....+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE----QDESDFLMEALIMSKFNHQNIVRLIGVS 78 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34578999999999999999999884 367899987654432 2244688999999999999999999987
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--Cce
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTI 165 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~ 165 (317)
.+. ..++||||+++++|.+++...+. ..+++..++.++.||+.||+|||+++++||||||+||+++.+. ..+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 654 78999999999999999976542 2489999999999999999999999999999999999998641 258
Q ss_pred EEcccCcccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------
Q 021127 166 KLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------- 213 (317)
||+|||+++....... ......+..|+|||++.+..... ..++|+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999985432211 11223356899999875432211 11111110
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111224567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=252.47 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=190.1
Q ss_pred Cceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 24 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
++|.+. ++||-|-.|.|-.+.++ ++.+|+|++.... +..+|++++-.. .|+|||.+++++.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----------KARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 345543 57999999999988775 8999999986432 356789988766 79999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 172 (317)
..+.+|||.++||.|...+++++...+++.++-+|+.||+.|+.|||+.+|.||||||+|+|.... ...+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 368899999999999999999998899999999999999999999999999999999999999742 24789999999
Q ss_pred ccccccccccccccCccceecccccccccccccccc----------------cccCC------------------CCCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK----------------HYNHK------------------NVRPS 218 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~----------------~~~~~------------------~~~~~ 218 (317)
|+.........+.+.|++|.|||++....++...+. +|+.. ...+.
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 998765566677789999999999876543332221 11111 11222
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCCCCCCccccC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS 272 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 272 (317)
...+++..+++|+.+|..+|.+|.|+.+++++-|-......|..++...+....
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~~ 344 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLKE 344 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcch
Confidence 456789999999999999999999999999997766666666666555554443
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=256.27 Aligned_cols=226 Identities=26% Similarity=0.463 Sum_probs=175.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 82 (317)
++.++|++.++||+|+||.||++.+. ...||+|++...... .....+.+|+.+++.++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~E~~~l~~l~ 77 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK----NARNDFLKEIKIMSRLK 77 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH----HHHHHHHHHHHHHHhCC
Confidence 34578999999999999999998542 346899998755332 23457889999999999
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
|+||+++++++... ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 99999999998754 78999999999999999976432 237788999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccCC----------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------- 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------- 213 (317)
|+||+++.+ +.++|+|||+++....... .....++..|+|||+..+..+. ...++|+.+
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999987 6899999999875432211 1122346789999975443221 112222211
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++..+.+|+.+||+.||.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 112234567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=256.40 Aligned_cols=221 Identities=27% Similarity=0.343 Sum_probs=173.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|.+. ++.||+|++....... ...+.+.+|+.++++++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP---VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 47999999999999999999885 7899999987543221 1233578899999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.|..++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 78 VFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCc
Confidence 999999988888776543 38999999999999999999999999999999999999988 789999999998654332
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
......++..|+|||++.+........++|+.+ ..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 223345788999999875422212222222211 00
Q ss_pred ----CCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----RPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+. ...++..+.+|+.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 12457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=252.09 Aligned_cols=222 Identities=27% Similarity=0.470 Sum_probs=176.9
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCCh-HHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||+|... ++.+|+|.+...... ....+....+.+|++++++++|+||+++++++.+. ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788999999999999999874 788999998754332 22234456789999999999999999999998765 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc---
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL--- 178 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~--- 178 (317)
+||+++++|.+++..... +++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhccc
Confidence 999999999999976543 8999999999999999999999999999999999999988 7899999999875321
Q ss_pred ----ccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChH
Q 021127 179 ----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPE 224 (317)
Q Consensus 179 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~ 224 (317)
........|+..|+|||++.+..... ..+.|..+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA 236 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcc-hhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence 11122346889999999876533221 11111111 11223556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 237 AAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=252.36 Aligned_cols=227 Identities=27% Similarity=0.483 Sum_probs=178.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
|.+.+|+..+.||+|+||.||+|... + ..+|+|.+...... .....+..|++++++++|+||+++++++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE----KQRQDFLSEASIMGQFSHHNIIRLEGVVTK 77 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH----HHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence 55678999999999999999999874 2 37999998765432 234568899999999999999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~ 155 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSR 155 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccce
Confidence 4 7899999999999999997643 348999999999999999999999999999999999999988 689999999987
Q ss_pred cccccccc----ccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 175 EESLTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 175 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
........ .....+..|+|||++....... ..++|+.+ ...+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 234 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD 234 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcCh-HhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCC
Confidence 54322111 1112345799999875432211 11111110 12233456
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=255.45 Aligned_cols=212 Identities=22% Similarity=0.395 Sum_probs=161.4
Q ss_pred eeccccceEEEEeEEC--------------------------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 021127 31 RIGEGAHAKVYEGKYK--------------------------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--------------------------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 84 (317)
+||+|+||.||+|... ...||+|++..... .....+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-----~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-----DIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-----HHHHHHHHHHHHHhcCCCC
Confidence 6999999999998641 23588998864321 2345688899999999999
Q ss_pred CeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC-
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL- 162 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~- 162 (317)
||+++++++.++ ..++||||+++|+|..++.... ..+++..+..++.|++.||+|||++||+||||||+||+++...
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 999999998755 7899999999999999987533 3489999999999999999999999999999999999997541
Q ss_pred -----CceEEcccCcccccccccccccccCccceecccccccccccccccccccCC------------------------
Q 021127 163 -----KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213 (317)
Q Consensus 163 -----~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------ 213 (317)
..+|++|||++...... ....++..|+|||.+.+........+.|+.+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 24899999988643211 2235778899999876432112222222111
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.....+...+..+.++|.+||+.+|++||++.++++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 00112333456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=253.98 Aligned_cols=226 Identities=24% Similarity=0.472 Sum_probs=178.2
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
|..++|++.+.||.|+||.||+|+.. .+.|++|.+...... .....+.+|++++++++|+||+++++++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch----HHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 45588999999999999999999863 467999988654432 2345688999999999999999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRP-------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
.+. ..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||+++.+ +.+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~ 156 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REV 156 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcE
Confidence 764 78999999999999999986551 148999999999999999999999999999999999999988 689
Q ss_pred EEcccCccccccccc--ccccccCccceecccccccccccccccccccCC------------------------------
Q 021127 166 KLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------ 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------ 213 (317)
+|+|||++....... ......++..|+|||.+.+..... ..++|+.+
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 999999987432221 122335677899999865432211 11111111
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+.+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 012234567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=271.83 Aligned_cols=231 Identities=28% Similarity=0.478 Sum_probs=193.9
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
..+....|..+++.+.++||+|+||.|++|.|+ ...||||+++...... ...+|++|+..+.+|+|+|+++
T Consensus 100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~----~mddflrEas~M~~L~H~hliR 175 (1039)
T KOG0199|consen 100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA----IMDDFLREASHMLKLQHPHLIR 175 (1039)
T ss_pred CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch----hHHHHHHHHHHHHhccCcceeE
Confidence 455678899999999999999999999999997 2569999998765432 3457999999999999999999
Q ss_pred EEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 89 l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
|||+..+....+|||+++.|+|.+.|++.....|-......|+.||+.||.||.++++|||||...|+++-.. ..+||+
T Consensus 176 LyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~ 254 (1039)
T KOG0199|consen 176 LYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKIC 254 (1039)
T ss_pred EeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeee
Confidence 9999998889999999999999999998666668899999999999999999999999999999999999886 689999
Q ss_pred ccCcccccccccccccc----cCccceecccccccccccccccccc----------------------------cCCCCC
Q 021127 169 DFGLAREESLTEMMTAE----TGTYRWMAPELYSTVTLRQGEKKHY----------------------------NHKNVR 216 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~~~~~----------------------------~~~~~~ 216 (317)
|||+.+.....+..... .-...|+|||.+....+....+.|. +.+...
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erL 334 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERL 334 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccC
Confidence 99999966544333222 2356899999987755544433221 112445
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
+.++.+++.+++++..||..+|.+|||+..|.+
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 668899999999999999999999999999974
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=256.51 Aligned_cols=221 Identities=29% Similarity=0.426 Sum_probs=177.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||.|++|.||++.+. +..||+|++..... .....+.+|+.++++++|+||+++++.+.++ ..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 367999999999999999999885 78999999875432 2345688999999999999999999998755 889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKST 156 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccc
Confidence 9999999999999987643 249999999999999999999999999999999999999988 79999999998644322
Q ss_pred -cccccccCccceecccccccccc----cccccccccCC---------------------------C---CCCCCCCChH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK---------------------------N---VRPSAENVPE 224 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~---------------------------~---~~~~~~~~~~ 224 (317)
.......+++.|+|||++..... .....+.|+.+ . ....+..++.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 12233468899999998753211 11122333221 0 1112346788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=250.32 Aligned_cols=221 Identities=27% Similarity=0.416 Sum_probs=178.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||+|+||.||++... ++.||+|.+....... .....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP---KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh---HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 5889999999999999999874 7899999987543322 2234688999999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+.+++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence 999999999999987554458999999999999999999999999999999999999988 6899999999975433221
Q ss_pred -cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....|++.|+|||++.+..... ..+.|+.+ ...+.+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCC-ccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence 22345788999999876543322 22333221 1122355678899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 236 LFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HhhCChhhCcCHHHHhhC
Confidence 999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=254.62 Aligned_cols=216 Identities=23% Similarity=0.377 Sum_probs=171.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||+|++...... .....+.+|++++.+++||||+++++.+... ..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV----ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 46888999999999999999874 788999998765432 2345688999999999999999999988654 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|..+. .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-
Confidence 99999999997542 27889999999999999999999999999999999999998 79999999999754322
Q ss_pred ccccccCccceecccccccccccccccccccCC------------------------------------CCCCCCCCChH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSAENVPE 224 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~ 224 (317)
......|+..|+|||++.+..... ..+.|+.+ .........+.
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGI-HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE 227 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCC-cchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence 233457899999999876533221 12222111 00001234678
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++.+++.+||+.+|++||++++++++.+
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 8999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=251.71 Aligned_cols=223 Identities=25% Similarity=0.409 Sum_probs=175.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
|.+|++.+.||+|+||.||+|.+. +..||+|.+..........+....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 467999999999999999999874 7899999987654333333445678899999999999999999998764 36
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++++||+++++|.+++..... +++..++.++.|++.||+|||+++++||||+|+||+++.+ +.+||+|||++....
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccc
Confidence 8899999999999999986544 8999999999999999999999999999999999999988 689999999987442
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||.+.+.... ...+.|+.+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 21 111234578899999988654322 222333322 01111344577
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++ +||..+|++||+++++++|
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 788888 6888999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=251.75 Aligned_cols=243 Identities=25% Similarity=0.303 Sum_probs=194.2
Q ss_pred CCCCccccccceecCC------ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHH
Q 021127 2 ESRSRFYLADELKLDA------KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73 (317)
Q Consensus 2 ~~~s~~~~~~~~~~~~------~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~ 73 (317)
.+-|..+..+++...+ .-.+--++|.++++||+|.||+|-+++.+ ++.+|||++++...-.. .....-+.
T Consensus 140 ~s~s~d~~~e~m~i~~t~~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak--dEVAHTlT 217 (516)
T KOG0690|consen 140 GSPSDDFGSEEMSIAETEEAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK--DEVAHTLT 217 (516)
T ss_pred CCCCccccceeeeecccccccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh--HHhhhhhh
Confidence 3444444555555542 22344577889999999999999998875 89999999987654331 22345567
Q ss_pred HHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 74 EVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 74 E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
|-++|+..+||.+..|-..|+.. .+++||||..||.|.-+|...+. +++.....+...|+.||.|||+++||+||||
T Consensus 218 E~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK 295 (516)
T KOG0690|consen 218 ENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRNIVYRDLK 295 (516)
T ss_pred HHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence 88999999999999998888755 89999999999999999986444 9999999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccc-cccccccccccCccceecccccccccccccccccccCC------------------
Q 021127 153 PENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------ 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------ 213 (317)
.+|.|++.+ |.+||+|||+++. ......+.+.||||.|+|||++....+... .+||..+
T Consensus 296 LENLlLDkD-GHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 296 LENLLLDKD-GHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred hhhheeccC-CceEeeecccchhcccccceeccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccch
Confidence 999999999 8999999999984 355566788999999999999987665543 3344433
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
.....|..++++.+.|+..+|..||.+|. .+.+|.++
T Consensus 374 ~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 374 EKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 12334778899999999999999999994 35566554
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=257.32 Aligned_cols=220 Identities=22% Similarity=0.376 Sum_probs=175.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. +..+|+|.+...... ....++.+|++++++++||||+++++++.++ ..++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP----AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 46899999999999999999875 788999988754332 2345688999999999999999999998654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
||||+++++|.+++..... +++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.+||+|||++......
T Consensus 77 v~ey~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EeeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc
Confidence 9999999999999986543 8999999999999999999998 599999999999999988 68999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
......++..|+|||++.+..... ..+.|+.+ ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTV-QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 223457889999999876533211 12222111 00
Q ss_pred -------------------CC--CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -------------------RP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -------------------~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+ ....++.++++|+.+||..+|++||++.+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 01135678999999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=251.55 Aligned_cols=222 Identities=26% Similarity=0.462 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH----HHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE----IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+|.+.+.||+|++|.||+|.+. ++.||+|.+........ .......+.+|+.++++++||||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999874 78899998876543221 123345788999999999999999999998754 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++...+. +++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCcccc
Confidence 8999999999999999987544 8999999999999999999999999999999999999988 689999999987543
Q ss_pred ccc-------ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCC
Q 021127 178 LTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENV 222 (317)
Q Consensus 178 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~ 222 (317)
... ......|+..|+|||.+.+..... ..+.|..+ .....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTR-KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI 236 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCc-hhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence 211 112235788999999876543221 12222211 112234567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+..+.++|.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 237 SSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 8999999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.46 Aligned_cols=222 Identities=25% Similarity=0.377 Sum_probs=172.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.++||.|+||.||+|++. ++.||+|.+....... ....+.+|+.++++++|+||+++++++.+. ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 367999999999999999999875 7899999987544322 123467899999999999999999998755 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+. ++|.+++..... .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence 9999996 699998876433 48999999999999999999999999999999999999988 68999999999754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC---------------------------------------------
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------- 213 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------- 213 (317)
.......+++.|+|||++.+........++|+.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223345788999999865422111111111111
Q ss_pred ----CCC--------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ----NVR--------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ----~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
... .....++..+.+||.+||+.||.+|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000 00135678899999999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=251.71 Aligned_cols=223 Identities=24% Similarity=0.397 Sum_probs=175.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+.+|++.+.||+|+||.||++.+. +..||||.+...............+.+|+.+++++.|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 478999999999999999999875 7899999986543222222345678899999999999999999998864 35
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++||||+++++|.+++..... +++..++.++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccc
Confidence 7899999999999999976543 8899999999999999999999999999999999999988 789999999987532
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||++.+... ....++|+.+ .....+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 21 11233458889999998865332 2223333222 01112345667
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++.+|+. +|.+||++++++++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 88999999995 99999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=255.45 Aligned_cols=218 Identities=25% Similarity=0.419 Sum_probs=175.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
..+|++.+.||+|++|.||+|.+. ++.||+|.+....... ...+.+|+.+++.+.|+||+++++.+.. ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-----HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 368999999999999999999874 7899999987655432 3457889999999999999999998865 4899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++... .+++.++..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccc
Confidence 999999999999998653 38999999999999999999999999999999999999988 68999999998754322
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......+++.|+|||.+.+.... ...+.|..+ .....+..++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence 1 22334688999999987653221 112222111 011124457788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||..+|++||++.+++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.24 Aligned_cols=213 Identities=23% Similarity=0.395 Sum_probs=166.3
Q ss_pred ceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 30 PRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
+.||+|+||.||+|.+. ...||+|.+.... ....+.+.+|+.+++.+.||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 46899999999999764 2348888875432 2334568889999999999999999999876 4889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-------ceEEcccCc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADFGL 172 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-------~~kl~Dfg~ 172 (317)
+||||+++|+|.+++...+. .+++..++.++.||+.||+|||++||+||||||+||+++.+.. .++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999999999986543 4899999999999999999999999999999999999987632 269999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHH
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEE 225 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~ 225 (317)
+...... ....++..|+|||++.+........++|+.+ .....+...+.+
T Consensus 155 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (258)
T cd05078 155 SITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE 231 (258)
T ss_pred ccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence 8654322 2346788999999987533223333333322 011123345578
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+|+.+||+.||++|||++++++.|
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.86 Aligned_cols=218 Identities=25% Similarity=0.430 Sum_probs=176.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||||.+....... ...+.+|+.+++.++|+||+++++++.+. ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-----KELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch-----HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 57999999999999999999864 8899999987544322 34578899999999999999999998754 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|+||+++++|..++... .+++.++..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhccccc
Confidence 99999999999988753 38999999999999999999999999999999999999988 789999999987543322
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......++..|+|||.+.+..... ..+.|+.+ .....+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 123346889999999876533221 12222211 0112245678899999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
|.+||..||.+||++.+++++-
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhCh
Confidence 9999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=258.00 Aligned_cols=223 Identities=28% Similarity=0.373 Sum_probs=174.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|.+. ++.||||.+...............+..|++++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888999999999999999875 78999999987654321123344577899999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+ +++|.+++.... ..+++..++.++.||++||+|||++|++|+||+|+||+++.+ +.++|+|||+++..... .
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCc
Confidence 9999 999999997654 349999999999999999999999999999999999999988 79999999999865432 2
Q ss_pred ccccccCccceecccccccccccccccccccCC--------C--------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N-------------------------------------- 214 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~-------------------------------------- 214 (317)
......+++.|+|||.+.+........+.|+.+ .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345678899999874422111112222111 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+..+.++|.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000013446789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=249.09 Aligned_cols=222 Identities=28% Similarity=0.526 Sum_probs=175.6
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++.+|++.+.||+|+||.||++.+. +..+|+|.+...... ...+.+|++++++++|||++++++++... ..
T Consensus 1 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred CChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 46789999999999999999999876 788999988755432 23578899999999999999999998654 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++.... ..++++.++.++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||++.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeeccc
Confidence 99999999999999987643 238999999999999999999999999999999999999987 6899999999875432
Q ss_pred ccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
... .....++..|+|||.+.+..... ..+.|+.+ .....+...+..+.
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVY 231 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211 11223457899999876432211 11222111 01112344688999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+|+.+||+.+|++||++.++++.|
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=253.39 Aligned_cols=224 Identities=24% Similarity=0.365 Sum_probs=173.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK--- 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 94 (317)
...++|++.+.||+|+||.||++.+. ++.+|+|++...... ...+.+|+.+++++ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI------DEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch------HHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 35579999999999999999999875 789999987653321 23467899999999 7999999999873
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~d 167 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVD 167 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEcc
Confidence 23689999999999999988642 22348899999999999999999999999999999999999988 6899999
Q ss_pred cCccccccccc-ccccccCccceecccccccccc----cccccccccCC------------------------------C
Q 021127 170 FGLAREESLTE-MMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK------------------------------N 214 (317)
Q Consensus 170 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~------------------------------~ 214 (317)
||++....... ......|++.|+|||++..... .....++|+.+ .
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence 99987543222 2233468999999998753210 11122222211 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....+..++..+.+++.+||+.||++|||+.++++++
T Consensus 248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0111334577899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.16 Aligned_cols=220 Identities=30% Similarity=0.491 Sum_probs=169.0
Q ss_pred ceeccccceEEEEeEEC--C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK--N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 103 (317)
+.||+|+||.||+|.+. + ..+++|.+...... .....+.+|+.++.++ .||||+++++++... ..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 36899999999999875 3 35788887743322 2244688999999999 899999999998754 7899999
Q ss_pred ccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 104 LLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
|+++++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~d 155 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIAD 155 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECC
Confidence 9999999999976431 247899999999999999999999999999999999999988 6899999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCC
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAE 220 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~ 220 (317)
||++..............+..|+|||++...... ...+.|+.+ .....+.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 9998643222111222345679999987543221 112222211 0112234
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.++.++.+++.+||+.||.+|||+.++++.|..++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 56788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=253.65 Aligned_cols=222 Identities=25% Similarity=0.405 Sum_probs=175.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---- 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 94 (317)
..+.|++.+.||+|+||.||+|.+. ++.||+|++..... ....+..|+.++.++ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED------EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH------HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 5578999999999999999999885 78999999865432 233577899999998 7999999999874
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 ---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+...+++|||+++|+|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg 166 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFG 166 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCc
Confidence 2368999999999999999987665568899999999999999999999999999999999999988 689999999
Q ss_pred cccccccc-cccccccCccceeccccccccc----ccccccccccCC-----------------------------CCCC
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
++...... .......|++.|+|||++.... ......+.|+.+ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 98754322 1223456889999999875311 111123333322 0011
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+||.+||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 123578899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=250.04 Aligned_cols=220 Identities=28% Similarity=0.419 Sum_probs=176.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||.|+||.||++.+. +..+++|++...... ....+.+|+.++++++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 478999999999999999999875 688999999865432 245688999999999999999999988654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhh
Confidence 9999999999999987642 238999999999999999999999999999999999999988 78999999998754432
Q ss_pred c-ccccccCccceecccccccc---cccccccccccCC---------------------------C--C---CCCCCCCh
Q 021127 180 E-MMTAETGTYRWMAPELYSTV---TLRQGEKKHYNHK---------------------------N--V---RPSAENVP 223 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~~---------------------------~--~---~~~~~~~~ 223 (317)
. ......++..|+|||++... ... ...+.|+.+ . . ......++
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence 2 22344678899999998654 222 223333222 0 0 00122346
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+|||+.+++.+
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 234 PVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=251.35 Aligned_cols=225 Identities=28% Similarity=0.543 Sum_probs=178.0
Q ss_pred CCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 95 (317)
...|++.+.||+|+||.||++.+. +..||||++...... .....+.+|+++++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 467889999999999999999864 578999999865543 235578999999999999999999998864
Q ss_pred -C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 -P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 -~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
. ..++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 3 68999999999999999986543 38999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccc----cccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 174 REESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
........ .....++..|+|||.+.+.... ...+.|+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 86542211 1122345679999976543221 111222211
Q ss_pred -------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 -------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+.+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=259.16 Aligned_cols=164 Identities=25% Similarity=0.381 Sum_probs=131.7
Q ss_pred cceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~lv 101 (317)
+++||+|+||.||+|++. ++.||+|.+...... ..+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-------HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 468999999999999863 578999998755432 236789999999999999999998843 368999
Q ss_pred EEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccC
Q 021127 102 TELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg 171 (317)
|||+ +++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++. ..+.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9999 568888876321 224899999999999999999999999999999999999942 22589999999
Q ss_pred ccccccccc----ccccccCccceecccccccc
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 200 (317)
+++...... ......||+.|+|||++.+.
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 997543221 22345689999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=259.05 Aligned_cols=168 Identities=15% Similarity=0.273 Sum_probs=137.2
Q ss_pred ecceeccc--cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 28 VGPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G--~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
+.++||+| +|++||++... ++.||||.+....... .....+.+|+.+++.++||||+++++++..+ ..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN---EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 57789999 78999999875 8999999987654433 2234577899999999999999999998654 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++++||+.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence 99999999999976544458999999999999999999999999999999999999988 68999999865432111
Q ss_pred -----cccccccCccceeccccccc
Q 021127 180 -----EMMTAETGTYRWMAPELYST 199 (317)
Q Consensus 180 -----~~~~~~~gt~~y~aPE~~~~ 199 (317)
.......++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccccccceecccChHHhhc
Confidence 01122346778999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.59 Aligned_cols=216 Identities=28% Similarity=0.525 Sum_probs=169.5
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
++||+|+||.||+|... +..+|+|.+...... .....+.+|++++++++||||+++++++... ..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ----ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH----HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999875 678999998765432 2234688999999999999999999998765 78999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc--ccc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM--TAE 185 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~--~~~ 185 (317)
++|.+++.... ..+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++......... ...
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCC
Confidence 99999987643 348999999999999999999999999999999999999988 68999999998754322111 122
Q ss_pred cCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhhc
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWKE 236 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~ 236 (317)
.++..|+|||++.+..... ..+.|+.+ .....+..++..+.+++.+||+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred CCcccccCHHHhccCCCCc-hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccc
Confidence 3456799999876532211 11111111 11122456789999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 021127 237 DPNARPNFTQIIQMLL 252 (317)
Q Consensus 237 ~p~~Rps~~~~~~~l~ 252 (317)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.90 Aligned_cols=220 Identities=25% Similarity=0.391 Sum_probs=172.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||+|++. |+.||+|.++...... .....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~---~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc---cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 5889999999999999999985 8899999987643322 1223577899999999999999999998765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||+. ++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence 99995 68888876543 338999999999999999999999999999999999999988 78999999999754322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC--------CCC------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------------ 216 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------------ 216 (317)
......++..|+|||++.+........+.|+.+ ...
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 223345788999999876533222222333221 000
Q ss_pred -------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.+++.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0112467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=248.77 Aligned_cols=222 Identities=27% Similarity=0.424 Sum_probs=178.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|+||+||+|... +..+|+|++....... ....+.+|+..++.++|+||+++++.+... ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch----HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 47899999999999999999874 7889999987654332 345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||++++++|.+++..... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccC
Confidence 9999999999999986543 458999999999999999999999999999999999999988 68999999998754322
Q ss_pred c-----ccccccCccceecccccccccccccccccccCC--------CC----------------------CCC---CCC
Q 021127 180 E-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------RPS---AEN 221 (317)
Q Consensus 180 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------~~~---~~~ 221 (317)
. ......|+..|+|||++..........+.|+.+ .. ... ...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccc
Confidence 1 113346889999999876653333333444322 00 000 125
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++..+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 67889999999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.90 Aligned_cols=217 Identities=27% Similarity=0.436 Sum_probs=164.2
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.||+|+||.||+|.+. +..+|+|.+....... ....+.+|+.++++++||||+++++++.+. ..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQ----EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChH----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 46899999999999764 4579999887654322 234688899999999999999999998765 78999999
Q ss_pred cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 105 LSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++|+|.+++..... ...++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||+++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcce
Confidence 999999999975332 236778888999999999999999999999999999999988 6899999999974332211
Q ss_pred ---cccccCccceecccccccccc------cccccccccCC----------C---------------------CCCC---
Q 021127 182 ---MTAETGTYRWMAPELYSTVTL------RQGEKKHYNHK----------N---------------------VRPS--- 218 (317)
Q Consensus 182 ---~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~----------~---------------------~~~~--- 218 (317)
.....++..|+|||++..... .....+.|+.+ . ..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 123356788999998753211 11122222211 0 0000
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
....+..+.+++.+|| .+|++|||+++|+..|.
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1245678899999999 68999999999997753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=254.38 Aligned_cols=220 Identities=28% Similarity=0.360 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||+|.+. +..||+|++....... .....+.+|+.++++++|+||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG---GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc---hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 5889999999999999999874 7899999998755322 2234688999999999999999999998755 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence 9999 999999987644 449999999999999999999999999999999999999987 789999999998654332
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------C-------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------- 214 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------- 214 (317)
......++..|+|||++.+........++|+.+ .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 123456889999999875432222222222211 0
Q ss_pred ---CC---------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---VR---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.. ......+..+.+++.+||+.+|.+||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0012456889999999999999999999999887
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=254.67 Aligned_cols=217 Identities=25% Similarity=0.423 Sum_probs=174.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. ++.||+|.+....... ...+.+|+.+++.++|+||+++++++..+ ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 78999999999999999999874 8899999987654332 34578899999999999999999998755 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCc
Confidence 99999999999998653 38999999999999999999999999999999999999988 789999999987543222
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......+++.|+|||.+.+..... ..+.|+.+ .....+..++..++++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDF 248 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHH
Confidence 123346888999999876532211 11111110 0111234567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||+.+|++||++.+++++
T Consensus 249 i~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=249.47 Aligned_cols=221 Identities=24% Similarity=0.412 Sum_probs=177.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~ 99 (317)
+|++.+.||.|+||.||++.+. ++.||+|.+....... ....++.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH---HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5889999999999999999875 7889999987654432 334568899999999999999999997742 3689
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 100 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLH-----SHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH-----~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
++|||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.+ +.+||+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccc
Confidence 9999999999999997532 345899999999999999999999 8999999999999999988 7999999999
Q ss_pred ccccccccc-cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCCh
Q 021127 173 AREESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVP 223 (317)
Q Consensus 173 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~ 223 (317)
+........ .....++..|+|||++.+..... ..+.|..+ .....+..++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYS 235 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCc-hhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccC
Confidence 986544332 33456899999999876543221 12222211 1123345678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|.+||++.+++++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=249.25 Aligned_cols=218 Identities=27% Similarity=0.414 Sum_probs=176.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.+++|.+..... ...+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence 478999999999999999999886 68999999865321 45688999999999999999999998765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccC
Confidence 9999999999999997643 348999999999999999999999999999999999999988 68999999999865433
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......++..|+|||++.+..... ..+.|+.+ .....+..++.++.+
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNN-KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND 231 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence 2 223345788999999876543322 22222211 000112346678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||+.||.+|||+.+++++
T Consensus 232 ~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 232 FVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHHHHhcChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=247.37 Aligned_cols=220 Identities=29% Similarity=0.484 Sum_probs=169.6
Q ss_pred ceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--cCceEEEE
Q 021127 30 PRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPVMVIVT 102 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~lv~ 102 (317)
+.||+|+||.||+|.+. ...||||.+...... .....+.+|+.+++.++||||+++++++. ++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 46899999999999863 357999987643322 23456889999999999999999999774 34688999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
||+.+++|.+++..... .+++..++.++.|++.||+|||+.+++||||||+||+++.+ +.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence 99999999999976432 36788889999999999999999999999999999999988 689999999987432211
Q ss_pred ---ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 181 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 181 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
......++..|+|||.+....... ..++|+.+ .....+..++..+.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred eecccccCcCCccccChhHhccCccch-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 111234567899999875433211 12222211 112224456889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
++.+||+.+|++||++.++++.|.+++.
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=251.82 Aligned_cols=220 Identities=26% Similarity=0.331 Sum_probs=178.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|+||.||++.+. +..||+|++....... .+....+.+|+.++++++||||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc--hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 5899999999999999999886 8899999997643222 13456789999999999999999999988765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+.+++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence 99999999999998753 38999999999999999999999999999999999999988 6899999999986544433
Q ss_pred cccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.....|+..|+|||++.+.... ...+.|..+ .....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN 234 (258)
T ss_pred ccccCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHH
Confidence 3455688899999987653321 222222222 112235567899999999
Q ss_pred HhhhcCCCCCCCH--HHHHHH
Q 021127 232 SCWKEDPNARPNF--TQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~--~~~~~~ 250 (317)
+||+.||.+||++ .+++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred HHccCChhHcCCccHHHHhcC
Confidence 9999999999999 776544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.45 Aligned_cols=223 Identities=27% Similarity=0.382 Sum_probs=177.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||++... ++.||||.+....... .....++.+|+++++.++|+||+++++.+.++ ..++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK--RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch--HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 47899999999999999999885 7899999998765432 23455788999999999999999999998765 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhcccccc
Confidence 9999999999999986544569999999999999999999999999999999999999988 789999999986432211
Q ss_pred ------------------------------ccccccCccceecccccccccccccccccccCC-----------------
Q 021127 181 ------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------- 213 (317)
Q Consensus 181 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------- 213 (317)
......|+..|+|||++.+..... ..++|+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 011235788999999876543221 22222211
Q ss_pred ------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 021127 214 ------------NVRPSAENVPEELSIILTSCWKEDPNARPN----FTQIIQM 250 (317)
Q Consensus 214 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~~~~~ 250 (317)
...+....++..+.+++.+||+.||++||+ +++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 011112236889999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=268.95 Aligned_cols=163 Identities=25% Similarity=0.305 Sum_probs=137.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 99 (317)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|++++++++|+||+++++++.. +..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 457999999999999999999986 68899996432 125689999999999999999998865 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|||++ .++|..++.... ..+++..++.|+.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccc
Confidence 999999 579999887543 249999999999999999999999999999999999999988 68999999999754322
Q ss_pred c---ccccccCccceeccccccc
Q 021127 180 E---MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 180 ~---~~~~~~gt~~y~aPE~~~~ 199 (317)
. ......||+.|+|||++.+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred cccccccccCCCcCCcCHHHHcC
Confidence 1 1223569999999998765
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.69 Aligned_cols=169 Identities=22% Similarity=0.336 Sum_probs=133.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC------CCCeeeEEee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------HRNLVKFIGA 92 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~ 92 (317)
+..++|++.++||+|+||+||+|.+. ++.||||+++..... ...+..|+.++..++ |.++++++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY------TRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh------HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 44678999999999999999999875 788999998653221 122344556555554 5568999998
Q ss_pred eec--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCC------
Q 021127 93 CKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK------ 163 (317)
Q Consensus 93 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~------ 163 (317)
+.. ...++||+++ +++|.+++...+. +++..+..|+.||+.||+|||+ .|||||||||+|||++.+..
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKHGP--FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 864 3789999998 8899999876543 9999999999999999999998 59999999999999986521
Q ss_pred ---------ceEEcccCcccccccccccccccCccceecccccccc
Q 021127 164 ---------TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 164 ---------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
.+||+|||.+..... .....+||+.|+|||++.+.
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcC
Confidence 499999998864322 23456799999999987653
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=248.10 Aligned_cols=220 Identities=35% Similarity=0.674 Sum_probs=174.4
Q ss_pred eeecceeccccceEEEEeEECC------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
+++.+.||.|+||.||++.+.+ ..||+|.+....... ....+..|+.++..++|+||+++++++.+ +..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ----QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH----HHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 3577899999999999998864 789999997655432 34568899999999999999999999876 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYD 155 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceeccc
Confidence 999999999999999986544338999999999999999999999999999999999999988 6899999999975543
Q ss_pred ccccc--cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
..... ...++..|+|||.+.+.... ...+.|..+ .....+...+.++.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIY 234 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence 32211 12367899999987432111 111111110 11223455789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||..||.+|||+.++++.|
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=250.43 Aligned_cols=218 Identities=27% Similarity=0.427 Sum_probs=176.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||+|.+....... ....+.+|+.+++.++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch----HHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 47889999999999999999875 7899999987654322 234578899999999999999999988655 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|+||+++++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccc
Confidence 99999999999999764 48999999999999999999999999999999999999998 78999999999865433
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCC-ChHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAEN-VPEELSIIL 230 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~-~~~~l~~li 230 (317)
.......++..|+|||.+.+... ....+.|+.+ .....+.. ++.++.+++
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231 (274)
T ss_pred cccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHH
Confidence 22334568889999998876442 2222233221 00011122 788899999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++|||+++++++
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHhhCChhhCcCHHHHhhC
Confidence 99999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=248.79 Aligned_cols=224 Identities=23% Similarity=0.352 Sum_probs=172.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
++-.+......||+|+||.||+|.+. +..||+|.+...... ..+.+.+|+.++++++|+||+++++++..+ .
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-----YVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34444445568999999999999875 678999988765432 244688999999999999999999998754 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCL--DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++|+||+++++|.+++..... .+ ++..+..++.|++.||+|||++||+||||||+||+++.+.+.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 8999999999999999986432 24 78889999999999999999999999999999999987446899999999875
Q ss_pred cccc-cccccccCccceeccccccccc-ccccccccccCC------------------------------CCCCCCCCCh
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK------------------------------NVRPSAENVP 223 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~------------------------------~~~~~~~~~~ 223 (317)
.... .......++..|+|||++.... ......+.|+.+ .....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 4322 1222345789999999875422 111122222211 0111244677
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 899999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=246.96 Aligned_cols=217 Identities=27% Similarity=0.493 Sum_probs=173.0
Q ss_pred ceeccccceEEEEeEEC---C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 104 (317)
++||+|++|.||+|.+. + ..||||.+...... ...+++.+|+.++++++|+||+++++.+.+...++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 46899999999999874 2 36999998776543 345678999999999999999999999877889999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc----
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---- 180 (317)
+++++|.+++.......+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 999999999987653458999999999999999999999999999999999999998 799999999997543321
Q ss_pred ccccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPEELSIIL 230 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~li 230 (317)
......++..|+|||.+.+...... .+.|+. ......+..+|..+.+++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVM 234 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHH
Confidence 1122356788999998654322111 111110 111223456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||+.+|++||++.++++.|.
T Consensus 235 ~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 235 LQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.30 Aligned_cols=223 Identities=22% Similarity=0.409 Sum_probs=175.9
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-HHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+|+..+.||+|++|.||++... ++.||+|++....... ...+....+.+|+.++++++|+||+++++++.++ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999874 8899999987544221 1223456789999999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++..... +++..++.++.|++.||+|||++|++|+||+|+||+++.+...+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999999999986543 89999999999999999999999999999999999998764469999999987543321
Q ss_pred -----ccccccCccceecccccccccccccccccccCC--------------------------------CCCCCCCCCh
Q 021127 181 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRPSAENVP 223 (317)
Q Consensus 181 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~ 223 (317)
......++..|+|||++.+.... ...+.|+.+ .....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11234578899999987653321 122222211 0112234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+||++.+++++
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 889999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=255.51 Aligned_cols=230 Identities=25% Similarity=0.482 Sum_probs=179.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+..++|+..+.||+|+||.||+|.+. +. .||+|.+...... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~ 79 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP----KANVEFMDEALIMASMDHPHLVRLLGVCL 79 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 45678899999999999999999873 33 5799988754432 22345889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
....++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 80 ~~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~ 157 (303)
T cd05110 80 SPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLAR 157 (303)
T ss_pred CCCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccc
Confidence 777889999999999999987643 238999999999999999999999999999999999999887 689999999998
Q ss_pred ccccccc---cccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 175 EESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
....... .....++..|+|||.+.+...... .+.|+. ....+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPIC 236 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 5432211 122335678999998754322111 111111 0112223456
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+..+.+++.+||..+|++||++.++++.+.++...
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 78899999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=252.99 Aligned_cols=223 Identities=21% Similarity=0.341 Sum_probs=176.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|+||.||++.+. +..||+|.+...... .....+.+|+.++++++|+||+++++.+.. +..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE----SKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH----HHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 46899999999999999999986 889999998754332 224568899999999999999999998865 48999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
||||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVA 155 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccC
Confidence 999999999999887632 2248999999999999999999997 599999999999999987 7899999999875432
Q ss_pred ccccccccCccceecccccccccc-----cccccccccCC-------------------------------CCCCCCCCC
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTL-----RQGEKKHYNHK-------------------------------NVRPSAENV 222 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~~~~-------------------------------~~~~~~~~~ 222 (317)
. ......++..|+|||++.+... .....+.|+.+ .....+..+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 S-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred C-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2 2233468889999998754322 11122222211 111224457
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.++.+||.+||+.+|.+||++.+++++.+
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 889999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=263.73 Aligned_cols=216 Identities=23% Similarity=0.326 Sum_probs=168.8
Q ss_pred ecCCceeecceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+...+|.+.+.||.|+||.||++... +..||+|.+.... ...+|++++++++|+||+++++++...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 44567999999999999999998753 5779999876532 245799999999999999999988754
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|||++ +++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 159 ~~~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccc
Confidence 899999999 578999885433 49999999999999999999999999999999999999988 7899999999975
Q ss_pred ccccc---ccccccCccceecccccccccccccccccccCC---------------------------------------
Q 021127 176 ESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------- 213 (317)
Q Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------- 213 (317)
..... ......||+.|+|||++.+..+.. ..++|+.+
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 43221 122456899999999876532211 11111111
Q ss_pred -----------------CCCC--------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -----------------NVRP--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -----------------~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
...+ ....++.++.++|.+||..||++|||+.+++.+-
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000 0123466788999999999999999999999983
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=249.03 Aligned_cols=216 Identities=26% Similarity=0.431 Sum_probs=162.5
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
++||+|+||.||+|... ...+|+|.+...... .....+.+|+..++.++|+||+++++.+.+. ..++||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP----DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCCh----HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 46899999999999653 457888887654332 2344688999999999999999999998755 79999999
Q ss_pred cCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 105 LSGGTLRKYLLNMRP---RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++|+|.+++..... ...++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchh
Confidence 999999999976442 235678889999999999999999999999999999999998 7999999999864322211
Q ss_pred ---cccccCccceeccccccccc------ccccccccccCC-------------------------------C---CCCC
Q 021127 182 ---MTAETGTYRWMAPELYSTVT------LRQGEKKHYNHK-------------------------------N---VRPS 218 (317)
Q Consensus 182 ---~~~~~gt~~y~aPE~~~~~~------~~~~~~~~~~~~-------------------------------~---~~~~ 218 (317)
.....++..|+|||++.... ......++|+.+ . ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcc
Confidence 12234567899999864211 111112222111 0 0111
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+..++..+.+++..|| .||++||+++++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3356788899999999 5999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=254.74 Aligned_cols=221 Identities=29% Similarity=0.380 Sum_probs=174.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|.+. ++.||+|.+....... .....+.+|+++++.++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK---MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc---hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 47899999999999999999985 7899999987544322 2344578899999999999999999998755 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|..+...... +++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCc
Confidence 9999999988887664333 8999999999999999999999999999999999999988 78999999998754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
.......++..|+|||++.+........++|+.+ ..
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2223346788999999875432222222222211 00
Q ss_pred --------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 --------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 --------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+|+.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00123567889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=248.69 Aligned_cols=221 Identities=28% Similarity=0.421 Sum_probs=175.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC---
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP--- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 96 (317)
.++|++.+.||+|++|.||+|.+. ++.+++|++..... ....+.+|+.+++++ .|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 478999999999999999999985 68899999876543 234688999999999 799999999998543
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCC
Confidence 4899999999999999987643 4458999999999999999999999999999999999999988 78999999
Q ss_pred Ccccccccc-cccccccCccceecccccccccc----cccccccccCC--------C----------------------C
Q 021127 171 GLAREESLT-EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK--------N----------------------V 215 (317)
Q Consensus 171 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~--------~----------------------~ 215 (317)
|++...... .......|+..|+|||++..... .....+.|+.+ . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 998754322 22234568899999998754221 11123333322 0 0
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+..++.++.+|+.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 01122366789999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=248.11 Aligned_cols=211 Identities=22% Similarity=0.407 Sum_probs=164.4
Q ss_pred ceeccccceEEEEeEECC------------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 30 PRIGEGAHAKVYEGKYKN------------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~------------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
+.||+|+||.||+|.+.+ ..+++|.+...... ...+.+|+.++++++|+||+++++++....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD------SLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh------HHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 468999999999998863 24788877644321 456889999999999999999999887677
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-------ceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-------~~kl~Df 170 (317)
.++||||+++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.+ + .+||+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~-~~~~~~~~~~kl~Df 152 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY-GLNEGYVPFIKLSDP 152 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecC-ccccCCceeEEeCCC
Confidence 8999999999999999986542 48999999999999999999999999999999999999977 4 6999999
Q ss_pred CcccccccccccccccCccceecccccccc-cccccccccccCC----------C-----------------CCCCCCCC
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK----------N-----------------VRPSAENV 222 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~----------~-----------------~~~~~~~~ 222 (317)
|++..... .....++..|+|||++.+. .......+.|+.+ . ....+...
T Consensus 153 g~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (259)
T cd05037 153 GIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD 229 (259)
T ss_pred Cccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence 99986433 2234567789999997654 1111122222211 0 00011122
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
...+.+++.+||..+|.+||++.++++.|
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 36899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=248.78 Aligned_cols=223 Identities=24% Similarity=0.408 Sum_probs=174.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-----HHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-----EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+|.+.+.||+|+||.||+|... ++.||||.+....... ......+.+.+|+.++++++|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5788999999999999999764 7899999886432211 1122345678899999999999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence 7899999999999999998764 38999999999999999999999999999999999999988 79999999999754
Q ss_pred cccc---ccccccCccceeccccccccc-ccccccccccCC-----------------------------CCCC----CC
Q 021127 177 SLTE---MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-----------------------------NVRP----SA 219 (317)
Q Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-----------------------------~~~~----~~ 219 (317)
.... ......++..|+|||.+.... ......+.|+.+ .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 3211 122345788999999876533 112222222211 0001 12
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++.++.+++.+||..+|.+||++++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3457899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=267.76 Aligned_cols=217 Identities=25% Similarity=0.439 Sum_probs=170.6
Q ss_pred Cce-eecceeccccceEEEEeEEC--CeEEE---EEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 24 KHL-FVGPRIGEGAHAKVYEGKYK--NQTVA---IKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y-~~~~~lG~G~~g~V~~~~~~--~~~va---iK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
++| ++..+||+|+|-+||+|.++ |..|| ||.-..... .+..++|..|+.+|+.|+||||+++|+++.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~----~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQS----PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcC----hHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 344 46778999999999999886 44444 332222222 24457899999999999999999999988643
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+.+|+|++..|+|..|+.+.+. ++.+.+..|+.||+.||.|||++ .|||||||.+||||+.+.|.|||+|+|+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL 192 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL 192 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence 58899999999999999998776 89999999999999999999998 5999999999999999999999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC----------------------------CCCCC--CCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPS--AENV 222 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~--~~~~ 222 (317)
|........ ....|||.|||||+|... + ....++|+++ +..|. ..--
T Consensus 193 Atl~r~s~a-ksvIGTPEFMAPEmYEE~-Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~ 269 (632)
T KOG0584|consen 193 ATLLRKSHA-KSVIGTPEFMAPEMYEEN-Y-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK 269 (632)
T ss_pred HHHhhcccc-ceeccCccccChHHHhhh-c-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence 987654433 336899999999998732 1 1222223322 11111 1112
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++++||.+||.. ..+|||+.|+|++
T Consensus 270 dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 46899999999999 9999999999976
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=249.83 Aligned_cols=215 Identities=25% Similarity=0.343 Sum_probs=170.8
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||+|+||+||++.+. ++.||+|.+....... ......+.+|++++++++||||+++++++... ..++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK--RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh--hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 699999999999775 8899999987643221 22345678899999999999999999988654 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|.+++.......+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCC
Confidence 99999987665569999999999999999999999999999999999999988 68999999998755433333345678
Q ss_pred cceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..|+|||++.+... ....+.|+.+ .....+..++..+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999998765332 1122222211 011123456889999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 021127 238 PNARP-----NFTQIIQM 250 (317)
Q Consensus 238 p~~Rp-----s~~~~~~~ 250 (317)
|.+|| ++.+++++
T Consensus 237 p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 237 PEKRLGCRGGSADEVREH 254 (277)
T ss_pred hhHccCCCcccHHHHHhC
Confidence 99999 77778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=257.20 Aligned_cols=219 Identities=25% Similarity=0.363 Sum_probs=184.1
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
.+.||+|.||+||-|++. |+.||||++.+...+. +.+..+.+|+.+|+.+.||.||.+...|+.. ..++|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~---kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT---KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC---chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 568999999999998775 9999999998876654 4456789999999999999999999999876 789999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC--CCCceEEcccCcccccccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREESLTEMMT 183 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~~~~~~~~ 183 (317)
.|++.+.|......++++.....++.||+.||.|||.++|+|+||||+|||+.. +.-++||||||+|+.........
T Consensus 646 -~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 -HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred -cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 678878777666677999999999999999999999999999999999999974 34589999999999988877888
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..+||+.|+|||++....+....+.| +.+ ........++.+..+||..+|
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMW-SVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMW-SVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred hhcCCccccCHHHHhhccccccccce-eeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHH
Confidence 88999999999999876655443332 211 111123567889999999999
Q ss_pred hcCCCCCCCHHHHHHHHH
Q 021127 235 KEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~ 252 (317)
+..-.+|.|++..+.|.|
T Consensus 804 qVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHhcchHhhccchh
Confidence 999999999999887754
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=248.45 Aligned_cols=221 Identities=25% Similarity=0.384 Sum_probs=170.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHH-HHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||++.+. ++.||||.+........ ..++..|+.. ++.++|+||+++++++..+ ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE----QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH----HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 47899999999999999999885 89999999876543221 2345556665 5567999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++...
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence 9999995 7898888653 223589999999999999999999998 99999999999999988 79999999999865
Q ss_pred ccccccccccCccceecccccccccc---cccccccccCC----------------------------CCCC--CCCCCh
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTL---RQGEKKHYNHK----------------------------NVRP--SAENVP 223 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~~----------------------------~~~~--~~~~~~ 223 (317)
..........++..|+|||++.+... .....+.|..+ ...+ ....++
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 43333333568889999998764211 11223333222 0001 123468
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++.+++.+||..+|.+||++.+++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=252.04 Aligned_cols=221 Identities=26% Similarity=0.393 Sum_probs=174.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||.|++|.||+|.+. ++.||||.+....... .....+.+|++++++++||||+++++++.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc---ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 4889999999999999999884 7899999887544322 1234688899999999999999999998654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence 99995 689999876555568999999999999999999999999999999999999988 68999999998754322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC--------CCC------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------------ 216 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------------ 216 (317)
......++..|+|||++.+........++|+.+ ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 223345788999999876533222223333322 000
Q ss_pred ------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.+++++|.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0012457788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=251.22 Aligned_cols=222 Identities=25% Similarity=0.343 Sum_probs=171.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||++.+. ++.||+|.+....... ......+.+|+++++.++||||+++++.+..+ ..++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL--RNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh--HHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 46899999999999999999886 6889999987653221 23345788999999999999999999988755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++|++|.+++...+. +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCc
Confidence 9999999999999977543 8999999999999999999999999999999999999987 799999999986311100
Q ss_pred ----------------ccccccCccceecccccccccccccccccccCC---------------------------C--C
Q 021127 181 ----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N--V 215 (317)
Q Consensus 181 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~--~ 215 (317)
......++..|+|||.+....... ..+.|+.+ . .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 011235788899999875532221 12222111 0 0
Q ss_pred CC-CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 RP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 ~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+ ....++.++.++|.+||+.||++||++.++.+.+
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 235 WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 11 1225788999999999999999999854444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=245.27 Aligned_cols=220 Identities=30% Similarity=0.452 Sum_probs=175.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||++... ++.||+|.++..... ......+.+|+.++++++|+||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 5889999999999999999874 789999999866543 24466789999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++..... +++..+..++.+++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCC
Confidence 999999999999986443 8899999999999999999999999999999999999997 7899999999875433222
Q ss_pred c-----ccccCccceeccccccccc--ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 182 M-----TAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 182 ~-----~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
. ....++..|+|||++.+.. ......+.|..+ ...+....++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLS 234 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccC
Confidence 1 1245788999999876543 111122222211 0111122347
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 889999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=250.23 Aligned_cols=223 Identities=26% Similarity=0.349 Sum_probs=173.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||.|++|.||+|.+. ++.||+|.+....... .....+.+|++++++++|+||+++++++.++ ..++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE---GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc---cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 57999999999999999999875 7889999986543321 2234578899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||++ ++|.+++.......+++..+..++.||+.||+|||++|++|+||+|+||+++.+.+.+||+|||++......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999995 688888876555447888999999999999999999999999999999999865467999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCCC----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------------- 217 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------------- 217 (317)
.......+++.|+|||++.+........++|+.+ ...+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 1223345788999999875532222222232221 0000
Q ss_pred --------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 --------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 --------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 023567889999999999999999999999986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.07 Aligned_cols=222 Identities=26% Similarity=0.449 Sum_probs=176.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|+||.||++.++ +..||+|.+....... .....+.+|+.+++.++|+||+++++.+.+. ..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 5889999999999999999885 7889999987643221 2234678899999999999999999988655 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
+||+++++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||+++.+...+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999875555589999999999999999999999999999999999999874457999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......|++.|+|||++.+..... ..+.|+.+ ...+....++.++.+++.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 222345888999999876532211 12222211 1112234568899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||..+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 237 LFKVSPRDRPSITSILKR 254 (257)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=247.70 Aligned_cols=220 Identities=27% Similarity=0.437 Sum_probs=176.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|+..++||.|+||.||+|.+. +..||||++...... .....+.+|+.++++++|+||+++++++.++ ..++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46788899999999999999874 789999998765432 2345688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCc
Confidence 99999999999998752 38999999999999999999999999999999999999988 689999999997543322
Q ss_pred c-cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 181 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 181 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. .....++..|+|||++.+.... ...+.|+.+ .....+..++..+.+++.
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234 (277)
T ss_pred cccccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHH
Confidence 1 2234578899999987653321 112222211 011123356788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.+|.+||++.+++++.+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred HHcccCcccCcCHHHHHhChH
Confidence 999999999999999998844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=243.16 Aligned_cols=216 Identities=33% Similarity=0.574 Sum_probs=171.3
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCC
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSG 107 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 107 (317)
++||.|+||.||++.+. ++.||+|.+...... .....+.+|++++++++|+||+++++++.+. ..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 46899999999999886 899999998765543 2345688999999999999999999998765 79999999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc---cc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM---TA 184 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~---~~ 184 (317)
++|.+++..... .+++..++.++.+++.||+|||+++++||||+|+||+++.+ +.++|+|||++......... ..
T Consensus 77 ~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceecccc
Confidence 999999976432 48899999999999999999999999999999999999988 79999999999754322111 11
Q ss_pred ccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
..++..|+|||++.+.... ...++|+.+ ...+.+..++.++.+++.+||+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 233 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWA 233 (251)
T ss_pred CcceeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhc
Confidence 2335679999987653221 112222211 1122345678899999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 021127 236 EDPNARPNFTQIIQMLL 252 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~l~ 252 (317)
.+|.+||++.++++.|.
T Consensus 234 ~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 234 YDPENRPSFSEIYNELQ 250 (251)
T ss_pred cChhhCcCHHHHHHHhh
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=244.30 Aligned_cols=223 Identities=23% Similarity=0.394 Sum_probs=177.1
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+.+|.+.+.||+|+||.||+|.+. +..||+|.+...............+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999874 7899999986543322223445678899999999999999999998864 35
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+++++||+++++|.+++..... +++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccc
Confidence 8899999999999999986544 8899999999999999999999999999999999999988 689999999997543
Q ss_pred cc----cccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 178 LT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 178 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
.. .......++..|+|||++.+.... ...+.|+.+ .....+..+++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 21 112234588999999988653322 122222211 11223567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+++.+||+ +|..||++.+++.|
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 99999999999 57999999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=250.93 Aligned_cols=221 Identities=28% Similarity=0.345 Sum_probs=173.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|.+. ++.||||.+....... .....+.+|++++++++|+||+++++++.++ ..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE---DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc---cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 47999999999999999999885 7899999987543322 2345688999999999999999999998754 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++++.+..+.... ..+++..++.++.|++.||+|||+++++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 78 VFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARP 154 (288)
T ss_pred EEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCc
Confidence 99999887666655443 338999999999999999999999999999999999999988 789999999988654332
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------CC-----------------------------------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------------- 215 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------------- 215 (317)
......++..|+|||++.+........+.|+.+ ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 223456788999999876652222223333211 00
Q ss_pred -----C-----------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----R-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ..+..++.++.+||.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0112347889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=266.70 Aligned_cols=228 Identities=29% Similarity=0.466 Sum_probs=179.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 95 (317)
.+...+.||+||||.||+|+++ |+.||||.++..... +.+++..+|++++++++|+|||+++++-++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~----r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL----RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhccc----chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3455677999999999999975 999999999876542 446678999999999999999999998643
Q ss_pred CceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcccC
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFG 171 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg 171 (317)
....+|||||.||+|...+..-.. ..+++..++.++.+++.||.|||++|||||||||.||++-.. ....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 247899999999999999985322 349999999999999999999999999999999999998632 1247999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
.|+..+......+..||..|.+||++..........+.|+.+
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 999888887888889999999999988533333333333332
Q ss_pred --------------CCCCCCCCCh----HHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHhhh
Q 021127 214 --------------NVRPSAENVP----EELSIILTSCWKEDPNARP--NFTQIIQMLLNYLS 256 (317)
Q Consensus 214 --------------~~~~~~~~~~----~~l~~li~~cl~~~p~~Rp--s~~~~~~~l~~~~~ 256 (317)
...|.+..++ ..+..++..+|..+|.+|- ...+....+.+.+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1112222333 3356778889999999998 77776666666554
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=246.60 Aligned_cols=218 Identities=26% Similarity=0.408 Sum_probs=173.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEeeeecC-ce
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEP-VM 98 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~-~~ 98 (317)
.|++.+.||+|+||.||+|.+. ++.||+|.+....... ...++.+|+.++++++ |||++++++++.++ ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD----DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch----hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 5788899999999999999974 7899999987654332 2345788999999986 99999999988655 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence 9999999999999998653 38999999999999999999999999999999999999987 7999999999875433
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC---------------------------CCCC-C-CCCChHHHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRP-S-AENVPEELSI 228 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~-~-~~~~~~~l~~ 228 (317)
.. ......|+..|+|||.+.+........+.|+.+ ...+ . ...++.++.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHH
Confidence 22 223346889999999875432222222333211 0001 1 1136789999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||+.||++||++.+++.+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhC
Confidence 9999999999999999999886
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=253.06 Aligned_cols=163 Identities=25% Similarity=0.387 Sum_probs=130.0
Q ss_pred cceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee---cCceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---~~~~~lv 101 (317)
+.+||+|+||.||+|+.. +..||+|.+...... ..+.+|+.++++++||||+++++++. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-------HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 467999999999999864 478999998754432 23678999999999999999999874 2478999
Q ss_pred EEccCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccC
Q 021127 102 TELLSGGTLRKYLLNM-------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFG 171 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg 171 (317)
|||+. ++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||++.. ..+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99995 6888877532 1224889999999999999999999999999999999999942 22689999999
Q ss_pred ccccccccc----ccccccCccceeccccccc
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~ 199 (317)
+++...... ......||+.|+|||++.+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcC
Confidence 998543321 1233468999999998765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.09 Aligned_cols=228 Identities=22% Similarity=0.331 Sum_probs=178.6
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
+..+.|....|+++++||+||.+.||++... .+.+|+|.+....... ....-|.+|+..|.+| .|.+||+|+++-
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~---qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN---QTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH---HHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 4567899999999999999999999999876 4667777665444333 3355699999999999 699999999997
Q ss_pred e-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 K-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
. ++.+|+||||- ..+|.+.|.+.... .+.-.+..+..|++.|+.++|+.||||.||||.|+|+.. |.+||+|||+
T Consensus 430 v~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGI 505 (677)
T KOG0596|consen 430 VTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGI 505 (677)
T ss_pred ccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeech
Confidence 5 66999999976 67999999876654 332377889999999999999999999999999999998 5899999999
Q ss_pred cccccccc---ccccccCccceeccccccccccc----------ccccccccCC--------------------------
Q 021127 173 AREESLTE---MMTAETGTYRWMAPELYSTVTLR----------QGEKKHYNHK-------------------------- 213 (317)
Q Consensus 173 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~----------~~~~~~~~~~-------------------------- 213 (317)
|+...... .....+||+.||+||.+...... ....++|+.+
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI 585 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAI 585 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhh
Confidence 98654332 23456899999999998765443 1234455544
Q ss_pred ---CC-CCCCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---NV-RPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---~~-~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+. .+.+.. -..++.++|+.||..||.+||++.++|++
T Consensus 586 ~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 00 011111 12349999999999999999999999987
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=249.21 Aligned_cols=220 Identities=26% Similarity=0.422 Sum_probs=174.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|+..+.||+|+||.||+|.+. ++.||+|.+....... ....+.+|+.++++++|+||+++++++..+ ..++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH----HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 45778889999999999999875 7889999987554322 245688999999999999999999988655 7999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcc
Confidence 9999999999998864 238999999999999999999999999999999999999988 789999999997544322
Q ss_pred -ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
......++..|+|||++.+.... ...+.|+.+ ........++.++.+++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence 12234578899999987654322 112222211 001112346788999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.+|.+||++.+++++.+
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred HHccCCcccCcCHHHHHHhHH
Confidence 999999999999999999743
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=246.93 Aligned_cols=217 Identities=33% Similarity=0.593 Sum_probs=168.7
Q ss_pred ceeccccceEEEEeEECC--------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 30 PRIGEGAHAKVYEGKYKN--------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~--------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.||+|+||.||+|++.+ +.+|||.+...... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD----QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccch----hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 468999999999998742 67999988654322 2244688999999999999999999998654 7999
Q ss_pred EEEccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-----ceEEccc
Q 021127 101 VTELLSGGTLRKYLLNMR-----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-----TIKLADF 170 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~-----~~kl~Df 170 (317)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+++++|+||+|+||+++.+ + .++|+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~df 155 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDF 155 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCc
Confidence 999999999999997532 2237889999999999999999999999999999999999986 4 7999999
Q ss_pred Ccccccccccc---cccccCccceecccccccccccccccccccCC-----------------------------CCCCC
Q 021127 171 GLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 218 (317)
|+++....... .....++..|+|||++.+..... ..+.|+.+ .....
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT-QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCccc-chhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence 99875432211 12234567899999876533221 11211111 11123
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+..+|..+.+++.+||+.+|.+||+++++++.|.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4567889999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=246.96 Aligned_cols=221 Identities=26% Similarity=0.395 Sum_probs=173.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
-++|.+.+.||+|+||.||++... ++.+|+|++...... ...+.+|+.+++++ +|||++++++++..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV------DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH------HHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 478999999999999999999884 789999998654321 23467889999998 89999999998853
Q ss_pred --CceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg 173 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFG 173 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecc
Confidence 2589999999999999988642 23348999999999999999999999999999999999999988 689999999
Q ss_pred ccccccccc-ccccccCccceecccccccccc----cccccccccCC---------------------------C---CC
Q 021127 172 LAREESLTE-MMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK---------------------------N---VR 216 (317)
Q Consensus 172 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~---------------------------~---~~ 216 (317)
++....... ......|+..|+|||++..... .....++|+.+ . ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 987543222 2233468899999998754221 12223333322 0 00
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+..++..+.++|.+||+.+|++||++.+++++
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1133456789999999999999999999999886
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=250.14 Aligned_cols=222 Identities=24% Similarity=0.387 Sum_probs=176.4
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||+||++.+. ++.||+|++...... ....++.+|+++++.++||||+++++.+... .+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS----SVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc----hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 4468999999999999999999886 889999998765432 2345688999999999999999999998765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
++||||+++++|.+++...+. +++..+..++.+++.||.|||+ .+++||||+|+||+++.+ +.++|+|||++....
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~ 155 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELI 155 (284)
T ss_pred EEEEecCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchh
Confidence 999999999999999876543 8999999999999999999997 589999999999999988 789999999986442
Q ss_pred cccccccccCccceecccccccccccccccccccCC--------------------------------------C-CCCC
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------N-VRPS 218 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------~-~~~~ 218 (317)
.. ......|+..|+|||++.+..... ..+.|+.+ . ....
T Consensus 156 ~~-~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 156 NS-IADTFVGTSTYMSPERIQGGKYTV-KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred hh-ccCccccCcccCCHHHHccCCCCc-cchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 22 223457899999999875432211 11222111 0 0001
Q ss_pred -CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 -~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...++.++.+|+.+||+.||++||++.+++++.+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1236778999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=243.70 Aligned_cols=217 Identities=24% Similarity=0.386 Sum_probs=162.7
Q ss_pred ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.||+|+||.||+|... ...+++|.+...... .....+.+|+.+++.++||||+++++.+.+. ..++||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS----KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh----HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 36899999999999753 234677776654432 2345789999999999999999999998765 78999999
Q ss_pred cCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 105 LSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
+++|+|.+++..... ...++..++.++.||+.||+|||+++++||||||+||+++.+ +.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhh
Confidence 999999999976432 236777888999999999999999999999999999999988 78999999998642211
Q ss_pred cccccccCccceecccccccccc------cccccccccCC------------------------------C---C-CCCC
Q 021127 180 EMMTAETGTYRWMAPELYSTVTL------RQGEKKHYNHK------------------------------N---V-RPSA 219 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~------------------------------~---~-~~~~ 219 (317)
.......++..|+|||++..... .....++|+.+ . . ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 11233467889999998743110 01112222211 0 0 1113
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
..++..+.+++..|| .+|++||++.++++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 346788999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=248.53 Aligned_cols=220 Identities=25% Similarity=0.354 Sum_probs=170.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|++|.||+|... ++.||||.+....... ....+.+|++++++++|+||+++++++.++ ..++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 68999999999999999999875 7899999987543221 122467899999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. ++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++......
T Consensus 81 v~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPS 157 (291)
T ss_pred EEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCC
Confidence 999996 599998876443 48999999999999999999999999999999999999988 789999999987543221
Q ss_pred -ccccccCccceecccccccccccccccccccCC--------CCCC----------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------------- 217 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------------- 217 (317)
......++..|+|||++.+........++|+.+ ...+
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 112234688999999875432222222222211 0000
Q ss_pred ----------------CCCCCh--HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------SAENVP--EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------~~~~~~--~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++ ..+.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 001233 778899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=242.39 Aligned_cols=221 Identities=27% Similarity=0.454 Sum_probs=179.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||.|++|.||++.+. +..||+|++....... .....+.+|+++++.++|+|++++++.+.++ ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE---KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh---HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 5889999999999999999986 8899999987655432 3345688999999999999999999988654 88999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||+++++|.+++.... ...+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 99999999999998753 3459999999999999999999999999999999999999987 68999999999755433
Q ss_pred c-ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li 230 (317)
. ......|++.|+|||.+....... ..+.|..+ ...+.+..++..+.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNY-KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235 (258)
T ss_pred cceecceeeeecccChhHhccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 2 223346888999999866543222 12222211 11222446789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++||++.+++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHcCCChhhCcCHHHHhcC
Confidence 99999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=247.40 Aligned_cols=215 Identities=24% Similarity=0.303 Sum_probs=163.8
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH---HhcCCCCeeeEEeeeec-CceEEEEEc
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHRNLVKFIGACKE-PVMVIVTEL 104 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~-~~~~lv~e~ 104 (317)
.||+|+||.||++.+. ++.+|+|.+........ .....+.+|..++ ...+|+||+.+++++.. +..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 4899999999999875 78999999876543221 1122234444433 33479999999998865 489999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 184 (317)
+++++|.+++...+. +++..+..++.|++.||+|||+++++||||||+||+++.+ +.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccC
Confidence 999999999876544 9999999999999999999999999999999999999988 799999999987543222 233
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||.+..........+.|+.+ .....+..++.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 234 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL 234 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence 46899999999875422222222333221 011124467889999999999
Q ss_pred hcCCCCCC-----CHHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~l 251 (317)
+.||.+|| ++.++++|.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCc
Confidence 99999999 599998873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=249.10 Aligned_cols=223 Identities=27% Similarity=0.373 Sum_probs=174.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..+.|.+.+.||+|+||.||+|... ++.||+|.+....... ......+.+|+++++.++||||+++++++.++ ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 3467999999999999999999874 8899999987543322 23345688999999999999999999998764 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCC
Confidence 99999995 67877776433 348999999999999999999999999999999999999988 7899999999875432
Q ss_pred ccccccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~ 227 (317)
. ....++..|+|||++.+. .......++|+.+ ........++..+.
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred C---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2 234678899999987431 1122223333322 00011234677899
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+++.+||..+|.+||++.+++.+.+
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChh
Confidence 9999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=249.91 Aligned_cols=221 Identities=24% Similarity=0.280 Sum_probs=173.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|++.+.||.|+||.||+|.+. ++.+|+|.++...... .....+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE---GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc---cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 57999999999999999999986 7889999997654322 223356789999999999999999998753 579
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+. ++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccC
Confidence 99999996 599998876433 48999999999999999999999999999999999999988 7999999999885543
Q ss_pred c-cccccccCccceecccccccccccccccccccCC--------C-----------------------------------
Q 021127 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N----------------------------------- 214 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~----------------------------------- 214 (317)
. .......+++.|+|||++.+........+.|+.+ .
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 2223345788999999876533222222222211 0
Q ss_pred --------------C-CCCCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 --------------V-RPSAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 --------------~-~~~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ...+.. ++..+.++|.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 000111 47889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=248.25 Aligned_cols=219 Identities=26% Similarity=0.407 Sum_probs=174.1
Q ss_pred CCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.+.||+|+||.||++.. ++..||+|.+...... ....+.+|+.+++.++||||+++++.+..+ ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-----KKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-----HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 36899999999999999999976 3788999998644322 234688999999999999999999998654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++.... +++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (293)
T ss_pred EEEecCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccc
Confidence 9999999999999987532 7899999999999999999999999999999999999988 68999999988644322
Q ss_pred c-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......+++.|+|||.+....... ..+.|+.+ .....+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 247 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence 2 223346888999999876533211 22222211 001112345678999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++.+||+.+|.+||++.+++.+-
T Consensus 248 li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 248 FLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred HHHHHccCChhhCcCHHHHhcCH
Confidence 99999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=250.25 Aligned_cols=223 Identities=23% Similarity=0.338 Sum_probs=171.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~ 98 (317)
.++|+..+.||+|+||.||++.+. ++.||+|.+...... .....+.+|+.++.++. |+||+++++++..+ ..
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE----KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh----HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 356778889999999999999885 789999998765433 23456889999999995 99999999987654 78
Q ss_pred EEEEEccCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 99 VIVTELLSGGTLRKYL---LNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+++|||+. ++|.++. .......+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~ 156 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISG 156 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhH
Confidence 99999984 5665543 222334599999999999999999999985 99999999999999987 689999999997
Q ss_pred ccccccccccccCccceeccccccccc--ccccccccccCC----------------------------CCCC-----CC
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK----------------------------NVRP-----SA 219 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~----------------------------~~~~-----~~ 219 (317)
............|+..|+|||++.+.. ......++|+.+ ...+ ..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 544333334446889999999886541 222223333221 0000 11
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..++.++.+|+.+||+.+|++|||+++++++-
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 24778899999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=246.64 Aligned_cols=219 Identities=23% Similarity=0.369 Sum_probs=176.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~l 100 (317)
++|++.+.||+|++|.||++.+. ++.||+|.+...... ....++.+|++++++++||||+++++.+.. ...++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE----AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh----HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 46888999999999999999886 789999998876543 335578899999999999999999998865 48999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHH
Confidence 999999999999998653 348999999999999999999999 999999999999999997 78999999998754332
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------------CCCCCCCC-ChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------NVRPSAEN-VPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~-~~~~ 225 (317)
.. ....++..|+|||.+.+..... ..+.|+.+ .....+.. ++.+
T Consensus 155 ~~-~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 155 LA-KTFVGTSSYMAPERIQGNDYSV-KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred Hh-hcccCChhccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 22 2267889999999876542221 12222211 00011122 6788
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.++|.+||..||.+|||+.+++.+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=242.59 Aligned_cols=214 Identities=26% Similarity=0.341 Sum_probs=172.1
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|++|.||++++. ++.||+|++....... ......+.+|+.+++.++|+||+++++.+.++ ..++||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh--hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999997 8899999998654332 23345789999999999999999999998755 899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt 188 (317)
+|.+++..... +++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.............++
T Consensus 79 ~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCC
Confidence 99999986544 8999999999999999999999999999999999999988 78999999999865443333345688
Q ss_pred cceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHHHHHHhhhcC
Q 021127 189 YRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSIILTSCWKED 237 (317)
Q Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~li~~cl~~~ 237 (317)
..|+|||.+.+..... ..+.|..+ .....+...+.++.++|.+||+.+
T Consensus 156 ~~~~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 156 PEYVAPEIILNKGYDF-SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred cCccChhHhcCCCCCC-hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 9999999875432211 12222211 111223445789999999999999
Q ss_pred CCCCCC-----HHHHHHHH
Q 021127 238 PNARPN-----FTQIIQML 251 (317)
Q Consensus 238 p~~Rps-----~~~~~~~l 251 (317)
|++||+ +.+++++-
T Consensus 235 p~~R~~~~~~~~~~l~~~~ 253 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHK 253 (262)
T ss_pred hhhCcCCcccCHHHHhcCh
Confidence 999999 88888763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=249.04 Aligned_cols=223 Identities=25% Similarity=0.327 Sum_probs=170.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c--
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V-- 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~-- 97 (317)
++|++.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE---GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc---CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 47899999999999999999875 7899999887543221 1223578899999999 469999999988643 2
Q ss_pred ---eEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 98 ---MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 98 ---~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
.++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++|++||||+|+||+++.+.+.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8998886543 23489999999999999999999999999999999999999833799999999
Q ss_pred cccccccc-cccccccCccceecccccccccccccccccccCC--------CCCC-------------------------
Q 021127 172 LAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP------------------------- 217 (317)
Q Consensus 172 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~------------------------- 217 (317)
++...... .......+++.|+|||++.+........++|+.+ ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98754322 1122335688899999875432222223333221 0000
Q ss_pred ----------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.++|.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 013467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=240.31 Aligned_cols=219 Identities=29% Similarity=0.508 Sum_probs=177.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.+.||+|++|.||++.+. ++.|++|.+....... .....+.+|++++.+++|+|++++++++.++ ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH---HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 5889999999999999999875 7889999998765432 3345789999999999999999999988654 88999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc
Confidence 99999999999998754 38999999999999999999999999999999999999987 7999999999986543322
Q ss_pred -cccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 182 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 182 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.....++..|+|||.+.+.. .....+.|..+ .....+..++..+.+++.+
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence 23346788999999875543 12222222211 1122345678999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||..+|++||++.+++.+
T Consensus 234 ~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HHhCChhhCcCHHHHhcC
Confidence 999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=278.32 Aligned_cols=226 Identities=24% Similarity=0.317 Sum_probs=185.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..+.+++|.++++||+|+||.|.+++.+ ++.||+|++.+-..-. ......|.+|-++|..-+.+-|+.++..|+++
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3467789999999999999999999885 7889999988632221 11234688999999999999999999888876
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++|+||||++||+|..++.+.. .++++.+..|+..|+.||.-||+.|+|||||||+||||+.+ |.+||+|||.+-.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClk 224 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLK 224 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHh
Confidence 8999999999999999999876 49999999999999999999999999999999999999999 8999999999875
Q ss_pred ccccc--ccccccCccceeccccccccccc----ccccccccCC-------------------------------CCCCC
Q 021127 176 ESLTE--MMTAETGTYRWMAPELYSTVTLR----QGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~----~~~~~~~~~~-------------------------------~~~~~ 218 (317)
..... .....+|||.|++||++..+... ....+||+.+ ...|.
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 54332 23456899999999998765433 2334566655 11223
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPN---FTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps---~~~~~~~ 250 (317)
...+|++.++||.+.+. +|+.|.+ ++++..|
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 35689999999998775 8888877 9998877
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=251.27 Aligned_cols=217 Identities=27% Similarity=0.392 Sum_probs=171.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|.....||+|+||.||++.+. +..||||.+..... .....+.+|+.+++.++|+||+++++.+..+ ..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-----HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 34555678999999999999874 78999999865332 2345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++... .+++..++.++.||+.||+|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhccccc
Confidence 99999999999988542 38999999999999999999999999999999999999988 78999999998743222
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
.......|+..|+|||.+.+..... ..+.|+.+ ...+....++..+.++
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHH
Confidence 1123346889999999875533221 22222211 0011123467889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||..||.+|||+.+++++
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=241.18 Aligned_cols=219 Identities=26% Similarity=0.397 Sum_probs=178.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
.+|++.+.||+|++|.||++.+. ++.||||.+...... .....+.+|+..+.+++|+||+++++++..+ ..++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 36889999999999999999886 889999998876542 2345688999999999999999999998754 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
||||+++++|.+++..... +++..++.++.|++.||+|||+ ++++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 77 v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENT 153 (264)
T ss_pred EEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccC
Confidence 9999999999999987543 8999999999999999999999 999999999999999998 78999999999865433
Q ss_pred ccc-ccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCC-ChHHH
Q 021127 180 EMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAEN-VPEEL 226 (317)
Q Consensus 180 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~-~~~~l 226 (317)
... ....++..|+|||.+.+..... ..+.|..+ .....+.. ++..+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred CCcccceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 222 2446788999999876542211 12222211 11112333 78899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++.+||..+|.+||++.+++++
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhC
Confidence 999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=243.93 Aligned_cols=226 Identities=25% Similarity=0.422 Sum_probs=175.5
Q ss_pred ceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChH-----HHHHHHHHHHHHHHHHHh-cCCCCeeeEEeeeec
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPE-----EIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~-----~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 95 (317)
+|++.+.||+|+||.||++.+. ++.+|+|.+....... .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788999999999999999885 4789999886432111 112334567788888875 799999999998865
Q ss_pred C-ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+ ..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccc
Confidence 4 899999999999999988542 23458999999999999999999996 689999999999999988 689999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC----------------------------CCCCC-CCCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPS-AENV 222 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~-~~~~ 222 (317)
.+.............|+..|+|||.+.+.... ...+.|+.+ ...+. ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 99865544334455788999999987653321 122222211 11111 2256
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+..+.+++.+||+.||++||++.++..++.
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=252.49 Aligned_cols=220 Identities=26% Similarity=0.326 Sum_probs=172.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
.+|.+.+.||+|+||+||++.+. +..||||.+....... ....++.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR---IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 47999999999999999999875 7899999987543221 2234577899999999999999999987532
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|+||+ +++|.+++..... +++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||+++.
T Consensus 82 ~~~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELM-DTDLHQIIRSSQT--LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCC-CCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 479999999 5799998876543 9999999999999999999999999999999999999988 7899999999985
Q ss_pred cccc-cccccccCccceecccccccccccccccccccCC--------CC-------------------------------
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------- 215 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------- 215 (317)
.... .......++..|+|||.+..........+.|+.+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 5332 2223446788999999875422222223333211 00
Q ss_pred -------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.++|.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00123567889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.81 Aligned_cols=224 Identities=27% Similarity=0.322 Sum_probs=172.4
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---C
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---P 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~ 96 (317)
..++|++.+.||.|+||.||+|.+. ++.||+|.+....... .....+.+|+.++++++|+||+++++++.+ +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 4478999999999999999999885 8899999987543322 112235679999999999999999999854 3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~ 158 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTY 158 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeec
Confidence 5899999995 58988887643 348999999999999999999999999999999999999988 79999999999855
Q ss_pred ccc-cccccccCccceecccccccccccccccccccCC--------C---------------------------------
Q 021127 177 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------- 214 (317)
Q Consensus 177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------- 214 (317)
... .......++..|+|||++.+........+.|+.+ .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 432 1222334578899999876432222222222211 0
Q ss_pred --------CCCC--------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 --------VRPS--------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 --------~~~~--------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.... ....+.++.++|.+||+.||++|||+.+++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 112478889999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=248.53 Aligned_cols=221 Identities=28% Similarity=0.465 Sum_probs=173.2
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc--CCCCeeeEEeeeec--C---
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFIGACKE--P--- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~--~--- 96 (317)
.++++.+.||+|.||.||+|+|.|+.||||++.... +..+.+|.++++.. +|+||+.+++.... +
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 678899999999999999999999999999997654 34578888888774 99999999987632 2
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEeeCCCCceEEc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
.+|||++|.+.|||++||..+. ++.+..++++..++.||++||.. .|.|||||..|||+.++ +++.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence 6999999999999999998743 99999999999999999999963 49999999999999999 799999
Q ss_pred ccCcccccccc-----cccccccCccceeccccccccccc--------------------------------cccccccc
Q 021127 169 DFGLAREESLT-----EMMTAETGTYRWMAPELYSTVTLR--------------------------------QGEKKHYN 211 (317)
Q Consensus 169 Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~--------------------------------~~~~~~~~ 211 (317)
|+|+|...+.. -..+..+||.+|||||++...... +...+++.
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99999754332 123556899999999987541110 00011111
Q ss_pred CC----------------CCCCCCC------CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 212 HK----------------NVRPSAE------NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 212 ~~----------------~~~~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.. ..+|..+ ..-..+..+|+.||..||..|-|+-.+.+.|.++..
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 1122111 112457889999999999999999999888887763
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=245.23 Aligned_cols=220 Identities=24% Similarity=0.354 Sum_probs=168.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|... ++.||+|++....... ....+.+|+.+++.++|+||+++++++.++ ..++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 68999999999999999999875 7899999987554321 122467899999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+. ++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++.....
T Consensus 81 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS 157 (291)
T ss_pred EEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence 999994 78887776533 337888899999999999999999999999999999999988 78999999998753322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCC-----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------------------- 216 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------------------- 216 (317)
.......+++.|+|||++.+........+.|+.+ ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1223345788999999875422111112222211 000
Q ss_pred ----------C-------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------P-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .....+..+.+++.+|++.||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0 001125678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=243.31 Aligned_cols=217 Identities=27% Similarity=0.431 Sum_probs=173.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
-|++.++||+|+||.||+|.+. +..||||.+...... .....+.+|+.++.+++|+||+++++++.++ ..++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 4678889999999999999874 789999998654432 2345688999999999999999999998765 79999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence 9999999999998642 38999999999999999999999999999999999999988 789999999987543322
Q ss_pred ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......++..|+|||.+.+..... ..+.|+.+ ........++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 122346788999999876532221 12222211 0111234567899999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=252.93 Aligned_cols=218 Identities=28% Similarity=0.341 Sum_probs=169.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
++|++.++||+|+||.||+|.+. ++.||||.+...... ....++.+|+.++++++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ----TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc----hhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 68999999999999999999874 789999998643222 2344578899999999999999999886432
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|+||+. ++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceee
Confidence 4799999995 5888877542 38999999999999999999999999999999999999988 7899999999875
Q ss_pred ccccc----ccccccCccceecccccccccccccccccccCC--------CCC---------------------------
Q 021127 176 ESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------------------- 216 (317)
Q Consensus 176 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------------------- 216 (317)
..... ......|+..|+|||++.+........++|+.+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 43221 112346789999999865422222222333221 000
Q ss_pred -----------------C------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -----------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -----------------~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .....+.++.++|.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 012356779999999999999999999999988
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=254.23 Aligned_cols=234 Identities=23% Similarity=0.302 Sum_probs=196.2
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeE--ECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
|+..+.+-+..+.|..-++||+||||.||-+. .+|+-+|+|.+.+..... .+.+...++|-.+|.+++.+.||.+-
T Consensus 174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk--r~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK--RKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH--hhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 44555567888899999999999999999764 468999999887654332 34456778999999999999999998
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..++.. .+++||..|.||+|.-+|.+.+...+++..++.++.+|+-||++||+.+||+|||||+|||+|+. |.+.|+|
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISD 330 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISD 330 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeec
Confidence 777655 89999999999999999999887789999999999999999999999999999999999999998 8999999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC-------------------------------CCCCC
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
+|+|............+||.+|||||++.+.. .....+||+.+ .....
T Consensus 331 LGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 331 LGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred cceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 99999887777777779999999999998877 34444555444 11223
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
++.++++.++|.+..|..||.+|.. ++++.+|
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 5788999999999999999999954 5566655
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=252.49 Aligned_cols=222 Identities=26% Similarity=0.338 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----C
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----P 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 96 (317)
.+|++.+.||.|++|.||+|... ++.||+|++....... .....+.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP---TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc---cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 78999999999999999999875 8899999987643322 223457789999999999999999988742 3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+ +++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLM-ESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehh-hhhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 689999999 4689998875444 8999999999999999999999999999999999999998 79999999998754
Q ss_pred cccc-----ccccccCccceecccccccccccccccccccCCC--------C----------------------------
Q 021127 177 SLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------V---------------------------- 215 (317)
Q Consensus 177 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~---------------------------- 215 (317)
.... ......++..|+|||++..........+.|+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 3221 1123468889999998755332233333333220 0
Q ss_pred -----------------CC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 -----------------RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 -----------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.. .....+.++.++|.+||+.+|.+||++.+++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00 01346788999999999999999999999998844
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=238.06 Aligned_cols=219 Identities=30% Similarity=0.476 Sum_probs=179.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~ 99 (317)
+|.+.+.||+|++|.||+|.+. +..|++|++...... ......+.+|+..+++++|+||+++++.+.+ ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 4788899999999999999986 889999998766543 2345678899999999999999999998865 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|+||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccc
Confidence 9999999999999998765 49999999999999999999999999999999999999997 78999999999865544
Q ss_pred cc---cccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChHHH
Q 021127 180 EM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPEEL 226 (317)
Q Consensus 180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l 226 (317)
.. .....++..|+|||.+.+..... ..+.|.. ......+..++..+
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGR-AADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHH
Confidence 32 34456889999999876543111 1111111 11222355678999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhC
Confidence 999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=245.88 Aligned_cols=224 Identities=26% Similarity=0.381 Sum_probs=175.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|...+.||+|+||.||++++. +..||+|.+....... .+....+.+|+.++++++|+|++++++++.++ ..++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS--NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc--hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 56788999999999999999874 7899999987653322 23345688999999999999999999998755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. |+|.+.+.... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 999996 58877775433 348999999999999999999999999999999999999988 7899999999865432
Q ss_pred ccccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
.....|+..|+|||++... .......++|+.+ ........++..+.++
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 2344688899999987421 1111122222211 1111234567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
+.+||+.+|.+||++.+++++++...
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999877644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=280.71 Aligned_cols=220 Identities=28% Similarity=0.397 Sum_probs=182.2
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
+++-+..||.|.||.||-|.+. |...|+|-+...... .+....+.+|..++..++|||+|+++|+-.. ...+|-
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 4566788999999999999774 888999988765543 3445568899999999999999999999754 478999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc--
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-- 179 (317)
||||++|+|.+.++..+. .++-....+..|++.|++|||+.|||||||||.||+++.+ |.+|++|||.|......
T Consensus 1313 MEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchh
Confidence 999999999999987544 7777778899999999999999999999999999999998 79999999999855433
Q ss_pred ---cccccccCccceeccccccccc--ccccccccccCC-----------------------------CCCCCCCCChHH
Q 021127 180 ---EMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-----------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 225 (317)
.......||+.|||||++.+.. ..-+..++|+.+ ...+.|..++.+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 1234557999999999998744 233445555544 234457778999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
-++|+.+||+.||++|.++.|++++
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHh
Confidence 9999999999999999999999887
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=246.26 Aligned_cols=230 Identities=23% Similarity=0.385 Sum_probs=178.0
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 92 (317)
+..|.++.++|++.+.||+|++|.||+|.+. ++.||||.+....... ....+..|+.++.+. .|+||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE----ENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH----HHHHHHHHHHHHHhccCCCchHhhhee
Confidence 3467788899999999999999999999987 8999999997654332 234566777777666 59999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEccc
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+.+. ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.+ +.+||+||
T Consensus 83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~df 159 (296)
T cd06618 83 FITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDF 159 (296)
T ss_pred eecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECcc
Confidence 8765 899999998 557877776533 358999999999999999999997 599999999999999987 79999999
Q ss_pred CcccccccccccccccCccceecccccccccc---cccccccccCC-------------------------------CCC
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTL---RQGEKKHYNHK-------------------------------NVR 216 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~~-------------------------------~~~ 216 (317)
|++.............++..|+|||.+.+... .....++|+.+ ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC
Confidence 99875543333334457889999998865320 11112222211 011
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+....++.++.+|+.+||..||.+||++.+++++.+
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 112246889999999999999999999999998844
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.88 Aligned_cols=221 Identities=26% Similarity=0.384 Sum_probs=169.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK------- 94 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------- 94 (317)
.+|+.++.||+||||.||+++++ |+.||||.++... .+ +...++.+|+..+++|+|||||+++..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~---~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SD---KLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HH---HHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 35567889999999999999986 9999999998876 22 44567899999999999999999974220
Q ss_pred -------------------------------------------------c------------------------------
Q 021127 95 -------------------------------------------------E------------------------------ 95 (317)
Q Consensus 95 -------------------------------------------------~------------------------------ 95 (317)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 021127 96 ----------------------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 96 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~l 141 (317)
-.+||=||||+...|.++++.+.... .....|+++.+|++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01467789998888888887655321 4677899999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCCCceEEcccCcccccc-------------------cccccccccCccceeccccccccc-
Q 021127 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES-------------------LTEMMTAETGTYRWMAPELYSTVT- 201 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~- 201 (317)
|++|||||||||.|||++.+ +.|||+|||+|+... .....+..+||--|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HhCceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99999999999999999988 789999999997511 011234567999999999998766
Q ss_pred -ccccccccccCC-------------------------CCCCCCC----CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 202 -LRQGEKKHYNHK-------------------------NVRPSAE----NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 202 -~~~~~~~~~~~~-------------------------~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....+.+.|+.+ ...|.+. +--+.-..+|+.|++.||.+|||+.|+++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 344444444433 1111121 112345789999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=248.77 Aligned_cols=225 Identities=30% Similarity=0.422 Sum_probs=176.4
Q ss_pred eecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh--cCCCCeeeEEeeeec--
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKE-- 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~-- 95 (317)
..+-..+++.+++|+|.||.||+|..+++.||||+++... .+.|.+|-++... ++|+||+++++.-..
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~--------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE--------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHH--------HHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 3445678899999999999999999999999999998543 4457788777765 589999999987642
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEeeCCCC
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---------~ivH~Dlkp~Nill~~~~~ 163 (317)
..++||++|.+.|+|.++|..+. ++|....+|+..+++||+|||+. .|+|||||..||||.+| .
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-l 353 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-L 353 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-C
Confidence 37999999999999999998755 99999999999999999999973 69999999999999999 6
Q ss_pred ceEEcccCccccccccc---ccccccCccceeccccccccccccc-----------------------------cccccc
Q 021127 164 TIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQG-----------------------------EKKHYN 211 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-----------------------------~~~~~~ 211 (317)
++.|+|||+|-...... .....+||.+|||||++.+....+. ..+.|.
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999997654332 2233689999999999887433221 111111
Q ss_pred CC---------------------CCCCC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 212 HK---------------------NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 212 ~~---------------------~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.. ..+|. .......+++.+..||..||+.|.|+.=+.+.++++..
T Consensus 434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 10 01111 01123568999999999999999999988888877654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=240.90 Aligned_cols=224 Identities=27% Similarity=0.472 Sum_probs=171.6
Q ss_pred eeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
|.+.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS---SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 567889999999999999753 5889999987654333 2345688999999999999999999987431
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
..+++++|+.+|+|..++.... ...+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECc
Confidence 2478899999999998875322 1247899999999999999999999999999999999999988 6899999
Q ss_pred cCccccccccc---ccccccCccceecccccccccccccccccccCC-----------------------------CCCC
Q 021127 170 FGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRP 217 (317)
Q Consensus 170 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~ 217 (317)
||+++...... ......+++.|++||.+....... ..++|+.+ ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT-HSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK 235 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccch-hhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99988543221 112234567899999765432221 11222211 1112
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=244.36 Aligned_cols=220 Identities=24% Similarity=0.385 Sum_probs=171.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|++|.||+|++. +..||||++....... ....+.+|+.++++++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 5889999999999999999985 8899999987654321 123467899999999999999999998764 78999
Q ss_pred EEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 102 TELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc
Confidence 99997 58999887644 2348999999999999999999999999999999999999988 78999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCC-----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------------------- 216 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------------------- 216 (317)
.......++..|++||++.+........++|..+ ...
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1223345788999999875432222222222211 000
Q ss_pred ----C---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----P---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 012356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=251.21 Aligned_cols=220 Identities=26% Similarity=0.323 Sum_probs=171.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
..++|++.+.||+|+||.||+|.+. ++.||||.+....... ....++.+|+.++++++|+||+++++++..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV---THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh---hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3578999999999999999999874 8899999986543222 223457789999999999999999998742
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCcc
Confidence 24799999994 6888887642 8899999999999999999999999999999999999998 7899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------C------------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------ 214 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------ 214 (317)
++............++..|+|||++.+..... ..++|+.+ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCC-chhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 98655443334456889999999876533221 11222111 0
Q ss_pred ------------C---------------CC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 ------------V---------------RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ------------~---------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
. .+ .....+..++++|.+||+.||.+|||+.+++++-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0 00 0113466789999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=245.62 Aligned_cols=220 Identities=27% Similarity=0.382 Sum_probs=172.3
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||.|++|.||+|.++ +..||+|++....... .....+.+|+++++.++|+|++++++++.++ ..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE---GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc---cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 577889999999999999874 8999999987654322 1223578899999999999999999998765 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||+ +++|.+++.......+++..++.++.|++.||+|||+++++||||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT 155 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence 999 5799999987654458999999999999999999999999999999999999987 799999999997543221 1
Q ss_pred cccccCccceecccccccccccccccccccCC--------C---------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------------- 214 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------------- 214 (317)
.....++..|+|||++.+........+.|+.+ .
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 22335688999999875432222222222211 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000124566889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=264.98 Aligned_cols=238 Identities=30% Similarity=0.545 Sum_probs=194.6
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-C
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (317)
...+..|+++.++..+.+.||+|.||.|++|... ...||||.++..... .....+..|+++++.+ .
T Consensus 285 ~~~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~----~~~~~~~~El~~m~~~g~ 360 (609)
T KOG0200|consen 285 LPEDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS----SEKKDLMSELNVLKELGK 360 (609)
T ss_pred cCcCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc----HHHHHHHHHHHHHHHhcC
Confidence 4455699999999999999999999999998753 356999998876654 2355789999999998 7
Q ss_pred CCCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcC-------C-------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 83 HRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR-------P-------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 83 h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~-------~-------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
|+||+.++|+|.+ +..++|+||+..|+|.++++..+ . ..++..+.+.++.||+.|++||+++++|
T Consensus 361 H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 361 HPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred CcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 9999999999976 58999999999999999999866 0 1288999999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCcccccccccccc--ccc--CccceecccccccccccccccccccCC----------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AET--GTYRWMAPELYSTVTLRQGEKKHYNHK---------- 213 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~--gt~~y~aPE~~~~~~~~~~~~~~~~~~---------- 213 (317)
||||.++|||+..+ ..+||+|||+|+......... ... -...|||||.+....+... .+.|+.+
T Consensus 441 HRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 441 HRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLG 518 (609)
T ss_pred chhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCC
Confidence 99999999999998 699999999998543332222 122 2456999998876333322 2333322
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.....|..++.+++++|..||+.+|++||++.++.+.+...+.
T Consensus 519 ~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 3445677889999999999999999999999999999998654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=237.37 Aligned_cols=218 Identities=30% Similarity=0.512 Sum_probs=176.8
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.+.||+|++|.||++.+. +..+++|++..... .....+.+|++++++++|+||+++++++... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4788899999999999999986 78899999976553 2345688999999999999999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+........
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeecccccccccccc
Confidence 99999999999987753 348999999999999999999999999999999999999987 7899999999986554332
Q ss_pred cccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHH
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.....++..|+|||.+.+... ....+.|..+ ...+....++..+.+++.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence 344568899999998765432 2222333221 001112223788999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.||.+|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=243.92 Aligned_cols=219 Identities=29% Similarity=0.390 Sum_probs=172.2
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv 101 (317)
|++.+.||+|++|.||+|... ++.||||.+....... ......+|+..+++++ |+||+++++++.++ ..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 678899999999999999985 7889999987654321 1223557899999998 99999999988654 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
|||+ +++|.+++.......+++..++.++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 9999 8899999987654458999999999999999999999999999999999999988 7999999999986554333
Q ss_pred cccccCccceecccccccccccccccccccCCCC----------------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV---------------------------------------------- 215 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~---------------------------------------------- 215 (317)
.....++..|+|||++..........+.|+.+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 3445688899999987543322222332221100
Q ss_pred ------C-----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------R-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 0011235789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=246.16 Aligned_cols=226 Identities=24% Similarity=0.294 Sum_probs=170.5
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+.-+-++|++.++||+|+||.||+|... ++.||||.+....... .....+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 3445578999999999999999999885 8899999987543322 1123456899999999999999999987532
Q ss_pred ---------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 97 ---------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 97 ---------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
..++||||+. ++|.+.+.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEE
Confidence 4599999995 58888886543 248999999999999999999999999999999999999988 79999
Q ss_pred cccCcccccccccc-----cccccCccceecccccccccccccccccccCCC--------CC------------------
Q 021127 168 ADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN--------VR------------------ 216 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~--------~~------------------ 216 (317)
+|||++........ .....++..|+|||++.+........+.|+.+. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999975432211 123457788999998754322222223332210 00
Q ss_pred ----------------------CC-----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------------------PS-----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------------------~~-----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+. ....+..+.+||.+||..||.+|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00124567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=248.20 Aligned_cols=218 Identities=26% Similarity=0.369 Sum_probs=172.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|.....||+|+||.||++.+. ++.||+|++...... ....+.+|+.++..++||||+++++.+..+ ..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-----hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 44556668999999999999874 889999998754332 234578899999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+++++|..++... .+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 96 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 96 LMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDV 171 (297)
T ss_pred EEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhccccc
Confidence 99999999999987652 38999999999999999999999999999999999999988 799999999987443221
Q ss_pred -ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......|+..|+|||++.+.... ...+.|+.+ ........++..+.++
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred ccccceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 22335688999999987653322 122222211 0011133567889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+||+.+|.+||++.+++++-
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 251 LERMLTREPQERATAQELLDHP 272 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhCh
Confidence 9999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=242.69 Aligned_cols=217 Identities=25% Similarity=0.332 Sum_probs=167.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec---CceE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE---PVMV 99 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---~~~~ 99 (317)
|++.++||+|+||.||+|.+. ++.||+|.+........ .....+|+.++.++. |+||+++++++.+ +..+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 678899999999999999874 78999999876433221 123457888898885 9999999998864 4789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++||||+|+||+++. +.+||+|||+++.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999995 68888887643 34899999999999999999999999999999999999998 68999999999865433
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CC------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------------ 215 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------------ 215 (317)
.......++..|+|||++..........++|+.+ ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 3333446788999999764322222223333211 00
Q ss_pred ------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.++|.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00012467899999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=241.12 Aligned_cols=214 Identities=23% Similarity=0.316 Sum_probs=164.0
Q ss_pred eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHH---HHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV---AMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
.||+|+||.||++.+. ++.||+|.+........ .....+..|. ..++...||||+++++++.+. ..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999874 78999999876543211 1111233343 344446899999999988764 88999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTA 184 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~ 184 (317)
+.|++|..++.... .+++..+..++.|++.||+|||+++++||||||+||+++.+ +.+||+|||++...... ....
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcC
Confidence 99999999887644 39999999999999999999999999999999999999988 78999999998754322 2234
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||++.+........+.|+.+ .....+..++.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 57899999999986432222333333322 011223456789999999999
Q ss_pred hcCCCCCC-----CHHHHHHH
Q 021127 235 KEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rp-----s~~~~~~~ 250 (317)
..+|.+|| ++.+++++
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhC
Confidence 99999999 99999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=244.04 Aligned_cols=222 Identities=24% Similarity=0.303 Sum_probs=172.3
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.+.||+|+||.||+++. ++..||+|++....... .......+.+|+.++.++ +|+||+++++++..+ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-cchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 488999999999999999886 47889999987543211 112345678899999999 699999999988765 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++..... +++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence 8899999999999999986543 8899999999999999999999999999999999999988 799999999987543
Q ss_pred ccc--ccccccCccceeccccccccc-ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
... ......|+..|+|||.+.... ......+.|+.+ ...+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCC
Confidence 321 222346889999999875421 111112222211 1122344577
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
..+.+++.+||+.||++|| ++.+++.+
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 8899999999999999997 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=246.57 Aligned_cols=223 Identities=24% Similarity=0.293 Sum_probs=171.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
.-++|++.+.||+|+||.||+|.+. ++.||+|.+....... .....+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3468999999999999999999985 7899999987643222 1223567899999999999999999987532
Q ss_pred --------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 97 --------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 97 --------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
..++|+||+++ +|...+... ...+++..++.++.|++.||+|||+.||+|+||+|+||+++.+ +.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeC
Confidence 58999999965 787877654 2348999999999999999999999999999999999999988 789999
Q ss_pred ccCccccccccc--ccccccCccceecccccccccccccccccccCC------------------------------C--
Q 021127 169 DFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------N-- 214 (317)
Q Consensus 169 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~-- 214 (317)
|||++....... ......++..|+|||.+.+........++|+.+ .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999997543322 112234577899999875432222222222211 0
Q ss_pred -------------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 -------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 -------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.+|.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000122468899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=240.52 Aligned_cols=221 Identities=27% Similarity=0.403 Sum_probs=172.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~ 98 (317)
++|...++||.|++|.||++.+. ++.+|+|.+...... ....++.+|++++++++|+||+++++++.+ +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch----HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 46889999999999999999984 789999998865442 234568899999999999999999998853 368
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++||||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~ 155 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGEL 155 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeeccccccc
Confidence 9999999999999987642 23448999999999999999999999999999999999999988 68999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-------------------------------C-CCCC------
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------N-VRPS------ 218 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~-~~~~------ 218 (317)
.... .....++..|+|||.+.+...... .+.|..+ . ..+.
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 3221 123457889999998654322111 1111100 0 0000
Q ss_pred -CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 219 -~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
....++.+.+++.+||+.+|.+|||+.+++++-
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 123467899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=241.91 Aligned_cols=216 Identities=27% Similarity=0.401 Sum_probs=171.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv 101 (317)
.|.-.+.||+|++|.||++.+. ++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.. +..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 4555679999999999999874 78899998864432 224458899999999999999999998865 489999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||+++++|.+++.. . .+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+...... .
T Consensus 95 ~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCc
Confidence 999999999999876 2 38999999999999999999999999999999999999988 79999999988644322 1
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------C---CCCCCCCChHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N---VRPSAENVPEELSIIL 230 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li 230 (317)
......|++.|+|||.+.+.... ...+.|+.+ . ....+..++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence 22334688999999987653322 122222211 0 0111233778999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||+.+|.+||++.+++++
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHcccChhhCcCHHHHccC
Confidence 99999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=247.44 Aligned_cols=171 Identities=25% Similarity=0.349 Sum_probs=137.1
Q ss_pred ceeecceeccccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
+|.+.++||+|+||.||+|.+ .++.||||.+....... ......+.+|+.++.+++||||+++++++.+ ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY--TGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc--cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 488899999999999999988 46899999998743111 1123356789999999999999999999864 36
Q ss_pred eEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC----CCCceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~----~~~~~kl~Df 170 (317)
.++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+++++||||||+||+++. + +.+||+||
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Df 156 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDL 156 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCC
Confidence 899999995 57777765322 225899999999999999999999999999999999999998 6 78999999
Q ss_pred Ccccccccccc----cccccCccceeccccccc
Q 021127 171 GLAREESLTEM----MTAETGTYRWMAPELYST 199 (317)
Q Consensus 171 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~ 199 (317)
|++........ .....++..|+|||++.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhC
Confidence 99885432211 223457889999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=240.97 Aligned_cols=220 Identities=25% Similarity=0.416 Sum_probs=177.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 98 (317)
..+.|++.+.||+|++|.||++.+. +..|++|++..... ....+.+|+++++.++|+||+++++.+.. ...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 3467889999999999999999986 88999999976543 24458899999999999999999998865 489
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTK 168 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhcc
Confidence 99999999999999998755 249999999999999999999999999999999999999987 7899999998864432
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
.. ......++..|+|||++.+.... ...+.|..+ ........++..+.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 21 12334578899999987654332 223333221 00111233788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++.+||+.+|.+||++.+++++
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhC
Confidence 99999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=243.93 Aligned_cols=221 Identities=29% Similarity=0.406 Sum_probs=176.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~ 99 (317)
++|.+.+.||+|++|.||++... ++.||+|++....... ......+.+|+.++++++ |+||+++++++.++ ..+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc--hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 47999999999999999999884 8899999987643222 133456888999999998 99999999988654 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|||++++++|.+++..... +++..++.++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPN 155 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCc
Confidence 99999999999999987543 9999999999999999999999999999999999999988 78999999998754322
Q ss_pred c---------------------ccccccCccceecccccccccccccccccccCC-------------------------
Q 021127 180 E---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------- 213 (317)
Q Consensus 180 ~---------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------- 213 (317)
. ......++..|+|||++....... ..+.|..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 1 112335788999999866533211 12222211
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNF----TQIIQM 250 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~----~~~~~~ 250 (317)
.....+..++..+.+++.+||+.+|.+||++ .+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1123355678899999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=248.98 Aligned_cols=219 Identities=21% Similarity=0.259 Sum_probs=169.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|.+.+.||.|+||.||+|.+. +..||+|.+...... ....+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-----~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-----SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-----hHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 478999999999999999999885 789999998765542 234578899999999999999999876432
Q ss_pred -----------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 97 -----------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 97 -----------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
..++||||+. ++|.+++... .+++..+..++.||+.||.|||+.|++||||||+||+++.+.+.+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 4789999996 6898888642 389999999999999999999999999999999999998654678
Q ss_pred EEcccCccccccccc----ccccccCccceecccccccccccccccccccCC--------CC------------------
Q 021127 166 KLADFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------ 215 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------ 215 (317)
||+|||+++...... ......++..|+|||++..........+.|+.+ ..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997543211 112335788999999764422222223333221 00
Q ss_pred -------------------------C------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -------------------------R------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -------------------------~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .....++.++.+|+.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 0012467789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=257.18 Aligned_cols=222 Identities=28% Similarity=0.427 Sum_probs=182.9
Q ss_pred cCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---- 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 94 (317)
+..-++|.+.||.|.+|.||+++. +++.+|+|++......++ .+..|.++++.. .|||++.++|++.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de------EiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE------EIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH------HHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 335678899999999999998866 489999999887665443 356788899887 7999999999873
Q ss_pred --cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 95 --EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 95 --~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
++.+|+|||||.||+..+++.+.....+.|+.+..|++.++.||.+||.+.++|||||-.|||++.+ +.|||+|||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGv 169 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGV 169 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeee
Confidence 3489999999999999999998888889999999999999999999999999999999999999999 7899999999
Q ss_pred ccccccc-cccccccCccceecccccccccccc----cccccccCC---------------------------CCCC---
Q 021127 173 AREESLT-EMMTAETGTYRWMAPELYSTVTLRQ----GEKKHYNHK---------------------------NVRP--- 217 (317)
Q Consensus 173 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~~~~~---------------------------~~~~--- 217 (317)
+...+.+ ....+..||+.|||||++....... ...+.|+.+ +.+|
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 9866544 3456678999999999987543322 223334433 1111
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+...+.++-++|..||..|-++||++.++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 145667899999999999999999999998876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=237.87 Aligned_cols=220 Identities=25% Similarity=0.402 Sum_probs=176.7
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||.|++|.||++.+. ++.+|+|.+....... ....++.+|+.+++.++|+||+++++++.+. ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ---KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH---HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 5889999999999999999875 7889999987654332 2345678899999999999999999887654 89999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 99999999999987632 2348999999999999999999999999999999999999987 68999999999765443
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
......++..|+|||.+.+..... ..+.|+.+ .....+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSY-KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 333456888999999876543322 22222211 111223456788999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.+|++||++.+++++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 235 SMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHcCCCcccCCCHHHHhcC
Confidence 9999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=245.74 Aligned_cols=167 Identities=19% Similarity=0.320 Sum_probs=134.9
Q ss_pred cceeccc--cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEE
Q 021127 29 GPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 29 ~~~lG~G--~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 103 (317)
...||+| +||+||++.+. ++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE---EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 3456766 99999999884 8999999987654433 2345788899999999999999999999765 7899999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc--
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-- 181 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-- 181 (317)
|+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccc
Confidence 9999999999987655568999999999999999999999999999999999999988 7899999986532211100
Q ss_pred ------cccccCccceeccccccc
Q 021127 182 ------MTAETGTYRWMAPELYST 199 (317)
Q Consensus 182 ------~~~~~gt~~y~aPE~~~~ 199 (317)
.....++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccccccCccCccChhhhcC
Confidence 011234567999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=231.17 Aligned_cols=227 Identities=21% Similarity=0.375 Sum_probs=182.3
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
+++..+.++++.+..||+|..|.||+++.. |...|||.+++....++ .++++..++++... ..|+||+.+|+|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee----~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE----NKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH----HHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 345566777788899999999999999886 68999999998776543 45688888887766 489999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
..+ ..++.||.| +..+..++...+ .++++..+-.+...++.||.||..+ ||+|||+||+|||+|.. |.+|+||||
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFG 237 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFG 237 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeeccc
Confidence 755 788999998 556666666543 4489998999999999999999976 89999999999999998 799999999
Q ss_pred cccccccccccccccCccceeccccccccc--ccccccccccCC-------------------------------CCCCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
++-........+...|.+.|||||-+.... ...-..+.|+.+ ...+.
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc
Confidence 998776666667778999999999876532 122233344433 11122
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++++.+.+|+..||..|+.+||...++++|
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 34589999999999999999999999999987
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=246.52 Aligned_cols=223 Identities=18% Similarity=0.317 Sum_probs=170.4
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
+.+++.+|.|+++.|+++..+++.||||++....... .....+.+|+.+++.++|+||+++++++.+. ..+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK---EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch---hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 4566677777888888887789999999998653222 2345689999999999999999999988754 88999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc----
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---- 180 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---- 180 (317)
+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.+||+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccc
Confidence 999999999987655558999999999999999999999999999999999999987 789999999886432111
Q ss_pred ----ccccccCccceeccccccccc-ccccccccccCC--------C---------------------------------
Q 021127 181 ----MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK--------N--------------------------------- 214 (317)
Q Consensus 181 ----~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~--------~--------------------------------- 214 (317)
......++..|+|||++.... ......+.|+.+ .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 112335678899999875421 111112222111 0
Q ss_pred --------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 --------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 --------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.......++.++.+|+.+||+.||++|||+++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00001123467889999999999999999999998744
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=246.32 Aligned_cols=219 Identities=25% Similarity=0.344 Sum_probs=171.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec--C-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE--P-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~-~ 97 (317)
++|++.+.||+|+||.||+|.+. ++.+|||.+....... .....+.+|+.+++++ +|+||+++++++.. . .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc---hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 67899999999999999999874 7899999886533221 2234577899999999 99999999998753 2 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+. ++|..++... .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 899999996 6999988764 38899999999999999999999999999999999999998 799999999987543
Q ss_pred ccc------ccccccCccceecccccccccccccccccccCC--------CC----------------------------
Q 021127 178 LTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV---------------------------- 215 (317)
Q Consensus 178 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~---------------------------- 215 (317)
... ......|+..|+|||++.+........+.|+.+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 221 222345888999999875533222333333322 00
Q ss_pred ----------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.+++.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00012367889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=245.39 Aligned_cols=219 Identities=24% Similarity=0.308 Sum_probs=166.9
Q ss_pred ceeecceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee---c-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK---E- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---~- 95 (317)
+|.+.+.||+|+||.||++.+. +..||||.+....... .....+.+|+.+++++ .|+||+++++.+. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK---ILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 5889999999999999999885 5589999987543222 2244578899999999 5999999998642 2
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...+++++++ +++|.+++..... +++..++.++.||+.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRSGQP--LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCce
Confidence 2578889988 5799998875443 8999999999999999999999999999999999999988 789999999997
Q ss_pred cccccc-----ccccccCccceecccccccccccccccccccCC--------CC--------------------------
Q 021127 175 EESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------- 215 (317)
Q Consensus 175 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------- 215 (317)
...... ......|+..|+|||++.+........++|+.+ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 543221 122346889999999865422111222222211 00
Q ss_pred ---------------------C---CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ---------------------R---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ---------------------~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......+..+.+++.+||+.||.+|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0012346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=219.77 Aligned_cols=220 Identities=26% Similarity=0.421 Sum_probs=176.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~lv 101 (317)
+|.-.++||+|.+|+||+|++. ++.||+|.++.....+.... ..++|+-+++.+.|+|||+++++.. ++.+-+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvps---salreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcH---HHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 4666789999999999999875 78999999987765543322 4688999999999999999999986 4589999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
+||| ..+|..+...... .++.+.+..++.|+++||.|+|++++.|||+||.|.+|+.+ |.+|++|||+++..... .
T Consensus 80 fe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvr 156 (292)
T KOG0662|consen 80 FEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceE
Confidence 9999 6689998876443 39999999999999999999999999999999999999999 89999999999865543 3
Q ss_pred ccccccCccceecccccccccccccccccccCC-----------------------------------------CCCC--
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------------NVRP-- 217 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~-- 217 (317)
..+..+-|..|.+|.++-+........+.|+.+ ...+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 445667899999999987755554444444332 0000
Q ss_pred -----C---------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 -----S---------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 -----~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .+.+...-++++...|.-+|.+|.+++..+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0 11223446889999999999999999998876
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=263.83 Aligned_cols=226 Identities=19% Similarity=0.251 Sum_probs=160.9
Q ss_pred CceeecceeccccceEEEEeEEC---CeEEEEEEeecCCC------------hHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGET------------PEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
++|++.++||+|+||+||++... +..+++|.+..... ..........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 67999999999999999998653 22222221110000 0001123456889999999999999999
Q ss_pred EEeeeecC-ceEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMR---PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
+++++.+. ..++|++++ +++|..++.... ........+..|+.||+.||+|||++|||||||||+|||++.+ +.
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-GK 305 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CC
Confidence 99999765 789999998 568888775432 1123466778899999999999999999999999999999988 78
Q ss_pred eEEcccCccccccccc--ccccccCccceecccccccccccccccccccCC---------CC------------------
Q 021127 165 IKLADFGLAREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------NV------------------ 215 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~~------------------ 215 (317)
+||+|||+++...... ......||..|+|||++.+..+.. ..++|+.+ ..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE-ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 9999999998554322 223457999999999876533211 11222111 00
Q ss_pred ---------CC--------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 216 ---------RP--------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 216 ---------~~--------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+ ....++..+.+++.+||+.||.+|||+.|++++-+
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 00 01124556778899999999999999999998743
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=248.48 Aligned_cols=219 Identities=27% Similarity=0.328 Sum_probs=175.1
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------ 96 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 96 (317)
+|++.+.||.|++|.||+|.+. ++.||||.+....... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL---IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc---hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5889999999999999999875 7899999987643211 2345688999999999999999999988543
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+. ++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 6899999996 58999887654 49999999999999999999999999999999999999998 79999999999865
Q ss_pred cccc----ccccccCccceecccccccccccccccccccCC--------CCC----------------------------
Q 021127 177 SLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------------- 216 (317)
Q Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------------- 216 (317)
.... ......++..|+|||++.+........+.|+.+ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 4432 233446788999999987653333333333221 000
Q ss_pred ----------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.++|.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0012367889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=240.95 Aligned_cols=223 Identities=24% Similarity=0.382 Sum_probs=169.6
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|.+.++||+|+||.||++.+. +..+++|+++.............++.+|+.++++++||||+++++++.+. ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999876 44566666554222111112233466789999999999999999988654 78999
Q ss_pred EEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeecCCC
Confidence 9999999999988752 22358999999999999999999999999999999999999864 6999999998754322
Q ss_pred -cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li 230 (317)
.......|+..|+|||.+.+..... ..+.|+.+ .....+..++.++.++|
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence 2223446788999999875533221 12222211 11122456788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+||..+|++||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHhcCChhhCcCHHHHhhC
Confidence 99999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=243.67 Aligned_cols=219 Identities=28% Similarity=0.364 Sum_probs=170.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--Cce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--PVM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 98 (317)
.++|++.+.||.|+||.||++.+. ++.||||.+.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP---VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc---chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 467999999999999999999875 7889999886543222 223457789999999999999999998854 378
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++|+||+ +++|.+++... .+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC
Confidence 9999999 67898887642 38888899999999999999999999999999999999987 7899999999875432
Q ss_pred ccccccccCccceecccccccccccccccccccCC--------C------------------------------------
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------------ 214 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------------ 214 (317)
. .....++..|+|||++.+........+.|+.+ .
T Consensus 161 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 Q--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred C--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2 23346788999999875422222222222211 0
Q ss_pred ---------CCC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 ---------VRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ---------~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+ ....++.++.++|.+||+.+|++||++.+++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~ 289 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 000 0134678899999999999999999999998873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=239.93 Aligned_cols=219 Identities=26% Similarity=0.330 Sum_probs=170.2
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---CceEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PVMVI 100 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~l 100 (317)
|++.++||.|++|.||+|.+. ++.+|+|.+....... .....+.+|+.++++++|+|++++++++.+ +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE---GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 678899999999999999886 6899999998764221 223457889999999999999999999864 47999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred Eecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 999996 58998887643 348999999999999999999999999999999999999998 799999999998554332
Q ss_pred --ccccccCccceecccccccccccccccccccCC--------C--------------------------CCC-------
Q 021127 181 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------VRP------- 217 (317)
Q Consensus 181 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------~~~------- 217 (317)
......++..|+|||.+.+........+.|+.+ . ..+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 123345688899999765422222222222211 0 000
Q ss_pred ----------------CCCC-ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------SAEN-VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------~~~~-~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.... ++..+.+++.+||..+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011 37789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=241.14 Aligned_cols=217 Identities=25% Similarity=0.390 Sum_probs=169.5
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|...++||+|+||+||+|++. ++.|++|.+....... ......+.+|+++++.++|+|++++++++.+. ..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT--NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 556778999999999999874 7899999987654322 13345688899999999999999999998765 789999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~ 182 (317)
||+. ++|.+++.... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.... ..
T Consensus 101 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---PA 174 (313)
T ss_pred ecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---CC
Confidence 9995 68888776533 348999999999999999999999999999999999999988 689999999986432 22
Q ss_pred ccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHHHHHH
Q 021127 183 TAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~ 231 (317)
....|+..|+|||++... .......+.|+.+ ........++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 345688999999997431 1111122222211 001112346678999999
Q ss_pred HhhhcCCCCCCCHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~ 250 (317)
+||+.+|.+||++.+++.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 255 YCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=240.78 Aligned_cols=223 Identities=23% Similarity=0.297 Sum_probs=171.9
Q ss_pred ceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
+|++.+.||+|++|.||++.. ++..||||++....... ......++.+|+.++.++ +|+||+++++.+..+ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-hhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478999999999999999875 36789999987543211 123345688999999999 699999999988655 7
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||+++...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence 889999999999999987644 38999999999999999999999999999999999999988 689999999987543
Q ss_pred ccc--ccccccCccceeccccccccc-ccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 178 LTE--MMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
... ......|+..|+|||.+.+.. ......+.|..+ ...+.+..++
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccC
Confidence 221 112345789999999875432 111122222211 1122244577
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+.+++.+||+.||++|||+.++.+.|
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence 8999999999999999999977665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=239.84 Aligned_cols=227 Identities=17% Similarity=0.229 Sum_probs=162.0
Q ss_pred eecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCCeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~ 88 (317)
.+..++|++.++||+|+||.||+|.+.+ ..+|+|+............ .......+...+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3666899999999999999999998753 3567776443332211010 0112233444556679999999
Q ss_pred EEeeeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 89 FIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 89 l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
+++++... ..+++++++ ..++.+.+..... .++..+..++.|++.||+|||+++|+||||||+|||++.+ +
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~ 163 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-N 163 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-C
Confidence 99876432 346788887 4577777665332 6788899999999999999999999999999999999987 6
Q ss_pred ceEEcccCcccccccc--------cccccccCccceecccccccccccccccccccCC----------------------
Q 021127 164 TIKLADFGLAREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------- 213 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------- 213 (317)
.++|+|||+++..... .......||+.|+|||++.+..... ..+.|+.+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~-~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR-RGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 8999999999754211 1122346999999999876543221 12222211
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.........+..+.+++..||..+|++||+++++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00112345678899999999999999999999998865
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=235.18 Aligned_cols=212 Identities=25% Similarity=0.342 Sum_probs=162.3
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH-HhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML-SRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|.+. ++.||||+++...... ......+..|..++ ...+|+|++++++++.++ ..++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA--KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH--HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 57899999999999884 7899999987543221 11222344554444 445899999999999765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 185 (317)
++++|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++.... ....
T Consensus 80 ~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccC
Confidence 99999999986544 8999999999999999999999999999999999999988 7899999999875432 2334
Q ss_pred cCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHHHHHHHhh
Q 021127 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 186 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~~li~~cl 234 (317)
.++..|+|||.+.+.. .....++|..+ . .......++..+.+++.+||
T Consensus 154 ~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 154 VGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 6888999999876643 22223333221 0 00112357899999999999
Q ss_pred hcCCCCCCCH---HHHHHH
Q 021127 235 KEDPNARPNF---TQIIQM 250 (317)
Q Consensus 235 ~~~p~~Rps~---~~~~~~ 250 (317)
+.+|++||++ .|++.+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cCCHHHccCCCcHHHHHcC
Confidence 9999999966 455554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=244.56 Aligned_cols=219 Identities=24% Similarity=0.268 Sum_probs=170.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||.||++.+. ++.||+|++....... .....+.+|+.++++++|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh---HHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 478999999999999999999864 8899999987643222 234457889999999999999999998742
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...+++++++ +++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~ 167 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLA 167 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccc
Confidence 2467888877 88998887643 38999999999999999999999999999999999999998 78999999998
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CCCC----------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------- 217 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------- 217 (317)
..... ......++..|+|||++.+........++|+.+ ...+
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 75432 223446788999999875422222223333221 0000
Q ss_pred ----------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 218 ----------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 218 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.....+.++.++|.+||+.||.+||++.+++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0113467789999999999999999999999883
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=240.81 Aligned_cols=221 Identities=25% Similarity=0.360 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
..|...+.||.|+||.||+|++. +..+|+|.+....... .....++.+|+++++.++|+|++++++++.+. ..++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 46778899999999999999885 7889999987533221 12345688999999999999999999988755 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. |+|.+.+.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||++......
T Consensus 93 v~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc-
Confidence 999995 68888776433 348999999999999999999999999999999999999988 78999999998754322
Q ss_pred ccccccCccceecccccccc--cccccccccccCC---------------------------C--CCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK---------------------------N--VRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~---------------------------~--~~~~~~~~~~~l~~l 229 (317)
....++..|+|||.+.+. .......++|+.+ . .......++..+.+|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 334678899999987431 1112223333322 0 011133577889999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
|.+||+.+|.+||++.+++++.+
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcc
Confidence 99999999999999999998844
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=244.60 Aligned_cols=218 Identities=24% Similarity=0.304 Sum_probs=170.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|++.+.||+|+||.||++.+. +..||||.+....... .....+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 567999999999999999999875 8899999986543222 2344678999999999999999999988532
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~ 165 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLA 165 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccc
Confidence 358999999 7899888764 238999999999999999999999999999999999999988 68999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC--------CC------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------ 215 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------ 215 (317)
...... .....+++.|+|||++.+........+.|+.+ ..
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 754322 23346788999999875422111112222111 00
Q ss_pred --------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 --------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 --------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00013567789999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=238.06 Aligned_cols=213 Identities=30% Similarity=0.406 Sum_probs=166.9
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|+||.||++.+. ++.+|+|++....... ......+.+|++++++++|+||+++++.+..+ ..++||||++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR--KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh--hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999986 8999999987654322 24456788999999999999999999988655 799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--------
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-------- 180 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------- 180 (317)
+|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCccccccccc
Confidence 9999998755 38999999999999999999999999999999999999998 799999999987543221
Q ss_pred -ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCC--ChHHHHHHH
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAEN--VPEELSIIL 230 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~--~~~~l~~li 230 (317)
......++..|+|||....... ....+.|..+ .....+.. ++..+.+++
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred ccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 1223457889999998655331 1122222211 01112222 388999999
Q ss_pred HHhhhcCCCCCCCH---HHHHHH
Q 021127 231 TSCWKEDPNARPNF---TQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps~---~~~~~~ 250 (317)
.+||+.+|.+|||+ .+++++
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcC
Confidence 99999999999999 555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=245.52 Aligned_cols=224 Identities=24% Similarity=0.335 Sum_probs=169.0
Q ss_pred Ccee-ecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHH---------HHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 24 KHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAK---------KESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 24 ~~y~-~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
++|. +.+.||.|+||.||+|.+. ++.||||.+........... ....+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 5678999999999999875 88999999876543221000 0124778999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
++... ..++||||+. ++|.+++..... +++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCc
Confidence 98654 8899999995 699999876443 8999999999999999999999999999999999999988 78999999
Q ss_pred Cccccccc---------------ccccccccCccceecccccccccccccccccccCC--------CC------------
Q 021127 171 GLAREESL---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------ 215 (317)
Q Consensus 171 g~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------ 215 (317)
|++..... ........++..|+|||.+.+........+.|+.+ ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99875431 11112234678899999876532222222222211 00
Q ss_pred -----------------------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 -----------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 -----------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.......+..+.+++.+||+.+|++||++++++.+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 000124577899999999999999999999999873
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=238.61 Aligned_cols=219 Identities=26% Similarity=0.410 Sum_probs=171.2
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
..+||+|+||.||++... ++.||||.+..... .....+.+|+.+++.++|+||+++++.+..+ ..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 457999999999999874 78999998764332 2345688999999999999999999988754 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-cccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 184 (317)
++++|.+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence 999999987543 28999999999999999999999999999999999999988 789999999987543221 1233
Q ss_pred ccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHHHHHhh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSIILTSCW 234 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl 234 (317)
..|+..|+|||.+.+..... ..+.|+.+ ........++..+.+++.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 46788999999876533221 12222211 011123356788999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 235 KEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 235 ~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
+.+|.+||++.+++++ .++....
T Consensus 255 ~~~P~~R~~~~~ll~~--~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKH--PFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcC--hHHhccC
Confidence 9999999999999987 4444433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.81 Aligned_cols=222 Identities=25% Similarity=0.326 Sum_probs=172.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.|.+ .++|++.+.||+|++|.||+|++. ++.||||++....... .....+.+|+.++++++|+|++++++++..
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA---IHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh---hHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 3444 467999999999999999999885 7899999986543222 233457789999999999999999987643
Q ss_pred C-------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 96 ~-------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. ..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~ 160 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKIL 160 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEc
Confidence 2 389999999 7799998875 238999999999999999999999999999999999999988 789999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC--------CCCC-----------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP----------------------- 217 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~----------------------- 217 (317)
|||++...... .....++..|+|||++.+........++|+.+ ...+
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99999865332 23446788999999865422222222222211 0000
Q ss_pred ---------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++..+.+++.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 012357889999999999999999999999887
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=241.12 Aligned_cols=222 Identities=23% Similarity=0.293 Sum_probs=167.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
-++|++.++||+|++|.||+|.+. ++.||||.+......+. ....+.+|++++++++|+||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 378999999999999999999885 78899999876543221 12246789999999999999999987632
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
..+++||||+. ++|...+.... ..+++..+..++.|+++||+|||++|++|+||||+||+++.+ +.++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCc
Confidence 24799999995 57877776533 349999999999999999999999999999999999999998 799999999
Q ss_pred cccccccccc------------cccccCccceecccccccccccccccccccCC--------CCC---------------
Q 021127 172 LAREESLTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------- 216 (317)
Q Consensus 172 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------- 216 (317)
++........ .....+++.|+|||++.+........++|+.+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9974332111 12234678899999875432222223333221 000
Q ss_pred -----------------C-----------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -----------------P-----------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -----------------~-----------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ ....++..+.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0 002334678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=235.70 Aligned_cols=219 Identities=29% Similarity=0.387 Sum_probs=168.8
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecC-c--
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEP-V-- 97 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-~-- 97 (317)
|++.+.||+|+||.||+|++. ++.||+|.+....... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE---GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc---hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678899999999999999985 7899999997554322 1123456677777665 699999999998653 3
Q ss_pred ---eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 98 ---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 98 ---~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
.+++|||+. ++|.+++.......+++..++.++.|++.||+|||+.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcce
Confidence 899999996 589998877554458999999999999999999999999999999999999998 799999999997
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC--------CCC------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------ 216 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------ 216 (317)
............++..|+|||++.+..... ..++|+.+ ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCC-cchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 654443333445788999999876533221 12222211 000
Q ss_pred --------C--------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 --------P--------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 --------~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ....++..+.+++.+||+.||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 011345778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=237.42 Aligned_cols=219 Identities=27% Similarity=0.351 Sum_probs=171.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||+|++|.||++... ++.+++|.+....... .....+.+|+.++++++|+||+++++++..+ ..++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE---GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc---hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 567889999999999999875 8889999987654432 2345688899999999999999999988654 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCccc
Confidence 9996 58988887643 348999999999999999999999999999999999999988 689999999987554332 2
Q ss_pred cccccCccceecccccccccccccccccccCC--------CC--------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------------------- 215 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------------------- 215 (317)
.....++..|+|||.+.+........+.|..+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 23345788999999876542222222222211 00
Q ss_pred -----------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.++|.+||+.||.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00012467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=230.67 Aligned_cols=213 Identities=31% Similarity=0.372 Sum_probs=170.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
||.|+||.||++.+. ++.+|+|++....... ......+..|+.++++++|+||+++++.+..+ ..++||||++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK--RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc--hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 699999999999885 7899999988765432 12355688999999999999999999988755 799999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cccccccC
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETG 187 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~g 187 (317)
+|.+++..... +++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcC
Confidence 99999986543 8999999999999999999999999999999999999988 78999999999765432 22344568
Q ss_pred ccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
+..|+|||.+.+..... ..+.|..+ .....+..++..+.+++.+||..||++
T Consensus 156 ~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 234 (250)
T cd05123 156 TPEYLAPEVLLGKGYGK-AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK 234 (250)
T ss_pred CccccChHHhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence 88999999875533211 12222111 112335566899999999999999999
Q ss_pred CCCH---HHHHHH
Q 021127 241 RPNF---TQIIQM 250 (317)
Q Consensus 241 Rps~---~~~~~~ 250 (317)
||++ .+++++
T Consensus 235 R~~~~~~~~l~~~ 247 (250)
T cd05123 235 RLGSGGAEEIKAH 247 (250)
T ss_pred CCCcccHHHHHhC
Confidence 9999 666554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=232.47 Aligned_cols=211 Identities=22% Similarity=0.262 Sum_probs=162.1
Q ss_pred Cceeeccee--ccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRI--GEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~l--G~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
++|.+.+.+ |+|+||.||++... +..+|+|.+....... .|+.....+ +|+||+++++++... .
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 355666665 99999999999875 7889999987543221 122222222 799999999998654 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.+.+.++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999999998754 499999999999999999999999999999999999999883389999999987554
Q ss_pred cccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l 226 (317)
.. ....++..|+|||++.+..... ..++|+.+ ...+.+..++..+
T Consensus 162 ~~---~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP---SCYDGTLDYFSPEKIKGHNYDV-SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC---ccCCCCCcccChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 22 2346889999999986543321 22222211 0112234578999
Q ss_pred HHHHHHhhhcCCCCCCC-HHHHHHH
Q 021127 227 SIILTSCWKEDPNARPN-FTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps-~~~~~~~ 250 (317)
.++|.+||+.+|.+||+ +++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999996 6999876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=242.33 Aligned_cols=222 Identities=25% Similarity=0.320 Sum_probs=170.2
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.+. .+|.+.+.||+|+||.||+|.+. ++.||||.+....... .....+.+|+.+++.++|+||+++++++.
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE---IFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc---cchhHHHHHHHHHHhcCCCCccchhheec
Confidence 356663 58999999999999999999874 8899999987643222 22345788999999999999999999875
Q ss_pred cC-------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 95 EP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 95 ~~-------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
.. .+++|+||+. .+|..++. ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL 158 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKI 158 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEE
Confidence 32 4689999995 57776552 238999999999999999999999999999999999999988 79999
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC--------CC------------------------
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------ 215 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------ 215 (317)
+|||+++..... .....++..|+|||++.+........++|+.+ ..
T Consensus 159 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 159 LDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred eeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999998754322 23346788999999875522222222222211 00
Q ss_pred ------------------C--CC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------------------R--PS------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------------------~--~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. +. ....+..+.+||.+||+.||.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00 12456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=253.85 Aligned_cols=227 Identities=23% Similarity=0.429 Sum_probs=185.5
Q ss_pred ceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
.....++||+|+||+||+|.+- .-+||||++....... ....+++|+-++.+++|||+++|+|+|..+..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~----~s~e~LdeAl~masldHpnl~RLLgvc~~s~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK----ASIELLDEALRMASLDHPNLLRLLGVCMLSTL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch----hhHHHHHHHHHHhcCCCchHHHHhhhcccchH
Confidence 4556789999999999999873 4679999998766543 34468999999999999999999999999889
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
.||++|++.|+|.++++..+.. +-....+.|..||++||.|||.+++|||||..+|||+..- +.+||+|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence 9999999999999999986544 8899999999999999999999999999999999999987 6899999999997654
Q ss_pred cccc---ccccCccceeccccccccccccccccc----------------------------ccCCCCCCCCCCChHHHH
Q 021127 179 TEMM---TAETGTYRWMAPELYSTVTLRQGEKKH----------------------------YNHKNVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~l~ 227 (317)
.... ....-.+.|||=|.+....+....+.| ...+...+.|+.++.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 4322 222235688998876654333322221 112244566888999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+|.+||..|++.||+++++...+..+.+.
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999988877653
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=237.00 Aligned_cols=225 Identities=22% Similarity=0.313 Sum_probs=178.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH--HHHHHHHHHHHHHHHhcCCCCeeeEEeeee--cCc
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGACK--EPV 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~ 97 (317)
++|-++.+||+|||+.||+|.+- .+.||||+-.......+. ....+...+|.++++.|.||.||++|+++. ...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 78999999999999999999774 789999987665544321 122345678999999999999999999984 347
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEeeCC--CCceEEcccCcc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--GIIHRDLKPENLLLTED--LKTIKLADFGLA 173 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 173 (317)
++-|+|||+|.+|+-+|..++- ++++.+..|+.||+.||.||.+. .|||-||||.|||+... .|.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 9999999999999999988765 99999999999999999999987 69999999999999643 357999999999
Q ss_pred ccccccc--------ccccccCccceecccccccc---cccccccccccCC-----------------------------
Q 021127 174 REESLTE--------MMTAETGTYRWMAPELYSTV---TLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 174 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~~----------------------------- 213 (317)
+..+... .++...||.+|++||.|.-. +......++|+.+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9654332 23456799999999986532 1122333444433
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...|.-+.++.+.++||++||++--++|....++...
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1123345678899999999999999999988887543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=235.97 Aligned_cols=219 Identities=26% Similarity=0.363 Sum_probs=171.0
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
|++.+.||+|++|.||+|... ++.||+|++....... .....+..|+.++++++|+|++++++++.+. ..++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE---GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc---cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 567889999999999999886 7899999998754222 2234577899999999999999999988764 899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-c
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-M 181 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-~ 181 (317)
||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||++....... .
T Consensus 78 e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccc
Confidence 9996 69999998753 239999999999999999999999999999999999999998 789999999997543322 2
Q ss_pred cccccCccceecccccccccccccccccccCC--------C---------------------------------------
Q 021127 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------------------- 214 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------------------- 214 (317)
.....++..|+|||.+.+........+.|..+ .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 22345677899999875542222222222211 0
Q ss_pred ---------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ---------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.......++..+.+++.+||+.||++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000012346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=240.00 Aligned_cols=224 Identities=22% Similarity=0.326 Sum_probs=174.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.++..-|..++.||-|+||.|.+++.. ...+|+|.+++...-. ..+...+..|.+||..-..+-||+||..|++.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~--rnQvaHVKAERDILAEADn~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM--RNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 702 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh--hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC
Confidence 467788889999999999999998654 6789999998765433 23455677899999999999999999999876
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+|+||+|++||++..+|...+- |.+..+..++..+..|+++.|..|+|||||||+|||||.+ |.+||+|||++...
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGF 779 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeeccccccc
Confidence 89999999999999999987665 8999999999999999999999999999999999999999 89999999998521
Q ss_pred ccc---------c----------------------------------ccccccCccceecccccccccccccccccccCC
Q 021127 177 SLT---------E----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213 (317)
Q Consensus 177 ~~~---------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 213 (317)
... . .....+||+.|+|||++....+.+.. +||..+
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c-dwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC-DWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc-hhhHhh
Confidence 000 0 00122599999999998764443322 222222
Q ss_pred -------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q 021127 214 -------------------------------NVRPSAENVPEELSIILTSCWKEDPNARP---NFTQIIQM 250 (317)
Q Consensus 214 -------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp---s~~~~~~~ 250 (317)
...+...+++.+..++|.+++. +++.|. .++++-.|
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAH 928 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcC
Confidence 2234456788999999876443 666664 45556555
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=246.25 Aligned_cols=226 Identities=23% Similarity=0.311 Sum_probs=191.7
Q ss_pred ecCCceeecceeccccceEEEEeEECCeE--EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+.-++++.+.-||-||||+|=+.+.+++. +|+|++++...-+ .++.+.+..|-++|..++.|.||++|..|.++ .
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd--tkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD--TKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc--hhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 44567788888999999999999887555 8999998877655 35667788999999999999999999999876 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|++||-|-||.|...|++++. ++..+...++..+++|++|||++|||+|||||+|.+++.+ |-+||.|||+|+...
T Consensus 495 vYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhc
Confidence 9999999999999999998765 9999999999999999999999999999999999999998 899999999999998
Q ss_pred cccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~ 228 (317)
....+.++|||+.|+|||++.+..-+... ++|..+ .....|..++....+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~av-DyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAV-DYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD 650 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhh-HHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence 88888999999999999998763322221 111111 223346678889999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPN-----FTQIIQMLL 252 (317)
Q Consensus 229 li~~cl~~~p~~Rps-----~~~~~~~l~ 252 (317)
||+++...+|.+|.. +.+|..|-|
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 999999999999965 788888865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-33 Score=226.07 Aligned_cols=227 Identities=23% Similarity=0.323 Sum_probs=183.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee-
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC- 93 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~- 93 (317)
.|.+...+++-+..||.|+||+|++..++ |+..|||.++..... +..++++.|.+...+- +.||||++||.+
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~----keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE----KEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch----HHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 57788888888999999999999998886 899999999877663 3455788888877665 899999999975
Q ss_pred ecCceEEEEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLL---NMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
.++..||.||+| ..+|..+.. .-.+..+++.-+-.|....+.||.||-.. .|||||+||+|||++.. |.+||||
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCD 211 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCD 211 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeec
Confidence 677999999999 678776543 23344599998889999999999999975 89999999999999998 7999999
Q ss_pred cCcccccccccccccccCccceecccccccccc-cccccccccCC----------------------------CCCC---
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK----------------------------NVRP--- 217 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~----------------------------~~~~--- 217 (317)
||++-.....-..+...|...|||||-+....- ..-..+.|+.+ ...|
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 999987766656677789999999998875433 33334444443 0011
Q ss_pred ---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ---SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..-.++..+..+|..||.+|-..||...++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 123478899999999999999999999999876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-34 Score=229.23 Aligned_cols=231 Identities=24% Similarity=0.309 Sum_probs=176.6
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
...+.++.+.|+-..++|+|.||.||+|+.. ++.||+|.+--..... ..-..-++|+++|..+.|+|++.++..|
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 3457788889999999999999999999775 7888888654321111 1112357899999999999999999887
Q ss_pred ec---------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 94 KE---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 94 ~~---------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
.. ..+|+||++| ..+|.-.|.+.. ..++..++..++.++..||.|+|...|+|||+||.|+||+.+ +.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gi 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GI 162 (376)
T ss_pred hhccCCcccccceeeeeHHHh-hhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ce
Confidence 31 2589999999 468888887653 349999999999999999999999999999999999999999 79
Q ss_pred eEEcccCccccccccc-----ccccccCccceecccccccccccccccccccCC--------------------------
Q 021127 165 IKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
+||+|||+++..+... ..+..+-|+.|.+||.+.+........+.|..+
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999997543221 234456699999999887754443333333322
Q ss_pred -----------------------CCCCCC-------------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -----------------------NVRPSA-------------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -----------------------~~~~~~-------------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...|.+ -.-.++..+|+..++..||.+|++++++++|-+
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 001111 111347889999999999999999999999844
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=228.53 Aligned_cols=177 Identities=24% Similarity=0.303 Sum_probs=140.8
Q ss_pred CceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--E 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~ 95 (317)
..|++...||+|.+|.||+|..+ ...+|||.++....... ......+|+.+++.++||||+.|..++. +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 57889999999999999999543 23689999886643221 1223678999999999999999999885 4
Q ss_pred CceEEEEEccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLAD 169 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~D 169 (317)
..+++++||.+ -+|.+.|+-. +.+.++...+..|++||+.|+.|||++=|+||||||.|||+..+ .|.|||+|
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 58999999995 5898888643 22459999999999999999999999999999999999999865 36899999
Q ss_pred cCccccccccc----ccccccCccceecccccccccccc
Q 021127 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ 204 (317)
Q Consensus 170 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ 204 (317)
||+++...+.- .....+-|..|.|||++.+..-..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT 218 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYT 218 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccccccc
Confidence 99998654331 123345799999999887744333
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=226.59 Aligned_cols=217 Identities=26% Similarity=0.388 Sum_probs=170.4
Q ss_pred cceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEc
Q 021127 29 GPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
.+.||+|+++.|--+.. ++..+|||++.+... ..+.++.+|++++.+. .|+||+.|+++|++. .+|+|||-
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 56799999999988765 589999999987743 3467899999999998 699999999999876 89999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccccccc---
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~~~--- 179 (317)
+.||+|..+|.+++- +++..+.++.++|+.||.|||.+||.||||||+|||-..- -.-+|||||.+.......
T Consensus 158 m~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999997655 9999999999999999999999999999999999998643 235899999998642211
Q ss_pred -----cccccccCccceeccccccc----ccccccccc--------------------------cccCCC----------
Q 021127 180 -----EMMTAETGTYRWMAPELYST----VTLRQGEKK--------------------------HYNHKN---------- 214 (317)
Q Consensus 180 -----~~~~~~~gt~~y~aPE~~~~----~~~~~~~~~--------------------------~~~~~~---------- 214 (317)
....+.+|+..|||||+..- ..+....-+ -|+.+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 12234578889999997432 111111111 122110
Q ss_pred ----------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 ----------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.......++.+.++++..+|..++.+|.++.+++++.|
T Consensus 316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 11123457889999999999999999999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=223.46 Aligned_cols=194 Identities=22% Similarity=0.243 Sum_probs=151.7
Q ss_pred ccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHH
Q 021127 35 GAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLR 111 (317)
Q Consensus 35 G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 111 (317)
|.+|.||++.+. ++.||+|.+..... +.+|...+....||||+++++++.+. ..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 889999999885 88999999876432 23344555556799999999998765 899999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccce
Q 021127 112 KYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191 (317)
Q Consensus 112 ~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 191 (317)
+++..... +++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+...... .....++..|
T Consensus 74 ~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 74 SHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccc
Confidence 99976543 8999999999999999999999999999999999999988 68999999987654322 2233557789
Q ss_pred ecccccccccccccccccccCC-----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCH
Q 021127 192 MAPELYSTVTLRQGEKKHYNHK-----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNF 244 (317)
Q Consensus 192 ~aPE~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~ 244 (317)
+|||.+....... ..+.|+.+ .....+..++..+++++.+||+.||.+||++
T Consensus 149 ~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 149 CAPEVGGISEETE-ACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cCCcccCCCCCCc-hhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 9999875433221 22222211 0111245678899999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=248.52 Aligned_cols=171 Identities=23% Similarity=0.300 Sum_probs=121.0
Q ss_pred eeecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.....++|++.++||+|+||.||+|++. +..||||.+....... .+..+ .+....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-------~~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-------IWMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-------HHHHH--HHHhhchhhHHHHHHh
Confidence 3456689999999999999999999874 5789999876433211 01111 1122222222222211
Q ss_pred -------eecCceEEEEEccCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 93 -------CKEPVMVIVTELLSGGTLRKYLLNMRPR------------------CLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 93 -------~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
..+...++|+||+.+++|.+++...... ......+..++.|++.||+|||+++|+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 1234799999999999999998753210 012344667999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCcccccccc--cccccccCccceecccccc
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT--EMMTAETGTYRWMAPELYS 198 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~ 198 (317)
||||||+|||++.+.+.+||+|||+++..... .......+++.|+|||.+.
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 99999999999975468999999999754322 2234567899999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=260.96 Aligned_cols=213 Identities=24% Similarity=0.349 Sum_probs=162.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.+...+.||+|+||.||+|.+. +..||||.+...... ...|++.+++++|||||+++|++.+. ..++|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3556678999999999999874 889999998654321 12468889999999999999999765 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH---SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|||+++|+|.++++. +++..+..|+.|++.||+||| +.+|+||||||+||+++.+ ...++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc
Confidence 999999999999963 899999999999999999999 6699999999999999987 466664 665543211
Q ss_pred ccccccccCccceecccccccccccccccccccCC--------CCC------------------------------CC--
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------PS-- 218 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------~~-- 218 (317)
.....+++.|+|||++.+..+.. ..++|+.+ ... +.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~-~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITE-KSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCc-ccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 12336789999999876543322 22333221 000 00
Q ss_pred -----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 -----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 -----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
......++.+++.+||+.||++||++.++++.|++..+.
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 001123567899999999999999999999999887653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=243.70 Aligned_cols=213 Identities=24% Similarity=0.378 Sum_probs=160.2
Q ss_pred ecceeccccceE-EEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEc
Q 021127 28 VGPRIGEGAHAK-VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 28 ~~~~lG~G~~g~-V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
-.+.+|.|+.|+ ||+|...++.||||.+-... .....+|+..|+.- +|||||++++.-.+. ..||..|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~--------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF--------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCCceehHHHHhhHh--------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 356689999985 89999999999999875432 23467899999887 799999999988765 89999999
Q ss_pred cCCCCHHHHHHhcC-C-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---C-CCceEEcccCccccccc
Q 021127 105 LSGGTLRKYLLNMR-P-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---D-LKTIKLADFGLAREESL 178 (317)
Q Consensus 105 ~~~g~L~~~l~~~~-~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~-~~~~kl~Dfg~a~~~~~ 178 (317)
| ..+|.+++.... . ........+..+.|+++||++||+.+||||||||.||||.. + ..+++|+|||+++....
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 569999998741 1 11122445778999999999999999999999999999986 2 24789999999996543
Q ss_pred c----cccccccCccceecccccccccccccccccccCC---------CCCCCC--------------------CCChHH
Q 021127 179 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------NVRPSA--------------------ENVPEE 225 (317)
Q Consensus 179 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------~~~~~~--------------------~~~~~~ 225 (317)
. .......||.+|+|||++....... ..++++.+ ...|.. .....+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e 742 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE 742 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence 3 2234557999999999987644333 22222211 000000 000117
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+||.+|++++|..||++.+++.|
T Consensus 743 A~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 743 AKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHHhcCCCcccCCCHHHHhCC
Confidence 8999999999999999999999887
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=239.15 Aligned_cols=215 Identities=25% Similarity=0.337 Sum_probs=174.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 98 (317)
..+|.+...+|.|+|+.|-.+.+. ++..++|++.+.... -.+|+.++... +||||+++.+++.++ +.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~---------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD---------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc---------cccccchhhhhcCCCcceeecceecCCcee
Confidence 467888888999999999998775 888999999877332 24577666555 899999999999877 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee-CCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a~~~~ 177 (317)
|+|||.+.|+-|.+.+..... +. ..+..|+.+|+.|+.|||++|+|||||||+|||++ .. ++++|+|||.++...
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~-g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSA-GHLRLTYFGFWSELE 467 (612)
T ss_pred eeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCC-CcEEEEEechhhhCc
Confidence 999999999999998876543 33 77778999999999999999999999999999995 55 789999999998765
Q ss_pred cccccccccCccceecccccccccccccccccccCC--------------------------CCCCCCCCChHHHHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.. ..+.+-|..|.|||++....+ ....++|+.+ ...+....+|.+.++|+.
T Consensus 468 ~~--~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQ 544 (612)
T ss_pred hh--hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHH
Confidence 44 344577899999999884333 3344455544 111112678999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+||+.||.+||++.++..+-|.
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999998554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=212.20 Aligned_cols=216 Identities=20% Similarity=0.360 Sum_probs=174.9
Q ss_pred cCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC--
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-- 96 (317)
..++|++.+++|+|.++.||.|.. +++.++||+++.- ..+++.+|+.+|..|. ||||++|+++..++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 457899999999999999999985 5889999999743 3446889999999996 99999999998764
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
...+|+||..+.+....... ++...+..++.+++.||.|+|+.||.|||+||.|++|+.....++|+|+|+|-+
T Consensus 108 ktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred cCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 67899999999887776654 888889999999999999999999999999999999997767899999999987
Q ss_pred cccccccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.-.....+..+.+..|--||++.......-..+.|+.+
T Consensus 183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 66655556667788899999866533333222222222
Q ss_pred ---------------C--------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------------N--------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------------~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ......-++++..+|+.++|..|-.+|+|+.|++.|
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 000112246889999999999999999999999887
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=235.11 Aligned_cols=230 Identities=20% Similarity=0.206 Sum_probs=162.3
Q ss_pred ecCCceeecceeccccceEEEEeEE------------------CCeEEEEEEeecCCChHHH---------HHHHHHHHH
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY------------------KNQTVAIKIVHKGETPEEI---------AKKESRFAR 73 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~------------------~~~~vaiK~~~~~~~~~~~---------~~~~~~~~~ 73 (317)
+..++|.+.++||+|+||.||+|.. .++.||||.+......... ....+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3578999999999999999999864 2467999998654321100 001122345
Q ss_pred HHHHHHhcCCCCe-----eeEEeeee---------cCceEEEEEccCCCCHHHHHHhcCC--------------------
Q 021127 74 EVAMLSRVQHRNL-----VKFIGACK---------EPVMVIVTELLSGGTLRKYLLNMRP-------------------- 119 (317)
Q Consensus 74 E~~~l~~l~h~ni-----v~l~~~~~---------~~~~~lv~e~~~~g~L~~~l~~~~~-------------------- 119 (317)
|+.++.+++|.++ ++++++|. ++..++||||+++++|.+++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777788876654 66677653 3468999999999999999874211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc--cccCccceeccc
Q 021127 120 --RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT--AETGTYRWMAPE 195 (317)
Q Consensus 120 --~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE 195 (317)
..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.+||+|||++.......... ...+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 124677888999999999999999999999999999999988 689999999997543322222 223578999999
Q ss_pred cccccccc---------------------ccccccccCC-----------------------------------------
Q 021127 196 LYSTVTLR---------------------QGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 196 ~~~~~~~~---------------------~~~~~~~~~~----------------------------------------- 213 (317)
++...... ....+.|+.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 87532110 0011222221
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCC---CCCCCHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDP---NARPNFTQIIQML 251 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p---~~Rps~~~~~~~l 251 (317)
.........+...++|+.+||..+| .+|+|+.|+++|-
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0001123456789999999999766 6899999999883
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=229.85 Aligned_cols=218 Identities=24% Similarity=0.307 Sum_probs=176.6
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
.|...+|.++.+||+|+||.|-+|..+ ++.+|||++++...-.+ ...+--+.|-++|+.. +-|.++++..+++.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd--DDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD--DDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec--CcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 577788999999999999999999876 67899999987543221 1122234567777655 678899999888764
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+|+||||+.||+|.-++++.+. +.+..+..++..|+-||-+||++|||+||||.+|||++.+ |.+||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccc
Confidence 89999999999999999998776 9999999999999999999999999999999999999999 8999999999985
Q ss_pred c-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
. .....+.+.+||+.|+|||++....+... .+||..+ .....|..++.+..
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv 578 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAV 578 (683)
T ss_pred cccCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHH
Confidence 3 23344567899999999999876555433 3444433 11234677889999
Q ss_pred HHHHHhhhcCCCCCCC
Q 021127 228 IILTSCWKEDPNARPN 243 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps 243 (317)
.+....|...|.+|..
T Consensus 579 ~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHhhcCCccccC
Confidence 9999999999999943
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=221.72 Aligned_cols=220 Identities=27% Similarity=0.360 Sum_probs=174.7
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC------c
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP------V 97 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 97 (317)
++-.+.||.|+||.||-.++. |+.||+|.+..-... ....+++.+|+.+|..++|.||+..++..+-. +
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~---L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN---LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH---HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344577999999999998885 899999988643322 23456799999999999999999999887532 4
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|+|++ ..+|.+.+-. ++.++.+.+.-+++||++||+|||+.+|.||||||.|.|+++| ..+||||||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccc
Confidence 67888988 5688887764 3449999999999999999999999999999999999999999 689999999999654
Q ss_pred cc--cccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 178 LT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
.. ..++..+-|.+|.|||++.+..-.++..++|+.+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 33 3345556789999999999887777777777765
Q ss_pred -------CCCCC------------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------NVRPS------------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------~~~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+. +..-..+...++..++..||++|.+..+.+.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00011 1222345677888899999999999999887743
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=219.01 Aligned_cols=172 Identities=24% Similarity=0.295 Sum_probs=141.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-C-----CeeeEEeeee
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R-----NLVKFIGACK 94 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~-----niv~l~~~~~ 94 (317)
..+|++.+.+|+|.||.|-.+.+. +..||||+++.- .+.++.-+-|+++++++.+ . -+|.+.+||+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 579999999999999999998775 788999998643 2344456679999999932 1 3567777775
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC------------
Q 021127 95 -EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED------------ 161 (317)
Q Consensus 95 -~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~------------ 161 (317)
.++.+||+|.+ |-++.+++.++.-.+++..++..|++|++++++|||+.+++|.||||+||++.+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 56999999999 7799999999887889999999999999999999999999999999999998432
Q ss_pred -------CCceEEcccCcccccccccccccccCccceeccccccccccc
Q 021127 162 -------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 162 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
...++|+|||.|...... .+..+.|..|.|||++.+..+.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS 287 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWS 287 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcC
Confidence 125899999999865432 3566789999999998774443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=240.24 Aligned_cols=221 Identities=25% Similarity=0.380 Sum_probs=177.2
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-cCce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-EPVM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 98 (317)
+..+|++..++|+|.+|.||++++. ++..|+|+++.....+ ..-+.+|+-+++..+|+|||.++|.+. ....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence 4479999999999999999999986 8999999998766544 233678999999999999999999875 4589
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|++||||.||+|.+..+..+. +++.++...++..+.||+|||++|-+|||||-.||+++.. |.+|+.|||.+-....
T Consensus 88 wicMEycgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITA 164 (829)
T ss_pred EEEEEecCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhh
Confidence 999999999999997776555 9999999999999999999999999999999999999988 7999999999875543
Q ss_pred c-cccccccCccceecccccccc--cccccccccccCC--------------------------------CCCCCCCCCh
Q 021127 179 T-EMMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK--------------------------------NVRPSAENVP 223 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~--------------------------------~~~~~~~~~~ 223 (317)
. .....+.||++|||||+-.-. .-.....++|..+ .........+
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws 244 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS 244 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence 3 233567899999999974210 0011111122211 1111234567
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+.+|++.||-.+|++||+++.+++|
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheec
Confidence 889999999999999999999988764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=218.66 Aligned_cols=220 Identities=24% Similarity=0.309 Sum_probs=177.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 93 (317)
..|-+.-.+|.++++||+|+|.+|.+++.. .+.+|+|++++....++ +...-+..|-.+..+. +||.+|-+..+|
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd--edidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc--ccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 467788899999999999999999998875 78999999987654432 2233355566666555 899999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.. .+++|.||++||+|.-+++.+++ ++++.+..+...|+.||.|||++|||+||||.+|+|++.. |.+||+|+|+
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygm 397 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGM 397 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-Cceeecccch
Confidence 754 89999999999999988887665 9999999999999999999999999999999999999998 7999999999
Q ss_pred ccc-cccccccccccCccceecccccccccccccccccccCC-----------------------------------CCC
Q 021127 173 ARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------NVR 216 (317)
Q Consensus 173 a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------~~~ 216 (317)
++. ......+++.|||+.|+|||++.+..+.-.. +||..+ .-.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsv-dwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV-DWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCcee-hHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 984 3556677889999999999999885543222 222211 111
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCC
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARP 242 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rp 242 (317)
..|..++.....+++..|++||.+|.
T Consensus 477 riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhc
Confidence 22455666778899999999999994
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=209.94 Aligned_cols=207 Identities=32% Similarity=0.471 Sum_probs=166.9
Q ss_pred cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCCCHHH
Q 021127 36 AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRK 112 (317)
Q Consensus 36 ~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~ 112 (317)
+||.||+|.+. ++.+|+|++........ ...+.+|+..+++++|+||+++++.+.. ...++++|++++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999986 68999999886654321 4568899999999999999999999875 48999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCcccee
Q 021127 113 YLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM 192 (317)
Q Consensus 113 ~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~ 192 (317)
++..... +++..++.++.+++.+|.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|+
T Consensus 77 ~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCC
Confidence 9987554 8999999999999999999999999999999999999998 799999999998665544445567889999
Q ss_pred cccccccccccccccccccCC-----------------------------CCCCCCC--CChHHHHHHHHHhhhcCCCCC
Q 021127 193 APELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAE--NVPEELSIILTSCWKEDPNAR 241 (317)
Q Consensus 193 aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~--~~~~~l~~li~~cl~~~p~~R 241 (317)
+||.+....... ..+.|..+ ....... .++.++.+++.+||..+|.+|
T Consensus 154 ~pE~~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 154 APEVLLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 999876433222 22222211 0000111 178899999999999999999
Q ss_pred CCHHHHHHH
Q 021127 242 PNFTQIIQM 250 (317)
Q Consensus 242 ps~~~~~~~ 250 (317)
|++.+++++
T Consensus 233 p~~~~~~~~ 241 (244)
T smart00220 233 LTAEEALQH 241 (244)
T ss_pred cCHHHHhhC
Confidence 999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=237.44 Aligned_cols=169 Identities=30% Similarity=0.431 Sum_probs=144.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.++||.|+||.||+|.+. ++.||||++....... ......+..|+.++..++|+||+++++++... ..++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC--HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 68999999999999999999987 8999999997654322 23345688999999999999999999988654 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+++|.+++...+. +++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus 82 VmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~~~~~~~ 158 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSKVTLNRE 158 (669)
T ss_pred EEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCccccCCc
Confidence 9999999999999976543 8999999999999999999999999999999999999988 799999999998643322
Q ss_pred -ccccccCccceeccccc
Q 021127 181 -MMTAETGTYRWMAPELY 197 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~ 197 (317)
......+|+.|++||..
T Consensus 159 ~~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 159 LNMMDILTTPSMAKPKND 176 (669)
T ss_pred ccccccccCccccCcccc
Confidence 23345789999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=203.06 Aligned_cols=209 Identities=32% Similarity=0.519 Sum_probs=169.3
Q ss_pred eccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCC
Q 021127 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g 108 (317)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.+.|++|+++++++.. ...++++|++.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999997 8999999998765432 24568899999999999999999999876 4899999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCccccccccc-cccccc
Q 021127 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLTE-MMTAET 186 (317)
Q Consensus 109 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 186 (317)
+|.+++.... ..+++..++.++.+++.+|++||++|++|+||+|.||+++. + +.++|+|||.+....... ......
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhccc
Confidence 9999998652 23899999999999999999999999999999999999998 6 689999999997554332 123345
Q ss_pred CccceecccccccccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 187 GTYRWMAPELYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 187 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+...|++||.+..........+.|..+...... ..+.+++..|++.+|.+||++.+++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 788999999987642333334444332111111 789999999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=195.36 Aligned_cols=181 Identities=25% Similarity=0.374 Sum_probs=149.2
Q ss_pred CCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 92 (317)
++.++++.+.+.-+..||+|++|.|-+.++ +|...|+|.+....... ..++.+.|+++..+. ..|.+|.+||.
T Consensus 38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q----~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ----EQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH----HHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 344778888888899999999998866655 59999999998766533 345678899987765 89999999996
Q ss_pred e-ecCceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEc
Q 021127 93 C-KEPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 93 ~-~~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. .+...||.||.| ..+|..+..+. ....+++..+-+|+..+++||.|||++ .+||||+||+||||+.+ |++|||
T Consensus 114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiC 191 (282)
T KOG0984|consen 114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKIC 191 (282)
T ss_pred hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEc
Confidence 5 566899999999 67998877642 334589999999999999999999987 89999999999999999 899999
Q ss_pred ccCcccccccccccccccCccceecccccccccc
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 202 (317)
|||++-...+.-..+...|+..|||||.+.....
T Consensus 192 DFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n 225 (282)
T KOG0984|consen 192 DFGISGYLVDSIAKTMDAGCKPYMAPERINPELN 225 (282)
T ss_pred ccccceeehhhhHHHHhcCCCccCChhhcCcccC
Confidence 9999987655544455689999999999876443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=208.75 Aligned_cols=222 Identities=27% Similarity=0.349 Sum_probs=175.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK- 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~- 94 (317)
.....+.+|.-++.+|.|.- .|.-+-+. +++||+|.+....... ..-++-.+|..++..++|+||++++.++.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~---~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ---THAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC---ccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 56677789999999999998 66666664 8999999876542221 12234678999999999999999999883
Q ss_pred ------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 95 ------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 95 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
....|+|||+| ..+|.+.+.. . ++-+++..|+.|++.|++|||+.||+||||||+||++..+ +.+||.
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~--e--lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~ 160 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVILM--E--LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKIL 160 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHHH--h--cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeec
Confidence 12689999999 6799998872 1 7889999999999999999999999999999999999998 799999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
|||+|+.....-..+..+.|..|.|||++.+..+.. ..++|+.+
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke-~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccCCcc-cchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 999999766655667778999999999988766332 22333322
Q ss_pred -------------------------CCCC---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -------------------------NVRP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -------------------------~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+ ....-+..+++++.+||..||++|.+++++++|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 011223568999999999999999999999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=215.53 Aligned_cols=167 Identities=20% Similarity=0.181 Sum_probs=127.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee-EEeeeec
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK-FIGACKE 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~ 95 (317)
..-.++|.+.+.||+|+||+||+|.+. ++.||||++...............+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 345578999999999999999999873 677899987643210001123456899999999999999985 4432
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEeeCCCCceEEcccCccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl-kp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+..++||||++|++|.. +. . .. ...++.+++.+|.|||++||+|||| ||+|||++.+ +.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccce
Confidence 45899999999999963 21 1 11 1467899999999999999999999 9999999877 689999999998
Q ss_pred cccccc---------ccccccCccceeccccccc
Q 021127 175 EESLTE---------MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 175 ~~~~~~---------~~~~~~gt~~y~aPE~~~~ 199 (317)
...... ......+++.|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 543221 1124467888999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=222.88 Aligned_cols=196 Identities=23% Similarity=0.285 Sum_probs=158.9
Q ss_pred cCCceeecCC---ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH---HHHHHHHHHHHHHHHhcC---C
Q 021127 15 LDAKWLIDPK---HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQ---H 83 (317)
Q Consensus 15 ~~~~~~i~~~---~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~---h 83 (317)
-+..|+..++ +|...+.||.|+||.|++|.++ ...|+||.+.+...-.+. .+..-.+--||.+|..++ |
T Consensus 549 ~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH 628 (772)
T KOG1152|consen 549 GNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSH 628 (772)
T ss_pred ccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCc
Confidence 3445555554 4789999999999999999987 567999998765432110 011122345999999997 9
Q ss_pred CCeeeEEeeeecC-ceEEEEEcc-CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 84 RNLVKFIGACKEP-VMVIVTELL-SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
+||++++++|+++ .+||+||-- +|-+|.++|.-.. .+++..+..|++||+.|+++||+.||||||||-+|+.++.+
T Consensus 629 ~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 629 ENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN 706 (772)
T ss_pred cchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecC
Confidence 9999999999876 788888865 4568899997543 39999999999999999999999999999999999999999
Q ss_pred CCceEEcccCcccccccccccccccCccceecccccccccccccccccccCCC
Q 021127 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN 214 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~ 214 (317)
|.+||+|||.+....+. ....++||..|.|||++.+..+.....++|..+.
T Consensus 707 -g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgi 757 (772)
T KOG1152|consen 707 -GFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGI 757 (772)
T ss_pred -CeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhh
Confidence 89999999999765544 3356789999999999999998888888887663
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=217.21 Aligned_cols=191 Identities=23% Similarity=0.283 Sum_probs=153.4
Q ss_pred cccccceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--
Q 021127 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-- 82 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-- 82 (317)
|...+.+.-....++-.++|.+....|+|-|++|.+|.+. ++.||||+++....-. +.=+.|+++|++|+
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~------KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH------KTGLKELEILKKLNDA 488 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh------hhhhHHHHHHHHhhcc
Confidence 3334444445555667789999999999999999999986 8899999998764321 22467999999994
Q ss_pred ----CCCeeeEEeeee-cCceEEEEEccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q 021127 83 ----HRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENL 156 (317)
Q Consensus 83 ----h~niv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Ni 156 (317)
--|+++|+..|. .++++||+|.+ ..+|.+.|.+.+.. .|....+..|+.|+..||..|-..||+|.||||+||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNI 567 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccce
Confidence 357888887775 56999999999 78999999987643 588899999999999999999999999999999999
Q ss_pred EeeCCCCceEEcccCcccccccccccccccCccceeccccccccccccc
Q 021127 157 LLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205 (317)
Q Consensus 157 ll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 205 (317)
|+++..+.+||||||.|........+ ...-+..|.|||++.+..+.-+
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~ 615 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYP 615 (752)
T ss_pred EeccCcceeeeccCcccccccccccc-HHHHHHhccCcceeecCcccCC
Confidence 99988789999999999876544432 2344668999999888655443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=210.00 Aligned_cols=141 Identities=30% Similarity=0.493 Sum_probs=126.6
Q ss_pred cCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
-.+.|.++++||.|.|++||++.+ +++.||+|.+.....+. ++.+|+++|..+ -+.||+++.+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-------ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-------RILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-------HHHHHHHHHHHhccchhhhcchhhhcc
Confidence 346788999999999999999865 36789999998877655 588999999998 69999999999875
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ...+|+||++.....+++.. ++...+..+++.++.||+++|.+|||||||||+|++.+...+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 4 89999999999999998876 78899999999999999999999999999999999999887889999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=207.72 Aligned_cols=145 Identities=25% Similarity=0.335 Sum_probs=121.4
Q ss_pred cccccceecCCceeecC-CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-
Q 021127 7 FYLADELKLDAKWLIDP-KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ- 82 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~-~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 82 (317)
.|...-++.+....... ++|.+.++||=|-|++||++.++ .+.||+|+.+.... ..+.-+.||.+|++++
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh------YtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH------YTEAALDEIKLLQQVRE 133 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH------HHHHHHHHHHHHHHHHh
Confidence 34444556666666555 89999999999999999999987 78999999875432 2334678999999883
Q ss_pred -------CCCeeeEEeeee-----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 021127 83 -------HRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHR 149 (317)
Q Consensus 83 -------h~niv~l~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~ 149 (317)
-.+||+|++.|. ..++++|+|++ |.+|..+|....-+.++...+.+|++||+.||.|||.+ ||||.
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 357999999985 23899999999 89999999887666799999999999999999999986 99999
Q ss_pred CCCCCcEEe
Q 021127 150 DLKPENLLL 158 (317)
Q Consensus 150 Dlkp~Nill 158 (317)
||||+|||+
T Consensus 213 DlKPENvLl 221 (590)
T KOG1290|consen 213 DLKPENVLL 221 (590)
T ss_pred CCCcceeee
Confidence 999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-25 Score=183.26 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=183.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
...|-+-+|.++++||.|+||.++.|++ ++++||||.-+...... ++..|.+..+.| ..++|..+|.+-.
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-------QLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-------QLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcc-------hHHHHHHHHHHHcCCCCCCceeeecc
Confidence 3457778999999999999999999987 49999999877665433 366788888887 5799999987777
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC----CCCceEEcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE----DLKTIKLAD 169 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~----~~~~~kl~D 169 (317)
++ +..||||++ |.+|.++..-.+ +.|+.++++.++.|++.-++|+|++.+|.|||||+|+||.. +.+.+.|+|
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 76 788999999 899999776544 44999999999999999999999999999999999999963 334689999
Q ss_pred cCccccccccccc--------ccccCccceeccccccccc----------------ccccccccccCC------------
Q 021127 170 FGLAREESLTEMM--------TAETGTYRWMAPELYSTVT----------------LRQGEKKHYNHK------------ 213 (317)
Q Consensus 170 fg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~----------------~~~~~~~~~~~~------------ 213 (317)
||+|+........ ....||..||+--...+.. +..+..+|....
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 9999865433322 3346999999987544421 122222222211
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 263 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~ 263 (317)
.....+.++|.++...++..-..+-.+-|..+-+...+.+++........
T Consensus 253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D 308 (449)
T KOG1165|consen 253 ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD 308 (449)
T ss_pred cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence 11112567899999999999999999999999999999998886654443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=184.88 Aligned_cols=216 Identities=22% Similarity=0.308 Sum_probs=160.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeee-ec-Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC-KE-PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-~~-~~~ 98 (317)
+.|.+.+.||+|.||.+-++++. ...+|+|.++.... ..++|.+|...--.| .|.||+.-|++- +. +.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t------t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT------TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh------hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 57889999999999999999997 67899999987653 345688888765555 699999988764 33 378
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee-CCCCceEEcccCcccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLADFGLAREES 177 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~-~~~~~~kl~Dfg~a~~~~ 177 (317)
++++||++.|+|..-+...+ +-+.....++.|+++||.|||++++||||||.+||||- .|..++||||||+....+
T Consensus 98 vF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 89999999999998886643 88888899999999999999999999999999999984 555689999999997654
Q ss_pred cccccccccCccceecccccccccc----cccccccccCC--------------------------------CCCC---C
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK--------------------------------NVRP---S 218 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~--------------------------------~~~~---~ 218 (317)
..-. ..-.+..|.+||+...... .....+.|..+ .... .
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 3211 1224667999997654211 11112222222 0111 1
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
-..+++.+..+.++-|..+|++|-.+.++.++
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 23456778888999999999999555555443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=196.05 Aligned_cols=234 Identities=22% Similarity=0.383 Sum_probs=187.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..+.+.++++..++.+|.||+||+|.+. .+.|-+|.++...++- +...++.|--++..+.|||+..+.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i----Qv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI----QVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH----HHHHHHHHHHHHhcCcCCCccceeE
Confidence 4567788999999999999999999653 3557788887766643 4567889999999999999999999
Q ss_pred eeecC--ceEEEEEccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 92 ACKEP--VMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 92 ~~~~~--~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
++.+. ..++++.++.-|+|..||... ..+.++..+...++.|++.|++|||+.|+||.||..+|++|++. -
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-L 433 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-L 433 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-e
Confidence 98543 788999999999999999832 23457888899999999999999999999999999999999998 5
Q ss_pred ceEEcccCccccccccccc---ccccCccceeccccccccccccccccccc----------------------------C
Q 021127 164 TIKLADFGLAREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYN----------------------------H 212 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~----------------------------~ 212 (317)
++||+|=.+++..-..+.. ........||+||.+....+.+..+.|.. .
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 8999999999865433221 22234678999999877655554433211 1
Q ss_pred CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.....|-++|+++..+|..||...|++||+++|+...|.++-.+
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 233445789999999999999999999999999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-25 Score=175.35 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=179.1
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 96 (317)
+|..++|.++++||+|+||.+|.|..- |..||||+-....... .+..|..+.+.|++ ..|+.+..+..+.
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-------qL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-------QLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-------chhHHHHHHHHhccCCCCchhhhhcccc
Confidence 567789999999999999999999874 8999999977655433 36778888888864 6677777666655
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLA 173 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a 173 (317)
...+||+++ |.+|.+++.- -.+.++..+++-++-|++.-++|+|.+++|||||||+|+|+.-+ .+.+.++|||+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred ccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 788999999 8899887653 23449999999999999999999999999999999999998633 247899999999
Q ss_pred cccccccc--------cccccCccceeccccccccc----------------ccccccccccCC----------------
Q 021127 174 REESLTEM--------MTAETGTYRWMAPELYSTVT----------------LRQGEKKHYNHK---------------- 213 (317)
Q Consensus 174 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~----------------~~~~~~~~~~~~---------------- 213 (317)
+....... .....||..|.+--...+.. +..+..+|....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 85432211 12346899998876544321 222222222211
Q ss_pred --CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCCCC
Q 021127 214 --NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMI 265 (317)
Q Consensus 214 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~~~ 265 (317)
.....+.++|.++...+..|-..--++-|...-+.+.+.-++...+-.....
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~i 295 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYI 295 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeE
Confidence 1112267889999999999999999999999998888888877666554443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=181.62 Aligned_cols=143 Identities=20% Similarity=0.177 Sum_probs=108.1
Q ss_pred cceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHH---------------------HHHHHHHHHHHHHHhcCCCCe
Q 021127 29 GPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIA---------------------KKESRFAREVAMLSRVQHRNL 86 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~ni 86 (317)
...||+|+||.||+|.+. |+.||||+++......... -.......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999875 8999999998653211000 001223459999999987776
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEeeCCCCce
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~l-H~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
........ ...++||||++|+++....... ..++...+..++.|++.+|.++ |+.||+||||||+||+++. +.+
T Consensus 82 ~~p~~~~~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~v 156 (190)
T cd05147 82 PCPEPILL-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GKL 156 (190)
T ss_pred CCCcEEEe-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--CcE
Confidence 43322222 2348999999888776554332 2489999999999999999999 6999999999999999985 579
Q ss_pred EEcccCccccc
Q 021127 166 KLADFGLAREE 176 (317)
Q Consensus 166 kl~Dfg~a~~~ 176 (317)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=174.51 Aligned_cols=145 Identities=20% Similarity=0.157 Sum_probs=110.5
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCChH---------------------HHHHHHHHHHHHHHHHHhcCCCC
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE---------------------EIAKKESRFAREVAMLSRVQHRN 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~---------------------~~~~~~~~~~~E~~~l~~l~h~n 85 (317)
+...||+|++|.||+|.+. |+.||||+++...... ........+..|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 3568999999999999875 9999999998753210 00011223457899999999988
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCc
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~ 164 (317)
+.....+... ..++||||++|+++........ .++...+..++.|++.+|.++|+ +||+||||||+||+++ + +.
T Consensus 81 i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~ 155 (190)
T cd05145 81 VPVPEPILLK-KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GK 155 (190)
T ss_pred CCCceEEEec-CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CC
Confidence 7443333222 3489999998886544322222 37888999999999999999999 9999999999999999 5 68
Q ss_pred eEEcccCcccccc
Q 021127 165 IKLADFGLAREES 177 (317)
Q Consensus 165 ~kl~Dfg~a~~~~ 177 (317)
++|+|||+++...
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=176.85 Aligned_cols=167 Identities=40% Similarity=0.598 Sum_probs=142.0
Q ss_pred eeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~ 102 (317)
|.+.+.||+|++|.||++... ++.+|+|.+...... .....+.+|++.+++++|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 567889999999999999886 589999999876543 235578899999999999999999998875 4899999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
|++++++|.+++...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.+ +.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 999999999999865432 7899999999999999999999999999999999999988 689999999998654332
Q ss_pred ccccccCccceecccccc
Q 021127 181 MMTAETGTYRWMAPELYS 198 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~ 198 (317)
......++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred cccceeccCCcCCHhHhc
Confidence 233456788899999874
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-23 Score=181.12 Aligned_cols=228 Identities=25% Similarity=0.339 Sum_probs=170.5
Q ss_pred ceeecceeccccceEEEEeEECC---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC----CCCeeeEEeeee-c-
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ----HRNLVKFIGACK-E- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~~-~- 95 (317)
+|.+.++||+|+||.||.+.+.. ..+|+|+......... ..+..|+.++..+. ..++..+++... .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999863 4799998876533221 13566888888876 368899998883 4
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC----CceEEcccC
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----KTIKLADFG 171 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~----~~~kl~Dfg 171 (317)
...++||+.+ |.+|.++......+.++..+++.++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4789999998 99999988766656799999999999999999999999999999999999998542 369999999
Q ss_pred ccc--cccccc--------c-cccccCccceecccccccccccccc----------------cccccCCC----------
Q 021127 172 LAR--EESLTE--------M-MTAETGTYRWMAPELYSTVTLRQGE----------------KKHYNHKN---------- 214 (317)
Q Consensus 172 ~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~----------------~~~~~~~~---------- 214 (317)
+++ ...... . .....||..|+++.+..+....... .+|-....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 1 1234599999999976553322211 11111110
Q ss_pred ----CCC-CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 215 ----VRP-SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 215 ----~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
... .....+.++..+...+-..+...+|....+...+.......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 000 12335678888888888899999999999999988877654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=165.54 Aligned_cols=134 Identities=17% Similarity=0.250 Sum_probs=103.6
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEeeeecC----c-e
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-----QHRNLVKFIGACKEP----V-M 98 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~----~-~ 98 (317)
.+.||+|+||.||....++.. +||++...... ....+.+|+.+++.+ .||||++++|++.++ . +
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~-----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG-----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc-----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 467999999999973333444 79988764332 234689999999999 679999999999765 3 3
Q ss_pred EEEEEc--cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCcEEeeCC---CCceEEcccCc
Q 021127 99 VIVTEL--LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM-ECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGL 172 (317)
Q Consensus 99 ~lv~e~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L-~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~ 172 (317)
.+|+|| +.+++|.+++.+. . +++. ..++.+++.++ +|||+++|+||||||+|||++.. ...++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-R--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-c--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 378999 5579999999753 2 6665 35678888888 99999999999999999999742 13799999544
Q ss_pred c
Q 021127 173 A 173 (317)
Q Consensus 173 a 173 (317)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=208.04 Aligned_cols=170 Identities=18% Similarity=0.241 Sum_probs=119.0
Q ss_pred hcCC-CCeeeEEeeee--------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 021127 80 RVQH-RNLVKFIGACK--------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRD 150 (317)
Q Consensus 80 ~l~h-~niv~l~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~D 150 (317)
.++| +||.++++++. ...+++++|++ +++|.++|... ...+++..++.++.||+.||+|||++||+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 57778888761 23567788887 77999999753 23499999999999999999999999999999
Q ss_pred CCCCcEEeeCC------------------CCceEEcccCcccccccc-----------------cccccccCccceeccc
Q 021127 151 LKPENLLLTED------------------LKTIKLADFGLAREESLT-----------------EMMTAETGTYRWMAPE 195 (317)
Q Consensus 151 lkp~Nill~~~------------------~~~~kl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPE 195 (317)
|||+||||+.. .+.+||+|||+++..... .......||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999532 145677777777532110 0011235788999999
Q ss_pred ccccccccccccccccCCC--------C------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 196 LYSTVTLRQGEKKHYNHKN--------V------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~--------~------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
++.+..+. ...++|+.+- . .+..........+++.+||+.+|.+||++.++++
T Consensus 186 ~~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 186 EDNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 98765542 3344444330 0 0000111335678899999999999999999988
Q ss_pred HHH
Q 021127 250 MLL 252 (317)
Q Consensus 250 ~l~ 252 (317)
+.+
T Consensus 265 h~~ 267 (793)
T PLN00181 265 SEF 267 (793)
T ss_pred chh
Confidence 643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-22 Score=164.75 Aligned_cols=142 Identities=14% Similarity=0.164 Sum_probs=116.7
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHH------HHHHHHHHHhcCCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESR------FAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
+-.++|.+.+.||.|+||.||++..++..+|||++.......+ ....+ +.+|+..+.+++|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~--~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTE--RFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchH--HHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4468999999999999999999877788999999986654432 22233 578999999999999999988754
Q ss_pred c---------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 95 E---------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 95 ~---------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
. +..++||||++|.+|.++.. +++. ...+++.+|..||+.|++|||++|+||+++.+ + +
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i 173 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-L 173 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-E
Confidence 2 25789999999999988732 3332 45699999999999999999999999999987 6 9
Q ss_pred EEcccCccccc
Q 021127 166 KLADFGLAREE 176 (317)
Q Consensus 166 kl~Dfg~a~~~ 176 (317)
+|+|||..+..
T Consensus 174 ~liDfg~~~~~ 184 (232)
T PRK10359 174 RIIDLSGKRCT 184 (232)
T ss_pred EEEECCCcccc
Confidence 99999988644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-23 Score=195.56 Aligned_cols=220 Identities=24% Similarity=0.284 Sum_probs=163.4
Q ss_pred eecceeccccceEEEEeEEC--CeEEEEEEeecCC-ChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEE
Q 021127 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVT 102 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 102 (317)
....++|.|++|.|+..... ...++.|.+.... ..+........+..|+-+-..+.|+|++..+..+.+. ..+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678899999977766543 3334444333110 1111112222377788888889999998877766543 333449
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
|||++ +|..++..... ++...+-.++.|++.|++|||+.||.|||+|++|++++.+ +.+||+|||.+......
T Consensus 401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcch
Confidence 99999 99999987533 8899999999999999999999999999999999999998 79999999998743222
Q ss_pred --cccccccCccceecccccccccccccccccccCCCC------------------------------------CCCCCC
Q 021127 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNV------------------------------------RPSAEN 221 (317)
Q Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~ 221 (317)
......+|+..|+|||++.+..++....+.|+.+.. ......
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 233556799999999999988777776666665400 000123
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+|..-+.+|.++|+.||.+|.|+++|++-
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhC
Confidence 56778999999999999999999999876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=168.09 Aligned_cols=146 Identities=23% Similarity=0.230 Sum_probs=112.6
Q ss_pred ceeecceeccccceEEEEeE-E--CCeEEEEEEeecCCChH-------------------HHHHHHHHHHHHHHHHHhcC
Q 021127 25 HLFVGPRIGEGAHAKVYEGK-Y--KNQTVAIKIVHKGETPE-------------------EIAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~-~--~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~ 82 (317)
-|.+.+.||+|++|.||+|. + +|+.||||+++...... ........+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57899999999999999998 3 48999999998643210 00112234678999999996
Q ss_pred C--CCeeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCcEEee
Q 021127 83 H--RNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG-IIHRDLKPENLLLT 159 (317)
Q Consensus 83 h--~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~-ivH~Dlkp~Nill~ 159 (317)
+ ..+++++++ ...++||||++|++|........ .+....+..++.|++.+|++||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe---cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 5 334555543 34589999999988876553322 2666677899999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccc
Q 021127 160 EDLKTIKLADFGLAREES 177 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~ 177 (317)
+ +.++|+|||.+....
T Consensus 184 -~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -D-GKVVIIDVSQSVELD 199 (237)
T ss_pred -C-CCEEEEEChhhhccC
Confidence 4 689999999987543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=158.84 Aligned_cols=136 Identities=16% Similarity=0.155 Sum_probs=108.3
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCceEEEEEccC
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELLS 106 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~~ 106 (317)
+...|++|+||+||.+...+.+++.+.+........ ......+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~-~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLR-GVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhh-hHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 567899999999998888889998887765443211 112336889999999994 5889999886 34799999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEeeCCCCceEEcccCcccccc
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDL-KPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl-kp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+|||++.+ +.++|+|||++....
T Consensus 82 G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 82 GAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGN 143 (218)
T ss_pred CccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecC
Confidence 9998754321 1 1357889999999999999999999 7999999987 789999999998443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-21 Score=159.80 Aligned_cols=138 Identities=28% Similarity=0.384 Sum_probs=112.8
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCChH---HHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ecCceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~~ 105 (317)
+.||+|++|.||+|.+.+..|++|+........ .......++.+|+.++..+.|++++....++ .....++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 578999999999999999999999866433211 1112335688899999999998886655554 345788999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+|++|.+++... .. .+..++.+++.+|.++|+.|++|+|++|+||+++ + +.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999988652 22 7888999999999999999999999999999999 4 6899999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=156.06 Aligned_cols=134 Identities=25% Similarity=0.360 Sum_probs=106.4
Q ss_pred eeccccceEEEEeEECCeEEEEEEeecCCCh---HHHHHHHHHHHHHHHHHHhcCCCCee--eEEeeeecCceEEEEEcc
Q 021127 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQHRNLV--KFIGACKEPVMVIVTELL 105 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~~~~~lv~e~~ 105 (317)
.||+|+||.||+|.+.+..|++|........ .+......++.+|++++..+.|+++. .++.. .+...++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEEEE
Confidence 4799999999999999999999986643321 11222345678999999999887643 44433 344678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ + +.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcCC
Confidence 9999999876421 1 7899999999999999999999999999999 4 68999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.9e-21 Score=178.25 Aligned_cols=148 Identities=23% Similarity=0.341 Sum_probs=116.3
Q ss_pred CceeecCCce---eecceeccccceEEEEeEECCeEEEEEEeecCCCh-H--HHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHL---FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETP-E--EIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y---~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~-~--~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
..|..+.... ...++||+|+||+||+|.+.+..+++|+....... . .......++.+|++++..++|++++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 3466666543 34889999999999999998777777654332211 1 1112345688999999999999998776
Q ss_pred eeeec-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
.++.+ ...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ + +.++|+|
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liD 470 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLID 470 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEe
Confidence 66544 46789999999999999885 2467899999999999999999999999999995 3 5899999
Q ss_pred cCccccc
Q 021127 170 FGLAREE 176 (317)
Q Consensus 170 fg~a~~~ 176 (317)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9999764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.8e-22 Score=161.49 Aligned_cols=227 Identities=25% Similarity=0.436 Sum_probs=175.3
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
|+-+++.+.-+|.....|..|+|++.|..+++|++...... .+..++|.+|.-.|+-+.||||..++|.|..+ ...
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t---~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT---ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc---hhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 56677778889999999999999999999999998766543 34556799999999999999999999999876 889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc-CCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHR-DLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~-Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
++..||+.|+|+..|.....-..+..++.+++.++++|++|||+. .++-| -|....++|+++. +.+|+- +-+++.-
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarism-ad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISM-ADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheec-ccceeee
Confidence 999999999999999987766688899999999999999999997 34444 6888899999984 666642 2122111
Q ss_pred cccccccccCccceeccccccccccccc--ccccccC-----------------------------CCCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQG--EKKHYNH-----------------------------KNVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~~-----------------------------~~~~~~~~~~~~~l 226 (317)
........+.||+||.+....-+.. ..+.|+. +.....|++++..+
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 1122345789999998765332211 1111111 12223477889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
..||.-|++.||.+||.++.++-.|+++.
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998887653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-20 Score=153.16 Aligned_cols=141 Identities=23% Similarity=0.226 Sum_probs=109.0
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChH-----------------HHHHHHHHHHHHHHHHHhcCCC--
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-----------------EIAKKESRFAREVAMLSRVQHR-- 84 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~-----------------~~~~~~~~~~~E~~~l~~l~h~-- 84 (317)
.|.+.+.||+|+||.||++... ++.||||+++...... ........+..|+.++..+.|.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3788899999999999999884 8999999987543110 0011223467789999988777
Q ss_pred CeeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 85 NLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 85 niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
.++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.+ +.
T Consensus 96 ~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 96 PVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 4455444 2456899999999998765421 2356788999999999999999999999999999987 69
Q ss_pred eEEcccCcccccc
Q 021127 165 IKLADFGLAREES 177 (317)
Q Consensus 165 ~kl~Dfg~a~~~~ 177 (317)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-19 Score=157.39 Aligned_cols=222 Identities=29% Similarity=0.455 Sum_probs=169.3
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeeEEeeeecC-ceEEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~-~~~lv~e 103 (317)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +++++++.+... ..+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999888 7889999887655432 2355789999999999988 799999999655 4699999
Q ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc--
Q 021127 104 LLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-- 180 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-- 180 (317)
++.+++|.+++..... ..++......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765431 1489999999999999999999999999999999999999873269999999997443222
Q ss_pred -----ccccccCccceecccccccc--cccccccccccCC----------------C---------------CCC-C---
Q 021127 181 -----MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK----------------N---------------VRP-S--- 218 (317)
Q Consensus 181 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~----------------~---------------~~~-~--- 218 (317)
......|+..|+|||.+.+. .......+.|..+ . ..+ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23566799999999987753 1222111211100 0 000 0
Q ss_pred -CCCC----hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 -AENV----PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 -~~~~----~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.... ...+.+++..|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0011 1468899999999999999998887765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=153.01 Aligned_cols=155 Identities=20% Similarity=0.216 Sum_probs=114.5
Q ss_pred eecCCceeecCCceee-cceec-cccceEEEEeEECCeEEEEEEeecCCChHH--------HHHHHHHHHHHHHHHHhcC
Q 021127 13 LKLDAKWLIDPKHLFV-GPRIG-EGAHAKVYEGKYKNQTVAIKIVHKGETPEE--------IAKKESRFAREVAMLSRVQ 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~-~~~lG-~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~ 82 (317)
+..+..+..+++.+.. ...|| .||.|+||.+...+..+|||.+.....-.. ......++.+|++++.++.
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~ 98 (239)
T PRK01723 19 LRDPDPALFDPDFWQQQARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY 98 (239)
T ss_pred cCCCchhhcCHHHHhhcCceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH
Confidence 3444444555544433 34577 899999999988899999998865321100 0123456889999999998
Q ss_pred CCCe--eeEEeeeec--C---ceEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 83 HRNL--VKFIGACKE--P---VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 83 h~ni--v~l~~~~~~--~---~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
|++| ++.+++... . ..++|||+++| .+|.+++... .+++.. +.+++.+|.+||++||+||||||.
T Consensus 99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~ 171 (239)
T PRK01723 99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAH 171 (239)
T ss_pred hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCch
Confidence 8775 677776432 2 23599999997 6999888652 255543 578999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCcccc
Q 021127 155 NLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~ 175 (317)
|||++.+ +.++|+|||.++.
T Consensus 172 NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 172 NILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred hEEEcCC-CCEEEEECCCccc
Confidence 9999987 6899999998865
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=148.44 Aligned_cols=134 Identities=21% Similarity=0.209 Sum_probs=102.3
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccC
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 187 (317)
|+|.+++...+ ..+++..++.|+.|++.||+|||+++ ||+||+++.+ +.+|+ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 68999998643 34999999999999999999999998 9999999988 68888 9999765432 2368
Q ss_pred ccceecccccccccccccccccccCC--------CC--------------------C-------CCCCCChH--HHHHHH
Q 021127 188 TYRWMAPELYSTVTLRQGEKKHYNHK--------NV--------------------R-------PSAENVPE--ELSIIL 230 (317)
Q Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~~~~--------~~--------------------~-------~~~~~~~~--~l~~li 230 (317)
|+.|+|||++.+..+.. ..++|+.+ .. . +.+..++. ++.+++
T Consensus 67 ~~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 89999999987654432 33333322 00 0 01112223 689999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 231 TSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+||..||.+||++.+++++++....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=170.65 Aligned_cols=234 Identities=23% Similarity=0.300 Sum_probs=162.9
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCCeee
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVK 88 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 88 (317)
++....+.+..+.|.|.+.||.|+||+||+|... ++.||||+-+.....+ |.--..++.+|+ -+.|..
T Consensus 687 l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--------fYI~~q~~~RLk~~~~~~~~~ 758 (974)
T KOG1166|consen 687 LNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--------FYICLQVMERLKPQMLPSIMH 758 (974)
T ss_pred cCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--------eeehHHHHHhhchhhhcchHH
Confidence 4455577888999999999999999999999875 8999999987776654 222233444444 122333
Q ss_pred EEeee-ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC------C
Q 021127 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------D 161 (317)
Q Consensus 89 l~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~------~ 161 (317)
+.... ..+..++|+||.+.|+|.+++...+ .+++.-+..+..|++..++.||..+|||+||||+|+||.. +
T Consensus 759 ~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 759 ISSAHVFQNASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred HHHHHccCCcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence 33222 2456889999999999999998444 4999999999999999999999999999999999999953 2
Q ss_pred CCceEEcccCcccccc---cccccccccCccceeccccccccccccccc-----------------ccccCCCCCCCCCC
Q 021127 162 LKTIKLADFGLAREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEK-----------------KHYNHKNVRPSAEN 221 (317)
Q Consensus 162 ~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~ 221 (317)
.-.++|+|||.+.... ........++|..+-.+|+..+..+.-..+ ..+..... ....+
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~-~~~~~ 915 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSW-MVKTN 915 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcce-ecccc
Confidence 2358999999987432 222335567888999999877643321110 11111111 11122
Q ss_pred Ch----HH-HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VP----EE-LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~----~~-l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++ .+ ..+|...+|+.|-..=|...++...++.++..
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 33 23 34677888884444458888888887776643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=155.43 Aligned_cols=167 Identities=25% Similarity=0.361 Sum_probs=121.4
Q ss_pred CCCCeeeEEeeeec----------------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHH
Q 021127 82 QHRNLVKFIGACKE----------------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133 (317)
Q Consensus 82 ~h~niv~l~~~~~~----------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~ 133 (317)
+|||||++.+.|.+ ..+|+||... ..+|..++..+. .+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999876511 2589999888 469999998654 677778889999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEeeCC---CCceEEcccCccccccc-------ccccccccCccceeccccccccccc
Q 021127 134 IARAMECLHSHGIIHRDLKPENLLLTED---LKTIKLADFGLAREESL-------TEMMTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 134 i~~~L~~lH~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
+++|+.|||.+||.|||+|.+|||+.-+ --.+.|+|||.+--... ........|.-.-||||+.....-.
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999999999999999999532 12578999998742221 1222334577889999987653211
Q ss_pred c-----cc-----------------cccc------------cCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 021127 204 Q-----GE-----------------KKHY------------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249 (317)
Q Consensus 204 ~-----~~-----------------~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~ 249 (317)
. ++ .++| ......+.++.+|..+++++...|+.||.+|++..-..+
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 1 11 1111 122345567889999999999999999999998766555
Q ss_pred HHH
Q 021127 250 MLL 252 (317)
Q Consensus 250 ~l~ 252 (317)
.+.
T Consensus 510 vl~ 512 (598)
T KOG4158|consen 510 VLN 512 (598)
T ss_pred HHH
Confidence 443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=141.60 Aligned_cols=141 Identities=28% Similarity=0.318 Sum_probs=99.0
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHH-------------------HHHHHHHHHHHHhcCCC--C
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKK-------------------ESRFAREVAMLSRVQHR--N 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~-------------------~~~~~~E~~~l~~l~h~--n 85 (317)
+.+.||+|+||+||+|.+. ++.||||++............ ......|...+.++.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999887 899999998764322110000 00113456666666433 3
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCC
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~ 163 (317)
+.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .||+|+||||+||+++ + +
T Consensus 81 ~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~ 151 (187)
T cd05119 81 VPKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G 151 (187)
T ss_pred CCceEec---CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence 4454443 24689999999854322 122111 11 5678899999999999999 9999999999999999 5 6
Q ss_pred ceEEcccCcccccc
Q 021127 164 TIKLADFGLAREES 177 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~ 177 (317)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 89999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-20 Score=173.96 Aligned_cols=220 Identities=18% Similarity=0.223 Sum_probs=158.5
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTE 103 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e 103 (317)
++...+.||++.|=+|.+|++....|+||++-+....-......++ ++|++ ...+++||++++..+... ...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQR-LEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHH-HHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7889999999999999999998767999999877654433333333 44455 556799999998877654 46788888
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc----
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---- 179 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---- 179 (317)
|. .-+|++.|..+.- +..-+..+|+.|++.||.-+|..||+|||||.+||||+.- +.+.|+||..-+.....
T Consensus 102 yv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCc
Confidence 88 5699999876433 7778888999999999999999999999999999999987 68999999876632111
Q ss_pred -c---ccccccCccceeccccccccc-cc---------ccccccccCC--------C-C-----------CCCCC-----
Q 021127 180 -E---MMTAETGTYRWMAPELYSTVT-LR---------QGEKKHYNHK--------N-V-----------RPSAE----- 220 (317)
Q Consensus 180 -~---~~~~~~gt~~y~aPE~~~~~~-~~---------~~~~~~~~~~--------~-~-----------~~~~~----- 220 (317)
+ ...+...-..|+|||-|.... .. ....++++.+ . . +....
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 1 112222345799999875522 11 1111222221 0 0 00000
Q ss_pred ----CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 221 ----NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 221 ----~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
--...+++++..|++.||.+|.++++.++.
T Consensus 258 ~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 112368999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-19 Score=162.63 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=159.0
Q ss_pred eeccccceEEEEeE-----ECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEEEEE
Q 021127 31 RIGEGAHAKVYEGK-----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 31 ~lG~G~~g~V~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e 103 (317)
.+|+|+||.|++++ +.+..+|+|++.+....... ......|..++..++ ||.++++...++.+ ..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~---~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD---RTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc---ccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999743 34788999988765443211 114556778888886 99999999888754 8999999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccc
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~ 183 (317)
+..||+|...+.+... +++.....+...++-+++++|+.+++|||+|++||+++.+ |.+++.|||+++..-..+..
T Consensus 78 ~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred hcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc-
Confidence 9999999998876554 8888888899999999999999999999999999999999 89999999999865444332
Q ss_pred cccCccceecccccccccccccccccccCC-----------------------CCCCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------NVRPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
|||..|||||++.+ .....++|..+ .....+..++..+++++..++..+|..
T Consensus 154 --cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 154 --CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred --ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence 99999999999883 23334444432 123345667778899999999999999
Q ss_pred CCCH
Q 021127 241 RPNF 244 (317)
Q Consensus 241 Rps~ 244 (317)
|-..
T Consensus 229 rLg~ 232 (612)
T KOG0603|consen 229 RLGA 232 (612)
T ss_pred Hhcc
Confidence 9644
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.1e-18 Score=131.54 Aligned_cols=132 Identities=23% Similarity=0.267 Sum_probs=110.7
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeec-CceEEEEEc
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE-PVMVIVTEL 104 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~-~~~~lv~e~ 104 (317)
+.+.||.|.++.||++...+..+++|....... ...+.+|+..+..+.| .++++++++... +..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 457799999999999999888999999866543 2357889999999976 588999887764 478999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+.++.+..+ +......++.+++.+|++||.. +++|+|++|+||+++.. +.++++|||.+...
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccCC
Confidence 988777653 4566777899999999999985 79999999999999986 68999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=141.76 Aligned_cols=211 Identities=18% Similarity=0.257 Sum_probs=127.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC----------CCeeeEEee
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----------RNLVKFIGA 92 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~ 92 (317)
.+..++.||.|+++.||.+++. ++.+|||++....... ....+.+.+|.-....+.+ -.++.-++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~--~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS--ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH--TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccc--hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 4567888999999999999996 6999999988766332 2345556666544443321 111111111
Q ss_pred e---------e---cC------ceEEEEEccCCCCHHHHHHh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021127 93 C---------K---EP------VMVIVTELLSGGTLRKYLLN---MRPR--CLDVCVAIGFALDIARAMECLHSHGIIHR 149 (317)
Q Consensus 93 ~---------~---~~------~~~lv~e~~~~g~L~~~l~~---~~~~--~l~~~~~~~i~~~i~~~L~~lH~~~ivH~ 149 (317)
. . +. ..+++|+-+ .++|.+++.. .... .+....++.+..|++..+++||+.|+||+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 1 1 11 246788888 6799888653 2211 13344556777999999999999999999
Q ss_pred CCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceeccccccccc-------ccccccccccCC---------
Q 021127 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT-------LRQGEKKHYNHK--------- 213 (317)
Q Consensus 150 Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~~--------- 213 (317)
||+|+|++++.+ |.++|+||+.....+..... ...+..|.+||...... ......+.|..+
T Consensus 170 di~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TT-S-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCC-CCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999 89999999887654433222 34457788998653320 001111111111
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCC
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNAR 241 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~R 241 (317)
.....+.++|+.++.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 0122344889999999999999999988
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.8e-15 Score=138.47 Aligned_cols=143 Identities=23% Similarity=0.285 Sum_probs=99.4
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHH-----------------------------------HHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEI-----------------------------------AKKESRFAR 73 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~-----------------------------------~~~~~~~~~ 73 (317)
+.||+|++|.||+|+.. |+.||||+.+......-. ...+-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999985 899999998754321100 001123556
Q ss_pred HHHHHHhcC----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 021127 74 EVAMLSRVQ----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR-AMECLHSHGI 146 (317)
Q Consensus 74 E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~-~L~~lH~~~i 146 (317)
|...+.++. +.+-+.+-.++. ....++||||++|++|.+....... ..+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 333333333332 2357999999999999887653221 122 3445666655 4788999999
Q ss_pred cccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 147 IHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 147 vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|++|+||+++.+ +.++++|||++...+
T Consensus 279 ~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 999999999999888 789999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=140.57 Aligned_cols=177 Identities=33% Similarity=0.500 Sum_probs=132.7
Q ss_pred HhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCcE
Q 021127 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-IHRDLKPENL 156 (317)
Q Consensus 79 ~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i-vH~Dlkp~Ni 156 (317)
+.+.|.|+.+++|.+.++ ..++|.+||..|+|.+.+.... ..+++.....++++|+.||+|+|+..| .|+.++..|+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 567899999999998665 8889999999999999998733 348899999999999999999999866 9999999999
Q ss_pred EeeCCCCceEEcccCcccccccc---cccccccCccceeccccccccccc------ccccccccCC--------------
Q 021127 157 LLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLR------QGEKKHYNHK-------------- 213 (317)
Q Consensus 157 ll~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~~~~-------------- 213 (317)
+++.. ..+||+|||+....... .......-..-|.|||++...... ....+.|+.+
T Consensus 81 lvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 81 LVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred eeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99998 58999999998765321 111111234579999987763111 1111111111
Q ss_pred ---------------------CCCCC---CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ---------------------NVRPS---AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ---------------------~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+|. ....++++..++.+||..+|.+||+++++...+......
T Consensus 160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 11221 114456789999999999999999999998887776654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=120.00 Aligned_cols=129 Identities=22% Similarity=0.225 Sum_probs=96.9
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecCceEEEEEccCC
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVIVTELLSG 107 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~ 107 (317)
.+.|+.|.++.||+++..+..|++|+....... ...+..|+.++..+.+.+ +++++++.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~------~~~~~~E~~~l~~l~~~~~~P~~~~~~~-~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL------LINRENEAENSKLAAEAGIGPKLYYFDP-ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc------ccCHHHHHHHHHHHHHhCCCCceEEEeC-CCCeEEEEecCC
Confidence 356889999999999999999999987654321 113567888888885444 445555543 345799999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI-----IHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i-----vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++... . .. ...++.+++.+|+.||+.++ +|+|++|+||+++ + +.++++|||.+...
T Consensus 76 ~~l~~~--~-----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~~ 137 (170)
T cd05151 76 SELLTE--D-----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGMN 137 (170)
T ss_pred Cccccc--c-----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccCC
Confidence 887643 0 11 12356899999999999985 9999999999999 4 57999999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.6e-14 Score=114.85 Aligned_cols=141 Identities=17% Similarity=0.161 Sum_probs=101.0
Q ss_pred cceeccccceEEEEeEEC--------CeEEEEEEeecCCChH-----HH------------HHHHHHHH----HHHHHHH
Q 021127 29 GPRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETPE-----EI------------AKKESRFA----REVAMLS 79 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--------~~~vaiK~~~~~~~~~-----~~------------~~~~~~~~----~E~~~l~ 79 (317)
...||.|-=+.||.|... +..+|||+++.....- .. ...+..+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 356899999999999764 3689999876422110 00 00122233 7999999
Q ss_pred hcC--CCCeeeEEeeeecCceEEEEEccCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCc
Q 021127 80 RVQ--HRNLVKFIGACKEPVMVIVTELLSGGTLRK-YLLNMRPRCLDVCVAIGFALDIARAMECL-HSHGIIHRDLKPEN 155 (317)
Q Consensus 80 ~l~--h~niv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~l~~~~~~~i~~~i~~~L~~l-H~~~ivH~Dlkp~N 155 (317)
++. .-++++.+++ ...++||||+.++.+.. .+.+ ..++......+..+++.+|..| |+.|+||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 884 3567777765 45789999997654432 2322 1256667778889999999999 89999999999999
Q ss_pred EEeeCCCCceEEcccCcccccc
Q 021127 156 LLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 156 ill~~~~~~~kl~Dfg~a~~~~ 177 (317)
|++.. +.++|+|||.+....
T Consensus 156 IL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC--CcEEEEECCCceeCC
Confidence 99985 479999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-15 Score=143.39 Aligned_cols=175 Identities=31% Similarity=0.430 Sum_probs=119.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCceEE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVI 100 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~l 100 (317)
..+|..++.+-.|++|.||..+++ .+++|+|+ .+... +++- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----------hhhc--cccccCCccee-------------
Confidence 367889999999999999999886 78899954 22211 2221 23223344444
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|+-...+...+. ++... +.+++|||+.||+|||+||+|.+|+.- |.+|++|||+.+.....
T Consensus 136 -------gDc~tllk~~g~--lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGP--LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccCCC--Ccchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhc
Confidence 555555655444 33322 788999999999999999999999987 89999999998732111
Q ss_pred --------------c-ccccccCccceecccccccccccccccccccCC------------------------------C
Q 021127 180 --------------E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------N 214 (317)
Q Consensus 180 --------------~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~ 214 (317)
. .....+||+.|+|||++....+... .+||..+ .
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0 1123479999999999765433222 2222211 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCC
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARP 242 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp 242 (317)
.......++.++++++.++|+.+|..|-
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1222456789999999999999999994
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.3e-13 Score=107.62 Aligned_cols=148 Identities=24% Similarity=0.310 Sum_probs=111.5
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCC---ChHHHHHHHHHHHHHHHHHHhcCCCCe--eeEEeeeecCceEEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE---TPEEIAKKESRFAREVAMLSRVQHRNL--VKFIGACKEPVMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~lv~ 102 (317)
....+-+|+=+.|+++.+.|+.++||.-.... ..-+..-...+..+|++.+.++.--.| ++++ +++...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-FIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-EEecCCCeEEE
Confidence 45667899999999999999999999654322 222333446678899999988853333 3333 33444567899
Q ss_pred EccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce--EEcccCccccc
Q 021127 103 ELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI--KLADFGLAREE 176 (317)
Q Consensus 103 e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~--kl~Dfg~a~~~ 176 (317)
||++| .++.+++..........+....++..|-+.+.-||.++|||+||..+||++..+.+.+ .++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99976 4888888876554444555588999999999999999999999999999998775555 89999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1e-15 Score=144.47 Aligned_cols=225 Identities=20% Similarity=0.303 Sum_probs=168.0
Q ss_pred cCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~- 96 (317)
....|.+.+-||+|+|+.|-..... ...+|+|.+....... ........|..+-..+. |.|++++++...+.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~---~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE---DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc---chhhhcCccccccccccccccccccCCccCCCc
Confidence 3467888888999999999877653 4556777665543111 11223445777777776 99999999998776
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEeeCCCC-ceEEcccCccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLK-TIKLADFGLAR 174 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~ 174 (317)
..++++++..|+++...+........+....-.++.|+..++.|+| ..++.|+||||+|.+++.. + ..++.|||+|.
T Consensus 95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At 173 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLAT 173 (601)
T ss_pred ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhc
Confidence 7889999999999999883222213777888889999999999999 9999999999999999988 5 89999999998
Q ss_pred cccc----ccccccccC-ccceecccccccccccccccccccCCC--------------------------------CCC
Q 021127 175 EESL----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNHKN--------------------------------VRP 217 (317)
Q Consensus 175 ~~~~----~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~~~~--------------------------------~~~ 217 (317)
.... .......+| ++.|+|||.+.+........+.|..+. ...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQL 253 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccC
Confidence 5433 223345578 999999999887544444444443330 112
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++....+++.+++..+|..|.+.+++...
T Consensus 254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ccccCChhhhhcccccccCCchhcccccccccc
Confidence 234566788899999999999999999887544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-14 Score=131.69 Aligned_cols=144 Identities=18% Similarity=0.228 Sum_probs=93.4
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH-----------------------------HH------HHH
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE-----------------------------EI------AKK 67 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~-----------------------------~~------~~~ 67 (317)
+|.. +.||+|++|.||+|+.. |+.||||+.+...... .. ...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3444 68999999999999884 8999999998653110 00 111
Q ss_pred HHHHHHHHHHHHhcC----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHH--HhcCCC--CCCHHHHHHHHHHHHHH
Q 021127 68 ESRFAREVAMLSRVQ----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYL--LNMRPR--CLDVCVAIGFALDIARA 137 (317)
Q Consensus 68 ~~~~~~E~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l--~~~~~~--~l~~~~~~~i~~~i~~~ 137 (317)
+-+|.+|...+.++. +.+.+.+=.++. ....++||||+.|+++.+.- ...+.. .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH----
Confidence 223455555555552 333343333333 24688999999999998743 222110 1223333333333
Q ss_pred HHHHHhCCccccCCCCCcEEeeCCCC----ceEEcccCcccccc
Q 021127 138 MECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLAREES 177 (317)
Q Consensus 138 L~~lH~~~ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~~~ 177 (317)
++..|++|+|+||+||+++.+ + +++++|||++...+
T Consensus 276 ---if~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ---VFRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ---HHhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECC
Confidence 446899999999999999987 5 89999999987543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.7e-13 Score=106.37 Aligned_cols=136 Identities=23% Similarity=0.306 Sum_probs=103.7
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCCh---HHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeecCceEEEEEc
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKEPVMVIVTEL 104 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~lv~e~ 104 (317)
..+++|+=+.+|.+.+.|..+++|.-...... -+..-...+-.+|.+++.++.- -+++.++++.. ....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-DNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCEEEEEE
Confidence 45789999999999888888888865433221 1222334567789999988843 34445554433 357799999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.+|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..+ .+.++|||++....
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccccc
Confidence 9998988888764 25578888999999999999999999999999986 59999999998544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.48 E-value=8.7e-15 Score=130.58 Aligned_cols=145 Identities=28% Similarity=0.455 Sum_probs=108.1
Q ss_pred ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++||.|++|...+|.++|..... ...++...+.++.|++.|+.| ++.+|+|+||.||+...+ ..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 58899999999999999974332 336778889999999999999 999999999999999988 5899999999875
Q ss_pred ccccc-------ccccccCccceecccccccccccccccccccCC--------------------------CCCC-CCCC
Q 021127 176 ESLTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------NVRP-SAEN 221 (317)
Q Consensus 176 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------~~~~-~~~~ 221 (317)
..... ..+...||..||+||.+.+..+..... +|..+ ...+ ...+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvd-IyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d 484 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVD-IYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQD 484 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcc-hhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhc
Confidence 54443 445668999999999988744433221 11111 1110 1222
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQI 247 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~ 247 (317)
+| .-..|+.+++.+.|.+||++.+.
T Consensus 485 ~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 485 YP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred Cc-HHHHHHHHhcCCCcccCchHHHH
Confidence 33 34679999999999999955443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.6e-11 Score=102.08 Aligned_cols=138 Identities=17% Similarity=0.117 Sum_probs=97.3
Q ss_pred eEEEEeEECCeEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCC--eeeEEeeeec------CceEEEEE
Q 021127 38 AKVYEGKYKNQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRN--LVKFIGACKE------PVMVIVTE 103 (317)
Q Consensus 38 g~V~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~------~~~~lv~e 103 (317)
..|++....|+.|.||............. -...+.+|...+.++...+ ++..+++... ...++|||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 34667888899999997643331110000 0013678888888874322 3344444321 24789999
Q ss_pred ccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC------CCCceEEcccCcccc
Q 021127 104 LLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE------DLKTIKLADFGLARE 175 (317)
Q Consensus 104 ~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~------~~~~~kl~Dfg~a~~ 175 (317)
++++. +|.+++........+......++.+++..+.-||..||+|+|++++|||++. +...+.++||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99876 8999886533333667778889999999999999999999999999999985 125789999998853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.2e-13 Score=120.02 Aligned_cols=224 Identities=24% Similarity=0.309 Sum_probs=157.8
Q ss_pred cCCceeecceecc--ccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 22 DPKHLFVGPRIGE--GAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~--G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
....+.+.+.+|. |.+|.||.++. .+..+|+|.-....... ....+=.+|+...+++ .|+|.++.+..+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p---~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP---LDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc---cccccccchhhcccccCccccccccCcccc
Confidence 3345567888999 99999999876 36788998733322211 1111234677777777 6999999877776
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR----AMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~----~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
+. ..++=+|+| +.+|..+...... .++...++.++.+... ||.++|+.+++|-|+||.||++..+...++++|
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 65 667777777 7899888876432 2778888889999999 999999999999999999999998855899999
Q ss_pred cCccccccccccccc------ccCccceeccccccccccccc----------------------ccccccCC-CC-C--C
Q 021127 170 FGLAREESLTEMMTA------ETGTYRWMAPELYSTVTLRQG----------------------EKKHYNHK-NV-R--P 217 (317)
Q Consensus 170 fg~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~----------------------~~~~~~~~-~~-~--~ 217 (317)
||+............ ..|...|++||+..+...... ....|... .. . .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 999886654432211 146778999998765322111 11111111 10 0 1
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+.+.++...+.++++.+|..|++.+.+.++
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 133446677789999999999999999887664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.1e-12 Score=105.59 Aligned_cols=140 Identities=22% Similarity=0.308 Sum_probs=106.1
Q ss_pred ceeccccceEEEEeEECC-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeeec----CceEEEE
Q 021127 30 PRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACKE----PVMVIVT 102 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----~~~~lv~ 102 (317)
+.|+.|..+.||++...+ ..+++|........ .....+..|+.++..+.+ .++++++.+..+ +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998875 89999987654321 012347889999999865 446778877754 2568999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------------------------------------- 143 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--------------------------------------- 143 (317)
||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888775532 226777777888888888888884
Q ss_pred -----------------CCccccCCCCCcEEeeCC-CCceEEcccCccccc
Q 021127 144 -----------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 176 (317)
Q Consensus 144 -----------------~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 176 (317)
..++|+|++|+||+++.+ .+.+.|+||+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 236999999999999983 256889999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.1e-11 Score=97.43 Aligned_cols=130 Identities=26% Similarity=0.271 Sum_probs=85.0
Q ss_pred EEEEeEEC-CeEEEEEEeecCCCh---------------------HHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeeee
Q 021127 39 KVYEGKYK-NQTVAIKIVHKGETP---------------------EEIAKKESRFAREVAMLSRVQHR--NLVKFIGACK 94 (317)
Q Consensus 39 ~V~~~~~~-~~~vaiK~~~~~~~~---------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 94 (317)
.||.|... +..+|||+.+..... .+.........+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999875 889999987642111 11223345667899999999655 567777553
Q ss_pred cCceEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 95 EPVMVIVTELLS--GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC-LHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 95 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~-lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...|||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.||+++.+ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 3579999998 65665543321 2244456677888885555 579999999999999999986 79999999
Q ss_pred cccccc
Q 021127 172 LAREES 177 (317)
Q Consensus 172 ~a~~~~ 177 (317)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.5e-12 Score=114.68 Aligned_cols=223 Identities=18% Similarity=0.165 Sum_probs=152.1
Q ss_pred CCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee-cCc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK-EPV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-~~~ 97 (317)
..++.++..||.|.|+.|+..... +..|++|.+........ ....-+.|+-+...+ .|.++++++..+. ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~---~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA---SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH---hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 367888999999999999986543 67889998776554331 111234566666665 6888888776554 457
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|+=.|||+++++...+.- ...+++..++.+..|++.++.++|+..++|+|++|+||++..++...++.|||.+....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 7788899999998877632 23388888999999999999999999999999999999999864578999999987421
Q ss_pred cccccccccCcccee--cccccccccccccccc----------------------cccC-CCCCCCCCCChHHHHHHHHH
Q 021127 178 LTEMMTAETGTYRWM--APELYSTVTLRQGEKK----------------------HYNH-KNVRPSAENVPEELSIILTS 232 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~~~----------------------~~~~-~~~~~~~~~~~~~l~~li~~ 232 (317)
. ......+...+. ++++............ ++.. ....+.......++..+...
T Consensus 419 ~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv 496 (524)
T KOG0601|consen 419 F--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKV 496 (524)
T ss_pred e--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhh
Confidence 1 112223333444 3333222211111110 0000 02233344555788889999
Q ss_pred hhhcCCCCCCCHHHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~l~ 252 (317)
+...++..||.+.++..+..
T Consensus 497 ~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 497 MINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hcCCccccchhhhhhcccch
Confidence 99999999999988766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=105.05 Aligned_cols=174 Identities=23% Similarity=0.343 Sum_probs=116.5
Q ss_pred HHHHHhcCCCCeeeEEeeeec------CceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 021127 75 VAMLSRVQHRNLVKFIGACKE------PVMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSH-- 144 (317)
Q Consensus 75 ~~~l~~l~h~niv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~-- 144 (317)
.+.+-++.|.|||+++.++.+ ....++.||+..|+|..+|+..+ ...+....+.+|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 445566789999999988753 25788999999999999998643 34588889999999999999999987
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccc-----cccccccccCccceecccccccccccccccccccCCC-----
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREES-----LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKN----- 214 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~----- 214 (317)
-|+|+++..+.|++..+ +-+||.--.-..... .........+-++|.|||.=.. ....+..+++..+.
T Consensus 198 piihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence 59999999999999987 667764211111000 0111223346788999985222 22222223322220
Q ss_pred ----CCCC---------------CCCC-hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ----VRPS---------------AENV-PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ----~~~~---------------~~~~-~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+. ...+ ...-+.++..|++..|..||++.+++-|
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 0000 0000 1123568899999999999999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.8e-10 Score=92.63 Aligned_cols=106 Identities=29% Similarity=0.328 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcC--CCCeeeEEeeeec-----CceEEEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 021127 69 SRFAREVAMLSRVQ--HRNLVKFIGACKE-----PVMVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140 (317)
Q Consensus 69 ~~~~~E~~~l~~l~--h~niv~l~~~~~~-----~~~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~ 140 (317)
.+..+|...+..+. .-.+++.+++... ...++|+|++++. +|.+++..... .+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 35778888887774 3334555555543 1468999999884 89999886444 6677788899999999999
Q ss_pred HHhCCccccCCCCCcEEeeCCC--CceEEcccCccccc
Q 021127 141 LHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREE 176 (317)
Q Consensus 141 lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~ 176 (317)
||.+||+|+|+++.|||++.+. ..+.++||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999872 16899999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.6e-09 Score=88.09 Aligned_cols=141 Identities=14% Similarity=0.091 Sum_probs=102.4
Q ss_pred ccccceEEEEeEECCeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcCC--CCeeeEEeee--ecC---ceEEEEEc
Q 021127 33 GEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQH--RNLVKFIGAC--KEP---VMVIVTEL 104 (317)
Q Consensus 33 G~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~--~~~---~~~lv~e~ 104 (317)
|.||.+.|++....|..+-+|.-......... +--+.-|.+|+..+.++.. -.+++..... ..+ ..+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 67999999998888888888865411111100 1123458999999998843 2245554221 111 47899997
Q ss_pred cCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc--eEEcccCccc
Q 021127 105 LSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADFGLAR 174 (317)
Q Consensus 105 ~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~--~kl~Dfg~a~ 174 (317)
+.| .+|.+++.+......+......++.+++..++-||+.|+.|+|+.+.||+++.+ +. ++++||.-++
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r 178 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSR 178 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccc
Confidence 744 589888876544446788888999999999999999999999999999999855 45 9999997665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.6e-10 Score=91.63 Aligned_cols=138 Identities=28% Similarity=0.302 Sum_probs=100.1
Q ss_pred eecceeccccceEEEEeEEC-CeEEEEEEeecCCC-----------------hHHHHHHHHHHHHHHHHHHhcCCC--Ce
Q 021127 27 FVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGET-----------------PEEIAKKESRFAREVAMLSRVQHR--NL 86 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~-----------------~~~~~~~~~~~~~E~~~l~~l~h~--ni 86 (317)
.++..||-|-=+.||.|... |.++|||.=+.+.. ..+....+....+|.+.|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 46789999999999999987 99999995432211 112233344556789999988544 66
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
++-+++ +...+|||+.+|-.|...- ++.+..-.++..|+.-+.-+-..|+||+|+++-||+++++ |.+.
T Consensus 174 P~P~~~---nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~ 242 (304)
T COG0478 174 PKPIAW---NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV 242 (304)
T ss_pred CCcccc---ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence 665443 4567999999987765532 2234444566667777777778999999999999999998 7899
Q ss_pred EcccCcccc
Q 021127 167 LADFGLARE 175 (317)
Q Consensus 167 l~Dfg~a~~ 175 (317)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.2e-09 Score=85.49 Aligned_cols=141 Identities=19% Similarity=0.230 Sum_probs=95.3
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHH------HHHHHHHHhcCC---CCeeeEEe
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRF------AREVAMLSRVQH---RNLVKFIG 91 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~------~~E~~~l~~l~h---~niv~l~~ 91 (317)
|-.++|.+.+.+-......|.+...++..+++|..+......+ +....| .+++..+.+++. .....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~e--r~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPE--RRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHH--HHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457888888888888888988888899999998765432211 111111 223333333322 22223222
Q ss_pred eee------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 92 ACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 92 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+.. ....++||||++|..|.+... +++ .+...+.+++.-||+.|+.|+|..|+|++++.+ .+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i 173 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GI 173 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cE
Confidence 221 235678999999988876543 333 245667788999999999999999999999975 59
Q ss_pred EEcccCcccc
Q 021127 166 KLADFGLARE 175 (317)
Q Consensus 166 kl~Dfg~a~~ 175 (317)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.5e-09 Score=94.46 Aligned_cols=207 Identities=13% Similarity=0.160 Sum_probs=132.9
Q ss_pred ceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee-----cCceEEEEEccCC-C
Q 021127 37 HAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK-----EPVMVIVTELLSG-G 108 (317)
Q Consensus 37 ~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~lv~e~~~~-g 108 (317)
..+.|++... |..|++|+++....... .....-+++++++.|.|||++.+++. +..+++|++|.++ +
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST-----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc-----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 4578888764 88999999943322211 01234578899999999999998774 4578999999976 5
Q ss_pred CHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 109 TLRKYLLNMRP-------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 109 ~L~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+|+++-..... ...++..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+. +++|+..|+...
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dv 442 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDV 442 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceee
Confidence 78876654321 2377899999999999999999999999999999999999884 889987777654
Q ss_pred cccccc-cccccCccceecc-ccccc---ccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 176 ESLTEM-MTAETGTYRWMAP-ELYST---VTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 176 ~~~~~~-~~~~~gt~~y~aP-E~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...... .........|.+= +++.. ........+.............++.++++++......++++ -++.+++.+
T Consensus 443 l~~d~~~~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 443 LQEDPTEPLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ecCCCCcchhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 332220 0000000000000 00000 00000011111111112224467889999999999999987 567776654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-09 Score=99.77 Aligned_cols=117 Identities=19% Similarity=0.287 Sum_probs=97.0
Q ss_pred CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcCCCCCCH
Q 021127 46 KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDV 124 (317)
Q Consensus 46 ~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~ 124 (317)
.+.+|.|..+..... .. .....+-+..++.++||||+++++.+.. +..|+|+|-+ ..|..++.+ +..
T Consensus 36 ~~~~vsVF~~~~~~~-~~----~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-----l~~ 103 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-EV----TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-----LGK 103 (690)
T ss_pred cCCceEEEEEeCCCc-hh----hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-----hHH
Confidence 378888888876654 21 2235667888999999999999998865 4899999998 678888876 446
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 125 CVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 125 ~~~~~i~~~i~~~L~~lH-~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..+...+.||+.||.||| ..+++|++|..+.|+++.. |..||++|.+++.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~ 154 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSK 154 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEec
Confidence 677778999999999998 4689999999999999998 7999999988754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.8e-08 Score=81.79 Aligned_cols=136 Identities=15% Similarity=0.195 Sum_probs=81.6
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeeEEeeeecC-ceEEEEEccC
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-~~~lv~e~~~ 106 (317)
..||+|..+.||+. .+..+++|..+...... ...+|.++++.+..-. +++.+++..++ ...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999984 35578899887544222 3577888888875333 46777777543 5788999998
Q ss_pred CCC-HHHHH--------------Hh----cCC---CCCCHHHHHH-HHH----------HHHHH-HHHHHh----CCccc
Q 021127 107 GGT-LRKYL--------------LN----MRP---RCLDVCVAIG-FAL----------DIARA-MECLHS----HGIIH 148 (317)
Q Consensus 107 ~g~-L~~~l--------------~~----~~~---~~l~~~~~~~-i~~----------~i~~~-L~~lH~----~~ivH 148 (317)
|.+ +...+ .. -.. .......... +.. .+... ..+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 10 000 0111111110 100 01111 122221 24789
Q ss_pred cCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 149 RDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 149 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+|+.|.||+++.+ + +.|+||+.+...
T Consensus 158 gD~~~~Nii~~~~-~-~~iIDwe~a~~G 183 (226)
T TIGR02172 158 GDFQIGNLITSGK-G-TYWIDLGDFGYG 183 (226)
T ss_pred cCCCCCcEEEcCC-C-cEEEechhcCcC
Confidence 9999999999987 5 899999988643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.7e-08 Score=91.28 Aligned_cols=143 Identities=21% Similarity=0.251 Sum_probs=93.1
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHH-----------------------------------HHHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEE-----------------------------------IAKKESRFAR 73 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~-----------------------------------~~~~~~~~~~ 73 (317)
..|+.++-|.||+|+.. |+.||||+.+.+-...- ....+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56899999999999998 99999999875432210 0111223444
Q ss_pred HHHHHHhcC-----CCCeeeEEeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021127 74 EVAMLSRVQ-----HRNLVKFIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146 (317)
Q Consensus 74 E~~~l~~l~-----h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i 146 (317)
|...+.+++ .++| ++=.++. .+...++|||++|..+.+...... ..++.+.+.....++ -+..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 555554441 2222 2222332 356889999999999998853322 225644443332222 2334445799
Q ss_pred cccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 147 IHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 147 vH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|.|.+|.||+++.+ +.+.+.|||+....+
T Consensus 287 fHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSD-GRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecC-CcEEEEcCcceecCC
Confidence 999999999999999 799999999986543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.3e-07 Score=76.27 Aligned_cols=141 Identities=18% Similarity=0.223 Sum_probs=82.1
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeeeec----CceEEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGACKE----PVMVIVT 102 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~----~~~~lv~ 102 (317)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.+... .+++++..... ...+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 356899999999999998889999996543 1233567788888877422 45677764422 2578999
Q ss_pred EccCCCCHHH----------------HHHh---c--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 021127 103 ELLSGGTLRK----------------YLLN---M--RPRCLDVCV---------AIGF------------ALDIAR-AME 139 (317)
Q Consensus 103 e~~~~g~L~~----------------~l~~---~--~~~~l~~~~---------~~~i------------~~~i~~-~L~ 139 (317)
++++|..+.. .+.. . ....+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 1111 1 001111100 0000 111222 233
Q ss_pred HHHh-------CCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 140 ~lH~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++ ..++|+|+.|.||+++...+.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 3332 369999999999999933255679999988643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.9e-07 Score=76.23 Aligned_cols=141 Identities=21% Similarity=0.188 Sum_probs=91.3
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHH-------------------HHHHHHHHHHHHHHhcC--CCCee
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIA-------------------KKESRFAREVAMLSRVQ--HRNLV 87 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~--h~niv 87 (317)
-.|.+|--+.||+|... +..+|+|+++......... ....-..+|+..|.++. +-.++
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35677777899998764 8999999987543322100 00011234666666662 33333
Q ss_pred eEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceE
Q 021127 88 KFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 88 ~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+-+++. ...+||||+... ..---..+...+..+....+..++++.+.-|-. .++||+||+.-|||+.. +.+.
T Consensus 134 ~Pi~~~---~nVLvMEfIg~~--g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~~p~ 206 (268)
T COG1718 134 EPIAFR---NNVLVMEFIGDD--GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--GEPY 206 (268)
T ss_pred Cceeec---CCeEEEEeccCC--CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--CeEE
Confidence 333322 357999999443 110000111224444678889999999998888 89999999999999994 5899
Q ss_pred EcccCcccccc
Q 021127 167 LADFGLAREES 177 (317)
Q Consensus 167 l~Dfg~a~~~~ 177 (317)
|+|||.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.4e-07 Score=78.42 Aligned_cols=227 Identities=18% Similarity=0.240 Sum_probs=141.5
Q ss_pred cCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEee--------
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA-------- 92 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-------- 92 (317)
-.+-+..++.||+|+-+.+|..-.-+.. +.|++........ .+.+..|... .||-+..=+.|
T Consensus 9 ~ge~i~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~--------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 9 YGEPIPPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQ--------AQKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cCcccCCCccccCCccceeeecchhhch-hheeecCCCchHH--------HHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 3344557888999999999964332223 4588776554331 1123344444 56655442222
Q ss_pred eecCceEEEEEccCCCCH-HHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 93 CKEPVMVIVTELLSGGTL-RKYLLN----MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L-~~~l~~----~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
-......++|..+.|..= ..++.- +.-....|...++.+..++.+.+-||+.|.+-+|+.++|+|+.++ +.+.|
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~L 158 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVL 158 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEE
Confidence 122247788888877532 222221 111237899999999999999999999999999999999999988 78999
Q ss_pred cccCcccccccccccccccCccceeccccccc----------------------------ccccccc-----------cc
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYST----------------------------VTLRQGE-----------KK 208 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----------------------------~~~~~~~-----------~~ 208 (317)
.|-..-....+.......+|...|.+||.-.- ....++. .+
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 88554433344444455678999999995220 0000000 00
Q ss_pred c------cc---CCCCCCC-----CCCChHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHhhhcc
Q 021127 209 H------YN---HKNVRPS-----AENVPEELSIILTSCWKED--PNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 209 ~------~~---~~~~~~~-----~~~~~~~l~~li~~cl~~~--p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+ +. .....+. ..-+++++..+..+|+... +.-|||++-.+..|..+..++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0 00 0011121 2345788999999999653 568999998887777665544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.6e-07 Score=73.63 Aligned_cols=134 Identities=22% Similarity=0.312 Sum_probs=95.2
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee-eEEeeeecCceEEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV-KFIGACKEPVMVIVT 102 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~lv~ 102 (317)
......+.||+|.+|.||++.+.+..+|+|+-+.... +..+..|+++|..+...++. +++.+..+ ++.|
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-------r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~m 91 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-------RRNLEKEAKILEILAGEGVTPEVYFYGED---FIRM 91 (201)
T ss_pred hhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-------hhhHHHHHHHHHHhhhcCCCceEEEechh---hhhh
Confidence 3445678899999999999999999999998765543 33477899999988776664 44444433 2449
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEeeCCCCceEEcccCcccccc
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK-PENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk-p~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
||+.|-+|.+.-... +.++ +..+++.---|-..||-|+.|. |..++|.++ +.+.|+||.-|+...
T Consensus 92 e~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k~ 157 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFKK 157 (201)
T ss_pred hhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhhcc
Confidence 999998988866531 2222 3445555445666799999886 445555555 479999999998443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=5.9e-09 Score=100.62 Aligned_cols=221 Identities=21% Similarity=0.246 Sum_probs=147.3
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-ec
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KE 95 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~ 95 (317)
+.+-++.+.+.+-+-+|+++.++.++-. +...++|+......-. ....+....+-.++-...+|-++...-.+ ..
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~--~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR--TNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc--cccccccCCccCccccCCCCceecccCCCCCC
Confidence 5567788888899999999999987654 4445555443222110 00011122222333223456666554443 23
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
...+++++|+.+++|...+++... .+.+-...+...+..+++|||+..++|+|++|.|+++..+ +..+++|||....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSK 953 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccc
Confidence 468999999999999999987653 6666677778889999999999999999999999999998 7899999984321
Q ss_pred cc-------c-------------------------ccccccccCccceecccccccccccccccccccCC----------
Q 021127 176 ES-------L-------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------- 213 (317)
Q Consensus 176 ~~-------~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------- 213 (317)
.. . ........||+.|.+||...+..-....+ ||..+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad-~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD-WWSSGVCLFEVLTGI 1032 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch-hhhhhhhhhhhhcCC
Confidence 00 0 00112335899999999887654443333 33322
Q ss_pred -----------------CCCC---CCCCChHHHHHHHHHhhhcCCCCCCCHH
Q 021127 214 -----------------NVRP---SAENVPEELSIILTSCWKEDPNARPNFT 245 (317)
Q Consensus 214 -----------------~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ 245 (317)
...+ .+...+.+.++++...+..+|.+|..+.
T Consensus 1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 0011 1334567899999999999999997766
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.5e-07 Score=84.61 Aligned_cols=141 Identities=21% Similarity=0.263 Sum_probs=90.0
Q ss_pred ceeccccceEEEEeEEC-CeEEEEEEeecCCChHHH--------------------------------HHHHHHHHHHHH
Q 021127 30 PRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEI--------------------------------AKKESRFAREVA 76 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~--------------------------------~~~~~~~~~E~~ 76 (317)
+.||.-+.|.||+|+.. |+.||||+-+.+-...-. .-.+-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56899999999999987 889999986654322200 001123444554
Q ss_pred HHHhc----CCCC------eeeEEeeeecCceEEEEEccCCCCHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHH-HHHh
Q 021127 77 MLSRV----QHRN------LVKFIGACKEPVMVIVTELLSGGTLRKY--LLNMRPRCLDVCVAIGFALDIARAME-CLHS 143 (317)
Q Consensus 77 ~l~~l----~h~n------iv~l~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~~i~~~L~-~lH~ 143 (317)
...++ .|-+ |++++..+ .....|+||||+|..+.+. +.+.+ ++...+.. .+.++.. -|=.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHH---HHHHHHHHHHHh
Confidence 44333 3545 34433222 2368999999999877654 33333 66664443 3333322 2334
Q ss_pred CCccccCCCCCcEEeeC---CCCceEEcccCcccccc
Q 021127 144 HGIIHRDLKPENLLLTE---DLKTIKLADFGLAREES 177 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~~~ 177 (317)
.|++|+|-+|.||+++. ....+.+.|||+....+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 68999999999999994 23689999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.4e-07 Score=76.08 Aligned_cols=74 Identities=23% Similarity=0.255 Sum_probs=51.8
Q ss_pred eccccc-eEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEEEEccCCC
Q 021127 32 IGEGAH-AKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGG 108 (317)
Q Consensus 32 lG~G~~-g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g 108 (317)
|-.|.+ ..||+....+..++||....... ..+.+|+++++.+ .+--+++++++...+ ..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPT--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcc--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 78999877777889998765431 1255688888777 344566778776543 678999999998
Q ss_pred CHHHH
Q 021127 109 TLRKY 113 (317)
Q Consensus 109 ~L~~~ 113 (317)
+|...
T Consensus 78 ~l~~~ 82 (244)
T cd05150 78 PAAAL 82 (244)
T ss_pred cHhHh
Confidence 77643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-06 Score=70.09 Aligned_cols=129 Identities=26% Similarity=0.368 Sum_probs=93.7
Q ss_pred Cceeecceeccccc-eEEEEeEECCeEEEEEEeec---CCCh--------H-----HHHHHHHHHHHHHHHHHhc---CC
Q 021127 24 KHLFVGPRIGEGAH-AKVYEGKYKNQTVAIKIVHK---GETP--------E-----EIAKKESRFAREVAMLSRV---QH 83 (317)
Q Consensus 24 ~~y~~~~~lG~G~~-g~V~~~~~~~~~vaiK~~~~---~~~~--------~-----~~~~~~~~~~~E~~~l~~l---~h 83 (317)
.+++.++.||.|.- |.||+++..|+.+|||++.. .... . ........|..|.+...+| .+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999322 1110 0 0012234688898888887 35
Q ss_pred CCe--eeEEeeee-c------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 021127 84 RNL--VKFIGACK-E------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142 (317)
Q Consensus 84 ~ni--v~l~~~~~-~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH 142 (317)
.++ |+.+||.. + ....||.||.+... .++..+ +.+|.+-|..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHHHH
Confidence 566 99999871 1 12468888886644 133333 456777789999
Q ss_pred hCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 143 ~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~------~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR------GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc------CCEEEecccC
Confidence 999999999999984 2489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=86.30 Aligned_cols=77 Identities=17% Similarity=0.283 Sum_probs=55.9
Q ss_pred cceeccccceEEEEeEECC----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCe--eeEEeeeec----Cc
Q 021127 29 GPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNL--VKFIGACKE----PV 97 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~----~~ 97 (317)
.+.++.|.++.+|+....+ ..+++|+.+...... ....+.+|+++++.+. |.+| ++++.+|.+ +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~----~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ----SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc----cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 5678999999999987653 468888765443211 1224778999999984 6655 888888765 36
Q ss_pred eEEEEEccCCCC
Q 021127 98 MVIVTELLSGGT 109 (317)
Q Consensus 98 ~~lv~e~~~~g~ 109 (317)
.|+||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 789999998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.3e-06 Score=72.29 Aligned_cols=72 Identities=14% Similarity=0.218 Sum_probs=45.6
Q ss_pred ceeccccce-EEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC---CeeeEEeeeec----CceEEE
Q 021127 30 PRIGEGAHA-KVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR---NLVKFIGACKE----PVMVIV 101 (317)
Q Consensus 30 ~~lG~G~~g-~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~----~~~~lv 101 (317)
+.++.||.. .||+. +..+++|..+.... ...+.+|.+++..+... -+.++++.... +..++|
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~-------~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGY-------AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccch-------HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457777776 59975 34577887554221 22477888888877432 34555554432 235889
Q ss_pred EEccCCCCHH
Q 021127 102 TELLSGGTLR 111 (317)
Q Consensus 102 ~e~~~~g~L~ 111 (317)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.2e-06 Score=71.02 Aligned_cols=99 Identities=23% Similarity=0.289 Sum_probs=79.0
Q ss_pred HHHHHHHHhcCC-CCeeeEEeeeecCceEEEEEccCCCCHHHH---HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 021127 72 AREVAMLSRVQH-RNLVKFIGACKEPVMVIVTELLSGGTLRKY---LLNMRPRCLDVCVAIGFALDIARAMECLHS---H 144 (317)
Q Consensus 72 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~ 144 (317)
..|.-+++.+++ +++++++|+|.+ ++|.||...+++... +..... .+|..+.+|+.++++.+.++++ .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~--~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQ--SPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccc--cCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888865 699999999965 578999977665421 111111 6899999999999999999998 3
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+.-.|++++|+-++.+ +.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 57788999999999988 78999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-05 Score=70.63 Aligned_cols=79 Identities=18% Similarity=0.082 Sum_probs=57.8
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC---CCeeeEEeeeec----Cc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH---RNLVKFIGACKE----PV 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~----~~ 97 (317)
...-.+.||.|..+.||+....+..+++|..+..... ..+..|.+.++.+.. -.++++++++.. +.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~-------~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFSTP-------GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccccc-------hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3344567999999999998776567788875432121 247889999988843 468899988753 46
Q ss_pred eEEEEEccCCCCH
Q 021127 98 MVIVTELLSGGTL 110 (317)
Q Consensus 98 ~~lv~e~~~~g~L 110 (317)
.+||||+++|+++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.9e-07 Score=82.30 Aligned_cols=118 Identities=20% Similarity=0.322 Sum_probs=80.2
Q ss_pred HHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCcccccccc-c---------ccccccCccceeccccccc
Q 021127 131 ALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E---------MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 131 ~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~---------~~~~~~gt~~y~aPE~~~~ 199 (317)
+.+++.||.|+|.. ++||++|.|++|.++.+ +.+||+.|+.+...... . ..........|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34555999999975 89999999999999998 79999999987643221 0 0011124568999998765
Q ss_pred cccccc----------------ccccccCC---------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHH
Q 021127 200 VTLRQG----------------EKKHYNHK---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 248 (317)
Q Consensus 200 ~~~~~~----------------~~~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~ 248 (317)
...... ........ .......++|.++++=+.+++..++..||++..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 221111 00000000 11122467899999999999999999999877765
Q ss_pred H
Q 021127 249 Q 249 (317)
Q Consensus 249 ~ 249 (317)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 4
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.28 E-value=3e-05 Score=63.30 Aligned_cols=133 Identities=20% Similarity=0.324 Sum_probs=89.5
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHH-----------HHHHHHHHHHHHHHHhcC------CCCeeeEEe
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-----------AKKESRFAREVAMLSRVQ------HRNLVKFIG 91 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~------h~niv~l~~ 91 (317)
...||+|+.-.||.--. +...+||+.......... .....+..+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 35689999999997533 345678988766500000 011234566666666655 889999999
Q ss_pred eeecC-ceEEEEEccCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--
Q 021127 92 ACKEP-VMVIVTELLSG------GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-- 162 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~-- 162 (317)
+.+.+ ...+|+|...+ .+|.+++.+.. ++. . +...+-+-..||-+.+|+.+|++|.||++....
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99876 67888887643 36888885432 555 2 333444555688889999999999999997432
Q ss_pred C-ceEEcc
Q 021127 163 K-TIKLAD 169 (317)
Q Consensus 163 ~-~~kl~D 169 (317)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.6e-07 Score=87.00 Aligned_cols=104 Identities=15% Similarity=0.123 Sum_probs=69.1
Q ss_pred cccCCCCC-cEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC---------
Q 021127 147 IHRDLKPE-NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------- 213 (317)
Q Consensus 147 vH~Dlkp~-Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------- 213 (317)
.|++..|. |++++.. +..++.|||.++...... ......||+.|+|||++.+..+. ...++|..+
T Consensus 499 ~~~~~~p~~~~~~~p~-~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG 576 (669)
T cd05610 499 PTQKPRPHGNLYQTPK-QVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTG 576 (669)
T ss_pred CCCCCCCCCceeECCc-cccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHC
Confidence 45666666 5566655 577889999987543221 12345799999999998764432 222222221
Q ss_pred ---------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ---------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
........++..+.+++..||..||.+||++.+++++.+
T Consensus 577 ~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~ 636 (669)
T cd05610 577 IPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636 (669)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHh
Confidence 001112356788999999999999999999999999844
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.25 E-value=9e-06 Score=69.56 Aligned_cols=136 Identities=18% Similarity=0.179 Sum_probs=78.8
Q ss_pred eccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecCceEEEEEccCCCCH
Q 021127 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPVMVIVTELLSGGTL 110 (317)
Q Consensus 32 lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~g~L 110 (317)
+..|-.+.+|+....+..+++|......... .....+|..+++.+.... .+++++... -++||||++|..+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL-----GVDRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc-----cCcHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCccc
Confidence 4567778999988778889999765432211 002356888888774322 345555443 3689999988765
Q ss_pred HH--------------HHHhcCC-----CCCCHHH-HHHHHHHH---------HHHHHHHHh--------CCccccCCCC
Q 021127 111 RK--------------YLLNMRP-----RCLDVCV-AIGFALDI---------ARAMECLHS--------HGIIHRDLKP 153 (317)
Q Consensus 111 ~~--------------~l~~~~~-----~~l~~~~-~~~i~~~i---------~~~L~~lH~--------~~ivH~Dlkp 153 (317)
.. .+.+-.. .+++... +..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111111 1122211 11221111 111222211 2589999999
Q ss_pred CcEEeeCCCCceEEcccCcccccc
Q 021127 154 ENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.||+++.+ + +.|+||..+...+
T Consensus 156 ~Nil~~~~-~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 156 YNLVVTPQ-G-LKLIDWEYASDGD 177 (256)
T ss_pred CcEEEeCC-C-CEEEeccccCcCC
Confidence 99999987 4 7899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.20 E-value=2e-05 Score=69.29 Aligned_cols=143 Identities=19% Similarity=0.236 Sum_probs=84.1
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeee-------c
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACK-------E 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-------~ 95 (317)
.....+.++.|....+|+...++..+++|+........ .+..|.+++..|.. -.+++++.... +
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~-------~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAE-------ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCCCHH-------HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 34456677888778999987766678899876543222 23445666666632 22455554321 3
Q ss_pred CceEEEEEccCCCCHH-----------HHHH---hcCCC---C----C---CHHHHH------------HHHHHHHHHHH
Q 021127 96 PVMVIVTELLSGGTLR-----------KYLL---NMRPR---C----L---DVCVAI------------GFALDIARAME 139 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~-----------~~l~---~~~~~---~----l---~~~~~~------------~i~~~i~~~L~ 139 (317)
+..++|++|++|..+. ..+. ..... . . .|.... .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 4578999999885432 1111 10000 0 0 011000 01112333455
Q ss_pred HHHh-------CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 140 ~lH~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++.. .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 5542 589999999999999987 5568999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.2e-05 Score=66.21 Aligned_cols=72 Identities=18% Similarity=0.233 Sum_probs=46.8
Q ss_pred ceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~ 105 (317)
+.|..|-...+|+.... +..|++|+........ ....+|+.+++.+. +.-.+++++.+.+ .+||||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~------~d~~~E~~~~~~l~~~gl~P~v~~~~~~---~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI------IDRERELRIHKLLSKHGLAPKLYATFQN---GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce------ecHHHHHHHHHHHHhCCCCCeEEEEeCC---cEEEEee
Confidence 45777888899998765 4788999765432111 11236788888773 3334566554432 4799999
Q ss_pred CCCCH
Q 021127 106 SGGTL 110 (317)
Q Consensus 106 ~~g~L 110 (317)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=3.6e-07 Score=84.48 Aligned_cols=161 Identities=21% Similarity=0.210 Sum_probs=112.5
Q ss_pred eeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeee-cCceEEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACK-EPVMVIVT 102 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~-~~~~~lv~ 102 (317)
+...+-+++|+.+++++.+.+ .+....+.+.... ...-++++|.+++||| .+..++.++ +...++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~l----------~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL----------SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccch----------hhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 345666799999999998876 3334456554331 1345789999999999 666666555 44889999
Q ss_pred EccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc
Q 021127 103 ELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181 (317)
Q Consensus 103 e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~ 181 (317)
+++.++ +...... .....+..-+...+...-+++|+++|+.--+|+| ||+..+. ..+..||+..........
T Consensus 314 ~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 314 RICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccc
Confidence 999776 2211111 0111244445556677788899999998888998 8887764 689999999887665555
Q ss_pred cccccCccceeccccccccccc
Q 021127 182 MTAETGTYRWMAPELYSTVTLR 203 (317)
Q Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~ 203 (317)
.....+++.++|||+.....+.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~ 408 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTID 408 (829)
T ss_pred cccCCCCCCCCCchhhcccccc
Confidence 5667899999999976654433
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.5e-05 Score=69.79 Aligned_cols=138 Identities=19% Similarity=0.190 Sum_probs=82.6
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC--CeeeEEeee-------ecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR--NLVKFIGAC-------KEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~-------~~~~~~ 99 (317)
.+.|..|....+|+....+..+++|+... ... ..+..|++++..+.+. .+++++... .++..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-VSA-------EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-CCh-------HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 45677788889999877777899998765 211 1355677777776322 355555432 133568
Q ss_pred EEEEccCCCCHHH-----------HHH---hcC----CC-----CCCHHHHH----------HHHHHHHHHHHHHHh---
Q 021127 100 IVTELLSGGTLRK-----------YLL---NMR----PR-----CLDVCVAI----------GFALDIARAMECLHS--- 143 (317)
Q Consensus 100 lv~e~~~~g~L~~-----------~l~---~~~----~~-----~l~~~~~~----------~i~~~i~~~L~~lH~--- 143 (317)
+|+++++|..+.. .+. ... .. ...+.... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998876421 111 000 00 01111100 011112334444443
Q ss_pred ----CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 ----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ----~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 379999999999999986 5568999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.4e-05 Score=68.38 Aligned_cols=80 Identities=20% Similarity=0.092 Sum_probs=52.5
Q ss_pred cceeccccceEEEEeEECC--eEEEEEEeecCCC--hHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeecCceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGET--PEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKEPVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~--~~vaiK~~~~~~~--~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~lv 101 (317)
.+.||.|.++.||++...+ +.|+||.-..... .+.-.....+...|.+.|..+ ...++++++.+.. ...++|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lV 109 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTV 109 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEE
Confidence 4678999999999998874 4899997431110 000001133566677777775 2356788887744 457899
Q ss_pred EEccCCCC
Q 021127 102 TELLSGGT 109 (317)
Q Consensus 102 ~e~~~~g~ 109 (317)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00016 Score=64.00 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=75.8
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeee-------ecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGAC-------KEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~-------~~~~~~ 99 (317)
.+.|+.|....+|+...++..+++|++. ..... .+..|+..+..|. .-.+++.+... ..+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~~~-------~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-RLTAE-------DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-cCChH-------HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4557778778999988776689999876 22211 1223444444442 11234444321 234678
Q ss_pred EEEEccCCCCH-----------HHHHHhc---CC-------C--CCCH-HHHHH------------HHHH-HHHHHHHHH
Q 021127 100 IVTELLSGGTL-----------RKYLLNM---RP-------R--CLDV-CVAIG------------FALD-IARAMECLH 142 (317)
Q Consensus 100 lv~e~~~~g~L-----------~~~l~~~---~~-------~--~l~~-~~~~~------------i~~~-i~~~L~~lH 142 (317)
++++|++|..+ .+.+.+. .. . .+.+ ..... .+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 99999988743 1122110 00 0 0111 11111 1111 111222332
Q ss_pred -------hCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 143 -------SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 143 -------~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||+|+.|+||+++.+ ...-|+||+.+..
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~ 217 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN 217 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence 2389999999999999966 4457999999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=9.4e-05 Score=64.91 Aligned_cols=73 Identities=18% Similarity=0.243 Sum_probs=45.9
Q ss_pred ceeccccceEEEEeEEC--------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecCceEE
Q 021127 30 PRIGEGAHAKVYEGKYK--------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEPVMVI 100 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~l 100 (317)
+.|..|-...+|+.... ++.+++|+....... .....+|.+++..+.. .-.+++++.+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL------LIDRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc------eechHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 34556666789988765 378999986653221 1124567777777732 224566666643 35
Q ss_pred EEEccCCCCHH
Q 021127 101 VTELLSGGTLR 111 (317)
Q Consensus 101 v~e~~~~g~L~ 111 (317)
|++|++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00018 Score=64.22 Aligned_cols=151 Identities=20% Similarity=0.294 Sum_probs=86.5
Q ss_pred CCcee--ecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-e
Q 021127 16 DAKWL--IDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-L 86 (317)
Q Consensus 16 ~~~~~--i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i 86 (317)
...|. .+++.+.+... -.|-...+|+.... ++.|++|+........ . ...+|..+++.+..-+ -
T Consensus 27 ~~~w~~~~~~~~~~i~~l-~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-----i-dR~~E~~~~~~l~~~gl~ 99 (344)
T PLN02236 27 ASKWGDVVDDEALQVIPL-KGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-----F-DRDDEIRTFECMSRHGQG 99 (344)
T ss_pred cchhcCCCCcCcEEEEEc-CCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-----e-chHHHHHHHHHHHHcCCC
Confidence 44564 25556666644 34777899998753 3678999876543211 1 1256888888874333 3
Q ss_pred eeEEeeeecCceEEEEEccCCCCHHHH--------------HH---hcC-C--C-CCCHHHHHHHHHHH-----------
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLRKY--------------LL---NMR-P--R-CLDVCVAIGFALDI----------- 134 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~~~--------------l~---~~~-~--~-~l~~~~~~~i~~~i----------- 134 (317)
+++++.+.++ .|.+|+++.+|... +. ... . . ...++.+..+..++
T Consensus 100 P~~~~~~~~g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~ 176 (344)
T PLN02236 100 PRLLGRFPNG---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKE 176 (344)
T ss_pred CceEEEECCc---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhh
Confidence 4666766544 57899987766421 11 101 0 0 11122222332111
Q ss_pred ------HHHHHHH----H----hCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 135 ------ARAMECL----H----SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 135 ------~~~L~~l----H----~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
...+..| . ...++|+|+++.||+++++.+.+.++||..+...
T Consensus 177 ~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 177 FRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1111122 1 2258999999999999864357999999998743
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.2e-05 Score=67.67 Aligned_cols=137 Identities=23% Similarity=0.281 Sum_probs=91.6
Q ss_pred eeecceeccccceEEEEeEEC-CeEEEEEEeecCC-----------------ChHHHHHHHHHHHHHHHHHHhcC-C-CC
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGE-----------------TPEEIAKKESRFAREVAMLSRVQ-H-RN 85 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~l~-h-~n 85 (317)
+.+++.||-|.=+.||.+.+. |++.++|.=+.+. ...|+.-.+-...+|...+..|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 457889999999999998886 8899998533221 11122222223445777777773 2 23
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
|++.++ .+..++|||++.|-.|.+.-+- .+..++. ..+..-+--|-..|+||+|+.--||+++.+ +.+
T Consensus 174 VPkpiD---~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly---~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i 241 (465)
T KOG2268|consen 174 VPKPID---HNRHCVVMELVDGYPLRQVRHV-----EDPPTLY---DDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI 241 (465)
T ss_pred CCCccc---ccceeeHHHhhcccceeeeeec-----CChHHHH---HHHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence 344333 3456789999999888764322 2333333 334444556778999999999999999987 689
Q ss_pred EEcccCccc
Q 021127 166 KLADFGLAR 174 (317)
Q Consensus 166 kl~Dfg~a~ 174 (317)
+++||-.+.
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999997654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0004 Score=60.73 Aligned_cols=139 Identities=19% Similarity=0.264 Sum_probs=81.2
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecC---ceEEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP---VMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~lv~ 102 (317)
+.+.+-.|-...+|....+++.+++. .+...... ....+..+|..+++.+. ---+.+.++.|.++ ..+.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPV---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccc---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 34444344444577776678889988 44322221 12233556777777763 33455667777543 579999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHH---------------------------------------
Q 021127 103 ELLSGGTLRKYLLNMRPRCLDVCVAIGFA-LDIARAMECLH--------------------------------------- 142 (317)
Q Consensus 103 e~~~~g~L~~~l~~~~~~~l~~~~~~~i~-~~i~~~L~~lH--------------------------------------- 142 (317)
+|++|..+.+.+.... .. ..++ ..+++.|+-||
T Consensus 105 ~~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 105 EWVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9998843322211100 00 0111 13333333333
Q ss_pred -----------hC--------CccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 143 -----------SH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 143 -----------~~--------~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
.+ .++|+|+.+.|++++.+ +-+-|.||+++...+.
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 22 48999999999999988 4688999999975443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00047 Score=61.28 Aligned_cols=150 Identities=17% Similarity=0.210 Sum_probs=84.6
Q ss_pred Ccee-ecCCceeecceeccccceEEEEeEECC-----eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCe-eeE
Q 021127 17 AKWL-IDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKF 89 (317)
Q Consensus 17 ~~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l 89 (317)
..|. ++.+.+++....| |-...+|+....+ ..|++|+........ -.-.+|..+++.+..-++ +++
T Consensus 7 ~~w~~~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~------IdR~~E~~il~~l~~~gl~P~~ 79 (330)
T PLN02421 7 KGWSDLDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV------IDRERELQAIKYLSAAGFGAKL 79 (330)
T ss_pred CccccCCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCcCeE------echHHHHHHHHHHHhcCCCCce
Confidence 3453 4456666666554 7777899886543 378899875432211 112467888888754444 566
Q ss_pred EeeeecCceEEEEEccCCCCHHH--------------HHHhcCCCC------C-CHHHHHHHHHHH--------------
Q 021127 90 IGACKEPVMVIVTELLSGGTLRK--------------YLLNMRPRC------L-DVCVAIGFALDI-------------- 134 (317)
Q Consensus 90 ~~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~------l-~~~~~~~i~~~i-------------- 134 (317)
++++..+ +|.+|++|..|.. .+....... . -+..+..+..++
T Consensus 80 l~~~~~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~ 156 (330)
T PLN02421 80 LGVFGNG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKY 156 (330)
T ss_pred eEEeCCc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhh
Confidence 6666443 5889987765521 111111100 1 122222222221
Q ss_pred --------HHHHHH---HH-hC----CccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 135 --------ARAMEC---LH-SH----GIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 135 --------~~~L~~---lH-~~----~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..-+.. +. .. -++|.|+.+.||+++.+.+.++++||..|...
T Consensus 157 ~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 157 ETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred cccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 111111 11 11 27999999999999854367999999998643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=60.00 Aligned_cols=85 Identities=18% Similarity=0.035 Sum_probs=53.8
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCCC---hHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEeeeecCceEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVIV 101 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~lv 101 (317)
-.+.||.|....||+....+..++||.-..... ..+ .....+-..|.+.|+.+. ..++++++.++.+. .+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~w-pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~-~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESW-PMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM-ALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccc-cCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC-CEEE
Confidence 466789999999999988777899997551111 000 001112233456665542 36888999888855 6678
Q ss_pred EEccCC--CCHHHHH
Q 021127 102 TELLSG--GTLRKYL 114 (317)
Q Consensus 102 ~e~~~~--g~L~~~l 114 (317)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3444433
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00035 Score=69.48 Aligned_cols=180 Identities=18% Similarity=0.162 Sum_probs=120.2
Q ss_pred HHHHHHHHHHhcCCCCeeeEEeeeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 70 RFAREVAMLSRVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 70 ~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
-..-|...+..+.|+|++.++.+-.+. ...+..++|.+.++...+..-.. ++....+.+..++..||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHh
Confidence 344577788888999999999887543 23456688999999998887554 88999999999999999999999
Q ss_pred CccccCCCCC---cEEeeCCCCceEEc--ccCcccccccccccccccCccceecccccccccccccc-cccccCC-----
Q 021127 145 GIIHRDLKPE---NLLLTEDLKTIKLA--DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE-KKHYNHK----- 213 (317)
Q Consensus 145 ~ivH~Dlkp~---Nill~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~~~~----- 213 (317)
...|.-+..+ +--.+.. +.+.++ ||+..+................+.|+|........... .+.|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ccceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 6666655555 3333433 355555 88887765554444444455667777765543322221 1111111
Q ss_pred -------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 -------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+......+.+...+|+..++++|+++.+++.+.-
T Consensus 385 ~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 000011122236788899999999999999999998743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00037 Score=61.32 Aligned_cols=143 Identities=22% Similarity=0.217 Sum_probs=92.1
Q ss_pred ecceeccccceEEEEeEEC-CeEEEEEEeecCCCh-------------------HHHHHHHH--HHHHHHHHHHhcCCCC
Q 021127 28 VGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-------------------EEIAKKES--RFAREVAMLSRVQHRN 85 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~-------------------~~~~~~~~--~~~~E~~~l~~l~h~n 85 (317)
+-..|..|-=+.||.+... |..+|||+++..... ..+++..- -...|++.|.+++.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 4456778888899998776 888999987532110 00011111 1234777788876554
Q ss_pred eeeEEeeeecCceEEEEEccCCCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCC
Q 021127 86 LVKFIGACKEPVMVIVTELLSGGTLR-KYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 86 iv~l~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~ 163 (317)
|.-- ....=....|||+|+....-- -.|. .-.++...+..+-.+++.-+.-|.+. ++||.||.--|+|+.. |
T Consensus 228 IP~P-ePIlLk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd--G 301 (520)
T KOG2270|consen 228 IPCP-EPILLKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD--G 301 (520)
T ss_pred CCCC-CceeeecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC--C
Confidence 3211 111112467999999432111 1122 22377778888888999888888764 8999999999999987 5
Q ss_pred ceEEcccCccccc
Q 021127 164 TIKLADFGLAREE 176 (317)
Q Consensus 164 ~~kl~Dfg~a~~~ 176 (317)
.+.|+|-+.+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 8999999887643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00096 Score=57.70 Aligned_cols=33 Identities=30% Similarity=0.537 Sum_probs=26.4
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|+|++|.||+++.+....-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 489999999999999752335699999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.001 Score=59.05 Aligned_cols=74 Identities=20% Similarity=0.164 Sum_probs=44.4
Q ss_pred eeccccceEEEEeEECC--eEEEEEEeec-----CCChHHHHHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeecCceEE
Q 021127 31 RIGEGAHAKVYEGKYKN--QTVAIKIVHK-----GETPEEIAKKESRFAREVAMLSRVQ--HR-NLVKFIGACKEPVMVI 100 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~~--~~vaiK~~~~-----~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~l 100 (317)
.||.|....||++...+ +.|+||.-.. ..... -...+..-|.+.|+... -| .+++++. +......+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wp---l~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWP---LTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCC---CCccHHHHHHHHHHHhhccCccccCeEEE-Ecccccee
Confidence 57999999999998774 5799996321 11100 11223345666665542 24 4555554 44445678
Q ss_pred EEEccCCC
Q 021127 101 VTELLSGG 108 (317)
Q Consensus 101 v~e~~~~g 108 (317)
|||+++..
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0032 Score=54.64 Aligned_cols=75 Identities=15% Similarity=0.135 Sum_probs=47.2
Q ss_pred eeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec-CceEEE
Q 021127 26 LFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~lv 101 (317)
++-.+.++-|....+|+....++.+.||+-..... ..|..|.+-|+.| ..-.+++++++... +..++|
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~--------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR--------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC--------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhH--------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 44566788899999999987789999998773222 2477888888888 34557788887653 356999
Q ss_pred EEccCCC
Q 021127 102 TELLSGG 108 (317)
Q Consensus 102 ~e~~~~g 108 (317)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0084 Score=52.73 Aligned_cols=30 Identities=27% Similarity=0.524 Sum_probs=25.7
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+++|+|+.+.||+++.+ .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~--~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDN--EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeCC--cEEEEECccccc
Confidence 478999999999999874 578999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.001 Score=59.85 Aligned_cols=75 Identities=20% Similarity=0.124 Sum_probs=46.3
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEe----ecCCChHHHHHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeecCceE
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIV----HKGETPEEIAKKESRFAREVAMLSRVQ--HR-NLVKFIGACKEPVMV 99 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~----~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~ 99 (317)
.+.||.|--..||++.+. ++.|+||.- +...... -...|..-|.+.|+... -| .+++++.+ ......
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swp---L~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFK---LSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCC---CChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhh
Confidence 667899999999999975 667999853 2211111 11223445666666552 33 45666644 444567
Q ss_pred EEEEccCC
Q 021127 100 IVTELLSG 107 (317)
Q Consensus 100 lv~e~~~~ 107 (317)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998854
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0078 Score=52.51 Aligned_cols=73 Identities=19% Similarity=0.246 Sum_probs=46.1
Q ss_pred ccccceEEEEeEEC----------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-------------CCCeeeE
Q 021127 33 GEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-------------HRNLVKF 89 (317)
Q Consensus 33 G~G~~g~V~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------------h~niv~l 89 (317)
|.|-.|.+|+++.+ ...++||..+..............|.+|+.+...+- ...++++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 67778889886542 245899997733333333344566778887776541 1345666
Q ss_pred EeeeecC-ceEEEEEcc
Q 021127 90 IGACKEP-VMVIVTELL 105 (317)
Q Consensus 90 ~~~~~~~-~~~lv~e~~ 105 (317)
+....++ ..+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 6666554 578899886
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0089 Score=52.85 Aligned_cols=136 Identities=23% Similarity=0.308 Sum_probs=79.5
Q ss_pred eccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCC---eeeEEeee---ecC--ceEE
Q 021127 32 IGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRN---LVKFIGAC---KEP--VMVI 100 (317)
Q Consensus 32 lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~~~---~~~--~~~l 100 (317)
|.+ .-..+|+....+..+++|+.+...... .+..|...+..|. .+- +..+=|-. ... ..+-
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~~~~~-------~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPGWTRA-------EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCCCCHH-------HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 456788888876666999998763222 2445666666662 221 22222211 123 6778
Q ss_pred EEEccCCCCHHH-----HHHh--------------cC---CC---CCCHHH-------------HHHHHHHHHHHHHHHH
Q 021127 101 VTELLSGGTLRK-----YLLN--------------MR---PR---CLDVCV-------------AIGFALDIARAMECLH 142 (317)
Q Consensus 101 v~e~~~~g~L~~-----~l~~--------------~~---~~---~l~~~~-------------~~~i~~~i~~~L~~lH 142 (317)
|++|++|..+.. .+.. .. +. ...|.. -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999987772 1110 00 00 122220 0113344555555555
Q ss_pred hC--------C--ccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 143 SH--------G--IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 143 ~~--------~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+. + +||+|+.|+||+++.+...+.++|||-+..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 42 3 999999999999998732388999998864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0024 Score=52.81 Aligned_cols=30 Identities=40% Similarity=0.633 Sum_probs=20.3
Q ss_pred CccccCCCCCcEEe-eCCCCceEEcccCcccc
Q 021127 145 GIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175 (317)
Q Consensus 145 ~ivH~Dlkp~Nill-~~~~~~~kl~Dfg~a~~ 175 (317)
.++|+|+.+.||++ +.+ +.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~-~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKD-GEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSS-SCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCC-CeEEEecHHHHhh
Confidence 58999999999999 444 6899999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=53.53 Aligned_cols=85 Identities=16% Similarity=0.278 Sum_probs=49.1
Q ss_pred Ccee-ecCCceeecceeccccceEEEEeEECC---eE-----EEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC-Ce
Q 021127 17 AKWL-IDPKHLFVGPRIGEGAHAKVYEGKYKN---QT-----VAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR-NL 86 (317)
Q Consensus 17 ~~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~~---~~-----vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-ni 86 (317)
..|. ++.+.+.+. .|..|-...+|++...+ .. |.++....... . .-.-.+|+.+++.+... .-
T Consensus 43 p~w~~~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~-l-----~IdR~~E~~i~~~Ls~~glg 115 (383)
T PTZ00384 43 PFWNNVNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNS-L-----VIDNDLQYNIAKLLGDNNFG 115 (383)
T ss_pred CccccCCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCc-e-----EeccHHHHHHHHHHHhCCCC
Confidence 3453 444555555 44458888999986542 12 44433211110 0 01124688888888544 44
Q ss_pred eeEEeeeecCceEEEEEccCCCCHH
Q 021127 87 VKFIGACKEPVMVIVTELLSGGTLR 111 (317)
Q Consensus 87 v~l~~~~~~~~~~lv~e~~~~g~L~ 111 (317)
.++++.+.+ ++|.||++|.+|.
T Consensus 116 P~l~~~f~~---g~l~efIeGr~l~ 137 (383)
T PTZ00384 116 PKIIGRFGD---FTIQEWVEGNTMG 137 (383)
T ss_pred CeEEEecCC---EEEEEEeccccCC
Confidence 666777654 5899999887764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.023 Score=50.06 Aligned_cols=30 Identities=20% Similarity=0.243 Sum_probs=26.9
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+++|+|+.++|++++.+ +.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 79999999999999887 6789999988864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.016 Score=59.20 Aligned_cols=32 Identities=38% Similarity=0.511 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEeeCCC-CceE-EcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDL-KTIK-LADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~-~~~k-l~Dfg~a~~ 175 (317)
.++||+|+.+.||+++.+. +.+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999762 1444 999998864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.019 Score=47.54 Aligned_cols=79 Identities=16% Similarity=0.180 Sum_probs=57.9
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec-CceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-PVMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-~~~~l 100 (317)
+++-.+.+.-|.....|...+...++-||+=.. .....|..|+.-|..| +.-.|.+++.+-.. .+.|+
T Consensus 17 ~i~er~~v~gG~inea~~v~dg~~~~FvK~n~~--------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl 88 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDGTDPFFVKCNQR--------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL 88 (286)
T ss_pred hhhcccccCCccccceeEeecCCcceEEEecch--------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence 445556677777788888888888999997432 3345688888877776 34567788877654 48999
Q ss_pred EEEccCCCCHH
Q 021127 101 VTELLSGGTLR 111 (317)
Q Consensus 101 v~e~~~~g~L~ 111 (317)
||||++-+.+.
T Consensus 89 Vle~L~~~~~d 99 (286)
T COG3001 89 VLEYLPTGPLD 99 (286)
T ss_pred EEeeccCCCCC
Confidence 99999887665
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.011 Score=48.65 Aligned_cols=157 Identities=15% Similarity=0.185 Sum_probs=90.2
Q ss_pred ccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHH
Q 021127 35 GAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKY 113 (317)
Q Consensus 35 G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~ 113 (317)
++.++.-.++.+-.+..+|.++.....- ...-|..+.++++++. .|+++..- ++ .+.++.|.|-....
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~----~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI----NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCccc----chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 4445555554442344555555433221 1224677888888775 47777632 33 67799999833110
Q ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccce
Q 021127 114 LLNMRPRCLDVCVAIGFALDIARAMECLHS--HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191 (317)
Q Consensus 114 l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 191 (317)
.. ..++..=+..|.-.|+ .+.+|+|-.|+|||-++. |.+||.|-+.--. .+..|
T Consensus 142 --------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~Ll~-----------~~V~~ 197 (308)
T PF07387_consen 142 --------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVCLLE-----------NQVNM 197 (308)
T ss_pred --------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhhhhh-----------heeeE
Confidence 10 1112222456777784 479999999999999998 8999998653310 11122
Q ss_pred ecccccccccccccccccccCCCCCCCCCCChHHHHHHHHHhhhcCCCCC-CCHHHH
Q 021127 192 MAPELYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQI 247 (317)
Q Consensus 192 ~aPE~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~~ 247 (317)
.- +.+.+ .....+...++.+|+..-..+| .+.+++
T Consensus 198 vN-~~Y~~--------------------lT~~aE~~~fv~s~l~~v~~~~~~~~~ei 233 (308)
T PF07387_consen 198 VN-IEYES--------------------LTQEAEVKVFVKSCLKLVEKQRSAETEEI 233 (308)
T ss_pred Ee-eeccc--------------------cChHHHHHHHHHHHHHHHHHHhcCcHhhh
Confidence 22 11111 1233567778888888777766 456665
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.15 Score=45.32 Aligned_cols=29 Identities=31% Similarity=0.358 Sum_probs=24.4
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++||+|+.++||+++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d--~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D--GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence 3689999999999995 4 367999998864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.044 Score=50.62 Aligned_cols=83 Identities=16% Similarity=0.219 Sum_probs=49.5
Q ss_pred cee-ecCCceeecceeccccceEEEEeEEC----------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCe
Q 021127 18 KWL-IDPKHLFVGPRIGEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86 (317)
Q Consensus 18 ~~~-i~~~~y~~~~~lG~G~~g~V~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 86 (317)
.|. +.++++ -.+.|..|-...+|+.... ++.|++++.-.....- . .-.+|..+++.+...+|
T Consensus 99 ~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-----I-dR~~E~~v~~~ls~~gi 171 (442)
T PTZ00296 99 EWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-----Y-NPISEFEVYKTMSKYRI 171 (442)
T ss_pred ccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-----e-CHHHHHHHHHHHHHCCC
Confidence 354 455566 4556666777788988654 3578888765432211 1 12457777777744344
Q ss_pred -eeEEeeeecCceEEEEEccCCCCH
Q 021127 87 -VKFIGACKEPVMVIVTELLSGGTL 110 (317)
Q Consensus 87 -v~l~~~~~~~~~~lv~e~~~~g~L 110 (317)
.++++.+.+ +.|.+|++|.+|
T Consensus 172 ~P~l~~~f~g---g~I~efi~g~~l 193 (442)
T PTZ00296 172 APQLLNTFSG---GRIEEWLYGDPL 193 (442)
T ss_pred CCceEEEeCC---CEEEEeeCCccC
Confidence 356666543 357899987644
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.05 Score=55.56 Aligned_cols=32 Identities=22% Similarity=0.288 Sum_probs=25.7
Q ss_pred CCccccCCCCCcEEeeCCC-Cc---eEEcccCcccc
Q 021127 144 HGIIHRDLKPENLLLTEDL-KT---IKLADFGLARE 175 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~-~~---~kl~Dfg~a~~ 175 (317)
.++||+|+.+.||+++.+. +. .-|+|||.+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 5899999999999998652 22 37999998863
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 317 | ||||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-24 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-23 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-23 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-22 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-22 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-22 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-21 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-21 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-21 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-21 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-21 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-21 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-20 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-20 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-19 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-19 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 6e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 7e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 7e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 7e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 |
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 284 bits (730), Expect = 9e-96
Identities = 84/317 (26%), Positives = 133/317 (41%), Gaps = 63/317 (19%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ID K + V +G GA V + K++ + VAIK + + F E+ L
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA-------FIVELRQL 55
Query: 79 SRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARA 137
SRV H N+VK GAC PV +V E GG+L L P A+ + L ++
Sbjct: 56 SRVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 138 MECLHSH---GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
+ LHS +IHRDLKP NLLL +K+ DFG A + + MT G+ WMAP
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAP 172
Query: 195 ELYSTVTLRQGEKKHYNHK------------------------------------NVRPS 218
E++ E +Y+ K RP
Sbjct: 173 EVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTIL 277
+N+P+ + ++T CW +DP+ RP+ +I++++ + + + + + +S L
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS----L 280
Query: 278 PPESPGTSSLMTVRDDI 294
PP G +
Sbjct: 281 PPGEDGRVEPYVDFAEF 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 1e-94
Identities = 82/291 (28%), Positives = 130/291 (44%), Gaps = 57/291 (19%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
I L + +IG G+ V+ ++ VA+KI+ + + E F REVA++
Sbjct: 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN---EFLREVAIM 88
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIAR 136
R++H N+V F+GA + P + IVTE LS G+L + L R LD + A D+A+
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 137 AMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMA 193
M LH+ I+HR+LK NLL+ + T+K+ DFGL+R ++ T + GT WMA
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 194 PELYSTVTLRQGEKKHYNHK-----------------------------------NVRPS 218
PE+ + N K R
Sbjct: 208 PEVL--------RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259
Query: 219 A-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 268
N+ +++ I+ CW +P RP+F I+ +L + + PP P+R
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP----PNR 306
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 6e-93
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 58/288 (20%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES 69
E + + +IG+G V++G+ VAIK + G++ E E
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 70 R--FAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
F REV ++S + H N+VK G P +V E + G L LL+ + + V
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHPIKWSVK 124
Query: 128 IGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLK----TIKLADFGLAREESLTEM 181
+ LDIA +E + + I+HRDL+ N+ L + K+ADFGL+++
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHS 182
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------- 213
++ G ++WMAPE E++ Y K
Sbjct: 183 VSGLLGNFQWMAPETIG------AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
Query: 214 ---------NVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+RP+ E+ P L ++ CW DP RP+F+ I++ L
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-92
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 51/278 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
+W I + L +G IG+G +VY G++ VAI+++ E+ K F REV
Sbjct: 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLK---AFKREVMA 82
Query: 78 LSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ +H N+V F+GAC P + I+T L G TL + + + LDV A +I +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVK 141
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT------EMMTAETGTYR 190
M LH+ GI+H+DLK +N+ D + + DFGL + + + + G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 191 WMAPELYSTVTL-RQGEKKHYNHK----------------------------------NV 215
+APE+ ++ + +K ++ +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259
Query: 216 RP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+P S + +E+S IL CW + RP FT+++ ML
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 3e-91
Identities = 53/278 (19%), Positives = 104/278 (37%), Gaps = 54/278 (19%)
Query: 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFARE 74
++ ID K L ++ E ++++G+++ + +K++ + ++ F E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR---DFNEE 57
Query: 75 VAMLSRVQHRNLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
L H N++ +GAC+ P ++T + G+L L +D A+ FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 132 LDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
LD+AR M LH+ I L ++++ ED+ T +++ +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAP 172
Query: 190 RWMAPELYSTVTLRQGEKKHYNHK-----------------------------------N 214
W+APE L++ +
Sbjct: 173 AWVAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 215 VRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+RP+ + +S ++ C EDP RP F I+ +L
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 4e-91
Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 60/280 (21%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
ID L + IG G KVY + VA+K + E+I++ +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARH-DPDEDISQTIENVRQEAKLF 60
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+ ++H N++ G C KEP + +V E GG L + L + + + + +A+ IAR
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARG 117
Query: 138 MECLHSHG---IIHRDLKPENLLLTEDL-------KTIKLADFGLAREESLTEMMTAETG 187
M LH IIHRDLK N+L+ + + K +K+ DFGLARE T M+A G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AG 176
Query: 188 TYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------- 213
Y WMAPE+ ++
Sbjct: 177 AYAWMAPEVI--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 214 -NVRPS-AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ PE + ++ CW DP++RP+FT I+ L
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 2e-89
Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 54/294 (18%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGET 60
M+ + W I + VG RIG G+ VY+GK+ VA+K+++
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP 59
Query: 61 PEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPR 120
+ + F EV +L + +H N++ F+G P + IVT+ G +L +L +
Sbjct: 60 TPQQLQ---AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK 116
Query: 121 CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
++ I A AR M+ LH+ IIHRDLK N+ L ED T+K+ DFGLA E+S
Sbjct: 117 -FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWS 174
Query: 181 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------ 213
+G+ WMAPE+ +R + Y+ +
Sbjct: 175 GSHQFEQLSGSILWMAPEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
Query: 214 ------------NVRPSA----ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
++ P N P+ + ++ C K+ + RP+F +I+ +
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-79
Identities = 70/296 (23%), Positives = 108/296 (36%), Gaps = 50/296 (16%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA 76
+ P L G +G+G + + ++ + + EE + F +EV
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT---FLKEVK 59
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++H N++KFIG K+ + +TE + GGTLR + +M + + FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIA 118
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-------------- 181
M LHS IIHRDL N L+ E+ + +ADFGLAR +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 182 -MTAETGTYRWMAPEL----------------------------YSTVTLRQGEKKHYNH 212
G WMAPE+ R +
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
Query: 213 KNVRPSA-ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPH 267
+ N P I C DP RP+F ++ L +A P+ P
Sbjct: 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQ 293
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-68
Identities = 61/311 (19%), Positives = 113/311 (36%), Gaps = 82/311 (26%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
K + + +IG+G + +V+ GK++ + VA+K+ E + E+
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQT 85
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N++ FI A + + ++T+ G+L YL + LD + A
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYS 142
Query: 134 IARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---- 181
+ LH+ I HRDLK +N+L+ ++ T +AD GLA +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDI 201
Query: 182 -MTAETGTYRWMAPEL------------------YS---------TVTLRQGEKKHYN-- 211
GT R+M PE+ YS + G + Y
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 212 -------------------HKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQ 246
K +RPS ++ ++ ++T CW +P +R +
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 247 IIQMLLNYLSA 257
+ + L +
Sbjct: 322 VKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 4e-66
Identities = 59/300 (19%), Positives = 110/300 (36%), Gaps = 82/300 (27%)
Query: 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+ + + +G+G + +V+ G ++ + VA+KI + +K E+ ++H
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRH 61
Query: 84 RNLVKFIGAC-----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
N++ FI + + ++T G+L YL + LD + L IA +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGL 118
Query: 139 ECLHS--------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-----TAE 185
LH I HRDLK +N+L+ ++ +AD GLA S +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 186 TGTYRWMAPEL------------------YS---------TVTLRQGEKKHYN------- 211
GT R+MAPE+ ++ + G + Y
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 212 --------------HKNVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
RP+ ++ L+ ++ CW ++P+AR +I + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-64
Identities = 63/305 (20%), Positives = 107/305 (35%), Gaps = 82/305 (26%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ + + IG+G +V+ GK++ + VA+KI E ++ E+
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQT 90
Query: 79 SRVQHRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N++ FI A + +V++ G+L YL + V I AL
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALS 147
Query: 134 IARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADFGLAREES-----LTE 180
A + LH I HRDLK +N+L+ ++ T +AD GLA +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDI 206
Query: 181 MMTAETGTYRWMAPEL------------------YS---------TVTLRQGEKKHYN-- 211
GT R+MAPE+ Y+ G + Y
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 212 -------------------HKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQ 246
+ +RP+ N ++ I+ CW + AR +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 247 IIQML 251
I + L
Sbjct: 327 IKKTL 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-59
Identities = 61/333 (18%), Positives = 101/333 (30%), Gaps = 97/333 (29%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM- 77
+D +L + IG G + VY+G + VA+K+ F E +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN--------RQNFINEKNIY 59
Query: 78 -LSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+ ++H N+ +FI + +V E G+L KYL D +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 131 ALDIARAMECLHS---------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
A + R + LH+ I HRDL N+L+ D T ++DFGL+ + +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRL 175
Query: 182 ---------MTAETGTYRWMAP-----------------------------ELYS--TVT 201
+E GT R+MAP E++ T
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 202 LRQGEKKHYN---------------------HKNVRP-------SAENVPEELSIILTSC 233
Y + RP L + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 234 WKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
W +D AR + + + + + P
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 5e-59
Identities = 64/305 (20%), Positives = 103/305 (33%), Gaps = 82/305 (26%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
L + G V++ + N+ VA+KI + K+ + EV L
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------KQSWQNEYEVYSL 72
Query: 79 SRVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++H N+++FIGA K + ++T G+L +L + + A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAET 129
Query: 134 IARAMECLHSH----------GIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTE 180
+AR + LH I HRD+K +N+LL +L T +ADFGLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAG 188
Query: 181 MMTAETGTYRWMAPEL-----------------YS-------TVTLRQ---GEKKHYN-- 211
+ GT R+MAPE+ Y+ + G Y
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 212 -------------------HKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQ 246
HK RP + L + CW D AR +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 247 IIQML 251
+ + +
Sbjct: 309 VGERI 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-58
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 50/276 (18%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ W ++ K L + IG+G V G Y+ VA+K + T + F E
Sbjct: 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEA 65
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++++++H NLV+ +G ++ + IVTE ++ G+L YL + L + F+LD
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 125
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L + +HRDL N+L++ED K++DFGL +E S + + +
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVK 179
Query: 191 WMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSAE 220
W APE L+ + G + + +
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSF--GRVPYPRIPLKDVVPRVEKGYKMDAPD 237
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256
P + ++ +CW D RP+F Q+ + L + +
Sbjct: 238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-57
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 46/273 (16%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ W ++ K L + IG+G V G Y+ VA+K + T + F E
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEA 237
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+++++++H NLV+ +G ++ + IVTE ++ G+L YL + L + F+LD
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 297
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L + +HRDL N+L++ED K++DFGL +E S + + +
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS-----STQDTGKLPVK 351
Query: 191 WMAPE-------------------LYSTVTLRQ--------GEKKHYNHKNVR-PSAENV 222
W APE L+ + + + K + + +
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 411
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
P + ++ +CW D RP F Q+ + L +
Sbjct: 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-55
Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 49/284 (17%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVA 76
+W + + L + R+G G +V+ G Y T VA+K + +G + F E
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAEAN 60
Query: 77 MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++QH+ LV+ +EP+ I+TE + G+L +L L + + A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRWM 192
M + IHRDL+ N+L+++ L + K+ADFGLAR E TA G +W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNE-YTAREGAKFPIKWT 177
Query: 193 APE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSAENV 222
APE L VT G + N +N
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTH--GRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP---PEP 263
PEEL ++ CWKE P RP F + +L ++ +A P+P
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 4e-55
Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 48/279 (17%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAR 73
KW ++ + + ++G G + +VYEG +K + VA+K + + E F +
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLK 58
Query: 74 EVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E A++ ++H NLV+ +G C + P I+TE ++ G L YL + + V + A
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 188
I+ AME L IHRDL N L+ E+ +K+ADFGL+R + + TA G
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFP 175
Query: 189 YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PS 218
+W APE L+ T G + +
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY--GMSPYPGIDLSQVYELLEKDYRMER 233
Query: 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
E PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 40/277 (14%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G+G +V+ G + T VAIK + G E F +E
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQE 229
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +++H LV+ +EP+ IVTE +S G+L +L + L + + A
Sbjct: 230 AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 191
IA M + +HRDL+ N+L+ E+L K+ADFGLAR E + +W
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 192 MAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVP 223
APE L T + ++ V P P
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 407
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260
E L ++ CW+++P RP F + L +Y ++ P
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-54
Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 48/277 (17%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREV 75
KW+IDP L IG G V+ G + N+ VAIK + +G EE F E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEA 54
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ ++ H LV+ G C + P+ +VTE + G L YL R +G LD
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLD 112
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ M L +IHRDL N L+ E+ IK++DFG+ R + T+ TGT +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQ-YTSSTGTKFPVK 170
Query: 191 WMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSAE 220
W +PE ++ + G+ + N N
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSE--GKIPYENRSNSEVVEDISTGFRLYKPR 228
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ I+ CW+E P RP F+++++ L +
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-54
Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 48/276 (17%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVA 76
+ + + + +G G V GK+K Q VA+K++ +G E+ F +E
Sbjct: 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED------EFFQEAQ 55
Query: 77 MLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+ ++ H LVKF G C + P+ IVTE +S G L YL + L+ + D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDV 113
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YRW 191
M L SH IHRDL N L+ DL +K++DFG+ R + + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKW 171
Query: 192 MAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSAEN 221
APE ++ +L G+ + + N
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSL--GKMPYDLYTNSEVVLKVSQGHRLYRPHL 229
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ + I+ SCW E P RP F Q++ +
Sbjct: 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-53
Identities = 77/328 (23%), Positives = 136/328 (41%), Gaps = 68/328 (20%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
++ A ++ + +W + + + + +G+G+ VYEG K VAIK V++
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ E + F E +++ ++V+ +G +P +VI EL++ G L+ YL ++
Sbjct: 68 SMRERIE----FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSL 122
Query: 118 RPRC--------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169
RP + I A +IA M L+++ +HRDL N ++ ED T+K+ D
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGD 181
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEK 207
FG+ R+ T+ RWM+PE L+ TL E+
Sbjct: 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL--AEQ 239
Query: 208 KHYNHKNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254
+ N +P +N P+ L ++ CW+ +P RP+F +II +
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 255 LSAIAPPEPMIPHRIFNSENTILPPESP 282
+ EP F PE
Sbjct: 298 M------EPGFREVSFYYSEENKLPEPE 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-53
Identities = 81/271 (29%), Positives = 123/271 (45%), Gaps = 46/271 (16%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT--VAIKIVHKGETPEEIAKKESRFAREV 75
KW+++ + L +G +IG G +V+ G+ + VA+K + P+ AK F +E
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK----FLQEA 163
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+L + H N+V+ IG C K+P+ IV EL+ GG +L R L V + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGD 221
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
A ME L S IHRDL N L+TE +K++DFG++REE+ + +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 191 WMAPE-------------------LYSTVTLRQGEKKHYNHKN--VR---------PSAE 220
W APE L+ T +L G + N N R P E
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSL--GASPYPNLSNQQTREFVEKGGRLPCPE 338
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQML 251
P+ + ++ CW +P RP+F+ I Q L
Sbjct: 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 71/277 (25%), Positives = 116/277 (41%), Gaps = 40/277 (14%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G+G +V+ G + T VAIK + G E F +E
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQE 312
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +++H LV+ +EP+ IVTE +S G+L +L + L + + A
Sbjct: 313 AQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRW 191
IA M + +HRDL+ N+L+ E+L K+ADFGLAR E + +W
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 192 MAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVP 223
APE L T + ++ V P P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260
E L ++ CW+++P RP F + L +Y ++ P
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-53
Identities = 74/275 (26%), Positives = 115/275 (41%), Gaps = 48/275 (17%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREV 75
W IDPK L +G G V GK++ Q VAIK++ +G E+ F E
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEA 70
Query: 76 AMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ + H LV+ G C + P+ I+TE ++ G L YL MR R + D
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRHR-FQTQQLLEMCKD 128
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
+ AME L S +HRDL N L+ + +K++DFGL+R E T+ G+ R
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDE-YTSSVGSKFPVR 186
Query: 191 WMAPE-------------------LYSTVTLRQGEKKHYNHKN--VR---------PSAE 220
W PE ++ +L G+ + N
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL--GKMPYERFTNSETAEHIAQGLRLYRPH 244
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
E++ I+ SCW E + RP F ++ +L+ +
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 75/278 (26%), Positives = 116/278 (41%), Gaps = 47/278 (16%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAKKESRFA 72
+ I + + +G IGEG V++G Y + VAIK + K F
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FL 64
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+E + + H ++VK IG + PV I+ EL + G LR +L + LD+ I +A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS-LDLASLILYA 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
++ A+ L S +HRD+ N+L++ + +KL DFGL+R + A G
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 190 RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSA 219
+WMAPE ++ + G K KN P
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMH--GVKPFQGVKNNDVIGRIENGERLPMP 239
Query: 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
N P L ++T CW DP+ RP FT++ L L
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 83/286 (29%), Positives = 116/286 (40%), Gaps = 46/286 (16%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFARE 74
W I + L + ++G G +V+ Y T VA+K + G E F E
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE------AFLAE 233
Query: 75 VAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ +QH LVK KEP+ I+TE ++ G+L +L + + I F+
Sbjct: 234 ANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT---YR 190
IA M + IHRDL+ N+L++ L K+ADFGLAR E TA G +
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNE-YTAREGAKFPIK 350
Query: 191 WMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSAE 220
W APE L VT G + N P E
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTY--GRIPYPGMSNPEVIRALERGYRMPRPE 408
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
N PEEL I+ CWK P RP F I +L ++ +A IP
Sbjct: 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 73/277 (26%), Positives = 121/277 (43%), Gaps = 44/277 (15%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAR 73
KW ++ + + ++G G + +VYEG +K TVA+K + + E F +
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLK 265
Query: 74 EVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E A++ ++H NLV+ +G C + P I+TE ++ G L YL + + V + A
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--- 188
I+ AME L IHR+L N L+ E+ +K+ADFGL+R + + TA G
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFP 382
Query: 189 YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAE 220
+W APE L+ T + V E
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 442
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
PE++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-52
Identities = 82/312 (26%), Positives = 128/312 (41%), Gaps = 71/312 (22%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D KW L +G +GEGA +V + TVA+K++ T +
Sbjct: 23 ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 83 DLSD----LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRP 137
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ + +AR ME L S IHRDL N+L+TE+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VM 196
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTLR 203
K+ADFGLAR+ + + T +WMAPE ++ TL
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL- 255
Query: 204 QGEKKHYNHKNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250
G + +P N EL +++ CW P+ RP F Q+++
Sbjct: 256 -GGSPYPGIPVEELFKLLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 251 LLNYLSAIAPPE 262
L L+ E
Sbjct: 313 LDRILTLTTNEE 324
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-52
Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 47/278 (16%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFA 72
++ I + + + +GEG +VYEG Y N VA+K K T + K F
Sbjct: 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK----FM 61
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E ++ + H ++VK IG +EP I+ EL G L YL + L V + ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNS-LKVLTLVLYS 119
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY-- 189
L I +AM L S +HRD+ N+L+ +KL DFGL+R + A
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPI 178
Query: 190 RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-----------PSA 219
+WM+PE ++ ++ G++ + +N P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSF--GKQPFFWLENKDVIGVLEKGDRLPKP 236
Query: 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ P L ++T CW DP+ RP FT+++ L +
Sbjct: 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-52
Identities = 71/314 (22%), Positives = 121/314 (38%), Gaps = 59/314 (18%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIA 65
+ + LI + +G +G+G V E + K VA+K++
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-------KEPVMVIVTELLSGGTLRKYLLNMR 118
++ F RE A + H ++ K +G + P+ +++ + G L +LL R
Sbjct: 70 EE---FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 119 P----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
L + + F +DIA ME L S IHRDL N +L ED+ T+ +ADFGL+R
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSR 185
Query: 175 EESLTEMMTAETGT---YRWMAPE-------------------LYSTVTLRQGEKKHYNH 212
+ + + +W+A E ++ +T G+ +
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR--GQTPYAGI 243
Query: 213 KNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
+N +P EE+ ++ CW DP RP+FT + L N L ++
Sbjct: 244 ENAEIYNYLIGGNRLKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 260 PPEPMIPHRIFNSE 273
N E
Sbjct: 302 VLSTSQDPLYINIE 315
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-52
Identities = 80/312 (25%), Positives = 117/312 (37%), Gaps = 80/312 (25%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
+L D KW L G +G GA KV E TVA+K++ E
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC 121
E+ +LS + H N+V +GAC P +VI TE G L +L R
Sbjct: 71 EA----LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRRKRDSF 125
Query: 122 LDVCVA----------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
+ + + F+ +A+ M L S IHRDL N+LLT
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-IT 184
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTL- 202
K+ DFGLAR+ + +WMAPE L+ +L
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 203 -----------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFT 245
++G + + P E+ P E+ I+ +CW DP RP F
Sbjct: 245 SSPYPGMPVDSKFYKMIKEG------FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 246 QIIQMLLNYLSA 257
QI+Q++ +S
Sbjct: 297 QIVQLIEKQISE 308
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-52
Identities = 68/289 (23%), Positives = 111/289 (38%), Gaps = 52/289 (17%)
Query: 18 KWLIDPKHLFV--GPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESR 70
+I P L V IG G VY G + A+K +++ E+++
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ---- 72
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI 128
F E ++ H N++ +G C E ++V + G LR ++ N V I
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 131
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
GF L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR+ E + T
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKT 190
Query: 189 Y-----RWMAPE-----LYST--------------VTLRQGEKKHYNHKNVR-------- 216
+WMA E ++T +T G + +
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR--GAPPYPDVNTFDITVYLLQG 248
Query: 217 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262
E P+ L ++ CW RP+F++++ + S
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-52
Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 58/291 (19%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFA 72
+ID L +G +GEG V EG K VA+K + + + ++ F
Sbjct: 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE---FL 84
Query: 73 REVAMLSRVQHRNLVKFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRC----L 122
E A + H N+++ +G C P +++ + G L YLL R +
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM 182
+ + F +DIA ME L + +HRDL N +L +D+ T+ +ADFGL+++ +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYY 203
Query: 183 TAETGT---YRWMAPE-----LYST--------------VTLRQGEKKHYNHKNV----- 215
+W+A E +Y++ T G + +N
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR--GMTPYPGVQNHEMYDY 261
Query: 216 --------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258
+P E+ +EL I+ SCW+ DP RP F+ + L L ++
Sbjct: 262 LLHGHRLKQP--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 50/281 (17%)
Query: 16 DAKW-LIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKE 68
A ++ +G GA VY+G + + VAIK + + +P+ +
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-- 63
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
E +++ V + ++ + +G C V ++T+L+ G L Y+ + +
Sbjct: 64 --ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYL 119
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ + + IA+ M L ++HRDL N+L+ +K+ DFGLA+ E G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEG 178
Query: 188 T---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR--------- 216
+WMA E ++ +T G K +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF--GSKPYDGIPASEISSILEKGE 236
Query: 217 --PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
P ++ +I+ CW D ++RP F ++I
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-51
Identities = 87/341 (25%), Positives = 139/341 (40%), Gaps = 84/341 (24%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D +W + L +G +GEGA +V + VA+K++ T +
Sbjct: 57 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 116
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 117 DLSD----LISEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLQARRP 171
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
L+ + A +AR ME L S IHRDL N+L+TED +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VM 230
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTL- 202
K+ADFGLAR+ + T +WMAPE L+ TL
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 203 ----------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQ 246
++G H+ +P N EL +++ CW P+ RP F Q
Sbjct: 291 GSPYPGVPVEELFKLLKEG------HRMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQ 342
Query: 247 IIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSL 287
+++ L ++ + E + + + P T +L
Sbjct: 343 LVEDLDRIVALTSNQE-----MGYYHHHHHHDYDIPTTENL 378
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-51
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 84/315 (26%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
++ D KW K+L +G +GEG KV + + TVA+K++ + +P E+
Sbjct: 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 65 AKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCL 122
E +L +V H +++K GAC P+++IV E G+LR +L R
Sbjct: 71 RD----LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGP 125
Query: 123 DVCVA----------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
+ I FA I++ M+ L ++HRDL N+L+ E
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185
Query: 161 DLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYS 198
+K++DFGL+R+ + + +WMA E L+
Sbjct: 186 GR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244
Query: 199 TVTL-----------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNAR 241
VTL + G H+ RP +N EE+ ++ CWK++P+ R
Sbjct: 245 IVTLGGNPYPGIPPERLFNLLKTG------HRMERP--DNCSEEMYRLMLQCWKQEPDKR 296
Query: 242 PNFTQIIQMLLNYLS 256
P F I + L +
Sbjct: 297 PVFADISKDLEKMMV 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 75/316 (23%), Positives = 115/316 (36%), Gaps = 85/316 (26%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
E + D KW ++L G +G GA KV VA+K++ + E
Sbjct: 33 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRC 121
E+ M++++ H N+V +GAC P+ +I E G L YL + R +
Sbjct: 93 EA----LMSELKMMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRSKREKF 147
Query: 122 LDVCVA---------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
+ + + FA +A+ ME L +HRDL N+L+T
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 161 DLKTIKLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYS 198
K +K+ DFGLAR+ +WMAPE L+
Sbjct: 208 G-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266
Query: 199 TVTL------------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNA 240
+L + G K +P EE+ II+ SCW D
Sbjct: 267 IFSLGVNPYPGIPVDANFYKLIQNG------FKMDQP--FYATEEIYIIMQSCWAFDSRK 318
Query: 241 RPNFTQIIQMLLNYLS 256
RP+F + L L+
Sbjct: 319 RPSFPNLTSFLGCQLA 334
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 53/300 (17%)
Query: 8 YLADELKLDAK-WLI--DPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGE 59
L L + K LI + IG+G VY G+Y AIK + +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT 61
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+++ F RE ++ + H N++ IG E + ++ + G L +++ +
Sbjct: 62 EMQQVEA----FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP 117
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177
+ V I F L +AR ME L +HRDL N +L E T+K+ADFGLAR+
Sbjct: 118 QRN-PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDIL 175
Query: 178 LTEMMTAETGTY-----RWMAPE-------------------LYSTVTLRQGEKKHYNHK 213
E + + + +W A E L+ +T G + +
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR--GAPPYRHID 233
Query: 214 NVR-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262
P E P+ L ++ CW+ DP RP F ++ + +SA+
Sbjct: 234 PFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 75/284 (26%), Positives = 117/284 (41%), Gaps = 47/284 (16%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ-----TVAIKIVHKGETPEEIAK 66
+ + I + + +G IGEG V++G Y + VAIK + K
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 67 KESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVC 125
F +E + + H ++VK IG + PV I+ EL + G LR +L + LD+
Sbjct: 438 ----FLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS-LDLA 491
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE 185
I +A ++ A+ L S +HRD+ N+L++ + +KL DFGL+R + A
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKAS 550
Query: 186 TGTY--RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-------- 216
G +WMAPE ++ + G K KN
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH--GVKPFQGVKNNDVIGRIENG 608
Query: 217 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
P N P L ++T CW DP+ RP FT++ L L
Sbjct: 609 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 81/312 (25%), Positives = 127/312 (40%), Gaps = 71/312 (22%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D KW L +G +GEG +V + TVA+K++ T +
Sbjct: 69 ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRP 119
+++ E+ M+ + +H+N++ +GAC P+ VI E S G LR+YL RP
Sbjct: 129 DLSD----LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRP 183
Query: 120 RCLDVCVA--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
++ + +AR ME L S IHRDL N+L+TE+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VM 242
Query: 166 KLADFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTLR 203
K+ADFGLAR+ + + T +WMAPE ++ TL
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL- 301
Query: 204 QGEKKHYNHKNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250
G + +P N EL +++ CW P+ RP F Q+++
Sbjct: 302 -GGSPYPGIPVEELFKLLKEGHRMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 251 LLNYLSAIAPPE 262
L L+ E
Sbjct: 359 LDRILTLTTNEE 370
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 75/308 (24%), Positives = 126/308 (40%), Gaps = 54/308 (17%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRF 71
I P + IG G +VY+G K + VAIK + G T ++ F
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD----F 93
Query: 72 AREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
E ++ + H N+++ G +P+M I+TE + G L K+L V +G
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLREKDGE-FSVLQLVG 151
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT 188
IA M+ L + +HRDL N+L+ +L K++DFGL+R E E +G
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 189 ---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------- 216
RW APE ++ +T GE+ ++ N
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY--GERPYWELSNHEVMKAINDGFR 268
Query: 217 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 275
P+ + P + ++ CW+++ RP F I+ +L + A P+ + F+ +
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA---PDSLKTLADFDPRVS 325
Query: 276 ILPPESPG 283
I P + G
Sbjct: 326 IRLPSTSG 333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-51
Identities = 74/296 (25%), Positives = 119/296 (40%), Gaps = 69/296 (23%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAR 73
++D + IGEG +V + + K AIK + + + ++ FA
Sbjct: 19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----FAG 74
Query: 74 EVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA--- 127
E+ +L ++ H N++ +GAC + + + E G L +L R D A
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 128 -----------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176
+ FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R +
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQ 192
Query: 177 SLTEMMTAETGT---YRWMAPE-----LYST--------------VTLRQGEKKHYNHKN 214
E+ +T RWMA E +Y+T V+L G +
Sbjct: 193 ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--GGTPYCGMTC 247
Query: 215 V-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+P N +E+ ++ CW+E P RP+F QI+ L L
Sbjct: 248 AELYEKLPQGYRLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-51
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 50/289 (17%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESR 70
+ IG G VY G + A+K +++ E+++
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ---- 136
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAI 128
F E ++ H N++ +G C E ++V + G LR ++ N V I
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLI 195
Query: 129 GFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
GF L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR+ E + T
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKT 254
Query: 189 Y-----RWMAPE-----LYST--------------VTLRQGEKKHYNHKNVR-------- 216
+WMA E ++T +T G + +
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR--GAPPYPDVNTFDITVYLLQG 312
Query: 217 ---PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262
E P+ L ++ CW RP+F++++ + S
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-51
Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 68/314 (21%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
+ + + K++ + +G GA +VYEG+ VA+K + +
Sbjct: 13 CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ ++ F E ++S+ H+N+V+ IG P I+ EL++GG L+ +L
Sbjct: 73 SEQDELD----FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRET 127
Query: 118 RPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLAD 169
RPR L + + A DIA + L + IHRD+ N LLT K+ D
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGD 186
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEK 207
FG+AR+ +WM PE L+ +L G
Sbjct: 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL--GYM 244
Query: 208 KHYNHKNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL-- 252
+ + N P +N P + I+T CW+ P RPNF I++ +
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
Query: 253 ----NYLSAIAPPE 262
+ ++ P E
Sbjct: 303 TQDPDVINTALPIE 316
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 56/320 (17%), Positives = 111/320 (34%), Gaps = 57/320 (17%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKESRF 71
+ L +G G V++G + + V IK++ +
Sbjct: 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA----V 62
Query: 72 AREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+ + + H ++V+ +G C + +VT+ L G+L ++ R L + + +
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNW 120
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-- 188
+ IA+ M L HG++HR+L N+LL +++ADFG+A + +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 189 -YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNV----------R-P 217
+WMA E ++ +T G + + + R
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF--GAEPYAGLRLAEVPDLLEKGERLA 237
Query: 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTIL 277
+ ++ +++ CW D N RP F ++ P R +
Sbjct: 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD--------PPRYLVIKRESG 289
Query: 278 PPESPGTSSLMTVRDDIGET 297
P +PG + E
Sbjct: 290 PGIAPGPEPHGLTNKKLEEV 309
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 73/312 (23%), Positives = 122/312 (39%), Gaps = 64/312 (20%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGE 59
+ + + K++ + +G GA +VYEG+ VA+K + +
Sbjct: 54 CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 113
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNM 117
+ ++ F E ++S+ H+N+V+ IG P I+ EL++GG L+ +L
Sbjct: 114 SEQDELD----FLMEALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRET 168
Query: 118 RPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLAD 169
RPR L + + A DIA + L + IHRD+ N LLT K+ D
Sbjct: 169 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGD 227
Query: 170 FGLAREESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEK 207
FG+AR+ +WM PE L+ +L G
Sbjct: 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL--GYM 285
Query: 208 KHYNHKN------VR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL---- 252
+ + N V +N P + I+T CW+ P RPNF I++ +
Sbjct: 286 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
Query: 253 --NYLSAIAPPE 262
+ ++ P E
Sbjct: 346 DPDVINTALPIE 357
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 73/309 (23%), Positives = 110/309 (35%), Gaps = 76/309 (24%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEE 63
+L + KW +L G +G GA KV E VA+K++ +E
Sbjct: 33 TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPR 120
E+ ++S + QH N+V +GAC PV+VI TE G L +L
Sbjct: 93 KEA----LMSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRRKSRV 147
Query: 121 CLDVCVA------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
+ F+ +A+ M L S IHRD+ N+LLT K+
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIG 206
Query: 169 DFGLAREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTL---- 202
DFGLAR+ + +WMAPE L+ +L
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 203 --------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQII 248
+ G ++ +P P+ + I+ +CW +P RP F QI
Sbjct: 267 YPGILVNSKFYKLVKDG------YQMAQP--AFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 249 QMLLNYLSA 257
L
Sbjct: 319 SFLQEQAQE 327
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-50
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 49/285 (17%)
Query: 16 DAKWLIDPKHL-FVGPRIGEGAHAKVYEGKYKNQT----VAIKIVHKGETPEEIAKKESR 70
D K + +L +G G V +G Y+ + VAIK++ +G + +
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE---- 56
Query: 71 FAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
RE ++ ++ + +V+ IG C E +M +V E+ GG L K+L+ R + V
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAE 114
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAETGT 188
++ M+ L +HRDL N+LL K++DFGL++ + TA +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAG 173
Query: 189 ---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------- 216
+W APE ++ ++ G+K + K
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY--GQKPYKKMKGPEVMAFIEQGKR 231
Query: 217 -PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260
P EL +++ CW RP+F + Q + ++A
Sbjct: 232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-50
Identities = 69/286 (24%), Positives = 110/286 (38%), Gaps = 52/286 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT-----VAIKIVHKGETPEEIAKKESRFA 72
LI K L + ++G+G+ V G++ + VA+K + + A + F
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FI 69
Query: 73 REVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
REV + + HRNL++ G P+ +VTEL G+L L + + +A
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYA 127
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT-- 188
+ +A M L S IHRDL NLLL +K+ DFGL R + +
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 189 -YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNV-----------R- 216
+ W APE L+ T G++ R
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY--GQEPWIGLNGSQILHKIDKEGERL 244
Query: 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262
P E+ P+++ ++ CW P RP F L ++L P +
Sbjct: 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEAQPTD 286
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 53/295 (17%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIA 65
I+ + + IG G +V G+ + + VAIK + G T +
Sbjct: 36 GRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLD 123
F E +++ + H N+++ G M IVTE + G+L +L +
Sbjct: 96 D----FLSEASIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQ-FT 149
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMM 182
+ +G + M L G +HRDL N+L+ +L K++DFGL+R E +
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAA 208
Query: 183 TAETGT---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---- 216
TG RW APE ++ + GE+ ++N N
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAY--GERPYWNMTNRDVISS 266
Query: 217 -------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPM 264
P+ P L ++ CW +D RP F+QI+ +L + + PE +
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS---PESL 318
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-50
Identities = 79/310 (25%), Positives = 122/310 (39%), Gaps = 79/310 (25%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---- 76
Query: 71 FAREVAMLSRV-QHRNLVKFIGAC---KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
E+ +L + H N+V +GAC P+MVI E G L YL + R + V
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 127 A--------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172
A I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGL
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGL 194
Query: 173 AREESLTEMMTAETGT---YRWMAPE-------------------LYSTVTL-------- 202
AR+ + +WMAPE L+ +L
Sbjct: 195 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
Query: 203 ----------RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252
++G + P + E+ + CW +P+ RP F+++++ L
Sbjct: 255 KIDEEFCRRLKEG------TRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306
Query: 253 NYLSAIAPPE 262
N L A A +
Sbjct: 307 NLLQANAQQD 316
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-50
Identities = 62/318 (19%), Positives = 118/318 (37%), Gaps = 53/318 (16%)
Query: 16 DAKW-LIDPKHLFVGPRIGEGAHAKVYEGKYKNQ------TVAIKIVHKGETPEEIAKKE 68
A ++ +G GA VY+G + + VAIK + + +P+ +
Sbjct: 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-- 63
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
E +++ V + ++ + +G C V ++T+L+ G L Y+ + +
Sbjct: 64 --ILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN-IGSQYL 119
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
+ + + IA+ M L ++HRDL N+L+ +K+ DFGLA+ E G
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEG 178
Query: 188 T---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR--------- 216
+WMA E ++ +T G K +
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF--GSKPYDGIPASEISSILEKGE 236
Query: 217 --PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSEN 274
P ++ +I+ CW D ++RP F ++I P+ + + +
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD---PQRYLVIQGDERMH 293
Query: 275 TILPPESPGTSSLMTVRD 292
P +S +LM D
Sbjct: 294 LPSPTDSNFYRALMDEED 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-49
Identities = 66/292 (22%), Positives = 108/292 (36%), Gaps = 64/292 (21%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRF 71
I + +GE KVY+G Q VAIK + + F
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE----F 59
Query: 72 AREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA-- 127
E + +R+QH N+V +G +P+ ++ S G L ++L+ P
Sbjct: 60 RHEAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 128 ------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ IA ME L SH ++H+DL N+L+ + L +K++D GL RE
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLFRE 177
Query: 176 ESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEKKHYNHK 213
+ + RWMAPE L+ + G + + +
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY--GLQPYCGYS 235
Query: 214 N------VR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254
N +R P ++ P + ++ CW E P+ RP F I L +
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-49
Identities = 68/315 (21%), Positives = 119/315 (37%), Gaps = 76/315 (24%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKE 68
++ IGEGA +V++ + VA+K++ + + + A
Sbjct: 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-- 96
Query: 69 SRFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
F RE A+++ + N+VK +G C +P+ ++ E ++ G L ++L +M P +
Sbjct: 97 --FQREAALMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 127 A----------------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164
+ A +A M L +HRDL N L+ E++
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-V 212
Query: 165 IKLADFGLAREESLTEMMTAETGTY---RWMAPE-----LYST--------------VTL 202
+K+ADFGL+R + A+ RWM PE Y+T +
Sbjct: 213 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 203 RQGEKKHYNHKNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
G + +Y + P EN P EL ++ CW + P RP+F I +
Sbjct: 273 --GLQPYYGMAHEEVIYYVRDGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 250 MLLNYLSAIAPPEPM 264
+L +
Sbjct: 329 ILQRMCERAEGTVGV 343
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-49
Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 50/289 (17%)
Query: 11 DELKLDAKWLIDPKHL-FVGPRIGEGAHAKVYEGKYKNQ----TVAIKIVHKGETPEEIA 65
+E++ + +D K L +G G V +G Y+ + TVA+KI+ +
Sbjct: 4 EEIRPK-EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 66 KKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
+ E ++ ++ + +V+ IG C E M +V E+ G L KYL R +
Sbjct: 63 DE---LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH--VKD 116
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMT 183
I ++ M+ L +HRDL N+LL K++DFGL++ +
Sbjct: 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYK 175
Query: 184 AETGT---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR----- 216
A+T +W APE ++ + G+K + K
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY--GQKPYRGMKGSEVTAML 233
Query: 217 ------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
P E+ ++ CW D RP F + L NY +
Sbjct: 234 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-49
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 65/299 (21%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ +HL ++G+G V +Y + VA+K + + T E + F
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD----F 58
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L +QH N+VK+ G C + + ++ E L G+LR YL + R +D
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKL 116
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ + I + ME L + IHRDL N+L+ + +K+ DFGL + E +
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 187 GT---YRWMAPE-----LYST--------VTL-------------------RQGEKKHYN 211
W APE +S V L G K
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 212 HKNVR-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-49
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 65/299 (21%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ +HL ++G+G V +Y + VA+K + + T E + F
Sbjct: 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRD----F 89
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L +QH N+VK+ G C + + ++ E L G+LR YL + R +D
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER-IDHIKL 147
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ + I + ME L + IHRDL N+L+ + +K+ DFGL + E +
Sbjct: 148 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 187 GT---YRWMAPE-----LYST--------VTL-------------------RQGEKKHYN 211
W APE +S V L G K
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 266
Query: 212 HKNVR-----------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
P + P+E+ +I+T CW + N RP+F + + +A
Sbjct: 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-49
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 69/298 (23%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
I + + + +GEGA KV+ + N VA+K + K T
Sbjct: 9 VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAA----RKD 63
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA- 127
F RE +L+ +QH ++VKF G C +P++ +V E + G L K+L P + +
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 128 -------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
+ A IA M L S +HRDL N L+ +L +K+ DFG++R
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR 181
Query: 175 EESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEKKHYNH 212
+ T+ T RWM PE L+ T G++ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY--GKQPWFQL 239
Query: 213 KNV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
N RP P+E+ ++ CW+ +P R N +I ++L A
Sbjct: 240 SNTEVIECITQGRVLERP--RVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-49
Identities = 74/309 (23%), Positives = 123/309 (39%), Gaps = 56/309 (18%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFA 72
+D ++ + +G G +V G+ K +VAIK + G T ++ F
Sbjct: 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD----FL 94
Query: 73 REVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
E +++ + H N+++ G +PVM IVTE + G+L +L + V +G
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQ-FTVIQLVGM 152
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGT- 188
IA M+ L G +HRDL N+L+ +L K++DFGL R E E G
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 189 --YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR----------- 216
RW +PE L+ ++ GE+ ++ N
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY--GERPYWEMSNQDVIKAVDEGYRL 269
Query: 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY------LSAIAPPEPMIPHRIF 270
P + P L ++ CW++D N RP F QI+ +L L I + +
Sbjct: 270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLL 329
Query: 271 NSENTILPP 279
+ N +
Sbjct: 330 DQSNVDITT 338
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-49
Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 67/292 (22%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ + L +GEG KV +Y + VA+K + IA
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD----L 70
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +L + H N+VK+ G C + ++ E L G+L++YL + + +++
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPKNKNK-INLKQQ 128
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ +A+ I + M+ L S +HRDL N+L+ + +K+ DFGL + E+ E T +
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKD 187
Query: 187 GT---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-------- 216
W APE L+ +T +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY--CDSDSSPMALFLKMIGPTHG 245
Query: 217 -----------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
P N P+E+ ++ CW+ P+ R +F +I+
Sbjct: 246 QMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-49
Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 68/297 (22%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESR 70
I + + + +GEGA KV+ + N VA+K + K +
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD---- 89
Query: 71 FAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA- 127
F RE +L+ +QH+++V+F G C P++++ E + G L ++L + P +
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 128 ------------IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ A +A M L +HRDL N L+ + L +K+ DFG++R+
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRD 207
Query: 176 ESLTEMMTAETGTY---RWMAPE-------------------LYSTVTLRQGEKKHYNHK 213
T+ T RWM PE L+ T G++ Y
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY--GKQPWYQLS 265
Query: 214 NV-------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
N RP P E+ I+ CW+ +P R + + L A
Sbjct: 266 NTEAIDCITQGRELERP--RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 64/304 (21%), Positives = 106/304 (34%), Gaps = 69/304 (22%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRF 71
+ ++L +GEG KV Y + VA+K + P+ + +
Sbjct: 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG----W 80
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +L + H +++K+ G C + +V E + G+LR YL + +
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQL 136
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ FA I M LH+ IHRDL N+LL D +K+ DFGLA+ E
Sbjct: 137 LLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 187 GT---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR-------- 216
W APE LY +T +
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH--CDSSQSPPTKFLELIGIAQG 253
Query: 217 -----------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
P + P E+ ++ +CW+ + + RP F +I +L
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
Query: 260 PPEP 263
P
Sbjct: 314 GQAP 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 64/302 (21%), Positives = 107/302 (35%), Gaps = 64/302 (21%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRF 71
+ + +HL ++G+G V +Y VA+K + ++ F
Sbjct: 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-----DQQRDF 71
Query: 72 AREVAMLSRVQHRNLVKFIGAC----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
RE+ +L + +VK+ G ++ + +V E L G LR +L R R LD
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRAR-LDASRL 129
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET 186
+ ++ I + ME L S +HRDL N+L+ + +K+ADFGLA+ +
Sbjct: 130 LLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVRE 188
Query: 187 GT---YRWMAPE-------------------LYSTVTL-------RQGEKKHYNHKNVRP 217
W APE LY T + + P
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 218 SAENV----------------PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261
+ + P E+ ++ CW P RP+F+ + L S
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
Query: 262 EP 263
E
Sbjct: 309 ET 310
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-46
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 13/195 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA A V+ G++K AIK+ + + RE +L ++ H+N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKN 68
Query: 86 LVK---FIGACKEPVMVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECL 141
+VK V++ E G+L L L + D+ M L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 142 HSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
+GI+HR++KP N++ KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 199 TVTLRQGEKKHYNHK 213
LR+ +K Y
Sbjct: 189 RAVLRKDHQKKYGAT 203
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 13/195 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA A V+ G++K AIK+ + + RE +L ++ H+N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLNHKN 68
Query: 86 LVK---FIGACKEPVMVIVTELLSGGTLRKYLL-NMRPRCLDVCVAIGFALDIARAMECL 141
+VK V++ E G+L L L + D+ M L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 142 HSHGIIHRDLKPENLLLTEDL---KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
+GI+HR++KP N++ KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 199 TVTLRQGEKKHYNHK 213
LR+ +K Y
Sbjct: 189 RAVLRKDHQKKYGAT 203
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-45
Identities = 55/289 (19%), Positives = 109/289 (37%), Gaps = 67/289 (23%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQ---------TVAIKIVHKGETPEEIAKKES 69
I + L +G+G K+++G + V +K++ K +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES---- 58
Query: 70 RFAREVAMLSRVQHRNLVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
F +M+S++ H++LV G C + + +V E + G+L YL + +++
Sbjct: 59 -FFEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNC-INILWK 115
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-------TIKLADFGLAREESLTE 180
+ A +A AM L + +IH ++ +N+LL + IKL+D G++
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT----- 170
Query: 181 MMTAETGTY----RWMAPE--------------------LYSTVTLRQGEKKHYNHKN-- 214
W+ PE L+ + G+K +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG--GDKPLSALDSQR 226
Query: 215 VRPSAEN-------VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256
E+ EL+ ++ +C +P+ RP+F II+ L + +
Sbjct: 227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 1e-44
Identities = 63/288 (21%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQT----VAIKIVHKGETPEEIAK 66
+ELK +L L +G G V +G Y+ + VAIK++ +G + +
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 67 KESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCV 126
RE ++ ++ + +V+ IG C+ +++V E+ GG L K+L+ R + V
Sbjct: 383 ----MMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSN 437
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMM-TAE 185
++ M+ L +HR+L N+LL K++DFGL++ + TA
Sbjct: 438 VAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 496
Query: 186 TGT---YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNV-------- 215
+ +W APE ++ ++ G+K + K
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY--GQKPYKKMKGPEVMAFIEQ 554
Query: 216 --R-PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260
R P EL +++ CW RP+F + Q + ++A
Sbjct: 555 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 67/270 (24%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G +V++ K++ +T IK + + REV L+++ H N+V
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIK---------RVKYNNEKAEREVKALAKLDHVNIVH 68
Query: 89 FIGA-----------------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+ G K + I E GTL +++ R LD +A+
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
I + ++ +HS +I+RDLKP N+ L + K +K+ DFGL T GT R+
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 192 MAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAEN 221
M+PE + Y + ++
Sbjct: 188 MSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI 239
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQML 251
++ +L + P RPN ++I++ L
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-41
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 46/217 (21%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G+GA +V + + ++ AIK + E +K S EV +L+ + H+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE------EKLSTILSEVMLLASLNHQY 63
Query: 86 LVKFIGA--------------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+V++ A K+ + I E GTL + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLF 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---------------EE 176
I A+ +HS GIIHRDLKP N+ + E + +K+ DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
++ +T+ GT ++A E+ HYN K
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLD-------GTGHYNEK 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-39
Identities = 61/281 (21%), Positives = 95/281 (33%), Gaps = 75/281 (26%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V+E K K + AIK + + REV L++++H +V+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE----LAREKVMREVKALAKLEHPGIVR 67
Query: 89 FIGACKE-------------PVMVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDI 134
+ A E + I +L L+ ++ + V + L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-------------EESLTEM 181
A A+E LHS G++HRDLKP N+ T D +K+ DFGL
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 182 MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------- 213
T + GT +M+PE Y+HK
Sbjct: 187 HTGQVGTKLYMSPEQI--------HGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLT 238
Query: 214 NVR-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
+VR P +++ P RP II+
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 69/300 (23%), Positives = 127/300 (42%), Gaps = 57/300 (19%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IGEG+ K K + IK ++ + ++ESR REVA+L+ ++H N+V++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESR--REVAVLANMKHPNIVQY 88
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ +E + IV + GG L K + + + + + I A++ +H I+H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH 148
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEK 207
RD+K +N+ LT+D T++L DFG+AR S E+ A GT +++PE+ E
Sbjct: 149 RDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC--------EN 199
Query: 208 KHYNHK-----------------------------------NVRPSAENVPEELSIILTS 232
K YN+K + P + + +L +++
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259
Query: 233 CWKEDPNARPNFTQIIQM------LLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 286
+K +P RP+ I++ + +LS E + +P + P +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQ 319
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-39
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 61/294 (20%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
ID KH ++GEG + V + A+K + E+ ++E++ RE M
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC---HEQQDREEAQ--READMH 80
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFA 131
H N+++ + C ++ GTL + ++ + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----------EESLTEM 181
L I R +E +H+ G HRDLKP N+LL ++ L D G + +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 182 MTAETGTYRWMAPE----------------------LYSTVTLR---QGEKKHYNHKNVR 216
A+ T + APE LY+ + + + +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 217 -------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 263
P + L +L S DP+ RP+ + L+ L A+ PP P
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL----LSQLEALQPPAP 309
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 9e-39
Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 24/198 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ R+G G V ++ + VAIK + E K R+ E+ ++ ++ H N
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ----ELSPKNRERWCLEIQIMKKLNHPN 73
Query: 86 LVKFI-------GACKEPVMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARA 137
+V + ++ E GG LRKYL L DI+ A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 138 MECLHSHGIIHRDLKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ LH + IIHRDLKPEN++L K+ D G A+E E+ T GT +++APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 196 LYSTVTLRQGEKKHYNHK 213
L E+K Y
Sbjct: 194 LL--------EQKKYTVT 203
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 63/248 (25%), Positives = 100/248 (40%), Gaps = 34/248 (13%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLV 87
R+G G++ +V++ + K + A+K P K +R EV +V QH V
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMS---PFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ A +E ++ + TEL G +L+++ L G+ D A+ LHS G+
Sbjct: 121 RLEQAWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL----YST--- 199
+H D+KP N+ L KL DFGL E + G R+MAPEL Y T
Sbjct: 179 VHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAAD 237
Query: 200 -----VTL----------RQGEKKHYNHKNVRPSA--ENVPEELSIILTSCWKEDPNARP 242
+T+ GE + P + EL +L + DP R
Sbjct: 238 VFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 243 NFTQIIQM 250
++ +
Sbjct: 298 TAEALLAL 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 46/196 (23%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---SYRNEIAYLNKLQQHSD 88
Query: 87 --VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 145
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPEL---Y 197
HGI+H DLKP N L+ + +KL DFG+A ++ + + ++ GT +M PE
Sbjct: 146 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 198 STVTLRQGEKKHYNHK 213
S+ K + K
Sbjct: 204 SSSRENGKSKSKISPK 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 47/196 (23%), Positives = 86/196 (43%), Gaps = 18/196 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD---SYRNEIAYLNKLQQHSD 69
Query: 87 --VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 126
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL---Y 197
HGI+H DLKP N L+ + +KL DFG+A + + T + ++ GT +M PE
Sbjct: 127 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 198 STVTLRQGEKKHYNHK 213
S+ K + K
Sbjct: 185 SSSRENGKSKSKISPK 200
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-37
Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES---RFARE---VAMLS 79
+G +G G ++V+ + ++ VA+K++ ++A+ S RF RE A L+
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLR-----ADLARDPSFYLRFRREAQNAAALN 70
Query: 80 RVQHRNLVK-----FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
H +V P+ IV E + G TLR + P + AI D
Sbjct: 71 ---HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADA 125
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET----GTYR 190
+A+ H +GIIHRD+KP N++++ +K+ DFG+AR + + +T GT +
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 191 WMAPE------------LYST-------VTLR---QGEK------KHYNHKNVRPSAEN- 221
+++PE +YS +T G+ +H + PSA +
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244
Query: 222 -VPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPP 279
+ +L ++ ++P R ++ L+ + P P + ++E T L
Sbjct: 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLT---DAERTSLLS 301
Query: 280 ESPGTSS 286
+ G S
Sbjct: 302 SAAGNLS 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-37
Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+ +IG G +KV++ + Q AIK V+ E + + E+A L+++Q +
Sbjct: 60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSD 116
Query: 87 --VKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
++ + +V E L +L + +D + ++ A+ +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ 173
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL 196
HGI+H DLKP N L+ + +KL DFG+A + + T + ++ G +M PE
Sbjct: 174 HGIVHSDLKPANFLIVDG--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 24/194 (12%)
Query: 29 GPRIGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
IG G+ VY+G VA + + + + RF E ML +QH N+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS---ERQRFKEEAEMLKGLQHPNI 87
Query: 87 VKFIGAC-----KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
V+F + + +V+VTEL++ GTL+ YL R + + + V + I + ++ L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 142 HSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
H+ IIHRDLK +N+ +T ++K+ D GLA + + GT +MAPE+Y
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMY-- 202
Query: 200 VTLRQGEKKHYNHK 213
++ Y+
Sbjct: 203 -------EEKYDES 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-36
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 14/193 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+ +G GA +V + + VAI+I+ K A E+ +L ++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 83 HRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
H ++K IV EL+ GG L ++ + L + + A++ LH
Sbjct: 199 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH 256
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
+GIIHRDLKPEN+LL+ E+ IK+ DFG ++ T +M GT ++APE+
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 312
Query: 201 TLRQGEKKHYNHK 213
L YN
Sbjct: 313 -LVSVGTAGYNRA 324
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-36
Identities = 60/269 (22%), Positives = 100/269 (37%), Gaps = 42/269 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYKN---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
V I G +Y +N + V +K + E A E L+ V H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA----MAMAERQFLAEVVHP 139
Query: 85 NLVK------FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
++V+ +PV IV E + G +L++ + L V AI + L+I A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPAL 195
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE--- 195
LHS G+++ DLKPEN++LTE+ +KL D G + + GT + APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR 250
Query: 196 --------LYST-VTLRQ---GEK----KHYNHKNVRPSAENVPEELSIILTSCWKEDPN 239
+Y+ TL ++ + + +L DP
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPR 310
Query: 240 ARP-NFTQIIQMLLNYLSAIAPPEPMIPH 267
R ++ L L + + +P
Sbjct: 311 QRFTTAEEMSAQLTGVLREVVAQDTGVPR 339
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 62/255 (24%), Positives = 110/255 (43%), Gaps = 39/255 (15%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG G ++VY VA+K V + + A+ + +E+ +L ++ H N++K+
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIKY 97
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGI 146
+ E + IV EL G L + + + + R + + + + A+E +HS +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE---------- 195
+HRD+KP N+ +T +KL D GL R S T + GT +M+PE
Sbjct: 158 MHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 196 ---------LYSTVTLR---QGEKKHY-------NHKNVRP-SAENVPEELSIILTSCWK 235
LY L+ G+K + + P +++ EEL ++ C
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276
Query: 236 EDPNARPNFTQIIQM 250
DP RP+ T + +
Sbjct: 277 PDPEKRPDVTYVYDV 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 10/175 (5%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKF 89
++GEG VY+G N TVA+K + K++ F +E+ ++++ QH NLV+
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ--FDQEIKVMAKCQHENLVEL 95
Query: 90 IGACKEPV-MVIVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGII 147
+G + + +V + G+L L + L + A A + LH + I
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYST 199
HRD+K N+LL E T K++DFGLAR + + T M + GT +MAPE
Sbjct: 156 HRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALR 208
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 48/278 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES---RFAREVAMLSRVQ 82
+ ++G G + VY + N VAIK + +KE RF REV S++
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-----IPPREKEETLKRFEREVHNSSQLS 69
Query: 83 HRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H+N+V I +E +V E + G TL +Y+ + P L V AI F I ++
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHA 127
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE---- 195
H I+HRD+KP+N+L+ + KT+K+ DFG+A+ S T + GT ++ +PE
Sbjct: 128 HDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 196 --------LYST-------VTLR---QGEK------KHYNHKNVRPSAE---NVPEELSI 228
+YS + GE KH + + ++P+ LS
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 229 ILTSCWKEDPNARP-NFTQIIQMLLNYLSAIAPPEPMI 265
++ ++D R ++ L + L E +
Sbjct: 247 VILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVY 284
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 14/193 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+ +G GA +V + + VAIKI+ K A E+ +L ++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 83 HRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
H ++K IV EL+ GG L ++ + L + + A++ LH
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH 131
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200
+GIIHRDLKPEN+LL+ E+ IK+ DFG ++ T +M GT ++APE+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 187
Query: 201 TLRQGEKKHYNHK 213
L YN
Sbjct: 188 -LVSVGTAGYNRA 199
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 47/175 (26%), Positives = 73/175 (41%), Gaps = 11/175 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
++G GA V+ + + IK ++K + + E+ +L + H N
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL--RKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++K ++ + IV E GG L R R + L + A+ H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
S ++H+DLKPEN+L IK+ DFGLA E T GT +MAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 52/151 (34%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
VG +G+G+ A VY + VAIK++ K + + K R EV + +++H
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDK----KAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++++ ++ V +V E+ G + +YL N R + A F I M LH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLH 129
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
SHGI+HRDL NLLLT ++ IK+ADFGLA
Sbjct: 130 SHGILHRDLTLSNLLLTRNM-NIKIADFGLA 159
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 28/182 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ +V + K + Q A+K+++K K S REV +L ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPN 82
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ IV EL +GG L D + A I +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H H I+HRDLKPEN+LL E IK+ DFGL+ M GT ++A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 194 PE 195
PE
Sbjct: 192 PE 193
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 58/268 (21%), Positives = 96/268 (35%), Gaps = 60/268 (22%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G++ + + + K + + K + G E K+ EV +L ++H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLV--SEVNLLRELKHPNIVR 69
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHS 143
+ + + IV E GG L + + LD + + A++ H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 144 -----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELY 197
H ++HRDLKP N+ L + +KL DFGLAR T GT +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 198 STVTLRQGEKKHYNHK-----------------------------------NVRPSAENV 222
+ YN K R
Sbjct: 189 --------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250
+EL+ I+T RP+ +I++
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 50/184 (27%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQHR 84
+G +G G A V + + K + A K + K + REV +L ++H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + +V++ EL+SGG L D A F I
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGEL-----------FDFLAEKESLTEDEATQFLKQI 117
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LHS I H DLKPEN++L IKL DFG+A + GT +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 192 MAPE 195
+APE
Sbjct: 178 VAPE 181
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 39/196 (19%), Positives = 78/196 (39%), Gaps = 22/196 (11%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVHK------------GETPEEIAKKESRFAREVAMLS 79
+ +G K+ + N+ A+K K I K F E+ +++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 80 RVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLN------MRPRCLDVCVAIGFAL 132
+++ + G V I+ E + ++ K+ + + V
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 133 DIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ + +H+ I HRD+KP N+L+ ++ +KL+DFG + ++ + GTY +
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GTYEF 216
Query: 192 MAPELYSTVTLRQGEK 207
M PE +S + G K
Sbjct: 217 MPPEFFSNESSYNGAK 232
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 23/180 (12%)
Query: 32 IGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESR-----FAREVAMLSRVQHRN 85
IG G KVY+G ++ VA+K ES F E+ LS +H +
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKR----------RTPESSQGIEEFETEIETLSFCRHPH 96
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLH 142
LV IG C E M+++ + + G L+++L ++ + + + AR + LH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYST 199
+ IIHRD+K N+LL E+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 157 TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 40/178 (22%), Positives = 75/178 (42%), Gaps = 23/178 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G G V+ +T K V + +E+++L+ +HRN
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRN 62
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
++ + + +V++ E +SG + + LN R + + + A+
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEAL 115
Query: 139 ECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ LHSH I H D++PEN++ T TIK+ +FG AR+ + + APE
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 53/185 (28%), Positives = 76/185 (41%), Gaps = 29/185 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK--GETPEEIAKKESRFAREVAMLSRVQH 83
+G +G G A V + + K A K + K +E REV++L +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IEREVSILRQVLH 74
Query: 84 RNLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALD 133
N++ + +V++ EL+SGG L D A F
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQ 123
Query: 134 IARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
I + LH+ I H DLKPEN++L + IKL DFGLA E GT
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183
Query: 191 WMAPE 195
++APE
Sbjct: 184 FVAPE 188
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK----GETPEEIAKKESRFAREVAMLSRV 81
+G G + V +K + A+KI+ + EE+ + +EV +L +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 82 -QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDI 134
H N+++ + +V +L+ G L D I
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-----------FDYLTEKVTLSEKETRKI 129
Query: 135 AR----AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYR 190
R + LH I+HRDLKPEN+LL +D+ IKL DFG + + E + GT
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 188
Query: 191 WMAPE 195
++APE
Sbjct: 189 YLAPE 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 49/184 (26%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRVQHR 84
G +G G A V + + K A K + K REV++L +QH
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + ++++ EL++GG L D A F I
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGEL-----------FDFLAEKESLTEEEATEFLKQI 123
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LHS I H DLKPEN++L IK+ DFGLA + GT +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 192 MAPE 195
+APE
Sbjct: 184 VAPE 187
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 32/229 (13%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVH- 56
M S S DE+ L A L DP +F + +G G + +VY+G++ Q AIK++
Sbjct: 2 MASDSPARSLDEIDLSA--LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV 59
Query: 57 KGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGA-------CKEPVMVIVTELLSGG 108
G+ EEI + E+ ML + HRN+ + GA + + +V E G
Sbjct: 60 TGDEEEEIKQ-------EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112
Query: 109 TLRKYLLNMRPRCLD-VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167
++ + N + L +A +I R + LH H +IHRD+K +N+LLTE+ + +KL
Sbjct: 113 SVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKL 170
Query: 168 ADFGLAREESLTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNHK 213
DFG++ + L + GT WMAPE+ + + Y+ K
Sbjct: 171 VDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEV---IACDENPDATYDFK 214
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 30/182 (16%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG G+ +V K A K + K + RF +E+ ++ + H N
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-----VEDVDRFKQEIEIMKSLDHPN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
+++ ++ + +V EL +GG L + V A I +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGEL-----------FERVVHKRVFRESDAARIMKDVL 116
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A+ H + HRDLKPEN L +KL DFGLA +MM + GT +++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 194 PE 195
P+
Sbjct: 177 PQ 178
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-33
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 20 LIDPKHL---FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFA 72
L+DP+ G +G+G AK +E + A KIV K + K + +
Sbjct: 8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMS 63
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E+++ + H+++V F G ++ V +V EL +L + R + L A +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 121
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
I + LH + +IHRDLK NL L EDL +K+ DFGLA
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 162
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 53/275 (19%), Positives = 91/275 (33%), Gaps = 69/275 (25%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLV 87
+IG G V++ + AIK K P + E REV + + QH ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKK---PLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLL--NMRPRCLDVCVAIGFALDIARAMECLHSH 144
++ A E M+I E +GG+L + L + R + +HS
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134
Query: 145 GIIHRDLKPENLLLTED------------------LKTIKLADFGLAREESLTEMMTAET 186
++H D+KP N+ ++ K+ D G ++ E
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT--RISSPQV-EE 191
Query: 187 GTYRWMAPELYSTVTLRQGEKKHYNHK--------------NVRPSAEN----------- 221
G R++A E+ E + K P N
Sbjct: 192 GDSRFLANEVLQ-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 244
Query: 222 ---VPEELSI----ILTSCWKEDPNARPNFTQIIQ 249
+P+ LS +L DP RP+ +++
Sbjct: 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 52/184 (28%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRVQHR 84
+G +G G A V + + K A K + K REV++L +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 85 NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCV---------AIGFALDI 134
N++ + +V++ EL+SGG L D A F I
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQI 124
Query: 135 ARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ LH+ I H DLKPEN++L + IKL DFGLA E GT +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 192 MAPE 195
+APE
Sbjct: 185 VAPE 188
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 66/319 (20%), Positives = 107/319 (33%), Gaps = 61/319 (19%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+ L V + EG A VYE + + A+K + E +K +EV +
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-----EKNRAIIQEVCFM 79
Query: 79 SRVQ-HRNLVKFIGACKEPVM--------VIVTELLSGGTLRKYLLNMRPR-CLDVCVAI 128
++ H N+V+F A ++ L G L ++L M R L +
Sbjct: 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 129 GFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAR------------ 174
RA++ +H IIHRDLK ENLLL+ TIKL DFG A
Sbjct: 140 KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSA 198
Query: 175 -EESLTEMMTAETGTYRWMAPE----------------------LYSTVTLR-----QGE 206
+L E T + PE LY + +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 207 KKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIP 266
+ N K P + ++ + + +P R + +++ L ++A P P
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE-IAAARNVNPKSP 317
Query: 267 HRIFNSENTILPPESPGTS 285
+N +
Sbjct: 318 ITELLEQNGGYGSATLSRG 336
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 26/193 (13%)
Query: 32 IGEGAHAK-VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89
+G GA VY G + N+ VA+K + + S REV +L +H N++++
Sbjct: 32 LGHGAEGTIVYRGMFDNRDVAVKRILP--------ECFSFADREVQLLRESDEHPNVIRY 83
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
K+ I EL TL++Y+ + I + LHS I+H
Sbjct: 84 FCTEKDRQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 149 RDLKPENLLLTEDLKT----IKLADFGLAR----EESLTEMMTAETGTYRWMAPELYSTV 200
RDLKP N+L++ ++DFGL + + GT W+APE+
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM---- 197
Query: 201 TLRQGEKKHYNHK 213
L + K++ +
Sbjct: 198 -LSEDCKENPTYT 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G GA ++V+ K + + A+K + K A ++S E+A+L +++H N
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-----SPAFRDSSLENEIAVLKKIKHEN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIA 135
+V + +V +L+SGG L D + G +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVL 116
Query: 136 RAMECLHSHGIIHRDLKPENLLL--TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A++ LH +GI+HRDLKPENLL E+ I + DFGL++ E +M+ GT ++A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVA 175
Query: 194 PE 195
PE
Sbjct: 176 PE 177
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 28/182 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G+GA + V +K A KI++ + A+ + RE + ++QH N
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG---------FALDIA 135
+V+ + +E +V +L++GG L + VA I
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDIVAREFYSEADASHCIQQIL 115
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMA 193
++ HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 175
Query: 194 PE 195
PE
Sbjct: 176 PE 177
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 25/193 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
+G +G+G VY + K +A+K++ K ++ K E + REV + S ++H
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFK----AQLEKAGVEHQLRREVEIQSHLRH 68
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ G + V ++ E GT+ + L + D + ++A A+ H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCH 126
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTV 200
S +IHRD+KPENLLL +K+ADFG + GT ++ PE+
Sbjct: 127 SKRVIHRDIKPENLLLGSAG-ELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI--- 179
Query: 201 TLRQGEKKHYNHK 213
E + ++ K
Sbjct: 180 -----EGRMHDEK 187
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 20 LIDPKHL---FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFA 72
L+DP+ G +G+G AK +E + A KIV K + K + +
Sbjct: 34 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPK----SLLLKPHQREKMS 89
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
E+++ + H+++V F G ++ V +V EL +L + R + L A +
Sbjct: 90 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYL 147
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
I + LH + +IHRDLK NL L EDL +K+ DFGLA
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 188
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 62/232 (26%), Positives = 91/232 (39%), Gaps = 43/232 (18%)
Query: 2 ESRSRFYLADELKLDAKWLIDPK------HLFVGPRIGEGAHAKVYEGKYK--NQTVAIK 53
R Y +L+ I K ++G GA+ +V + K + AIK
Sbjct: 9 SGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK 68
Query: 54 IVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRK 112
I+ K S+ EVA+L + H N++K ++ +V E GG L
Sbjct: 69 IIRKTSVS---TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-- 123
Query: 113 YLLNMRPRCLDVCVAIGF-----ALDIAR----AMECLHSHGIIHRDLKPENLLLT--ED 161
D + A I + + LH H I+HRDLKPENLLL E
Sbjct: 124 ---------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 162 LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
IK+ DFGL+ + M GT ++APE+ +K Y+ K
Sbjct: 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---------RKKYDEK 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 49/174 (28%), Positives = 78/174 (44%), Gaps = 22/174 (12%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G G +V++ + +A KI+ K + E+++++++ H NL++
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQL 151
Query: 90 IGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
A + +V+V E + GG L Y L I F I + +H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-------DTILFMKQICEGIRHMH 204
Query: 143 SHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
I+H DLKPEN+L D K IK+ DFGLAR E + GT ++APE
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 28/184 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRV- 81
IG G + V ++ A+KI+ +PE++ + RE +L +V
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 82 QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------A 131
H +++ I + + + +V +L+ G L D
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTEKVALSEKETRSIM 206
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
+ A+ LH++ I+HRDLKPEN+LL ++++ I+L+DFG + E + GT +
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLRELCGTPGY 265
Query: 192 MAPE 195
+APE
Sbjct: 266 LAPE 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 34/190 (17%)
Query: 32 IGEGAHAKV-YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89
+G G+ V ++G ++ + VA+K + E+ +L+ H N++++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTESDDHPNVIRY 74
Query: 90 IGACKEPVMV-IVTELLSGGTL-----RKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ + I EL L K + + + I IA + LHS
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 144 HGIIHRDLKPENLLLTEDLKT------------IKLADFGLAR-----EESLTEMMTAET 186
IIHRDLKP+N+L++ + I ++DFGL + + S + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 187 GTYRWMAPEL 196
GT W APEL
Sbjct: 194 GTSGWRAPEL 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ +V + K + Q A+K+++K K S REV +L ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTSTILREVELLKKLDHPN 82
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ IV EL +GG L D + A I +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVF 131
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H H I+HRDLKPEN+LL E IK+ DFGL+ M GT ++A
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 194 PELYSTVTLRQGEKKHYNHK 213
PE+ + Y+ K
Sbjct: 192 PEVL---------RGTYDEK 202
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 65/255 (25%), Positives = 102/255 (40%), Gaps = 51/255 (20%)
Query: 28 VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKES---RFAREVAMLSRVQ 82
+ +G G VYE + + + VA+K++ E ++ R RE R+Q
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMS-----ETLSSDPVFRTRMQREARTAGRLQ 92
Query: 83 HRNLVKF--IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
++V G + + + L++G L L P L A+ I A++
Sbjct: 93 EPHVVPIHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDA 149
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPE-- 195
H+ G HRD+KPEN+L++ D L DFG+A +E LT++ GT +MAPE
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPERF 207
Query: 196 -----------------LYSTVTLR---QGE-----KKHYNHKNVRPSAEN--VPEEL-S 227
LY +T QG+ H N RPS +P +
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA 267
Query: 228 IILTSCWKEDPNARP 242
+I K +P R
Sbjct: 268 VIARGMAK-NPEDRY 281
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ K + K ++ + E+++++++ H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPK 109
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
L+ A ++ MV++ E LSGG L Y ++ I + +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACEGL 162
Query: 139 ECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ +H H I+H D+KPEN++ T+ ++K+ DFGLA + + E++ T T + APE
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP ++ + +G+GA KVY+ K K A K++ + ++ + E+ +L
Sbjct: 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI-----ETKSEEELEDYIVEIEIL 70
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD-VCVAIGFALDIAR 136
+ H +VK +GA + + I+ E GG + ++ R L + + +
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLE 128
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT-AET--GTYRWMA 193
A+ LHS IIHRDLK N+L+T + I+LADFG++ + + + ++ GT WMA
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAK--NLKTLQKRDSFIGTPYWMA 185
Query: 194 PELYSTVTLRQGEKKHYNHK 213
PE+ V + Y++K
Sbjct: 186 PEV---VMCETMKDTPYDYK 202
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 27/182 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G+G+ +V K K Q A+K++ K + ++ K+ REV +L ++ H N
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE--SLLREVQLLKQLDHPN 87
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K ++ +V E+ +GG L D ++ A I R
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGEL-----------FDEIISRKRFSEVDAARIIRQVL 136
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
+ +H + I+HRDLKPENLLL I++ DFGL+ ++ M + GT ++A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 194 PE 195
PE
Sbjct: 197 PE 198
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 60/281 (21%), Positives = 100/281 (35%), Gaps = 51/281 (18%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVG-PRIGEGAHAKVYEGKYKN--QTVAIKIVHK 57
E L ++LK + H PR+G G+ +V+ K K A+K V
Sbjct: 34 TEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL 93
Query: 58 GETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLN 116
E E+ + + +V GA +E V I ELL GG+L + +
Sbjct: 94 EVFRVE----------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----L 172
M L A+ + +E LH+ I+H D+K +N+LL+ D L DFG L
Sbjct: 144 MGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 173 AREESLTEMMTAET--GTYRWMAPEL-----YST-----------VTLRQGEKKHYNHKN 214
+ ++T + GT MAPE+ + + G +
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
Query: 215 VR---------PSAENVPEELSII----LTSCWKEDPNARP 242
P +P + + + +++P R
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 8/176 (4%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG+G + V + Q A+KIV + RE ++ ++H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH 142
+V+ + M+ +V E + G L ++ VA + I A+ H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE 195
+ IIHRD+KP +LL E+ +KL FG+A + + GT +MAPE
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 21/191 (10%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKK--ESRFAREVAMLSRVQH 83
+G +G+G VY + K +A+K++ K ++ K+ E + RE+ + S ++H
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFK----SQLEKEGVEHQLRREIEIQSHLRH 73
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ + + ++ E G L K L + D + F ++A A+ H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHYCH 131
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
+IHRD+KPENLL+ +K+ADFG + T GT ++ PE+
Sbjct: 132 ERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI----- 184
Query: 203 RQGEKKHYNHK 213
E K ++ K
Sbjct: 185 ---EGKTHDEK 192
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 42/208 (20%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK--------GETPEEIAKKESRFAREVAM 77
++G GA+ +V K K + AIK++ K + + I K E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 78 LSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----A 131
L + H N++K ++ +VTE GG L + + A
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-----------FEQIINRHKFDECDA 148
Query: 132 LDIAR----AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAE 185
+I + + LH H I+HRD+KPEN+LL L IK+ DFGL+ S +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 186 TGTYRWMAPELYSTVTLRQGEKKHYNHK 213
GT ++APE+ KK YN K
Sbjct: 209 LGTAYYIAPEVL---------KKKYNEK 227
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ + A K V + +E+ +S ++H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPT 215
Query: 86 LVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A ++ MV++ E +SGG L + + + + + A+ + + + + +H +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 145 GIIHRDLKPENLLL-TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+H DLKPEN++ T+ +KL DFGL + + TGT + APE
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 56/182 (30%), Positives = 84/182 (46%), Gaps = 32/182 (17%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G GA + VY K K + A+K++ K + E+ +L R+ H N
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKK-------TVDKKIVRTEIGVLLRLSHPN 109
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
++K + P + +V EL++GG L D V G+ A D +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-----------FDRIVEKGYYSERDAADAVKQIL 158
Query: 137 -AMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMA 193
A+ LH +GI+HRDLKPENLL +K+ADFGL++ +M GT + A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 194 PE 195
PE
Sbjct: 219 PE 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE 68
E W I+ + IG GA A V + VAIK ++ + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM---- 57
Query: 69 SRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA 127
+E+ +S+ H N+V + + + + +V +LLSGG++ + ++ +
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 128 -----IGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG----LAREES 177
I L ++ +E LH +G IHRD+K N+LL ED ++++ADFG LA
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 178 LTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNHK 213
+T +T GT WMAPE+ + + Y+ K
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVME-------QVRGYDFK 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 54/179 (30%), Positives = 87/179 (48%), Gaps = 22/179 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
V +G+GA + V +K A KI++ + A+ + RE + ++QH N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPN 89
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL------RKYLLNMRPRCLDVCVAIGFALDIARAM 138
+V+ + +E +V +L++GG L R++ A I ++
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--------DASHCIQQILESI 141
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
HS+GI+HR+LKPENLLL K +KLADFGLA E + +E GT +++PE
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 38/205 (18%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
P+ +F V ++GEG++ VY+ +K Q VAIK V +EI K E++++
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-------EISIM 78
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
+ ++VK+ G+ K + IV E G++ ++ +R + L +
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATIL------ 131
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +E LH IHRD+K N+LL + KLADFG+A + LT+ M GT
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQ--LTDTMAKRNTVIGT 188
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHK 213
WMAPE+ + YN
Sbjct: 189 PFWMAPEVIQ--------EIGYNCV 205
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 10/169 (5%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G + VY G +AIK + PE ++ E+A+ ++H+N+V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIG-FALDIARAMECLHSHGII 147
+G+ E + I E + GG+L L + D IG + I ++ LH + I+
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE 195
HRD+K +N+L+ +K++DFG ++ + TGT ++MAPE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 50/227 (22%), Positives = 87/227 (38%), Gaps = 37/227 (16%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEE 63
+K ++ + K ++V +GEGA A+VYE + Q +K+ P E
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWE 110
Query: 64 IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--- 119
+ + L +KF A V+V EL S GTL + +
Sbjct: 111 FYIGT----QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL----------KTIKLAD 169
+ + + I FA+ + +E +H IIH D+KP+N +L + L D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 170 FGLAREESL---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
G + + L + TA+ T + E+ K +N++
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEML--------SNKPWNYQ 265
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 56/187 (29%), Positives = 81/187 (43%), Gaps = 39/187 (20%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVK 88
+GEGAHA+V +Q A+KI+ K SR REV ML + Q HRN+++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLE 75
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIARAM 138
I +E +V E + GG++ L D+A A+
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASAL 124
Query: 139 ECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAR--------EESLTEMMTAETGT 188
+ LH+ GI HRDLKPEN+L + +K+ DF L T + G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 189 YRWMAPE 195
+MAPE
Sbjct: 185 AEYMAPE 191
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-31
Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG++ V++ + + Q VAIK + E I + RE+ ML +++H NLV
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI---KKIALREIRMLKQLKHPNLVN 66
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + + + +V E T+ L + R + + +A+ H H I
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YS 198
HRD+KPEN+L+T+ IKL DFG AR + ++ E T YR +PEL Y
Sbjct: 125 HRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYG 181
Query: 199 T 199
Sbjct: 182 P 182
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 33/204 (16%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF IG G+ VY + ++ VAIK + ++ +EV L
Sbjct: 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD--IIKEVRFL 108
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
+++H N +++ G +E +V E G LL + + L V
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVT------ 160
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTY 189
+ + LHSH +IHRD+K N+LL+E +KL DFG A + M A + GT
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA-----SIMAPANSFVGTP 214
Query: 190 RWMAPELYSTVTLRQGEKKHYNHK 213
WMAPE+ + ++ Y+ K
Sbjct: 215 YWMAPEV-----ILAMDEGQYDGK 233
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 9/175 (5%)
Query: 27 FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR 84
+G G A V + K Q A K + K + E+A+L +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSC 88
Query: 85 -NLVKFIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
++ + ++++ E +GG + L + I I + LH
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 143 SHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ I+H DLKP+N+LL+ L IK+ DFG++R+ + GT ++APE
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 27/200 (13%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF +IG+G+ +V++G + VAIKI+ E +EI +E+ +L
Sbjct: 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----EDIQQEITVL 74
Query: 79 SRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL-DIAR 136
S+ + K+ G+ K+ + I+ E L GG+ + P LD I L +I +
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL---LEPGPLDE-TQIATILREILK 130
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GTYRWMA 193
++ LHS IHRD+K N+LL+E +KLADFG+A LT+ GT WMA
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMA 187
Query: 194 PELYSTVTLRQGEKKHYNHK 213
PE V + Y+ K
Sbjct: 188 PE----VIKQSA----YDSK 199
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 35/183 (19%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRN 85
+GEG+ + + +K NQ A+KI+ K + E+ +E+ L + H N
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK--------RMEANTQKEITALKLCEGHPN 67
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDIA 135
+VK + + +V ELL+GG L + +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGEL-----------FERIKKKKHFSETEASYIMRKLV 116
Query: 136 RAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE-ESLTEMMTAETGTYRWM 192
A+ +H G++HRDLKPENLL T D IK+ DFG AR + + T +
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 193 APE 195
APE
Sbjct: 177 APE 179
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 53/233 (22%), Positives = 84/233 (36%), Gaps = 53/233 (22%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ IG+G++ V AIKI++K + + K R EV ++ ++ H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTL------RKYLLNMRPRCLDVCV------------ 126
+ + ++ + +V EL GG L + V
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 127 --------------------AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK-TI 165
I A+ LH+ GI HRD+KPEN L + + I
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 166 KLADFGLAR-----EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
KL DFGL++ MT + GT ++APE+ L + Y K
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-TTNESYGPK 256
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 28 VGPRIGEGAHAKVYEGK--YKNQTVAIKIVHK---------------------GETPEEI 64
+ IG+G++ V N A+K++ K +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 65 AKKESRFAREVAMLSRVQHRNLVKF---IGACKEPVMVIVTELLSGGTLRKYLLNMRPRC 121
+ +E+A+L ++ H N+VK + E + +V EL++ G + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133
Query: 122 LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM 181
L A + D+ + +E LH IIHRD+KP NLL+ ED IK+ADFG++ E ++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDA 192
Query: 182 MTAET-GTYRWMAPELYSTVTLRQGEKKHYN 211
+ + T GT +MAPE S +K ++
Sbjct: 193 LLSNTVGTPAFMAPESLS------ETRKIFS 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 15/181 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +GEG++ KV E A+KI+ K + I E+ +E+ +L R++H+N
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 86 LVKF---IGACKEPVMVIVTELLSGGT--LRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+++ + ++ M +V E G + + R VC A G+ + +E
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---FPVCQAHGYFCQLIDGLEY 124
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPELY 197
LHS GI+H+D+KP NLLLT T+K++ G+A T T G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 198 S 198
+
Sbjct: 184 N 184
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 37/185 (20%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHR 84
V IG G+++ +K N A+KI I K + E+ +L R QH
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKI---------IDKSKRDPTEEIEILLRYGQHP 76
Query: 85 NLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF---------ALDI 134
N++ + V +VTEL+ GG L LD + F I
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL-----------LDKILRQKFFSEREASAVLFTI 125
Query: 135 ARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLARE-ESLTEMMTAETGTYR 190
+ +E LH+ G++HRDLKP N+L + ++I++ DFG A++ + ++ T
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 191 WMAPE 195
++APE
Sbjct: 186 FVAPE 190
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 21/174 (12%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVK 88
+G G + KV E ++ Q A+K++ + +EV + ++V
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLL----------YDSPKARQEVDHHWQASGGPHIVC 86
Query: 89 FIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ + I+ E + GG L + + A DI A++ LHS
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 144 HGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
H I HRD+KPENLL T E +KL DFG A+E + + T T ++APE
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPE 199
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 40/325 (12%), Positives = 96/325 (29%), Gaps = 86/325 (26%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP------------------- 61
P+ L G +G+ E + ++ + + + E P
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 62 ----EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM---VIVTELLSG--GTLRK 112
++ AK RF ++ Q + +++ ++ + + + T +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 113 YLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
LL+ + L + L + R + LH +G++H L+P +++L + + L F
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGF 250
Query: 171 GLAREESLTEMMTAETGTYRWMAPEL---YSTVTLRQGEKKHYNHK-------------- 213
+ + + + PEL +T++ + +
Sbjct: 251 EHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 214 ----------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ S +N+P+ + +L + R Q ++
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME-------- 359
Query: 258 IAPPEPMIPHRIFNSENTILPPESP 282
+ T L P
Sbjct: 360 ---------TPEYEQLRTELSAALP 375
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 57/175 (32%), Positives = 83/175 (47%), Gaps = 18/175 (10%)
Query: 32 IGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
+G G KVY+G+ + VA+K + + T E +F EV M+S HRNL++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLR 93
Query: 91 GACKEPVM-VIVTELLSGGTLRKYLLNMRPRCL----DVCVAIGFALDIARAMECLHSHG 145
G C P ++V ++ G++ L I AL AR + LH H
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI--ALGSARGLAYLHDHC 151
Query: 146 ---IIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE 195
IIHRD+K N+LL E+ + DFGLA+ + T + TA GT +APE
Sbjct: 152 DPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEG++ V + + K + VAIK + + + + + RE+ +L +++H NLV
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV---KKIAMREIKLLKQLRHENLVN 88
Query: 89 FIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ CK + +V E + T+ L + P LD V + I + HSH II
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YS 198
HRD+KPEN+L+++ +KL DFG AR + E+ E T YR APEL Y
Sbjct: 147 HRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203
Query: 199 T 199
Sbjct: 204 K 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+GA + V Q A I++ + A+ + RE + ++H N
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS---ARDHQKLEREARICRLLKHPN 71
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF-----ALDIAR--- 136
+V+ + E ++ +L++GG L + VA + A +
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGEL-----------FEDIVAREYYSEADASHCIQQIL 120
Query: 137 -AMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE-ESLTEMMTAETGTYRWM 192
A+ H G++HR+LKPENLLL LK +KLADFGLA E E + GT ++
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 193 APE 195
+PE
Sbjct: 181 SPE 183
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 20/177 (11%)
Query: 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRN 85
+G G + KV + K + A+K++ + + REV + R +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRASQCPH 116
Query: 86 LVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+V+ + + IV E L GG L + + + A I A++
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 141 LHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
LHS I HRD+KPENLL T +KL DFG A+E + +T T ++APE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 5e-29
Identities = 27/224 (12%), Positives = 57/224 (25%), Gaps = 44/224 (19%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
+ L + + G + V+ + + A+K+ G + R +R
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR--SELERLHEATFAAAR 118
Query: 81 VQHRNLVKFIGACK------------EPVMVIVTELLSGGTLRKYLLNM----------- 117
+ + + + +P ++ + YLL M
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 118 --------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169
+ + R L S G++H P+NL + D + L D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGD 237
Query: 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
+ A + + E + H
Sbjct: 238 VSALWKVG--TRGPASSVPVTYAPRE------FLNASTATFTHA 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 36/228 (15%), Positives = 88/228 (38%), Gaps = 26/228 (11%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLF-VGPRIGEGAH--AKVYEGKYK--NQTVAIKIV 55
M ++ + + + + IG+G V +YK + V ++ +
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 56 HKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA-CKEPVMVIVTELLSGGTLRKYL 114
+ E+ E+ + H N+V + + + +VT ++ G+ + +
Sbjct: 61 NLEACSNEMVT---FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117
Query: 115 LNMRPRCLDVCVAIGFAL-DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
++ +AI + L + +A++ +H G +HR +K ++L++ D + L+
Sbjct: 118 CTHFMDGMNE-LAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSN 175
Query: 174 --------REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK 213
R+ + + W++PE+ L+Q + Y+ K
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEV-----LQQ-NLQGYDAK 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 38/205 (18%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ + + K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQPKKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
++ N+V ++ + + +V E L+GG+L + C+D VC
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVC------ 122
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +A+E LHS+ +IHRD+K +N+LL D ++KL DFG + +T + + GT
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHK 213
WMAPE+ + +K Y K
Sbjct: 180 PYWMAPEVVT--------RKAYGPK 196
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 10/178 (5%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHK---GETPEEIAKKESRFAREVAMLSRVQ 82
+G GA V+ K N+ V +K + K E K + E+A+LSRV+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 83 HRNLVKFIGACKEPVMV-IVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
H N++K + + +V E SG L ++ PR LD +A + A+
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPR-LDEPLASYIFRQLVSAVGY 145
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
L IIHRD+K EN+++ ED TIKL DFG A ++ GT + APE+
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 22 DPKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ L +IGEG+ V + K + VA+K++ ++ EV ++
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-----DLRKQQRRELLFNEVVIM 96
Query: 79 SRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLD------VCVAIGFA 131
QH N+V+ + + ++ E L GG L + L+ VC
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIATVC------ 147
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET---GT 188
+ +A+ LH+ G+IHRD+K +++LLT D +KL+DFG +++ + GT
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFC--AQISKDVPKRKSLVGT 204
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHK 213
WMAPE+ S + Y +
Sbjct: 205 PYWMAPEVIS--------RSLYATE 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEGA+ +V + + VA+KIV + +E+ + + H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHEN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VKF G +E + + E SGG L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYS 198
GI HRD+KPENLLL E +K++DFGLA R + ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 61/187 (32%), Positives = 84/187 (44%), Gaps = 22/187 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA---MLSRVQHRN 85
IG GA+ VY+ + VA+K V REVA L +H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 86 LVKFI------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
+V+ + +E + +V E + LR YL P L R ++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPEL- 196
LH++ I+HRDLKPEN+L+T T+KLADFGLAR S +T T YR APE+
Sbjct: 135 FLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL 191
Query: 197 ----YST 199
Y+T
Sbjct: 192 LQSTYAT 198
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 39/327 (11%), Positives = 94/327 (28%), Gaps = 64/327 (19%)
Query: 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE----------------- 63
P+ L G +G+ E + ++ + + + E P
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 64 ------IAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVMVIVTELL-----SGGTLRK 112
AK RF ++ Q + +++ ++ ++ L + T +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 113 YLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
LL+ + L + L + R + LH +G++H L+P +++L + + L F
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGF 255
Query: 171 GLAREESLTEMMTAET--GTYRWMAPE------------------------LYSTVTLR- 203
+ + + A +Y
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 204 --QGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ--MLLNYLSAIA 259
+ + + S +N+P+ + +L + R Q ++ + ++
Sbjct: 316 PNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 260 PPEPMIPHRIFNSENTILPPESPGTSS 286
P+ + PP
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTSQPD 402
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 54/170 (31%), Positives = 83/170 (48%), Gaps = 9/170 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G AKV ++ + VAIKI+ K + + REV ++ + H N+VK
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNP---TSLQKLFREVRIMKILNHPNIVKL 79
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + ++ E SGG + YL + + A I A++ H I+H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
RDLK ENLLL D+ IK+ADFG + E ++ + A G + APEL+
Sbjct: 138 RDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ 186
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEGA+ +V + + VA+KIV + +E+ + + H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHEN 66
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+VKF G +E + + E SGG L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI 124
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLA---REESLTEMMTAETGTYRWMAPELYS 198
GI HRD+KPENLLL E +K++DFGLA R + ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 58/252 (23%), Positives = 94/252 (37%), Gaps = 35/252 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHR 84
VGP +G G VY G N VAIK V K + +R EV +L +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 85 --NLVKFIGACKEPVM-VIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+++ + + P V++ E L ++ L +A F + A+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRH 164
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE----- 195
H+ G++HRD+K EN+L+ + +KL DFG T + GT + PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYH 223
Query: 196 ---------------LYSTVTLR---QGEKKHYNHKNVRPSAENVPEELSIILTSCWKED 237
LY V + +++ + V E ++ C
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ--RVSSECQHLIRWCLALR 281
Query: 238 PNARPNFTQIIQ 249
P+ RP F +I
Sbjct: 282 PSDRPTFEEIQN 293
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 45/171 (26%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V++ +K +A K++H P ++ RE+ +L +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVG 95
Query: 89 FIGA-CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
F GA + + I E + GG+L + L + + ++ + + + L H I
Sbjct: 96 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV--SIAVIKGLTYLREKHKI 153
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPE 195
+HRD+KP N+L+ IKL DFG++ + L + M A + GT +M+PE
Sbjct: 154 MHRDVKPSNILVNSR-GEIKLCDFGVSGQ--LIDSM-ANSFVGTRSYMSPE 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 20/162 (12%)
Query: 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81
+ +G G + KV + K + A+K++ + + REV + R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRA 67
Query: 82 -QHRNLVKFIGACKEPVMV-----IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
Q ++V+ + + IV E L GG L + + + A I
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 136 RAMECLHSHGIIHRDLKPENLLLT--EDLKTIKLADFGLARE 175
A++ LHS I HRD+KPENLL T +KL DFG A+E
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 47/191 (24%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLV 87
+G GA+ V + ++ Q +A+K + +E R ++ + + V V
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----KRLLMDLDISMRTVDCPFTV 69
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKY-LLNMRPRCLDVCVAIGFALDIARAMECLHS-H 144
F GA +E + I EL+ + Y + + + + + A+ I +A+E LHS
Sbjct: 70 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTL 202
+IHRD+KP N+L+ +K+ DFG++ L + + + G +MAPE
Sbjct: 130 SVIHRDVKPSNVLINAL-GQVKMCDFGISGY--LVDDVAKDIDAGCKPYMAPE----RIN 182
Query: 203 RQGEKKHYNHK 213
+ +K Y+ K
Sbjct: 183 PELNQKGYSVK 193
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 12/175 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
IG G + K + VA+K + +G + RE+ ++H N
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA------AIDENVQREIINHRSLRHPN 77
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V+F P + I+ E SGG L + + N R A F + + HS
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICN-AGR-FSEDEARFFFQQLLSGVSYCHSM 135
Query: 145 GIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
I HRDLK EN LL +K+ DFG ++ L + GT ++APE+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
+ W + L IG GA+ V + +K Q +A+K + +E +
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ----KQLLM 69
Query: 74 EVA-MLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLR--KYLLNMRPRCLDVCVAIG 129
++ ++ +V+F GA +E I EL+S + KY+ ++ + +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 130 FALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT 188
L +A+ L IIHRD+KP N+LL IKL DFG++ + + T + G
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 189 YRWMAPELYSTVTLRQGEKKHYNHK 213
+MAPE ++ Y+ +
Sbjct: 189 RPYMAPE----RIDPSASRQGYDVR 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-27
Identities = 40/188 (21%), Positives = 77/188 (40%), Gaps = 15/188 (7%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLV 87
+G G +V++ +++ +A+K + + EE R ++ ++ + +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN----KRILMDLDVVLKSHDCPYIV 87
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HG 145
+ G + I EL+ + + + + I +A+ L HG
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQG 205
+IHRD+KP N+LL E + IKL DFG++ + G +MAPE +
Sbjct: 146 VIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 206 EKKHYNHK 213
Y+ +
Sbjct: 205 ---DYDIR 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 56/274 (20%), Positives = 99/274 (36%), Gaps = 40/274 (14%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIA-KKESRFAREVAMLSRV--- 81
+GP +G+G V+ G VAIK++ + EVA+L +V
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 82 -QHRNLVKFIGACKEPVM-VIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
H +++ + + ++V E L L Y+ L + F + A+
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEGPSRCFFGQVVAAI 152
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE--- 195
+ HS G++HRD+K EN+L+ KL DFG + GT + PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS 211
Query: 196 -----------------LYSTVTLR---QGEKKHYNHKNVRPSAENVPEELSIILTSCWK 235
LY V + +++ + P+ +V + ++ C
Sbjct: 212 RHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPA--HVSPDCCALIRRCLA 269
Query: 236 EDPNARPNFTQIIQ---MLLNYLSAIAPPEPMIP 266
P++RP+ +I+ M P P
Sbjct: 270 PKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-26
Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 12/176 (6%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE--SRFAREVAMLSRVQH 83
+G +G G KV G+++ VA+KI+++ ++I + + RE+ L +H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR----QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+++K P +V E +SGG L Y+ ++ A I A++ H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCH 128
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
H ++HRDLKPEN+LL + K+ADFGL+ S E + G+ + APE+ S
Sbjct: 129 RHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG+ + V + ++ AIKI+ K +E K RE ++SR+ H VK
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKE--NKVPYVTRERDVMSRLDHPFFVKL 95
Query: 90 IGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
++ + G L KY+ + D + +I A+E LH GIIH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAET--GTYRWMAPEL 196
RDLKPEN+LL ED+ I++ DFG A+ ++ A + GT ++++PEL
Sbjct: 154 RDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 37/257 (14%), Positives = 83/257 (32%), Gaps = 41/257 (15%)
Query: 31 RIGEGAHAKVYEGK--YKNQTVAIKIVH--KGETPEEIAKKESRFAREVAMLSRVQHRNL 86
G + ++ ++ VA+ V + + LSR+ +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQ----ETLSRTLRLSRIDKPGV 93
Query: 87 VKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
+ + ++V E + GG+L++ + + P AI +A A + H G
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQE-VADTSP---SPVGAIRAMQSLAAAADAAHRAG 149
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREES-----------LTEMMTAETGTYRWMAP 194
+ P + ++ D + LA + + L ++ RW P
Sbjct: 150 VALSIDHPSRVRVSID-GDVVLAYPATMPDANPQDDIRGIGASLYALLVN-----RW--P 201
Query: 195 ELYSTVTLRQGEKKHYNHKN---VRPSAEN--VPEELSIILTSCWKEDPNARPNFTQIIQ 249
+R G + P+ + +P ++S + + D R +
Sbjct: 202 --LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS--ASTLL 257
Query: 250 MLLNYLSAIAPPEPMIP 266
L+ +A+A ++
Sbjct: 258 NLMQQATAVADRTEVLG 274
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 59/323 (18%), Positives = 96/323 (29%), Gaps = 112/323 (34%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIV--HKGETPEEIAKKESR---------------- 70
+G G V+E K K + AIK + E E +E +
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 71 -----------------------------------FAREVAMLSRVQHRNLVKFIGACKE 95
+ ++ + +N V +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 96 PVMV-IVTELLSGGTLRKYLLNMRPRC-LDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153
V + I +L L+ ++ + V + + IA A+E LHS G++HRDLKP
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 154 ENLLLTEDLKTIKLADFGLAR-------------EESLTEMMTAETGTYRWMAPELYSTV 200
N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 193 SNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE----- 246
Query: 201 TLRQGEKKHYNHK----------------------------NVR-----PSAENVPEELS 227
Q +Y+HK +VR +
Sbjct: 247 ---QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 228 IILTSCWKEDPNARPNFTQIIQM 250
+++ P RP T II+
Sbjct: 304 MMVQDMLSPSPTERPEATDIIEN 326
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 31 RIGEGAHAKVYEG---KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML---SRVQHR 84
IGEGA+ KV++ K + VA+K V E + REVA+L +H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHP 74
Query: 85 NLVKFI------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
N+V+ +E + +V E + L YL + + + R +
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPEL 196
+ LHSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T YR APE+
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYR--APEV 190
Query: 197 -----YST 199
Y+T
Sbjct: 191 LLQSSYAT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 51/174 (29%), Positives = 86/174 (49%), Gaps = 9/174 (5%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +GEG+ KV + Q VA+K + + + R RE++ L ++H +
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS--DMHMRVEREISYLKLLRHPH 70
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++K P + +V E +GG L Y++ + + F I A+E H H
Sbjct: 71 IIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH 127
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
I+HRDLKPENLLL ++L +K+ADFGL+ + + G+ + APE+ +
Sbjct: 128 KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 33/188 (17%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG G+ VY+ K + VAIK V ++ RF RE+ ++ ++ H N+V+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 89 FI-------GACKEPVMVIVTELLSGGTLRKYL--LNMRPRCLDVCVAIGFALDIARAME 139
E + +V + + T+ + + + L V + + R++
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT--YRWMAPEL- 196
+HS GI HRD+KP+NLLL D +KL DFG A++ E + + YR APEL
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APELI 228
Query: 197 -----YST 199
Y++
Sbjct: 229 FGATDYTS 236
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 21/181 (11%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+IGEG + VY+ + +T A+K + + E I RE+++L ++H N+VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTIREISILKELKHSNIVK 64
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ +V+V E L L+K L L+ A F L + + H ++
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YS 198
HRDLKP+NLL+ + +K+ADFGLAR + T E T YR AP++ YS
Sbjct: 123 HRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKKYS 179
Query: 199 T 199
T
Sbjct: 180 T 180
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 59/180 (32%), Positives = 86/180 (47%), Gaps = 19/180 (10%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
++GEG + VY+ K + VA+K + E I S RE+++L + H N+V
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKELHHPNIVSL 84
Query: 90 IGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
I E + +V E + L+K L + L + + R + H H I+H
Sbjct: 85 IDVIHSERCLTLVFEFMEKD-LKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YST 199
RDLKP+NLL+ D +KLADFGLAR + T E T YR AP++ YST
Sbjct: 143 RDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGSKKYST 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 8/174 (4%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +G G KV GK++ VA+KI+++ + + RE+ L +H +
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPH 77
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++K P + +V E +SGG L Y+ LD + I ++ H H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRH 135
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYS 198
++HRDLKPEN+LL + K+ADFGL+ S E + G+ + APE+ S
Sbjct: 136 MVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + ++ VA+K V + E + S RE+ +L ++H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVR 65
Query: 89 FIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ + +V E L+KY + LD + F + + + HS ++
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL------YS 198
HRDLKP+NLL+ + +KLA+FGLAR + +AE T YR P++ YS
Sbjct: 124 HRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYS 180
Query: 199 T 199
T
Sbjct: 181 T 181
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 32/187 (17%)
Query: 32 IGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVKF 89
IG G+ V++ K + VAIK V ++ RF RE+ ++ V+H N+V
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKV----------LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 90 I-------GACKEPVMVIVTELLSGGTLRKYL--LNMRPRCLDVCVAIGFALDIARAMEC 140
E + +V E + T+ + + + + + + + R++
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAE--TGTYRWMAPEL-- 196
+HS GI HRD+KP+NLLL +KL DFG A+ E + + YR APEL
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIF 214
Query: 197 ----YST 199
Y+T
Sbjct: 215 GATNYTT 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 61/184 (33%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES--RFA-REVAMLSRVQHRN 85
+GEG A VY+ + K NQ VAIK + G E K+ R A RE+ +L + H N
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA---KDGINRTALREIKLLQELSHPN 73
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
++ + A + + +V + + L + + L + L + +E LH H
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV-LTPSHIKAYMLMTLQGLEYLHQH 131
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL----- 196
I+HRDLKP NLLL E+ +KLADFGLA+ T + T YR APEL
Sbjct: 132 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APELLFGAR 188
Query: 197 -YST 199
Y
Sbjct: 189 MYGV 192
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 49/172 (28%), Positives = 87/172 (50%), Gaps = 10/172 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
IG+G+ KV + + A+K ++K + + + E R +E+ ++ ++H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC---VERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ ++ M +V +LL GG LR Y L + F ++ A++ L + II
Sbjct: 80 LWYSFQDEEDMFMVVDLLLGGDLR-YHLQ-QNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST 199
HRD+KP+N+LL E + + DF +A +T GT +MAPE++S+
Sbjct: 138 HRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 41/173 (23%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLV 87
++G G +++V+E N+ V +KI+ P K+ + RE+ +L ++ N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILK----PV----KKKKIKREIKILENLRGGPNII 94
Query: 88 KFIGACKEPVM---VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
K+PV +V E ++ ++ + D+ + +I +A++ HS
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD--YDIRF---YMYEILKALDYCHSM 149
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWM-APEL 196
GI+HRD+KP N+++ + + ++L D+GLA + + R+ PEL
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPEL 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 1e-23
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 37/164 (22%)
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR+ +
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGD 254
Query: 188 T---YRWMAPE-------------------LYSTVTL-------RQGEKKHYN-----HK 213
+WMAPE L+ +L + +++ +
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
P + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 315 MRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 3e-15
Identities = 46/163 (28%), Positives = 65/163 (39%), Gaps = 23/163 (14%)
Query: 10 ADELKLDA-KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETP 61
+ L DA KW L +G +G GA +V E +TVA+K++ +G T
Sbjct: 7 CERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 66
Query: 62 EEIAKKESRFAREVAMLSRV-QHRNLVKFIGAC---KEPVMVIVTELLSGGTLRKYLLNM 117
E E+ +L + H N+V +GAC P+MVIV E G L YL +
Sbjct: 67 SEHRA----LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSK 121
Query: 118 RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160
R + AR + G I DLK +T
Sbjct: 122 RNEFVPYKT------KGARFRQGKDYVGAIPVDLKRRLDSITS 158
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 26/186 (13%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLV 87
++GEG + +VY+ N+TVAIK + E + A REV++L +QHRN++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV----PGTAIREVSLLKELQHRNII 96
Query: 88 KFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
+ + ++ E L+KY+ + + V F + + HS
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 147 IHRDLKPENLLLTEDLKT----IKLADFGLAREESL-TEMMTAETGT--YRWMAPEL--- 196
+HRDLKP+NLLL+ + +K+ DFGLAR + T E T YR PE+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEILLG 211
Query: 197 ---YST 199
YST
Sbjct: 212 SRHYST 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-23
Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA +V ++K + A+K++ K E I + +S F E +++ +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM---IKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V E + GG L + N + A + ++ A++ +HS G I
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+LL + +KLADFG + + M+ +T GT +++PE V QG
Sbjct: 191 HRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLKSQG 245
Query: 206 EKKHYN 211
+Y
Sbjct: 246 GDGYYG 251
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 36/191 (18%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE------IAKKESRFAREVAMLSRVQ 82
++G G +A VY+G K VA+K V EE I RE++++ ++
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAI--------REISLMKELK 61
Query: 83 HRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYL----LNMRPRCLDVCVAIGFALDIARA 137
H N+V+ E + +V E + L+KY+ + PR L++ + F + +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAP 194
+ H + I+HRDLKP+NLL+ + +KL DFGLAR + ++E T YR AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--AP 177
Query: 195 EL------YST 199
++ YST
Sbjct: 178 DVLMGSRTYST 188
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-23
Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA ++V K K Q A+KI++K + + + E R E +L R + +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM---LKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V E GG L LL+ + +A + +I A++ +H G +
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV 184
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+LL I+LADFG + + + GT +++PE+ V G
Sbjct: 185 HRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 206 EKKH 209
+
Sbjct: 244 TGSY 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 14/187 (7%)
Query: 32 IGEGAHAKVY--EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
IG GA +V + K ++ A+KI++K E + + E+ R E +L + +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEM---LKRAETACFREERDVLVNGDSKWITT 138
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ + +V + GG L LL+ L +A + ++ A++ +H +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV 197
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPELYSTVTLRQG 205
HRD+KP+N+L+ + I+LADFG + + + GT +++PE+ + +G
Sbjct: 198 HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAMEG 253
Query: 206 EKKHYNH 212
K Y
Sbjct: 254 GKGRYGP 260
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 59/184 (32%), Positives = 93/184 (50%), Gaps = 27/184 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKE---SRFAREVAMLSRVQHRN 85
++GEG +A VY+GK K + VA+K + + +E REV++L ++H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 86 LVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V E + +V E L L++YL + +++ F + R + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGT--YRWMAPEL----- 196
++HRDLKP+NLL+ E +KLADFGLAR +S+ T+ E T YR P++
Sbjct: 120 KVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGST 176
Query: 197 -YST 199
YST
Sbjct: 177 DYST 180
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 8/169 (4%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G +V + + + A K + K +K A E +L +V R +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + +V L++GG L+ ++ +M A+ +A +I +E LH I+
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIV 308
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+RDLKPEN+LL + I+++D GLA + + GT +MAPE+
Sbjct: 309 YRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 23/211 (10%)
Query: 1 MESRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGE 59
M+++ + D + + + I G++ V G VAIK V
Sbjct: 2 MQAKGEAAMRDLIA--ELHAMQSPYTVQRF-ISSGSYGAVCAGVDSEGIPVAIKRVFNTV 58
Query: 60 TPEEIAKKES------RFAREVAMLSRVQHRNLVKFIGACKEPVMV------IVTELLSG 107
+ S R RE+ +L+ H N++ +VTEL+
Sbjct: 59 SDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-R 117
Query: 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167
L + + + R + F I + LH G++HRDL P N+LL ++ I +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQY-FMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITI 175
Query: 168 ADFGLAREESLTEMMTAETGT--YRWMAPEL 196
DF LARE++ T YR APEL
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYR--APEL 204
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 16/171 (9%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G G+ +V K+K A+KI+ K + + K+ E +L V LVK
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKV---VKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ K+ + +V E ++GG + +L R A +A I E LHS +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+RDLKPENLL+ + I++ DFG A+ T GT +APE+
Sbjct: 164 YRDLKPENLLIDQQ-GYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEI 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G G +V+ + K + A K ++K +K + A E +L++V R +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRL---KKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG 145
A + + +V +++GG +R ++ N+ AI + I +E LH
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
II+RDLKPEN+LL +D ++++D GLA E + GT +MAPEL
Sbjct: 310 IIYRDLKPENVLLDDD-GNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPEL 360
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-21
Identities = 49/177 (27%), Positives = 88/177 (49%), Gaps = 28/177 (15%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-------MLSRVQ 82
+G G+ +V+ + + + A+K++ K E + + ++V MLS V
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKK----EIVVRL-----KQVEHTNDERLMLSIVT 64
Query: 83 HRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
H +++ G ++ + ++ + + GG L L + + VA +A ++ A+E L
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
HS II+RDLKPEN+LL ++ IK+ DFG A+ T GT ++APE+
Sbjct: 123 HSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEV 174
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
D+ + + ++ + P IG GA V ++ VAIK + + + AK R R
Sbjct: 55 DSTFTVLKRYQNLKP-IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYR 110
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ ++ V H+N++ + + +V EL+ ++ L + R
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-- 168
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT
Sbjct: 169 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMT 221
Query: 184 AETGT--YRWMAPEL 196
T YR APE+
Sbjct: 222 PYVVTRYYR--APEV 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 50/202 (24%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI---AKKESRFAREVAMLSRVQHRN 85
+IG+G +V++ +++ Q VA+K V E A RE+ +L ++H N
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQLLKHEN 77
Query: 86 LVKFIGACKEPVMVIVTELLSGGT---------------LRKYLLNMRPRCLDVCVAIGF 130
+V I + T+ L L N+ + +
Sbjct: 78 VVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV 129
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-----ESLTEMMTAE 185
+ + +H + I+HRD+K N+L+T D +KLADFGLAR S T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 186 TGT--YRWMAPEL------YST 199
T YR PEL Y
Sbjct: 189 VVTLWYR--PPELLLGERDYGP 208
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 54/194 (27%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
D+ + + ++ + P IG GA V + VAIK + + + AK R R
Sbjct: 18 DSTFTVLKRYQNLKP-IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYR 73
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ ++ V H+N++ + + IV EL+ ++ L + R
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-- 131
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ ++ LHS GIIHRDLKP N+++ D +K+ DFGLAR + MMT
Sbjct: 132 ------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMT 184
Query: 184 AETGTYRWM-APEL 196
T R+ APE+
Sbjct: 185 PYVVT-RYYRAPEV 197
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 45/197 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA----REVAMLSRVQHRN 85
G+G V GK K +VAIK V + + RF + + L+ + H N
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ----------DPRFRNRELQIMQDLAVLHHPN 80
Query: 86 LVKFI--------GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLD-----VCVAIGFAL 132
+V+ ++ + +V E + TL + N R + + V F
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKV---FLF 136
Query: 133 DIARAMECLH--SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGT-- 188
+ R++ CLH S + HRD+KP N+L+ E T+KL DFG A++ S +E A +
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 189 YRWMAPEL------YST 199
YR APEL Y+T
Sbjct: 197 YR--APELIFGNQHYTT 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 29/194 (14%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
W + ++ +G GA+ V K + VAIK + + E AK R R
Sbjct: 17 KTAWELPKTYVSPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYR 72
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLS---GGTLRKYLLNMRPRCLD 123
E+ +L +QH N++ + + +V + + + +
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-- 130
Query: 124 VCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMT 183
+ + ++ +HS G++HRDLKP NL + ED + +K+ DFGLAR MT
Sbjct: 131 ------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHAD--AEMT 181
Query: 184 AETGTYRW-MAPEL 196
T RW APE+
Sbjct: 182 GYVVT-RWYRAPEV 194
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 43/204 (21%)
Query: 27 FVGPRIGEGAHAKVYEGKYK----NQTVAIKIVHK-GETPEEIAKKESRFAREVAMLSRV 81
+ G ++G G + VY+ K K ++ A+K + G + RE+A+L +
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--------REIALLREL 75
Query: 82 QHRNLVKFIGACKEPVM---VIVTELLSGGTLRKYLLNMRPRCLDVCVAI-------GFA 131
+H N++ ++ + L + R +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE-----ESLTEMMT 183
I + LH++ ++HRDLKP N+L+ + +K+AD G AR + L + +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD-LD 193
Query: 184 AETGT--YRWMAPEL------YST 199
T YR APEL Y+
Sbjct: 194 PVVVTFWYR--APELLLGARHYTK 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 55/171 (32%), Positives = 85/171 (49%), Gaps = 13/171 (7%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G KV + K + A+KI+ K IAK E E +L +H L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + V E +GG L +L R R A + +I A+E LHS ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
+RD+K ENL+L +D IK+ DFGL +E +++ T +T GT ++APE+
Sbjct: 128 YRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEV 176
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 54/188 (28%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
W + ++ + P +G GA+ V VA+K + + AK R RE+
Sbjct: 25 WEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELR 80
Query: 77 MLSRVQHRNLVKFIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
+L ++H N++ + + +VT L+ G L ++ + L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNI---VKCQKLTDDHVQF 136
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTY 189
I R ++ +HS IIHRDLKP NL + ED + +K+ DFGLAR + MT T
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT- 192
Query: 190 RW-MAPEL 196
RW APE+
Sbjct: 193 RWYRAPEI 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-19
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 42/186 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
IG G++AKV + K ++ A+K+V K E + E + ++
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKK----ELVNDDE-----------DIDWVQTEKH 61
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ F A P +V V E ++GG L ++ R R L A ++
Sbjct: 62 V--FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSA 117
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I+ A+ LH GII+RDLK +N+LL + IKL D+G+ +E L T T GT
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPN 175
Query: 191 WMAPEL 196
++APE+
Sbjct: 176 YIAPEI 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 46/219 (21%), Positives = 74/219 (33%), Gaps = 63/219 (28%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFA-REVAMLSRVQHRNLVK 88
+G G+ V E + A+K V + + R+ RE+ ++ + H N++K
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ----------DPRYKNRELDIMKVLDHVNIIK 64
Query: 89 ---FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD------------ 133
+ + L + V V
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 134 -------------------------IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168
+ RA+ +HS GI HRD+KP+NLL+ T+KL
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 169 DFGLAREESLTEMMTAETGT--YRWMAPEL------YST 199
DFG A++ +E A + YR APEL Y+
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTP 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 20/203 (9%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
W I ++ IG G++ V E K + VAIK + + K R RE+
Sbjct: 48 DWQIPDRYEIRHL-IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---RILREI 103
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGT-LRKYLLNMRPRCLD-VCVA 127
A+L+R+ H ++VK + + +V E+ + +K +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKT- 160
Query: 128 IGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETG 187
++ ++ +HS GI+HRDLKP N L+ +D ++K+ DFGLAR E ++
Sbjct: 161 --LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLP 217
Query: 188 TYRWMAPELYSTVTLRQGEKKHY 210
T + K+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQL 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 22/191 (11%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR 73
W + + + P +G GA+ V VAIK +++ E AK R R
Sbjct: 18 KTAWEVRAVYRDLQP-VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYR 73
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCV 126
E+ +L ++H N++ + + +V + G L K + + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDR 129
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186
+ + + +H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT
Sbjct: 130 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD--SEMTGYV 186
Query: 187 GTYRWM-APEL 196
T RW APE+
Sbjct: 187 VT-RWYRAPEV 196
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-19
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 42/186 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
IG G++AKV + K ++ A+++V K E + E + ++
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKK----ELVNDDE-----------DIDWVQTEKH 104
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ F A P +V V E ++GG L ++ R R L A ++
Sbjct: 105 V--FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSA 160
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I+ A+ LH GII+RDLK +N+LL + IKL D+G+ +E L T T GT
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPN 218
Query: 191 WMAPEL 196
++APE+
Sbjct: 219 YIAPEI 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 14/172 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRV---QHRN 85
IG G +VY + + A+K + K K+ A E MLS V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSLVSTGDCPF 253
Query: 86 LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
+V A P + + +L++GG L +L +A +I +E +H+
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR 311
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
+++RDLKP N+LL E ++++D GLA + S + + GT+ +MAPE+
Sbjct: 312 FVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 361
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 26/192 (13%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
+ + P++ + IGEGA+ V VAIK + E + R RE+
Sbjct: 23 FDVGPRYTNLSY-IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQ---RTLREIK 77
Query: 77 MLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
+L R +H N++ + P + IV +L+ L K L + + L F
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL---KTQHLSNDHICYF 133
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAET 186
I R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYV 192
Query: 187 GT--YRWMAPEL 196
T YR APE+
Sbjct: 193 ATRWYR--APEI 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAR---EVAMLSRVQH 83
+G GA+ KV+ G + A+K++ K I +K E +L ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK----ATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 84 RN-LVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
LV A + + ++ + ++GG L +L + + +I A+E L
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYVGEIVLALEHL 175
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
H GII+RD+K EN+LL + + L DFGL++E E A GT +MAP++
Sbjct: 176 HKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 42/186 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
+G+G+ KV + K A+K++ K + I + + V+ +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKK----DVILQDD-----------DVECTMTEKR 75
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ A P + V E ++GG L ++ + R D A +A
Sbjct: 76 I--LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I A+ LH GII+RDLK +N+LL + KLADFG+ +E + +T T GT
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPD 189
Query: 191 WMAPEL 196
++APE+
Sbjct: 190 YIAPEI 195
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 42/186 (22%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH----RN 85
+G+G+ KV+ ++K NQ AIK + K + + + V+ +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDD-----------DVECTMVEKR 69
Query: 86 LVKFIGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+ A + P + V E L+GG L ++ D+ A +A
Sbjct: 70 V--LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYR 190
+I ++ LHS GI++RDLK +N+LL +D IK+ADFG+ +E + T GT
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKEN-MLGDAKTNTFCGTPD 183
Query: 191 WMAPEL 196
++APE+
Sbjct: 184 YIAPEI 189
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-18
Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL 86
+G+G+ KV+ G Q A+K++ K + R E +L V H +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVEVNHPFI 88
Query: 87 VKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
VK A + + ++ + L GG L L + + ++A A++ LHS G
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALDHLHSLG 146
Query: 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
II+RDLKPEN+LL E+ IKL DFGL++ ES+ A + GT +MAPE+
Sbjct: 147 IIYRDLKPENILLDEE-GHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEV 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 34/182 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K ++ A+KI+ K + + + + +V V+ R L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDD-----DVECT-MVEKRVLAL- 76
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
K P + V E ++GG L ++ + A+ +A +IA
Sbjct: 77 --PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAI 132
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
+ L S GII+RDLK +N++L + IK+ADFG+ + E++ + +T +T GT ++AP
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAP 190
Query: 195 EL 196
E+
Sbjct: 191 EI 192
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 26/178 (14%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA--------MLSRV 81
IG+G+ KV ++K A+K++ K + I KK +E +L V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQK----KAILKK-----KEEKHIMSERNVLLKNV 96
Query: 82 QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMEC 140
+H LV + + + V + ++GG L +L R RC A +A +IA A+
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGY 154
Query: 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
LHS I++RDLKPEN+LL I L DFGL +E + T T GT ++APE+
Sbjct: 155 LHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPEV 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-18
Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 32 IGEGAHAKVY-----EGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVA-------MLS 79
+G+G + KV+ G + A+K++ K I + ++ A +L
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKK----AMIVRNA----KDTAHTKAERNILE 76
Query: 80 RVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
V+H +V I A + + ++ E LSGG L L R A + +I+ A+
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAEISMAL 134
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
LH GII+RDLKPEN++L +KL DFGL + ES+ + T GT +MAPE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPEI 192
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 34/182 (18%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G+G+ KV + K ++ A+KI+ K + + + + +V V+ R L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKK----DVVIQDD-----DVECT-MVEKRVLAL- 397
Query: 90 IGACKEPVMV-------------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
K P + V E ++GG L ++ + A+ +A +IA
Sbjct: 398 --PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAI 453
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAP 194
+ L S GII+RDLK +N++L + IK+ADFG+ +E + + +T +T GT ++AP
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAP 511
Query: 195 EL 196
E+
Sbjct: 512 EI 513
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 29/199 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIK-IVHKGETPEEIAKKESRFARE 74
+ + +++ + P +G G + V+ ++ VAIK IV K RE
Sbjct: 6 GFDLGSRYMDLKP-LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVK---HALRE 58
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG----- 129
+ ++ R+ H N+VK + ++ S L + D+ +
Sbjct: 59 IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL 118
Query: 130 ------FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLT 179
F + R ++ +HS ++HRDLKP NL + + +K+ DFGLAR S
Sbjct: 119 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 180 EMMTAETGT--YRWMAPEL 196
++ T YR +P L
Sbjct: 179 GHLSEGLVTKWYR--SPRL 195
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 53/203 (26%), Positives = 80/203 (39%), Gaps = 39/203 (19%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ I +GEGA+ V +K + VAIK + + P A R RE+
Sbjct: 6 VYNISSDFQLKSL-LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-AL---RTLREI 60
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELLSGGTLRKYLLNMRPRCLD---VCV 126
+L +H N++ + I+ EL+ L + + + L +
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY 116
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----------E 175
F RA++ LH +IHRDLKP NLL+ + +K+ DFGLAR
Sbjct: 117 ---FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEP 172
Query: 176 ESLTEMMTAETGT--YRWMAPEL 196
M T YR APE+
Sbjct: 173 TGQQSGMVEFVATRWYR--APEV 193
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 54/172 (31%), Positives = 84/172 (48%), Gaps = 14/172 (8%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR-EVAMLSRVQHRNLVK 88
+G+G KV K K + A+KI+ K +AK E E +L +H L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVI---VAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 89 FIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
+ + + V E +GG L +L R R A + +I A++ LHS +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNV 270
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET--GTYRWMAPEL 196
++RDLK ENL+L +D IK+ DFGL +E + + T +T GT ++APE+
Sbjct: 271 VYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAPEV 320
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 53/225 (23%), Positives = 85/225 (37%), Gaps = 69/225 (30%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ ++ IG G++ VY K + VAIK V++ K R RE+
Sbjct: 21 NVHVPDNYIIKHL-IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREI 76
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV------IVTELL---------SGGTL----RKYLLN 116
+L+R++ +++ ++ IV E+ + L K +L
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL- 135
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-- 174
++ +H GIIHRDLKP N LL +D +K+ DFGLAR
Sbjct: 136 ---------------YNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTI 179
Query: 175 ---------------------EESLTEMMTAETGT--YRWMAPEL 196
++L + +T+ T YR APEL
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APEL 222
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
VG +IG G ++ GK N+ VAIK+ ++ E RF +++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQ-- 69
Query: 86 LVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
V + G C + MV+ ELL G +L + L ++ R + + A+ + ME +HS
Sbjct: 70 -VYYFGPCGKYNAMVL--ELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 145 GIIHRDLKPENLLL----TEDLKTIKLADFGLARE 175
+I+RD+KPEN L+ + + I + DF LA+E
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R 84
VG RIGEG+ ++EG NQ VAIK E + E +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 85 NLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ +E V+VI +LL G +L + LL++ R V A + ++ +
Sbjct: 67 GIPNVYYFGQEGLHNVLVI--DLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 142 HSHGIIHRDLKPENLLL----TEDLKTIKLADFGLARE 175
H +++RD+KP+N L+ +++ I + DFG+ +
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 19/156 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-R 84
+G +IG G+ +Y G + VAIK+ E + K + E + +Q
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLHIESKIYKMMQGGV 65
Query: 85 NLVKFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ E VMV+ ELL G +L + L N R + + A + +E +
Sbjct: 66 GIPTIRWCGAEGDYNVMVM--ELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 142 HSHGIIHRDLKPENLLL--TEDLKTIKLADFGLARE 175
HS IHRD+KP+N L+ + + + DFGLA++
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 65/221 (29%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+ K+ V +G+GA+ V++ + + VA+K + A+ R RE+
Sbjct: 4 DRHVLRKYELVKK-LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREI 59
Query: 76 AMLSRVQ-HRNLVKFIGACKEPVMV---IVTEL--------LSGGTL----RKYLLNMRP 119
+L+ + H N+V + + +V + + L ++Y
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY------ 113
Query: 120 RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----- 174
+ + ++ LHS G++HRD+KP N+LL + +K+ADFGL+R
Sbjct: 114 ----------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNI 162
Query: 175 -----------------EESLTEMMTAETGT--YRWMAPEL 196
+ ++T T YR APE+
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYR--APEI 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-14
Identities = 30/166 (18%), Positives = 56/166 (33%), Gaps = 19/166 (11%)
Query: 28 VGPRIGEGAHAKVYEG----------KYKNQTVAIKIVHKGETPEEIAKKESRFAR--EV 75
+ +YE + Q ++K+ K R A+ +V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 76 AMLSRVQHRNL-----VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGF 130
++ L G ++ +V L G +L+ L L +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 131 ALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175
A + A+E LH + +H ++ EN+ + ED + LA +G A
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 19/156 (12%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G+ ++Y G N+ VAIK+ E + K + E + +Q
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYRILQGGT 63
Query: 86 LV-KFIGACKEP---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ E V+V+ +LL G +L + L N R L + + A + +E +
Sbjct: 64 GIPNVRWFGVEGDYNVLVM--DLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 142 HSHGIIHRDLKPENLLL--TEDLKTIKLADFGLARE 175
HS +HRD+KP+N L+ + + DFGLA++
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ +V + +Q VA+K+V + A +E R + + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 90 IGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ C + ELLS L + + + + + + FA I + ++ LH
Sbjct: 165 LENFTFRNHIC------MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 143 SHGIIHRDLKPENLLLTEDLKT-IKLADFGLA 173
+ IIH DLKPEN+LL + ++ IK+ DFG +
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 33/170 (19%), Positives = 60/170 (35%), Gaps = 27/170 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYKNQT-------VAIKIVHKGETPEEIAKKESRFAREVAMLSR 80
VG IG+G +Y + +K+ P E +F + A +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP---LFTELKFYQRAAKPEQ 95
Query: 81 VQHRNLVKFIGACKEPVM--------------VIVTELLSGGTLRKYLLNMRPRCLDVCV 126
+Q + + P ++ + G L+K + +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRKT 153
Query: 127 AIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175
+ +L I +E +H H +H D+K NLLL ++ + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 32/171 (18%)
Query: 28 VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G +Y K + A +V K E ++ E+ RV ++
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-KVE-----YQENGPLFSELKFYQRVAKKD 94
Query: 86 LVKFIGACKEPVM--------------------VIVTELLSGGTLRKYLLNMRPRCLDVC 125
+K K+ +V E L G L+K
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 126 VAIGFALDIARAMECLHSHGIIHRDLKPENLLL-TEDLKTIKLADFGLARE 175
+ + + + +E +H + +H D+K NLLL ++ + LAD+GL+
Sbjct: 154 LQL--GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 21/176 (11%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG+G+ +V + + + VAIKI+ + A+ E R + +V
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 90 IGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
C +V E+LS L L N R + + + FA + A+ L
Sbjct: 122 KRHFMFRNHLC------LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 143 SH--GIIHRDLKPENLLLTEDLKT-IKLADFGLAREESLTEMMTAETGTYRWMAPE 195
+ IIH DLKPEN+LL ++ IK+ DFG + + ++ YR +PE
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 1e-11
Identities = 35/188 (18%), Positives = 58/188 (30%), Gaps = 48/188 (25%)
Query: 32 IGEGAHAKVYEGKYKNQTVAIKIVH---------KGETPEEIAKKESRFAREVAMLS--- 79
IGEG +V++ + VAIKI+ + E E ++E+++LS
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 80 RVQHRNLVKFIGAC-------------------------------KEPVMVIVTELLSGG 108
+ + K+ + IV E GG
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 109 TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKPENLLLTEDLKTIKL 167
L MR + + A + ++ S HRDL N+LL + KL
Sbjct: 148 ID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT-SLKKL 203
Query: 168 ADFGLARE 175
+
Sbjct: 204 HYTLNGKS 211
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 35/189 (18%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------- 82
+G G + V+ K N VA+KIV + E A+ E + +L RV
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE------IKLLQRVNDADNTKE 80
Query: 83 ----HRNLVK------FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
+++K G +V+V E+L G L + R + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVH-VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 133 DIARAMECLHSH-GIIHRDLKPENLLLT-----EDLKTIKLADFGLAREESLTEMMTAET 186
+ ++ +H GIIH D+KPEN+L+ E+L IK+AD G A + +T
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 187 GTYRWMAPE 195
YR +PE
Sbjct: 199 REYR--SPE 205
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 9e-11
Identities = 50/192 (26%), Positives = 72/192 (37%), Gaps = 37/192 (19%)
Query: 32 IGEGAHAKVYEG---KYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEGA KV E K + VA+KIV + E A+ E + + V+
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 89 FIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ C IV ELL G + ++ + A I +++ L
Sbjct: 82 MLEWFEHHGHIC------IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 142 HSHGIIHRDLKPENLLLTEDLKT------------------IKLADFGLAREESLTEMMT 183
HS+ + H DLKPEN+L + T IK+ DFG A +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194
Query: 184 AETGTYRWMAPE 195
T YR APE
Sbjct: 195 VSTRHYR--APE 204
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 42/202 (20%), Positives = 67/202 (33%), Gaps = 57/202 (28%)
Query: 32 IGEGAHAKV---YEGKYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHR 84
+GEG KV + VA+KI+ + ++ E+ +L +++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII----------RNVGKYREAARLEINVLKKIKEK 76
Query: 85 ------NLVKFIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
V C I ELL G ++L + + A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMC------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLKT------------------IKLADFGLA 173
+ A+ LH + + H DLKPEN+L I++ADFG A
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189
Query: 174 REESLTEMMTAETGTYRWMAPE 195
+ T YR PE
Sbjct: 190 TFDHEHHTTIVATRHYR--PPE 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 37/182 (20%), Positives = 66/182 (36%), Gaps = 59/182 (32%)
Query: 32 IGEGAHAKVYEG--KYKNQTVAIKIVHKGETPEEIAKKESRFAR----EVAMLSRVQHR- 84
+G+G +V + A+K+V + ++ R E +L ++Q+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVV----------RNIKKYTRSAKIEADILKKIQNDD 92
Query: 85 ----NLVKFIGA-------CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
N+VK+ G C ++ E L G +L + + + + ++
Sbjct: 93 INNNNIVKYHGKFMYYDHMC------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKT------------------------IKLAD 169
I +A+ L + H DLKPEN+LL + IKL D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 170 FG 171
FG
Sbjct: 206 FG 207
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 44/234 (18%), Positives = 87/234 (37%), Gaps = 39/234 (16%)
Query: 32 IGEGAHAKVYEGK--YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ------- 82
+G G + V+ + VA+K+V E E A E+ +L V+
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL------DEIRLLKSVRNSDPNDP 98
Query: 83 -HRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+V+ + K + +V E+L G L K+++ + L + + +
Sbjct: 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 137 AMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
++ LH+ IIH D+KPEN+LL+ + + I+ + + + A
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 196 LYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
+ +AE + +++ + +CW FT+ IQ
Sbjct: 218 GN-----------FLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 23/184 (12%)
Query: 4 RSRFYLADELKLDAKWLIDPKHLFVGPR---IGEGAHAKVYEGKYKNQTVAIKI-VHKGE 59
+ D + + W+ + K IG+GA A + Y + V IK V KG
Sbjct: 316 IPNYRT-DMV--EVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGY 372
Query: 60 TPEEIAKK--ESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELLSGGTLRKYLLN 116
E + + +SR ARE L+ V+ + +I I+ ++G + + +
Sbjct: 373 RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED 432
Query: 117 MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176
+ +G LH + +IH DL N + +DL I DFGL +
Sbjct: 433 NLDIAYKIGEIVG----------KLHKNDVIHNDLTTSNFIFDKDLYII---DFGLGKIS 479
Query: 177 SLTE 180
+L E
Sbjct: 480 NLDE 483
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 22/158 (13%)
Query: 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKES------RFAREVAMLSR 80
+G +GEG + V+ + + HK KE F+ +R
Sbjct: 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 152
Query: 81 VQHRNLVKFIGA-CKEPVM----VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
+ R L K G + ++ EL+ L + + LD I
Sbjct: 153 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD---------MIL 203
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173
+ + GI+H DL N+L++E+ I + DF +
Sbjct: 204 EEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQS 239
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 5e-06
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 27/163 (16%)
Query: 28 VGPRIGEGAHAKVYEGK----YKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83
+G I G A V+ K +A+KI ++ ET E E + E + R+
Sbjct: 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKI-YRIETSEFDKMDEYLYGDERFDMRRISP 109
Query: 84 RNLVKFIGACKE------------PV--------MVIVTELLSGGTLRKYLLNMRPRCLD 123
+ V I KE V V++ E + L L R L
Sbjct: 110 KEKVF-IWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 124 VCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTI 165
G D+ ++ L+ ++H DL N++ + + I
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDKVYFI 211
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 4e-05
Identities = 46/264 (17%), Positives = 79/264 (29%), Gaps = 104/264 (39%)
Query: 109 TLRKYLLNMRPR--------------CL--DVC---------------VAIG-------- 129
LR+ LL +RP + DVC + +
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 130 --------FALDIARAMECLHSHGIIHR--DLK------------PENLLLTEDL---KT 164
+ +D HS I R ++ LL+ ++ K
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 165 IKLADFG-----LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKNVRPSA 219
+ R + +T+ ++A T T+ + +TL E K K +
Sbjct: 259 WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS---MTLTPDEVKSLLLKYLDCRP 315
Query: 220 ENVPEE--------LSIILTSCWKEDPNARPNF--------TQIIQMLLNYLSAIAPPEP 263
+++P E LSII S ++ N+ T II+ LN L P E
Sbjct: 316 QDLPREVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESSLNVLE---PAE- 370
Query: 264 MIPHR-------IFNSENTILPPE 280
+R +F + +P
Sbjct: 371 ---YRKMFDRLSVFP-PSAHIPTI 390
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.87 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.65 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.24 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.01 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.94 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.56 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.11 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.01 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.2 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.04 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 89.86 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.08 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.26 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-55 Score=380.50 Aligned_cols=237 Identities=30% Similarity=0.476 Sum_probs=190.6
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
+....|+|+.+++++.++||+|+||+||+|++.+ .||||+++...... ...+.|.+|+.++++++|||||+++|++
T Consensus 26 ~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~ 101 (307)
T 3omv_A 26 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTP---EQFQAFRNEVAVLRKTRHVNILLFMGYM 101 (307)
T ss_dssp ---CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4445799999999999999999999999998875 58999997654433 3456799999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++.++||||||+||+|.++|.... ..+++..++.|+.||+.||+|||+++||||||||+||||+.+ +.+||+|||+|
T Consensus 102 ~~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla 179 (307)
T 3omv_A 102 TKDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLA 179 (307)
T ss_dssp CSSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSC
T ss_pred ECCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCc
Confidence 8888999999999999999997643 349999999999999999999999999999999999999998 69999999999
Q ss_pred cccccc---cccccccCccceeccccccccc--ccccccccccCC-----------------------------CC----
Q 021127 174 REESLT---EMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-----------------------------NV---- 215 (317)
Q Consensus 174 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-----------------------------~~---- 215 (317)
+..... ......+||+.|||||++.+.. ..+...++|+.+ ..
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL 259 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 854322 2334568999999999985421 111122222221 11
Q ss_pred CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 216 RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 216 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
...+.++|.++.+||.+||+.||++|||+.+++++|+.+..
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 12346789999999999999999999999999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=382.64 Aligned_cols=225 Identities=25% Similarity=0.410 Sum_probs=186.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|+++++||+|+||+||+|++. ++.||||++.+..... ...+++.+|++++++++|||||++++++.++ .+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS---KEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH---HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 368999999999999999999986 8999999998765443 3356799999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
||||||+||+|.++|...+...+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecCC
Confidence 99999999999999987666668999999999999999999999999999999999999998 79999999999866543
Q ss_pred -cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHHH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li 230 (317)
......+||+.|||||++.+..+.. ..++|+.+ ...+.+..++.++++||
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li 257 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV 257 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence 2335568999999999988755433 33444333 22344668899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||+.||.+|||++|+++|-+
T Consensus 258 ~~~L~~dP~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 258 SQLFKRNPRDRPSVNSILEKGF 279 (350)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHccCChhHCcCHHHHhcCHH
Confidence 9999999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=365.36 Aligned_cols=223 Identities=27% Similarity=0.380 Sum_probs=175.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||+||+|++. ++.||||++.+..... .....++.+|++++++++|||||++++++.++ .+|+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK--SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 58999999999999999999885 8999999998765433 23355789999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||| +|+|.+++.+.+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 91 vmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCC
Confidence 99999 7899999987654 9999999999999999999999999999999999999988 799999999998766555
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
...+.+||+.|||||++.+..+.....++|+.+ .....+..+++++++||.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 566779999999999998766555455555543 22334667899999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|+.||++|||++|+++|-|
T Consensus 247 L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHH
T ss_pred ccCChhHCcCHHHHHcCcc
Confidence 9999999999999999843
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=370.52 Aligned_cols=236 Identities=25% Similarity=0.465 Sum_probs=188.0
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
...+.|+.++|.+.++||+|+||+||+|++. ++.||||+++... ....++|.+|++++++++|||||+
T Consensus 33 ~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----ESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-----HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-----HHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3456788899999999999999999999863 6789999997543 233567999999999999999999
Q ss_pred EEeeeecC-ceEEEEEccCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMR-------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
++|+|.++ ..+||||||++|+|.+++.... ...+++.+++.|+.||+.||+|||+++||||||||+
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 99999765 7999999999999999997643 235999999999999999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc-----------------cccccccC--
Q 021127 155 NLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-- 212 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-- 212 (317)
||||+.+ +.+||+|||+++...... .....+||+.|||||++.+..+.. +..++...
T Consensus 188 NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 188 NCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp GEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred hEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999998 699999999998543322 223457999999999877643322 11111111
Q ss_pred ---------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 ---------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+...+.+..+|+++.+||.+||+.||++|||+.+|+++|+.+.+.
T Consensus 267 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 123445778999999999999999999999999999999988653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=368.14 Aligned_cols=233 Identities=29% Similarity=0.489 Sum_probs=190.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
+.|++++|.+.++||+|+||+||+|++. +..||||+++.... ...++|.+|++++++++|||||+++|
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-----~~~~~f~~E~~il~~l~HpnIV~l~g 82 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-----NARKDFHREAELLTNLQHEHIVKFYG 82 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-----HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 4688899999999999999999999863 67899999975432 33567999999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMR-----------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
+|.++ ..+||||||++|+|.++|...+ ...+++.+++.|+.||+.||+|||+++||||||||+|||++
T Consensus 83 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~ 162 (299)
T 4asz_A 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162 (299)
T ss_dssp EECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC
Confidence 99765 8999999999999999997643 34599999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCcccccccccc---cccccCccceeccccccccccccc-----------------ccccccC-------
Q 021127 160 EDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQG-----------------EKKHYNH------- 212 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~-----------------~~~~~~~------- 212 (317)
.+ +.+||+|||+|+....... .....||+.|||||++.+..+... ..++...
T Consensus 163 ~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 163 EN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 98 6999999999985433322 223468999999998765433221 1111111
Q ss_pred ----CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 ----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+...+.+..+|.++.+||.+||+.||++|||+.++.+.|+++.+.
T Consensus 242 ~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 123455778999999999999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=367.86 Aligned_cols=232 Identities=26% Similarity=0.434 Sum_probs=190.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.++|+.+++++.++||+|+||+||+|++. ++.||||+++...... ..+.|.+|+.++++++|||||+++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~----~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP----LREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-----CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH----HHHHHHHHHHHHHhCCCCCCCCcc
Confidence 45688899999999999999999999862 5789999997654322 245699999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~N 155 (317)
|+|.++ ..++|||||++|+|.++|.... ...+++..++.|+.||+.||+|||+++||||||||+|
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N 175 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN 175 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence 999765 7999999999999999997542 1348999999999999999999999999999999999
Q ss_pred EEeeCCCCceEEcccCccccccccc---ccccccCccceeccccccccccccc-----------------cccccc----
Q 021127 156 LLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQG-----------------EKKHYN---- 211 (317)
Q Consensus 156 ill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~-----------------~~~~~~---- 211 (317)
|||+.+ +.+||+|||+++...... .....+||+.|||||++.+..+... ..++..
T Consensus 176 ILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 176 VLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred eEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 999998 699999999998653332 2344679999999998765332211 111111
Q ss_pred -------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 212 -------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 212 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+...+.+..+|.++.+||.+||+.||++|||+.+|+++|+.+
T Consensus 255 ~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 255 DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1133456788999999999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=368.57 Aligned_cols=229 Identities=22% Similarity=0.267 Sum_probs=189.2
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+....+.|++.++||+|+||+||+|++. ++.||||+++.... ..+|+.++++++|||||++++++.+
T Consensus 52 ~~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp BCCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred hhhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 44556678999999999999999999986 89999999986543 3469999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ .+|||||||+||+|.++|...+. +++..+..|+.||+.||+|||++|||||||||+||||+.+...+||+|||+|+
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred CCEEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 5 89999999999999999987654 99999999999999999999999999999999999999873369999999998
Q ss_pred cccccc------ccccccCccceecccccccccccccccccccCC------------------------------CCCCC
Q 021127 175 EESLTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS 218 (317)
Q Consensus 175 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 218 (317)
...... .....+||+.|||||++.+..+.. ..++|+.+ .....
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 278 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGS
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhc
Confidence 653321 123357999999999988754432 23333322 01123
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
+..+++++.+||.+||+.||.+|||+.|++++|...+....
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 56789999999999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=372.43 Aligned_cols=224 Identities=26% Similarity=0.392 Sum_probs=186.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.++||+|+||+||+|++. |+.||||++....... .+.+.+|+.++++++|||||++++++.++ .+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56999999999999999999985 8999999997654322 34588999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
|||||+||+|.+++.+. .+++..+..|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.... .
T Consensus 149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCC
Confidence 99999999999999763 39999999999999999999999999999999999999998 7999999999986543 3
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------C---CCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N---VRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~l 229 (317)
....+.+||+.|||||++.+..+. ...++|+.+ . ..+.+..+++++++|
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence 345667899999999998765543 233444332 1 112244688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
|.+||+.||++|||++|+++| .|+....
T Consensus 304 i~~~L~~dP~~R~ta~e~l~H--p~~~~~~ 331 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKH--PFLAKAG 331 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC--GGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcC--HhhcCCC
Confidence 999999999999999999988 4454433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=370.07 Aligned_cols=235 Identities=29% Similarity=0.515 Sum_probs=192.9
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 89 (317)
.|+|++++|+++++||+|+||+||+|++. ++.||||.+....... ..+.|.+|+.++.+++| ||||++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~----~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH----HHHHHHHHHHHHHHcCCCCcEEEE
Confidence 69999999999999999999999999874 2679999998765543 34569999999999965 899999
Q ss_pred Eeeeec--CceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 90 IGACKE--PVMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 90 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
+|+|.+ ..++||||||++|+|.++|+... ...+++..++.|+.||+.||+|||+++||||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 999864 36899999999999999997632 23489999999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc-----------------ccccccc--
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-- 211 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-- 211 (317)
+|||++.+ +.+||+|||+|+...... .....+||+.|||||++.+..+.. +..++..
T Consensus 214 ~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 214 RNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999998 699999999998543221 233457899999999876533221 1111111
Q ss_pred ----------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 212 ----------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 212 ----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+...+.+..+++++.+||.+||+.||++|||+.+|+++|..+++.
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1123345678899999999999999999999999999999998864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=367.48 Aligned_cols=224 Identities=26% Similarity=0.353 Sum_probs=187.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
..+++|++++.||+|+||+||+|++. ++.||||++.+..... ....+.+.+|++++++++|||||++++++.++ .
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 106 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 106 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 44578999999999999999999985 8999999997643211 12345789999999999999999999999865 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+|+|||||+||+|.+++.+.+. +++..+..|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLS 183 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecC
Confidence 9999999999999999987655 9999999999999999999999999999999999999998 799999999998653
Q ss_pred cc---cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 178 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
.. ....+.+||+.|||||++.+..+.. ..++|+.+ .....+..++++++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 262 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKAR 262 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHH
Confidence 22 2345678999999999987754432 23344332 12234667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+||.+||+.||++|||++|++++
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCH
T ss_pred HHHHHHccCCHhHCcChHHHcCC
Confidence 99999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=358.73 Aligned_cols=220 Identities=27% Similarity=0.474 Sum_probs=180.7
Q ss_pred CCce-eecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec----
Q 021127 23 PKHL-FVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 23 ~~~y-~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---- 95 (317)
.++| ++.++||+|+||+||+|.+. ++.||||++....... ...++|.+|++++++++|||||++++++.+
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 3455 78889999999999999986 7899999998655433 235679999999999999999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..+|||||||+||+|.+++..... +++..+..|+.||+.||+|||++| ||||||||+||||+...+.+||+|||+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 358999999999999999987654 999999999999999999999998 999999999999985337899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC----------------------------CCC--CCCCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVR--PSAENV 222 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~--~~~~~~ 222 (317)
|+.... ....+.+||+.|||||++.+. + ....++|+.+ ... ..+..+
T Consensus 179 a~~~~~-~~~~~~~GTp~YmAPE~~~~~-y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 255 (290)
T 3fpq_A 179 ATLKRA-SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255 (290)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred CEeCCC-CccCCcccCccccCHHHcCCC-C-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccC
Confidence 986443 334567899999999998652 2 2333444332 011 123456
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++++++||.+||+.||++|||++|+++|
T Consensus 256 ~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 7899999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=373.81 Aligned_cols=224 Identities=26% Similarity=0.397 Sum_probs=187.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.++||+|+||.||+|++. |+.||||++....... .+.+.+|+.+|++++|||||++++++.++ .+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 56999999999999999999986 8999999998655432 34588999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||+||+|.+++.... +++..+..|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+.....
T Consensus 226 VmEy~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCC
Confidence 999999999999997532 9999999999999999999999999999999999999998 79999999999865433
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~l 229 (317)
......+||+.|||||++.+..+.. ..++|+.+ .....+..++.++++|
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence 3445678999999999987755432 33444332 1122345789999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
|.+||+.||++|||+.|+++| .++....
T Consensus 381 i~~~L~~dP~~R~ta~ell~H--p~~~~~~ 408 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKH--PFLAKAG 408 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTC--GGGGGCC
T ss_pred HHHHcCCChhHCcCHHHHhcC--HHhcCCC
Confidence 999999999999999999988 4454433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=364.54 Aligned_cols=226 Identities=28% Similarity=0.359 Sum_probs=181.2
Q ss_pred ceeecCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
...+++++|++++.||+|+||+||+|++ +++.||||++++..... ....++.+|++++++++|||||+++++
T Consensus 18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV---RDRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE---EECC------CCCCCCCCTTEECEEEE
T ss_pred cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh---HHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 3457889999999999999999999986 36889999997543221 112247889999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.++ .+|+|||||+||+|.+++.+.+. +++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFG 171 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFG 171 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccc
Confidence 9765 89999999999999999987655 9999999999999999999999999999999999999998 799999999
Q ss_pred cccccc-cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCCh
Q 021127 172 LAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVP 223 (317)
Q Consensus 172 ~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~ 223 (317)
+|+... ......+.+||+.|||||++.+..+.. ..++|+.+ .....+..+|
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 250 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCC-CCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCC
Confidence 998543 233445678999999999987655433 33444332 2234467889
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
+++++||.+||+.||++||| ++|+++|
T Consensus 251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999999999998 4688876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=349.39 Aligned_cols=221 Identities=26% Similarity=0.386 Sum_probs=169.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
++|++.+.||+|+||+||+|++. ++.||||++...... ...+++.+|++++++++|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE----LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 46899999999999999999986 899999999876543 2345789999999999999999999988532
Q ss_pred --------ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 97 --------VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 97 --------~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
.+|+|||||+||+|.+++..... ...++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl 159 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKV 159 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEE
Confidence 36899999999999999986543 124567788999999999999999999999999999999998 79999
Q ss_pred cccCccccccccc-------------ccccccCccceecccccccccccccccccccCC---------------------
Q 021127 168 ADFGLAREESLTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------- 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------- 213 (317)
+|||+|+...... .....+||+.|||||++.+..+.. ..++|+.+
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyell~Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELLYPFSTQMERVRTLT 238 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHSCCSSHHHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCC-HHHHHHHHHHHHHHccCCCCccHHHHHHH
Confidence 9999998643321 123457999999999988754432 33444433
Q ss_pred -----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+.....++.+.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000111233557889999999999999999999886
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=348.66 Aligned_cols=224 Identities=27% Similarity=0.422 Sum_probs=172.4
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----ce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-----VM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 98 (317)
++|.+.++||+|+||+||+|+++|+.||||++..... ....+..|+..+.+++|||||+++|++.++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~------~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch------hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999999999999999865421 112234566666788999999999998642 47
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEeeCCCCceEEccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+||||||++|+|.+++.... ++++.++.|+.|++.||+|||++ +||||||||+||||+.+ +.+||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeC
Confidence 99999999999999998643 99999999999999999999987 99999999999999998 79999999
Q ss_pred Cccccccccc-----ccccccCccceecccccccccc-----cccccccccCC---------------------------
Q 021127 171 GLAREESLTE-----MMTAETGTYRWMAPELYSTVTL-----RQGEKKHYNHK--------------------------- 213 (317)
Q Consensus 171 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~~~~~~~--------------------------- 213 (317)
|+|+...... .....+||+.|||||++.+... .....++|+.+
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~ 232 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence 9998554322 1234579999999998864210 01111111111
Q ss_pred ----------------CCCCC-CC-----CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ----------------NVRPS-AE-----NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ----------------~~~~~-~~-----~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..++. +. ..+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111 11 1235789999999999999999999999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=347.56 Aligned_cols=226 Identities=24% Similarity=0.361 Sum_probs=183.1
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++++.||+|+||+||+|++. |+.||||+++...... ...+++.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV---TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch---HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 368999999999999999999985 8999999997665433 334578899999999999999999998742
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+.+|||||||+ |+|.+++...+. +++..+..|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~~~~--l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHSSQP--LTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTSSSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeeccee
Confidence 46899999995 789999986544 9999999999999999999999999999999999999998 79999999999
Q ss_pred cccccc-----cccccccCccceecccccccccccccccccccCC--------CC-------------------------
Q 021127 174 REESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------- 215 (317)
Q Consensus 174 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------- 215 (317)
+..... ....+.+||+.|+|||++.+........++|+.+ ..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 854322 2334568999999999987654444444444433 00
Q ss_pred --------------------CCC-----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 216 --------------------RPS-----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 216 --------------------~~~-----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+. ...++.++.+||.+||+.||.+|||+.|+++| .++..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~ 350 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLAK 350 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhCc
Confidence 000 13467899999999999999999999999998 44443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=336.88 Aligned_cols=215 Identities=24% Similarity=0.361 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
++|++.++||+|+||+||+|+++ ++.||||.+...... .++.+|+++++.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-------IRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-------HHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-------HHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 67999999999999999999763 678999998765432 2478899999998 699999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+|+|||||+||+|.+++.. +++.++..++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 89999999999999999842 8999999999999999999999999999999999999987679999999999743
Q ss_pred ccc-----------------------------cccccccCccceecccccccccccccccccccCC--------C-----
Q 021127 177 SLT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N----- 214 (317)
Q Consensus 177 ~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~----- 214 (317)
... ......+||+.|+|||++.+........++|+.+ .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 221 1123457999999999886643322222333221 0
Q ss_pred ---------------------------------------------------------------------CCCCCCCChHH
Q 021127 215 ---------------------------------------------------------------------VRPSAENVPEE 225 (317)
Q Consensus 215 ---------------------------------------------------------------------~~~~~~~~~~~ 225 (317)
.......++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 00112357889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||.+||+.||.+|||++|+++|
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=352.43 Aligned_cols=225 Identities=22% Similarity=0.291 Sum_probs=181.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHH---HHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR---EVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+.-++|+++++||+|+||+||+|++. |+.||||++.+..... ......+.+ ++.+++.++|||||++++++++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~--~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch--hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 34468999999999999999999985 8999999997532111 011122333 4566667799999999999987
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. .+|+|||||+||+|.++|...+. +++..+..|+.||+.||+|||++|||||||||+||||+.+ |.+||+|||+|+
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceee
Confidence 6 89999999999999999987655 9999999999999999999999999999999999999998 799999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChH
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~ 224 (317)
..... ...+.+||+.|||||++..........++|+.+ .....+..++.
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 65443 335579999999999986433233334444332 12234678899
Q ss_pred HHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps-----~~~~~~~l 251 (317)
++++||.+||+.||.+|++ +++|++|-
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 9999999999999999998 78998874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=349.84 Aligned_cols=221 Identities=22% Similarity=0.348 Sum_probs=185.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. |+.||||++..... .....+.+|+.+|+.++|||||++++++.++ .+||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-----hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999985 89999999986542 2245688999999999999999999999865 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-CCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~ 179 (317)
|||||+||+|.++|.... ..+++..+..|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.....
T Consensus 232 v~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999999997533 349999999999999999999999999999999999999853 368999999999977666
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~~ 228 (317)
......+||+.|||||++.+..+.. ..++|+.+ . .......++.++++
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~-~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5666778999999999988755432 22223211 0 11123568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l 251 (317)
||.+||+.||.+|||+.|+++|-
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHST
T ss_pred HHHHHccCChhHCcCHHHHhcCc
Confidence 99999999999999999999983
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=317.17 Aligned_cols=222 Identities=27% Similarity=0.352 Sum_probs=189.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
-++|++.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP---TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 368999999999999999999984 8999999998754432 3345688999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++...+. +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSS
T ss_pred EEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCC
Confidence 99999999999999987654 9999999999999999999999999999999999999988 78999999999866555
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
......+||+.|+|||++.+........++|+.+ .....+..++.++.+|+.+
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5556778999999999987765544444444433 1123355688999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.||.+|||+++++++
T Consensus 248 ~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCSSTTTSCCHHHHTTC
T ss_pred HCCCChhHCcCHHHHhcC
Confidence 999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=315.35 Aligned_cols=241 Identities=32% Similarity=0.554 Sum_probs=187.0
Q ss_pred CCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...+.+..++|++.+.||+|+||+||+|+++++.||||++....... .....+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA---ERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34677889999999999999999999999999999999998765443 334578999999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++| |+||||||+||+++.+ +.+||+|||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg 184 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFG 184 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCC
Confidence 5 78999999999999999986432 23899999999999999999999999 9999999999999988 799999999
Q ss_pred ccccccccc-ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCC
Q 021127 172 LAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAEN 221 (317)
Q Consensus 172 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 221 (317)
+++...... ......||+.|+|||++.+..... ..++|+.+ .....+..
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 263 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE-KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCT-THHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 997543322 234457999999999987644322 22222221 22334667
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
++.++.+||.+||+.||.+|||+.++++.|+.+++...++
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 8999999999999999999999999999999998765443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.79 Aligned_cols=235 Identities=29% Similarity=0.458 Sum_probs=191.2
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.+.+++|++.++||+|+||+||+|.+. ++.||+|++.... ......+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-----EETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-----HHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 45688899999999999999999999986 8899999886533 2345678999999999999999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~ 156 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLAR 156 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCE
T ss_pred CCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccce
Confidence 5 8999999999999999998743 349999999999999999999999999999999999999988 789999999997
Q ss_pred cccccccc---------------ccccCccceecccccccccccccccccccCC--------------------------
Q 021127 175 EESLTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
........ ....||+.|+|||++.+..+.. ..++|+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 54322211 1457999999999987643322 22222211
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.....+..++..+.+|+.+||+.||++|||+.++++.|+.+......
T Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00112456788999999999999999999999999999988766543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=311.92 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=184.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.+.||+|+||+||++++. ++.||||++.+..... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 34578999999999999999999985 8999999997532111 12244688999999999999999999999865 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||++||+|..++...+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcc
Confidence 9999999999999999987554 9999999999999999999999999999999999999988 799999999998532
Q ss_pred -cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHH
Q 021127 178 -LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 178 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~l 229 (317)
........+||+.|+|||++.+..+. ...++|+.+ .....+..++.++.+|
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cCCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 23334566899999999998764432 223333322 1123356789999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 230 LTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
|.+||+.||.+|| ++.++++|-
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 9999999999999 899999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=299.82 Aligned_cols=232 Identities=28% Similarity=0.523 Sum_probs=189.6
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
..|.|++++|++.+.||+|+||.||+|.+. ++.||+|++....... +++.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH------HHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 478999999999999999999999999985 7889999998655432 358899999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTR 154 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGG
T ss_pred CCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccc
Confidence 5 7999999999999999997644 348999999999999999999999999999999999999988 689999999998
Q ss_pred cccccc--ccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCCh
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 223 (317)
...... ......+++.|+|||++.+..... ..+.|+. ......+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 233 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCc-hhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCC
Confidence 543322 223345678899999876432221 1111111 01223355678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999988753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.58 Aligned_cols=239 Identities=31% Similarity=0.539 Sum_probs=193.0
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CC
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QH 83 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 83 (317)
..+..|.+..++|++.+.||+|+||.||+|++. +..||||++...... .....+.+|+.+++++ +|
T Consensus 71 ~~~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~h 146 (370)
T 2psq_A 71 PEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMIGKH 146 (370)
T ss_dssp CCCTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH----HHHHHHHHHHHHHHHSCCC
T ss_pred cccccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH----HHHHHHHHHHHHHHHhcCC
Confidence 344567888899999999999999999999862 457999999765432 3355789999999999 89
Q ss_pred CCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 021127 84 RNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIH 148 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH 148 (317)
|||+++++++.+. ..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+|
T Consensus 147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 226 (370)
T 2psq_A 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226 (370)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9999999999765 89999999999999999987542 34899999999999999999999999999
Q ss_pred cCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccC-------------
Q 021127 149 RDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------- 212 (317)
Q Consensus 149 ~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------- 212 (317)
|||||+|||++.+ +.+||+|||+++...... ......+|+.|+|||++.+..+... .++|+.
T Consensus 227 rDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~ 304 (370)
T 2psq_A 227 RDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGS 304 (370)
T ss_dssp SCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCC
T ss_pred cccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCC
Confidence 9999999999988 799999999998543321 2233467889999998755322111 111110
Q ss_pred ----------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 ----------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 ----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
......+..++.++.+||.+||+.||.+||++.++++.|+.++...
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1123345678899999999999999999999999999999987653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.63 Aligned_cols=246 Identities=31% Similarity=0.540 Sum_probs=199.4
Q ss_pred cceecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
-....+..|.+..++|.+.++||+|+||.||+|++. +..||||++...... ....++.+|+++++++
T Consensus 56 ~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l 131 (382)
T 3tt0_A 56 YELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE----KDLSDLISEMEMMKMI 131 (382)
T ss_dssp CCCCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH----HHHHHHHHHHHHHHHH
T ss_pred cccccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH----HHHHHHHHHHHHHHHh
Confidence 344556689999999999999999999999999863 367999999876543 3345789999999999
Q ss_pred -CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021127 82 -QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHG 145 (317)
Q Consensus 82 -~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ 145 (317)
+||||+++++++.+. ..++||||+++|+|.+++..... ..+++..++.|+.||+.||+|||++|
T Consensus 132 ~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 211 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211 (382)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999765 79999999999999999987542 34999999999999999999999999
Q ss_pred ccccCCCCCcEEeeCCCCceEEcccCcccccccc---cccccccCccceecccccccccccccccccccCC---------
Q 021127 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------- 213 (317)
Q Consensus 146 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------- 213 (317)
|+||||||+|||++.+ +.+||+|||+++..... .......+|+.|+|||++.+..... ..++|+.+
T Consensus 212 ivH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 212 CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp CCCSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTT
T ss_pred EecCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc-hhHHHHHHHHHHHHHhC
Confidence 9999999999999988 79999999999855432 2233446788999999876533221 11111111
Q ss_pred --------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021127 214 --------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262 (317)
Q Consensus 214 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 262 (317)
.....+..++.++.+|+.+||+.||.+|||+.+++++|+.++.......
T Consensus 290 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 290 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1223356789999999999999999999999999999999987654433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=313.30 Aligned_cols=236 Identities=24% Similarity=0.312 Sum_probs=178.4
Q ss_pred ccceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCe
Q 021127 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNL 86 (317)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 86 (317)
+.....+..-.+..++|++.+.||+|+||+||+|++. ++.||||++.+..... ......+.+|..++..+ +||||
T Consensus 9 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~I 86 (353)
T 3txo_A 9 GNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ--DDDVECTMTEKRILSLARNHPFL 86 (353)
T ss_dssp --------------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--HTTHHHHHHHHHHHHHTTTCTTB
T ss_pred CCCCCCCCcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc--hhHHHHHHHHHHHHHhccCCCce
Confidence 3344555556677899999999999999999999886 7899999997642211 22345678899999988 79999
Q ss_pred eeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCce
Q 021127 87 VKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 87 v~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+++++++.+. ..++||||++||+|..++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 87 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~i 163 (353)
T 3txo_A 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHC 163 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCE
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCE
Confidence 9999999865 89999999999999999987654 9999999999999999999999999999999999999998 799
Q ss_pred EEcccCcccccc-cccccccccCccceecccccccccccccccccccCC---------------------------CCCC
Q 021127 166 KLADFGLAREES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRP 217 (317)
Q Consensus 166 kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~ 217 (317)
||+|||+++... ........+||+.|+|||++.+..+.. ..++|+.+ ....
T Consensus 164 kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3txo_A 164 KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGP-AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 242 (353)
T ss_dssp EECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EEccccceeecccCCccccccCCCcCeEChhhcCCCCcCC-ccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999998532 233345568999999999886543322 22333222 1223
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCH------HHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNF------TQIIQML 251 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~------~~~~~~l 251 (317)
.+..++.++.+||.+||+.||.+||++ .++++|-
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 356688999999999999999999998 7888873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.32 Aligned_cols=235 Identities=26% Similarity=0.489 Sum_probs=189.0
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
...+..++|++.+.||+|+||.||+|.+. +..||||++...... .....+.+|+.++++++||||++++++
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE----RQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 35678899999999999999999999984 456999999865543 335578999999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.++ ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 196 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFG 196 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCS
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCC
Confidence 9765 7899999999999999997643 349999999999999999999999999999999999999988 799999999
Q ss_pred ccccccccc----ccccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCC
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSA 219 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~ 219 (317)
+++...... ......+|+.|+|||++.+..+.. +..++... ....+.+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence 998543321 122334678899999876533221 11111111 1233446
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
..++..+.+||.+||+.||.+|||+.++++.|+.++...
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 678999999999999999999999999999999988753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=314.98 Aligned_cols=226 Identities=23% Similarity=0.309 Sum_probs=182.9
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
..+..++|++.++||+|+||+||+|++. ++.||||++.+..... ......+.+|..++.++ +||||+++++++.+
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~--~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 124 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence 3466689999999999999999999886 7899999998654332 12334578899999887 89999999999986
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||++||+|..++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~ 201 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCK 201 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCB
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceee
Confidence 5 89999999999999999987654 9999999999999999999999999999999999999998 799999999998
Q ss_pred c-cccccccccccCccceecccccccccccccccccccCC------------------------------------CCCC
Q 021127 175 E-ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRP 217 (317)
Q Consensus 175 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~ 217 (317)
. ..........+||+.|+|||++.+..+.. ..++|+.+ ....
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~-~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred ecccCCCccccccCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence 5 33334456678999999999987643321 12222211 1123
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNF------TQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~------~~~~~~ 250 (317)
.+..++.++.+||.+||+.||.+||++ .++++|
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 356789999999999999999999985 677776
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.27 Aligned_cols=223 Identities=26% Similarity=0.384 Sum_probs=186.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||+|.+. ++.||||++....... .....++.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc--hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 68999999999999999999984 8999999987532111 11134688999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+ +|+|.+++...+. +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence 99999 7899999987654 9999999999999999999999999999999999999988 689999999998766555
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....+||+.|+|||++.+........++|+.+ .....+..++.++.+||.+|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence 556678999999999987755433333333322 11223566889999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|+.||.+|||+.+++++.+
T Consensus 243 L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHH
T ss_pred cCCChhHCcCHHHHHhChh
Confidence 9999999999999999854
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.06 Aligned_cols=226 Identities=23% Similarity=0.316 Sum_probs=178.0
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
...+.++|++.+.||+|+||.||++++. ++.||||++....... ..+.+|+.+++.++||||+++++++.++
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID------ENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC------HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc------HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 4567789999999999999999999985 8899999998655432 2477899999999999999999999765
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC-CceEEcccCccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAR 174 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~-~~~kl~Dfg~a~ 174 (317)
..++||||+++|+|.+++...+. +++..++.++.|++.||+|||++||+||||||+||+++.+. +.+||+|||+++
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 89999999999999999987554 99999999999999999999999999999999999998662 249999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC---------------------------------CCCCCCCC
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------NVRPSAEN 221 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~ 221 (317)
............||+.|+|||++.+........++|+.+ ...+....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCC
Confidence 544444445567999999999986654433323333322 11222336
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++.++.+||.+||+.||.+|||+.++++|-+
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSW 277 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence 7899999999999999999999999999854
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=318.40 Aligned_cols=232 Identities=29% Similarity=0.512 Sum_probs=191.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...|.++.++|++.+.||+|+||.||+|.++++.||||+++.... .+.|.+|+.++++++||||+++++++.+
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT-------SHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH-------HHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 356899999999999999999999999999999999999986543 2358999999999999999999999764
Q ss_pred C--ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 P--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 ~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
. ..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a 336 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLT 336 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTC
T ss_pred CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCc
Confidence 3 68999999999999999998765558999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCChHH
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENVPEE 225 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~~~~ 225 (317)
+..... .....+++.|+|||++.+..+.. +..++.. .+...+.+..+|.+
T Consensus 337 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~ 414 (450)
T 1k9a_A 337 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 414 (450)
T ss_dssp EECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 854322 22346788999999876532211 1111100 11223446788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+||.+||+.||.+|||+.++++.|+++...
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=322.22 Aligned_cols=235 Identities=29% Similarity=0.492 Sum_probs=194.3
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
...|+|..++|++.++||+|+||.||+|.++ +..||||++...... .+.|.+|+.++++++||||+++++++.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~l~~~~~ 253 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAVVT 253 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc------HHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 4679999999999999999999999999987 788999999865432 346899999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+...++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 332 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLAR 332 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCce
Confidence 8889999999999999999986543348999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccc--cccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCCh
Q 021127 175 EESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 223 (317)
....... .....+++.|+|||++....+.. ..++|+. +...+.+..++
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 411 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 411 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCc-HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 6543221 22334678999999876432211 1111111 12334567889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.++.+||.+||+.||++|||+.++++.|+++....
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=315.65 Aligned_cols=235 Identities=30% Similarity=0.553 Sum_probs=191.5
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
...|.++.++|++.+.||+|+||.||+|++. ++.||||++...... .....+.+|++++++++||||+++++++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP----DLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH----HHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH----HHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3578999999999999999999999999985 889999998765432 2345688999999999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+. ..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~ 259 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGM 259 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGG
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCC
Confidence 765 79999999999999999986432 38999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccccc---ccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCC
Q 021127 173 AREESLTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAE 220 (317)
Q Consensus 173 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 220 (317)
++........ ....+++.|+|||++.+..+.. ..++|+ .....+.+.
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 338 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE 338 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 9854322111 1223577899999876432211 111111 112334567
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+|.++.+||.+||+.||.+|||+.++++.|+++...
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 7899999999999999999999999999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.98 Aligned_cols=248 Identities=31% Similarity=0.486 Sum_probs=200.7
Q ss_pred ccccccceecCCceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHH
Q 021127 6 RFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78 (317)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l 78 (317)
.++.+........|.+..++|++.+.||+|+||.||+|++ +++.||||++....... ....+.+|+.++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l 80 (313)
T 1t46_A 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT----EREALMSELKVL 80 (313)
T ss_dssp CCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHH
T ss_pred EEeccccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH----HHHHHHHHHHHH
Confidence 4566777888889999999999999999999999999985 26889999998665432 345789999999
Q ss_pred Hhc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHH
Q 021127 79 SRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPR----------------CLDVCVAIGFALDIARAMEC 140 (317)
Q Consensus 79 ~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~----------------~l~~~~~~~i~~~i~~~L~~ 140 (317)
.++ +||||+++++++.++ ..++||||+++|+|.+++...... .+++..++.++.|++.||+|
T Consensus 81 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 160 (313)
T 1t46_A 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (313)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred hhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 999 999999999999755 899999999999999999875422 48999999999999999999
Q ss_pred HHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccc-------------
Q 021127 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQ------------- 204 (317)
Q Consensus 141 lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~------------- 204 (317)
||++||+||||||+||+++.+ +.+||+|||+++....... .....+|+.|+|||++.+.....
T Consensus 161 lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 161 LASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHCCeecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHH
Confidence 999999999999999999988 7999999999986543321 22345678999999865432211
Q ss_pred ----cccccccC------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 205 ----GEKKHYNH------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 205 ----~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+..++... ......+..++..+.+|+.+||+.||.+|||+.+++++|++.+...
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111000 0122335678899999999999999999999999999999988653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=307.80 Aligned_cols=221 Identities=26% Similarity=0.359 Sum_probs=179.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc----hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 78999999999999999999886 8899999997654322 234588999999999999999999999865 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCC
Confidence 9999999999999976444 9999999999999999999999999999999999999988 68999999999754322
Q ss_pred --cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
.......||+.|+|||++.+........++|+.+ ........++..+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 2234567999999999987654433333333322 11111245788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+|+.+||+.||.+|||+.|++++.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHccCChhhCcCHHHHhhCh
Confidence 999999999999999999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=298.92 Aligned_cols=235 Identities=29% Similarity=0.496 Sum_probs=181.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..|.+..++|++.+.||+|+||.||+|.+. +..||+|++...... ...+.+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCccceEEE
Confidence 467899999999999999999999999874 457999998765432 33557899999999999999999999
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg 161 (281)
T 1mp8_A 84 VITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFG 161 (281)
T ss_dssp EECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--
T ss_pred EEccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccc
Confidence 998888999999999999999998643 349999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccc--cccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCC
Q 021127 172 LAREESLTEM--MTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAEN 221 (317)
Q Consensus 172 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~ 221 (317)
+++....... .....+++.|+|||++.+..... +..++.. .....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 9986543322 23345678999999875422111 1111110 0112344667
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++..+.+++.+||+.||.+|||+.+++++|++++..
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=308.24 Aligned_cols=236 Identities=25% Similarity=0.303 Sum_probs=186.7
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
+-.-..+|.+..++|++.++||+|+||.||+|++.++.||||++..... ....+.+|+.++++++||||+++++
T Consensus 12 ~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~ 85 (322)
T 3soc_A 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK------QSWQNEYEVYSLPGMKHENILQFIG 85 (322)
T ss_dssp --CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCch------HHHHHHHHHHHHhcCCCCCchhhcc
Confidence 3345668999999999999999999999999999999999999965432 2334566899999999999999999
Q ss_pred eeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCcE
Q 021127 92 ACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH----------GIIHRDLKPENL 156 (317)
Q Consensus 92 ~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~----------~ivH~Dlkp~Ni 156 (317)
++.+. .+++||||+++|+|.+++.... +++..++.++.|++.||+|||+. ||+||||||+||
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Ni 162 (322)
T 3soc_A 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162 (322)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGE
T ss_pred eeccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhE
Confidence 98653 3799999999999999997633 99999999999999999999999 999999999999
Q ss_pred EeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccc----cccccccccCC----------------
Q 021127 157 LLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK---------------- 213 (317)
Q Consensus 157 ll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~---------------- 213 (317)
|++.+ +.+||+|||+++...... ......||+.|+|||++.+... .....++|+.+
T Consensus 163 ll~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 163 LLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp EECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred EECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99988 799999999997543322 2233579999999998865211 11111222111
Q ss_pred ----------------------------CCCCC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ----------------------------NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ----------------------------~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
...+. ....+.++.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111 112245699999999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.01 Aligned_cols=231 Identities=22% Similarity=0.374 Sum_probs=192.4
Q ss_pred CceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 95 (317)
..+.++.++|++.+.||+|+||.||+|+++++.||||++....... ...+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST---RKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp -CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCH---HHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CcCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCH---HHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 4567888999999999999999999999999999999998765443 334568999999999999999999999865
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...++||||+++|+|.+++.......+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.++|+|||
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~ 158 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMAD 158 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGG
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEecc
Confidence 46899999999999999998766556999999999999999999999999 9999999999999988 689999888
Q ss_pred cccccccccccccccCccceeccccccccccccc--ccccccCC-----------------------------CCCCCCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQG--EKKHYNHK-----------------------------NVRPSAE 220 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~~~-----------------------------~~~~~~~ 220 (317)
++..... ....||+.|+|||++.+...... ..+.|+.+ .....+.
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT
T ss_pred ceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC
Confidence 8754322 33578999999999876433221 23333222 1233456
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.++.++.+++.+||+.||.+|||+.++++.|.++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 78999999999999999999999999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=313.49 Aligned_cols=229 Identities=23% Similarity=0.342 Sum_probs=188.5
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
....+..++|++.+.||+|+||.||++.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE--RNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 445677789999999999999999999886 7889999987532111 122456889999999999999999999998
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||+.||+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a 162 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA 162 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEecccee
Confidence 65 89999999999999999986544 9999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccccccccCccceeccccccccc--ccccccccccCC------------------------------CCCCCCCC
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK------------------------------NVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~------------------------------~~~~~~~~ 221 (317)
+...........+||+.|+|||++.... ......++|+.+ .....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTT
T ss_pred eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCc
Confidence 8766555566778999999999986421 122233333322 12233567
Q ss_pred ChHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPN-FTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps-~~~~~~~ 250 (317)
++..+.+||.+||+.||.+||+ ++++++|
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 8899999999999999999998 7888775
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=300.29 Aligned_cols=232 Identities=25% Similarity=0.508 Sum_probs=184.8
Q ss_pred eeecCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
..+..++|++.++||+|+||.||+|++ +++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-----EHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 356779999999999999999999984 378999999875432 334568999999999999999999999
Q ss_pred eec---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 93 CKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 93 ~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
+.. ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~D 157 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGD 157 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEcc
Confidence 853 368999999999999999987533 38999999999999999999999999999999999999988 7999999
Q ss_pred cCccccccccc----ccccccCccceeccccccccccccccccccc----------------------------------
Q 021127 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYN---------------------------------- 211 (317)
Q Consensus 170 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~---------------------------------- 211 (317)
||+++...... ......++..|+|||++.+..+.. ..++|+
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCCh-HHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 99998653321 223345778899999876533211 111111
Q ss_pred ----------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 212 ----------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 212 ----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+.+..++.++.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11233446788999999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=297.83 Aligned_cols=232 Identities=28% Similarity=0.519 Sum_probs=188.1
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
..|.+++++|++.+.||+|+||.||++.+. +..||||++....... ..+.+|++++.+++||||+++++++.+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH------HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 588999999999999999999999999987 6789999998665432 358899999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~ 168 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSR 168 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccc
Confidence 5 79999999999999999986332 39999999999999999999999999999999999999988 699999999998
Q ss_pred cccccc--ccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCCh
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 223 (317)
...... ......+|+.|+|||++.+..... ..++|+. ......+..++
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCC
Confidence 553322 223345678899999876433211 1111111 11223456678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..+.+|+.+||+.||.+|||+.+++++|++++..
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.34 Aligned_cols=238 Identities=30% Similarity=0.543 Sum_probs=180.7
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
..-.+.++|..++|++.++||+|+||.||+|++.+ .||||++....... ...+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP---QQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCH---HHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 34456789999999999999999999999998765 59999998665443 345678999999999999999999998
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~ 166 (289)
T 3og7_A 89 STAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGL 166 (289)
T ss_dssp ECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC-
T ss_pred ccCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEcccee
Confidence 88888999999999999999997543 349999999999999999999999999999999999999998 7999999999
Q ss_pred cccccc---ccccccccCccceeccccccccc--ccccccccccCC---------------------------------C
Q 021127 173 AREESL---TEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK---------------------------------N 214 (317)
Q Consensus 173 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~---------------------------------~ 214 (317)
++.... ........||+.|+|||++.... ......+.|+.+ .
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 975432 12223456899999999875211 111111222111 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.......++..+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111234788999999999999999999999999999988753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.41 Aligned_cols=218 Identities=25% Similarity=0.418 Sum_probs=180.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||+||+|.+. ++.||||++....... ...+.+|+.++++++||||+++++++..+ ..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEE
Confidence 468999999999999999999874 8999999987654432 34588999999999999999999998754 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCc
Confidence 999999999999999864 38999999999999999999999999999999999999988 79999999998755433
Q ss_pred -cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
.......||+.|+|||++.+..+.. ..++|+.+ .....+..++..+.+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence 2334567999999999987644322 22222221 112235567899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||.+||+.||.+|||+.+++++
T Consensus 249 li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=297.78 Aligned_cols=238 Identities=28% Similarity=0.491 Sum_probs=193.0
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
++.|.+..++|++.+.||+|+||.||+|.+. +..||||++...... ...+.+|++++++++||||+++++++.
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc------HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 4578999999999999999999999999987 678999999765432 235889999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
++..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLAR 157 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccc
Confidence 8889999999999999999976433349999999999999999999999999999999999999988 789999999998
Q ss_pred cccccc--ccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCChH
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~~~ 224 (317)
...... ......++..|+|||++.+..... +..++.. .......+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 654322 122345678999999875422211 1111100 0112233567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
++.+|+.+||..||++|||+.++++.|++++.....
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 999999999999999999999999999999876543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=309.35 Aligned_cols=238 Identities=27% Similarity=0.461 Sum_probs=190.5
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
....+.+..++|++.+.||+|+||.||+|.+. ++.||||++....... ...++.+|+.++++++||||+
T Consensus 62 ~~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv 137 (367)
T 3l9p_A 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ----DELDFLMEALIISKFNHQNIV 137 (367)
T ss_dssp GGGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH----HHHHHHHHHHHHHHCCCTTBC
T ss_pred CcchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh----hHHHHHHHHHHHHhCCCCCCC
Confidence 34456788899999999999999999999843 5689999997654433 344688999999999999999
Q ss_pred eEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 88 ~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
++++++.+. ..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 138 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 217 (367)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred eEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC
Confidence 999999765 78999999999999999987542 348999999999999999999999999999999999999844
Q ss_pred --CCceEEcccCcccccccc---cccccccCccceecccccccccccccccccccCC-----------------------
Q 021127 162 --LKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------- 213 (317)
Q Consensus 162 --~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------- 213 (317)
...+||+|||+++..... .......||+.|+|||++.+..+.. ..++|+.+
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 135999999999743222 2223456789999999875533221 11111111
Q ss_pred ------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.....+..++..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus 297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 12334567899999999999999999999999999999988764
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.47 Aligned_cols=237 Identities=27% Similarity=0.486 Sum_probs=189.8
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
...|.|+.++|++.++||+|+||.||+|.+. +..||||++...... .+.|.+|+.++++++||||+++++++.
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4579999999999999999999999999997 578999999865432 235899999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
++..++||||+++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 250 ~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~ 328 (452)
T 1fmk_A 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLAR 328 (452)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC
T ss_pred CCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccce
Confidence 8889999999999999999976443448999999999999999999999999999999999999988 689999999998
Q ss_pred cccccc--ccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCChH
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~~~ 224 (317)
...... ......++..|+|||++....+.. +..++.. .+...+.+..+|.
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 408 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 408 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 654322 122335678999999875432211 1111100 1122344678899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
.+.+||.+||+.||++|||++++++.|++++....
T Consensus 409 ~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 99999999999999999999999999998876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.66 Aligned_cols=231 Identities=25% Similarity=0.307 Sum_probs=180.0
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeee
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVK 88 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 88 (317)
.+.......+..++|++.++||+|+||+||+|++. ++.||||++....... ....++..|+..+.++ +|+||++
T Consensus 45 ~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~~~~~~~h~~iv~ 121 (311)
T 3p1a_A 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP---KDRARKLAEVGSHEKVGQHPCCVR 121 (311)
T ss_dssp TCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH---HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh---HHHHHHHHHHHHHHHhcCCCcEEE
Confidence 33333333444478999999999999999999986 8999999987654433 2233456666666665 9999999
Q ss_pred EEeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
+++++.++ ..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||
T Consensus 122 l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl 198 (311)
T 3p1a_A 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKL 198 (311)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEE
T ss_pred EEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEE
Confidence 99999765 899999999 789999988754 349999999999999999999999999999999999999988 69999
Q ss_pred cccCcccccccccccccccCccceecccccccccccccccccccCC--------C-C-----------------CCCCCC
Q 021127 168 ADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N-V-----------------RPSAEN 221 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~-~-----------------~~~~~~ 221 (317)
+|||++.............||+.|+|||++.+. .....++|+.+ . . ...+..
T Consensus 199 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (311)
T 3p1a_A 199 GDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAG 276 (311)
T ss_dssp CCCTTCEECC------CCCCCGGGCCGGGGGTC--CSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTT
T ss_pred ccceeeeecccCCCCcccCCCccccCHhHhcCC--CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccC
Confidence 999999876555555566799999999998752 22233333322 0 0 001346
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.++.+||.+||+.||++|||+.+++++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 78999999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=308.45 Aligned_cols=235 Identities=29% Similarity=0.535 Sum_probs=189.6
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVK 88 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 88 (317)
..|.+..++|++.+.||+|+||.||+|++. ++.||||++....... ..+.+.+|+.++.++ +||||++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH----HHHHHHHHHHHHHhhcCCcceee
Confidence 378899999999999999999999999842 5889999998665433 345689999999999 8999999
Q ss_pred EEeeeecC--ceEEEEEccCCCCHHHHHHhcCC-----------------------------------------------
Q 021127 89 FIGACKEP--VMVIVTELLSGGTLRKYLLNMRP----------------------------------------------- 119 (317)
Q Consensus 89 l~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------- 119 (317)
+++++.+. ..++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 99998753 58999999999999999986532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 120 -----------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 120 -----------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTC
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccc
Confidence 128999999999999999999999999999999999999988 68999999999854322
Q ss_pred cccccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPEELSII 229 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~l 229 (317)
.......||+.|+|||++.+..+.. ..++|+. ......+..++.++.++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCc-hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1223446789999999876533221 1111110 01223456788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+||+.||.+|||+.+++++|+.++..
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=294.37 Aligned_cols=241 Identities=25% Similarity=0.487 Sum_probs=194.6
Q ss_pred CCceeecCCceeecc-eeccccceEEEEeEE----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 16 DAKWLIDPKHLFVGP-RIGEGAHAKVYEGKY----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~-~lG~G~~g~V~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
|..|.++.++|.+.+ .||+|+||.||+|.+ ++..||||++...... .....+.+|+.++++++||||++++
T Consensus 1 d~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~ 76 (287)
T 1u59_A 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK----ADTEEMMREAQIMHQLDNPYIVRLI 76 (287)
T ss_dssp -CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH----HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch----hHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 456889999999988 999999999999986 3788999999876443 3355689999999999999999999
Q ss_pred eeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+++.++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Df 154 (287)
T 1u59_A 77 GVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDF 154 (287)
T ss_dssp EEEESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCC
T ss_pred EEecCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcc
Confidence 9998888999999999999999997533 349999999999999999999999999999999999999988 79999999
Q ss_pred Ccccccccccc----cccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCC
Q 021127 171 GLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~ 218 (317)
|++........ .....+|+.|+|||++.+..... +..++.. .......
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 234 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence 99985532211 22335688999999875422111 1111110 0112334
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 262 (317)
+..++.++.++|.+||+.||.+||++.+++++|+.++.....+.
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 56889999999999999999999999999999999987655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=313.05 Aligned_cols=229 Identities=22% Similarity=0.314 Sum_probs=184.5
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.+..++|++.++||+|+||+||+|++. ++.||||++.+..... ......+.+|+.+++.++||||+++++++.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK--RSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh--hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34567789999999999999999999986 7899999997521100 0112247789999999999999999999987
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~ 216 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCM 216 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeE
Confidence 6 799999999999999999763 28999999999999999999999999999999999999998 799999999998
Q ss_pred cccccc--ccccccCccceecccccccccc---cccccccccCC-------------------------------CCCCC
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTL---RQGEKKHYNHK-------------------------------NVRPS 218 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~~~-------------------------------~~~~~ 218 (317)
...... .....+||+.|+|||++.+... .....++|+.+ ...+.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 296 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC
Confidence 654332 2345689999999999865331 22233333322 12233
Q ss_pred CCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNA--RPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l~ 252 (317)
...++.++++||.+||..+|.+ ||+++++++|.+
T Consensus 297 ~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 4578999999999999988988 999999999843
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=313.84 Aligned_cols=228 Identities=25% Similarity=0.305 Sum_probs=181.4
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+.+..++|++.+.||+|+||.||++++. ++.||||++.+..... ......+.+|+.++..++||||+++++++.+.
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK--RGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 4567789999999999999999999985 8999999997532111 12234578899999999999999999999865
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..|+||||++||+|.+++...+. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~ 211 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLK 211 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhhee
Confidence 79999999999999999987542 39999999999999999999999999999999999999998 7999999999986
Q ss_pred cccccc--cccccCccceecccccccc------cccccccccccCC-------------------------------CCC
Q 021127 176 ESLTEM--MTAETGTYRWMAPELYSTV------TLRQGEKKHYNHK-------------------------------NVR 216 (317)
Q Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~~~~~~~~-------------------------------~~~ 216 (317)
...... ....+||+.|+|||++... .......++|+.+ ...
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 291 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCC
Confidence 543322 2345899999999998731 1112223333222 001
Q ss_pred C-CCCCChHHHHHHHHHhhhcCCCCC---CCHHHHHHHH
Q 021127 217 P-SAENVPEELSIILTSCWKEDPNAR---PNFTQIIQML 251 (317)
Q Consensus 217 ~-~~~~~~~~l~~li~~cl~~~p~~R---ps~~~~~~~l 251 (317)
+ ....++.++++||.+||. +|.+| |+++++++|-
T Consensus 292 p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 1 135789999999999999 99998 6899999883
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=293.50 Aligned_cols=230 Identities=27% Similarity=0.477 Sum_probs=188.0
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
.|.+..++|++.+.||+|+||.||+|.+. +..||||++....... ..+.+|+.++.+++||||+++++++.+.
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE------DEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH------HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH------HHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 46788899999999999999999999887 5689999998765432 3588999999999999999999999765
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++..
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRY 153 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEE
T ss_pred CceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCcccee
Confidence 78999999999999999987532 38999999999999999999999999999999999999988 7999999999985
Q ss_pred cccccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 176 ESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
...... .....+|+.|+|||++.+..... ..+.|+.+ .....+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD 232 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHHSEEET-THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cchhhhhcccCCCcCcccCCHHHHhccCCch-hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChH
Confidence 433321 22345677899999876533221 11111111 12233556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999999999999999988754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.20 Aligned_cols=236 Identities=28% Similarity=0.480 Sum_probs=189.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEECC-------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.+.+..++|++.+.||+|+||.||+|++.+ +.||||++...... .....+.+|+.++++++||||++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 356788999999999999999999998853 88999999866543 3355789999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
+++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999765 89999999999999999987431 4599999999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc-----------------ccc
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ-----------------GEK 207 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~ 207 (317)
||||||+||+++.+ +.+||+|||+++...... ......+|+.|+|||++.+..... +..
T Consensus 197 H~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 197 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999988 699999999997543221 223446789999999865432211 111
Q ss_pred cccc-----------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 208 KHYN-----------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 208 ~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
++.. .......+..++.++.+|+.+||+.||.+||++.+++++|+++....
T Consensus 276 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred cCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1111 01223346678999999999999999999999999999999886543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=304.62 Aligned_cols=241 Identities=29% Similarity=0.461 Sum_probs=189.7
Q ss_pred ceecCCceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CC
Q 021127 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QH 83 (317)
Q Consensus 12 ~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 83 (317)
....+..|.++.++|.+.+.||+|+||.||+|.+ ++..||||++...... .....+.+|+.++.++ +|
T Consensus 33 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~~h 108 (344)
T 1rjb_A 33 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS----SEREALMSELKMMTQLGSH 108 (344)
T ss_dssp GSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCC
T ss_pred hcccCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH----HHHHHHHHHHHHHHhhcCC
Confidence 3455668999999999999999999999999986 2568999999754322 2345789999999999 99
Q ss_pred CCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHH
Q 021127 84 RNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L~~l 141 (317)
|||+++++++.+. ..++||||+++|+|.+++..... ..+++..++.++.||+.||+||
T Consensus 109 p~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 188 (344)
T 1rjb_A 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188 (344)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred CCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 9999999998765 89999999999999999986542 2379999999999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc--------------
Q 021127 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ-------------- 204 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-------------- 204 (317)
|++||+||||||+||+++.+ +.+||+|||++....... ......||+.|+|||++.+.....
T Consensus 189 H~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 189 EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267 (344)
T ss_dssp HHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence 99999999999999999988 799999999998543322 123345788999999875432211
Q ss_pred ---ccccccc------------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 205 ---GEKKHYN------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 205 ---~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+..++.. .......+..++.++.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus 268 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111 0112233566789999999999999999999999999999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.99 Aligned_cols=227 Identities=26% Similarity=0.396 Sum_probs=188.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|.+.+.||+|+||.||+|++. ++.||||++....... ......+.+|+.+++.++||||+++++++.+. .
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH--TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34478999999999999999999985 8999999997532111 12245688999999999999999999999765 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||+++|+|.+++...+. +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSS--CCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhcc
Confidence 9999999999999999976543 9999999999999999999999999999999999999988 689999999998765
Q ss_pred cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li 230 (317)
........+||+.|+|||++.+........++|+.+ .....+..++.++.+||
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li 247 (476)
T 2y94_A 168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247 (476)
T ss_dssp TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence 555556678999999999987654433333443322 11233556889999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||+.||.+|||+.++++|-+
T Consensus 248 ~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 248 KHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHcCCCchhCcCHHHHHhCHH
Confidence 9999999999999999999744
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=297.42 Aligned_cols=221 Identities=25% Similarity=0.385 Sum_probs=177.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||+||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.++ ..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST---THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC---CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 58999999999999999999985 7899999998665433 2244688999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++ +|.+.+.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 79 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCC
T ss_pred EEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcc
Confidence 9999965 6666665533 349999999999999999999999999999999999999988 79999999999865422
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
.......||+.|+|||++.+........++|+.+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 2334557899999999876543222222222211
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++.++++|+.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0001123578899999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=302.18 Aligned_cols=246 Identities=26% Similarity=0.454 Sum_probs=197.1
Q ss_pred ccccccceecCCceeecCCceeecceeccccceEEEEeEEC--C-----eEEEEEEeecCCChHHHHHHHHHHHHHHHHH
Q 021127 6 RFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--N-----QTVAIKIVHKGETPEEIAKKESRFAREVAML 78 (317)
Q Consensus 6 ~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~-----~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l 78 (317)
.++.+..+..++.|.+..++|++.+.||+|+||.||+|.+. + ..||+|++....... ....+.+|+.++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l 103 (333)
T 2i1m_A 28 TFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD----EKEALMSELKIM 103 (333)
T ss_dssp CSCCTTSSCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH----HHHHHHHHHHHH
T ss_pred cccCCccccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH----HHHHHHHHHHHH
Confidence 44566777778899999999999999999999999999875 2 479999998665432 345689999999
Q ss_pred Hhc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 79 SRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR------------PRCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 79 ~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
+++ +||||+++++++.++ ..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++
T Consensus 104 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 183 (333)
T 2i1m_A 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK 183 (333)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 999 899999999999765 8999999999999999997542 23489999999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccC---------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------- 212 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--------- 212 (317)
||+||||||+||+++.+ +.+||+|||+++....... .....+|+.|+|||++.+..... ..++|+.
T Consensus 184 ~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t 261 (333)
T 2i1m_A 184 NCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFS 261 (333)
T ss_dssp TEECSCCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTT
T ss_pred CcccCCcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh-HHHHHHHHHHHHHHHc
Confidence 99999999999999988 6999999999985433221 22345678999999865432211 1111110
Q ss_pred ---------------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 ---------------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
......+..++..+.+|+.+||+.||.+|||+.+++++|+++...
T Consensus 262 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 262 LGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp TSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 011233556789999999999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.01 Aligned_cols=244 Identities=31% Similarity=0.540 Sum_probs=195.7
Q ss_pred cceecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.++..+..|.+..++|++.+.||+|+||.||+|++. +..||||++...... .....+.+|+.+++++
T Consensus 22 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l 97 (334)
T 2pvf_A 22 YELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE----KDLSDLVSEMEMMKMI 97 (334)
T ss_dssp -CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH----HHHHHHHHHHHHHHHH
T ss_pred ccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH----HHHHHHHHHHHHHHHh
Confidence 345566789999999999999999999999999863 568999999866543 3355688999999999
Q ss_pred -CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021127 82 -QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHG 145 (317)
Q Consensus 82 -~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ 145 (317)
+||||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|||++|
T Consensus 98 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 177 (334)
T 2pvf_A 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177 (334)
T ss_dssp CCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999765 89999999999999999986542 24899999999999999999999999
Q ss_pred ccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccC----------
Q 021127 146 IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------- 212 (317)
Q Consensus 146 ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~---------- 212 (317)
|+||||||+||+++.+ +.+||+|||+++...... ......+++.|+|||++.+..... ..++|+.
T Consensus 178 ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 178 CIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp EECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTT
T ss_pred eeCCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh-HHHHHHHHHHHHHHHhC
Confidence 9999999999999988 799999999998554322 223345788999999875432211 1111111
Q ss_pred -------------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 213 -------------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 213 -------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
......+..++.++.+++.+||+.||.+|||+.+++++|+.++.....
T Consensus 256 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 256 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp SCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 012334567889999999999999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.46 Aligned_cols=241 Identities=28% Similarity=0.513 Sum_probs=193.1
Q ss_pred cceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC
Q 021127 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH 83 (317)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 83 (317)
.+...+..|.+..++|.+.+.||+|+||.||+|.+. ++.||||++...... ...+.+.+|+.++++++|
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 10 FKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP----SELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp ----CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHTTCCC
T ss_pred eeccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH----HHHHHHHHHHHHHhhCCC
Confidence 344556789999999999999999999999999862 478999999865543 334568999999999999
Q ss_pred CCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHH
Q 021127 84 RNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP----------------------RCLDVCVAIGFALDIARAMEC 140 (317)
Q Consensus 84 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~~i~~~L~~ 140 (317)
|||+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 165 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165 (314)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence 9999999998765 89999999999999999987543 238999999999999999999
Q ss_pred HHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceeccccccccccccccccccc------
Q 021127 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN------ 211 (317)
Q Consensus 141 lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~------ 211 (317)
||++||+||||||+||+++.+ +.+||+|||+++...... ......+++.|+|||++.+..... ..++|+
T Consensus 166 lH~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ 243 (314)
T 2ivs_A 166 LAEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLW 243 (314)
T ss_dssp HHHTTEECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH-HHHHHHHHHHHH
T ss_pred HHHCCCcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc-hhhHHHHHHHHH
Confidence 999999999999999999988 799999999997543221 223345788999999865432211 111111
Q ss_pred -----------------------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 212 -----------------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 212 -----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.......+..++.++.+|+.+||+.||.+||++.+++++|++++..
T Consensus 244 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 244 EIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 0112334567899999999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=296.83 Aligned_cols=231 Identities=27% Similarity=0.401 Sum_probs=184.0
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
-.++|++.+.||+|+||.||+|++. ++.||||++....... .....++.+|+.++++++||||+++++++.++ ..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK--EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc--HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 3478999999999999999999875 8899999987654433 24456789999999999999999999999765 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred EEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence 999999999999999987654 9999999999999999999999999999999999999988 7999999999986543
Q ss_pred cc--ccccccCccceecccccccccccccccccccCC---------------------------CCC-----CCCCCChH
Q 021127 179 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVR-----PSAENVPE 224 (317)
Q Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~-----~~~~~~~~ 224 (317)
.. ......||+.|+|||++.+.... ...++|+.+ ... .....+|.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred ccccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 32 22345689999999988764432 222333221 000 11356789
Q ss_pred HHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhhhcc
Q 021127 225 ELSIILTSCWKEDPNARP-NFTQIIQMLLNYLSAI 258 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rp-s~~~~~~~l~~~~~~~ 258 (317)
.+.+++.+||+.||.+|| +++++.+.|..++...
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 999999999999999998 8888888888766543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.07 Aligned_cols=223 Identities=22% Similarity=0.304 Sum_probs=182.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH---HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 68999999999999999999885 8999999998766543 3355689999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~~ 178 (317)
||||+.||+|.+.+..... +++..+..++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++.....
T Consensus 88 v~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999999987654 9999999999999999999999999999999999999842 26899999999976543
Q ss_pred c-cccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHH
Q 021127 179 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 179 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l 226 (317)
. .......||+.|+|||++.+..+.. ..++|+.+ ...+....++.++
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCceeecccCCcccCCHHHhcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 3 2234567999999999987643322 22222221 1112234789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||.+||+.||.+|||+.++++|.+
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPW 270 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 99999999999999999999999743
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=306.48 Aligned_cols=223 Identities=26% Similarity=0.369 Sum_probs=183.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 57999999999999999999986 8899999998765433 3345688999999999999999999999765 8899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~~~ 178 (317)
||||+++|+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999999976543 99999999999999999999999999999999999998642 3699999999987655
Q ss_pred ccccccccCccceecccccccccccccccccccCC-----------------------------C--CCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N--VRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~--~~~~~~~~~~~l~ 227 (317)
........||+.|+|||++.+..+.. ..++|+.+ . ..+....++.++.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CcccccCCCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 54445668999999999987643322 22222221 0 0111245789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||.+||+.||.+|||+.+++++.+
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPW 287 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcc
Confidence 9999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=318.27 Aligned_cols=232 Identities=28% Similarity=0.525 Sum_probs=191.9
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.+...+|++.++||+|+||.||+|.+. +..||||++...... ...|.+|+.++++++||||+++++++.
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc------hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 478999999999999999999999999987 789999999765432 346899999999999999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||+++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 287 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a 365 (495)
T 1opk_A 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLS 365 (495)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCE
T ss_pred cCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccc
Confidence 65 89999999999999999987665669999999999999999999999999999999999999988 68999999999
Q ss_pred ccccccc--ccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCCC
Q 021127 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 222 (317)
+...... ......+++.|+|||++....+.. ..++|+ .......+..+
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 444 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eeccCCceeecCCCcCCcceeCHhHHhcCCCCc-HHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 8653322 122334678999999875432211 111111 11123346778
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+..+.+||.+||+.||.+|||+.++++.|+.++.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999987653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=300.65 Aligned_cols=249 Identities=25% Similarity=0.475 Sum_probs=195.5
Q ss_pred CCCCcc-ccccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHH
Q 021127 2 ESRSRF-YLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAR 73 (317)
Q Consensus 2 ~~~s~~-~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~ 73 (317)
.|.++. +...+....+.|.+..++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+
T Consensus 2 ~s~~p~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~ 77 (322)
T 1p4o_A 2 ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM----RERIEFLN 77 (322)
T ss_dssp ----CCSSBCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH----HHHHHHHH
T ss_pred CccChhhcccccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH----HHHHHHHH
Confidence 344442 333445567789999999999999999999999999764 578999999865543 23456899
Q ss_pred HHHHHHhcCCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021127 74 EVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSH 144 (317)
Q Consensus 74 E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~lH~~ 144 (317)
|+.++++++||||+++++++.++ ..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++
T Consensus 78 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 157 (322)
T 1p4o_A 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 157 (322)
T ss_dssp HHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999765 7899999999999999997632 13479999999999999999999999
Q ss_pred CccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccC---------
Q 021127 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------- 212 (317)
Q Consensus 145 ~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--------- 212 (317)
||+||||||+||+++.+ +.+||+|||+++...... ......+|+.|+|||++.+..... ..++|+.
T Consensus 158 ~i~H~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~ 235 (322)
T 1p4o_A 158 KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIAT 235 (322)
T ss_dssp TCBCSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHH
T ss_pred CCccCCCccceEEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHh
Confidence 99999999999999988 799999999998543322 123345688999999876532211 1111111
Q ss_pred --------------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 213 --------------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 213 --------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
......+..++..+.+|+.+||+.||.+|||+.+++++|++...
T Consensus 236 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 236 LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 12233466789999999999999999999999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=303.47 Aligned_cols=224 Identities=24% Similarity=0.259 Sum_probs=184.7
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
....++|++.+.||+|+||.||++++. ++.||||++.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 355689999999999999999999985 8999999997532111 12345688999999999999999999999865
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceec
Confidence 89999999999999999987654 9999999999999999999999999999999999999988 79999999999865
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~l 229 (317)
... ....+||+.|+|||++.+..+. ...++|+.+ .....+..++.++.+|
T Consensus 192 ~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 192 KGR--TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268 (350)
T ss_dssp SSC--BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred cCC--cccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 432 2456799999999998764332 122222221 1223356789999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHHHH
Q 021127 230 LTSCWKEDPNARPN-----FTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps-----~~~~~~~l 251 (317)
|.+||+.||.+||+ ++++++|-
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 99999999999998 89998874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=301.34 Aligned_cols=222 Identities=18% Similarity=0.265 Sum_probs=182.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc------cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 378999999999999999999986 89999999875431 234588999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-CCceEEcccCccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESL 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~ 178 (317)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|||+++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999999997643 349999999999999999999999999999999999999862 26899999999987655
Q ss_pred ccccccccCccceecccccccccccccccccccCC----------------------------CCCC---CCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRP---SAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~---~~~~~~~~l~ 227 (317)
........||+.|+|||++.+..... ..++|+.+ .... ....++.++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 157 GDNFRLLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCccccccCChhhcCcHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 54455567999999999987643221 22222221 0000 1246789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+|+.+||..||.+|||+.++++|.+
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHcCCChhHCcCHHHHhcChh
Confidence 9999999999999999999999855
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=297.21 Aligned_cols=225 Identities=26% Similarity=0.337 Sum_probs=176.6
Q ss_pred eecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
..-.++|++.++||+|+||+||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.++ .
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE---GIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc---hhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 344589999999999999999999985 8899999997654322 2345688999999999999999999999765 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFG 170 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETT
T ss_pred EEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecC
Confidence 999999996 58888887644 349999999999999999999999999999999999999988 799999999998654
Q ss_pred cc-cccccccCccceecccccccccccccccccccCC--------CCC--------------------C-----------
Q 021127 178 LT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------------P----------- 217 (317)
Q Consensus 178 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------------~----------- 217 (317)
.. .......||+.|+|||++.+........++|+.+ ... +
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 22 2334457899999999876533222222332211 000 0
Q ss_pred ------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+||.+||+.||.+|||+.++++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 023467889999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=306.18 Aligned_cols=225 Identities=25% Similarity=0.328 Sum_probs=182.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH-HHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||+|++. ++.||||++........ .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 67999999999999999999986 89999999987653210 001134588999999999999999999999865 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC---ceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~~ 176 (317)
+||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+.. .+||+|||+++..
T Consensus 92 lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999997644 3999999999999999999999999999999999999987632 7999999999876
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------------CCCC----CCCCChHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRP----SAENVPEE 225 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~----~~~~~~~~ 225 (317)
.........+||+.|+|||++.+..+.. ..++|+.+ .... ....++.+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 248 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 5554455678999999999987643321 22222221 0000 12467889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++||.+||..||.+|||+.++++|.
T Consensus 249 ~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 249 AKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 99999999999999999999999873
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=299.03 Aligned_cols=228 Identities=23% Similarity=0.426 Sum_probs=184.7
Q ss_pred eecCCceeecceeccccceEEEEeEEC--C-------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--N-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.|..++|++.+.||+|+||.||+|.+. + ..||+|++...... ..+.+.+|+.++++++||||++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~ 78 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-----YSESFFEAASMMSKLSHKHLVLNY 78 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG-----GHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH-----HHHHHHHHHHHHHhCCCCCEeEEE
Confidence 567789999999999999999999875 3 57999998754322 245689999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc-----
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT----- 164 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~----- 164 (317)
+++.++ ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.
T Consensus 79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~ 156 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGN 156 (289)
T ss_dssp EEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTB
T ss_pred EEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccc
Confidence 999765 7899999999999999998643 338999999999999999999999999999999999999987 45
Q ss_pred ---eEEcccCcccccccccccccccCccceecccccccccccccccccccCC---------------------------C
Q 021127 165 ---IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N 214 (317)
Q Consensus 165 ---~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~ 214 (317)
+||+|||++...... ....||+.|+|||++.+........++|+.+ .
T Consensus 157 ~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~ 233 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233 (289)
T ss_dssp CCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred cceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence 999999999754332 2345788999999987633333333333322 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
....+...+.++.+|+.+||+.||.+|||+.+++++|+.++..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1223455678899999999999999999999999999987753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.02 Aligned_cols=224 Identities=24% Similarity=0.323 Sum_probs=183.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
+..++|++.+.||+|+||.||++++. ++.||||++.+..... ......+.+|+.++.++ +||||+++++++.+.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND--DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc--hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 34578999999999999999999986 8999999998754332 23345688999999988 899999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++|+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG 160 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccc
Confidence 89999999999999999987654 9999999999999999999999999999999999999988 79999999999853
Q ss_pred -ccccccccccCccceecccccccccccccccccccCC------------------------------------CCCCCC
Q 021127 177 -SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------NVRPSA 219 (317)
Q Consensus 177 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~ 219 (317)
.........+||+.|+|||++.+..+.. ..++|+.+ .....+
T Consensus 161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 239 (345)
T 3a8x_A 161 LRPGDTTSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred cCCCCcccccCCCccccCccccCCCCCCh-HHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence 2233445668999999999887643221 11222111 112235
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNF------TQIIQM 250 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~------~~~~~~ 250 (317)
..++.++.+||.+||+.||.+||++ .++++|
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 6788999999999999999999995 678776
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.03 Aligned_cols=227 Identities=26% Similarity=0.350 Sum_probs=176.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH---------------------HHHHHHHHHHHHHHH
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---------------------IAKKESRFAREVAML 78 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~---------------------~~~~~~~~~~E~~~l 78 (317)
..++|++.+.||+|+||.||+|.+. ++.||||++........ .......+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 3478999999999999999999875 89999999976542211 011235688999999
Q ss_pred HhcCCCCeeeEEeeeec---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021127 79 SRVQHRNLVKFIGACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (317)
Q Consensus 79 ~~l~h~niv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~N 155 (317)
++++||||+++++++.+ ...++||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999874 478999999999999886543 349999999999999999999999999999999999
Q ss_pred EEeeCCCCceEEcccCcccccccc-cccccccCccceecccccccccc--cccccccccCC-------------------
Q 021127 156 LLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTVTL--RQGEKKHYNHK------------------- 213 (317)
Q Consensus 156 ill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~~------------------- 213 (317)
|+++.+ +.+||+|||+++..... .......||+.|+|||++.+... .....++|+.+
T Consensus 168 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999988 79999999999865432 22345679999999999865331 12222333221
Q ss_pred ----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+....++.++.+||.+||+.||.+|||+.++++|-+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 112234578899999999999999999999999988743
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.39 Aligned_cols=233 Identities=28% Similarity=0.525 Sum_probs=192.9
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.+..++|++.+.||+|+||.||+|.+. +..||||++...... ...+.+|+.++++++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH------HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 468899999999999999999999999987 889999999765432 346889999999999999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~ 158 (288)
T 3kfa_A 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLS 158 (288)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGG
T ss_pred cCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccc
Confidence 65 79999999999999999988666669999999999999999999999999999999999999988 68999999999
Q ss_pred ccccccc--ccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCC
Q 021127 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 222 (317)
....... ......+++.|+|||++.+..... ..++|+. ......+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 3kfa_A 159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 237 (288)
T ss_dssp GTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTC
T ss_pred eeccCCccccccCCccccCcCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCC
Confidence 8654332 223345678899999875432211 1111110 1123345678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+..+.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999988764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=306.33 Aligned_cols=225 Identities=26% Similarity=0.324 Sum_probs=174.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHH-HHhcCCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM-LSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~ 96 (317)
.+..++|++.+.||+|+||.||+|++. ++.||||++.+..... ......+.+|..+ ++.++||||+++++++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 355679999999999999999999986 7889999998754322 1223456677776 4668999999999999865
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..|+||||++||+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKE 188 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGG
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCccccc
Confidence 89999999999999999987554 8999999999999999999999999999999999999988 7999999999985
Q ss_pred c-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 E-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
. .........+||+.|+|||++.+..+. ...++|+.+ .....+..++.++.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 267 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSAR 267 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHH
T ss_pred cccCCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Confidence 3 223344567899999999998764332 222333222 11223567899999
Q ss_pred HHHHHhhhcCCCCCCCHH----HHHHH
Q 021127 228 IILTSCWKEDPNARPNFT----QIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~----~~~~~ 250 (317)
+||.+||+.||.+||++. ++++|
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 999999999999999974 55554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=289.67 Aligned_cols=230 Identities=29% Similarity=0.532 Sum_probs=188.5
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
.|.|++++|++.+.||+|+||.||++.+. ++.||+|++....... +.+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH------HHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 68999999999999999999999999985 7899999998765432 3588999999999999999999999765
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRF 153 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEcccccccc
Confidence 8999999999999999998653 348999999999999999999999999999999999999988 6899999999985
Q ss_pred ccccc--ccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCChH
Q 021127 176 ESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 224 (317)
..... ......++..|+|||++.+..... ..+.|+. ......+..++.
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 232 (267)
T 3t9t_A 154 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 232 (267)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred cccccccccccccccccccChhhhcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcH
Confidence 43321 223345778999999876432211 1111110 012233556789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+.+++.+||+.||.+|||+.+++++|.++..
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999998865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=292.00 Aligned_cols=228 Identities=30% Similarity=0.562 Sum_probs=174.7
Q ss_pred eecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
.++.++|++.+.||+|+||.||+|.++++.||||++........ ....+.+.+|+.+++.++||||+++++++.++ ..
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI-SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccH-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 56789999999999999999999999999999999876543221 23345688999999999999999999999765 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcEEeeCC-------CCceEEc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG---IIHRDLKPENLLLTED-------LKTIKLA 168 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---ivH~Dlkp~Nill~~~-------~~~~kl~ 168 (317)
++||||+++++|.+++.. ..+++..++.++.|++.||+|||++| |+||||||+||+++.+ .+.+||+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999999864 24999999999999999999999999 8999999999999862 2679999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------CCCCCC
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSA 219 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~ 219 (317)
|||+++...... .....||+.|+|||++.+..... ..+.|+.+ ...+.+
T Consensus 159 Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 159 DFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCCC--------------CCGGGSCHHHHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred cCCccccccccc-ccCCCCccceeCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence 999998554332 23457899999999876533221 11222111 123345
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
..++..+.+++.+||+.||.+|||+.+++++|++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 6789999999999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=293.26 Aligned_cols=231 Identities=32% Similarity=0.600 Sum_probs=182.5
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
..|+.++|++.+.||+|+||.||+|++.++.||||.+.... ..+.+.+|+.++++++||||+++++++.+. .
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 74 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-------ERKAFIVELRQLSRVNHPNIVKLYGACLNP-V 74 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-T
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-c
Confidence 35788999999999999999999999999999999986432 234688999999999999999999998754 7
Q ss_pred EEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHS---HGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.+...+||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 899999999999999986543 237899999999999999999999 8999999999999999873348999999997
Q ss_pred ccccccccccccCccceecccccccccccccccccccC------------------------------CCCCCCCCCChH
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------------KNVRPSAENVPE 224 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 224 (317)
..... .....||+.|+|||++.+..... ..++|+. ....+.+..++.
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGSNYSE-KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK 231 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCT-HHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCH
T ss_pred ccccc--cccCCCCCceEChhhhCCCCCCc-HHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCH
Confidence 54322 23446899999999876533221 1111111 112233567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.+.+|+.+||+.||.+|||+.+++++|..+......
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 999999999999999999999999999998765543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=321.19 Aligned_cols=236 Identities=27% Similarity=0.495 Sum_probs=193.6
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
...|+|..++|++.++||+|+||.||+|.+. +..||||++...... .+.|.+|+.++++++|+||+++++++.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4579999999999999999999999999997 578999999865432 235899999999999999999999998
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 95 EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 95 ~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
++..++||||+++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 333 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~ 411 (535)
T 2h8h_A 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLAR 411 (535)
T ss_dssp SSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTT
T ss_pred eccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccce
Confidence 8889999999999999999976443448999999999999999999999999999999999999988 689999999998
Q ss_pred cccccc--ccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCCCh
Q 021127 175 EESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~ 223 (317)
...... ......++..|+|||++....+.. ..++|+ .+...+.+..++
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~ 490 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 654322 122335678999999865432211 111111 112234466889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
..+.+||.+||+.||++|||+.+|++.|++++....
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 999999999999999999999999999998875443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=305.95 Aligned_cols=233 Identities=15% Similarity=0.267 Sum_probs=185.5
Q ss_pred ecCCceeecCCceeecceeccc--cceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEG--AHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G--~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
+-.+.+....++|++.++||+| +||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++
T Consensus 15 ~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~ 91 (389)
T 3gni_B 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN---EMVTFLQGELHVSKLFNHPNIVPY 91 (389)
T ss_dssp C--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh---HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3455778889999999999999 99999999986 8999999998765433 345568899999999999999999
Q ss_pred EeeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 90 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
++++.++ ..++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~ 170 (389)
T 3gni_B 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLS 170 (389)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEEC
T ss_pred eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEc
Confidence 9998765 89999999999999999987655569999999999999999999999999999999999999988 799999
Q ss_pred ccCcccccccc--------cccccccCccceecccccccc-cccccccccccCC--------------------------
Q 021127 169 DFGLAREESLT--------EMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 169 Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~-------------------------- 213 (317)
|||.+...... .......||+.|+|||++.+. .......++|+.+
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 99988643211 112234689999999988652 1111122222211
Q ss_pred -----------------------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHH
Q 021127 214 -----------------------------------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQ 246 (317)
Q Consensus 214 -----------------------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 246 (317)
...+.+..++.++.+||.+||+.||.+|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 000123456788999999999999999999999
Q ss_pred HHHH
Q 021127 247 IIQM 250 (317)
Q Consensus 247 ~~~~ 250 (317)
+++|
T Consensus 331 ll~h 334 (389)
T 3gni_B 331 LLNH 334 (389)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=306.62 Aligned_cols=234 Identities=27% Similarity=0.497 Sum_probs=179.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
...++.++|.+.+.||+|+||.||+|++. +..||||++...... ...+.|.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~ 114 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE----KQRRDFLGEASIMGQFDHPNIIRLEGV 114 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH----HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34677789999999999999999999864 567999999765442 335679999999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.++ ..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 115 ~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg 192 (373)
T 2qol_A 115 VTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFG 192 (373)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-
T ss_pred EeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCc
Confidence 9765 7899999999999999998643 349999999999999999999999999999999999999988 799999999
Q ss_pred ccccccccc----ccccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCC
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSA 219 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~ 219 (317)
+++...... ......+++.|+|||++.+..+.. +..+++.. ....+.+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 272 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP 272 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998543321 112234577899999876532221 11111110 0123345
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
..++..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 67889999999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.70 Aligned_cols=232 Identities=22% Similarity=0.431 Sum_probs=181.5
Q ss_pred eecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+..++|++.++||+|+||+||+|++. ++ .||+|.+..... ......+.+|+.++++++||||+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 86 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 466789999999999999999999874 33 468887764332 23345789999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++|+||+.+|+|.+++.... ..+++..++.|+.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a 164 (327)
T 3poz_A 87 LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 164 (327)
T ss_dssp ESSSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHH
T ss_pred ecCCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcce
Confidence 9888999999999999999998754 349999999999999999999999999999999999999988 79999999999
Q ss_pred cccccccc---cccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCC
Q 021127 174 REESLTEM---MTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~ 222 (317)
+....... .....+|+.|+|||++.+..+.. +..++.. .....+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccC
Confidence 85433221 22345688999999876532221 1111100 11223446678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.||.+||++.+++++|..+...
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999988653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=292.41 Aligned_cols=236 Identities=25% Similarity=0.441 Sum_probs=186.5
Q ss_pred CceeecCCceeecc-eeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 17 AKWLIDPKHLFVGP-RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 17 ~~~~i~~~~y~~~~-~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..+.++.++|.+.+ .||+|+||.||+|.+. ++.||||++....... ...+.+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C---HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH---HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45678889999998 9999999999999652 6889999997654322 33557899999999999999999999
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++.++..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg 162 (291)
T 1xbb_A 86 ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFG 162 (291)
T ss_dssp EEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCT
T ss_pred EECCCCcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCC
Confidence 9987889999999999999999987544 9999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccc----cccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCC
Q 021127 172 LAREESLTEM----MTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSA 219 (317)
Q Consensus 172 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~ 219 (317)
++........ .....+++.|+|||++.+..... +..++.. .......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 242 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9975433221 22334678999999875432211 1111110 01123345
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
..++..+.+++.+||+.||.+||++.++++.|++++...
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 678999999999999999999999999999999988653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.47 Aligned_cols=235 Identities=29% Similarity=0.508 Sum_probs=188.4
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..|.+..++|.+.+.||+|+||.||+|.+. +..||||++...... ...+++.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL----DNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH----HHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc----hHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 356788899999999999999999999864 346999999876543 23567899999999999999999999
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++.++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||
T Consensus 81 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg 158 (281)
T 3cc6_A 81 IIEEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFG 158 (281)
T ss_dssp EECSSSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCC
T ss_pred EEcCCCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccC
Confidence 998888899999999999999998654 338999999999999999999999999999999999999988 799999999
Q ss_pred ccccccccc--ccccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCC
Q 021127 172 LAREESLTE--MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAEN 221 (317)
Q Consensus 172 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~ 221 (317)
++....... ......+++.|+|||++.+..... +..++... ....+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCC
Confidence 998654332 123345788999999875432211 11111100 122334567
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++..+.+++.+||..||.+|||+.+++++|+++...
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 889999999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.95 Aligned_cols=229 Identities=20% Similarity=0.264 Sum_probs=181.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..+..++|++.++||+|+||+||+|++. ++.||||++.+..... ......+.+|+.++..++||||+++++++.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--RAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3466789999999999999999999986 7899999997532111 01122378899999999999999999999865
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLK 224 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhh
Confidence 8999999999999999998633 349999999999999999999999999999999999999988 7999999999975
Q ss_pred ccccc--ccccccCccceeccccccc----ccccccccccccCC--------------------------------CCCC
Q 021127 176 ESLTE--MMTAETGTYRWMAPELYST----VTLRQGEKKHYNHK--------------------------------NVRP 217 (317)
Q Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~~~~~~~--------------------------------~~~~ 217 (317)
..... .....+||+.|+|||++.. ........++|+.+ ....
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 43322 2234689999999999862 11112223333222 1111
Q ss_pred CCCCChHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNA--RPNFTQIIQML 251 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~--Rps~~~~~~~l 251 (317)
....++.++++||.+||..+|++ ||+++++++|-
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 22458999999999999888888 99999999983
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=295.50 Aligned_cols=234 Identities=26% Similarity=0.487 Sum_probs=187.7
Q ss_pred eecCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+....|++.++||+|+||+||++.+ +++.||||++...... .....+.+|++++++++||||+++++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP----QHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH----HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh----HHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 34555569999999999999988765 4789999999876543 3355689999999999999999999998
Q ss_pred ec---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 94 KE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 94 ~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
.+ ...++||||+++++|.+++.... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Df 178 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDF 178 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCc
Confidence 75 36899999999999999997643 8999999999999999999999999999999999999988 78999999
Q ss_pred Cccccccccc----ccccccCccceeccccccccccccccccccc-----------------------------------
Q 021127 171 GLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYN----------------------------------- 211 (317)
Q Consensus 171 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~----------------------------------- 211 (317)
|++....... ......+|..|+|||++.+..... ..++|+
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 9998654322 223446788999999876533221 111111
Q ss_pred --------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021127 212 --------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262 (317)
Q Consensus 212 --------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 262 (317)
.....+.+..++.++.+||.+||+.||.+|||+.++++.|+.+......+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~ 316 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA 316 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence 112334467889999999999999999999999999999999887665443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.26 Aligned_cols=230 Identities=24% Similarity=0.482 Sum_probs=184.1
Q ss_pred eeecCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
..+...+|++.+.||+|+||.||+|++ +++.||||++...... .....+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG----NHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc----hhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 345667899999999999999999984 3899999999765432 223568899999999999999999999
Q ss_pred eec---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 93 CKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 93 ~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
+.+ ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~D 169 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGD 169 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECc
Confidence 864 368999999999999999966443 39999999999999999999999999999999999999988 7999999
Q ss_pred cCccccccccc----ccccccCccceeccccccccccccccccccc----------------------------------
Q 021127 170 FGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYN---------------------------------- 211 (317)
Q Consensus 170 fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~---------------------------------- 211 (317)
||++....... ......||..|+|||++.+...... .+.|+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 99998554322 2234568889999998754322211 11111
Q ss_pred ---------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 212 ---------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 212 ---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.....+.+..++.++.+|+.+||+.||.+|||+.++++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11233446688999999999999999999999999999998875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=297.25 Aligned_cols=233 Identities=26% Similarity=0.468 Sum_probs=186.6
Q ss_pred ceeecCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
.-.++.++|++.+.||+|+||.||++++ +++.||||++..... ...+.+.+|+.++++++|+||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-----DQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-----HHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 3457889999999999999999999984 378999999976532 33456899999999999999999999
Q ss_pred eee---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 92 ACK---EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 92 ~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
++. +...++||||+++++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~ 169 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIA 169 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEEC
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEc
Confidence 885 3468999999999999999986432 38999999999999999999999999999999999999988 799999
Q ss_pred ccCccccccccc----ccccccCccceeccccccccccccccccccc---------------------------------
Q 021127 169 DFGLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYN--------------------------------- 211 (317)
Q Consensus 169 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~--------------------------------- 211 (317)
|||+++...... ......||+.|+|||++.+..... ..++|+
T Consensus 170 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3lxl_A 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248 (327)
T ss_dssp CGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred ccccceecccCCccceeeccCCccccccCHHHhccCCCCh-HHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence 999998543222 223345888999999875532211 111111
Q ss_pred ----------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 212 ----------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 212 ----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
.....+.+..++..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11223446678999999999999999999999999999999887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=303.38 Aligned_cols=227 Identities=25% Similarity=0.346 Sum_probs=181.5
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
...+..++|++.+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ +||||+++++++.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~ 88 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 88 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh--hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 34567789999999999999999999985 8999999997532110 11234577889999877 9999999999998
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a 165 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMC 165 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhh
Confidence 65 89999999999999999987654 9999999999999999999999999999999999999988 79999999999
Q ss_pred cccc-cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHH
Q 021127 174 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEE 225 (317)
Q Consensus 174 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~ 225 (317)
+... ........+||+.|+|||++.+..+. ...++|+.+ .....+..++.+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHH
Confidence 8542 22334566899999999998764332 222333222 112235678899
Q ss_pred HHHHHHHhhhcCCCCCCCHH-HHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFT-QIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~-~~~~~ 250 (317)
+.+||.+||+.||.+||++. ++++|
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 99999999999999999998 88776
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.99 Aligned_cols=229 Identities=25% Similarity=0.322 Sum_probs=175.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
...+..++|++.+.||+|+||.||++++ +++.||||++.+...... ......+.+|+.+++.++||||++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh-hhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 3456778999999999999999999987 488999999986542211 1234567889999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.+. ..++||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg 166 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFG 166 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCS
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCC
Confidence 9765 89999999999999999987654 8999999999999999999999999999999999999988 799999999
Q ss_pred ccccccc-ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCCh
Q 021127 172 LAREESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVP 223 (317)
Q Consensus 172 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~ 223 (317)
+++.... .......+||+.|+|||++.+.... ...++|+.+ .....+..++
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~ 245 (327)
T 3a62_A 167 LCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT 245 (327)
T ss_dssp CC----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred cccccccCCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 9975332 2233456799999999998654322 122222221 1123356788
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
.++.+||.+||+.||.+|| ++.++++|-
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 9999999999999999999 788998873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=289.34 Aligned_cols=224 Identities=26% Similarity=0.368 Sum_probs=184.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||+|++....... .....+.+|+.++++++||||+++++++.++ ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH---HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 478999999999999999999886 8899999998655433 2345688999999999999999999999765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCcccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREES 177 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~~ 177 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+. +.+||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999987654 99999999999999999999999999999999999998652 349999999998665
Q ss_pred cccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l 226 (317)
.........||+.|+|||++.+..... ..++|+.+ ...+....++.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCc-ccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 555555568999999999987643322 22222211 1112235788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+|+.+||+.||.+|||+.+++++-+
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHcccChhhCCCHHHHhcCcc
Confidence 99999999999999999999999743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=296.62 Aligned_cols=229 Identities=23% Similarity=0.288 Sum_probs=184.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
+..++|++.+.||+|+||.||+|++. ++.||||++....... .+.+|+.+++++ +||||+++++++.++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 78 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDGIPQVYYFGPCGK 78 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC-------CHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH-------HHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence 45689999999999999999999964 8999999998654322 478899999999 999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc-----eEEcccC
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLADFG 171 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~-----~kl~Dfg 171 (317)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +. +||+|||
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg 155 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCT
T ss_pred ccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcc
Confidence 789999999 999999998642 349999999999999999999999999999999999999977 45 9999999
Q ss_pred cccccccccc--------cccccCccceecccccccccccccccccccCC--------CCCCC-----------------
Q 021127 172 LAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRPS----------------- 218 (317)
Q Consensus 172 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~~----------------- 218 (317)
+++....... .....||+.|+|||++.+..... ..++|+.+ ...|.
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9985433221 23567999999999987644321 22222221 00000
Q ss_pred ----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 219 ----------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 219 ----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
...+| ++.+|+..||+.||.+||+++++++.|+++.......
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 12355 8999999999999999999999999999988765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=296.27 Aligned_cols=231 Identities=23% Similarity=0.332 Sum_probs=182.9
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|++.++||+|+||+||+|.+. ++.||||++....... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence 345689999999999999999999986 8999999997543222 134578999999999999999999998643
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe----eCCCCceEEcc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLAD 169 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill----~~~~~~~kl~D 169 (317)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||++ +.+ +.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~D 159 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTD 159 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEcc
Confidence 67999999999999999986433 238999999999999999999999999999999999998 555 5799999
Q ss_pred cCcccccccccccccccCccceecccccccc-------cccccccccccCC-----------------------------
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTV-------TLRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~~~~~~~----------------------------- 213 (317)
||+++............||+.|+|||++... .......++|+.+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 9999876555555566799999999987521 1111112222211
Q ss_pred -----------------------CCCC----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -----------------------NVRP----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -----------------------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+ ....++..+.+|+.+||+.||++|||++|++++..+-.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 0001 11234568899999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.65 Aligned_cols=225 Identities=26% Similarity=0.349 Sum_probs=184.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH---HHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE---IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
++|++.+.||+|+||.||+|.+. ++.||||++........ .......+.+|+.++++++||||+++++++.+. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 68999999999999999999875 89999999987542110 000122467899999999999999999999765 7
Q ss_pred eEEEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSGG-TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+.+| +|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccceEC
Confidence 89999999776 99999986544 9999999999999999999999999999999999999988 79999999999876
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
..........||+.|+|||++.+........++|+.+ .....+..++.++.+||.+||+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 260 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQ 260 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHHTC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHHcc
Confidence 5555555668999999999987655433333444322 1222355689999999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 021127 236 EDPNARPNFTQIIQML 251 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~l 251 (317)
.||.+|||+.+++++.
T Consensus 261 ~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 261 PVPERRTTLEKLVTDP 276 (335)
T ss_dssp SSGGGSCCHHHHHHCT
T ss_pred CChhhCcCHHHHhcCc
Confidence 9999999999999983
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=289.61 Aligned_cols=232 Identities=29% Similarity=0.499 Sum_probs=185.1
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH--HHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI--AKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
....+..++|++.+.||+|+||.||+|++. ++.||||++......... ....+.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 344677899999999999999999999985 889999998765443211 1112578999999999999999999999
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCc-----e
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKT-----I 165 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~-----~ 165 (317)
+.+.. ++||||+++++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+||+++.+ +. +
T Consensus 92 ~~~~~-~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~ 168 (287)
T 4f0f_A 92 MHNPP-RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCA 168 (287)
T ss_dssp ETTTT-EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCE
T ss_pred ecCCC-eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeE
Confidence 97664 69999999999999987643 34999999999999999999999999 9999999999999876 44 9
Q ss_pred EEcccCcccccccccccccccCccceeccccccccc-ccccccccccCC-------------------------------
Q 021127 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNHK------------------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~~------------------------------- 213 (317)
||+|||+++.... ......||+.|+|||++.... ......++|+.+
T Consensus 169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred EeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 9999999985433 234467999999999984211 111111222111
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.....+..++.++.+|+.+||+.||.+|||+.++++.|++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1223456789999999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=297.42 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=176.7
Q ss_pred cceecCCceeecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 021127 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85 (317)
Q Consensus 11 ~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 85 (317)
+....-..+.+..++|++.+.||+|+||.||+|.+. + ..||||++....... ...+++.+|+.++++++|||
T Consensus 10 ~~~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~ 86 (323)
T 3qup_A 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS---SDIEEFLREAACMKEFDHPH 86 (323)
T ss_dssp ------CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C---HHHHHHHHHHHHHTTCCCTT
T ss_pred HHHHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH---HHHHHHHHHHHHHHHCCCCc
Confidence 334445677899999999999999999999999875 2 279999997654322 23567899999999999999
Q ss_pred eeeEEeeeecC-c------eEEEEEccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021127 86 LVKFIGACKEP-V------MVIVTELLSGGTLRKYLLNMRP----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPE 154 (317)
Q Consensus 86 iv~l~~~~~~~-~------~~lv~e~~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~ 154 (317)
|+++++++... . .++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||+
T Consensus 87 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~ 166 (323)
T 3qup_A 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166 (323)
T ss_dssp BCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcc
Confidence 99999998654 2 3899999999999999975431 24899999999999999999999999999999999
Q ss_pred cEEeeCCCCceEEcccCcccccccccc---cccccCccceecccccccccccccccccccC-------------------
Q 021127 155 NLLLTEDLKTIKLADFGLAREESLTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------- 212 (317)
Q Consensus 155 Nill~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------- 212 (317)
||+++.+ +.+||+|||+++....... .....+++.|+|||++.+..... ..++|+.
T Consensus 167 NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 167 NCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV-HSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp GEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCC-ccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999988 7999999999985433322 22335678999999875532211 1111110
Q ss_pred ----------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 ----------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 ----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
......+..++.++.+|+.+||+.||.+|||+.++++.|++++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 245 NAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1223446678899999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.26 Aligned_cols=222 Identities=24% Similarity=0.331 Sum_probs=183.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||++++. ++.||||++.+..... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh--hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence 4478999999999999999999985 8999999997532111 12244678899999999999999999999865 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||++||+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS
T ss_pred EEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC
Confidence 999999999999999987544 9999999999999999999999999999999999999988 7999999999986543
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
.....+||+.|+|||++.+..+.. ..++|+.+ .....+..++.++.+||.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 235 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred --ccccccCCccccCHhHhcCCCCCc-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 234568999999999987644322 23333322 112335678899999999
Q ss_pred HhhhcCCCCCC-----CHHHHHHHH
Q 021127 232 SCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 232 ~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
+||+.||.+|| +++++++|-
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCc
Confidence 99999999999 899999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.81 Aligned_cols=236 Identities=23% Similarity=0.325 Sum_probs=186.8
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
...+.+.++.++|++.+.||+|+||.||++.+. ++.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~ 93 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-----QDREEAQREADMHRLFNHPNILRLVA 93 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH-----HHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH-----HHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 344567899999999999999999999999974 89999999876432 33556889999999999999999999
Q ss_pred eee-----cCceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 92 ACK-----EPVMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 92 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
++. ....++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ +.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~ 172 (317)
T 2buj_A 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQ 172 (317)
T ss_dssp EEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SC
T ss_pred EEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CC
Confidence 985 22789999999999999999763 23459999999999999999999999999999999999999988 68
Q ss_pred eEEcccCccccccccc----------ccccccCccceecccccccccc--cccccccccCC-------------------
Q 021127 165 IKLADFGLAREESLTE----------MMTAETGTYRWMAPELYSTVTL--RQGEKKHYNHK------------------- 213 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~~------------------- 213 (317)
+||+|||++....... ......||+.|+|||++.+... .....++|+.+
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 9999999987532211 1123457999999998764321 11122222211
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+....++.++.+||.+||+.||.+|||+.+++++|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 122334578899999999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.70 Aligned_cols=225 Identities=22% Similarity=0.261 Sum_probs=181.5
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 96 (317)
.+..++|++.+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ +||||+++++++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc--chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 466789999999999999999999986 6889999997642111 12234578899999887 899999999999865
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||++||+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKE 170 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccc
Confidence 89999999999999999987654 9999999999999999999999999999999999999988 7999999999985
Q ss_pred cc-cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 176 ES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 176 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
.. ........+||+.|+|||++.+..+. ...++|+.+ .....+..++.++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 249 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 249 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccCCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 32 22334566899999999998764432 222333222 11233567899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHH
Q 021127 228 IILTSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
+||.+||+.||.+||+ +.++++|
T Consensus 250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 250 AICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999995 5888877
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.86 Aligned_cols=221 Identities=25% Similarity=0.379 Sum_probs=174.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
++|++.+.||+|+||.||+|++. ++.||||++....... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL----AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT----HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 57999999999999999999985 8999999998655332 245689999999999999999999987432
Q ss_pred -----------------------------------------------------ceEEEEEccCCCCHHHHHHhcCC-CCC
Q 021127 97 -----------------------------------------------------VMVIVTELLSGGTLRKYLLNMRP-RCL 122 (317)
Q Consensus 97 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~-~~l 122 (317)
..++|||||++++|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 27999999999999999987543 235
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-------------ccccccCcc
Q 021127 123 DVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-------------MMTAETGTY 189 (317)
Q Consensus 123 ~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~gt~ 189 (317)
++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++...... ......||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 677789999999999999999999999999999999988 799999999998654321 223356999
Q ss_pred ceecccccccccccccccccccCC--------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCC
Q 021127 190 RWMAPELYSTVTLRQGEKKHYNHK--------------------------NVRPSAENVPEELSIILTSCWKEDPNARPN 243 (317)
Q Consensus 190 ~y~aPE~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps 243 (317)
.|+|||++.+..+. ...++|+.+ .........+.++.+||.+||+.||.+|||
T Consensus 241 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp GGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred CccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 99999998764432 223333322 000001234567899999999999999999
Q ss_pred HHHHHHH
Q 021127 244 FTQIIQM 250 (317)
Q Consensus 244 ~~~~~~~ 250 (317)
+.+++++
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=289.95 Aligned_cols=227 Identities=26% Similarity=0.392 Sum_probs=177.8
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc--hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345578999999999999999999986 8999999987532111 12245688999999999999999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeeccccccc
Confidence 89999999999999999987654 8999999999999999999999999999999999999988 68999999999866
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~l 229 (317)
..........|++.|+|||++.+........+.|+.+ .....+..++..+.++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 241 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHH
Confidence 5544445567899999999987644332233333222 1122356678999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
+.+||+.||.+|||+.+++++-
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHccCChhhCCCHHHHHhCh
Confidence 9999999999999999999973
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.47 Aligned_cols=235 Identities=28% Similarity=0.482 Sum_probs=184.5
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
.+.|.+++|.+.+.||+|+||.||+|.+. +..||||++...... .....+.+|+.++++++||||+++++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH----HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 45789999999999999999999999874 245999999865543 33456899999999999999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
++.+. ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Df 191 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDF 191 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCC
Confidence 99765 8999999999999999998643 349999999999999999999999999999999999999988 79999999
Q ss_pred Cccccccccc----ccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCC
Q 021127 171 GLAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPS 218 (317)
Q Consensus 171 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~ 218 (317)
|+++...... ......+|+.|+|||++.+..... +..++.. .....+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 271 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence 9998543221 112234678999999876432211 1111111 0112344
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+..++..+.+++.+||+.||.+||++.+++++|++++...
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 5678999999999999999999999999999999988643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=297.45 Aligned_cols=223 Identities=26% Similarity=0.359 Sum_probs=181.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|.+.+.||+|+||.||+|.+. ++.||||++......... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999986 889999999875432100 01134688999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC----ceEEcccCcccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLARE 175 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~ 175 (317)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ + .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCCeE
Confidence 9999999999999997644 39999999999999999999999999999999999999876 4 799999999987
Q ss_pred cccccccccccCccceecccccccccccccccccccCC----------------------------CCCC---CCCCChH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRP---SAENVPE 224 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~---~~~~~~~ 224 (317)
...........||+.|+|||++.+..... ..++|+.+ .... ....++.
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCCccccccCCcCcCCceeecCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 65444445567999999999886543222 22222221 0000 0246788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 99999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.64 Aligned_cols=232 Identities=21% Similarity=0.401 Sum_probs=181.8
Q ss_pred eecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+..++|++.++||+|+||.||+|.+. ++ .||+|.+....... ....+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ----SFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS----CBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH----HHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 456789999999999999999999875 33 38888875443211 123467899999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 85 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a 162 (325)
T 3kex_A 85 PGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVA 162 (325)
T ss_dssp CBSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGG
T ss_pred cCCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCcc
Confidence 8889999999999999999998642 248999999999999999999999999999999999999988 78999999999
Q ss_pred ccccccc---ccccccCccceecccccccccccc-----------------cccccccC-----------CCCCCCCCCC
Q 021127 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH-----------KNVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~-----------~~~~~~~~~~ 222 (317)
+...... ......|+..|+|||++.+..... +..++... ......+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC 242 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTB
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcC
Confidence 8653322 223446788999999876433211 11111110 1123335567
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++.+++.+||+.||.+|||+.+++++|..+...
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 88899999999999999999999999999988653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.71 Aligned_cols=231 Identities=20% Similarity=0.277 Sum_probs=180.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.+.||+|+||.||+|.+. ++.||||++...............+.+|+.+++.++||||+++++++.+. .
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 33468999999999999999999885 89999999864221000000134688999999999999999999998765 8
Q ss_pred eEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCcc
Q 021127 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLA 173 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a 173 (317)
.++|||||++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999999888653 233489999999999999999999999999999999999998652 24999999999
Q ss_pred ccccccc-ccccccCccceecccccccccccccccccccCC---------------------------CCCCC---CCCC
Q 021127 174 REESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS---AENV 222 (317)
Q Consensus 174 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~---~~~~ 222 (317)
+...... .....+||+.|+|||++.+..+. ...++|+.+ ..... ...+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccC
Confidence 8654332 23456799999999998764332 222233221 00011 1467
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+.++.+||.+||+.||.+|||+.++++|-+
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence 899999999999999999999999998744
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=299.49 Aligned_cols=217 Identities=29% Similarity=0.411 Sum_probs=163.6
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|++. ++.||||++..... .+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 356999999999999999999986 78899999986432 23578899999999999999999999765 799
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~~ 176 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++. + +.+||+|||+++..
T Consensus 125 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~-~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPD-APLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTT-CCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCC-CCEEEccCcccccc
Confidence 99999999999999986543 899999999999999999999999999999999999975 4 68999999999866
Q ss_pred ccccccccccCccceecccccccccccccccccccCC--------------------------------CCCCCCCCChH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------NVRPSAENVPE 224 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~ 224 (317)
..........||+.|+|||++.+..+.. ..++|+.+ ...+....++.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 5544445567999999999877643221 11222111 01122356889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||.+||+.||++|||+.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.83 Aligned_cols=232 Identities=29% Similarity=0.510 Sum_probs=182.3
Q ss_pred CCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
...|.++.++|++.+.||+|+||.||+++++++.||||++..... .+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 346889999999999999999999999999999999999876542 3458899999999999999999998743
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~ 164 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLT 164 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC-
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccc
Confidence 378999999999999999986544348899999999999999999999999999999999999988 79999999999
Q ss_pred cccccccccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCChHH
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENVPEE 225 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~~~~ 225 (317)
...... .....+++.|+|||++.+..... +..++.. .......+..++..
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (278)
T 1byg_A 165 KEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred cccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHH
Confidence 754432 22346788999999875422211 1111100 01122335678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=295.88 Aligned_cols=224 Identities=24% Similarity=0.371 Sum_probs=173.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|++.+.||+|+||.||+|++. ++.||||++....... .....++.+|+.++++++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS--HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC--HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 478999999999999999999974 8999999998765433 23456789999999999999999999998543
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCccc
Confidence 34999999999999999987654 9999999999999999999999999999999999999988 7899999999975
Q ss_pred cccc----cccccccCccceecccccccccccccccccccCC----------------------------CCCC---CCC
Q 021127 176 ESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRP---SAE 220 (317)
Q Consensus 176 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~---~~~ 220 (317)
.... .......||+.|+|||++.+..... ..++|+.+ ...+ ...
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 4322 1223346899999999887643322 22222221 0000 134
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.++.++.+||.+||+.||.+||++.+++.+-+
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 57899999999999999999998887776533
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.26 Aligned_cols=228 Identities=22% Similarity=0.369 Sum_probs=179.9
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeeee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGACK 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~ 94 (317)
...+..++|++.+.||+|+||.||++.+. ++.||||++....... .....+.+|+.++.+++| +||+++++++.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch---HHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 45678899999999999999999999876 7889999998765443 334568999999999976 99999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++|||+ .+++|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++. +.+||+|||++
T Consensus 80 ~~~~~~lv~e~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a 154 (343)
T 3dbq_A 80 TDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIA 154 (343)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSS
T ss_pred eCCEEEEEEeC-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccc
Confidence 65 88999994 58899999987554 999999999999999999999999999999999999985 58999999999
Q ss_pred ccccccc---ccccccCccceeccccccccc----------ccccccccccCC---------------------------
Q 021127 174 REESLTE---MMTAETGTYRWMAPELYSTVT----------LRQGEKKHYNHK--------------------------- 213 (317)
Q Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~~~~~--------------------------- 213 (317)
+...... ......||+.|+|||++.+.. ......++|+.+
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 8653322 223457999999999985411 111112222211
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.....+...+.++.+|+.+||+.||.+|||+.+++++.+-
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 1122345667899999999999999999999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=302.06 Aligned_cols=221 Identities=20% Similarity=0.323 Sum_probs=181.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.+++.++||||+++++++.+. ..++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 57999999999999999999885 88999999976542 2234688999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-CCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~ 179 (317)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 126 v~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999999997543 349999999999999999999999999999999999999743 357999999999876555
Q ss_pred cccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~ 228 (317)
.......||+.|+|||++.+..... ..++|+.+ ........++.++.+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 283 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred cceeeeccCCCccCchhccCCCCCC-cccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence 4445568999999999987543221 12222211 011123568999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l 251 (317)
||.+||+.||.+|||+.+++++.
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 284 FIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTST
T ss_pred HHHHHcCCChhHCcCHHHHhhCc
Confidence 99999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=285.80 Aligned_cols=232 Identities=22% Similarity=0.274 Sum_probs=187.1
Q ss_pred eeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
..+..++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+|+.++..+ +|+|++++++++.+
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-------HHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 356678999999999999999999996 48999999987654432 377899999999 89999999999876
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc-----eEEcc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT-----IKLAD 169 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~-----~kl~D 169 (317)
+ ..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +. +||+|
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~D 154 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVD 154 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECC
T ss_pred CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEE
Confidence 5 889999999 999999998643 349999999999999999999999999999999999999866 34 99999
Q ss_pred cCccccccccc--------ccccccCccceecccccccccccccccccccCC--------CCC-----------------
Q 021127 170 FGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------- 216 (317)
Q Consensus 170 fg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------- 216 (317)
||+++...... ......||+.|+|||++.+..... ..++|+.+ ...
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99998544321 123456999999999987643321 22222221 000
Q ss_pred -------C---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 217 -------P---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 217 -------~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
+ ....++.++.+|+.+||+.||.+||++.++++.|++++......
T Consensus 234 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 234 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 0 12367899999999999999999999999999999998876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=291.00 Aligned_cols=221 Identities=26% Similarity=0.343 Sum_probs=174.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP---VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 68999999999999999999986 8899999987665433 3345688999999999999999999999765 8899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
||||+++++|.+++..... +++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++..... .
T Consensus 80 v~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc
Confidence 9999999999998876544 9999999999999999999999999999999999999988 7999999999986542 2
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
.......||+.|+|||++.+........+.|+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2334557899999999876522222222222211
Q ss_pred --CCCCC----------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --NVRPS----------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...+. ...++.++.+|+.+||+.||.+|||++++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 14578889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.86 Aligned_cols=239 Identities=18% Similarity=0.266 Sum_probs=182.7
Q ss_pred ecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCCee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv 87 (317)
+..++|++.++||+|+||.||+|.+. ++.||||++........... ....+..|+..+..++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45679999999999999999999884 37899999886543211000 011234566677788999999
Q ss_pred eEEeeeec-----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee--C
Q 021127 88 KFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT--E 160 (317)
Q Consensus 88 ~l~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~--~ 160 (317)
++++++.. ...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 99999854 3589999999 999999998743 3499999999999999999999999999999999999998 6
Q ss_pred CCCceEEcccCcccccccccc--------cccccCccceecccccccccccccccccccCC--------CCC--------
Q 021127 161 DLKTIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR-------- 216 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~-------- 216 (317)
+ +.+||+|||+++....... .....||+.|+|||++.+..+.. ..++|+.+ ...
T Consensus 190 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 190 P-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR-RGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp T-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred C-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCccccccC
Confidence 6 7899999999975433221 12345999999999987643221 22222211 000
Q ss_pred ----------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 021127 217 ----------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEP 263 (317)
Q Consensus 217 ----------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~~ 263 (317)
.....+|.++.+++..||+.||.+||++.++++.|.+++........
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 01256789999999999999999999999999999999987655443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=310.14 Aligned_cols=227 Identities=26% Similarity=0.300 Sum_probs=174.9
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.+..++|++.++||+|+||.||+|++. ++.||||++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA--KDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEE
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh--hHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 34456688999999999999999999885 8899999997532111 1224467889999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
. ..++||||+++|+|.+++..... +++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||++
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a 296 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLC 296 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCc
Confidence 5 89999999999999999987654 9999999999999999999998 999999999999999988 79999999999
Q ss_pred cccc-cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHH
Q 021127 174 REES-LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEE 225 (317)
Q Consensus 174 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~ 225 (317)
+... ........+||+.|+|||++.+..+.. ..++|+.+ .....+..++.+
T Consensus 297 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 375 (446)
T 4ejn_A 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375 (446)
T ss_dssp CTTCC-----CCSSSCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred eeccCCCcccccccCCccccCHhhcCCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 8532 233345568999999999986543322 22222211 122345678999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
+.+||.+||+.||.+|| ++.++++|
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 99999999999999999 99999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=286.71 Aligned_cols=219 Identities=24% Similarity=0.347 Sum_probs=181.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. +..||+|.+....... ...+.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-----VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 57999999999999999999986 6789999998654332 34588999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe---eCCCCceEEcccCcccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREES 177 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~~~~ 177 (317)
||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||++ +.+ +.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceecc
Confidence 9999999999999987654 9999999999999999999999999999999999999 555 689999999998765
Q ss_pred cccccccccCccceecccccccccccccccccccCC---------------------------CCCCCC----CCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSA----ENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~----~~~~~~l 226 (317)
.........||+.|+|||++.+. .....+.|+.+ .....+ ..++..+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence 55555667899999999987653 22233333322 001111 2678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+|+.+||+.||.+|||+.+++++-+
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEW 264 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHH
Confidence 99999999999999999999998743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.45 Aligned_cols=237 Identities=24% Similarity=0.489 Sum_probs=187.8
Q ss_pred ceeecCCceeecc-eeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGP-RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~-~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.|.+..+++.+.+ +||+|+||.||+|.+. +..||||+++...... ..+.+.+|++++++++||||++++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA----DTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST----THHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 5677888888877 8999999999999773 5679999998654322 24468999999999999999999999
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.++..++||||+++|+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 405 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGl 482 (613)
T 2ozo_A 405 CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGL 482 (613)
T ss_dssp EESSSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCST
T ss_pred eccCCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccC
Confidence 98888999999999999999997643 349999999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccc----cccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCC
Q 021127 173 AREESLTEM----MTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAE 220 (317)
Q Consensus 173 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~ 220 (317)
++....... .....+++.|+|||++.+..+.. +..++.. .+.....+.
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 986532221 12234568999999875432211 1111110 112234466
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.++.++.+||.+||+.||++||++.++++.|+.+......
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 7899999999999999999999999999999998776543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=304.16 Aligned_cols=170 Identities=29% Similarity=0.393 Sum_probs=142.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.++++++|+||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL---IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh---HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 478999999999999999999886 7999999997654332 335578999999999999999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...|+||||+. ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~~~~--l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKTPIF--LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCcc
Confidence 35899999995 699999986543 9999999999999999999999999999999999999998 799999999998
Q ss_pred cccccc-----------------------ccccccCccceeccccccc
Q 021127 175 EESLTE-----------------------MMTAETGTYRWMAPELYST 199 (317)
Q Consensus 175 ~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~ 199 (317)
...... .....+||+.|+|||++..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 643321 2255679999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.47 Aligned_cols=169 Identities=30% Similarity=0.411 Sum_probs=133.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||+||+|.+. ++.||||++....... ...+++.+|+.++++++||||+++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL---IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH---HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 378999999999999999999875 8899999997654332 335578999999999999999999999832
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...|+||||+ +++|.+++..... +++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVY--LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred CceEEEEEecc-ccchhhhcccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccch
Confidence 3689999998 6799999986543 9999999999999999999999999999999999999998 799999999998
Q ss_pred ccccc----------------------------cccccccCccceecccccc
Q 021127 175 EESLT----------------------------EMMTAETGTYRWMAPELYS 198 (317)
Q Consensus 175 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~ 198 (317)
..... ......+||+.|+|||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 54321 1223457899999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.13 Aligned_cols=227 Identities=28% Similarity=0.364 Sum_probs=174.6
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 95 (317)
+..++|++.++||+|+||+||+|++. ++.||||++...............+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44689999999999999999999964 89999999875432110001112355677766665 59999999999864
Q ss_pred C------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 96 P------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 96 ~------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
. ..++||||+. ++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~D 163 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLAD 163 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECS
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEee
Confidence 3 4799999995 699999988766669999999999999999999999999999999999999988 7999999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC--------CC--------------------------
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------- 215 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------- 215 (317)
||+++............||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCS-THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998765555556678999999999876533221 12222111 00
Q ss_pred ---------------C-----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ---------------R-----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ---------------~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .....++.++.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 0023577899999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=291.34 Aligned_cols=221 Identities=27% Similarity=0.377 Sum_probs=173.1
Q ss_pred CceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
++|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.+. ..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG---CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc---ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 58999999999999999999986 8899999997654322 1124578999999999999999999999765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++..... .
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence 99996 49999987643 349999999999999999999999999999999999999988 79999999999754322 2
Q ss_pred ccccccCccceecccccccccccccccccccCC--------------------------------------------CC-
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------------------NV- 215 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------------------~~- 215 (317)
......||+.|+|||++.+........++|+.+ ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 234457899999999875432212122222111 00
Q ss_pred -----------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 -----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 -----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.+||.+||+.||.+|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00124578999999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=310.99 Aligned_cols=221 Identities=26% Similarity=0.337 Sum_probs=177.3
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
+|++.++||+|+||+||+|++. +..||||++....... .....+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST---SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC--------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc---hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 6999999999999999999985 7899999998654322 1234688999999999999999999999865 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccccccc
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESLT 179 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~~~ 179 (317)
||||++|+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.. .+.+||+|||+++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999999987654 9999999999999999999999999999999999999753 245999999999876655
Q ss_pred cccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~ 228 (317)
......+||+.|+|||++.+. .....++|+.+ ...+....++..+.+
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred ccccccCCCcCeeCHHHHccc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 555667899999999987642 12222333222 011113468899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
||.+||+.||.+|||+.++++|.+
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPW 294 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcc
Confidence 999999999999999999998744
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=315.83 Aligned_cols=228 Identities=22% Similarity=0.314 Sum_probs=188.0
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|++.+.||+|+||.||+|++. ++.||||++.+..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 367789999999999999999999985 8999999997532111 12234678999999999999999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||++||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence 89999999999999999987665569999999999999999999999999999999999999988 79999999999876
Q ss_pred ccccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~ 225 (317)
.........+||+.|+|||++.+..+.. ..++|+.+ .....+..++.+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~-~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESS-HHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccCccccccCCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 5544445668999999999987643221 22222211 112235678999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARP-----NFTQIIQML 251 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rp-----s~~~~~~~l 251 (317)
+.+||.+||+.||.+|| +++++++|-
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 99999999999999999 789999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.20 Aligned_cols=221 Identities=21% Similarity=0.328 Sum_probs=180.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+..+..+ +||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS---VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS---HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 68999999999999999999985 8999999998754433 2345688999999999 999999999998754 899
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC----------------
Q 021127 100 IVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED---------------- 161 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~---------------- 161 (317)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999998642 1348999999999999999999999999999999999999843
Q ss_pred --CCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC-------------------------C
Q 021127 162 --LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------N 214 (317)
Q Consensus 162 --~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------~ 214 (317)
...+||+|||.+...... ....||+.|+|||++.+........++|+.+ .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGR 244 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTC
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCC
Confidence 137999999999865433 2346899999999987543222233333222 1
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 245 LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 223356789999999999999999999999999887
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=288.71 Aligned_cols=223 Identities=27% Similarity=0.431 Sum_probs=185.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
++|++.+.||+|+||.||+|.+. ++.||||++..... .+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG---------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH---------HHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 67999999999999999999986 89999999986532 36789999999999999999998743
Q ss_pred -----------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc
Q 021127 96 -----------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT 164 (317)
Q Consensus 96 -----------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~ 164 (317)
...++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.+ +.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~ 160 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQ 160 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CC
Confidence 258999999999999999987654559999999999999999999999999999999999999988 79
Q ss_pred eEEcccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------CCCCCCCC
Q 021127 165 IKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------NVRPSAEN 221 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~ 221 (317)
+||+|||++.............|++.|+|||++.+..... ..+.|+.+ .....+..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK-EVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI 239 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCT-HHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTT
T ss_pred EEECcchhheeccccccccccCCcccccChhhhccCCCcc-hhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccccccc
Confidence 9999999998665544445567999999999876543222 22222221 11123456
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 240 ~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 889999999999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=286.56 Aligned_cols=224 Identities=25% Similarity=0.356 Sum_probs=183.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.+.||+|+||.||++.+. ++.||+|++....... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC--HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 368999999999999999999986 7899999997654332 23455788999999999999999999999765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 178 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceecccC
Confidence 99999999999999887554 9999999999999999999999999999999999999988 7899999999986432
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
........||+.|+|||++.+..... ..+.|+.+ .....+..++..+.+++.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 22334457899999999876533221 12222211 112335678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.||.+|||+.+++++.+
T Consensus 248 ~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 248 KMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH
T ss_pred HHcccChhhCcCHHHHhhChh
Confidence 999999999999999999743
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=312.02 Aligned_cols=222 Identities=25% Similarity=0.382 Sum_probs=179.4
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||+||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 68999999999999999999986 8999999986432111 1134688999999999999999999999865 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~~ 178 (317)
|||||.+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.. .+.+||+|||+++....
T Consensus 99 v~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999999987654 9999999999999999999999999999999999999632 25799999999986655
Q ss_pred ccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~ 227 (317)
.......+||+.|+|||++.+. .....++|+.+ ...+....++.++.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 5555567899999999998753 11222233221 01122346789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||.+||+.||.+|||+.++++|.+
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHh
Confidence 9999999999999999999999854
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.77 Aligned_cols=224 Identities=25% Similarity=0.352 Sum_probs=183.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|.+.+.||+|+||.||++.+. ++.||+|++....... ......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK--PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 468999999999999999999986 7899999998654322 23455788999999999999999999999765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 178 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecccC
Confidence 99999999999999887554 9999999999999999999999999999999999999988 7899999999986532
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
........||+.|+|||++.+.... ...++|+.+ .....+..++..+.+||.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 2233445789999999987654322 122222211 112335678899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.||.+|||+.+++++-+
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHH
T ss_pred HHccCChhHCcCHHHHhcCcc
Confidence 999999999999999998743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.32 Aligned_cols=220 Identities=26% Similarity=0.376 Sum_probs=168.0
Q ss_pred Cceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh-cCCCCeeeEEeeeec----
Q 021127 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR-VQHRNLVKFIGACKE---- 95 (317)
Q Consensus 24 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~---- 95 (317)
++|.+. +.||+|+||+||++.+. ++.||||++... ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 456665 78999999999999986 889999998642 135678888755 589999999998853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 172 (317)
..+++||||++||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 368999999999999999987655569999999999999999999999999999999999999972 26899999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC-----------------------------------CCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------NVRP 217 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------~~~~ 217 (317)
++...........+||+.|+|||++.+..+.. ..++|+.+ ...+
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSS-HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 98665444455678999999999986533221 12222211 0011
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
....++.++.+||.+||+.||.+|||+.++++|.+-.
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 1246889999999999999999999999999996644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=293.96 Aligned_cols=221 Identities=25% Similarity=0.358 Sum_probs=179.5
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.+.||+|+||.||+|++. ++.||||++....... ......+.+|++++++++||||+++++++.++ ..++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 46999999999999999999974 8999999998664433 23456789999999999999999999998755 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+. |+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 132 v~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-
T ss_pred EEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCCC-
Confidence 999996 68888886543 349999999999999999999999999999999999999988 79999999999765432
Q ss_pred ccccccCccceecccccccc--cccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
....||+.|+|||++.+. .......++|+.+ ........++..+.+|
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 345799999999987421 1112222333221 1112245688999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
|.+||+.||.+|||+.+++++.+
T Consensus 286 i~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 286 VDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHH
T ss_pred HHHHcccChhhCcCHHHHhhChh
Confidence 99999999999999999998855
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.83 Aligned_cols=227 Identities=25% Similarity=0.339 Sum_probs=171.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCCh---HHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP---EEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 97 (317)
.++|.+.+.||+|+||.||+|.+. ++.||||++...... .........+.+|+.++++++||||+++++++..+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 213 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCc
Confidence 478999999999999999999886 789999999764311 111122335789999999999999999999998888
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~ 175 (317)
.++||||+++|+|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.+. ..+||+|||+++.
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 9999999999999998876544 99999999999999999999999999999999999997541 3599999999987
Q ss_pred cccccccccccCccceecccccccc--cccccccccccCC-----------------------------CCCC---CCCC
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTV--TLRQGEKKHYNHK-----------------------------NVRP---SAEN 221 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~~-----------------------------~~~~---~~~~ 221 (317)
..........+||+.|+|||++.+. .......++|+.+ .... ....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 6655555667899999999997531 1111122222211 0000 0235
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
++..+.+||.+||+.||.+|||+.++++|-
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 788999999999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.76 Aligned_cols=236 Identities=30% Similarity=0.526 Sum_probs=189.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKF 89 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 89 (317)
.|.+..++|++.+.||+|+||.||+|.+ +++.||||++....... ....+.+|+.++.++ +||||+++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH----HHHHHHHHHHHHHhcccCCCeeeE
Confidence 6788999999999999999999999975 25889999998765432 345688999999999 79999999
Q ss_pred EeeeecC--ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 021127 90 IGACKEP--VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKP 153 (317)
Q Consensus 90 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp 153 (317)
++++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 9998653 58999999999999999987543 1288999999999999999999999999999999
Q ss_pred CcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc-----------------cccccccC-
Q 021127 154 ENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYNH- 212 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~~- 212 (317)
+||+++.+ +.+||+|||+++...... ......||+.|+|||++.+..... +..++...
T Consensus 177 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999987 689999999997543221 123345788999999875432211 11111000
Q ss_pred -----------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 -----------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 -----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
......+..++..+.+++.+||+.||.+|||+.+++++|+.++...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0122335668899999999999999999999999999999988653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=295.18 Aligned_cols=229 Identities=24% Similarity=0.393 Sum_probs=182.8
Q ss_pred cCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
..++|++.+.||+|+||.||+|++. ++.||||++...... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-----GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS-----HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4478999999999999999999986 889999998765432 244688999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGT 190 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeecccccccc
Confidence 99999999999999976432 248999999999999999999999999999999999999988 799999999997533
Q ss_pred cc---cccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 178 LT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
.. .......||+.|+|||++.+..... ..++|+.+
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCT-HHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCc-ccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 21 1223345899999999875432211 11111100
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.........+..+.+++.+||+.||++|||+.+++++|+..++.
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 00011223467799999999999999999999999999988764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.60 Aligned_cols=236 Identities=25% Similarity=0.443 Sum_probs=186.3
Q ss_pred CceeecCCceeecc-eeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 17 AKWLIDPKHLFVGP-RIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 17 ~~~~i~~~~y~~~~-~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..|.++.+.+.+.. +||+|+||.||+|.+. ++.||||+++...... .....+.+|+.++++++||||+++++
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~l~~ 437 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIG 437 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG---GGHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 45677777777755 8999999999999652 5789999997643322 22456899999999999999999999
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++.++..++||||+++|+|.+++..... +++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 438 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFG 514 (635)
T 4fl3_A 438 ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFG 514 (635)
T ss_dssp EEESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTT
T ss_pred EEecCCEEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcC
Confidence 9988889999999999999999986544 9999999999999999999999999999999999999988 699999999
Q ss_pred ccccccccc----ccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCC
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSA 219 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~ 219 (317)
+++...... ......+|+.|+|||++.+..+.. +..++.. .+.....+
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 594 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 594 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998543321 123345678999999876533221 1111111 11223446
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
..++.++.+||.+||+.||++||++.++++.|++++...
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 788999999999999999999999999999999887653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=286.13 Aligned_cols=237 Identities=27% Similarity=0.447 Sum_probs=185.8
Q ss_pred CceeecC--CceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 17 AKWLIDP--KHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 17 ~~~~i~~--~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
..+.+++ .+|++.++||+|+||.||+|.+. ...||+|.+...... .....+.+|+.++++++||||+++
T Consensus 16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~ 91 (298)
T 3f66_A 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEGIIMKDFSHPNVLSL 91 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH----HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH----HHHHHHHHHHHHHHhCCCCCEeee
Confidence 3444554 36788999999999999999864 235899998765543 335568999999999999999999
Q ss_pred Eeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 90 IGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 90 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
++++. ++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||
T Consensus 92 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl 169 (298)
T 3f66_A 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKV 169 (298)
T ss_dssp CEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEE
T ss_pred eeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEE
Confidence 99864 347899999999999999997643 348999999999999999999999999999999999999988 79999
Q ss_pred cccCccccccccc-----ccccccCccceecccccccccccccccccccC-----------------------------C
Q 021127 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------K 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~ 213 (317)
+|||+++...... ......+|+.|+|||++.+..... ..+.|+. .
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence 9999998543322 123345788999999876533221 1111111 1
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.....+..++..+.+++.+||+.||.+|||+.++++.|.+++.....
T Consensus 249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 12233567889999999999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.23 Aligned_cols=222 Identities=26% Similarity=0.455 Sum_probs=174.0
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh--cCCCCeeeEEeeeec---
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKE--- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--- 95 (317)
+..++|++.+.||+|+||+||+|+++++.||||++.... ...+..|.+++.. ++||||+++++++.+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD--------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG--------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc--------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 445799999999999999999999999999999986532 2235667777766 799999999998643
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEeeCCCCce
Q 021127 96 --PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 96 --~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH--------~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
...++||||+++|+|.+++... .+++..++.++.|++.||+||| ++||+||||||+|||++.+ +.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~ 152 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQC 152 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCE
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCE
Confidence 2589999999999999999643 3999999999999999999999 9999999999999999988 699
Q ss_pred EEcccCcccccccccc-----cccccCccceecccccccccccc-----cccccccCC----------------------
Q 021127 166 KLADFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQ-----GEKKHYNHK---------------------- 213 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~-----~~~~~~~~~---------------------- 213 (317)
||+|||+++....... .....||+.|+|||++.+..... ...++|+.+
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 9999999975433221 22347999999999876542110 111111111
Q ss_pred ---------------------CCCCC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 214 ---------------------NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 214 ---------------------~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
...+. ....+.++.+|+.+||+.||.+|||+.++++.|+++
T Consensus 233 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 00010 112457899999999999999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.92 Aligned_cols=237 Identities=25% Similarity=0.354 Sum_probs=174.8
Q ss_pred CCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGA 92 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 92 (317)
...+.+...+|++.++||+|+||.||+|++ +++.||||++..... .....+.+|+.++.++. ||||++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-----EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-----HHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-----HHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 357788899999999999999999999998 489999999866532 33456889999999995 9999999998
Q ss_pred ee--------cC-ceEEEEEccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeC
Q 021127 93 CK--------EP-VMVIVTELLSGGTLRKYLLNM-RPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTE 160 (317)
Q Consensus 93 ~~--------~~-~~~lv~e~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~ 160 (317)
+. +. .+++||||+ +|+|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~ 173 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT
T ss_pred ccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC
Confidence 83 22 589999999 57999988752 2335999999999999999999999999 999999999999998
Q ss_pred CCCceEEcccCcccccccccc-------------cccccCccceecccccc---cccccccccccccCC-----------
Q 021127 161 DLKTIKLADFGLAREESLTEM-------------MTAETGTYRWMAPELYS---TVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~~~~~~~----------- 213 (317)
+ +.+||+|||+++....... .....||+.|+|||++. +..+ ....++|+.+
T Consensus 174 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 174 Q-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp T-SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSC
T ss_pred C-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCC
Confidence 8 6999999999985433211 11345899999999973 2111 1112222211
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
...+.....+..+.+|+.+||+.||.+|||+.+++++|+.+......
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 252 PFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp CC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred CCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 11223456677899999999999999999999999999998875443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=297.16 Aligned_cols=229 Identities=21% Similarity=0.362 Sum_probs=180.5
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 93 (317)
....+...+|++.+.||+|+||.||++.+. ++.||||++....... .....+.+|+.++.+++ |+||+++++++
T Consensus 49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp CCEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred ccccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH---HHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 345667778999999999999999999876 7889999998765433 34567899999999996 59999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
... ..++||| +.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~ 200 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGI 200 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCc
Confidence 755 7899999 568999999987553 899999999999999999999999999999999999964 5899999999
Q ss_pred cccccccc---ccccccCccceeccccccccc----------ccccccccccCC--------------------------
Q 021127 173 AREESLTE---MMTAETGTYRWMAPELYSTVT----------LRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 173 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~~~~~-------------------------- 213 (317)
++...... .....+||+.|+|||++.+.. ......++|+.+
T Consensus 201 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~ 280 (390)
T 2zmd_A 201 ANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 280 (390)
T ss_dssp SCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH
Confidence 98654322 234557999999999986421 111112222211
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.....+...+.++.+||.+||+.||.+|||+.+++++.+-
T Consensus 281 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 281 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 1122345567899999999999999999999999998553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.13 Aligned_cols=221 Identities=24% Similarity=0.386 Sum_probs=173.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.++||+|+||.||++.+. +..||+|++....... ....+.+|++++++++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV----PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch----hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 68999999999999999999985 7899999998654322 134688999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCccccc
Q 021127 101 VTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREE 176 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~ 176 (317)
||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999998653 22449999999999999999999999999999999999999532 257999999999866
Q ss_pred ccccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l 226 (317)
..........||+.|+|||++.+.. ....+.|+.+ ........+++++
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFKRDV--TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ---------CTTGGGCCHHHHTTCC--CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred CCcccCcCcccccCcCChHHhccCC--CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence 5554555667999999999875421 1112222211 1111234578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.14 Aligned_cols=224 Identities=24% Similarity=0.400 Sum_probs=180.5
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
.-++|++.+.||+|+||.||+|.+. +..||||++....... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch--hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 3478999999999999999999886 6789999987533211 12245688999999999999999999999765 79
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCc
Confidence 999999999999999987654 9999999999999999999999999999999999999988 7999999999865433
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
. ......|++.|+|||++.+..... ..+.|+.+ .....+..++..+.+|+.
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 S-RRTDLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred c-cccccCCCCCccCHhHhccCCCCc-cchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 3 224457899999999876543322 22222221 112335668899999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHH
Q 021127 232 SCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 232 ~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+||+.||.+|||+.++++|.+
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHH
T ss_pred HHhccChhhCCCHHHHhhCcc
Confidence 999999999999999999854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=288.23 Aligned_cols=229 Identities=21% Similarity=0.305 Sum_probs=168.7
Q ss_pred eeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+.+..++|++.+.||+|+||.||+|++ +++.||||++....... .....+.++...++.++||||+++++++.++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ---EQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH---HHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 567889999999999999999999998 48999999997665433 2233344555567778999999999999765
Q ss_pred -ceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||++ |+|.+++... ....+++..++.++.|++.||+|||++ |++||||||+||+++.+ +.+||+|||+
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 156 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGI 156 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC--
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCC
Confidence 8999999996 5888887642 334599999999999999999999998 99999999999999988 6999999999
Q ss_pred ccccccccccccccCccceeccccccc---ccccccccccccCC------------------------------CCCCCC
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYST---VTLRQGEKKHYNHK------------------------------NVRPSA 219 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~~~~~------------------------------~~~~~~ 219 (317)
++............||+.|+|||++.. ........+.|+.+ ......
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 986655544455679999999999631 11111112222211 112223
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
..++.++.+|+.+||+.||.+|||+.+++++.+
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence 568899999999999999999999999999744
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.64 Aligned_cols=230 Identities=25% Similarity=0.380 Sum_probs=175.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHH--HHhcCCCCeeeEEeeee-
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM--LSRVQHRNLVKFIGACK- 94 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~- 94 (317)
.+.++.++|++.+.||+|+||.||+|+++++.||||++..... ..+..|.++ +..++|+||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR--------QNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch--------hhHHHHHHHHHHHhccCcchhhheecccc
Confidence 4567789999999999999999999999999999999975432 123344444 44589999999998653
Q ss_pred ----cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCcEEeeC
Q 021127 95 ----EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH---------GIIHRDLKPENLLLTE 160 (317)
Q Consensus 95 ----~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---------~ivH~Dlkp~Nill~~ 160 (317)
+. .+++||||+++|+|.+++.... .++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 12 5789999999999999997643 68999999999999999999999 9999999999999998
Q ss_pred CCCceEEcccCcccccccc---------cccccccCccceecccccccccc------cccccccccCC------------
Q 021127 161 DLKTIKLADFGLAREESLT---------EMMTAETGTYRWMAPELYSTVTL------RQGEKKHYNHK------------ 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~~~------------ 213 (317)
+ +.+||+|||+++..... .......||+.|+|||++.+... .....++|+.+
T Consensus 156 ~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 234 (336)
T 3g2f_A 156 D-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234 (336)
T ss_dssp T-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred C-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence 8 79999999999754321 11224469999999999865210 00111111111
Q ss_pred ----------------------------------C-CCCCC------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ----------------------------------N-VRPSA------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ----------------------------------~-~~~~~------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
. ....+ ..++.++.+||.+||+.||.+|||+.++++.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp GSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 0 00011 124557999999999999999999999999999
Q ss_pred HhhhccC
Q 021127 253 NYLSAIA 259 (317)
Q Consensus 253 ~~~~~~~ 259 (317)
+++....
T Consensus 315 ~ll~~~~ 321 (336)
T 3g2f_A 315 ELMMIWE 321 (336)
T ss_dssp HHHHCCC
T ss_pred HHHHHHH
Confidence 9987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=296.80 Aligned_cols=237 Identities=27% Similarity=0.450 Sum_probs=178.9
Q ss_pred CceeecCC--ceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Q 021127 17 AKWLIDPK--HLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 17 ~~~~i~~~--~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 89 (317)
..+.|++. .|.+.+.||+|+||.||+|.+. ...||||.+....... ...++.+|+.++++++||||+++
T Consensus 80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~~ 155 (373)
T 3c1x_A 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG----EVSQFLTEGIIMKDFSHPNVLSL 155 (373)
T ss_dssp TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSH----HHHHHHHHHTTSTTCCCTTBCCC
T ss_pred cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHH----HHHHHHHHHHHHHhCCCCCcceE
Confidence 34555555 4678899999999999999863 2468999987644432 35578999999999999999999
Q ss_pred Eeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 90 IGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 90 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
++++. ++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||
T Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL 233 (373)
T 3c1x_A 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKV 233 (373)
T ss_dssp CEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEE
T ss_pred EEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEE
Confidence 99874 347899999999999999997643 348999999999999999999999999999999999999988 69999
Q ss_pred cccCccccccccc-----ccccccCccceecccccccccccccccccccC-----------------------------C
Q 021127 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------K 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~ 213 (317)
+|||+++...... ......+|+.|+|||++.+..+.. ..++|+. .
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence 9999998543221 112345778999999876532211 1111111 1
Q ss_pred CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.....+..++..+.+++.+||+.||.+|||+.++++.|++++.....
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 12233567899999999999999999999999999999999876554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=297.17 Aligned_cols=231 Identities=22% Similarity=0.441 Sum_probs=180.7
Q ss_pred eecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+..++|++.++||+|+||.||+|.+. ++ .||+|.+....... ....+.+|+.++++++||||+++++++
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK----ANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC----CHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH----HHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 466789999999999999999999874 44 46778776543322 244688999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++|++++.+|+|.+++..... .+++..++.|+.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 87 ~~~~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a 164 (327)
T 3lzb_A 87 LTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 164 (327)
T ss_dssp ESSSEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC-
T ss_pred ecCCceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcce
Confidence 98889999999999999999987543 49999999999999999999999999999999999999988 79999999999
Q ss_pred ccccccc---ccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCC
Q 021127 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 221 (317)
+...... ......+|+.|+|||++.+..+.. ..++|+ .....+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 243 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCCh-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 8643322 122345688999999876532221 111111 1122344667
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++.++.+|+.+||+.||.+||++.++++.|..+...
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 899999999999999999999999999999988753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=292.38 Aligned_cols=219 Identities=23% Similarity=0.362 Sum_probs=176.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 98 (317)
.++|++.+.||+|+||.||++.+. ++.||||++...... ..+|++++.++ +||||+++++++.++ ..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 468999999999999999999986 899999999865432 34688888887 799999999999865 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC---ceEEcccCcccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLARE 175 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~ 175 (317)
++||||++||+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||+..+.+ .+||+|||+++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999986544 999999999999999999999999999999999999854322 499999999985
Q ss_pred cccc-cccccccCccceecccccccccccccccccccCC-------------------------------C---CCCCCC
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------N---VRPSAE 220 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~---~~~~~~ 220 (317)
.... ......+||+.|+|||++.+..+.. ..++|+.+ . ......
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 4332 2344568999999999876532211 11111111 0 011235
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.++.++.+||.+||..||.+|||+.++++|-+-
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 689999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.53 Aligned_cols=222 Identities=25% Similarity=0.401 Sum_probs=163.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||+++++++.++ ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 468999999999999999999875 8999999997654321 123578899999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 100 IVTELLSGGTLRKYLLNMR----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+||||++ ++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++.
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARA 157 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEE
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCcccee
Confidence 9999996 69999987542 2348999999999999999999999999999999999999988 7999999999986
Q ss_pred cccc-cccccccCccceecccccccccccccccccccCC--------CC-------------------------------
Q 021127 176 ESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------------------------- 215 (317)
Q Consensus 176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------------------------- 215 (317)
.... .......||+.|+|||++.+........++|+.+ ..
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 5422 2234457899999999876532222222222211 00
Q ss_pred ----------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ----------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......++.++.+||.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00122577899999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=288.88 Aligned_cols=239 Identities=27% Similarity=0.484 Sum_probs=182.2
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
-..+.++.++|.+.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++++++||||++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ---REIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH---HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch---hHHHHHHHHHHHHhcCCCCCeeeee
Confidence 3467789999999999999999999999763 4589999998665433 3345689999999999999999999
Q ss_pred eeeecC------ceEEEEEccCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 91 GACKEP------VMVIVTELLSGGTLRKYLLNM----RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 91 ~~~~~~------~~~lv~e~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
+++.+. ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 998643 359999999999999999542 2345999999999999999999999999999999999999998
Q ss_pred CCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccC-------------------------
Q 021127 161 DLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------- 212 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------- 212 (317)
+ +.+||+|||+++...... ......+++.|+|||++.+..... ..++|+.
T Consensus 183 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 183 D-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp T-SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred C-CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 8 689999999997543322 122345788999999875532211 1111110
Q ss_pred ----CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 213 ----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 213 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
......+..++..+.+++.+||..||.+|||+.+++++|++++...+
T Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11233456788999999999999999999999999999999887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=298.63 Aligned_cols=219 Identities=22% Similarity=0.336 Sum_probs=167.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC---c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP---V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~---~ 97 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.++.++. ||||+++++++... .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS---TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH---HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh---HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 68999999999999999999885 8999999987554332 33456889999999997 99999999998632 6
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence 899999996 6999999763 38999999999999999999999999999999999999998 799999999997532
Q ss_pred c----------------------ccccccccCccceecccccccccccccccccccCC--------CCCC----------
Q 021127 178 L----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------- 217 (317)
Q Consensus 178 ~----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------- 217 (317)
. .......+||+.|+|||++.+........++|+.+ ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 1 11223457999999999987633333333333322 0000
Q ss_pred --------------------------------------------------------CCCCChHHHHHHHHHhhhcCCCCC
Q 021127 218 --------------------------------------------------------SAENVPEELSIILTSCWKEDPNAR 241 (317)
Q Consensus 218 --------------------------------------------------------~~~~~~~~l~~li~~cl~~~p~~R 241 (317)
....++.++.+||.+||+.||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 012668899999999999999999
Q ss_pred CCHHHHHHH
Q 021127 242 PNFTQIIQM 250 (317)
Q Consensus 242 ps~~~~~~~ 250 (317)
||++++++|
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999988
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.77 Aligned_cols=217 Identities=26% Similarity=0.369 Sum_probs=177.5
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
.|...++||+|+||.||+|++. ++.||||++....... ...+.+|+.++++++||||+++++++... ..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-----RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS-----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 4777889999999999999885 8999999998655432 34588999999999999999999998754 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++...... .
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc
Confidence 9999999999998653 39999999999999999999999999999999999999988 79999999999755432 2
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------C---CCCCCCCChHHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------N---VRPSAENVPEELSIIL 230 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~---~~~~~~~~~~~l~~li 230 (317)
......||+.|+|||++.+..... ..++|+.+ . .......++..+.+++
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence 234567999999999986643322 22222221 0 0112335788999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHH
Q 021127 231 TSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 231 ~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+||+.||.+|||+.+++++.
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHccCChhhCcCHHHHhcCh
Confidence 999999999999999999873
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=313.01 Aligned_cols=225 Identities=24% Similarity=0.366 Sum_probs=184.3
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+..++|++.+.||+|+||.||+|.+. ++.||||++........ .....+.+|+.++++++||||+++++++.+. .
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK--TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS--SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 44568999999999999999999985 89999999976543210 1234688999999999999999999999865 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee---CCCCceEEcccCccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLAR 174 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~---~~~~~~kl~Dfg~a~ 174 (317)
.++||||+.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++ .+ +.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~-~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKD-ANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTT-CCEEECCTTHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCC-CcEEEEeeeeeE
Confidence 9999999999999999986544 99999999999999999999999999999999999995 44 689999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCCh
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVP 223 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 223 (317)
............||+.|+|||++.+. .....++|+.+ ...+....++
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 178 HFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp HBCCCCSHHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred EcccccccccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence 66555555566899999999987652 12222333222 0111234678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.++++||.+||+.||.+|||+.++++|.+
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 99999999999999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=309.45 Aligned_cols=226 Identities=26% Similarity=0.389 Sum_probs=180.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH--------HHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE--------IAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.++|++.++||+|+||+||+|.+. ++.||||++........ .......+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 367999999999999999999986 78999999986543210 01224568899999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC--ceEEcc
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLAD 169 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~--~~kl~D 169 (317)
+.++ ..++|||||++|+|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+.. .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9876 79999999999999999987654 999999999999999999999999999999999999987622 699999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC---------------------------CCC----CC
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVR----PS 218 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~----~~ 218 (317)
||+++............||+.|+|||++.+. .....++|+.+ ... +.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhccC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 9999876655555667899999999997642 22223333322 000 01
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...++.++.+||.+||+.||.+|||+.++++|.+
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 2467899999999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=288.89 Aligned_cols=233 Identities=25% Similarity=0.497 Sum_probs=186.4
Q ss_pred CceeecCCceeecceeccccceEEEEeEE------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKY------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
....+..++|++.+.||+|+||.||++++ +++.||||++..... ...+.+.+|+.++++++||||++++
T Consensus 34 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~ 108 (326)
T 2w1i_A 34 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-----EHLRDFEREIEILKSLQHDNIVKYK 108 (326)
T ss_dssp ---CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-----HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34556778999999999999999999984 388999999986543 2345689999999999999999999
Q ss_pred eeeec---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 91 GACKE---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 91 ~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
+++.. ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||
T Consensus 109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL 186 (326)
T 2w1i_A 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKI 186 (326)
T ss_dssp EEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEE
T ss_pred EEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEE
Confidence 98753 26899999999999999998754 349999999999999999999999999999999999999988 79999
Q ss_pred cccCcccccccccc----cccccCccceecccccccccccccccccc---------------------------------
Q 021127 168 ADFGLAREESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHY--------------------------------- 210 (317)
Q Consensus 168 ~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~--------------------------------- 210 (317)
+|||++........ .....++..|+|||++.+..... ..++|
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCT
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccch
Confidence 99999986543221 22345778899999865422111 00000
Q ss_pred -----------cCCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 211 -----------NHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 211 -----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
......+.+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 01122344678899999999999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=284.83 Aligned_cols=226 Identities=23% Similarity=0.335 Sum_probs=184.0
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCC----ChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeee
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE----TPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACK 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 94 (317)
..++|++.+.||+|+||.||+|.+. ++.||||++.... ...........+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3489999999999999999999985 7999999998654 22333445667899999999995 999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
++ ..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence 65 79999999999999999987544 9999999999999999999999999999999999999988 78999999999
Q ss_pred cccccccccccccCccceeccccccccc-----ccccccccccCC----------------------------C---CCC
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHK----------------------------N---VRP 217 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~----------------------------~---~~~ 217 (317)
.............|++.|+|||++.+.. ......+.|+.+ . ..+
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence 8665544455567999999999875311 111112222211 0 011
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++..+.+|+.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 124678999999999999999999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.60 Aligned_cols=226 Identities=28% Similarity=0.357 Sum_probs=170.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++...............+.+|+.++++++||||+++++++.+. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 478999999999999999999885 88999999976543322122234688999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++ +|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceeccCC
Confidence 99999965 8998887643 348999999999999999999999999999999999999988 79999999999865332
Q ss_pred -cccccccCccceecccccccccccccccccccCC-----------------------------------------C---
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------------N--- 214 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------------~--- 214 (317)
.......||+.|+|||++.+........++|+.+ .
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 2334567899999999875432211112222111 0
Q ss_pred ------CCC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 ------VRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 ------~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
... ....++.++.+||.+||+.||.+|||+.|++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0145678999999999999999999999999983
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.38 Aligned_cols=234 Identities=28% Similarity=0.468 Sum_probs=184.5
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeE--EEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQT--VAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~--vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
.++.++|++.+.||+|+||.||+|++. +.. ||||.+...... ....++.+|+++++++ +||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 96 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK----DDHRDFAGELEVLCKLGHHPNIINLLGACE 96 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch----HHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence 366689999999999999999999874 554 499998754332 2345688999999999 9999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
+. ..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176 (327)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence 65 8999999999999999998643 23599999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCcccccccccccccccCccceecccccccccccccccccccC---------------------------
Q 021127 160 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH--------------------------- 212 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~--------------------------- 212 (317)
.+ +.+||+|||+++............+++.|+|||++.+..... ..++|+.
T Consensus 177 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 254 (327)
T 1fvr_A 177 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254 (327)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence 88 689999999998544433334456788999999875432211 1111110
Q ss_pred --CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 213 --KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 213 --~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
......+..++..+.+|+.+||+.||.+|||+.+++++|..++....
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 255 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11223456788999999999999999999999999999999987644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=291.23 Aligned_cols=238 Identities=27% Similarity=0.462 Sum_probs=186.5
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEE-------CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY-------KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 87 (317)
......+..++|++.+.||+|+||.||+|++ +++.||||++...... ....++.+|+.++++++||||+
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE----QDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH----HHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch----hhHHHHHHHHHHHhhCCCCCCC
Confidence 3445678889999999999999999999984 2678999999755443 2345688999999999999999
Q ss_pred eEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC
Q 021127 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161 (317)
Q Consensus 88 ~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~ 161 (317)
++++++.+. ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 176 (327)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred eEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC
Confidence 999999765 78999999999999999987542 348999999999999999999999999999999999999843
Q ss_pred --CCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccC------------------------
Q 021127 162 --LKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------------------------ 212 (317)
Q Consensus 162 --~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------------------------ 212 (317)
...+||+|||++....... ......|++.|+|||++.+..... ..++|+.
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 1469999999997432221 223346789999999875432211 1111110
Q ss_pred -----CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 -----KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
......+..++..+.+|+.+||+.||.+||++.+++++|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 112233567889999999999999999999999999999988764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=287.08 Aligned_cols=230 Identities=22% Similarity=0.336 Sum_probs=179.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++++++||||+++++++.++ ..+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD--PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC--HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 478999999999999999999975 8999999987654332 23456788999999999999999999998754 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCcccccc
Confidence 99999999999999987654 9999999999999999999999999999999999999988 79999999999755432
Q ss_pred c--ccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 180 E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 180 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
. ......|++.|+|||++.+..... ..++|+.+ .....+..+|.++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----C-CCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCc-hHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 2 223456899999999986543322 22222221 01112457889999
Q ss_pred HHHHHhhhcCCCCCC-CHHHHHHHHHHhhhcc
Q 021127 228 IILTSCWKEDPNARP-NFTQIIQMLLNYLSAI 258 (317)
Q Consensus 228 ~li~~cl~~~p~~Rp-s~~~~~~~l~~~~~~~ 258 (317)
++|.+||+.||.+|| +++++++.|++.+...
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 999999999999999 9999999998876544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=284.47 Aligned_cols=226 Identities=21% Similarity=0.330 Sum_probs=184.0
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|++++++++||||+++++++.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK--EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch--HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 345578999999999999999999986 7899999987532111 11234688999999999999999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHA 164 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccC
Confidence 88999999999999999987654 9999999999999999999999999999999999999988 68999999998754
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~l 229 (317)
... ......|++.|+|||++.+..... ..+.|+.+ .....+..++..+.++
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (284)
T 2vgo_A 165 PSL-RRRTMCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242 (284)
T ss_dssp SSS-CBCCCCSCGGGCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred ccc-ccccccCCCCcCCHHHhccCCCCc-ccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence 432 234457899999999887643322 22222221 1122356788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
|.+||+.||.+||++.+++++-+
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHH
T ss_pred HHHHhhcCHhhCCCHHHHhhCHH
Confidence 99999999999999999998744
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.79 Aligned_cols=240 Identities=28% Similarity=0.443 Sum_probs=189.5
Q ss_pred CCceeecCCc--eeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 021127 16 DAKWLIDPKH--LFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 16 ~~~~~i~~~~--y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
...+.++..+ |.+.++||+|+||.||+|.+. +..||+|.+...... ...+.+.+|+.++++++||||++
T Consensus 11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM----QQVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH----HHHHHHHHHHHHHHhCCCCCeee
Confidence 3455666664 456799999999999999863 237999998765443 33557899999999999999999
Q ss_pred EEeeeecC--ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 89 FIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 89 l~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+++++.+. ..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+|
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~k 164 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVK 164 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEE
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEE
Confidence 99998643 4589999999999999998633 348999999999999999999999999999999999999988 7999
Q ss_pred EcccCccccccccc-----ccccccCccceecccccccccccccccccccCC----------------------------
Q 021127 167 LADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------- 213 (317)
Q Consensus 167 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------- 213 (317)
|+|||+++...... ......+++.|+|||++.+..... ..+.|+.+
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT-KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh-hhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 99999997543221 223346789999999876543221 11111111
Q ss_pred -CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCCC
Q 021127 214 -NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262 (317)
Q Consensus 214 -~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~~ 262 (317)
...+.+..++..+.+++.+||+.||.+|||+.++++.|++++.......
T Consensus 244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 2233456788999999999999999999999999999999988765433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=293.38 Aligned_cols=223 Identities=25% Similarity=0.345 Sum_probs=169.2
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.++||+|+||+||+|.+. ++.||||++....... .....+.+|+.++++++||||+++++++.++ ..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE---GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc---ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3468999999999999999999875 8999999997654332 2344678999999999999999999999765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC----CCceEEcccCccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGLAR 174 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~----~~~~kl~Dfg~a~ 174 (317)
++||||++ ++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999996 599999987654 9999999999999999999999999999999999999533 1469999999997
Q ss_pred ccccc-cccccccCccceecccccccccccccccccccCC--------CCCC--------------------C-------
Q 021127 175 EESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP--------------------S------- 218 (317)
Q Consensus 175 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~--------------------~------- 218 (317)
..... .......||+.|+|||++.+........++|+.+ ...+ .
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 54322 2334457899999999886533222223333222 0000 0
Q ss_pred ----------------------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 ----------------------AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ----------------------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
...++.++.+||.+||+.||.+|||+.++++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 01167889999999999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=317.78 Aligned_cols=226 Identities=22% Similarity=0.254 Sum_probs=182.5
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE 95 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 95 (317)
..+..++|++.+.||+|+||.||+|++. ++.||||++.+..... ......+..|..++..+ +||||+++++++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ--DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH--TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 4466789999999999999999999986 7889999997532111 12234577899999887 79999999999986
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. .+|+||||++||+|.+++...+. +++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+++
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~ 490 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCK 490 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceee
Confidence 5 89999999999999999987654 9999999999999999999999999999999999999998 799999999998
Q ss_pred cc-ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHH
Q 021127 175 EE-SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 175 ~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l 226 (317)
.. .........+||+.|+|||++.+..+. ...++|+.+ .....+..++.++
T Consensus 491 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 569 (674)
T 3pfq_A 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569 (674)
T ss_dssp ECCCTTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHH
T ss_pred ccccCCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHH
Confidence 53 223344567899999999998764432 222333222 1223466789999
Q ss_pred HHHHHHhhhcCCCCCCCH-----HHHHHH
Q 021127 227 SIILTSCWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~-----~~~~~~ 250 (317)
.+||.+||+.||.+||++ ++|++|
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 999999999999999997 788776
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=302.95 Aligned_cols=221 Identities=25% Similarity=0.310 Sum_probs=170.6
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
..++|++.+.||+|+||+||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh---HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 3578999999999999999999885 8999999998653222 3355788999999999999999999998532
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEe
Confidence 57999999965 57776643 28999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CCCCC--------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRPS-------------------------- 218 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~~-------------------------- 218 (317)
++...........+||+.|+|||++.+..+. ...++|+.+ ...+.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876655555667899999999998765433 223333322 00000
Q ss_pred ------------------------CC-----------CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 ------------------------AE-----------NVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ------------------------~~-----------~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+. ..+.++.+||.+||+.||.+|||++|+++|-+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 00 01567899999999999999999999999843
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=293.27 Aligned_cols=223 Identities=27% Similarity=0.474 Sum_probs=175.4
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc--CCCCeeeEEeeeec-----C
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFIGACKE-----P 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~-----~ 96 (317)
++|++.++||+|+||.||+|+++++.||||++..... ..+..|.+++..+ +||||+++++++.+ .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE--------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGH--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEecccc--------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 6899999999999999999999999999999865321 2344555555554 99999999999854 4
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCcEEeeCCCCceEEc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------GIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
..++||||+++|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.+ +.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEE
Confidence 689999999999999999764 399999999999999999999999 99999999999999988 699999
Q ss_pred ccCcccccccccc-----cccccCccceeccccccccccccc-----ccccccCC-------------------------
Q 021127 169 DFGLAREESLTEM-----MTAETGTYRWMAPELYSTVTLRQG-----EKKHYNHK------------------------- 213 (317)
Q Consensus 169 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~~~~~~~------------------------- 213 (317)
|||+++....... .....||+.|+|||++.+...... ..++|+.+
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999975433221 124579999999998865432222 12222211
Q ss_pred ------------------CCCCC------CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ------------------NVRPS------AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ------------------~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
...+. ...++.++.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 00010 1245677999999999999999999999999999987653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.81 Aligned_cols=236 Identities=24% Similarity=0.403 Sum_probs=177.3
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..++|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 4468999999999999999999874 8999999998644322 23456789999999999999999999998754 89
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceeee
Confidence 9999999999999999752 23458999999999999999999999999999999999999988 79999999999754
Q ss_pred ccc-cccccccCccceecccccccccccccccccccCC------------------------------CCC-CCCCCChH
Q 021127 177 SLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVR-PSAENVPE 224 (317)
Q Consensus 177 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~-~~~~~~~~ 224 (317)
... .......|++.|+|||++.+..... ..+.|+.+ ... .....++.
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 332 2223456899999999876532211 11111111 111 11356889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
++.+|+.+||+.||.+|||+.++++.|+++......+
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999999999999998765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=289.49 Aligned_cols=217 Identities=19% Similarity=0.309 Sum_probs=178.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec--
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-- 95 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-- 95 (317)
...++|++.++||+|+||.||+|.+. ++.||||++.... ...+.+|+.++++++ ||||+++++++.+
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 44578999999999999999999874 8899999987543 235889999999997 9999999999975
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...++||||+.+++|.+++.. +++..++.++.|++.||+|||++||+||||||+|||++.+...+||+|||+++
T Consensus 105 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 105 SRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 368999999999999998854 89999999999999999999999999999999999999774489999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC--------CCC------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------------ 216 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------------ 216 (317)
............|+..|+|||++.+........++|+.+ ...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred EcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 665554555668999999999876533222222222221 000
Q ss_pred ---------------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 ---------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.+||.+||+.||.+|||++++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112268999999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.40 Aligned_cols=233 Identities=23% Similarity=0.330 Sum_probs=184.3
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|++.++||+|+||.||+|++. ++.||||++....... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR----PVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS----CHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc----hHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 345689999999999999999999986 8999999997543222 234578899999999999999999998643
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe----eCCCCceEEcc
Q 021127 97 --VMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKTIKLAD 169 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill----~~~~~~~kl~D 169 (317)
..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||+|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~D 159 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTD 159 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECC
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEec
Confidence 67999999999999999976432 238999999999999999999999999999999999998 555 5799999
Q ss_pred cCcccccccccccccccCccceeccccccccc-------ccccccccccCC-----------------------------
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVT-------LRQGEKKHYNHK----------------------------- 213 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~~~~~~~----------------------------- 213 (317)
||+++............||+.|+|||++.+.. ......++|+.+
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp GGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred CCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 99998765555555667999999999875310 001111111111
Q ss_pred -----------------------CCCCC----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 214 -----------------------NVRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 214 -----------------------~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
...+. ...++..+.+++.+||+.||++||+++++++.+.+++..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00011 123467789999999999999999999999999998864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=292.91 Aligned_cols=224 Identities=25% Similarity=0.384 Sum_probs=183.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCC---hHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET---PEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 96 (317)
++|.+.+.||+|+||.||+|.+. |+.||||++..... ..........+.+|+.+++++ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999985 89999999986542 233344466788999999999 899999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++||||+++++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||+++.+ +.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCccccc
Confidence 89999999999999999987544 9999999999999999999999999999999999999988 79999999999866
Q ss_pred ccccccccccCccceeccccccccc-----ccccccccccCC----------------------------CCC---CCCC
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVT-----LRQGEKKHYNHK----------------------------NVR---PSAE 220 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~~~----------------------------~~~---~~~~ 220 (317)
..........||+.|+|||++.+.. ......++|+.+ ... +...
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 5554555678999999999876321 111222333222 000 0124
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++..+.+||.+||+.||.+|||+.+++++
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 567889999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=290.60 Aligned_cols=225 Identities=25% Similarity=0.339 Sum_probs=175.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChH---HHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecCce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLVKFIGACKEPVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 98 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... ........+.+|+.++++++||||+++++++..+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 68999999999999999999885 7899999987643211 111223457899999999999999999999988889
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREE 176 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~ 176 (317)
++||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+. ..+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 999999999999999976443 99999999999999999999999999999999999998652 24999999999866
Q ss_pred ccccccccccCccceeccccccc--ccccccccccccCC-----------------------------CCCC---CCCCC
Q 021127 177 SLTEMMTAETGTYRWMAPELYST--VTLRQGEKKHYNHK-----------------------------NVRP---SAENV 222 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~~-----------------------------~~~~---~~~~~ 222 (317)
..........||+.|+|||++.. ........++|+.+ .... ....+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence 54444445679999999998742 11111122222211 0000 02457
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+..+.+|+.+||+.||.+||++.+++++
T Consensus 248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 248 SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 8899999999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.51 Aligned_cols=229 Identities=25% Similarity=0.332 Sum_probs=174.5
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++...............+.+|+.++++++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 368999999999999999999885 78999999875422111123356789999999999999999999999765 799
Q ss_pred EEEEccCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 021127 100 IVTELLSGGTLRKYLLNMR--------------------------------------PRCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~i~~~L~~l 141 (317)
+||||+++|+|.+++.... ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 11246788899999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCC-CceEEcccCccccccccc-----ccccccCccceecccccccc-cccccccccccCC-
Q 021127 142 HSHGIIHRDLKPENLLLTEDL-KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK- 213 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~-~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~- 213 (317)
|++||+||||||+||+++.+. ..+||+|||+++...... ......||+.|+|||++.+. .......++|+.+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998652 279999999998543211 22455799999999998642 1112223333222
Q ss_pred ---------------------------C---CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ---------------------------N---VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ---------------------------~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
. ..+....++..+.+||.+||+.||.+||++.+++++-
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 0 0111224788999999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.78 Aligned_cols=221 Identities=27% Similarity=0.373 Sum_probs=170.8
Q ss_pred CCceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-c
Q 021127 23 PKHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-V 97 (317)
Q Consensus 23 ~~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 97 (317)
.+.|++. +.||+|+||.||+|.+. ++.||||++....... ..++.+|+.++.++ +||||+++++++.++ .
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-----RSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC-----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh-----HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3678884 78999999999999874 8999999998654322 34688999999985 799999999999765 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC--ceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~--~~kl~Dfg~a~~ 175 (317)
.++||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.+.. .+||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999999987654 999999999999999999999999999999999999987621 399999999875
Q ss_pred cccc--------cccccccCccceecccccccc----cccccccccccCC--------C---------------------
Q 021127 176 ESLT--------EMMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK--------N--------------------- 214 (317)
Q Consensus 176 ~~~~--------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~--------~--------------------- 214 (317)
.... ......+||+.|+|||++... .......++|+.+ .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 4321 112234699999999987641 1111122222211 0
Q ss_pred -------------CCCC----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 -------------VRPS----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 -------------~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.... ...++.++.+||.+||+.||.+|||+.+++++
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001 13578899999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.82 Aligned_cols=229 Identities=26% Similarity=0.379 Sum_probs=179.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+....++|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK---MVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch---HHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 45556789999999999999999999986 8899999997665443 234567899999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..++||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~ 172 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFAR 172 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC-
T ss_pred CCEEEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCce
Confidence 5 78999999999988887765443 9999999999999999999999999999999999999988 699999999997
Q ss_pred cccc-ccccccccCccceecccccccccccccccccccCC--------C-------------------------------
Q 021127 175 EESL-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------- 214 (317)
Q Consensus 175 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------- 214 (317)
.... ........||+.|+|||++.+........++|+.+ .
T Consensus 173 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 173 TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred eecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 5433 22334557899999999876532222222222211 0
Q ss_pred ---------CCC----------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 ---------VRP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 ---------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
..+ ....++..+.+||.+||+.||.+|||+.+++++-+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000 01357889999999999999999999999998744
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.66 Aligned_cols=222 Identities=27% Similarity=0.402 Sum_probs=162.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|++. ++.||||++....... .....++.+|+.++++++||||+++++++.+. ..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK--AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh--hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 57999999999999999999974 8999999987532111 11235688999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCCC
Confidence 999999999999998643 348999999999999999999999999999999999999988 78999999999865422
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTS 232 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~ 232 (317)
.......||+.|+|||++.+..... ..+.|+.+ .....+..++.++.+||.+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence 2223457899999999876533221 11221111 0112345678999999999
Q ss_pred hhhcCCCCCCCHHHHHHH
Q 021127 233 CWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 233 cl~~~p~~Rps~~~~~~~ 250 (317)
||+.||.+|||+.+++++
T Consensus 246 ~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HSCSSGGGSCCHHHHTTS
T ss_pred HcccCHhhCCCHHHHhcC
Confidence 999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.23 Aligned_cols=223 Identities=27% Similarity=0.461 Sum_probs=179.5
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-- 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 95 (317)
..+...|.+.+.||+|+||.||+|.+. +..||+|++....... .....+.+|+.++++++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH---HHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 345567899999999999999999886 7889999998655433 335678999999999999999999998753
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCceEEccc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
...++||||+++++|.+++..... +++..++.++.|++.||+|||++| |+||||||+||+++.+.+.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 368999999999999999987654 899999999999999999999999 9999999999999843379999999
Q ss_pred CcccccccccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCC
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAE 220 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~ 220 (317)
|++...... ......||+.|+|||++.+. .....+.|+.+ .....+.
T Consensus 177 g~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 177 GLATLKRAS-FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253 (290)
T ss_dssp TGGGGCCTT-SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred CCccccccc-ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCC
Confidence 999754332 23445799999999987642 12222222221 0011133
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+.++.+||.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 456889999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=285.32 Aligned_cols=235 Identities=29% Similarity=0.513 Sum_probs=177.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC---C--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK---N--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
...+..++|++.+.||+|+||.||+|++. + ..||||++....... ....+.+.+|+.++++++||||++++++
T Consensus 12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ--PEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 45778899999999999999999999863 2 368999987653222 2345678999999999999999999999
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.++..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 90 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~ 167 (291)
T 1u46_A 90 VLTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGL 167 (291)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTT
T ss_pred EccCCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccc
Confidence 98888999999999999999998643 238999999999999999999999999999999999999988 6999999999
Q ss_pred cccccccc----ccccccCccceecccccccccccc-----------------ccccccc------------CCCCCCCC
Q 021127 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN------------HKNVRPSA 219 (317)
Q Consensus 173 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~------------~~~~~~~~ 219 (317)
+....... ......++..|+|||++.+..... +..++.. .....+.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence 97553322 122345788999999875432211 1111100 11223345
Q ss_pred CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
..++.++.+++.+||+.||.+|||+.+++++|.+...
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 6789999999999999999999999999999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=286.65 Aligned_cols=227 Identities=27% Similarity=0.417 Sum_probs=178.7
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTE 103 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 103 (317)
.|..++.||+|+||.||+|.++++.||||++........ ....+.+.+|+.++++++||||+++++++.+. ..++|||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT-TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcch-HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 344568999999999999999999999999875432110 12345688999999999999999999999765 8999999
Q ss_pred ccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---
Q 021127 104 LLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT--- 179 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~--- 179 (317)
|+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSSC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeeccccccccccccc
Confidence 999999999997532 3359999999999999999999999999999999999999988 79999999999754322
Q ss_pred cccccccCccceecccccccccccccccccccCC------------------------------------------CCCC
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------NVRP 217 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------~~~~ 217 (317)
.......||+.|+|||++.+.. ....+.|+.+ ....
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTEE--CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCCC--CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 1223457899999999876521 1111222111 0011
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
.+...+..+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 12234577999999999999999999999999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=283.43 Aligned_cols=220 Identities=26% Similarity=0.364 Sum_probs=179.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT----HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh----hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 57999999999999999999885 8899999997654332 234688999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCc
Confidence 999999999999987543 39999999999999999999999999999999999999988 78999999999754322
Q ss_pred --cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
.......|++.|+|||++.+........++|+.+ ........++..+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 2234457899999999987644322223333221 01112245788999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+|+.+||+.||.+|||+.+++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHCCCCchhCCCHHHHhcC
Confidence 99999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.13 Aligned_cols=217 Identities=24% Similarity=0.354 Sum_probs=170.7
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
.+.||+|+||.||+|.+. ++.||+|++..... .....+.+|+.++++++||||+++++++.+. ..++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 678999999999999885 88999999986542 2345688999999999999999999999765 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCccccccccccccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLTEMMTA 184 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~~~~~~ 184 (317)
++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.. +.+.+||+|||+++..........
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999999987543 23899999999999999999999999999999999999942 226899999999987655544555
Q ss_pred ccCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHHHHHHHh
Q 021127 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELSIILTSC 233 (317)
Q Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~~li~~c 233 (317)
..||+.|+|||++.+..... ..++|+.+ . .......++.++.+||.+|
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred ccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 67999999999876532221 11222211 0 0111246789999999999
Q ss_pred hhcCCCCCCCHHHHHHHHH
Q 021127 234 WKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 234 l~~~p~~Rps~~~~~~~l~ 252 (317)
|+.||.+|||+.+++++-+
T Consensus 327 L~~dp~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 327 LIKEKSWRISASEALKHPW 345 (373)
T ss_dssp SCSSGGGSCCHHHHHHSHH
T ss_pred cCCChhhCCCHHHHhcCcC
Confidence 9999999999999999743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=295.37 Aligned_cols=230 Identities=29% Similarity=0.434 Sum_probs=180.8
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
.+.+..++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG----GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch----HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 44567789999999999999999999875 8899999987654321 123588999999999999999999999765
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEeeCCCCceEEccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRP--RCLDVCVAIGFALDIARAMECLHSH---GIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ ||+||||||+||+++.+ +.+||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Df 178 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 178 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccC
Confidence 78999999999999999986543 3499999999999999999999999 99999999999999988 69999999
Q ss_pred Ccccccccc--cccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 171 GLAREESLT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 171 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
|+++..... .......||+.|+|||++.+..... ..++|+.+
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECH-HHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCc-cccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999854322 2233456999999999875432211 11111110
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
.........+..+.+++.+||+.||.+|||+.+++++|+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0001112234789999999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.91 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=178.1
Q ss_pred CCCccccccceecCCceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh
Q 021127 3 SRSRFYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80 (317)
Q Consensus 3 ~~s~~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 80 (317)
+.|+....++++.. ......++|++.+.||+|+||.||+|++ +++.||||++...... ...+.+|+.++++
T Consensus 4 ~~~~~~~~~~~~~~-~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~ 76 (326)
T 2x7f_A 4 SDSPARSLDEIDLS-ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKK 76 (326)
T ss_dssp ------------CC-CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHH
T ss_pred CCCCCCcchhccch-hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHh
Confidence 34444444455443 3345678999999999999999999998 4899999999765432 2357889999999
Q ss_pred c-CCCCeeeEEeeeec-------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 81 V-QHRNLVKFIGACKE-------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 81 l-~h~niv~l~~~~~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
+ +||||+++++++.. ...++||||+++++|.+++.......+++..++.++.||+.||+|||++||+|||||
T Consensus 77 l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlk 156 (326)
T 2x7f_A 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156 (326)
T ss_dssp HCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred ccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 9 89999999999853 478999999999999999987654559999999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccc-cccccccCccceecccccccc----cccccccccccCC--------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK-------------- 213 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~-------------- 213 (317)
|+||+++.+ +.+||+|||++...... .......|++.|+|||++... .......++|+.+
T Consensus 157 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 157 GQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp GGGEEECTT-CCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred HHHEEEcCC-CCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 999999988 78999999999754332 223445789999999998631 1111122222211
Q ss_pred ---------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 ---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 ---------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
........++..+.+||.+||..||.+||++.+++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp TSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred CCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence 11122456789999999999999999999999999873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=289.26 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=181.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||+|++. ++.||||++......... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 67999999999999999999985 889999999875432100 01134588999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC---ceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~~ 176 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+.. .+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSC--EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999986543 999999999999999999999999999999999999998722 7999999999866
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------------CCCCC----CCCChHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS----AENVPEE 225 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~----~~~~~~~ 225 (317)
..........||+.|+|||++.+..... ..+.|+.+ ..... ...++..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CccccccccCCCCCccCcccccCCCCCC-ccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHH
Confidence 5544445567999999999886543321 22222221 00001 2467889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+.+||.+||+.||.+|||+.+++++
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcC
Confidence 9999999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.07 Aligned_cols=226 Identities=26% Similarity=0.393 Sum_probs=179.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--c-Cce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--E-PVM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~-~~~ 98 (317)
++|++.+.||+|+||.||++.+. ++.||||++....... .......+.+|+.++++++||||+++++++. + ...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc-cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 68999999999999999999885 7899999987532111 0123457899999999999999999999984 2 378
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+.++ |.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence 9999999766 8888877656669999999999999999999999999999999999999988 7999999999975432
Q ss_pred ---ccccccccCccceecccccccccc-cccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 179 ---TEMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
........||+.|+|||++.+... .....+.|+.+ .....+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 222334568999999998865322 11122333221 11233567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+|+.+||+.||.+|||+.+++++.+
T Consensus 242 ~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHHccCChhhCCCHHHHhcCcc
Confidence 9999999999999999999999843
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.41 Aligned_cols=227 Identities=16% Similarity=0.248 Sum_probs=174.6
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHH---HHHHhcCCCCeeeEE-
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV---AMLSRVQHRNLVKFI- 90 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~- 90 (317)
..|....++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+.+|+ .++++++||||++++
T Consensus 66 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~ 143 (377)
T 3byv_A 66 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143 (377)
T ss_dssp ESSSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHH
T ss_pred eecCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHh
Confidence 445556789999999999999999999864 8999999998543222 12345688999 555566899999998
Q ss_pred ------eeeecC------------------ceEEEEEccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHH
Q 021127 91 ------GACKEP------------------VMVIVTELLSGGTLRKYLLNMRP-----RCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 91 ------~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~~L~~l 141 (317)
+++.+. ..++||||+ +|+|.+++..... ..+++..++.|+.||+.||+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 555433 378999999 6899999986432 1133588889999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceecccccccc----------ccccccccccc
Q 021127 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV----------TLRQGEKKHYN 211 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~~~~~ 211 (317)
|++||+||||||+|||++.+ +.+||+|||+++.... .....+| +.|+|||++.+. .......++|+
T Consensus 223 H~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 223 HHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp HHTTEECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 99999999999999999988 7999999999985433 2345567 999999998765 11222333333
Q ss_pred CC-----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 212 HK-----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 212 ~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+ ........++.++.+||.+||+.||.+|||+.+++++
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 22 0112235789999999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=288.87 Aligned_cols=234 Identities=21% Similarity=0.268 Sum_probs=186.5
Q ss_pred cCCceeecCCceeecceeccccceEEEEeE-----E--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CC
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGK-----Y--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HR 84 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~-----~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ 84 (317)
....+.+..++|.+.++||+|+||.||+|. . .++.||||++..... ..+..|+.++..++ |+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--------WEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH--------HHHHHHHHHHHHSCGGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh--------hHHHHHHHHHHHhhhhhhh
Confidence 445778888999999999999999999994 2 378999999976532 24677888888886 99
Q ss_pred CeeeEEeeeec-CceEEEEEccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 85 NLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNM---RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 85 niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
||+++++++.. +..++||||+++|+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 99999999875 4899999999999999999753 2345999999999999999999999999999999999999987
Q ss_pred -----------CCCceEEcccCcccccc---cccccccccCccceecccccccccccccccccccCC-------------
Q 021127 161 -----------DLKTIKLADFGLAREES---LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------- 213 (317)
Q Consensus 161 -----------~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------- 213 (317)
+ +.+||+|||+++... ........+||+.|+|||++.+..+. ...++|+.+
T Consensus 208 ~~~~~~~~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 208 GFLEQDDEDDLS-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGTCC------C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCcccccccc-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCcc
Confidence 6 689999999996432 22334556799999999998775432 233333322
Q ss_pred ----------CCCCCCCCChHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHhhhcc
Q 021127 214 ----------NVRPSAENVPEELSIILTSCWKEDPNAR-PNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ----------~~~~~~~~~~~~l~~li~~cl~~~p~~R-ps~~~~~~~l~~~~~~~ 258 (317)
.........++.+.+++..||+.+|.+| |++.++.+.|++++...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 286 VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEEETTEEEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccCCCCceeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011122357889999999999999998 67888888998888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=310.71 Aligned_cols=234 Identities=29% Similarity=0.487 Sum_probs=188.6
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
..|.+..++|++.+.||+|+||.||+|.+. +..||||.+...... .....+.+|+.++++++||||+++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~ 458 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLIG 458 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356788899999999999999999999874 467999998765432 33457899999999999999999999
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
++.++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 459 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG 536 (656)
T 2j0j_A 459 VITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFG 536 (656)
T ss_dssp EECSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCC
T ss_pred EEecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecC
Confidence 998888999999999999999998643 348999999999999999999999999999999999999988 799999999
Q ss_pred cccccccccc--cccccCccceecccccccccccccccccccC-----------------------------CCCCCCCC
Q 021127 172 LAREESLTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAE 220 (317)
Q Consensus 172 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~ 220 (317)
+++....... .....+|+.|+|||++.+..+.. ..++|+. ....+.+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 615 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 615 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCc-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 9986543322 22345678999999875432211 1111111 12234467
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.++..+.+||.+||..||.+|||+.++++.|.+++..
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999988753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.49 Aligned_cols=218 Identities=23% Similarity=0.267 Sum_probs=172.2
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH---HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 578999999999999999999985 8999999997654332 3355788999999999999999999998643
Q ss_pred ---ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 97 ---VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.+++||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecc
Confidence 469999999 89999999763 38999999999999999999999999999999999999998 79999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC----------------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------- 213 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------- 213 (317)
+..... .....+|+.|+|||++.+........++|+.+
T Consensus 176 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 176 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 865432 34567899999999876532222223333221
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++..+.+|+.+||+.||.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0001124568899999999999999999999999997
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=291.72 Aligned_cols=222 Identities=21% Similarity=0.314 Sum_probs=175.7
Q ss_pred Cceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ce
Q 021127 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 24 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 98 (317)
++|.+. +.||+|+||.||+|.+. ++.||||++....... .....+.+|+.++..+ .||||+++++++.+. ..
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ---DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE---ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 567776 88999999999999886 8999999998644322 1234588999999999 569999999999765 79
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC---CCCceEEcccCcccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---DLKTIKLADFGLARE 175 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~ 175 (317)
++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++. + +.+||+|||+++.
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~-~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPL-GDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTB-CCEEECCGGGCEE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCC-CcEEEeeCccccc
Confidence 99999999999999987655556999999999999999999999999999999999999987 4 6899999999987
Q ss_pred cccccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~ 224 (317)
...........||+.|+|||++.+..... ..++|+.+ ........++.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 262 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ 262 (327)
T ss_dssp C---------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCccccccccCCcCccCCeeecCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence 65554445568999999999886543221 12222211 11222456889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+.+||.+||+.||.+|||+++++++
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 99999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=291.35 Aligned_cols=220 Identities=25% Similarity=0.380 Sum_probs=169.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|++. ++.||||++....... ....+.+|+.++++++||||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc----cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 57999999999999999999985 8899999987544221 122356799999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.....
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC----
T ss_pred Eecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCc
Confidence 999996 69999988754 348999999999999999999999999999999999999988 79999999999754422
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCC-----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------------------- 216 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------------------- 216 (317)
.......||+.|+|||++.+........++|+.+ ...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 2234457899999999876533222222322221 000
Q ss_pred --------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 --------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 --------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....++.++.+||.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0023567889999999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=306.70 Aligned_cols=227 Identities=23% Similarity=0.321 Sum_probs=183.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
.+..++|.+.+.||+|+||.||+|++. ++.||||++.+..... ......+.+|+.++++++||||+++++++.+.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK--RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh--hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 356689999999999999999999985 8999999997532211 12235688999999999999999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
..++||||++||+|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~ 337 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAV 337 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceee
Confidence 8999999999999999998654 3459999999999999999999999999999999999999998 799999999998
Q ss_pred ccccccc-cccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCC
Q 021127 175 EESLTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENV 222 (317)
Q Consensus 175 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~ 222 (317)
....... ....+||+.|+|||++.+..+.. ..++|+.+ .....+..+
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~-~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~ 416 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF 416 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred eccCCCcccccccCCccccChhhhcCCCCCh-HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence 6543322 33458999999999987643221 12222211 112335678
Q ss_pred hHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 021127 223 PEELSIILTSCWKEDPNARPNF-----TQIIQM 250 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~-----~~~~~~ 250 (317)
+.++.+||.+||+.||.+||++ +++++|
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 9999999999999999999964 778776
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=296.06 Aligned_cols=228 Identities=23% Similarity=0.311 Sum_probs=180.2
Q ss_pred ecCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
+..++|++.+.||+|+||.||++++ +++.||||++........ ......+.+|+.++.++ +||||+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-hhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 4457999999999999999999987 589999999865321000 01122466799999999 7999999999987
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a 206 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS 206 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCC
Confidence 65 89999999999999999987654 9999999999999999999999999999999999999988 79999999999
Q ss_pred cccccc--cccccccCccceecccccccccc-cccccccccCC-------------------------------CCCCCC
Q 021127 174 REESLT--EMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK-------------------------------NVRPSA 219 (317)
Q Consensus 174 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~-------------------------------~~~~~~ 219 (317)
+..... ......+||+.|+|||++.+... .....++|+.+ ...+.+
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 286 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 286 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC
Confidence 754322 22334579999999999875221 11222222211 122345
Q ss_pred CCChHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHH
Q 021127 220 ENVPEELSIILTSCWKEDPNARP-----NFTQIIQMLL 252 (317)
Q Consensus 220 ~~~~~~l~~li~~cl~~~p~~Rp-----s~~~~~~~l~ 252 (317)
..++..+.+||.+||+.||.+|| ++++++++.+
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 67889999999999999999999 9999998743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=282.36 Aligned_cols=219 Identities=26% Similarity=0.416 Sum_probs=177.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|.+.+.||+|+||.||++++. ++.||||++...... ....+.+|+.++++++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 68999999999999999999985 899999999865432 234588999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe---eCCCCceEEcccCcccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAREES 177 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~~~~ 177 (317)
||||+++++|.+++...+. +++..++.++.|++.||+|||++|++||||||+||++ +.+ +.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQ 160 (304)
T ss_dssp EECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCC
T ss_pred EEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecC
Confidence 9999999999999987654 8999999999999999999999999999999999999 555 689999999997544
Q ss_pred cccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l 226 (317)
.. ......||+.|+|||++.+..... ..+.|+.+ ...+....++.++
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 32 233456899999999986543221 11222111 0112245788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.+||.+||+.||.+|||+.+++++.+
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 99999999999999999999998744
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=285.71 Aligned_cols=225 Identities=26% Similarity=0.376 Sum_probs=175.3
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
.....++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-----ELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-----CHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-----HHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 3445578999999999999999999986 889999998754322 244688999999999999999999998765
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++..
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAK 166 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCCCcc
Confidence 8999999999999999987643 339999999999999999999999999999999999999988 6899999999764
Q ss_pred ccc-ccccccccCccceecccccccc----cccccccccccCC------------------------------CCCCCCC
Q 021127 176 ESL-TEMMTAETGTYRWMAPELYSTV----TLRQGEKKHYNHK------------------------------NVRPSAE 220 (317)
Q Consensus 176 ~~~-~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~~------------------------------~~~~~~~ 220 (317)
... ........||+.|+|||++... .......+.|+.+ .....+.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCcc
Confidence 321 1222345789999999987421 1111122222211 0112245
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.++..+.+|+.+||+.||.+|||+.+++++
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 678899999999999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=282.61 Aligned_cols=219 Identities=26% Similarity=0.359 Sum_probs=172.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
++|++.+.||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE------EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH------HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 57999999999999999999975 8999999996531 334568899999999999999999998743
Q ss_pred --------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 96 --------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 96 --------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl 157 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKI 157 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEE
Confidence 36899999999999999998643 348899999999999999999999999999999999999988 68999
Q ss_pred cccCcccccccc---------------cccccccCccceecccccccccccccccccccCC-------------------
Q 021127 168 ADFGLAREESLT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------- 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------- 213 (317)
+|||++...... .......||+.|+|||++.+........+.|+.+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~~ 237 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHHH
Confidence 999999754321 1223456899999999986532222222332221
Q ss_pred ----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0111244667889999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=287.86 Aligned_cols=219 Identities=26% Similarity=0.290 Sum_probs=176.8
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ....++.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc----HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 468999999999999999999885 889999999764432 334568899999999999999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...++||||+. ++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceE
Confidence 25899999995 6999999763 39999999999999999999999999999999999999988 689999999998
Q ss_pred ccccccc----cccccCccceecccccccccccccccccccCC--------CCCC-------------------------
Q 021127 175 EESLTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP------------------------- 217 (317)
Q Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~------------------------- 217 (317)
....... .....||+.|+|||++.+........++|+.+ ...+
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 5543321 23457999999999865433222222333221 0000
Q ss_pred -------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 -------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 -------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++.++.+||.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 014568899999999999999999999999988
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.43 Aligned_cols=222 Identities=24% Similarity=0.298 Sum_probs=174.4
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.++||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc---cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 478999999999999999999985 8899999987654332 112357789999999999999999999864
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+..++||||++ ++|.+.+..... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg 169 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFG 169 (351)
T ss_dssp ----CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred ccCCceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccch
Confidence 35899999996 588888876433 39999999999999999999999999999999999999988 799999999
Q ss_pred ccccccc-----ccccccccCccceecccccccccccccccccccCC--------CC----------------------C
Q 021127 172 LAREESL-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------R 216 (317)
Q Consensus 172 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------~ 216 (317)
+++.... ........||+.|+|||++.+........++|+.+ .. .
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9975432 12234457899999999886533323333333322 00 0
Q ss_pred C-CCCC----------------------------ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 P-SAEN----------------------------VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 ~-~~~~----------------------------~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .... .++.+.+||.+||+.||.+|||++|+++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 0000 25678999999999999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.97 Aligned_cols=221 Identities=24% Similarity=0.297 Sum_probs=174.2
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-- 95 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-- 95 (317)
.+..++|++.+.||+|+||.||+|.+. ++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~ 73 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTG 73 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecC
Confidence 456789999999999999999999884 899999998755332 3469999999999999999998732
Q ss_pred -------------------------------------CceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHH
Q 021127 96 -------------------------------------PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIAR 136 (317)
Q Consensus 96 -------------------------------------~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~ 136 (317)
...++||||++ ++|.+.+.. .....+++..++.++.||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp ------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 13889999996 588887764 23345999999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC---
Q 021127 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--- 213 (317)
Q Consensus 137 ~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--- 213 (317)
||+|||++||+||||||+||+++.+.+.+||+|||+++............||+.|+|||++.+........++|+.+
T Consensus 153 aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 99999999999999999999998543799999999998665555555668899999999876543222233333221
Q ss_pred -----CCC------------------------------------------------CCCCCChHHHHHHHHHhhhcCCCC
Q 021127 214 -----NVR------------------------------------------------PSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 214 -----~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
... ..+..++.++.+||.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 000 013457889999999999999999
Q ss_pred CCCHHHHHHH
Q 021127 241 RPNFTQIIQM 250 (317)
Q Consensus 241 Rps~~~~~~~ 250 (317)
|||+.|+++|
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.03 Aligned_cols=223 Identities=26% Similarity=0.422 Sum_probs=182.8
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
..+.|++.+.||+|+||.||+|.+. ++.||||++....... ....+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED----EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST----THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH----HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 3467999999999999999999875 8899999998665432 244688999999999999999999998754 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCc
Confidence 999999999999999865 239999999999999999999999999999999999999988 7899999999976543
Q ss_pred cc-ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCCChHHHHHH
Q 021127 179 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~l 229 (317)
.. ......|++.|+|||++.+..... ..+.|+.+ .....+..++..+.+|
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 250 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF 250 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence 32 234457899999999986543322 12222211 1122345788999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+.+||+.||.+|||+.+++++.+-
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHcCCChhhCcCHHHHhhChhh
Confidence 999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=288.71 Aligned_cols=229 Identities=25% Similarity=0.426 Sum_probs=162.2
Q ss_pred CceeecCCceeecceeccccceEEEEeEE--CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.+..++|++.+.||+|+||.||+|.+ +++.||||++...... .....+.+|+.++++++||||+++++++.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEE
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc----hhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 35789999999999999999999999987 4889999998754332 23456889999999999999999999987
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEE
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNM------RPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
.. ..++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl 162 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQI 162 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEE
Confidence 54 899999999999999999742 23348999999999999999999999999999999999999988 78999
Q ss_pred cccCcccccccc------cccccccCccceecccccccccccccccccccCC----------------------------
Q 021127 168 ADFGLAREESLT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------- 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------- 213 (317)
+|||++...... .......||+.|+|||++.+........+.|+.+
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 999998754322 1123456899999999875422111111222111
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++.++.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011234678899999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=281.88 Aligned_cols=230 Identities=25% Similarity=0.328 Sum_probs=175.0
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
+..+.......++|++.+.||+|+||.||+|.+. ++.||||.+...... ..+.+|+.++++++||||++++
T Consensus 18 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~ 90 (314)
T 3com_A 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-------QEIIKEISIMQQCDSPHVVKYY 90 (314)
T ss_dssp ------------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC-------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCchhhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH-------HHHHHHHHHHHhCCCCCCccEE
Confidence 3444445567789999999999999999999986 899999999875432 2478899999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
+++.+. ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~d 168 (314)
T 3com_A 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLAD 168 (314)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECC
T ss_pred EEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEee
Confidence 998754 7899999999999999997533 349999999999999999999999999999999999999988 7899999
Q ss_pred cCcccccccc-cccccccCccceecccccccccccccccccccCC------------------------------CCCCC
Q 021127 170 FGLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPS 218 (317)
Q Consensus 170 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~ 218 (317)
||++...... .......|++.|+|||++.+..... ..++|+.+ .....
T Consensus 169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T 3com_A 169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK 247 (314)
T ss_dssp CTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCT-THHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred cccchhhhhhccccCccCCCCCccChhhcCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCC
Confidence 9999754432 2234457899999999876643222 22222221 01112
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+..++..+.+||.+||+.||.+|||+.+++++.+
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~ 281 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 3456889999999999999999999999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.42 Aligned_cols=210 Identities=28% Similarity=0.383 Sum_probs=154.0
Q ss_pred ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecC-ceEEEEEcc
Q 021127 30 PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEP-VMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~ 105 (317)
+.||+|+||.||+|.+. ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+. ..++||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh--------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 78999999999999986 8899999997532 234778999999996 99999999999865 899999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCcccccccc-ccc
Q 021127 106 SGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREESLT-EMM 182 (317)
Q Consensus 106 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~~~~-~~~ 182 (317)
++|+|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+. ..+||+|||+++..... ...
T Consensus 89 ~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 89 NGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999999987544 99999999999999999999999999999999999998652 27999999999854332 233
Q ss_pred ccccCccceecccccccccccccccccccCC----------------------------------CCCCC----CCCChH
Q 021127 183 TAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------NVRPS----AENVPE 224 (317)
Q Consensus 183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------~~~~~----~~~~~~ 224 (317)
...+||+.|+|||++.+..+.. ..++|+.+ ..... ...++.
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp -----------------CCCCH-HHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred cccCCCcCccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 4557899999999986543322 11222211 00000 125789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.+||.+||+.||.+|||+.+++++
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 99999999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=282.45 Aligned_cols=225 Identities=24% Similarity=0.369 Sum_probs=180.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee---cCc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---EPV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---~~~ 97 (317)
.++|++.+.||+|+||.||++.+. ++.||+|++....... ...+.+.+|+.++++++||||+++++++. +..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH---HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH---HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 368999999999999999999985 8899999998765433 33557899999999999999999999874 347
Q ss_pred eEEEEEccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEeeCCCCceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMR--PRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~~-----ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||++| ++||||||+||+++.+ +.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 899999999999999997532 334899999999999999999999999 9999999999999988 68999999
Q ss_pred Cccccccccc-ccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCC
Q 021127 171 GLAREESLTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAEN 221 (317)
Q Consensus 171 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~ 221 (317)
|+++...... ......|++.|+|||++.+..... ..+.|+.+ .....+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 9997543321 223456899999999876533221 11222111 12234567
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
++.++.+++.+||+.||.+||++.+++++++
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 8999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=282.99 Aligned_cols=224 Identities=27% Similarity=0.385 Sum_probs=176.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++.+.||+|+||.||++.+. ++.||+|++......... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999986 889999999865432100 01134688999999999999999999999765 799
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC----ceEEcccCcccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK----TIKLADFGLARE 175 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~----~~kl~Dfg~a~~ 175 (317)
+||||+++++|.+++..... +++..++.++.|++.||+|||++|++||||||+||+++.+ + .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDK-NVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-SSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecC-CCCCCceEEEeccccee
Confidence 99999999999999987554 9999999999999999999999999999999999999876 4 799999999986
Q ss_pred cccccccccccCccceecccccccccccccccccccCC----------------------------CCC---CCCCCChH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVR---PSAENVPE 224 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~---~~~~~~~~ 224 (317)
...........|++.|+|||++.+..... ..+.|+.+ ... .....++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCc-chhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 65444445567999999999876533221 12222211 000 01246788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+.+|+.+||+.||.+|||+.+++++-
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 899999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=288.67 Aligned_cols=225 Identities=16% Similarity=0.193 Sum_probs=179.5
Q ss_pred CCceeecceeccccceEEEEeEEC----------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeee----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK----------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK---- 88 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 88 (317)
.++|++.+.||+|+||.||+|++. ++.||||++.... .+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG----------RLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS----------THHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc----------hHHHHHHHHHHhcccchhhhhhh
Confidence 589999999999999999999874 5789999998652 3778999999999999987
Q ss_pred -----------EEeeee--cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021127 89 -----------FIGACK--EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPEN 155 (317)
Q Consensus 89 -----------l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~N 155 (317)
+++++. +...++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 556654 35889999999 9999999987633459999999999999999999999999999999999
Q ss_pred EEeeCCCC--ceEEcccCcccccccccc--------cccccCccceecccccccccccccccccccCC------------
Q 021127 156 LLLTEDLK--TIKLADFGLAREESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------ 213 (317)
Q Consensus 156 ill~~~~~--~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------ 213 (317)
|+++.+ + .+||+|||+++....... .....||+.|+|||++.+..... ..++|+.+
T Consensus 190 Il~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCC
Confidence 999987 5 899999999975433221 13347899999999876633221 11112111
Q ss_pred --------------------CCC------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 --------------------NVR------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 --------------------~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
... .....++.++.+|+.+||+.||.+|||+.++++.|+.++.....
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 000 00125689999999999999999999999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=286.73 Aligned_cols=229 Identities=17% Similarity=0.234 Sum_probs=173.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHH------HHHHHHHHHHHHHhcCCCCeeeE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAK------KESRFAREVAMLSRVQHRNLVKF 89 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l 89 (317)
+..++|++.+.||+|+||.||+|.+. +..||||++........... ....+.+|+..+..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 45689999999999999999999984 57899999987654321111 12246678899999999999999
Q ss_pred Eeeeec----C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-
Q 021127 90 IGACKE----P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK- 163 (317)
Q Consensus 90 ~~~~~~----~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~- 163 (317)
++++.. . ..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~ 189 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NP 189 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-ST
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CC
Confidence 999864 3 789999999 999999998755 49999999999999999999999999999999999999976 4
Q ss_pred -ceEEcccCccccccccc--------ccccccCccceecccccccccccccccccccCC--------CCC----------
Q 021127 164 -TIKLADFGLAREESLTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------- 216 (317)
Q Consensus 164 -~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------- 216 (317)
.+||+|||+++...... ......||+.|+|||++.+..... ..++|+.+ ...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-RSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 89999999997543221 113457999999999877643221 12222211 000
Q ss_pred -------------C-------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 217 -------------P-------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 217 -------------~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
+ ....++.++.+++.+||+.||.+||++.++++.|+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 0 0126788999999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=279.31 Aligned_cols=228 Identities=22% Similarity=0.328 Sum_probs=182.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee--cCce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK--EPVM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 98 (317)
.++|++.+.||+|+||.||+|++. ++.||||++....... .+.+|+.+++.++|++++..++.+. +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-------HHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-------HHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 478999999999999999999974 8999999987665433 4788999999999888777666653 3478
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee---CCCCceEEcccCcccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT---EDLKTIKLADFGLARE 175 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~---~~~~~~kl~Dfg~a~~ 175 (317)
++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++ .+ +.+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCccc
Confidence 9999999 999999997533 3499999999999999999999999999999999999995 55 6899999999985
Q ss_pred cccccc--------cccccCccceecccccccccccccccccccCC-----------------CC---------------
Q 021127 176 ESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------NV--------------- 215 (317)
Q Consensus 176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------~~--------------- 215 (317)
...... .....||+.|+|||++.+..... ..++|+.+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 443321 23457999999999987643321 22222211 00
Q ss_pred CC---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 216 RP---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 216 ~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
.+ ....+|.++.+|+.+||+.||.+|||+.++++.|+++.......
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00 12567899999999999999999999999999999998765543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=289.20 Aligned_cols=225 Identities=21% Similarity=0.341 Sum_probs=182.1
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
..+..++|++.+.||+|+||.||++.+. ++.||+|++...... .....+.+|+.++++++||||+++++++.++
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP----AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH----HHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 4566789999999999999999999986 889999999876543 3355789999999999999999999998755
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
..++||||+++++|.+++..... +++..+..++.|++.||+|||++ ||+||||||+||+++.+ +.+||+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCc
Confidence 89999999999999999987654 99999999999999999999996 99999999999999988 789999999997
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC-----------------------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------- 213 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------- 213 (317)
..... ......||+.|+|||++.+..+.. ..++|+.+
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTCCCSH-HHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 54322 234457999999999876532211 11111110
Q ss_pred ------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ------------------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
........++.++.+||.+||+.||.+|||+.++++|.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 001112346889999999999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=286.57 Aligned_cols=174 Identities=25% Similarity=0.347 Sum_probs=147.6
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-----CCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----HRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 91 (317)
..+-.++|++.++||+|+||.||+|++. ++.||||++.... .....+..|+.+++.+. ||||+++++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK------KYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH------HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch------hhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 3455689999999999999999999984 8899999987432 23345678999999986 999999999
Q ss_pred eeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC----------
Q 021127 92 ACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE---------- 160 (317)
Q Consensus 92 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~---------- 160 (317)
++... ..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~ 182 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccch
Confidence 98754 899999999 999999998876666999999999999999999999999999999999999974
Q ss_pred --------------CCCceEEcccCcccccccccccccccCccceeccccccccc
Q 021127 161 --------------DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVT 201 (317)
Q Consensus 161 --------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 201 (317)
..+.+||+|||+++.... ......||+.|+|||++.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 235 (360)
T 3llt_A 183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG 235 (360)
T ss_dssp ECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC
T ss_pred hcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC
Confidence 126899999999985433 224567899999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=279.92 Aligned_cols=228 Identities=22% Similarity=0.327 Sum_probs=178.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee-e-cCce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-K-EPVM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~-~~~~ 98 (317)
.++|++.+.||+|+||.||+|++. ++.||||++....... .+.+|+.+++.++|++++..++.+ . +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-------CHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-------HHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 478999999999999999999964 8999999876544322 478899999999988877777666 3 3478
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe---eCCCCceEEcccCcccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLARE 175 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~~ 175 (317)
++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||++ +.+ +.+||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCcccee
Confidence 9999999 999999998543 339999999999999999999999999999999999999 566 6899999999985
Q ss_pred cccccc--------cccccCccceecccccccccccccccccccCC--------CCC-----------------------
Q 021127 176 ESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR----------------------- 216 (317)
Q Consensus 176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~----------------------- 216 (317)
...... .....||+.|+|||++.+..... ..++|+.+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 443221 23457899999999987644322 22222211 000
Q ss_pred -C---CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 217 -P---SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 217 -~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
+ ....+|.++.+|+.+||+.||++|||+.++++.|++++......
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 0 02567899999999999999999999999999999998876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.62 Aligned_cols=221 Identities=26% Similarity=0.318 Sum_probs=166.6
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP--- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 96 (317)
..++|++.+.||+|+||.||+|.+. ++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH---HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCST
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh---HHHHHHHHHHHHHHhcCCCCccceEEeecccccc
Confidence 3478999999999999999999875 8999999998654333 3345688999999999999999999998532
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 ----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 ----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred ccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeec
Confidence 5799999996 588888862 28999999999999999999999999999999999999988 7999999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------CCC----------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------------- 216 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------------- 216 (317)
++............||+.|+|||++.+..+.. ..++|+.+ ...
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 98665444445568999999999987643221 22222211 000
Q ss_pred ------------CC---------------C------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 217 ------------PS---------------A------ENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 217 ------------~~---------------~------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+. + ...+.++.+||.+||+.||.+|||++++++|-+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00 0 001567899999999999999999999999854
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.23 Aligned_cols=221 Identities=25% Similarity=0.392 Sum_probs=179.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.+.||+|+||.||+|++. ++.||||++....... .....+.+|+.++++++||||+++++++.+. ..++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 68999999999999999999985 8899999987543221 1234688999999999999999999999765 8899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC--CceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL--KTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~--~~~kl~Dfg~a~~~~~ 178 (317)
||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.+. ..+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999987654 99999999999999999999999999999999999997542 3699999999986554
Q ss_pred ccccccccCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~ 227 (317)
........|++.|+|||++.+. .....+.|+.+ . ..+....++.++.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CCccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 4444445689999999987653 11112222211 0 0111256789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+++.+||+.||.+|||+.+++++.
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp 278 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHP 278 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHcccChhhCcCHHHHhcCH
Confidence 999999999999999999999873
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=285.22 Aligned_cols=224 Identities=28% Similarity=0.451 Sum_probs=178.6
Q ss_pred CCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh--cCCCCeeeEEeeeecC----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR--VQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---- 96 (317)
.++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|++++.. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG--------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh--------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3689999999999999999999999999999986432 2347788888887 7999999999998653
Q ss_pred -ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCcEEeeCCCCceEE
Q 021127 97 -VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--------SHGIIHRDLKPENLLLTEDLKTIKL 167 (317)
Q Consensus 97 -~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH--------~~~ivH~Dlkp~Nill~~~~~~~kl 167 (317)
..++||||+++|+|.+++... .+++..++.++.|++.||+||| ++||+||||||+||+++.+ +.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEE
Confidence 689999999999999999763 3999999999999999999999 8999999999999999988 69999
Q ss_pred cccCccccccccc-----ccccccCccceecccccccccccc-----cccccccCC------------------------
Q 021127 168 ADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQ-----GEKKHYNHK------------------------ 213 (317)
Q Consensus 168 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~~~~~~~------------------------ 213 (317)
+|||++....... ......||+.|+|||++.+..... ...++|+.+
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999997554332 223457999999999876531100 011111100
Q ss_pred -------------------CCCCC-C-----CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 -------------------NVRPS-A-----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 -------------------~~~~~-~-----~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
...+. + ...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 00111 1 123467999999999999999999999999999987653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.17 Aligned_cols=228 Identities=21% Similarity=0.346 Sum_probs=178.5
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.+.....+|.....||+|+||.||+|.+. ++.||||.+...... ....+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 90 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-----YSQPLHEEIALHKHLKHKNIVQYLGSFSE 90 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH-----HHHHHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence 34455555666669999999999999985 789999999865432 24468899999999999999999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMR-PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
. ..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++...+.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 91 NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 5 8899999999999999998753 2347799999999999999999999999999999999999973379999999999
Q ss_pred cccccc-cccccccCccceecccccccccc-cccccccccCC------------------------------CCCCCCCC
Q 021127 174 REESLT-EMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK------------------------------NVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~------------------------------~~~~~~~~ 221 (317)
+..... .......|++.|+|||++.+... .....++|+.+ .....+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (295)
T 2clq_A 171 KRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES 250 (295)
T ss_dssp EESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTT
T ss_pred cccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccccc
Confidence 754332 22344578999999998764321 11111222111 11233567
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.++.+|+.+||+.||++||++.+++++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999999886
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.19 Aligned_cols=237 Identities=29% Similarity=0.504 Sum_probs=182.9
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
....|.|+.++|++.+.||+|+||.||+|.+.+ .||+|++....... ...+.+.+|+.++++++|+||+++++++.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 446889999999999999999999999999876 48999987543221 11234678999999999999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
+. ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++. +.+||+|||++
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~--~~~~l~Dfg~~ 176 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLF 176 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCC
T ss_pred cCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC--CCEEEeecCCc
Confidence 65 7999999999999999997643 34899999999999999999999999999999999999984 58999999998
Q ss_pred ccccc------ccccccccCccceecccccccccc--------cccccccccCC--------------------------
Q 021127 174 REESL------TEMMTAETGTYRWMAPELYSTVTL--------RQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 174 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~~~~~-------------------------- 213 (317)
+.... ........|++.|+|||++..... .....++|+.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 74321 112233458999999999864211 11122222211
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
........++.++.+|+.+||..||.+|||+.++++.|+.+....
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111123367889999999999999999999999999998877653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=288.61 Aligned_cols=222 Identities=24% Similarity=0.294 Sum_probs=161.3
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.|.+. ++|++.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 99 (367)
T 2fst_X 24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFTP 99 (367)
T ss_dssp EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 45454 78999999999999999999875 8999999997654332 334568899999999999999999999853
Q ss_pred -------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 96 -------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 96 -------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
...++|||++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~ 174 (367)
T 2fst_X 100 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKIL 174 (367)
T ss_dssp CSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred CCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEe
Confidence 3579999999 7899998875 239999999999999999999999999999999999999988 799999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC--------CCC------------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR------------------------ 216 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~------------------------ 216 (317)
|||+++..... .....||+.|+|||++.+........++|+.+ ...
T Consensus 175 DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999864432 34457899999999876532222233333222 000
Q ss_pred --------------------C------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 --------------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 --------------------~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+ .....+..+.+||.+||+.||.+|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 012457889999999999999999999999988
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=291.64 Aligned_cols=228 Identities=13% Similarity=0.131 Sum_probs=163.4
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc--CCCCeeeEE-
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV--QHRNLVKFI- 90 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~- 90 (317)
...|.....+|++.+.||+|+||.||+|.+. ++.||||++....... ......+.+|+.++..+ +||||++++
T Consensus 54 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~~~~l~~~hp~iv~~~~ 131 (371)
T 3q60_A 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS--RSELERLHEATFAAARLLGESPEEARDRR 131 (371)
T ss_dssp EETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH--HHHHHHHHHHHHHHHHHHC----------
T ss_pred EecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc--ccHHHHHHHHHHHHHHhcccChhhhhhce
Confidence 3344445567999999999999999999975 8999999999876533 23455677885555444 699988865
Q ss_pred ------eeeec------------------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHH
Q 021127 91 ------GACKE------------------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVA------IGFALDIARAMEC 140 (317)
Q Consensus 91 ------~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~~i~~~L~~ 140 (317)
+++.. ...++||||++ ++|.+++..... .+++..+ +.++.||+.||+|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 33321 23799999997 899999986432 2455555 7788999999999
Q ss_pred HHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceeccccccc--ccccccccccccCC-----
Q 021127 141 LHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST--VTLRQGEKKHYNHK----- 213 (317)
Q Consensus 141 lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~~----- 213 (317)
||++||+||||||+|||++.+ +.+||+|||+++...... ....+|+.|+|||++.+ ..+. ...++|+.+
T Consensus 210 LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~e 285 (371)
T 3q60_A 210 LQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYR 285 (371)
T ss_dssp HHHTTEEETTCSGGGEEECTT-SCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHH
T ss_pred HHHCCCccCcCCHHHEEECCC-CCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHH
Confidence 999999999999999999988 799999999998654322 24456799999999865 2221 111111111
Q ss_pred -------------------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 214 -------------------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 214 -------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
...+....++..+.+||.+||+.||++|||+.++++|-
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 11122357899999999999999999999999998763
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=291.87 Aligned_cols=218 Identities=24% Similarity=0.289 Sum_probs=171.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----C
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----P 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 96 (317)
.+|++.+.||+|+||.||+|++. ++.||||++..... .+.+|+++++.++||||+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 47999999999999999999985 89999999875432 13469999999999999999998742 1
Q ss_pred --ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 97 --VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 97 --~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
..++||||+++ +|.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 36799999964 77776653 23345999999999999999999999999999999999999997646789999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------C------------------------------
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N------------------------------ 214 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~------------------------------ 214 (317)
++............||+.|+|||++.+........++|+.+ .
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 98655444445568899999999876532222222222211 0
Q ss_pred --------CCC----------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 215 --------VRP----------SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 215 --------~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
..+ .+..++.++.+||.+||+.||.+|||+.++++|.
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 000 1235678999999999999999999999999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=281.16 Aligned_cols=233 Identities=21% Similarity=0.330 Sum_probs=163.7
Q ss_pred ecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeeEE
Q 021127 14 KLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA-MLSRVQHRNLVKFI 90 (317)
Q Consensus 14 ~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~ 90 (317)
.....|.+..++|++.+.||+|+||.||+|.+. ++.||||++....... ...++..|+. +++.++||||++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 12 SPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK----EQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp CCCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH----HHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred ChHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch----HHHHHHHHHHHHHHcCCCCcEeeee
Confidence 344578899999999999999999999999986 8999999998765433 2334556665 66677999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCce
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLN---MRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~ 165 (317)
+++.+. ..++||||+. ++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+||+++.+ +.+
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~ 165 (327)
T 3aln_A 88 GALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNI 165 (327)
T ss_dssp EEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEE
T ss_pred eEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCE
Confidence 998765 8899999996 588887763 2234599999999999999999999999 99999999999999988 799
Q ss_pred EEcccCcccccccccccccccCccceecccccccc---cccccccccccCC----------------------------C
Q 021127 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTV---TLRQGEKKHYNHK----------------------------N 214 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~~~~----------------------------~ 214 (317)
||+|||+++............||+.|+|||++... .......++|+.+ .
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 166 KLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp EECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred EEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 99999999866544444445799999999998321 0001111111110 0
Q ss_pred CCC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 215 VRP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 215 ~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
..+ ....++..+.+|+.+||+.||.+|||+.+++++.+
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence 001 12357899999999999999999999999998744
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=281.80 Aligned_cols=219 Identities=26% Similarity=0.328 Sum_probs=173.7
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE----- 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 95 (317)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ....++.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP----LFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc----hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 478999999999999999999986 899999999754432 234568899999999999999999998753
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...++||||+. ++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccc
Confidence 46899999995 6999998763 39999999999999999999999999999999999999988 789999999997
Q ss_pred cccccc-----------ccccccCccceecccccccccccccccccccCC--------C---------------------
Q 021127 175 EESLTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------- 214 (317)
Q Consensus 175 ~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------- 214 (317)
...... ......||+.|+|||++.+........++|+.+ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 543221 112346899999999865422111122222111 0
Q ss_pred ------------------------CCC------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ------------------------VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ------------------------~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+ ....++.++.+||.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 023678899999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=281.81 Aligned_cols=221 Identities=24% Similarity=0.313 Sum_probs=174.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.|.+. ++|.+.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 37 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE---IFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred eeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch---hHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 45554 68999999999999999999885 8999999998655433 335578899999999999999999999865
Q ss_pred C-c------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 96 P-V------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 96 ~-~------~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. . .++||||+. ++|.+++.. .+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 113 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~ 186 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKIL 186 (371)
T ss_dssp CSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEEC
T ss_pred cCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEE
Confidence 3 2 399999995 688887742 29999999999999999999999999999999999999988 789999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC--------CCCC-----------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP----------------------- 217 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~----------------------- 217 (317)
|||+++..... .....||+.|+|||++.+........++|+.+ ...+
T Consensus 187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 99999855432 34457899999999887633233333333322 0000
Q ss_pred ---------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
....++..+.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 023568899999999999999999999999988
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.38 Aligned_cols=228 Identities=18% Similarity=0.263 Sum_probs=182.0
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHH------------HHHHHHHHHHHHHHHhcCCCCeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEI------------AKKESRFAREVAMLSRVQHRNLVK 88 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~ 88 (317)
+..++|++.+.||+|+||.||+|.++++.||||++......... ......+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 34579999999999999999999999999999998753211000 000156889999999999999999
Q ss_pred EEeeeecC-ceEEEEEccCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeC
Q 021127 89 FIGACKEP-VMVIVTELLSGGTLRKY------LLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTE 160 (317)
Q Consensus 89 l~~~~~~~-~~~lv~e~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~ 160 (317)
+++++.+. ..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ +|++||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999765 89999999999999998 655334569999999999999999999999 99999999999999998
Q ss_pred CCCceEEcccCcccccccccccccccCccceecccccccc-cccccccccccCC--------------------------
Q 021127 161 DLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV-TLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~~-------------------------- 213 (317)
+ +.+||+|||++...... ......|++.|+|||++.+. .......++|+.+
T Consensus 188 ~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i 265 (348)
T 2pml_X 188 N-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265 (348)
T ss_dssp T-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred C-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 8 69999999999865433 33456799999999998765 2222122322211
Q ss_pred --CCCCCC-------------------CCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 --NVRPSA-------------------ENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 --~~~~~~-------------------~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.....+ ..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111 5688999999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.83 Aligned_cols=238 Identities=24% Similarity=0.326 Sum_probs=182.6
Q ss_pred ccceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhcC--CC
Q 021127 10 ADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRVQ--HR 84 (317)
Q Consensus 10 ~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~--h~ 84 (317)
+..+..........++|++.+.||+|+||.||+|.+. ++.||||++......... .....++.+|+.++++++ |+
T Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~ 108 (320)
T 3a99_A 29 ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108 (320)
T ss_dssp -----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred hhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence 3344445566677889999999999999999999874 899999999764321100 001124677999999996 59
Q ss_pred CeeeEEeeeecC-ceEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCC
Q 021127 85 NLVKFIGACKEP-VMVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDL 162 (317)
Q Consensus 85 niv~l~~~~~~~-~~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~ 162 (317)
||+++++++.++ ..++|||++.+ ++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++.+.
T Consensus 109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence 999999999765 78999999976 899999987654 99999999999999999999999999999999999999443
Q ss_pred CceEEcccCcccccccccccccccCccceecccccccccccccccccccCC---------------------CCCCCCCC
Q 021127 163 KTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------NVRPSAEN 221 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~ 221 (317)
+.+||+|||+++..... ......||+.|+|||++.+........++|+.+ .....+..
T Consensus 187 ~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 265 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265 (320)
T ss_dssp TEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSC
T ss_pred CCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhccccccccc
Confidence 79999999999865433 234457999999999887644433333444332 11223567
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
++.++.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 89999999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=286.18 Aligned_cols=228 Identities=22% Similarity=0.254 Sum_probs=171.1
Q ss_pred eecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChH------HHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE------EIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
....++|++.+.||+|+||.||+|.+. ++.||||++....... ......+++.+|+.++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345689999999999999999999876 8899999986543321 112334678999999999999999999998
Q ss_pred eec------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceE
Q 021127 93 CKE------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166 (317)
Q Consensus 93 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~k 166 (317)
+.. ...++||||+. |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEE
Confidence 832 25899999996 68988887543 349999999999999999999999999999999999999988 6899
Q ss_pred EcccCcccccccccccccccCccceecccccccccccccccccccCC--------CCC----------------------
Q 021127 167 LADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------- 216 (317)
Q Consensus 167 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------- 216 (317)
|+|||+++............||+.|+|||++.+........++|+.+ ...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999998655554555667899999999876532222222322221 000
Q ss_pred -----------------------------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 217 -----------------------------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 217 -----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
......+..+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0123567889999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.90 Aligned_cols=227 Identities=21% Similarity=0.310 Sum_probs=178.9
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeec-Cc
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKE-PV 97 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~-~~ 97 (317)
..++|++.++||+|+||.||+|.+. ++.||||++....... .+.+|+++++.++| +++..+..++.+ ..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-------CHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 3578999999999999999999975 8999999987655433 37789999999977 455555555444 47
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe---eCCCCceEEcccCccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL---TEDLKTIKLADFGLAR 174 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill---~~~~~~~kl~Dfg~a~ 174 (317)
.++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.+ +.+||+|||+++
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~ 154 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK 154 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCE
T ss_pred EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcce
Confidence 89999999 999999998543 349999999999999999999999999999999999999 455 689999999998
Q ss_pred ccccccc--------cccccCccceecccccccccccccccccccCC--------CCC----------------------
Q 021127 175 EESLTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR---------------------- 216 (317)
Q Consensus 175 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~---------------------- 216 (317)
....... .....||+.|+|||++.+..+.. ..++|..+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence 6543221 12557999999999987644322 22222221 000
Q ss_pred -----CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccC
Q 021127 217 -----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259 (317)
Q Consensus 217 -----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~ 259 (317)
.....++.++.+||..||+.||++||++.+|++.|++++....
T Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 234 ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 0125678999999999999999999999999999999876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.94 Aligned_cols=228 Identities=22% Similarity=0.375 Sum_probs=178.6
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGAC 93 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 93 (317)
+...+..++|++.+.||+|+||.||++.+. ++.||||++....... .....+.+|+.++.+++ |+||+++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN---QTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH---HHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc---cchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 456788899999999999999999999886 7889999998655433 33557899999999997 59999999998
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.+. ..++||| +.+++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+++. +.+||+|||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~ 172 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGI 172 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSS
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccc
Confidence 765 7899999 558999999987554 899999999999999999999999999999999999975 5899999999
Q ss_pred cccccccc---ccccccCccceeccccccccc----------ccccccccccCC--------------------------
Q 021127 173 AREESLTE---MMTAETGTYRWMAPELYSTVT----------LRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 173 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----------~~~~~~~~~~~~-------------------------- 213 (317)
++...... ......|++.|+|||++.+.. ......++|+.+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 98643322 123456899999999986421 111112222211
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
.....+...+.++.+|+.+||+.||.+||++.+++++.+
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 112234566889999999999999999999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=278.73 Aligned_cols=223 Identities=27% Similarity=0.389 Sum_probs=175.3
Q ss_pred cCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeee-
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACK- 94 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~- 94 (317)
..++|++.+.||+|+||.||+|++. ++.||||++........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS---CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc---CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 3478999999999999999999883 78999999875432210 011355677777666 8999999999885
Q ss_pred ----c-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 95 ----E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 95 ----~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
. ...++||||+. |+|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~D 163 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLAD 163 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECS
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEec
Confidence 2 37899999996 699999988666669999999999999999999999999999999999999988 7999999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC------------------------------------
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------ 213 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------ 213 (317)
||+++............||+.|+|||++.+..... ..++|+.+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99998665444445667899999999875532211 11111100
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++..+.+|+.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0001134678999999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=276.38 Aligned_cols=223 Identities=22% Similarity=0.256 Sum_probs=170.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee----
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---- 94 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---- 94 (317)
.-.++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-----HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-----HHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 34589999999999999999999986 89999999876532 33556889999999999999999999863
Q ss_pred -----------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC
Q 021127 95 -----------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK 163 (317)
Q Consensus 95 -----------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~ 163 (317)
....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.+.+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 246899999996 699999864 33899999999999999999999999999999999999985436
Q ss_pred ceEEcccCcccccccc----cccccccCccceecccccccccccccccccccCC--------CCC---------------
Q 021127 164 TIKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVR--------------- 216 (317)
Q Consensus 164 ~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~--------------- 216 (317)
.+||+|||+++..... .......++..|+|||++.+........+.|+.+ ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 8999999999864322 1223446789999999875422222222222211 000
Q ss_pred ----------------------------C------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 217 ----------------------------P------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 217 ----------------------------~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+ ....++.++.+||.+||+.||.+|||+.+++++-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 0 02457899999999999999999999999999843
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=288.97 Aligned_cols=184 Identities=23% Similarity=0.309 Sum_probs=148.0
Q ss_pred ccccceecCCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---
Q 021127 8 YLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--- 82 (317)
Q Consensus 8 ~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 82 (317)
+.++.+.......+..++|++.++||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~ 94 (397)
T 1wak_A 21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE------HYTETALDEIRLLKSVRNSD 94 (397)
T ss_dssp -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC------cchHHHHHHHHHHHHHhhcC
Confidence 333444444444555789999999999999999999875 8999999997432 23456889999999985
Q ss_pred -----CCCeeeEEeeee----c-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 021127 83 -----HRNLVKFIGACK----E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDL 151 (317)
Q Consensus 83 -----h~niv~l~~~~~----~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dl 151 (317)
|+||+++++++. + ...++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||
T Consensus 95 ~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDi 173 (397)
T 1wak_A 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDI 173 (397)
T ss_dssp TTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCC
T ss_pred CCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 788999999886 2 3789999999 77888877765545699999999999999999999999 9999999
Q ss_pred CCCcEEeeCCC------------------------------------------------CceEEcccCcccccccccccc
Q 021127 152 KPENLLLTEDL------------------------------------------------KTIKLADFGLAREESLTEMMT 183 (317)
Q Consensus 152 kp~Nill~~~~------------------------------------------------~~~kl~Dfg~a~~~~~~~~~~ 183 (317)
||+|||++.+. ..+||+|||+++..... ..
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~ 251 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FT 251 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SC
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--Cc
Confidence 99999998762 17999999999865432 34
Q ss_pred cccCccceecccccccc
Q 021127 184 AETGTYRWMAPELYSTV 200 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~ 200 (317)
...||+.|+|||++.+.
T Consensus 252 ~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp SCCSCGGGCCHHHHHTS
T ss_pred cCCCCCcccCChhhcCC
Confidence 45799999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.88 Aligned_cols=223 Identities=22% Similarity=0.290 Sum_probs=160.1
Q ss_pred Cceee-cceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee---c
Q 021127 24 KHLFV-GPRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK---E 95 (317)
Q Consensus 24 ~~y~~-~~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---~ 95 (317)
+.|++ +++||+|+||.||+|++. ++.||||++....... .+.+|+.++++++||||+++++++. +
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-------HHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-------HHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 45666 568999999999999864 6789999997655432 4778999999999999999999984 2
Q ss_pred CceEEEEEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe----eCCCCc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMR-------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL----TEDLKT 164 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill----~~~~~~ 164 (317)
...++||||+. ++|.+++.... ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.+ +.
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~ 170 (405)
T 3rgf_A 93 RKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GR 170 (405)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TC
T ss_pred CeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-Cc
Confidence 47999999995 68888876321 1249999999999999999999999999999999999999 444 68
Q ss_pred eEEcccCcccccccc----cccccccCccceecccccccccccccccccccCC--------CCCC---------------
Q 021127 165 IKLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP--------------- 217 (317)
Q Consensus 165 ~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~--------------- 217 (317)
+||+|||+++..... ......+||+.|+|||++.+........++|+.+ ...+
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999865432 2234457899999999887633222223333221 0000
Q ss_pred ---------------------------------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHH
Q 021127 218 ---------------------------------------------------SAENVPEELSIILTSCWKEDPNARPNFTQ 246 (317)
Q Consensus 218 ---------------------------------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 246 (317)
.....+..+.+||.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 00112567889999999999999999999
Q ss_pred HHHHHHHhhhc
Q 021127 247 IIQMLLNYLSA 257 (317)
Q Consensus 247 ~~~~l~~~~~~ 257 (317)
+++| .++..
T Consensus 331 ~L~h--p~f~~ 339 (405)
T 3rgf_A 331 AMQD--PYFLE 339 (405)
T ss_dssp HHTS--GGGTS
T ss_pred HhcC--hhhcc
Confidence 9998 44443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=286.02 Aligned_cols=219 Identities=23% Similarity=0.267 Sum_probs=170.4
Q ss_pred cCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC----
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP---- 96 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 96 (317)
...+|++.+.||+|+||.||+|++. +..||+|.+...... ..+|+.+++.++||||+++++++...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 3467999999999999999999985 566899988654322 23699999999999999999998421
Q ss_pred ---ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 97 ---VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 97 ---~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
..++||||+++ ++...+.. .....+++..++.++.||+.||+|||++||+||||||+|||++...+.+||+|||
T Consensus 109 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 37899999966 44444432 1234599999999999999999999999999999999999999433799999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------CC----------------------------
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV---------------------------- 215 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~---------------------------- 215 (317)
+++............||+.|+|||++.+........++|+.+ ..
T Consensus 188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998765554555668899999999876533222233333222 00
Q ss_pred --------------C------CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 --------------R------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 --------------~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ..+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 0123478899999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.23 Aligned_cols=169 Identities=25% Similarity=0.345 Sum_probs=142.7
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc------CCCCeeeEEeee
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV------QHRNLVKFIGAC 93 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~ 93 (317)
...+|++.++||+|+||.||+|.+. ++.||||++.... .....+.+|+.++..+ +|+||+++++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK------RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc------chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 3467999999999999999999886 7999999997532 2234567788888777 577999999998
Q ss_pred ec-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCc--eEEccc
Q 021127 94 KE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKT--IKLADF 170 (317)
Q Consensus 94 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~--~kl~Df 170 (317)
.. ...++||||+ +++|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+ +. +||+||
T Consensus 169 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DF 246 (429)
T 3kvw_A 169 TFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDF 246 (429)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCC
T ss_pred ccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeec
Confidence 75 4899999999 5799999988766669999999999999999999999999999999999999987 45 999999
Q ss_pred CcccccccccccccccCccceecccccccc
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
|+++..... .....||+.|+|||++.+.
T Consensus 247 G~a~~~~~~--~~~~~gt~~y~aPE~~~~~ 274 (429)
T 3kvw_A 247 GSSCYEHQR--VYTYIQSRFYRAPEVILGA 274 (429)
T ss_dssp TTCEETTCC--CCSSCSCGGGCCHHHHHTB
T ss_pred ccceecCCc--ccccCCCCCccChHHHhCC
Confidence 999754332 3345799999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=282.15 Aligned_cols=229 Identities=24% Similarity=0.270 Sum_probs=166.3
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
....++|++.+.||+|+||.||+|++. ++.||||++....... .++.+++..+..++||||+++++++...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 344578999999999999999999986 8899999986643322 2356788888899999999999998431
Q ss_pred -------ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEeeCCCCce
Q 021127 97 -------VMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTEDLKTI 165 (317)
Q Consensus 97 -------~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~ivH~Dlkp~Nill~~~~~~~ 165 (317)
..++||||+++ +|...+.. .....+++..+..++.|++.||.||| ++||+||||||+|||++...+.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 27899999965 66555543 23344899999999999999999999 99999999999999999733799
Q ss_pred EEcccCcccccccccccccccCccceecccccccccccccccccccCC--------C-----------------------
Q 021127 166 KLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N----------------------- 214 (317)
Q Consensus 166 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~----------------------- 214 (317)
||+|||+++............||+.|+|||++.+........++|+.+ .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 999999998766555555667899999999875533222222333221 0
Q ss_pred ----------------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 215 ----------------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 215 ----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
........+.++.+||.+||+.||.+|||+.++++| .++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~ 320 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH--PYFDE 320 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS--GGGGG
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC--ccccc
Confidence 001122357889999999999999999999999987 44443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=280.80 Aligned_cols=228 Identities=23% Similarity=0.322 Sum_probs=176.1
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHH-HHHHHHHHHHHHHHHhc----CCCCeeeEEe
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEI-AKKESRFAREVAMLSRV----QHRNLVKFIG 91 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~-~~~~~~~~~E~~~l~~l----~h~niv~l~~ 91 (317)
...-.++|++.+.||+|+||.||+|.+. ++.||||++......... ......+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445688999999999999999999884 889999999765432210 11233466799999998 8999999999
Q ss_pred eeecC-ceEEEEEc-cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee-CCCCceEEc
Q 021127 92 ACKEP-VMVIVTEL-LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT-EDLKTIKLA 168 (317)
Q Consensus 92 ~~~~~-~~~lv~e~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~-~~~~~~kl~ 168 (317)
++.+. ..++|||+ +.+++|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++ .+ +.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR-GCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTT-TEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCC-CeEEEE
Confidence 98654 78999999 789999999987654 99999999999999999999999999999999999999 55 799999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC---------------------CCCCCCCCChHHHH
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------NVRPSAENVPEELS 227 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~ 227 (317)
|||+++..... ......|+..|+|||++.+........++|+.+ .....+..++..+.
T Consensus 183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 261 (312)
T 2iwi_A 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCC 261 (312)
T ss_dssp CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHH
T ss_pred EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHH
Confidence 99999865433 234557899999999886544433333444332 11223567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+||.+||+.||++|||+.+++++
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=293.15 Aligned_cols=228 Identities=22% Similarity=0.327 Sum_probs=168.1
Q ss_pred eecCCceeecCCceeecceeccccceE-EEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAK-VYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFI 90 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~-V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 90 (317)
-.....+.+...+|.+.+.||+|+||+ ||++..+++.||||++...... .+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--------~~~~E~~~l~~l~~HpnIv~l~ 84 (432)
T 3p23_A 13 DEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--------FADREVQLLRESDEHPNVIRYF 84 (432)
T ss_dssp -----CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--------ECHHHHHHHHHSCCCTTBCCEE
T ss_pred cccCCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--------HHHHHHHHHHhccCCCCcCeEE
Confidence 334556888889999999999999998 5566667999999998764432 256799999999 899999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC----CCce
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTI 165 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~----~~~~ 165 (317)
+++.+. ..++|||||. |+|.+++..... .+.+..++.++.||+.||+|||++||+||||||+|||++.+ ...+
T Consensus 85 ~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 999765 7899999995 699999986543 25556678899999999999999999999999999999532 1257
Q ss_pred EEcccCcccccccc----cccccccCccceeccccccccc--ccccccccccCC---------C----------------
Q 021127 166 KLADFGLAREESLT----EMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK---------N---------------- 214 (317)
Q Consensus 166 kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~---------~---------------- 214 (317)
||+|||+++..... .......||+.|+|||++.+.. ......++|+.+ .
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~ 242 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence 89999999865432 2234457999999999986421 111122222211 0
Q ss_pred ------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 ------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+..+.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000112235668999999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=277.04 Aligned_cols=231 Identities=20% Similarity=0.344 Sum_probs=164.8
Q ss_pred CCceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 16 ~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
...|.+..++|++.+.||+|+||.||+|.+. ++.||||++........ ....+.++..+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE---NKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH---HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH---HHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 3467788899999999999999999999985 89999999987655432 223344555677888999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccC
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
.++ ..++||||+ ++.+..+.... ...+++..++.++.|++.||.|||++ |++||||||+||+++.+ +.+||+|||
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg 170 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFG 170 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCT
T ss_pred ecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECC
Confidence 765 899999999 55665555442 33499999999999999999999996 99999999999999988 799999999
Q ss_pred cccccccccccccccCccceeccccccccc----ccccccccccCC-------------------------------CCC
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVT----LRQGEKKHYNHK-------------------------------NVR 216 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~~~~~-------------------------------~~~ 216 (317)
++.............||+.|+|||++.... ......++|+.+ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250 (318)
T ss_dssp TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC
T ss_pred CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC
Confidence 997655444445567999999999985311 111112222111 111
Q ss_pred CCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 217 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
+....++.++.+||.+||+.||.+||++.+++++.+
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence 223457899999999999999999999999998743
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=276.37 Aligned_cols=221 Identities=25% Similarity=0.346 Sum_probs=155.4
Q ss_pred ecCCceeecc-eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHH-HHHHhcCCCCeeeEEeeeec-
Q 021127 21 IDPKHLFVGP-RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV-AMLSRVQHRNLVKFIGACKE- 95 (317)
Q Consensus 21 i~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~- 95 (317)
.-.++|++.+ .||+|+||.||+|.+. ++.||||++.... . ..+|+ ..++.+.||||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~----~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------K----ARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------H----HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------H----HHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3446788855 6999999999999986 8999999987531 1 12222 33566799999999999854
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcc
Q 021127 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLAD 169 (317)
Q Consensus 96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~D 169 (317)
...++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 258999999999999999988765669999999999999999999999999999999999999853 24699999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------------C
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------------N 214 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------------~ 214 (317)
||+++..... ......||+.|+|||++.+..+.. ..++|+.+ .
T Consensus 175 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 175 FGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CTTCEEC-----------------------CHHHH-HHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred cccceecccc-ccccCCCCcCccChhhhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999865432 234457899999999875432211 11111100 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
..+....++.++.+||.+||+.||.+|||+.+++++.+-
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 111224689999999999999999999999999998553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=279.02 Aligned_cols=221 Identities=24% Similarity=0.330 Sum_probs=173.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
.|.+ +++|.+.+.||+|+||.||+|.+. ++.||||++....... ....++.+|+.+++.++||||+++++++..
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE---IFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch---HHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 3444 368999999999999999999885 8999999997654433 335568899999999999999999999865
Q ss_pred C-------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 96 P-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 96 ~-------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. ..++||||+. ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+
T Consensus 95 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~ 168 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKIL 168 (353)
T ss_dssp CSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEEC
T ss_pred ccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEe
Confidence 3 2599999996 688877642 38999999999999999999999999999999999999988 789999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC-----------------------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------- 213 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------- 213 (317)
|||+++..... .....||+.|+|||++.+........++|+.+
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99999864432 23457899999999876522222222222211
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++.++.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011134678999999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=272.50 Aligned_cols=221 Identities=23% Similarity=0.278 Sum_probs=174.5
Q ss_pred eecCCceeecceeccccceEEEEeEE---CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC------CeeeEE
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKY---KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR------NLVKFI 90 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~ 90 (317)
.+-.++|++.+.||+|+||.||+|.+ +++.||||++.... .....+.+|+.+++.++|+ ++++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD------RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH------HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC------chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 34568999999999999999999987 37899999987432 2344678899999888655 499999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--------
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-------- 161 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-------- 161 (317)
+++.+. ..++||||+ +++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 998754 899999999 8999999988765569999999999999999999999999999999999999862
Q ss_pred ----------CCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC--------CC--------
Q 021127 162 ----------LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------- 215 (317)
Q Consensus 162 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------- 215 (317)
.+.+||+|||+++.... ......||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQ-PCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 25799999999986432 224457899999999876533221 12222211 00
Q ss_pred -------------------------------------------------------CCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 216 -------------------------------------------------------RPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 216 -------------------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
.......+.++.+||.+||+.||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 0011223577899999999999999
Q ss_pred CCCHHHHHHH
Q 021127 241 RPNFTQIIQM 250 (317)
Q Consensus 241 Rps~~~~~~~ 250 (317)
|||+.+++++
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999887
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=276.30 Aligned_cols=221 Identities=23% Similarity=0.316 Sum_probs=175.1
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-----------CCCe
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----------HRNL 86 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ni 86 (317)
.+..++|++.+.||+|+||.||+|++. ++.||||++.... .....+.+|+.++++++ |+||
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK------VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc------cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 456689999999999999999999974 8999999987432 22345788999988886 8999
Q ss_pred eeEEeeeecC-----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeC
Q 021127 87 VKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTE 160 (317)
Q Consensus 87 v~l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~ 160 (317)
+++++++... ..++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 9999998632 689999999 99999999886666699999999999999999999998 9999999999999963
Q ss_pred C-----CCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC--------CC------------
Q 021127 161 D-----LKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV------------ 215 (317)
Q Consensus 161 ~-----~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~------------ 215 (317)
+ .+.+||+|||+++..... .....||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 2 137999999999865432 34457899999999876543221 11222111 00
Q ss_pred -------------------------------------------------------CCCCCCChHHHHHHHHHhhhcCCCC
Q 021127 216 -------------------------------------------------------RPSAENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 216 -------------------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~ 240 (317)
...+..++.++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 0112234678899999999999999
Q ss_pred CCCHHHHHHH
Q 021127 241 RPNFTQIIQM 250 (317)
Q Consensus 241 Rps~~~~~~~ 250 (317)
|||+.++++|
T Consensus 325 Rpt~~ell~h 334 (373)
T 1q8y_A 325 RADAGGLVNH 334 (373)
T ss_dssp CBCHHHHHTC
T ss_pred cCCHHHHhhC
Confidence 9999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=278.76 Aligned_cols=215 Identities=17% Similarity=0.201 Sum_probs=165.3
Q ss_pred ecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChH---HHHHHHHHHHHHHHHHHhcC---------CCCeee
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQ---------HRNLVK 88 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~---------h~niv~ 88 (317)
+..++|++.++||+|+||+||+|+++++.||||++....... ........+.+|+.+++.++ |+||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 556889999999999999999999999999999998764210 00011245778888888875 888887
Q ss_pred EEeeee-------------------------------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q 021127 89 FIGACK-------------------------------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137 (317)
Q Consensus 89 l~~~~~-------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~ 137 (317)
+.+++. +...++||||+++|++.+.+.+ ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 777542 4589999999999987776644 338999999999999999
Q ss_pred HHHHH-hCCccccCCCCCcEEeeCCCC--------------------ceEEcccCcccccccccccccccCccceecccc
Q 021127 138 MECLH-SHGIIHRDLKPENLLLTEDLK--------------------TIKLADFGLAREESLTEMMTAETGTYRWMAPEL 196 (317)
Q Consensus 138 L~~lH-~~~ivH~Dlkp~Nill~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~ 196 (317)
|+||| ++||+||||||+|||++.+ + .+||+|||+|+..... ..+||+.|+|||+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhh
Confidence 99999 9999999999999999987 4 8999999999865432 3479999999999
Q ss_pred cccccccccccccccCC-------------------------------CCCCC-----CCCChHHHHHHHHHhhhcCCCC
Q 021127 197 YSTVTLRQGEKKHYNHK-------------------------------NVRPS-----AENVPEELSIILTSCWKEDPNA 240 (317)
Q Consensus 197 ~~~~~~~~~~~~~~~~~-------------------------------~~~~~-----~~~~~~~l~~li~~cl~~~p~~ 240 (317)
+.+.. ....++|+.. ..... ...+++++.+||.+||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 87643 1122222210 00000 1246788999999999976
Q ss_pred CCCHHHHH-HH
Q 021127 241 RPNFTQII-QM 250 (317)
Q Consensus 241 Rps~~~~~-~~ 250 (317)
|+.|++ +|
T Consensus 324 --sa~e~l~~H 332 (336)
T 2vuw_A 324 --SATDLLCQH 332 (336)
T ss_dssp --SHHHHHHHC
T ss_pred --CHHHHHhcC
Confidence 999998 76
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=268.82 Aligned_cols=170 Identities=25% Similarity=0.327 Sum_probs=142.0
Q ss_pred ecCCceeecceeccccceEEEEeEEC--C-eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC------eeeEEe
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--N-QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN------LVKFIG 91 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~-~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~ 91 (317)
+-.++|++.+.||+|+||.||+|.+. + +.||||++.... .....+.+|+.++++++|++ ++.+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG------KYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH------HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc------cchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 34689999999999999999999885 3 789999997432 23456788999999887655 899999
Q ss_pred eeec-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEe------------
Q 021127 92 ACKE-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLL------------ 158 (317)
Q Consensus 92 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill------------ 158 (317)
++.. +..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 8865 4899999999 7788888877655569999999999999999999999999999999999999
Q ss_pred -------eCCCCceEEcccCcccccccccccccccCccceecccccccc
Q 021127 159 -------TEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 159 -------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
+.+ +.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 169 ~~~~~~~~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 169 KSCEEKSVKN-TSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL 214 (355)
T ss_dssp -CCCEEEESC-CCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC
T ss_pred ccccccccCC-CcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC
Confidence 445 68999999999854332 2445799999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.03 Aligned_cols=221 Identities=25% Similarity=0.307 Sum_probs=172.1
Q ss_pred ecCCceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+..++|++.+.||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++...
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA----EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH----HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH----HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 44589999999999999999999874 789999998765432 3345688999999999999999999998643
Q ss_pred c-----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 97 V-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 97 ~-----~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
. .|+||||++|++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG 226 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLG 226 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecc
Confidence 2 6999999999999987754 39999999999999999999999999999999999999975 79999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC----------------CCCCCCC-----CChHHHHHHH
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------NVRPSAE-----NVPEELSIIL 230 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------~~~~~~~-----~~~~~l~~li 230 (317)
+++..... ....||+.|+|||++.+.. ....++|+.+ .....+. ..+..+.+||
T Consensus 227 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 227 AVSRINSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp TCEETTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHH
T ss_pred cchhcccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHH
Confidence 99865433 4457999999999876532 2233333322 0000111 1246799999
Q ss_pred HHhhhcCCCCCCC-HHHHHHHHHHhhh
Q 021127 231 TSCWKEDPNARPN-FTQIIQMLLNYLS 256 (317)
Q Consensus 231 ~~cl~~~p~~Rps-~~~~~~~l~~~~~ 256 (317)
.+||+.||.+||+ ++++...+...+.
T Consensus 302 ~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 302 RRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred hhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999996 5555555655543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=270.78 Aligned_cols=169 Identities=26% Similarity=0.322 Sum_probs=139.9
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CC-----CeeeEEeeee
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HR-----NLVKFIGACK 94 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~ 94 (317)
.++|++.+.||+|+||+||+|.+. ++.||||++.... .....+..|+.++..++ |+ +|+++++++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK------AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH------HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH------HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 478999999999999999999886 8899999997432 22345677888888874 44 4999999986
Q ss_pred c-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCcEEeeC-CCCceEEccc
Q 021127 95 E-PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH--SHGIIHRDLKPENLLLTE-DLKTIKLADF 170 (317)
Q Consensus 95 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~ivH~Dlkp~Nill~~-~~~~~kl~Df 170 (317)
. +..++||||+. ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++. +.+.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 5 48999999995 69999998866556999999999999999999999 579999999999999964 2267999999
Q ss_pred CcccccccccccccccCccceecccccccc
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
|+++..... .....||+.|+|||++.+.
T Consensus 206 G~a~~~~~~--~~~~~~t~~y~aPE~~~~~ 233 (382)
T 2vx3_A 206 GSSCQLGQR--IYQYIQSRFYRSPEVLLGM 233 (382)
T ss_dssp TTCEETTCC--CCSSCSCGGGCCHHHHTTC
T ss_pred cCceecccc--cccccCCccccChHHHcCC
Confidence 999865432 3456789999999987653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=281.93 Aligned_cols=220 Identities=22% Similarity=0.313 Sum_probs=158.2
Q ss_pred CCceeecceeccccceEEEE-eEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYE-GKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~ 99 (317)
.+.|.+.+.||+|+||+||. +..+++.||||++.... ...+.+|+.+++++ +||||+++++++.++ ..+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 35566788999999999975 44569999999987532 22467899999886 899999999998765 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC------------C
Q 021127 100 IVTELLSGGTLRKYLLNMRPRC-----LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED------------L 162 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~-----l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~------------~ 162 (317)
+|||||. |+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||++.+ .
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999995 69999998654311 1333467899999999999999999999999999999753 1
Q ss_pred CceEEcccCccccccccc-----ccccccCccceeccccccccc------ccccccccccCC---------CC-------
Q 021127 163 KTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVT------LRQGEKKHYNHK---------NV------- 215 (317)
Q Consensus 163 ~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~~~~~~~~---------~~------- 215 (317)
..+||+|||+++...... ......||+.|+|||++.+.. ......++|+.+ ..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 379999999998654322 123457999999999986411 111112222111 00
Q ss_pred ------------CC-----CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 ------------RP-----SAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 ------------~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
.+ ....++.++.+||.+||+.||.+|||+.++++|.
T Consensus 245 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp THHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 00 0113457899999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.25 Aligned_cols=228 Identities=28% Similarity=0.354 Sum_probs=174.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
++|++.++||+|+||.||+|.+. ++.||||++...... .....+.+|+.++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~----~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP----KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH----HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH----HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 78999999999999999999874 899999998765443 335678999999999999999999998643
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC--ceEEcccC
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRP-RCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFG 171 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~--~~kl~Dfg 171 (317)
+..++||||++||+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.+.+ .+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 368999999999999999986442 24899999999999999999999999999999999999997622 38999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
++.............||+.|+|||++.+..+.. ..++|+.+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCST-THHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCc-hhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 998766555555678999999999876532211 11111100
Q ss_pred ---------CCCC----CCCCChHHHHHHHHHhhhcCCCCCCCHHHH-----HHHHHHhhh
Q 021127 214 ---------NVRP----SAENVPEELSIILTSCWKEDPNARPNFTQI-----IQMLLNYLS 256 (317)
Q Consensus 214 ---------~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~~-----~~~l~~~~~ 256 (317)
...+ ....++..+.+||.+||..||.+|||+.++ ++.+.+++.
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0001 122367899999999999999999999884 455555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=257.58 Aligned_cols=220 Identities=25% Similarity=0.331 Sum_probs=160.2
Q ss_pred Cceeec-ceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHH-HhcCCCCeeeEEeeeec----
Q 021127 24 KHLFVG-PRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML-SRVQHRNLVKFIGACKE---- 95 (317)
Q Consensus 24 ~~y~~~-~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~---- 95 (317)
++|.+. +.||+|+||.||++.+. ++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 456666 78999999999999885 889999998642 1356788888 55699999999998864
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 172 (317)
...++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.+ .+.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 378999999999999999998765669999999999999999999999999999999999999972 26899999999
Q ss_pred ccccccccccc-cccCccceecccccccccccccc---------cccccCCCCC-C--CCCCChHHHHHHHHHhhhcCCC
Q 021127 173 AREESLTEMMT-AETGTYRWMAPELYSTVTLRQGE---------KKHYNHKNVR-P--SAENVPEELSIILTSCWKEDPN 239 (317)
Q Consensus 173 a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~---------~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~~p~ 239 (317)
+.......... ...-..+.+.=|++.+....... .......... + ....++.++.+|+.+||+.||.
T Consensus 167 a~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 246 (299)
T 3m2w_A 167 AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPT 246 (299)
T ss_dssp CEECTTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTT
T ss_pred ccccccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChh
Confidence 97543221110 00000000111222211111000 0000000000 0 0156889999999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 021127 240 ARPNFTQIIQMLLN 253 (317)
Q Consensus 240 ~Rps~~~~~~~l~~ 253 (317)
+|||+.++++|.+-
T Consensus 247 ~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 247 QRMTITEFMNHPWI 260 (299)
T ss_dssp TSCCHHHHHTSHHH
T ss_pred hCCCHHHHhcChhh
Confidence 99999999998553
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=253.42 Aligned_cols=225 Identities=12% Similarity=0.103 Sum_probs=167.9
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
+-.++|++.+.||+|+||.||+|++. ++.||||++....... ......+.+|+.++.+++||||+++++++.+. .
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 105 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP--DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG 105 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC--HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc
Confidence 44578999999999999999999986 8999999998765543 23456789999999999999999999999765 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|+||||++|++|.+++... .....+..|+.|++.||+|||++||+||||||+|||++.+ +.+||+++|.....+
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~~~~~~ 180 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPATMPDAN 180 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCCCTTCC
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccccCCCC
Confidence 99999999999999999542 4566789999999999999999999999999999999988 799999887654221
Q ss_pred cccccccccCccceecccccccccccccccc---------cccCCCC--CCCCCCChHHHHHHHHHhhhcCCCCCCCHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKK---------HYNHKNV--RPSAENVPEELSIILTSCWKEDPNARPNFTQ 246 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 246 (317)
... ..-..+.+.=|++.+.....+... ....... ......++.++.+||.+||+.||.+| |+.+
T Consensus 181 ~~~----Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~e 255 (286)
T 3uqc_A 181 PQD----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SAST 255 (286)
T ss_dssp HHH----HHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHH
T ss_pred chh----HHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHH
Confidence 110 000001111122222111111110 0000000 01135789999999999999999999 9999
Q ss_pred HHHHHHHhhhc
Q 021127 247 IIQMLLNYLSA 257 (317)
Q Consensus 247 ~~~~l~~~~~~ 257 (317)
+++.|......
T Consensus 256 l~~~L~~~~~~ 266 (286)
T 3uqc_A 256 LLNLMQQATAV 266 (286)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHhcc
Confidence 99999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=273.62 Aligned_cols=225 Identities=16% Similarity=0.214 Sum_probs=162.2
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCe---------
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNL--------- 86 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni--------- 86 (317)
+.....+|.+.++||+|+||.||+|.+. ++.||||++....... ....+.+.+|+.+++.+.| +|.
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~--~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc--HHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3345556889999999999999999986 8999999988544332 1334568899999999877 221
Q ss_pred ------------eeEEeeee------cCceEEEEEccCCCCHHHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 021127 87 ------------VKFIGACK------EPVMVIVTELLSGGTLRKYLLN-----MRPRCLDVCVAIGFALDIARAMECLHS 143 (317)
Q Consensus 87 ------------v~l~~~~~------~~~~~lv~e~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~~i~~~L~~lH~ 143 (317)
..++.++. ....+++|+++ +++|.+++.. .....+++..++.++.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11111111 12467777776 7899999852 223347888999999999999999999
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCcccccccccccccccCccceecccccccc---------cccccccccccCC-
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV---------TLRQGEKKHYNHK- 213 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~~~~~~~- 213 (317)
+||+||||||+|||++.+ +.+||+|||+++..... ....+| +.|+|||++... .......++|+.+
T Consensus 230 ~~iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TTEECSCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CCcccCCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999998 68999999999865433 345577 999999998321 1111122222221
Q ss_pred ----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+|.++.+||.+||+.||.+||++.+++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111235788999999999999999999998888654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=257.04 Aligned_cols=164 Identities=18% Similarity=0.209 Sum_probs=127.2
Q ss_pred eeccccceEEEEeEE--CCeEEEEEEeecCC-----ChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEE
Q 021127 31 RIGEGAHAKVYEGKY--KNQTVAIKIVHKGE-----TPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv 101 (317)
..+.|++|.+..++. .|+.||+|++.+.. .........++|.+|+++|+++ .|+||++++++++++ ..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777776665544 48899999998653 2234455667899999999999 799999999999876 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-c
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-E 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~ 180 (317)
|||++|++|.++|...+. +++. +|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCc
Confidence 999999999999987554 6664 478999999999999999999999999999998 79999999999865432 3
Q ss_pred ccccccCccceecccccccc
Q 021127 181 MMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~ 200 (317)
...+.+||+.|+|||++.+.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp CSHHHHHHHHHHHHHHC---
T ss_pred cccCceechhhccHHHhCCC
Confidence 34556899999999998764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=241.10 Aligned_cols=157 Identities=24% Similarity=0.316 Sum_probs=124.1
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChH---HHHHHHHHHHHHHHHHHhcCCCCee--eEEeeeecCceEEEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPE---EIAKKESRFAREVAMLSRVQHRNLV--KFIGACKEPVMVIVTE 103 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~~~~~lv~e 103 (317)
.++||+|+||.||+|...++.+++|......... ......+++.+|++++++++||||+ .++++ .+...++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEEEE
Confidence 5689999999999998889999999876543321 1223356789999999999999999 55555 3446799999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccccc--
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEM-- 181 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~-- 181 (317)
|++|++|.+++.. ++.++.|++.||+|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 420 ~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 420 YINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp CCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHH
T ss_pred CCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccc
Confidence 9999999999875 4579999999999999999999999999999997 799999999986654322
Q ss_pred ------cccccCccceeccccccc
Q 021127 182 ------MTAETGTYRWMAPELYST 199 (317)
Q Consensus 182 ------~~~~~gt~~y~aPE~~~~ 199 (317)
....+||+.|+|||++..
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred cchhhhhhhhcCCCCcCCHHHHHH
Confidence 235679999999999876
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=204.74 Aligned_cols=148 Identities=18% Similarity=0.152 Sum_probs=117.2
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChH-------------HHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPE-------------EIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.|.+++.||+|+||.||+|.+. ++.||||+++...... +.......+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 4445699999999999999985 8999999997543211 11124567899999999998 5 6666
Q ss_pred eeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEccc
Q 021127 91 GACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 91 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+++..+..++||||++|++|.+ +. . .....++.|++.||.|||++||+||||||+|||++ + +.+||+||
T Consensus 168 ~~~~~~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~DF 236 (282)
T 1zar_A 168 KVYAWEGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIIDF 236 (282)
T ss_dssp CEEEEETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECCC
T ss_pred eEEeccceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEEC
Confidence 6666677899999999999988 42 1 12446999999999999999999999999999999 6 79999999
Q ss_pred CcccccccccccccccCccceecccccc
Q 021127 171 GLAREESLTEMMTAETGTYRWMAPELYS 198 (317)
Q Consensus 171 g~a~~~~~~~~~~~~~gt~~y~aPE~~~ 198 (317)
|+++. +..+.|||++.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99963 23467888765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.2e-24 Score=181.00 Aligned_cols=141 Identities=19% Similarity=0.194 Sum_probs=108.5
Q ss_pred ceeecceeccccceEEEEeEE--CCeE--EEEEEeecCCChHH-------------------HHHHHHHHHHHHHHHHhc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKY--KNQT--VAIKIVHKGETPEE-------------------IAKKESRFAREVAMLSRV 81 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~--~~~~--vaiK~~~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l 81 (317)
-|.+.+.||+|+||.||+|.+ +|+. ||||+++....... .......+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999998 6888 99999765421110 012234678899999999
Q ss_pred CCCCe--eeEEeeeecCceEEEEEccCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCC
Q 021127 82 QHRNL--VKFIGACKEPVMVIVTELLSG-G----TLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH-SHGIIHRDLKP 153 (317)
Q Consensus 82 ~h~ni--v~l~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~ivH~Dlkp 153 (317)
.|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 87753 444443 357899999942 3 77776543 335567889999999999999 99999999999
Q ss_pred CcEEeeCCCCceEEcccCccccc
Q 021127 154 ENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 154 ~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS---SEEECCCTTCEET
T ss_pred HHEEEcC---cEEEEECcccccC
Confidence 9999987 6999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-21 Score=168.64 Aligned_cols=140 Identities=21% Similarity=0.231 Sum_probs=99.1
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCC---------------hHHHHHH--HHHHHHHHHHHHhcCCCCe
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGET---------------PEEIAKK--ESRFAREVAMLSRVQHRNL 86 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~---------------~~~~~~~--~~~~~~E~~~l~~l~h~ni 86 (317)
=|.++++||+|++|.||+|.+. |+.||||+++.... ....... +....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3789999999999999999876 89999998764211 0000111 1112346677777744433
Q ss_pred --eeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC-
Q 021127 87 --VKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK- 163 (317)
Q Consensus 87 --v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~- 163 (317)
...++. ...+|||||++|++|.++.. . +....++.|++.+|.+||++|||||||||.|||++.+ +
T Consensus 176 ~vp~p~~~---~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-gd 243 (397)
T 4gyi_A 176 PVPEPIAQ---SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-KD 243 (397)
T ss_dssp SCCCEEEE---ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-EC
T ss_pred CCCeeeec---cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-CC
Confidence 222222 23479999999988865432 1 2345678999999999999999999999999999876 3
Q ss_pred ---------ceEEcccCccccc
Q 021127 164 ---------TIKLADFGLAREE 176 (317)
Q Consensus 164 ---------~~kl~Dfg~a~~~ 176 (317)
.+.|+||+.+...
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEET
T ss_pred cccccccccceEEEEeCCcccC
Confidence 3889999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.3e-14 Score=123.43 Aligned_cols=139 Identities=16% Similarity=0.101 Sum_probs=109.2
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeecC-ceEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~lv 101 (317)
..|.+...++.|+.+.||++...++.+++|+........ ...+.+|+.+++.+ .+..++++++++.+. ..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 358888889999999999998778999999987521111 11377899999988 467788999888654 78999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-------------------------------------- 143 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-------------------------------------- 143 (317)
||+++|.+|.+.+. +......++.+++.+|+.||+
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999987632 112234678999999999998
Q ss_pred ---------------------CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 144 ---------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 144 ---------------------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|+|++|.||+++.+ +.+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence 448999999999999875 4567999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.5e-12 Score=110.22 Aligned_cols=132 Identities=17% Similarity=0.121 Sum_probs=95.9
Q ss_pred ceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeeEEeeeecC-ceEE
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGACKEP-VMVI 100 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~-~~~l 100 (317)
.+.+....+.|..+.||++... +..+++|+...... ..+.+|+.+++.+.+.+ +++++++..++ ..++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~--------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc--------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4555444456666999998765 67799999765421 13677889888885434 56788887654 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG----------------------------------- 145 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~----------------------------------- 145 (317)
||||++|.+|. ... .+. ..++.+++..|+.||+..
T Consensus 93 v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 211 222 256777888888888743
Q ss_pred -----------------------ccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 146 -----------------------IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 146 -----------------------ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
++|+|++|+||+++.+ +.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 9999999999999876 4567999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=116.28 Aligned_cols=142 Identities=15% Similarity=0.245 Sum_probs=107.0
Q ss_pred eecceeccccceEEEEeEECCeEEEEEEee--cCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecC----ce
Q 021127 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVH--KGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP----VM 98 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~----~~ 98 (317)
.-.+.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.+. +..+++++.++.+. ..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~----~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL----PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC----CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 346678999999999998888889999876 33211 11235778999999986 45688999888654 48
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS----------------------------------- 143 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~----------------------------------- 143 (317)
++||||++|..+.+.. ...++...+..++.+++..|+.||+
T Consensus 117 ~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999999998774411 1227888889999999999999997
Q ss_pred -----------------------CCccccCCCCCcEEeeCCCC-ceEEcccCccccc
Q 021127 144 -----------------------HGIIHRDLKPENLLLTEDLK-TIKLADFGLAREE 176 (317)
Q Consensus 144 -----------------------~~ivH~Dlkp~Nill~~~~~-~~kl~Dfg~a~~~ 176 (317)
.+++|+|+++.||+++.+.. .+.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997632 3589999998743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.8e-09 Score=92.37 Aligned_cols=134 Identities=23% Similarity=0.276 Sum_probs=99.4
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCC--eeeEEeeeecC----ceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRN--LVKFIGACKEP----VMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~----~~~lv 101 (317)
.+.++.|.++.||+.. ..+++|+.... ....++.+|..+++.+ .+.. +++++...... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH-------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc-------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4558999999999874 56889985422 2234688899999887 3322 45666554332 35889
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-------------------------------------- 143 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-------------------------------------- 143 (317)
|++++|.+|...... .++..++..++.+++..|+.||+
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988764332 17888888899999999999996
Q ss_pred --------------------CCccccCCCCCcEEeeCC-CCceEEcccCccccc
Q 021127 144 --------------------HGIIHRDLKPENLLLTED-LKTIKLADFGLAREE 176 (317)
Q Consensus 144 --------------------~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~ 176 (317)
..++|+|++|.||+++.+ .+.+.|+||+.+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 136999999999999973 256789999998643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.87 E-value=4.4e-08 Score=84.89 Aligned_cols=135 Identities=19% Similarity=0.219 Sum_probs=94.6
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCC---CeeeEEeeee--cCceEEEEE
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR---NLVKFIGACK--EPVMVIVTE 103 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~--~~~~~lv~e 103 (317)
.+.++.|....||+. +..+++|+-.. . ....++.+|..+++.+.+. .|.+++.+.. ++..++||+
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~---~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS---Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS---H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC---c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 345788888899987 67788998421 1 2234688999999998642 3567776664 346789999
Q ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 021127 104 LLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH--------------------------------------- 144 (317)
Q Consensus 104 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~--------------------------------------- 144 (317)
+++|.+|...... . ++......++.+++..|+.||+.
T Consensus 94 ~i~G~~l~~~~~~--~--l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA--V--LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT--T--SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh--h--CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763221 1 45555566666666666666642
Q ss_pred ---------------------CccccCCCCCcEEeeC---CCCceEEcccCcccccc
Q 021127 145 ---------------------GIIHRDLKPENLLLTE---DLKTIKLADFGLAREES 177 (317)
Q Consensus 145 ---------------------~ivH~Dlkp~Nill~~---~~~~~kl~Dfg~a~~~~ 177 (317)
.++|+|++|.||+++. +...+.|+||+.+...+
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999987 32345899999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=1.4e-08 Score=86.28 Aligned_cols=129 Identities=19% Similarity=0.141 Sum_probs=91.4
Q ss_pred eccccce-EEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec-CceEEEEEccC
Q 021127 32 IGEGAHA-KVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVIVTELLS 106 (317)
Q Consensus 32 lG~G~~g-~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv~e~~~ 106 (317)
+..|..| .||+.... +..+++|+-+.. ....+.+|...|+.+. +--|.++++++.+ +..++|||+++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 3345444 68987654 567999986532 1234778999988873 3447788888765 47899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 021127 107 GGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH------------------------------------------ 144 (317)
Q Consensus 107 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~------------------------------------------ 144 (317)
|.++.+..... ......+..+++..|+.||+.
T Consensus 104 G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 104 GKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp SEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred CccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 99888765431 122334566777777777740
Q ss_pred ----------------CccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 145 ----------------GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 145 ----------------~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++|+|+.+.||+++.+ +.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 26899999999999976 5567999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=1e-07 Score=84.26 Aligned_cols=81 Identities=9% Similarity=0.080 Sum_probs=55.0
Q ss_pred eeeccee-ccccceEEEEeEEC--------CeEEEEEEeecCC---ChHHHHHHHHHHHHHHHHHHhcC---CCCeeeEE
Q 021127 26 LFVGPRI-GEGAHAKVYEGKYK--------NQTVAIKIVHKGE---TPEEIAKKESRFAREVAMLSRVQ---HRNLVKFI 90 (317)
Q Consensus 26 y~~~~~l-G~G~~g~V~~~~~~--------~~~vaiK~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~ 90 (317)
....+.| +.|..+.+|+.... ++.+++|+..... ... ...+.+|+.+++.+. .-.+.+++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-----~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-----TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-----CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-----hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 4445678 88888999988765 6789999865422 000 013567788877773 24577888
Q ss_pred eeeecC----ceEEEEEccCCCCHH
Q 021127 91 GACKEP----VMVIVTELLSGGTLR 111 (317)
Q Consensus 91 ~~~~~~----~~~lv~e~~~~g~L~ 111 (317)
.++.+. ..++|||+++|..+.
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCC
T ss_pred EEccCCCccCCceEEEEecCCCChh
Confidence 877543 468999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.6e-07 Score=84.29 Aligned_cols=80 Identities=20% Similarity=0.101 Sum_probs=49.5
Q ss_pred ecceeccccceEEEEeEE--CCeEEEEEEeecCCC-hHHH-HHHHHHHHHHHHHHHhcC---CCCeeeEEeeeecCceEE
Q 021127 28 VGPRIGEGAHAKVYEGKY--KNQTVAIKIVHKGET-PEEI-AKKESRFAREVAMLSRVQ---HRNLVKFIGACKEPVMVI 100 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~--~~~~vaiK~~~~~~~-~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~l 100 (317)
-.+.||.|..+.||++.. .++.++||....... .... .....++..|.++++.+. ...+++++.+ .....++
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~l 112 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVT 112 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEE
Confidence 356789999999999964 467899998653211 0000 001224567888888763 2345566654 3445789
Q ss_pred EEEccCCC
Q 021127 101 VTELLSGG 108 (317)
Q Consensus 101 v~e~~~~g 108 (317)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.42 E-value=3.4e-06 Score=73.77 Aligned_cols=136 Identities=18% Similarity=0.174 Sum_probs=76.9
Q ss_pred ceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEee-------eecCceEE
Q 021127 30 PRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGA-------CKEPVMVI 100 (317)
Q Consensus 30 ~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~-------~~~~~~~l 100 (317)
+.|+.|..+.||+....+..+++|+.... .. ++..|..+++.+. .-.+++++.. ..++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~--~~-------~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP--EK-------KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC--HH-------HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC--HH-------HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 34566778899999887777999998752 11 1223444444432 1133444431 12456889
Q ss_pred EEEccCCCCHH-----------HH---HHhc-C----CC-------CCCHHHH---------------------------
Q 021127 101 VTELLSGGTLR-----------KY---LLNM-R----PR-------CLDVCVA--------------------------- 127 (317)
Q Consensus 101 v~e~~~~g~L~-----------~~---l~~~-~----~~-------~l~~~~~--------------------------- 127 (317)
||+|++|.++. .. ++.. . .. ...|...
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 11 1111 0 00 0112110
Q ss_pred ----HHHHHHHHHHHHHHH-------------hCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 128 ----IGFALDIARAMECLH-------------SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 128 ----~~i~~~i~~~L~~lH-------------~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..+...+..++++|+ ..+++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence 011122344566665 2579999999999999766 5799999998864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.24 E-value=8.7e-06 Score=70.45 Aligned_cols=76 Identities=18% Similarity=0.143 Sum_probs=58.8
Q ss_pred eecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC---CCCeeeEEeeeec-CceEEEE
Q 021127 27 FVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ---HRNLVKFIGACKE-PVMVIVT 102 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~-~~~~lv~ 102 (317)
.-.+.|+.|....+|+....++.+++|+..... ...+..|...|+.|. ...+++++++... +..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~--------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY--------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG--------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCccc--------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 345678999999999998778889999876431 235778888888873 3678888888754 4789999
Q ss_pred EccCCCCH
Q 021127 103 ELLSGGTL 110 (317)
Q Consensus 103 e~~~~g~L 110 (317)
|+++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.16 E-value=1e-05 Score=73.06 Aligned_cols=79 Identities=13% Similarity=0.074 Sum_probs=46.2
Q ss_pred ecceeccccceEEEEeEECCeEEEEEEeecCC---ChH-HHHHHHHHHHHHHHHHH-hcCCCCeeeEEeeeecCceEEEE
Q 021127 28 VGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGE---TPE-EIAKKESRFAREVAMLS-RVQHRNLVKFIGACKEPVMVIVT 102 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~---~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~lv~ 102 (317)
-.+.||.|..+.||++...++.++||...... ... ........+..|+..+. ......+++++.+. .+..++||
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~-~~~~~lv~ 116 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD-RTMALIGM 116 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE-TTTTEEEE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC-CCccEEEE
Confidence 34568999999999997777889999432110 000 00000112333333222 22345677777765 55789999
Q ss_pred Ecc-CC
Q 021127 103 ELL-SG 107 (317)
Q Consensus 103 e~~-~~ 107 (317)
|++ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.07 E-value=2e-05 Score=68.74 Aligned_cols=138 Identities=13% Similarity=0.113 Sum_probs=73.0
Q ss_pred ceeccccceE-EEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecCceEEEEEcc
Q 021127 30 PRIGEGAHAK-VYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEPVMVIVTELL 105 (317)
Q Consensus 30 ~~lG~G~~g~-V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~lv~e~~ 105 (317)
+.|+.|+... +|+.... +..+++|........ .+..|+.+++.+. .-.+++++.+..+.. ++|||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~--------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g-~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG--------DTQPFVDLAQYLRNLDISAPEIYAEEHARG-LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC--------CSHHHHHHHHHHHHTTCBCCCEEEEETTTT-EEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc--------cccHHHHHHHHHHhCCCCCCceeeecCCCC-EEEEeeC
Confidence 3465555444 7787764 777888875543211 1344666666552 234567777644333 6899999
Q ss_pred CCCCHHHHHHhcC---------------------C---CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 021127 106 SGGTLRKYLLNMR---------------------P---RCLDVCVAI-------G-FA------------LDIARAMECL 141 (317)
Q Consensus 106 ~~g~L~~~l~~~~---------------------~---~~l~~~~~~-------~-i~------------~~i~~~L~~l 141 (317)
.+..+.+++.... . ..++..... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7767655443210 0 012221110 0 00 0111122222
Q ss_pred ------HhCCccccCCCCCcEEeeCC---CCceEEcccCccccc
Q 021127 142 ------HSHGIIHRDLKPENLLLTED---LKTIKLADFGLAREE 176 (317)
Q Consensus 142 ------H~~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~~ 176 (317)
+...++|+|+.+.||+++.+ .+.+.|+||+.+...
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 23479999999999999863 146899999988743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.3e-05 Score=66.92 Aligned_cols=80 Identities=10% Similarity=0.085 Sum_probs=56.6
Q ss_pred CCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-C--CCeeeEEeeeecCce
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-H--RNLVKFIGACKEPVM 98 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~ 98 (317)
+..+.-.+.+|.|..+.||+.+.. |+.|++|+-+...... ...|..|...|+.|. . --+++++++. ..
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWD---DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE---TT
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEecc---Cc
Confidence 456667788999999999999875 7899999876443211 124678999888873 2 2355666543 34
Q ss_pred EEEEEccCCCCH
Q 021127 99 VIVTELLSGGTL 110 (317)
Q Consensus 99 ~lv~e~~~~g~L 110 (317)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.01 E-value=3.8e-05 Score=66.54 Aligned_cols=143 Identities=17% Similarity=0.170 Sum_probs=80.1
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEeee-------ec
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGAC-------KE 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~-------~~ 95 (317)
...-.+.|+.|....+|+....+..+++|+........ .+..|+.++..+.. -.+++++... .+
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~-------~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCCCHH-------HHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 33445667888889999998776688999987632211 24456666666521 1234444221 23
Q ss_pred CceEEEEEccCCCCHH-----------HH---HHhcC----CC---CCC---HHHHHH------------HHHHHHHHHH
Q 021127 96 PVMVIVTELLSGGTLR-----------KY---LLNMR----PR---CLD---VCVAIG------------FALDIARAME 139 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~-----------~~---l~~~~----~~---~l~---~~~~~~------------i~~~i~~~L~ 139 (317)
+..++||++++|..+. .. ++... .. ... |...+. +...+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 4678999999886531 11 11110 00 011 111100 0012344555
Q ss_pred HHHh-------CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 140 CLHS-------HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 140 ~lH~-------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.++. .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 5553 369999999999999976 4457999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.94 E-value=1.5e-05 Score=68.61 Aligned_cols=71 Identities=15% Similarity=0.109 Sum_probs=44.0
Q ss_pred cceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCceEEEEEcc-C
Q 021127 29 GPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVMVIVTELL-S 106 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~-~ 106 (317)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+. +.-..++++.+.+ .-++|+||+ +
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~------~~r~~E~~~l~~l~~~g~~P~~~~~~~~-~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY------INRANEAVAAREAAKAGVSPEVLHVDPA-TGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C------CCHHHHHHHHHHHHHTTSSCCEEEECTT-TCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce------eCHHHHHHHHHHHHHcCCCCceEEEECC-CCEEEEeecCC
Confidence 677888999999998 578899876432110 01245777776663 2222566665433 356899999 6
Q ss_pred CCCH
Q 021127 107 GGTL 110 (317)
Q Consensus 107 ~g~L 110 (317)
|.+|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.88 E-value=2.8e-05 Score=70.48 Aligned_cols=72 Identities=15% Similarity=0.205 Sum_probs=48.4
Q ss_pred cceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCce
Q 021127 29 GPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVM 98 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 98 (317)
.+.|+.|....+|+.... ++.+++|+........ .+..|..+++.+. +.-.+++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~-------~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETES-------HLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHH-------HHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHH-------HHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 456788888999998864 4789999884322201 2456888888773 3334677776654
Q ss_pred EEEEEccCCCCH
Q 021127 99 VIVTELLSGGTL 110 (317)
Q Consensus 99 ~lv~e~~~~g~L 110 (317)
.+|+||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999976443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00014 Score=64.62 Aligned_cols=143 Identities=16% Similarity=0.211 Sum_probs=82.8
Q ss_pred CCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEee
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGA 92 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~ 92 (317)
.+.+.+ +.|..|-...+|+.... ++.+++|+....... ...+.+|..+++.+. +.-..++++.
T Consensus 50 ~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~------~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 50 PEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG------VDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC------HHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred cCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch------HHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 344443 45666778889998763 368999985321111 123557888888773 3334777877
Q ss_pred eecCceEEEEEccCCCCHHH--------------HHHh---cC---CCCCC--HHHHHHHHHHHHH--------------
Q 021127 93 CKEPVMVIVTELLSGGTLRK--------------YLLN---MR---PRCLD--VCVAIGFALDIAR-------------- 136 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~--------------~l~~---~~---~~~l~--~~~~~~i~~~i~~-------------- 136 (317)
+.++ +||||++|.+|.. .|.+ .. .+... +.++.++..++..
T Consensus 123 ~~~g---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~ 199 (379)
T 3feg_A 123 FPEG---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM 199 (379)
T ss_dssp ETTE---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred cCCc---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence 7653 8999998865431 1111 10 11122 3455555544322
Q ss_pred -----HHHHHH----h----CCccccCCCCCcEEeeCC---CCceEEcccCcccc
Q 021127 137 -----AMECLH----S----HGIIHRDLKPENLLLTED---LKTIKLADFGLARE 175 (317)
Q Consensus 137 -----~L~~lH----~----~~ivH~Dlkp~Nill~~~---~~~~kl~Dfg~a~~ 175 (317)
.+..|. . ..++|+|+.+.||+++.+ .+.+.|+||..+..
T Consensus 200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 2 258999999999999875 24789999999874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=6.5e-05 Score=66.53 Aligned_cols=73 Identities=16% Similarity=0.154 Sum_probs=43.1
Q ss_pred cceeccccceEEEEeEECC----------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEeeeecCc
Q 021127 29 GPRIGEGAHAKVYEGKYKN----------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN-LVKFIGACKEPV 97 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~ 97 (317)
.+.|+.|....+|+....+ +.+++|+........ .....|..+++.+...+ ++++++...
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~------~~~~~E~~~l~~L~~~g~~P~~~~~~~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL------YNTISEFEVYKTMSKYKIAPQLLNTFN--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT------SCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce------ecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence 3457788888999988764 688999865432110 01245777777763222 457776542
Q ss_pred eEEEEEccCCCCH
Q 021127 98 MVIVTELLSGGTL 110 (317)
Q Consensus 98 ~~lv~e~~~~g~L 110 (317)
-++||+|++|.++
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3689999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0008 Score=58.27 Aligned_cols=136 Identities=13% Similarity=0.157 Sum_probs=76.3
Q ss_pred eeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC--CCeeeEEee------eecCceEEE
Q 021127 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH--RNLVKFIGA------CKEPVMVIV 101 (317)
Q Consensus 31 ~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~lv 101 (317)
.|+ |....||+.... |+.+++|......... ..+..|..++..+.. -.+++++.. ..++..++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~------~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH------HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 455 778899988765 5679999987432211 235567777766631 224444443 113456789
Q ss_pred EEccCCCCHH-----------HHH---Hhc-C--C----CCCCHHHH----------------------HHHHHHHHHHH
Q 021127 102 TELLSGGTLR-----------KYL---LNM-R--P----RCLDVCVA----------------------IGFALDIARAM 138 (317)
Q Consensus 102 ~e~~~~g~L~-----------~~l---~~~-~--~----~~l~~~~~----------------------~~i~~~i~~~L 138 (317)
|++++|..+. ..+ +.. . . ..++.... ...+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 111 110 0 0 01222211 01111222222
Q ss_pred HHH----HhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 139 ECL----HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 139 ~~l----H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.-+ ....++|+|+++.||+++ + .+.|+||+.+...
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcC
Confidence 222 224689999999999998 4 6899999988643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00086 Score=61.08 Aligned_cols=73 Identities=15% Similarity=0.078 Sum_probs=47.6
Q ss_pred cceeccccceEEEEeEECC--eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCe-eeEEeeeecCceEEEEEcc
Q 021127 29 GPRIGEGAHAKVYEGKYKN--QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNL-VKFIGACKEPVMVIVTELL 105 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~ 105 (317)
.+.|+.|-...+|+....+ ..+++|+......... ...+|..+++.|...++ +++++.+.+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFTN---GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEETT---EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEee
Confidence 3567788889999998876 8899998754321100 01468888888854334 678877743 3599999
Q ss_pred CCCCH
Q 021127 106 SGGTL 110 (317)
Q Consensus 106 ~~g~L 110 (317)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00082 Score=58.73 Aligned_cols=32 Identities=19% Similarity=0.330 Sum_probs=27.3
Q ss_pred CCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 144 ~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCeeC
Confidence 369999999999999876 57899999888643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00094 Score=60.12 Aligned_cols=73 Identities=12% Similarity=0.079 Sum_probs=46.7
Q ss_pred cceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeecCce
Q 021127 29 GPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKEPVM 98 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 98 (317)
.+.+..|-...+|+.... ++.+++|+........ -...+|..+++.+. +.-.+++++.+. -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~~---~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADFP---E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEET---T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEcC---C
Confidence 445666778899998876 5789999865432110 01245777777763 333566666443 3
Q ss_pred EEEEEccCCCCH
Q 021127 99 VIVTELLSGGTL 110 (317)
Q Consensus 99 ~lv~e~~~~g~L 110 (317)
++||+|++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.20 E-value=0.013 Score=52.41 Aligned_cols=30 Identities=30% Similarity=0.472 Sum_probs=24.7
Q ss_pred ccccCCCCCcEEeeC-----CCCceEEcccCcccc
Q 021127 146 IIHRDLKPENLLLTE-----DLKTIKLADFGLARE 175 (317)
Q Consensus 146 ivH~Dlkp~Nill~~-----~~~~~kl~Dfg~a~~ 175 (317)
++|+|+.+.||++.. ..+.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 225799999999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.04 E-value=0.044 Score=44.19 Aligned_cols=134 Identities=11% Similarity=0.046 Sum_probs=79.8
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCCceEEcccCccccccccccccccc
Q 021127 108 GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAET 186 (317)
Q Consensus 108 g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 186 (317)
-+|.+.|...+ .+++++++|-++.|.+.+|.-+-. +.-..+=+.|..|++..+ |.|.+.+ +.+. .
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------c
Confidence 47999888755 459999999999999999987621 221233445688999988 7777653 1110 1
Q ss_pred Cccceeccccccccc------ccccccccc--cCCCCCCCCCCChHHHHHHHHHhhhc----------------------
Q 021127 187 GTYRWMAPELYSTVT------LRQGEKKHY--NHKNVRPSAENVPEELSIILTSCWKE---------------------- 236 (317)
Q Consensus 187 gt~~y~aPE~~~~~~------~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~---------------------- 236 (317)
....+.|||...... +.-+...++ ..+.....+..+++.|..||..|...
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~ 178 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDED 178 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC--------------------
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccccccccc
Confidence 223466888753110 011111111 11222233568899999999999866
Q ss_pred ---CCCCCCCHHHHHHHHHHhh
Q 021127 237 ---DPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 237 ---~p~~Rps~~~~~~~l~~~~ 255 (317)
.+..|++.++|++....-+
T Consensus 179 ~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 179 EKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp CCSCCCCCCSHHHHHHHHHTTS
T ss_pred ccccccCcCCHHHHHHHHHhhc
Confidence 2457889999988766544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=89.86 E-value=0.023 Score=51.69 Aligned_cols=61 Identities=11% Similarity=0.047 Sum_probs=17.5
Q ss_pred eecceeccccceEEEEeEECC--eEEEE------EEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 27 FVGPRIGEGAHAKVYEGKYKN--QTVAI------KIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 27 ~~~~~lG~G~~g~V~~~~~~~--~~vai------K~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+.++|| ||.||+|.+.+ .+||+ |......... .....+.+|..+.+.++|+|+++.+++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~---e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE---KRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccc---cccccccccccccccccccccCCCcceE
Confidence 4566777 99999998874 57888 6554332221 2334678889999889999999987754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.08 E-value=1.2 Score=35.89 Aligned_cols=84 Identities=14% Similarity=0.075 Sum_probs=57.9
Q ss_pred CCCCeeeEEeeeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCcEEeeC
Q 021127 82 QHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME-CLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 82 ~h~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~-~lH~~~ivH~Dlkp~Nill~~ 160 (317)
.||++..-+. ..++.+.+.++.-+++.=...++. ++...+++++..|+.... ++ ..-+|--|+|+||+++.
T Consensus 48 ~~~~f~~~I~-~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCIVRDID-VSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSSEEEEE-ECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCCCeEEE-EeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 6788833232 334566666666544443344443 788999999888877665 43 45577889999999999
Q ss_pred CCCceEEcccCccc
Q 021127 161 DLKTIKLADFGLAR 174 (317)
Q Consensus 161 ~~~~~kl~Dfg~a~ 174 (317)
+ +.++|.-.|+-.
T Consensus 120 ~-~~p~i~hRGi~~ 132 (219)
T 4ano_A 120 A-LEPFFLHVGVKE 132 (219)
T ss_dssp T-CCEEESCCEETT
T ss_pred C-CcEEEEEcCCcc
Confidence 8 799998777643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.26 E-value=1.5 Score=35.07 Aligned_cols=83 Identities=14% Similarity=0.105 Sum_probs=55.9
Q ss_pred CCCCeeeEEeeee-cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC
Q 021127 82 QHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE 160 (317)
Q Consensus 82 ~h~niv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~ 160 (317)
.||+++..- +-. ++.+.+.++.-+.+.=...+.. ++...+++++..|+....++ ..-+|--|+|+||+++.
T Consensus 43 ~~~~Fl~~~-I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDAE-LTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCEE-EEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred cCCcccceE-EEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence 688888662 333 3355555554432221222332 78899999999998887444 34567789999999999
Q ss_pred CCCceEEcccCcc
Q 021127 161 DLKTIKLADFGLA 173 (317)
Q Consensus 161 ~~~~~kl~Dfg~a 173 (317)
+ +.+++.-.|+-
T Consensus 115 ~-~~p~i~~RGik 126 (215)
T 4ann_A 115 D-GLPIAKTRGLQ 126 (215)
T ss_dssp T-SCEEESCCEET
T ss_pred C-CCEEEEEccCc
Confidence 9 68999877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 317 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-32 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 3e-60
Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 44/272 (16%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
W I + VG RIG G+ VY+GK+ VA+K+++ + + F EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ---AFKNEVGV 57
Query: 78 LSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
L + +H N++ F+G P + IVT+ G +L +L + + ++ I A A+
Sbjct: 58 LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQG 116
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAP 194
M+ LH+ IIHRDLK N+ L EDL T+K+ DFGLA S + +G+ WMAP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 195 E----------------------LYSTVT-------------LRQGEKKHYNHKNVRPSA 219
E LY +T + + Y ++
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 220 ENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
N P+ + ++ C K+ + RP F QI+ +
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-57
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 38/273 (13%)
Query: 16 DAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFARE 74
+ +W + + L + R+G G +V+ G Y + VA+K + +G + F E
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD------AFLAE 58
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
++ ++QH+ LV+ + + I+TE + G+L +L L + + A I
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
A M + IHRDL+ N+L+++ L + K+ADFGLAR E++ +W
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 193 APE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPE 224
APE L VT + + V +N PE
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
EL ++ CWKE P RP F + +L ++ +A
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-55
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 40/263 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
W ++ K L + IG+G V G Y+ VA+K + T + F E +++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-------AFLAEASVM 54
Query: 79 SRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++++H NLV+ +G E + IVTE ++ G+L YL + L + F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE- 195
AME L + +HRDL N+L++ED K++DFGL +E + +W APE
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEA 171
Query: 196 ------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPEELSI 228
L+ + + K+V + + P +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 229 ILTSCWKEDPNARPNFTQIIQML 251
++ +CW D RP+F Q+ + L
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-52
Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 38/275 (13%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVA 76
W I + L + ++G+G +V+ G + VAIK + G E F +E
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE------AFLQEAQ 64
Query: 77 MLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
++ +++H LV+ E + IVTE +S G+L +L + L + + A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAP 194
M + +HRDL+ N+L+ E+L K+ADFGLAR E++ +W AP
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 195 E-------------------LYSTVTLRQGEKKHYNHKNV---------RPSAENVPEEL 226
E L T + ++ V P PE L
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 227 SIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261
++ CW+++P RP F + L +Y ++ P
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-51
Identities = 67/265 (25%), Positives = 108/265 (40%), Gaps = 40/265 (15%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT-VAIKIVHKGETPEEIAKKESRFAREVAMLS 79
IDPK L +G G V GK++ Q VAIK++ +G E+ F E ++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMM 54
Query: 80 RVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAM 138
+ H LV+ G C + + I+TE ++ G L YL MR R + D+ AM
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAM 113
Query: 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPE- 195
E L S +HRDL N L+ + +K++DFGL+R + RW PE
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 196 ------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPEELSI 228
++ +L + + + + E++
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 229 ILTSCWKEDPNARPNFTQIIQMLLN 253
I+ SCW E + RP F ++ +L+
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-50
Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 43/279 (15%)
Query: 18 KWLIDPKHLFVGPR-IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFA 72
K + +L + +G G V +G Y+ VAIK++ +G +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE----EMM 57
Query: 73 REVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFAL 132
RE ++ ++ + +V+ IG C+ +++V E+ GG L K+L+ R + V
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 133 DIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGT 188
++ M+ L +HRDL N+LL K++DFGL++ ++S +A
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 189 YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAE 220
+W APE ++ ++ Q K V
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
P EL +++ CW RP+F + Q + ++A
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 4e-50
Identities = 72/267 (26%), Positives = 118/267 (44%), Gaps = 40/267 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
KW ++ + + ++G G + +VYEG +K + TVA+K + + E F +E
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE------EFLKEA 64
Query: 76 AMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
A++ ++H NLV+ +G C +EP I+TE ++ G L YL + + V + A I
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWM 192
+ AME L IHRDL N L+ E+ +K+ADFGL+R +W
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 193 APE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPE 224
APE L+ T + V E PE
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 225 ELSIILTSCWKEDPNARPNFTQIIQML 251
++ ++ +CW+ +P+ RP+F +I Q
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-50
Identities = 71/302 (23%), Positives = 109/302 (36%), Gaps = 67/302 (22%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEI 64
E + D KW ++L G +G GA KV VA+K++ + E
Sbjct: 25 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE- 83
Query: 65 AKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPR-- 120
E+ M++++ H N+V +GAC + ++ E G L YL + R +
Sbjct: 84 ---REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 121 -------------------CLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED 161
L + FA +A+ ME L +HRDL N+L+T
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 162 LKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPE----------------------- 195
K +K+ DFGLAR +S + +WMAPE
Sbjct: 201 -KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 196 ------LYSTVTLRQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
Y + + K + EE+ II+ SCW D RP+F +
Sbjct: 260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 250 ML 251
L
Sbjct: 320 FL 321
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-50
Identities = 57/261 (21%), Positives = 110/261 (42%), Gaps = 37/261 (14%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV 75
+W ++ +G +G+G VY + K +A+K++ K + + E + REV
Sbjct: 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--GVEHQLRREV 57
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+ S ++H N+++ G + V ++ E GT+ + L + D + ++
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITEL 115
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAP 194
A A+ HS +IHRD+KPENLLL +K+ADFG + + T GT ++ P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPP 173
Query: 195 ELYST-------------VTL------------RQGEKKHYNHKNVRPSA-ENVPEELSI 228
E+ V ++ + V + + V E
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233
Query: 229 ILTSCWKEDPNARPNFTQIIQ 249
+++ K +P+ RP ++++
Sbjct: 234 LISRLLKHNPSQRPMLREVLE 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 79/303 (26%), Positives = 115/303 (37%), Gaps = 62/303 (20%)
Query: 11 DELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEE 63
+L D KW L G +G GA KV E TVA+K++ E
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 64 IAKKESRFAREVAMLSRV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRC 121
E+ +LS + H N+V +GAC +++TE G L +L R
Sbjct: 70 ----REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 122 ----------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTI 165
LD+ + F+ +A+ M L S IHRDL N+LLT +
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RIT 184
Query: 166 KLADFGLAR---EESLTEMMTAETGTYRWMAPE-------------------LYSTVTLR 203
K+ DFGLAR +S + +WMAPE L+ +L
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 204 QGEKKHYNHKNV----------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253
+ S E+ P E+ I+ +CW DP RP F QI+Q++
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 254 YLS 256
+S
Sbjct: 305 QIS 307
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-49
Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 43/271 (15%)
Query: 21 IDPKHLFVGPR-IGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREV 75
+D K L + + +G G V +G Y+ +TVA+KI+ + E
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD---ELLAEA 59
Query: 76 AMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIA 135
++ ++ + +V+ IG C+ ++V E+ G L KYL + R + I ++
Sbjct: 60 NVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVS 117
Query: 136 RAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYRW 191
M+ L +HRDL N+LL K++DFGL++ +E+ + T +W
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 192 MAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVP 223
APE ++ + Q + V P
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNY 254
E+ ++ CW D RP F + L NY
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 40/264 (15%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAKKESRFAREVAML 78
+IDP L IG G V+ G + N VAIK + +G EE F E ++
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVM 54
Query: 79 SRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ H LV+ G C E + +V E + G L YL R +G LD+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG 113
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRWMAPE 195
M L +IHRDL N L+ E+ IK++DFG+ R + T +W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 196 -------------------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPEELS 227
++ + + ++ ++ V +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232
Query: 228 IILTSCWKEDPNARPNFTQIIQML 251
I+ CWKE P RP F+++++ L
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 68/271 (25%), Positives = 104/271 (38%), Gaps = 42/271 (15%)
Query: 20 LIDPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFARE 74
LI K L + ++G+G+ V G++ K +VA+K + + + F RE
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP--EAMDDFIRE 61
Query: 75 VAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
V + + HRNL++ G P M +VTEL G+L L + + +A+ +
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQV 120
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYR 190
A M L S IHRDL NLLL +K+ DFGL R + M +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 191 WMAPEL-----------------------------YSTVTLRQGEKKHYNHKNVRPSAEN 221
W APE + + Q K P E+
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLL 252
P+++ ++ CW P RP F + LL
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-48
Identities = 62/266 (23%), Positives = 111/266 (41%), Gaps = 43/266 (16%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
D + L IG G+ VY+G VA + + + + RF E ML
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS---ERQRFKEEAEML 62
Query: 79 SRVQHRNLVKFIGACKEPV-----MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
+QH N+V+F + + V +V+VTEL++ GTL+ YL + + + V +
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQ 120
Query: 134 IARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRW 191
I + ++ LH+ IIHRDLK +N+ +T ++K+ D GLA + A GT +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEF 179
Query: 192 MAPELYST------------VTL----------------RQGEKKHYNHKNVRPSAENVP 223
MAPE+Y + + Q ++ + +
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQ 249
E+ I+ C +++ + R + ++
Sbjct: 240 PEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-48
Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 41/268 (15%)
Query: 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN-----QTVAIKIVHKGETPEEIAKKESRFAR 73
+ I + + +G IGEG V++G Y + VAIK + +F +
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFLQ 57
Query: 74 EVAMLSRVQHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
E + + H ++VK IG E + I+ EL + G LR +L + LD+ I +A
Sbjct: 58 EALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQ 116
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR--EESLTEMMTAETGTYRW 191
++ A+ L S +HRD+ N+L++ + +KL DFGL+R E+S + +W
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 192 MAPE-------------------LYSTVTLRQGEKKHYNHKNV---------RPSAENVP 223
MAPE ++ + + + +V P N P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 224 EELSIILTSCWKEDPNARPNFTQIIQML 251
L ++T CW DP+ RP FT++ L
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 1e-47
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 43/263 (16%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DP+ LF IG G+ VY + ++ VAIK + +K +EV L
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFL 69
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++H N +++ G +V E G ++ +P L +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQG 127
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL- 196
+ LHSH +IHRD+K N+LL+E +KL DFG A + + GT WMAPE+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSAS---IMAPANSFVGTPYWMAPEVI 183
Query: 197 ------------------------------YSTVTLRQGEKKHYNHKNVRPSAENVPEEL 226
+ +++ + + E
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 227 SIILTSCWKEDPNARPNFTQIIQ 249
+ SC ++ P RP +++
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 46/268 (17%)
Query: 21 IDPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
++P+ + + +G+GA KVY+ + K + A K++ + ++ + E+ +
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT-----KSEEELEDYMVEIDI 62
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L+ H N+VK + A + I+ E +GG + +L + R L
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLD 121
Query: 137 AMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPE 195
A+ LH + IIHRDLK N+L T D IKLADFG++ + + + GT WMAPE
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 196 LYSTVTLRQG----------------------------------EKKHYNHKNVRPSAEN 221
+ T + K +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQ 249
L C +++ +AR +Q++Q
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-46
Identities = 67/292 (22%), Positives = 126/292 (43%), Gaps = 52/292 (17%)
Query: 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGE 59
++ A ++ + +W + + + + +G+G+ VYEG K VAIK V++
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 60 TPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC-KEPVMVIVTELLSGGTLRKYLLNMR 118
+ E F E +++ ++V+ +G + +++ EL++ G L+ YL ++R
Sbjct: 63 SMRE----RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 119 PRC--------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADF 170
P + I A +IA M L+++ +HRDL N ++ ED T+K+ DF
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDF 177
Query: 171 GLAR---EESLTEMMTAETGTYRWMAPE-------------------LYSTVTLRQGEKK 208
G+ R E RWM+PE L+ TL + +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 209 HYNHKNV---------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+++ V +N P+ L ++ CW+ +P RP+F +II +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-45
Identities = 61/255 (23%), Positives = 96/255 (37%), Gaps = 43/255 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+GEGA+ +V + + VA+KIV + +E+ + + H N+VK
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNHENVVK 67
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
F G +E + + E SGG L + + A F + + LH GI
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPELYST----- 199
HRD+KPENLLL E +K++DFGLA + ++ GT ++APEL
Sbjct: 126 HRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 200 ---------VTL----------------RQGEKKHYNHKNVRPSAENVPEELSIILTSCW 234
+ L Q K + + +L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 235 KEDPNARPNFTQIIQ 249
E+P+AR I +
Sbjct: 245 VENPSARITIPDIKK 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 4e-45
Identities = 64/271 (23%), Positives = 106/271 (39%), Gaps = 46/271 (16%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREV 75
ID + + IG G +V G K VAIK + G T ++ F E
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR----DFLSEA 78
Query: 76 AMLSRVQHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
+++ + H N++ G + V I+TE + G+L +L + V +G I
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGI 137
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR------EESLTEMMTAETGT 188
A M+ L +HRDL N+L+ +L K++DFGL+R +
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 189 YRWMAPE-------------------LYSTVTLRQGEKKHYNHKNV---------RPSAE 220
RW APE ++ ++ + +++V P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 221 NVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ P L ++ CW++D N RP F QI+ L
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 38/294 (12%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+G GA VY+G + + V I + K K E +++ V + ++ +
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
+G C + ++T+L+ G L Y+ + + + + IA+ M L ++HR
Sbjct: 77 LGICLTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLVHR 135
Query: 150 DLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAPE----------- 195
DL N+L+ +K+ DFGLA+ E +WMA E
Sbjct: 136 DLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 194
Query: 196 --------LYSTVTLRQGEKKHYNHKNVR---------PSAENVPEELSIILTSCWKEDP 238
++ +T + P ++ +I+ CW D
Sbjct: 195 DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 254
Query: 239 NARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSSLMTVRD 292
++RP F ++I P+ + + + P +S +LM D
Sbjct: 255 DSRPKFRELIIEFSKMAR---DPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-44
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 44/259 (16%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG G++ + + + K + + K + G E ++ EV +L ++H N+V+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVR 67
Query: 89 FIGACKEP---VMVIVTELLSGGTLRKYLLNMRPR--CLDVCVAIGFALDIARAMECLH- 142
+ + + IV E GG L + LD + + A++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 143 ----SHGIIHRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELY 197
H ++HRDLKP N+ L + +KL DFGLAR T A GT +M+PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 198 ST-------------VTL--------------RQGEKKHYNHKNVRPSAENVPEELSIIL 230
+ L ++ R +EL+ I+
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEII 246
Query: 231 TSCWKEDPNARPNFTQIIQ 249
T RP+ +I++
Sbjct: 247 TRMLNLKDYHRPSVEEILE 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (386), Expect = 2e-44
Identities = 49/253 (19%), Positives = 100/253 (39%), Gaps = 40/253 (15%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA V+ K + K ++ + E+++++++ H L+
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A ++ MV++ E LSGG L + + + I + ++ +H H I+
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 148 HRDLKPENLLLT-EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE----------- 195
H D+KPEN++ + ++K+ DFGLA + + E++ T T + APE
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 196 --------LYSTVTLR---QGEKKHYNHKNVR--------PSAENVPEELSIILTSCWKE 236
Y ++ GE +NV+ + +V E + + ++
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269
Query: 237 DPNARPNFTQIIQ 249
+P R ++
Sbjct: 270 EPRKRLTVHDALE 282
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-44
Identities = 64/270 (23%), Positives = 111/270 (41%), Gaps = 45/270 (16%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKNQT------VAIKIVHKGETPEEIAKKESRFARE 74
I P + IG G +VY+G K + VAIK + G T ++ F E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----RVDFLGE 59
Query: 75 VAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALD 133
++ + H N+++ G + M+I+TE + G L K+L + V +G
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRG 118
Query: 134 IARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTY 189
IA M+ L + +HRDL N+L+ +L K++DFGL+R + T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 190 RWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR---------PSAEN 221
RW APE ++ +T + ++ V P+ +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 222 VPEELSIILTSCWKEDPNARPNFTQIIQML 251
P + ++ CW+++ RP F I+ +L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-44
Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 53/303 (17%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYKN----QTVAIKIVHKGETPEEIAKKESRFAREVA 76
+D + IGEG +V + + K AIK + + + ++ FA E+
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELE 62
Query: 77 MLSRV-QHRNLVKFIGACK-EPVMVIVTELLSGGTLRKYLLNMRPRC------------- 121
+L ++ H N++ +GAC+ + + E G L +L R
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 122 -LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180
L + FA D+AR M+ L IHRDL N+L+ E+ K+ADFGL+R + +
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYV 181
Query: 181 MMTAETGTYRWMAPE-------------------LYSTVTLRQGEKKHYNHKNVR----- 216
T RWMA E L+ V+L +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 217 ----PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNS 272
N +E+ ++ CW+E P RP+F QI+ L L + F
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 301
Query: 273 ENT 275
Sbjct: 302 AGI 304
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 2e-43
Identities = 64/296 (21%), Positives = 111/296 (37%), Gaps = 66/296 (22%)
Query: 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKES 69
++ IGEGA +V++ + VA+K++ + + + ++
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QA 61
Query: 70 RFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRC------- 121
F RE A+++ + N+VK +G C M ++ E ++ G L ++L +M P
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 122 ---------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
L + A +A M L +HRDL N L+ E++ +K
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVK 180
Query: 167 LADFGLAR---EESLTEMMTAETGTYRWMAPELYST----------------VTLRQGEK 207
+ADFGL+R + + RWM PE +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 208 KHYN------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ Y N+ EN P EL ++ CW + P RP+F I ++L
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-43
Identities = 68/286 (23%), Positives = 106/286 (37%), Gaps = 48/286 (16%)
Query: 19 WLIDPKHLFV--GPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRF 71
+I P L V IG G VY G K A+K +++ E+ S+F
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV----SQF 75
Query: 72 AREVAMLSRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIG 129
E ++ H N++ +G C ++V + G LR ++ V IG
Sbjct: 76 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIG 134
Query: 130 FALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTA 184
F L +A+ M+ L S +HRDL N +L E T+K+ADFGLAR E T
Sbjct: 135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 185 ETGTYRWMAPE-------------------LYSTVTLRQGEKKHYNHKNV---------R 216
+WMA E L+ +T N ++
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 253
Query: 217 PSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPE 262
E P+ L ++ CW RP+F++++ + S
Sbjct: 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (379), Expect = 2e-43
Identities = 57/286 (19%), Positives = 103/286 (36%), Gaps = 45/286 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G GA V+ + A K V + +E+ +S ++H
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPT 84
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
LV A ++ MV++ E +SGG L + + + + A+ + + + + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 145 GIIHRDLKPENLLLTEDLK-TIKLADFGLAREESLTEMMTAETGTYRWMAPELYST---- 199
+H DLKPEN++ T +KL DFGL + + TGT + APE+
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 200 ----------------------------VTLRQGEKKHYNHKNVRPSAENVPEELSIILT 231
TLR + +N + S + E+ +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS--GISEDGKDFIR 261
Query: 232 SCWKEDPNARPNFTQIIQM-LLNYLSAIAPPEPMIPHRIFNSENTI 276
DPN R Q ++ L +A + R ++I
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-43
Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 45/288 (15%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
DPK + +IG+GA VY Q VAI+ ++ + K+ E+ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-----QPKKELIINEILVM 71
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
++ N+V ++ + + +V E L+GG+L + C+D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQA 128
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPE- 195
+E LHS+ +IHRD+K +N+LL D ++KL DFG + + + + GT WMAPE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 196 ------------------LYSTVT----------LRQGEKKHYNHKNVRPSAENVPEELS 227
+ LR N + E +
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 228 IILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHRIFNSENT 275
L C D R + +++Q +L P + P E T
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-43
Identities = 57/275 (20%), Positives = 101/275 (36%), Gaps = 35/275 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G V++ +K +A K++H P ++ RE+ +L +V
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLHECNSPYIVG 68
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGI 146
F GA + I E + GG+L + L + + + ++ + + + L H I
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGE 206
+HRD+KP N+L+ IKL DFG++ + M + GT +M+PE
Sbjct: 127 MHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQG------- 177
Query: 207 KKHYNHK---------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
HY+ + P +EL ++ + D P +
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 252 LNYLSAIAPPEPMIPHRIFNSENTILPPESPGTSS 286
L+ + P I + N P G S
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 144 bits (365), Expect = 5e-42
Identities = 52/263 (19%), Positives = 93/263 (35%), Gaps = 47/263 (17%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHK----GETPEEIAKKESRFAREVAMLSRVQ-H 83
+G G + V +K + A+KI+ + EE+ + +EV +L +V H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 84 RNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
N+++ + +V +L+ G L YL L + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALH 127
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTL 202
I+HRDLKPEN+LL +D IKL DFG + + E + GT ++APE+
Sbjct: 128 KLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 186
Query: 203 RQGEK------------------------------------KHYNHKNVRPSAENVPEEL 226
N++ P ++ + +
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246
Query: 227 SIILTSCWKEDPNARPNFTQIIQ 249
+++ P R + +
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-42
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 82/293 (27%)
Query: 31 RIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90
IG+G +V+ GK++ + VA+KI E ++ E+ ++H N++ FI
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFI 63
Query: 91 GACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH- 144
A + + +V++ G+L YL + V I AL A + LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 145 -------GIIHRDLKPENLLLTEDLKTIKLADFGLAR-----EESLTEMMTAETGTYRWM 192
I HRDLK +N+L+ ++ T +AD GLA +++ GT R+M
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 193 APELYSTVTLRQGEK--------------------------------------------- 207
APE+ + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 208 ---KHYNHKNVRPSAEN------VPEELSIILTSCWKEDPNARPNFTQIIQML 251
K + +RP+ N ++ I+ CW + AR +I + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 61/296 (20%)
Query: 12 ELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN---------QTVAIKIVHKGETPE 62
EL D +W + L +G +GEGA +V + VA+K++ T +
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 63 EIAKKESRFAREVAMLSRV-QHRNLVKFIGACKEPVMV-IVTELLSGGTLRKYLLNMRPR 120
++ S E+ M+ + +H+N++ +GAC + + ++ E S G LR+YL RP
Sbjct: 61 DL----SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 121 C--------------LDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIK 166
L + A +AR ME L S IHRDL N+L+TED +K
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMK 175
Query: 167 LADFGLAR---EESLTEMMTAETGTYRWMAPE-------------------LYSTVTLRQ 204
+ADFGLAR + T +WMAPE L+ TL
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 205 GEKKHYNHKNVR---------PSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251
+ + N EL +++ CW P+ RP F Q+++ L
Sbjct: 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-41
Identities = 60/261 (22%), Positives = 100/261 (38%), Gaps = 37/261 (14%)
Query: 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
P+ G +GEG+ + V + ++ AIKI+ K +E K RE ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE--NKVPYVTRERDVM 62
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
SR+ H VK ++ + G L KY+ + D + +I A
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSA 120
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWMAP 194
+E LH GIIHRDLKPEN+LL ED I++ DFG A+ ES + GT ++++P
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 195 ELYST-------------VTLR---------QGEKKH---YNHKNVRPSA-ENVPEELSI 228
EL + + + ++ + E +
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 229 ILTSCWKEDPNARPNFTQIIQ 249
++ D R ++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEG 260
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-41
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 59/295 (20%)
Query: 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESR 70
KW L +G +G GA +V E +TVA+K++ +G T E +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE---HRAL 63
Query: 71 FAREVAMLSRVQHRNLVKFIGACKEP--VMVIVTELLSGGTLRKYLLNMR---------- 118
+ ++ H N+V +GAC +P ++++ E G L YL + R
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 119 ----PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174
L + I ++ +A+ ME L S IHRDL N+LL+E +K+ DFGLAR
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLAR 182
Query: 175 EESLTEMMTAET---GTYRWMAPEL-----------------------------YSTVTL 202
+ + +WMAPE Y V +
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 203 RQGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257
+ + + + E+ + CW +P+ RP F+++++ L N L A
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-41
Identities = 75/338 (22%), Positives = 128/338 (37%), Gaps = 56/338 (16%)
Query: 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESR 70
L++ +ID + +G G + KV + K + A+K++ + +
Sbjct: 2 LQIKKNAIID-DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPK 50
Query: 71 FAREVAMLSRV-QHRNLVKFIGACK-----EPVMVIVTELLSGGTLRKYLLNMRPRCLDV 124
REV + R Q ++V+ + + ++IV E L GG L + + +
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110
Query: 125 CVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREESLTEMM 182
A I A++ LHS I HRD+KPENLL T +KL DFG A+E + +
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 183 TAETGTYRWMAPELYST----------------VTLRQGEKKHYNHKNV----------- 215
T T ++APE+ L G Y++ +
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 216 -------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPPEPMIPHR 268
P V EE+ +++ + K +P R T+ + S P P+ R
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSR 290
Query: 269 IFNSENTILPP-ESPGTSSLMTVRDDIGETPKAKMGDK 305
+ + + TS+L T+R D + K+ D
Sbjct: 291 VLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 46/264 (17%), Positives = 99/264 (37%), Gaps = 45/264 (17%)
Query: 24 KHLF----VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAM 77
K L+ + +G G V+ +T K V T + +E+++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISI 54
Query: 78 LSRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
L+ +HRN++ + + +V++ E +SG + + + N L+ + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCE 113
Query: 137 AMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
A++ LHSH I H D++PEN++ TIK+ +FG AR+ + + APE
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 196 LYST-------------VTL------------RQGEKKHYNHKNVRPS-----AENVPEE 225
++ + ++ N N + + + E
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 226 LSIILTSCWKEDPNARPNFTQIIQ 249
+ ++ +R ++ +Q
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 2e-40
Identities = 59/264 (22%), Positives = 109/264 (41%), Gaps = 42/264 (15%)
Query: 22 DPKHLF-VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAML 78
D + ++ +G GA ++V + K + VAIK + K + + KE E+A+L
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVL 61
Query: 79 SRVQHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARA 137
+++H N+V + + ++ +L+SGG L + + A + A
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDA 119
Query: 138 MECLHSHGIIHRDLKPENLLLTEDLK--TIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
++ LH GI+HRDLKPENLL + I ++DFGL++ E +++ GT ++APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179
Query: 196 -------------------LYSTVTLR---QGEK--------KHYNHKNVRPSAENVPEE 225
Y + E ++ P +++ +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 226 LSIILTSCWKEDPNARPNFTQIIQ 249
+ ++DP R Q +Q
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-40
Identities = 58/251 (23%), Positives = 94/251 (37%), Gaps = 33/251 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGE-TPEEIAKKESRFAREVAMLSRVQ-- 82
VGP +G G VY G N VAIK V K + +R EV +L +V
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+++ + + P V++ E + R L +A F + A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHC 126
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE------ 195
H+ G++HRD+K EN+L+ + +KL DFG + T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHR 185
Query: 196 --------------LYSTVTLR---QGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDP 238
LY V + +++ + + V E ++ C P
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR--QRVSSECQHLIRWCLALRP 243
Query: 239 NARPNFTQIIQ 249
+ RP F +I
Sbjct: 244 SDRPTFEEIQN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 60/259 (23%), Positives = 91/259 (35%), Gaps = 39/259 (15%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGET-PEEIAKKESRFAREVAMLSRVQHR 84
G +G G A V + + K A K + K T REV++L +QH
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
N++ + ++++ EL++GG L + L A F I + LHS
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDF--LAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 144 HGIIHRDLKPENLLLTED---LKTIKLADFGLAREESLTEMMTAETGTYRWMAPE----- 195
I H DLKPEN++L + IK+ DFGLA + GT ++APE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 196 --------------LYSTVTLR---QGEKKHYNHKNV--------RPSAENVPEELSIIL 230
Y ++ G+ K NV N +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 231 TSCWKEDPNARPNFTQIIQ 249
+DP R +Q
Sbjct: 252 RRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 1e-37
Identities = 55/276 (19%), Positives = 93/276 (33%), Gaps = 57/276 (20%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+G +IG G+ +Y G + VAIK+ K + E + +Q
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIYKMMQGGV 63
Query: 86 LVKFIGAC--KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
+ I C + V+V ELL + R + + A + +E +HS
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS 121
Query: 144 HGIIHRDLKPENLL--LTEDLKTIKLADFGLAR--------EESLTEMMTAETGTYRWMA 193
IHRD+KP+N L L + + + DFGLA+ + TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 194 PELYST-------------------------------VTLRQGEKKHYNHKNVRPSAE-- 220
+ T RQ ++ K P
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 221 -NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
P E + L C + +P+++ + Q+ N
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-37
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 34/251 (13%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
+ +G+G+ KV+ ++K NQ AIK + K + E + + +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPF 64
Query: 86 LVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH 144
L + + V E L+GG L ++ + D+ A +A +I ++ LHS
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK 122
Query: 145 GIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-MMTAETGTYRWMAPE-------- 195
GI++RDLK +N+LL +D IK+ADFG+ +E L + GT ++APE
Sbjct: 123 GIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 196 -----------LYSTVTLR-------QGEKKHYNHKNVRPSAENVPEELSIILTSCWKED 237
LY + + + E H + + +E +L + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE 241
Query: 238 PNARPNFTQII 248
P R I
Sbjct: 242 PEKRLGVRGDI 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 130 bits (327), Expect = 1e-36
Identities = 54/279 (19%), Positives = 101/279 (36%), Gaps = 49/279 (17%)
Query: 23 PKHLF----VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVA 76
P HL +G +G G ++V+ + ++ VA+K++ + RF RE
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP--SFYLRFRREAQ 59
Query: 77 MLSRVQHRNLVKFIGACKE-----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFA 131
+ + H +V + P+ IV E + G TLR + P + AI
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI 117
Query: 132 LDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREESLTEMMTAETGT 188
D +A+ H +GIIHRD+KP N++++ +A + A GT
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 189 YRWMAPELYST----------------------------VTLRQGEKKHYNHKNVRPSA- 219
++++PE + +H + PSA
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 220 -ENVPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYLS 256
E + +L ++ ++P R ++ L+ +
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (327), Expect = 2e-36
Identities = 55/276 (19%), Positives = 96/276 (34%), Gaps = 55/276 (19%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN 85
VG RIGEG+ ++EG NQ VAIK + ++ R +L+
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGCTGIP 64
Query: 86 LVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG 145
V + G V+V +LL G + LL++ R V A + ++ +H
Sbjct: 65 NVYYFGQEGLH-NVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 146 IIHRDLKPENLLLTEDLK----TIKLADFGLAR--------EESLTEMMTAETGTYRWMA 193
+++RD+KP+N L+ I + DFG+ + + +GT R+M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 194 PELY-------------------------------STVTLRQGEKKHYNHKNVRPSAE-- 220
+ T +Q ++ K P E
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 221 -NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255
PEE + +A P++ + + L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 4e-36
Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 36/245 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V+ + + + A+K++ K K+ E MLS V H +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTNDERLMLSIVTHPFIIR 68
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
G ++ + ++ + + GG L + + VA +A ++ A+E LHS II
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 126
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST-------- 199
+RDLKPEN+LL ++ IK+ DFG A+ + ++ GT ++APE+ ST
Sbjct: 127 YRDLKPENILLDKNG-HIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 200 -----VTLRQ--GEKKHYNHKNVR-----------PSAENVPEELSIILTSCWKEDPNAR 241
+ + + + N E++ +L+ D + R
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 243
Query: 242 PNFTQ 246
Q
Sbjct: 244 LGNLQ 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 127 bits (321), Expect = 8e-35
Identities = 50/246 (20%), Positives = 92/246 (37%), Gaps = 38/246 (15%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKES-RFAREVAMLSRVQHRNLV 87
IG G +VY + + A+K + K + + + ++++S +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 88 KFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGI 146
A P + + +L++GG L +L A +I +E +H+ +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHMHNRFV 128
Query: 147 IHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE----------- 195
++RDLKP N+LL E ++++D GLA + S + A GT+ +MAPE
Sbjct: 129 VYRDLKPANILLDEH-GHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 196 ---------LYSTVTLR----------QGEKKHYNHKNVRPSAENVPEELSIILTSCWKE 236
L+ + + E ++ EL +L +
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 237 DPNARP 242
D N R
Sbjct: 247 DVNRRL 252
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-33
Identities = 58/187 (31%), Positives = 80/187 (42%), Gaps = 25/187 (13%)
Query: 28 VGPR------IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79
VGPR IGEGA+ V VAIK + E R RE+ +L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ----RTLREIKILL 61
Query: 80 RVQHRNLVKFIGACKEP-----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDI 134
R +H N++ + P V + L G L K L + + L F I
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQI 118
Query: 135 ARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR----EESLTEMMTAETGTYR 190
R ++ +HS ++HRDLKP NLLL +K+ DFGLAR + T +T T
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 191 WMAPELY 197
+ APE+
Sbjct: 178 YRAPEIM 184
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-32
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 19/176 (10%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
IG G+ VY+ K + VAIK V + + RE+ ++ ++ H N+V+
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQ---------DKRFKNRELQIMRKLDHCNIVRL 78
Query: 90 IGACKEP-------VMVIVTELLSGGTLRKYLLNMRPR-CLDVCVAIGFALDIARAMECL 141
+ +V + + R R + L V + + R++ +
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
HS GI HRD+KP+NLLL D +KL DFG A++ E + + + APEL
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-32
Identities = 59/243 (24%), Positives = 94/243 (38%), Gaps = 35/243 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G+G KV + K + A+KI+ K + + + E +L +H L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK--DEVAHTVTESRVLQNTRHPFLTA 69
Query: 89 FIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
A + + V E +GG L +L R R A + +I A+E LHS ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELYST------- 199
+RD+K ENL+L +D IK+ DFGL +E S M GT ++APE+
Sbjct: 128 YRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 200 ------VTLRQ------------GEKKHYNHKNVRPSA-ENVPEELSIILTSCWKEDPNA 240
V + + E+ + E +L K+DP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 246
Query: 241 RPN 243
R
Sbjct: 247 RLG 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-32
Identities = 60/281 (21%), Positives = 99/281 (35%), Gaps = 64/281 (22%)
Query: 31 RIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLV 87
IGEGA+ KV++ + + VA+K V E + R + L +H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 88 KFIGAC------KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ C +E + +V E + YL + + + R ++ L
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYST-- 199
HSH ++HRDLKP+N+L+T IKLADFGLAR S +T+ T + APE+
Sbjct: 133 HSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191
Query: 200 ---------------------------------------------------VTLRQGEKK 208
V L +
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 209 HYNHKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQ 249
+ + + ++ E +L C +P R + +
Sbjct: 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-31
Identities = 56/170 (32%), Positives = 78/170 (45%), Gaps = 7/170 (4%)
Query: 32 IGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+GEG A VY+ + K NQ VAIK + G E RE+ +L + H N++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 90 IGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ A + +V + + N A L + +E LH H I+H
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYLHQHWILH 123
Query: 149 RDLKPENLLLTEDLKTIKLADFGLARE-ESLTEMMTAETGTYRWMAPELY 197
RDLKP NLLL E+ +KLADFGLA+ S T + T + APEL
Sbjct: 124 RDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 4e-31
Identities = 39/176 (22%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HR 84
+ ++G G +++V+E N+ V +KI+ K+ + RE+ +L ++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGP 90
Query: 85 NLVKFIGACKEPV---MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
N++ K+PV +V E ++ ++ + L + +I +A++
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 145
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
HS GI+HRD+KP N+++ + + ++L D+GLA + + + PEL
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 6e-30
Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 22/183 (12%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IG+G +V++ +++ Q VA+K V E RE+ +L ++H N+V
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIKILQLLKHENVVN 73
Query: 89 FIGACKEPV---------MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAME 139
I C+ + +V + + L + + +
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV--MQMLLNGLY 131
Query: 140 CLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAP 194
+H + I+HRD+K N+L+T D +KLADFGLAR SL + T T + P
Sbjct: 132 YIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 195 ELY 197
EL
Sbjct: 191 ELL 193
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (282), Expect = 6e-30
Identities = 53/250 (21%), Positives = 93/250 (37%), Gaps = 16/250 (6%)
Query: 31 RIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKF 89
+IGEG + VY+ + +T A+K + + E I RE+++L ++H N+VK
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSNIVKL 65
Query: 90 IGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHR 149
+++ L+K L L+ A F L + + H ++HR
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 150 DLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKK- 208
DLKP+NLL+ + +K+ADFGLAR + W + +
Sbjct: 125 DLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 209 -------HYNHKNVRP--SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIA 259
N P + ++L I + PN T++ + N+
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 260 PPEPMIPHRI 269
P +
Sbjct: 244 LPWESFLKGL 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-29
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 7/170 (4%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + VY+ + K + VA+K + E + RE+++L + H N+VK
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS---TAIREISLLKELNHPNIVK 65
Query: 89 FIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIH 148
+ + + L+K++ + + + + + + + HSH ++H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 149 RDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMTAETGTYRWMAPELY 197
RDLKP+NLL+ + IKLADFGLAR + T E T + APE+
Sbjct: 126 RDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (277), Expect = 1e-28
Identities = 55/242 (22%), Positives = 88/242 (36%), Gaps = 36/242 (14%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G G+ +V K+K A+KI+ K + + K+ E +L V LVK
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL--KQIEHTLNEKRILQAVNFPFLVK 105
Query: 89 FIGACKEPVMVI-VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ K+ + V E ++GG + +L R A +A I E LHS +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPEL----------- 196
+RDLKPENLL+ + I++ DFG A+ GT +APE+
Sbjct: 164 YRDLKPENLLIDQQ-GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 197 --------YSTVTLR-------QGEKKHYNHKNVRPSAENVPEELSIILTSCWKEDPNAR 241
Y + + +L +L + + D R
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
Query: 242 PN 243
Sbjct: 281 FG 282
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 10/171 (5%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+IGEG + V++ K + ++ VA+K V + E + RE+ +L ++H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVR 65
Query: 89 FIGACKEPV-MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGII 147
+ +V E + + ++ + + + + HS ++
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSRNVL 123
Query: 148 HRDLKPENLLLTEDLKTIKLADFGLAREESL-TEMMTAETGTYRWMAPELY 197
HRDLKP+NLL+ + +KLA+FGLAR + +AE T + P++
Sbjct: 124 HRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-27
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 18/174 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
IG GA V ++ VAIK + + + AK R RE+ ++ V H+N++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNIIS 80
Query: 89 FIGACKEPVMV-------IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ + +V EL+ + + + + ++ L
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLCGIKHL 135
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPE 195
HS GIIHRDLKP N+++ D T+K+ DFGLAR + MMT T + APE
Sbjct: 136 HSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-25
Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 19/176 (10%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V VAIK +++ E AK R RE+ +L ++H N++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHENVIG 81
Query: 89 FIGACKEP-------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ +V + GT L+ L + + + +
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYI 137
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
H+ GIIHRDLKP NL + ED + +K+ DFGLAR+ MT T + APE+
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 3e-25
Identities = 53/253 (20%), Positives = 97/253 (38%), Gaps = 45/253 (17%)
Query: 31 RIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHR- 84
+G GA+ KV+ + + A+K++ K ++ AK E +L ++
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSP 89
Query: 85 NLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS 143
LV A + + ++ + ++GG L +L + +I A+E LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK 147
Query: 144 HGIIHRDLKPENLLLTEDLKTIKLADFGLARE--ESLTEMMTAETGTYRWMAPE------ 195
GII+RD+K EN+LL + + L DFGL++E TE GT +MAP+
Sbjct: 148 LGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 196 ---------------LYSTVTLR---QGEKKHYNHKNVR--------PSAENVPEELSII 229
+Y +T + + + + P + + +
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 266
Query: 230 LTSCWKEDPNARP 242
+ +DP R
Sbjct: 267 IQRLLMKDPKKRL 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 1e-23
Identities = 50/175 (28%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 31 RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVK 88
+G GA+ V VA+K + + AK R RE+ +L ++H N++
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIG 81
Query: 89 FIGACK------EPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLH 142
+ E V + L G L ++ + L I R ++ +H
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 143 SHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELY 197
S IIHRDLKP NL + ED +K+ DFGLAR + MT T + APE+
Sbjct: 139 SADIIHRDLKPSNLAVNED-CELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 2e-23
Identities = 31/154 (20%), Positives = 55/154 (35%), Gaps = 12/154 (7%)
Query: 28 VGPRIGEGAHAKVYEGKYKN-QTVAIKIVHKGETPEEIAK-----KESRFAREVAMLSRV 81
+G +GEG + V+ + +K G T + K + F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 82 QHRNLVKFIGACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECL 141
+ R L K G + V L + + + V I +
Sbjct: 64 EFRALQKLQGLA----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175
+ GI+H DL N+L++E+ I + DF + E
Sbjct: 120 YHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVE 151
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.7 bits (195), Expect = 2e-17
Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 15/187 (8%)
Query: 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREV-----AMLSR 80
+ ++G G + V+ K N VA+KIV + E A+ E + + V
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 81 VQHRNLVKFIGACKEP----VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIAR 136
+ +++K + V V++ + G L + R + + + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 137 AMECLH-SHGIIHRDLKPENLLLTEDLKTIKLADFGLAR---EESLTEMMTAETGTYRWM 192
++ +H GIIH D+KPEN+L+ L +A E T T +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 193 APELYST 199
+PE+
Sbjct: 197 SPEVLLG 203
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 317 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.55 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.45 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=365.59 Aligned_cols=235 Identities=30% Similarity=0.523 Sum_probs=190.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
+.|+|++++|++.++||+|+||+||+|++++ .||||+++...... ...+.|.+|+.++++++|||||++++++.++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 76 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP---QQLQAFKNEVGVLRKTRHVNILLFMGYSTAP 76 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT---THHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence 3689999999999999999999999998765 59999997654433 2345789999999999999999999999888
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++|||||++|+|.+++..... .+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVK 154 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC-
T ss_pred EEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeec
Confidence 89999999999999999976443 49999999999999999999999999999999999999998 79999999999865
Q ss_pred ccc---cccccccCccceecccccccccc--cccccccccCC-----------------------------CCC----CC
Q 021127 177 SLT---EMMTAETGTYRWMAPELYSTVTL--RQGEKKHYNHK-----------------------------NVR----PS 218 (317)
Q Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~~-----------------------------~~~----~~ 218 (317)
... .......||+.|+|||++.+... .....++|+.+ ... ..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 322 22345679999999999864221 11222333222 111 12
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.++|+++.+||.+||+.||++|||+.+++++|+.+.+.
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 457889999999999999999999999999999987754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=361.61 Aligned_cols=235 Identities=28% Similarity=0.506 Sum_probs=197.9
Q ss_pred cCCceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 15 LDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 15 ~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.++.|+|+.++|++.++||+|+||+||+|.++ ++.||||++...... .+.|.+|+.++++++|||||+++|++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS------PDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC------HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 46789999999999999999999999999997 678999999765433 23589999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++|||||++|+|.+++.......+++..++.|+.||+.||+|||+++|+||||||+||||+.+ +.+||+|||+|
T Consensus 78 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla 156 (272)
T d1qpca_ 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLA 156 (272)
T ss_dssp CSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred ccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccce
Confidence 88889999999999999998876544459999999999999999999999999999999999999998 69999999999
Q ss_pred ccccccc--ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
+...... ......||+.|+|||++.+..+.. ..++|+.+ ...+.+..+
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~-~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred EEccCCccccccccCCcccccChHHHhCCCCCc-hhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccC
Confidence 8654332 234457899999999876543321 12222211 233446789
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
++++.+|+.+||+.||++|||++++++.|++++.+
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999999999999999988764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-52 Score=360.11 Aligned_cols=232 Identities=28% Similarity=0.525 Sum_probs=194.7
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
++|+|++++|++.++||+|+||+||+|.+. ++.||||+++..... .++|.+|+.++++++|||||+++|++.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch------HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 469999999999999999999999999985 889999998765432 235899999999999999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
++ ..++|||||++|+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a 162 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLS 162 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCT
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccce
Confidence 65 89999999999999999987666679999999999999999999999999999999999999988 79999999999
Q ss_pred ccccccc--ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCC
Q 021127 174 REESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENV 222 (317)
Q Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 222 (317)
+...... ......|++.|+|||++.+..+.. ..++|+.+ ...+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccc
Confidence 8654332 223345789999999876543321 12222211 223446789
Q ss_pred hHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 223 PEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 223 ~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
|+++.+||.+||+.||++|||++++++.|+.++.
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999887654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=349.73 Aligned_cols=228 Identities=28% Similarity=0.508 Sum_probs=182.4
Q ss_pred eecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-Cc
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-PV 97 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 97 (317)
.|++++|++.++||+|+||+||+|++. ++.||||+++...... ++|.+|+.++++++|||||+++|++.+ +.
T Consensus 1 ~idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (263)
T d1sm2a_ 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74 (263)
T ss_dssp CBCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CCChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH------HHHHHHHHHHHhcCCCCcccccceeccCCc
Confidence 378999999999999999999999986 7889999998654432 358999999999999999999999875 48
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.++|||||++|+|.+++.... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVL 152 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC------
T ss_pred eEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheecc
Confidence 999999999999999987643 348999999999999999999999999999999999999998 689999999998654
Q ss_pred cccc--cccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChHHH
Q 021127 178 LTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPEEL 226 (317)
Q Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l 226 (317)
.... .....||+.|+|||++.+..+.. ..++|+.+ .....+..+++++
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l 231 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence 3322 23356899999999987644332 22332222 2233466789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 227 SIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 227 ~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.+|+.+||+.||++|||+++++++|+++.+
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=355.15 Aligned_cols=220 Identities=26% Similarity=0.364 Sum_probs=182.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||+||+|++. ++.||||++......+ ..+++.+|+.++++++|||||++++++.++ ..|+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch----HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 57999999999999999999985 8999999998654322 234688999999999999999999999765 8899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 vmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCC
Confidence 999999999999997544 39999999999999999999999999999999999999988 68999999999864322
Q ss_pred --cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 180 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 180 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
......+||+.|+|||++.+........++|+.+ ........++.++.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 2334568999999999987765544444555433 11112346789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+||.+||+.||++|||++|+++|
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=350.72 Aligned_cols=225 Identities=24% Similarity=0.426 Sum_probs=188.4
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
+|.| ++|++.+.||+|+||+||+|++. ++.||||++.+....+ ......+.+|++++++++|||||++++++.+
T Consensus 2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK--AGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC--hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 3544 47999999999999999999985 8899999987532211 1234568899999999999999999999987
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..++|||||++|+|.+++..... +++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~ 154 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSV 154 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCS
T ss_pred CCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceee
Confidence 5 89999999999999999987655 9999999999999999999999999999999999999988 789999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHH
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~ 227 (317)
..... ......||+.|+|||++.+..+. ...++|+.+ .....+..++++++
T Consensus 155 ~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 232 (263)
T d2j4za1 155 HAPSS-RRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 232 (263)
T ss_dssp CCCCC-CCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHH
T ss_pred ecCCC-cccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHH
Confidence 65433 23456899999999999875543 334444433 12234567899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
+||.+||+.||.+|||++|+++|-
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred HHHHHHccCCHhHCcCHHHHHcCc
Confidence 999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=353.42 Aligned_cols=234 Identities=27% Similarity=0.498 Sum_probs=191.3
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
..|+|+.++|++++.||+|+||+||+|+++ ++.||||++....... +.|.+|+.++++++|||||+++|++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~------~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH------HHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 468899999999999999999999999987 5789999997655432 358999999999999999999999988
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+..++|||||++|+|..++.......+++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL 162 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhh
Confidence 889999999999999999876554559999999999999999999999999999999999999988 6999999999986
Q ss_pred ccccc--ccccccCccceecccccccccccccccccccCC-----------------------------CCCCCCCCChH
Q 021127 176 ESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPSAENVPE 224 (317)
Q Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~ 224 (317)
..... ......||+.|+|||++.+..... ..++|+.+ ...+.+..+++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCH
T ss_pred ccCCCceeeccccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCH
Confidence 53322 233456899999999876543322 12222211 23455778999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 225 ELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 225 ~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
++.+||.+||+.||++||++++|++.|++++...
T Consensus 242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999999999999999887654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=351.85 Aligned_cols=218 Identities=25% Similarity=0.417 Sum_probs=184.1
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
.++|++.++||+|+||+||+|.+. |+.||||++....... .+.+.+|+.++++++|||||++++++.++ ..|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-----HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence 358999999999999999999875 8999999998654332 34688999999999999999999999765 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT 179 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~ 179 (317)
+|||||+||+|.+++.+. .+++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeeccc
Confidence 999999999999988753 39999999999999999999999999999999999999988 79999999999865433
Q ss_pred -cccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHHH
Q 021127 180 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~ 228 (317)
......+||+.|+|||++.+..+.. ..++|+.+ .....+..++.++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHH
Confidence 3345567999999999988755432 33444332 112234568899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||.+||+.||.+|||++|+++|
T Consensus 249 li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999887
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=344.67 Aligned_cols=234 Identities=24% Similarity=0.488 Sum_probs=190.7
Q ss_pred ceeecCCceeecce-eccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPR-IGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~-lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
+|.+..++|.+.+. ||+|+||+||+|.+. +..||||+++...... ..++|.+|++++++++|||||+++|+
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA----DTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH----HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH----HHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 56788899999985 999999999999764 4579999998665432 35579999999999999999999999
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.++..++|||||++|+|.+++...+ ..+++..++.|+.||+.||+|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 78 ~~~~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGl 155 (285)
T d1u59a_ 78 CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGL 155 (285)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTT
T ss_pred eccCeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchh
Confidence 98888999999999999999986543 349999999999999999999999999999999999999988 7999999999
Q ss_pred cccccccc----ccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCC
Q 021127 173 AREESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAE 220 (317)
Q Consensus 173 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~ 220 (317)
++...... ......||+.|+|||++.+..+.. +..++.. .+...+.+.
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 235 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 235 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 98653322 223456899999999876432211 1111110 112334567
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+|.++.+||.+||+.||++|||+.++++.|+.....
T Consensus 236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 8999999999999999999999999999988876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=354.94 Aligned_cols=240 Identities=28% Similarity=0.448 Sum_probs=191.1
Q ss_pred cccceecCCceeecCCceeecceeccccceEEEEeEECC-------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYKN-------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.+.++..+..|+|++++|+++++||+|+||+||+|++.+ ..||+|.+...... .....+.+|+.++.++
T Consensus 22 ~~~~~~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l 97 (325)
T d1rjba_ 22 DFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS----SEREALMSELKMMTQL 97 (325)
T ss_dssp CGGGSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHH
T ss_pred ChhhcCCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH----HHHHHHHHHHHHHHHh
Confidence 445677788999999999999999999999999998742 36999998765432 2345689999999998
Q ss_pred -CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHH
Q 021127 82 -QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP---------------------RCLDVCVAIGFALDIARAM 138 (317)
Q Consensus 82 -~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~L 138 (317)
+|||||++++++.+. ..++|||||++|+|.++|..... ..+++..++.|+.||+.||
T Consensus 98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl 177 (325)
T d1rjba_ 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177 (325)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred cCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 899999999999765 89999999999999999976432 2489999999999999999
Q ss_pred HHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccc-----------
Q 021127 139 ECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQ----------- 204 (317)
Q Consensus 139 ~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~----------- 204 (317)
+|||++|||||||||+||+++.+ +.+||+|||+|+...... ......||+.|+|||++.+..+..
T Consensus 178 ~yLH~~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 178 EFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHhCCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 99999999999999999999998 799999999998654332 223456899999999875532221
Q ss_pred ------ccccccc------------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 205 ------GEKKHYN------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 205 ------~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+..++.. .+...+.+..+|+++++||.+||+.||++|||++||+++|..
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1111110 112234467889999999999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-50 Score=346.91 Aligned_cols=232 Identities=26% Similarity=0.449 Sum_probs=180.8
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--C---eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--N---QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+++.++|++.++||+|+||+||+|++. + ..||||.+....... ..++|.+|+.++++++|||||+++|++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK----QRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH----HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH----HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3578899999999999999999999884 2 358999887655533 345799999999999999999999999
Q ss_pred ecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 94 KEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 94 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
.++ ..++|||||++|+|.+++.... ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGl 174 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGL 174 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--
T ss_pred eeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCccc
Confidence 755 8999999999999999888643 349999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccccc------cccccCccceecccccccccccccccccccC-----------------------------CCCCC
Q 021127 173 AREESLTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRP 217 (317)
Q Consensus 173 a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 217 (317)
++....... .....||+.|+|||++.+..+... .++|+. ....+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 253 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 985433221 112357899999998765332211 111111 12344
Q ss_pred CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 218 SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 218 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+..+|.++.+||.+||+.||.+|||+.++++.|+++++.
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 5678899999999999999999999999999999988763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=339.25 Aligned_cols=224 Identities=29% Similarity=0.518 Sum_probs=186.5
Q ss_pred ecCCceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
|++++|++.++||+|+||+||+|+++ ++.||||+++...... ..|.+|+.++++++||||++++|++.++ ..
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~------~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH------HHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH------HHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 57899999999999999999999996 6789999998765432 3589999999999999999999999764 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
++||||+++|+|.+++..... .+++..++.|+.|+++||+|||++||+||||||+||+++.+ +.+||+|||+++....
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSS
T ss_pred EEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccC
Confidence 999999999999999876443 38999999999999999999999999999999999999998 6999999999985433
Q ss_pred ccc--cccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCChHHHH
Q 021127 179 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~ 227 (317)
... .....||+.|+|||++.+..+.. ..++|+. +...+.+..++.++.
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHH
Confidence 322 23356899999999876543321 1222211 123445778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLN 253 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~ 253 (317)
+||.+||+.||++|||+++++++|.+
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 99999999999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=343.11 Aligned_cols=233 Identities=29% Similarity=0.492 Sum_probs=183.1
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
.|+|++++|++.+.||+|+||.||+|++. +..||||.++..... .....|.+|+.++++++||||++++|+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH----HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 48999999999999999999999999874 356889988655443 335579999999999999999999999
Q ss_pred eecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 93 CKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 93 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
+.++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++.+ +.+||+|||+
T Consensus 77 ~~~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~ 154 (273)
T d1mp8a_ 77 ITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGL 154 (273)
T ss_dssp ECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC---
T ss_pred EecCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchh
Confidence 98889999999999999999887643 349999999999999999999999999999999999999998 6999999999
Q ss_pred cccccccc--ccccccCccceeccccccccccccccccccc-----------------------------CCCCCCCCCC
Q 021127 173 AREESLTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYN-----------------------------HKNVRPSAEN 221 (317)
Q Consensus 173 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 221 (317)
|+...... ......||+.|+|||++.+..+.. ..++|+ .+...+.+.+
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 233 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98654322 233456899999999876533221 111111 1123455778
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+|+++.+||.+||+.||++|||+.+|+++|..++..
T Consensus 234 ~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=342.18 Aligned_cols=230 Identities=26% Similarity=0.450 Sum_probs=181.4
Q ss_pred ecCCceeec-ceeccccceEEEEeEEC----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec
Q 021127 21 IDPKHLFVG-PRIGEGAHAKVYEGKYK----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE 95 (317)
Q Consensus 21 i~~~~y~~~-~~lG~G~~g~V~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 95 (317)
++.+.+.+. ++||+|+||+||+|.+. ++.||||+++...... ...++|.+|++++++++|||||+++|++.+
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~g~~~~ 79 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---ALKDELLAEANVMQQLDNPYIVRMIGICEA 79 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C---HHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH---HHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence 455556665 46999999999999763 4689999997544322 334579999999999999999999999988
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+..++|||||++|+|.+++..... +++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~ 156 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKA 156 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred CCEEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhh
Confidence 888999999999999999987554 9999999999999999999999999999999999999988 7999999999985
Q ss_pred cccc----cccccccCccceecccccccccccc-----------------ccccccc-----------CCCCCCCCCCCh
Q 021127 176 ESLT----EMMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKHYN-----------HKNVRPSAENVP 223 (317)
Q Consensus 176 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~~~~~~ 223 (317)
.... .......||+.|+|||++.+..+.. +..++.. .+...+.+..+|
T Consensus 157 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 236 (277)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence 4322 1223356899999999876533211 1111110 112344567899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 224 EELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 224 ~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
.++++||.+||+.||++|||+++|++.|+..+.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999999999999988887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=341.29 Aligned_cols=232 Identities=27% Similarity=0.471 Sum_probs=185.5
Q ss_pred eeecCCceeecceeccccceEEEEeEECC------eEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKN------QTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGA 92 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 92 (317)
-+|+++.|++.++||+|+||.||+|.+.+ ..||||++....... ...+|.+|+.++++++|||||+++|+
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK----QRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH----HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH----HHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 36888999999999999999999998742 479999997665533 34568999999999999999999999
Q ss_pred eecC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 93 CKEP-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 93 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.+. ..++|||||.+++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+.+ +.+||+|||
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG 155 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFG 155 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCC
T ss_pred EecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccc
Confidence 9764 8899999999999999887643 349999999999999999999999999999999999999998 699999999
Q ss_pred ccccccccc----ccccccCccceecccccccccccccccccccCC-----------------------------CCCCC
Q 021127 172 LAREESLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------NVRPS 218 (317)
Q Consensus 172 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~~~~~ 218 (317)
+++...... ......||+.|+|||++.+..+.. ..++|+.+ ...+.
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCC-cccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence 998643321 223346899999999876643322 12222211 23445
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+..++.++.+||.+||+.||++|||+.+|++.|+.+.+.
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 678899999999999999999999999999999988763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-50 Score=346.57 Aligned_cols=220 Identities=25% Similarity=0.366 Sum_probs=183.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.+.||+|+||+||+|++. ++.||||++....... ....+.+.+|+.++++++|||||++++++.++ ..|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS--NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 35999999999999999999875 8999999998765543 24456799999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|||||.+|+|..++...+. +++..++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB-
T ss_pred EEEecCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCCC-
Confidence 9999999999877665443 9999999999999999999999999999999999999988 79999999999865432
Q ss_pred ccccccCccceeccccccccc--ccccccccccCC-----------------------------CCCCCCCCChHHHHHH
Q 021127 181 MMTAETGTYRWMAPELYSTVT--LRQGEKKHYNHK-----------------------------NVRPSAENVPEELSII 229 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~l 229 (317)
....||+.|+|||++.+.. ......++|+.+ .....+..+|+++.+|
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 3468999999999986432 122234444433 1122345689999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHH
Q 021127 230 LTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 230 i~~cl~~~p~~Rps~~~~~~~l 251 (317)
|.+||+.||.+|||++++++|-
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHHCcCChhHCcCHHHHHhCH
Confidence 9999999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=346.52 Aligned_cols=220 Identities=27% Similarity=0.394 Sum_probs=181.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++++.||+|+||+||+|++. ++.||||++....... .+.+.+|++++++++|||||++++++.++ ..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-----LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG-----GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH-----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 46899999999999999999985 8899999998654332 34688999999999999999999998754 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT- 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~- 179 (317)
|||||++|+|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHH
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCCc
Confidence 999999999999987643 349999999999999999999999999999999999999988 79999999999754332
Q ss_pred cccccccCccceecccccccccc----cccccccccCC------------------------------CCCCCCCCChHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTL----RQGEKKHYNHK------------------------------NVRPSAENVPEE 225 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~~~------------------------------~~~~~~~~~~~~ 225 (317)
......+||+.|+|||++..... .....++|+.+ .....+..++.+
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHH
Confidence 23345689999999999753221 11223333322 112224578899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++||.+||+.||.+|||+.|+++|
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999887
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-50 Score=347.91 Aligned_cols=220 Identities=25% Similarity=0.384 Sum_probs=167.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
+.|++.+.||+|+||+||+|++. ++.||||++.+..... ....+.+|+.++++++|||||++++++.++ .+|+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG----KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56999999999999999999985 8899999998765432 234688999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC--CCCceEEcccCccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE--DLKTIKLADFGLAREESL 178 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~--~~~~~kl~Dfg~a~~~~~ 178 (317)
|||||+||+|.+++...+. +++..+..++.||+.||+|||++||+||||||+||++.. +.+.+||+|||+++....
T Consensus 85 vmE~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EECCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEeccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999986544 999999999999999999999999999999999999963 226899999999987665
Q ss_pred ccccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~ 227 (317)
.......+||+.|+|||++.+..+.. ..++|+.+ ...+....+|+++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCc-HHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 55556678999999999987754432 23333322 11223457899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q 021127 228 IILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+||.+||+.||.+|||++|+++|
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=338.83 Aligned_cols=218 Identities=28% Similarity=0.477 Sum_probs=178.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-----Cc
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE-----PV 97 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 97 (317)
-|++.++||+|+||+||+|.+. ++.||+|.+....... ...+++.+|++++++++|||||++++++.+ ..
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK---SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3478889999999999999986 7899999998755433 235578999999999999999999999853 25
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHG--IIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
+++|||||++|+|.+++.+... +++..+..|+.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+|+.
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 8999999999999999987654 999999999999999999999998 999999999999975337899999999986
Q ss_pred cccccccccccCccceecccccccccccccccccccCC----------------------------CC--CCCCCCChHH
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NV--RPSAENVPEE 225 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~--~~~~~~~~~~ 225 (317)
.... .....+||+.|+|||++.+. .....++|+.+ .. ...+...+++
T Consensus 165 ~~~~-~~~~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 165 KRAS-FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp CCTT-SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ccCC-ccCCcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 4433 33456899999999998653 22223333322 00 1113456789
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++||.+||+.||++|||++|+++|
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=342.62 Aligned_cols=223 Identities=24% Similarity=0.377 Sum_probs=175.0
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec---Cc
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE---PV 97 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~ 97 (317)
.++|++.+.||+|+||+||+|++. |+.||||++......+ ...+.+.+|++++++++|||||++++++.+ +.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH---HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH---HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCE
Confidence 368999999999999999999885 8899999998765443 234578999999999999999999998853 36
Q ss_pred eEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCcEEeeCCCCceEEccc
Q 021127 98 MVIVTELLSGGTLRKYLLNM--RPRCLDVCVAIGFALDIARAMECLHSHG-----IIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~-----ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
+|+|||||++|+|.+++.+. ....+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DF 158 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 158 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeec
Confidence 89999999999999998753 2345999999999999999999999976 9999999999999998 79999999
Q ss_pred Ccccccccc-cccccccCccceecccccccccccccccccccCC----------------------------CCCCCCCC
Q 021127 171 GLAREESLT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVRPSAEN 221 (317)
Q Consensus 171 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~ 221 (317)
|+++..... ......+||+.|+|||++.+..+.. ..++|+.+ .....+..
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCCh-HHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 999865433 2334568999999999987654432 22333222 22344668
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++++.+||.+||+.||.+|||++|+++|
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 89999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=347.61 Aligned_cols=223 Identities=25% Similarity=0.302 Sum_probs=188.6
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
.-++|++++.||+|+||+||+|++. ++.||||++.+..... ......+.+|+.++++++||||+++++++.+. .+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA--KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 3468999999999999999999985 8999999997542211 12245688999999999999999999999876 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+|||||+||+|.+++...+. +++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred ccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeeccccccccc
Confidence 999999999999999987665 9999999999999999999999999999999999999998 7999999999986433
Q ss_pred -ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHH
Q 021127 179 -TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIIL 230 (317)
Q Consensus 179 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li 230 (317)
.......+||+.|+|||++.+..+.. ..++|+.+ .....+..++.++++||
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~-~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccceeCHHHhhhhhccCCCCCh-hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHH
Confidence 33445678999999999998766533 44555443 22344678999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHHH
Q 021127 231 TSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 231 ~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
.+||+.||.+||+ +.++++|
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhhccCCchhhcccccccHHHHHcC
Confidence 9999999999995 8899887
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=347.02 Aligned_cols=224 Identities=26% Similarity=0.350 Sum_probs=183.1
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ce
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VM 98 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 98 (317)
.+++|++++.||+|+||+||+|++. ++.||||++.+..... ......+.+|++++++++||||+++++++.++ ..
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 4578999999999999999999985 8899999997532211 12245689999999999999999999999765 89
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL 178 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~ 178 (317)
|+|||||+||+|.+++...+. +++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC-
T ss_pred EEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceeccc
Confidence 999999999999999987665 9999999999999999999999999999999999999988 7899999999986542
Q ss_pred c---cccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHH
Q 021127 179 T---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 179 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~ 228 (317)
. ......+||+.|+|||++.+..+.. ..++|+.+ .....+..+++++++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 239 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred CCcccccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 2 2334567999999999987654432 23333322 112345678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l 251 (317)
||.+||+.||.+|||++|++++.
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHH
T ss_pred HHHHHccCCHhHCcCHHHHcCCH
Confidence 99999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=348.91 Aligned_cols=223 Identities=21% Similarity=0.349 Sum_probs=182.3
Q ss_pred eecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP- 96 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 96 (317)
+|..++|++.++||+|+||+||+|++. ++.||||+++...... ...++.+|+.++++++|||||++++++.+.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 77 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 77 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT----HHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 355689999999999999999999985 8999999998765433 245689999999999999999999999765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSH-GIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
..++|||||+||+|.+++.+.+. +++..+..++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHH
T ss_pred EEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccc
Confidence 89999999999999999987654 99999999999999999999975 99999999999999988 7999999999986
Q ss_pred cccccccccccCccceecccccccccccccccccccCC--------CC--------------------------------
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV-------------------------------- 215 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~-------------------------------- 215 (317)
.... ...+.+||+.|+|||++.+..+.. ..++|+.+ ..
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCSCCCT-THHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 5432 334568999999999987644332 22222211 00
Q ss_pred -------------------------------CCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 021127 216 -------------------------------RPSAENVPEELSIILTSCWKEDPNARPNFTQIIQML 251 (317)
Q Consensus 216 -------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l 251 (317)
......++.++.+||.+||+.||.+|||++|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 000123578899999999999999999999999983
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=337.87 Aligned_cols=227 Identities=29% Similarity=0.530 Sum_probs=183.9
Q ss_pred eeecCCceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec--C
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE--P 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 96 (317)
|+|+.++|++.++||+|+||.||+|+++|..||||+++.... .+.|.+|++++++++||||++++|++.+ +
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-------HHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 899999999999999999999999999999999999976543 2358899999999999999999998853 3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.+++||||+++|+|.+++.......+++..++.|+.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 153 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceec
Confidence 68999999999999999976544458999999999999999999999999999999999999998 78999999999865
Q ss_pred ccccccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCCChHHHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAENVPEELS 227 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~ 227 (317)
... .....++..|+|||++.+..+.. ..++|+. +...+.+..++++++
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred CCC--CccccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 433 23456899999999876533221 1122211 123344677899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 228 IILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
+||.+||+.||.+|||+.+++++|+.+..
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=340.78 Aligned_cols=235 Identities=29% Similarity=0.536 Sum_probs=181.4
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVK 88 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 88 (317)
.+|+|+.++|++.++||+|+||.||+|++. ++.||||++....... ..+.+.+|...+.++ +|+||+.
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~----~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS----EHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH----HHHHHHHHHHHHHhhcCCCeEEE
Confidence 368899999999999999999999999863 4689999997655433 245678888888877 7899999
Q ss_pred EEeeeecC--ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021127 89 FIGACKEP--VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLK 152 (317)
Q Consensus 89 l~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlk 152 (317)
+++++.+. ..++|||||++|+|.+++.... ...+++..++.|+.||+.||+|||++||||||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 99988643 6899999999999999997542 2348999999999999999999999999999999
Q ss_pred CCcEEeeCCCCceEEcccCcccccccc---cccccccCccceecccccccccccccccccccC-----------------
Q 021127 153 PENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH----------------- 212 (317)
Q Consensus 153 p~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~----------------- 212 (317)
|+|||++.+ +.+||+|||+|+..... .......||+.|+|||++.+..+.. ..++|+.
T Consensus 162 p~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 162 ARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp GGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCC
Confidence 999999988 79999999999854322 2234457999999999876533221 1111111
Q ss_pred -------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 -------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 -------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+...+.+..+++++.+||.+||+.||++|||+++++++|+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 122334667899999999999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-49 Score=347.98 Aligned_cols=220 Identities=22% Similarity=0.353 Sum_probs=183.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|++. |+.||||++..... ...+.+.+|+.++++++|||||++++++.+. .+++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 47999999999999999999985 89999999976542 2245688999999999999999999998765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-CCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~ 179 (317)
|||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+++.....
T Consensus 101 vmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999999996533 339999999999999999999999999999999999999742 268999999999877666
Q ss_pred cccccccCccceecccccccccccccccccccCC----------------------------C---CCCCCCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------N---VRPSAENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~---~~~~~~~~~~~l~~ 228 (317)
.......||+.|+|||++.+..+.. ..++|+.+ . .......+++++++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCCh-hHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 6666778999999999987654432 23333322 0 01112457899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||.+||+.||++|||++|+++|
T Consensus 259 li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999997
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-48 Score=332.49 Aligned_cols=225 Identities=24% Similarity=0.340 Sum_probs=188.3
Q ss_pred CCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCCh----HHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec
Q 021127 23 PKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETP----EEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE 95 (317)
Q Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 95 (317)
.++|++.+.||+|+||+||+|++. ++.||||++++.... ........++.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999984 899999999875432 233445567899999999996 9999999999987
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
+ ..|+|||||++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence 6 89999999999999999987654 9999999999999999999999999999999999999988 799999999998
Q ss_pred ccccccccccccCccceeccccccccccc-----ccccccccCC----------------------------C---CCCC
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLR-----QGEKKHYNHK----------------------------N---VRPS 218 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~~~----------------------------~---~~~~ 218 (317)
............||+.|+|||++.+.... ....++|+.+ . ..+.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 76655555667899999999998653221 1123333322 1 1122
Q ss_pred CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 219 AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 219 ~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..++|+++++|+.+||+.||.+|||++|+++|
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 34789999999999999999999999999887
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=340.38 Aligned_cols=224 Identities=26% Similarity=0.350 Sum_probs=184.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH-HHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++++.||+|+||+||+|++. |+.||||++.+...... .....+.+.+|+.++++++|||||++++++.+. ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999985 89999999976543211 011245689999999999999999999999876 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCC---ceEEcccCccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLK---TIKLADFGLAREE 176 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~---~~kl~Dfg~a~~~ 176 (317)
+|||||+||+|.+++...+. +++..++.++.|++.||+|||++||+||||||+||+++.+.. .+||+|||+++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 99999999999999987654 999999999999999999999999999999999999987621 5999999999876
Q ss_pred ccccccccccCccceecccccccccccccccccccCC----------------------------CCC---CCCCCChHH
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------NVR---PSAENVPEE 225 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------~~~---~~~~~~~~~ 225 (317)
..........||+.|+|||++.+..+. ...++|+.+ ... ..+..+|.+
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred CCCccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 655555667899999999998764432 223333332 000 013567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 226 LSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 226 l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
+++||.+||+.||.+|||++|+++|
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-48 Score=344.75 Aligned_cols=220 Identities=20% Similarity=0.328 Sum_probs=183.8
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||.||+|++. ++.||||++...... ....+.+|+.++++++|||||++++++.++ .+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-----DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46999999999999999999985 899999999865422 245688999999999999999999999765 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeC-CCCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTE-DLKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~-~~~~~kl~Dfg~a~~~~~~ 179 (317)
|||||+||+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.....
T Consensus 104 vmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999886543 34999999999999999999999999999999999999983 2368999999999977666
Q ss_pred cccccccCccceecccccccccccccccccccCC-------------------------------CCCCCCCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------NVRPSAENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~ 228 (317)
.......||+.|+|||++.+..+.. ..++|+.+ ........++.++.+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5666678999999999987654322 22223222 111224578999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~ 250 (317)
||.+||+.||.+|||+.|+++|
T Consensus 262 li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=338.51 Aligned_cols=242 Identities=25% Similarity=0.494 Sum_probs=195.8
Q ss_pred ccccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHh
Q 021127 8 YLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSR 80 (317)
Q Consensus 8 ~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~ 80 (317)
++.++..+.+.|+|++++|++.++||+|+||+||+|.+. +..||||+++..... +....|.+|+.++++
T Consensus 4 ~~~~~~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~----~~~~~~~~E~~il~~ 79 (308)
T d1p4oa_ 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM----RERIEFLNEASVMKE 79 (308)
T ss_dssp SBCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH----HHHHHHHHHHHHGGG
T ss_pred cCcccCcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh----HHHHHHHHHHHHHHH
Confidence 344555555679999999999999999999999999874 468999999765443 234578999999999
Q ss_pred cCCCCeeeEEeeeec-CceEEEEEccCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021127 81 VQHRNLVKFIGACKE-PVMVIVTELLSGGTLRKYLLNMR--------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDL 151 (317)
Q Consensus 81 l~h~niv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dl 151 (317)
++||||++++|++.. ...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||
T Consensus 80 l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDl 159 (308)
T d1p4oa_ 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDL 159 (308)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred cCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceE
Confidence 999999999999965 48999999999999999987432 123789999999999999999999999999999
Q ss_pred CCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceecccccccccccccccccccCC---------------
Q 021127 152 KPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------- 213 (317)
Q Consensus 152 kp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------- 213 (317)
||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+...... .+.|+.+
T Consensus 160 k~~NiLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 160 AARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp SGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTT
T ss_pred cCCceeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCC
Confidence 9999999998 699999999998543322 2233468999999998765433221 1222111
Q ss_pred --------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 --------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+.+..++..+.+||.+||+.||.+|||+.+++++|++.+
T Consensus 238 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 233446788999999999999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=334.95 Aligned_cols=245 Identities=31% Similarity=0.501 Sum_probs=201.4
Q ss_pred cccccceecCCceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHH
Q 021127 7 FYLADELKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS 79 (317)
Q Consensus 7 ~~~~~~~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~ 79 (317)
+..|.++..+..|+|+.++|++.++||+|+||.||+|++. ++.||||+++...... ....|.+|+.++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~~E~~~~~ 81 (311)
T d1t46a_ 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT----EREALMSELKVLS 81 (311)
T ss_dssp CCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH----HHHHHHHHHHHHH
T ss_pred eeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH----HHHHHHHHHHHHH
Confidence 4567888889999999999999999999999999999862 5689999998765433 3456899999999
Q ss_pred hc-CCCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 021127 80 RV-QHRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP----------------RCLDVCVAIGFALDIARAMECL 141 (317)
Q Consensus 80 ~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~~i~~~L~~l 141 (317)
++ +|||||+++|++.++ ..++|||||++|+|.+++..... ..+++..++.|+.||+.||+||
T Consensus 82 ~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 99 799999999999765 79999999999999999976432 2489999999999999999999
Q ss_pred HhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc---cccccccCccceecccccccccccccccccccC------
Q 021127 142 HSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNH------ 212 (317)
Q Consensus 142 H~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~------ 212 (317)
|++++|||||||+||+++.+ +.+||+|||+++..... .......||+.|+|||++.+..... ..++|+.
T Consensus 162 H~~~ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DIwS~G~~l~e 239 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWE 239 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHH
T ss_pred HhCCeeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC-cccccchHHHHHH
Confidence 99999999999999999988 79999999999865432 2223456899999999876532211 1111111
Q ss_pred ------------------------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 213 ------------------------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 213 ------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
+.....+..++.++.+||.+||+.||.+|||+++|+++|++.++.
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 122334567899999999999999999999999999999987765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=333.92 Aligned_cols=239 Identities=31% Similarity=0.546 Sum_probs=191.5
Q ss_pred eecCCceeecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-C
Q 021127 13 LKLDAKWLIDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-Q 82 (317)
Q Consensus 13 ~~~~~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 82 (317)
+-.+.+|.|+.++|++++.||+|+||.||+|+.. +..||||+++...... ....+.+|...+.++ +
T Consensus 2 ~~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~e~~~l~~~~~ 77 (299)
T d1fgka_ 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK----DLSDLISEMEMMKMIGK 77 (299)
T ss_dssp CCCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH----HHHHHHHHHHHHHHHCC
T ss_pred cCcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH----HHHHHHHHHHHHHHhcC
Confidence 4467789999999999999999999999999863 2479999998766533 345688899999888 8
Q ss_pred CCCeeeEEeeeecC-ceEEEEEccCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 83 HRNLVKFIGACKEP-VMVIVTELLSGGTLRKYLLNMRP--------------RCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 83 h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
|||||++++++.++ ..++|||||++|+|.+++..... ..+++.+++.++.||+.||+|||+++||
T Consensus 78 HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv 157 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI 157 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEE
Confidence 99999999999765 79999999999999999976532 3489999999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCccccccccc---ccccccCccceeccccccccccccccccccc-------------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN------------- 211 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~------------- 211 (317)
||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||++.+..+... .++|+
T Consensus 158 HrDiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp CSCCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSC
T ss_pred eeeecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCC
Confidence 99999999999998 799999999998654332 2233568999999998765333221 12221
Q ss_pred ----------------CCCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 212 ----------------HKNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 212 ----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.+...+.+..++.++.+||.+||+.||.+|||+.++++.|+.+++.
T Consensus 236 ~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 236 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 1123345678899999999999999999999999999999988753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=332.56 Aligned_cols=232 Identities=29% Similarity=0.518 Sum_probs=177.3
Q ss_pred eeecCCceeecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
..|++++|++.+.||+|+||.||+|++. ...||||++....... ....++|.+|+.++++++||||++++|++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ--PEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4688899999999999999999999863 2478999987654332 23456799999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++|||||++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 81 ~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~ 158 (273)
T d1u46a_ 81 LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLM 158 (273)
T ss_dssp CSSSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTC
T ss_pred eecchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhh
Confidence 88888999999999999998876433 39999999999999999999999999999999999999998 69999999999
Q ss_pred ccccccc----ccccccCccceecccccccccccc-----------------ccccc------------ccCCCCCCCCC
Q 021127 174 REESLTE----MMTAETGTYRWMAPELYSTVTLRQ-----------------GEKKH------------YNHKNVRPSAE 220 (317)
Q Consensus 174 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-----------------~~~~~------------~~~~~~~~~~~ 220 (317)
+...... ......|+..|+|||++.+..... +..++ ...+...+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence 8643221 223345788999999876532211 11111 01112334567
Q ss_pred CChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHh
Q 021127 221 NVPEELSIILTSCWKEDPNARPNFTQIIQMLLNY 254 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~ 254 (317)
.+|.++.+||.+||+.||++|||+.+|++.|.+.
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8899999999999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-48 Score=334.04 Aligned_cols=232 Identities=28% Similarity=0.472 Sum_probs=189.7
Q ss_pred ceeecCCceeecceeccccceEEEEeEEC-------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEE
Q 021127 18 KWLIDPKHLFVGPRIGEGAHAKVYEGKYK-------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFI 90 (317)
Q Consensus 18 ~~~i~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 90 (317)
.|+++.++|++.+.||+|+||+||+|++. ++.||||++...... ....+|.+|+.++++++||||++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA----DMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH----HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh----HHHHHHHHHHHHHHhcCCCCcccce
Confidence 36788899999999999999999999874 378999999865543 2356799999999999999999999
Q ss_pred eeeecC-ceEEEEEccCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021127 91 GACKEP-VMVIVTELLSGGTLRKYLLNMR----------------------PRCLDVCVAIGFALDIARAMECLHSHGII 147 (317)
Q Consensus 91 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~L~~lH~~~iv 147 (317)
+++.+. ..++||||+++|+|.+++.... ...+++..++.|+.|++.||+|||+++||
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 999765 8999999999999999997532 12488999999999999999999999999
Q ss_pred ccCCCCCcEEeeCCCCceEEcccCcccccccc---cccccccCccceecccccccccccccccccccCC-----------
Q 021127 148 HRDLKPENLLLTEDLKTIKLADFGLAREESLT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------- 213 (317)
Q Consensus 148 H~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------- 213 (317)
||||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+..+.. ..++|+.+
T Consensus 163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTC
T ss_pred eeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCC
Confidence 99999999999998 68999999999854332 2233457899999999876643332 22222211
Q ss_pred ------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhh
Q 021127 214 ------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYL 255 (317)
Q Consensus 214 ------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~ 255 (317)
...+.+..+|.++.+||.+||+.||.+|||+.+|++.|+++.
T Consensus 241 ~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 233456789999999999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=337.38 Aligned_cols=230 Identities=22% Similarity=0.443 Sum_probs=183.7
Q ss_pred eecCCceeecceeccccceEEEEeEEC--Ce----EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ----TVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGAC 93 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 93 (317)
.+..++|+++++||+|+||+||+|.+. |+ .||+|.+...... +..+.|.+|++++++++|||||+++|++
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP----KANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 355678999999999999999999875 33 6899988654332 2345699999999999999999999999
Q ss_pred ecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 94 KEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 94 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
.++..++++|++.+|+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||++
T Consensus 81 ~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla 158 (317)
T d1xkka_ 81 LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLA 158 (317)
T ss_dssp ESSSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHH
T ss_pred ecCCeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccc
Confidence 9988999999999999999887643 349999999999999999999999999999999999999998 69999999999
Q ss_pred ccccccc---ccccccCccceecccccccccccccccccccC-----------------------------CCCCCCCCC
Q 021127 174 REESLTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH-----------------------------KNVRPSAEN 221 (317)
Q Consensus 174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~ 221 (317)
+...... ......||+.|+|||++.+..+.. ..++|+. +...+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~ 237 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI 237 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTT
T ss_pred eecccccccccccccccCccccChHHHhcCCCCh-hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 8653322 223346899999999876543321 1112211 123445678
Q ss_pred ChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhh
Q 021127 222 VPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLS 256 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~ 256 (317)
++.++.+|+.+||+.||.+|||+.+++++|..+..
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.7e-48 Score=335.45 Aligned_cols=219 Identities=25% Similarity=0.339 Sum_probs=184.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|+++++||+|+||+||+|++. |+.||||++++..... ....+.+.+|+.++++++|||||++++++.++ ..|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR--LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 57999999999999999999985 8999999997532211 12345688999999999999999999999865 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|||||+||+|..++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSSC-
T ss_pred EeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEeccc-
Confidence 9999999999999987655 8999999999999999999999999999999999999998 79999999999865433
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
....+||+.|+|||++.+..+.. ..++|+.+ .....+..+++++.+++.+|
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 235 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred -cccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 34568999999999988755443 34444433 12334677899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 021127 234 WKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rp-----s~~~~~~~ 250 (317)
|+.||.+|+ |++++++|
T Consensus 236 L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccchhhHHHHHcC
Confidence 999999996 89999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-47 Score=334.89 Aligned_cols=219 Identities=25% Similarity=0.277 Sum_probs=184.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++++.||+|+||.||+|++. |+.||||++.+..... ......+.+|+.+++.++|||||++++++.+. ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK--LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC--HHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 68999999999999999999985 8999999987532111 12345688999999999999999999999765 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
||||+.+|+|..++...+. +++..++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-
T ss_pred ccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecccc-
Confidence 9999999999999987665 9999999999999999999999999999999999999988 79999999999865432
Q ss_pred ccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHHHh
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILTSC 233 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~c 233 (317)
.....||+.|+|||++.+..+.. ..++|+.+ .....+..+++++.+||.+|
T Consensus 195 -~~~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred -cccccCccccCCHHHHcCCCCCc-cccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 34568999999999988755432 33444333 22334667899999999999
Q ss_pred hhcCCCCCC-----CHHHHHHH
Q 021127 234 WKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 234 l~~~p~~Rp-----s~~~~~~~ 250 (317)
|+.||.+|+ |++++++|
T Consensus 273 L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTS
T ss_pred hhhCHHhccccccccHHHHHcC
Confidence 999999994 89999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=332.53 Aligned_cols=233 Identities=28% Similarity=0.473 Sum_probs=187.0
Q ss_pred eecCCceeecceeccccceEEEEeEEC--Ce--EEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeee
Q 021127 20 LIDPKHLFVGPRIGEGAHAKVYEGKYK--NQ--TVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACK 94 (317)
Q Consensus 20 ~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~--~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 94 (317)
.|+.++|++.++||+|+||+||+|++. +. .||||.+......+ ..+.|.+|++++.++ +|||||+++|++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----DHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH----HHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 467799999999999999999999885 43 57888876544322 345699999999998 7999999999997
Q ss_pred cC-ceEEEEEccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 95 EP-VMVIVTELLSGGTLRKYLLNMR--------------PRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 95 ~~-~~~lv~e~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
++ ..++||||+++|+|.++|.... ...+++..++.++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 65 8999999999999999997541 24599999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCcccccccccccccccCccceecccccccccccccccccccCC--------------------------
Q 021127 160 EDLKTIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------- 213 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------- 213 (317)
.+ +.+||+|||+++............||..|+|||.+.+..+... .++|+.+
T Consensus 162 ~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CC-CceEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 98 6899999999986655544455678999999998765433221 2222211
Q ss_pred ---CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ---NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
...+.+..+++++.+||.+||+.||++|||+.+++++|.+++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 223446788999999999999999999999999999999988643
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.6e-47 Score=338.53 Aligned_cols=221 Identities=23% Similarity=0.299 Sum_probs=179.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHH---HHHHHHhcCCCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAR---EVAMLSRVQHRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~-~ 97 (317)
++|++.++||+|+||.||+|++. |+.||||++.+..... ......+.+ ++.+++.++|||||++++++.+. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~--~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--HTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcch--hhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 68999999999999999999985 8999999987533211 111222333 46667777899999999999765 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccc
Q 021127 98 MVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREES 177 (317)
Q Consensus 98 ~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~ 177 (317)
.|+|||||+||+|.+++..... +++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred EEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence 9999999999999999987655 8999999999999999999999999999999999999988 799999999998654
Q ss_pred cccccccccCccceecccccccccccccccccccCC------------------------------CCCCCCCCChHHHH
Q 021127 178 LTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------NVRPSAENVPEELS 227 (317)
Q Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~ 227 (317)
.. .....+||+.|+|||++..........++|+.+ .....+..++++++
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 43 234568999999999986543333333444332 12223567899999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHHH
Q 021127 228 IILTSCWKEDPNARPN-----FTQIIQM 250 (317)
Q Consensus 228 ~li~~cl~~~p~~Rps-----~~~~~~~ 250 (317)
+||.+||+.||.+||| ++++++|
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999 7899987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=331.66 Aligned_cols=220 Identities=29% Similarity=0.356 Sum_probs=168.8
Q ss_pred ecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEEEEc
Q 021127 28 VGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIVTEL 104 (317)
Q Consensus 28 ~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 104 (317)
.+++||+|+||+||+|++. ++.||||+++............+++.+|+.++++++|||||++++++.++ ..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999885 88999999976554332223345688999999999999999999999765 89999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccccccc-cccc
Q 021127 105 LSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLT-EMMT 183 (317)
Q Consensus 105 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~-~~~~ 183 (317)
+.++++....... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ....
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCccccc
Confidence 9887766655433 349999999999999999999999999999999999999988 79999999999865433 2334
Q ss_pred cccCccceecccccccccccccccccccCC-------------------------------------------------C
Q 021127 184 AETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------------------N 214 (317)
Q Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------------------~ 214 (317)
..+||+.|+|||++..........++|+.+ .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 567999999999876533222222333221 0
Q ss_pred CCC------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 215 VRP------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 215 ~~~------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
..+ ....+++++.+||.+||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 013567899999999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=332.54 Aligned_cols=221 Identities=26% Similarity=0.373 Sum_probs=181.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHH-hcCCCCeeeEEeeeecC-ceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLS-RVQHRNLVKFIGACKEP-VMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~-~~~ 99 (317)
++|++++.||+|+||+||+|++. ++.||||++++..... ......+..|+.++. .++|||||++++++.++ ..|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM--DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 57999999999999999999985 8999999997532111 112334667777665 68999999999999865 899
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL- 178 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~- 178 (317)
+|||||++|+|.+++..... +++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 80 ivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccc
Confidence 99999999999999987665 8999999999999999999999999999999999999988 7999999999985543
Q ss_pred ccccccccCccceecccccccccccccccccccCC---------------------------CCCCCCCCChHHHHHHHH
Q 021127 179 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPSAENVPEELSIILT 231 (317)
Q Consensus 179 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~ 231 (317)
........||+.|+|||++.+..+.. ..++|+.+ .....+..+|.++.+||.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~ 235 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 33344568999999999998765543 34444433 222346678999999999
Q ss_pred HhhhcCCCCCCCHH-HHHHH
Q 021127 232 SCWKEDPNARPNFT-QIIQM 250 (317)
Q Consensus 232 ~cl~~~p~~Rps~~-~~~~~ 250 (317)
+||+.||.+|||+. ++++|
T Consensus 236 ~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 236 KLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHSCSSGGGSBTTBSCGGGS
T ss_pred HhcccCCCCCcCHHHHHHhC
Confidence 99999999999995 78775
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=331.82 Aligned_cols=221 Identities=19% Similarity=0.265 Sum_probs=183.0
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++++.||+|+||+||+|.+. ++.||||+++.... ....+.+|+++|++++|||||++++++.+. .+|+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT------DQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH------HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc------cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 68999999999999999999985 89999999976542 234578999999999999999999999764 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC-CCceEEcccCcccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED-LKTIKLADFGLAREESLT 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~-~~~~kl~Dfg~a~~~~~~ 179 (317)
|||||+||+|.+++...+ ..+++.+++.|+.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999999997643 239999999999999999999999999999999999999853 247999999999876655
Q ss_pred cccccccCccceecccccccccccccccccccCC---------------------------CCCCC----CCCChHHHHH
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------NVRPS----AENVPEELSI 228 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------~~~~~----~~~~~~~l~~ 228 (317)
.......+|+.|+|||++.+..+.. ..++|+.+ ..... ...++.++++
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred CcccccccccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence 5556668999999999877654432 23333322 00011 2367899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 229 ILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 229 li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
||.+||+.||.+|||++|+++|-+
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHccCChhHCcCHHHHhcCHh
Confidence 999999999999999999999843
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=326.93 Aligned_cols=231 Identities=26% Similarity=0.402 Sum_probs=180.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|++.++||+|+||+||+|++. ++.||||+++...... ....++.+|++++++++|||||++++++.++ ..|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh---HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 58999999999999999999985 8999999997543221 2345688999999999999999999999866 8999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccc-c
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESL-T 179 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~-~ 179 (317)
||||+. +++..++.......+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.... .
T Consensus 79 v~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCS
T ss_pred EEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCc
Confidence 999995 566666655555569999999999999999999999999999999999999988 6999999999986543 2
Q ss_pred cccccccCccceecccccccccccccccccccCC--------CCCC----------------------------------
Q 021127 180 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------------------- 217 (317)
Q Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------------------- 217 (317)
.......||+.|+|||++..........+.|+.+ ...|
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3344567999999999866544333223333221 0000
Q ss_pred --------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCCC
Q 021127 218 --------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAPP 261 (317)
Q Consensus 218 --------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~~ 261 (317)
....++.++.+|+.+||+.||.+|||++|+++| .+++....|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H--~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH--PFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC--HhhccCCCC
Confidence 013567889999999999999999999999987 455544433
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=334.08 Aligned_cols=218 Identities=27% Similarity=0.388 Sum_probs=177.4
Q ss_pred Cceeecc-eeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEeeeec----
Q 021127 24 KHLFVGP-RIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFIGACKE---- 95 (317)
Q Consensus 24 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 95 (317)
++|++.. .||+|+||+||+|++. ++.||||+++.. ..+.+|+.++.++ +|||||++++++.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 4788765 5999999999999985 899999998643 1366899987655 89999999999853
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGL 172 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~ 172 (317)
..+|+|||||+||+|.+++...+...+++.++..|+.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 468999999999999999987665669999999999999999999999999999999999999853 25799999999
Q ss_pred ccccccccccccccCccceecccccccccccccccccccCC--------------------------------C-CCCC-
Q 021127 173 AREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------------------------------N-VRPS- 218 (317)
Q Consensus 173 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------------------------------~-~~~~- 218 (317)
|+...........+||+.|+|||++.+..+... .++|+.+ . ..+.
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 987665555667789999999999877544322 2222221 0 0000
Q ss_pred -CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 021127 219 -AENVPEELSIILTSCWKEDPNARPNFTQIIQMLL 252 (317)
Q Consensus 219 -~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~ 252 (317)
...+++++.+||.+||+.||++|||+.|+++|-+
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 1246889999999999999999999999999843
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-46 Score=322.99 Aligned_cols=226 Identities=23% Similarity=0.356 Sum_probs=179.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
++|++.+.||+|+||+||+|++. ++.||||+++.....+ .....++.+|+.++++++||||+++++++...
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD--PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC--HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 67999999999999999999985 8999999998765443 24456799999999999999999999988532
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..|+|||||+|++|.+++...+. +++.+++.|+.||+.||+|||++||+||||||+|||++.+ +..+|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhh
Confidence 48899999999999999987655 9999999999999999999999999999999999999988 68999999998743
Q ss_pred ccc----cccccccCccceecccccccccccccccccccCC-----------------------------C--CCCCCCC
Q 021127 177 SLT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------------------N--VRPSAEN 221 (317)
Q Consensus 177 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------------------~--~~~~~~~ 221 (317)
... ......+||+.|+|||++.+..+.. ..++|+.+ . .......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCc-ceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 322 2234457999999999987654432 23333322 0 0112457
Q ss_pred ChHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHhh
Q 021127 222 VPEELSIILTSCWKEDPNARP-NFTQIIQMLLNYL 255 (317)
Q Consensus 222 ~~~~l~~li~~cl~~~p~~Rp-s~~~~~~~l~~~~ 255 (317)
+|+++.+||.+||+.||.+|| |++++++.|.++.
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 899999999999999999999 8899888776653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=328.93 Aligned_cols=224 Identities=25% Similarity=0.360 Sum_probs=183.3
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHH-HHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecC-c
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEE-IAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP-V 97 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~-~ 97 (317)
++|++.++||+|+||+||+|++. ++.||||++.+...... ......++.+|+.++++++ |||||++++++.++ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999985 89999999875422110 0001123668999999996 89999999999865 8
Q ss_pred eEEEEEccCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 98 MVIVTELLSG-GTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 98 ~~lv~e~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
.++||||+.+ +++.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 688888877654 9999999999999999999999999999999999999966578999999999865
Q ss_pred ccccccccccCccceecccccccccccccccccccCC---------------------CCCCCCCCChHHHHHHHHHhhh
Q 021127 177 SLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------NVRPSAENVPEELSIILTSCWK 235 (317)
Q Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~ 235 (317)
... ......||+.|+|||++.+........++|+.+ .....+..+|.++++||.+||+
T Consensus 162 ~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 240 (273)
T d1xwsa_ 162 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLA 240 (273)
T ss_dssp CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHTC
T ss_pred ccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHcc
Confidence 433 345568999999999987765544445555544 1223356789999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 021127 236 EDPNARPNFTQIIQM 250 (317)
Q Consensus 236 ~~p~~Rps~~~~~~~ 250 (317)
.||++|||++|+++|
T Consensus 241 ~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 241 LRPSDRPTFEEIQNH 255 (273)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CCHhHCcCHHHHhcC
Confidence 999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=323.19 Aligned_cols=243 Identities=26% Similarity=0.435 Sum_probs=189.9
Q ss_pred cccceecCCceeecCCcee--ecceeccccceEEEEeEEC-----CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc
Q 021127 9 LADELKLDAKWLIDPKHLF--VGPRIGEGAHAKVYEGKYK-----NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV 81 (317)
Q Consensus 9 ~~~~~~~~~~~~i~~~~y~--~~~~lG~G~~g~V~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l 81 (317)
.|+.++......++++.+. +.++||+|+||+||+|++. ...||||.++..... ...++|.+|+++++++
T Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~~~E~~~l~~l 85 (311)
T d1r0pa_ 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI----GEVSQFLTEGIIMKDF 85 (311)
T ss_dssp CHHHHHHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH----HHHHHHHHHHHHHHTC
T ss_pred CHHHHHHhhceEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH----HHHHHHHHHHHHHHhC
Confidence 3444444445556666554 3788999999999999874 236899999764443 3356799999999999
Q ss_pred CCCCeeeEEeeeec--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEee
Q 021127 82 QHRNLVKFIGACKE--PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLT 159 (317)
Q Consensus 82 ~h~niv~l~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~ 159 (317)
+||||++++|++.+ +..++|||||++|+|.+++..... .+++..++.++.|++.||.|||+.+|+||||||+|||++
T Consensus 86 ~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~ 164 (311)
T d1r0pa_ 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164 (311)
T ss_dssp CCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC
Confidence 99999999999753 478999999999999999876443 488999999999999999999999999999999999999
Q ss_pred CCCCceEEcccCccccccccc-----ccccccCccceecccccccccccccccccccC----------------------
Q 021127 160 EDLKTIKLADFGLAREESLTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNH---------------------- 212 (317)
Q Consensus 160 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~---------------------- 212 (317)
.+ +.+||+|||+++...... ......||+.|+|||++.+...... .++|+.
T Consensus 165 ~~-~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~ 242 (311)
T d1r0pa_ 165 EK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFD 242 (311)
T ss_dssp TT-CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------
T ss_pred CC-CCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 88 689999999998543221 1223468999999998665332211 111111
Q ss_pred -------CCCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 213 -------KNVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 213 -------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
+.....+..+++++.+||.+||+.||++||++.||+++|+.++...
T Consensus 243 ~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 243 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1233346778999999999999999999999999999999988653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=319.89 Aligned_cols=225 Identities=27% Similarity=0.406 Sum_probs=171.8
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----ce
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-----VM 98 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 98 (317)
.+|.+.++||+|+||.||+|+++|+.||||++..... .......|+..+.+++||||+++++++.+. .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~------~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch------hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4788999999999999999999999999999865321 111223455555678999999999998532 57
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCcEEeeCCCCceEEccc
Q 021127 99 VIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS--------HGIIHRDLKPENLLLTEDLKTIKLADF 170 (317)
Q Consensus 99 ~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--------~~ivH~Dlkp~Nill~~~~~~~kl~Df 170 (317)
++|||||++|+|.+++.... +++..++.++.|++.||+|||+ +|||||||||+||||+.+ +.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEec
Confidence 99999999999999998642 9999999999999999999996 599999999999999988 79999999
Q ss_pred Cccccccccc-----ccccccCccceeccccccccccc-----ccccccccCC---------------------------
Q 021127 171 GLAREESLTE-----MMTAETGTYRWMAPELYSTVTLR-----QGEKKHYNHK--------------------------- 213 (317)
Q Consensus 171 g~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~~~~~~~--------------------------- 213 (317)
|+++...... ......||+.|+|||++.+.... ....+.|+.+
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998553322 22345799999999987642110 0111111111
Q ss_pred ----------------CCCCC-C-----CCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 214 ----------------NVRPS-A-----ENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 214 ----------------~~~~~-~-----~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
..++. + ...+..+.+|+.+||+.||++|||+.|+++.|.++....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 01111 1 112346899999999999999999999999999887653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-45 Score=317.18 Aligned_cols=221 Identities=26% Similarity=0.345 Sum_probs=173.4
Q ss_pred CceeecceeccccceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVIV 101 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~lv 101 (317)
++|++.++||+|+||+||+|+++ ++.||||++....... ....++.+|+.++++++||||+++++++.++ ..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE---GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG---CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh---HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 58999999999999999999987 7999999997654322 2245688999999999999999999999765 89999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc-
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE- 180 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~- 180 (317)
||++.++.+..+.... ..+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||.+.......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCcc
Confidence 9999776666655543 349999999999999999999999999999999999999998 799999999998654332
Q ss_pred ccccccCccceecccccccccccccccccccCC-----------------------------------------------
Q 021127 181 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK----------------------------------------------- 213 (317)
Q Consensus 181 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~----------------------------------------------- 213 (317)
......|++.|+|||++.+........+.|+.+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 234456899999999876533222222222111
Q ss_pred ---------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ---------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++.++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011134678899999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-45 Score=321.76 Aligned_cols=216 Identities=19% Similarity=0.310 Sum_probs=175.2
Q ss_pred cCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec---
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE--- 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--- 95 (317)
..++|+++++||+|+||+||+|++. ++.||||+++... .+++.+|+.+|++++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 3468999999999999999999985 8999999987543 235789999999995 9999999999863
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 96 PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
...++|||||.+++|..+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus 105 ~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 36999999999999876542 3999999999999999999999999999999999999997645799999999987
Q ss_pred cccccccccccCccceecccccccccccccccccccCC------------------------------------------
Q 021127 176 ESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------------------ 213 (317)
Q Consensus 176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------------------ 213 (317)
..........++|+.|+|||++.+........+.|+.+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 66555556678999999999876533222111111111
Q ss_pred -----------------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -----------------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+++++.+||.+||+.||.+|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001123467899999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=320.05 Aligned_cols=226 Identities=23% Similarity=0.292 Sum_probs=178.0
Q ss_pred eeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC
Q 021127 19 WLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP 96 (317)
Q Consensus 19 ~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 96 (317)
|++ +++|+++++||+|+||+||+|.+. ++.||||++....... ...+++.+|+.+|++++|||||++++++...
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE---LFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH---HHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh---HHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 555 579999999999999999999985 8999999998655433 3355789999999999999999999998542
Q ss_pred -------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcc
Q 021127 97 -------VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLAD 169 (317)
Q Consensus 97 -------~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~D 169 (317)
.+++||||| +.+|...+... .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~D 164 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILD 164 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECC
T ss_pred ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-ccccccc
Confidence 479999999 77888877653 39999999999999999999999999999999999999998 7999999
Q ss_pred cCcccccccccccccccCccceecccccccccccccccccccCC--------C---------------------------
Q 021127 170 FGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------N--------------------------- 214 (317)
Q Consensus 170 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~--------------------------- 214 (317)
||+|+..... .+...||+.|+|||++.+........++|+.+ .
T Consensus 165 fg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 165 FGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9999865432 34568999999999987644433344444332 0
Q ss_pred -----------------------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 215 -----------------------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 215 -----------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
.......+++++.+||.+||..||.+|||+.|+++| .+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H--p~f~~ 306 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFES 306 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--hhhCc
Confidence 001124568899999999999999999999999998 44443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=317.70 Aligned_cols=219 Identities=27% Similarity=0.316 Sum_probs=173.7
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-----
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP----- 96 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 96 (317)
.+|+++++||+|+||+||+|.++ ++.||||++.+.... ....++++|+.+|++++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH----HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh----HHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 46999999999999999999885 899999999765542 3345689999999999999999999998542
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..+++++++.+|+|.+++... .+++..+..++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+++..
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVA 159 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred ceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeec
Confidence 235555667799999999764 39999999999999999999999999999999999999988 79999999999754
Q ss_pred cccc----ccccccCccceecccccccccccccccccccCC--------CC-----------------------------
Q 021127 177 SLTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NV----------------------------- 215 (317)
Q Consensus 177 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~----------------------------- 215 (317)
.... .....+||+.|+|||++..........++|+.+ ..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 3322 234457999999999986544444444444332 00
Q ss_pred ------------CC---------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 216 ------------RP---------SAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 216 ------------~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
.+ ....++.++.+|+.+||+.||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 023567789999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=313.41 Aligned_cols=221 Identities=26% Similarity=0.355 Sum_probs=173.3
Q ss_pred CceeecceeccccceEEEEeEEC---CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc---CCCCeeeEEeeeec--
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK---NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV---QHRNLVKFIGACKE-- 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-- 95 (317)
++|+++++||+|+||+||+|++. ++.||||+++....... ....+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS---CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch---HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 68999999999999999999984 67899999875433221 111355677776665 89999999998842
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 96 ----PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 96 ----~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
...+++|||+.++.+..... .....+++..+..++.|++.||+|||++|||||||||+|||++.+ +.+||+|||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg 161 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFG 161 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCC
T ss_pred cccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchh
Confidence 36899999997766654443 344559999999999999999999999999999999999999988 699999999
Q ss_pred cccccccccccccccCccceecccccccccccccccccccCC--------------------------------------
Q 021127 172 LAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-------------------------------------- 213 (317)
Q Consensus 172 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-------------------------------------- 213 (317)
+++............||+.|+|||++.+..+.. ..++|+.+
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCCh-hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 998766666667778999999999876643322 12222111
Q ss_pred ----------------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----------------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........+++.+.+||.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0011234678899999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=308.49 Aligned_cols=221 Identities=24% Similarity=0.350 Sum_probs=179.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeecC-ceEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKEP-VMVI 100 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~l 100 (317)
++|+++++||+|+||+||+|++. ++.||||+++...... ....++.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE---GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST---THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh---HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 58999999999999999999985 7899999997665433 3355789999999999999999999999876 7899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccccccccc
Q 021127 101 VTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAREESLTE 180 (317)
Q Consensus 101 v~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~~~~~ 180 (317)
|++++.+++|..++...+. +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.++......
T Consensus 79 v~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCC
T ss_pred Eeeeccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCC
Confidence 9999999988888776544 8999999999999999999999999999999999999988 689999999998654332
Q ss_pred -ccccccCccceecccccccccccccccccccCC----------------------------------------------
Q 021127 181 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------------- 213 (317)
Q Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------------- 213 (317)
......+++.|+|||++..........+.|+.+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence 333446788999999876533222222222111
Q ss_pred -----------CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 -----------NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
........++..+.+|+.+||+.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111234567899999999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=317.46 Aligned_cols=216 Identities=24% Similarity=0.287 Sum_probs=172.0
Q ss_pred ceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec-------
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------- 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 95 (317)
+|+..++||+|+||+||+|++. ++.||||++...... ..+|++++++++|+||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 6999999999999999999985 899999999765432 3479999999999999999998842
Q ss_pred CceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCcc
Q 021127 96 PVMVIVTELLSGGTLRKYLLN--MRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLA 173 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a 173 (317)
...++|||||+++ +.+.+.. .....+++..+..|+.||+.||+|||++||+||||||+|||++.+...+||+|||++
T Consensus 92 ~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 92 VYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred eEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 1478999999765 4444432 233459999999999999999999999999999999999999977458999999999
Q ss_pred cccccccccccccCccceecccccccccccccccccccCC----------------------------------------
Q 021127 174 REESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK---------------------------------------- 213 (317)
Q Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~---------------------------------------- 213 (317)
+............||+.|+|||++.+........++|+.+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred hhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 8766555556678999999999866533222222332221
Q ss_pred ----------C------CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 214 ----------N------VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 214 ----------~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. .......+++++.+||.+||+.||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 001123578899999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=313.80 Aligned_cols=229 Identities=24% Similarity=0.268 Sum_probs=181.0
Q ss_pred CceeecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 021127 17 AKWLIDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACK 94 (317)
Q Consensus 17 ~~~~i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 94 (317)
..|.| +++|++.++||+|+||+||+|++. ++.||||++.+..... ....++.+|+.++++++|||||++++++.
T Consensus 12 ~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 12 TIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI---IHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp SEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 35777 578999999999999999999885 8999999998665433 23456889999999999999999999884
Q ss_pred c------CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEc
Q 021127 95 E------PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLA 168 (317)
Q Consensus 95 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~ 168 (317)
. ...++||+++.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+|++
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~ 163 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKIL 163 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-cccccc
Confidence 2 2456677788899999998643 39999999999999999999999999999999999999998 799999
Q ss_pred ccCcccccccccccccccCccceecccccccccccccccccccCC--------CCCC-----------------------
Q 021127 169 DFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP----------------------- 217 (317)
Q Consensus 169 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~----------------------- 217 (317)
|||++..... ......|++.|+|||++.+........++|+.+ ...+
T Consensus 164 dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 164 DFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241 (348)
T ss_dssp CC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 9999975543 234567899999999876654444444444332 0000
Q ss_pred ---------------------------CCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhc
Q 021127 218 ---------------------------SAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSA 257 (317)
Q Consensus 218 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~ 257 (317)
...+++.++.+||.+||+.||.+|||+.|+++| .++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~ 306 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ 306 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCC
Confidence 023568889999999999999999999999998 44544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=307.63 Aligned_cols=221 Identities=22% Similarity=0.259 Sum_probs=169.6
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
++|++.++||+|+||+||+|++. ++.||||++....... ....++.+|+.++++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 89999999999999999999985 8999999987654432 223458899999999999999999998743
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCc
Q 021127 96 ---PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGL 172 (317)
Q Consensus 96 ---~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~ 172 (317)
...++||||+.++.+....... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~ 163 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGL 163 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTT
T ss_pred ccCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecce
Confidence 3589999999776665444332 348999999999999999999999999999999999999998 7999999999
Q ss_pred ccccccc-----cccccccCccceecccccccccccccccccccCC--------CCCC----------------------
Q 021127 173 AREESLT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP---------------------- 217 (317)
Q Consensus 173 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~---------------------- 217 (317)
++..... ......+||+.|+|||++.+........++|+.+ ...+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9754322 1223357999999999876543333333333332 0000
Q ss_pred --------------------CCC---------CChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 --------------------SAE---------NVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 --------------------~~~---------~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
... ..++++.+||.+||+.||++|||++|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 124567899999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=299.97 Aligned_cols=225 Identities=22% Similarity=0.309 Sum_probs=174.2
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEe-eeec-CceE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIG-ACKE-PVMV 99 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~-~~~~ 99 (317)
++|++.++||+|+||.||+|++. ++.||||++....... ++..|+++++.++|+|++..++ +..+ ...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-------CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-------HHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 57999999999999999999985 8999999988754432 3778999999998777655554 4444 4788
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC--CCceEEcccCcccccc
Q 021127 100 IVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED--LKTIKLADFGLAREES 177 (317)
Q Consensus 100 lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~--~~~~kl~Dfg~a~~~~ 177 (317)
+||||+ +++|.+.+.... ..+++..++.++.|++.||+|||++||+||||||+|||++.. ...+||+|||+|+...
T Consensus 80 ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999999 677777766533 349999999999999999999999999999999999998632 2479999999998643
Q ss_pred ccc--------ccccccCccceecccccccccccccccccccCC-----------------C------------------
Q 021127 178 LTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK-----------------N------------------ 214 (317)
Q Consensus 178 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-----------------~------------------ 214 (317)
... ......||+.|+|||++.+..+.. ..++|+.+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH-HHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCC-hhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 321 123457999999999987754322 22222222 0
Q ss_pred CCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhcc
Q 021127 215 VRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAI 258 (317)
Q Consensus 215 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~ 258 (317)
......++|+++.+||..||+.||++||++.++.+.|+......
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00013568899999999999999999999999999888876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-42 Score=297.22 Aligned_cols=230 Identities=22% Similarity=0.282 Sum_probs=183.4
Q ss_pred ecCCceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeecC-
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKEP- 96 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 96 (317)
|-.++|+++++||+|+||+||+|++. ++.||||++....... .+.+|++.++.+.| +|++.+++++.++
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGL 74 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-------HHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence 34689999999999999999999985 8999999987654432 36788999999965 8999999998765
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCC----CCceEEcccCc
Q 021127 97 VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTED----LKTIKLADFGL 172 (317)
Q Consensus 97 ~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~----~~~~kl~Dfg~ 172 (317)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 889999999 789999887644 349999999999999999999999999999999999999742 25799999999
Q ss_pred ccccccc--------cccccccCccceecccccccccccccccccccCC-------------------------------
Q 021127 173 AREESLT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK------------------------------- 213 (317)
Q Consensus 173 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~------------------------------- 213 (317)
|+..... ......+||+.|+|||++.+..... ..+.|+.+
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~-~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCCh-HHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9854321 1223457999999999987644332 12222222
Q ss_pred ----CCCCCCCCChHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHhhhccCC
Q 021127 214 ----NVRPSAENVPEELSIILTSCWKEDPNARPNFTQIIQMLLNYLSAIAP 260 (317)
Q Consensus 214 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~l~~~~~~~~~ 260 (317)
.......++|+++.+++..|+..+|++||+++.+.+.|++++.....
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 00001356889999999999999999999999999999988876543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-43 Score=309.32 Aligned_cols=217 Identities=26% Similarity=0.335 Sum_probs=162.1
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCCeeeEEeeeec------
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRNLVKFIGACKE------ 95 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 95 (317)
++|++.++||+|+||+||+|.+. |+.||||++....... ....++.+|+.++++++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ---THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH---HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH---HHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 57999999999999999999986 8999999998765443 334578999999999999999999999842
Q ss_pred -CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 -PVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 -~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
...|+|||||.++ +.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||+++
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred CceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhh
Confidence 4789999999654 544443 238999999999999999999999999999999999999998 689999999998
Q ss_pred ccccccccccccCccceecccccccccccccccccccCC--------CCCC-----------------------------
Q 021127 175 EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHK--------NVRP----------------------------- 217 (317)
Q Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~--------~~~~----------------------------- 217 (317)
...........++|+.|+|||++.+..+.. ..+.|+.+ ...+
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~-~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCCCCCC-CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 766665666678999999999987643322 12222211 0000
Q ss_pred ----------------------------C----CCCChHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 021127 218 ----------------------------S----AENVPEELSIILTSCWKEDPNARPNFTQIIQM 250 (317)
Q Consensus 218 ----------------------------~----~~~~~~~l~~li~~cl~~~p~~Rps~~~~~~~ 250 (317)
. ....+.++.+||.+||..||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 01135678999999999999999999999988
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=305.08 Aligned_cols=225 Identities=23% Similarity=0.306 Sum_probs=180.4
Q ss_pred cCCceeecceeccccceEEEEeEE-----CCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEeeeec
Q 021127 22 DPKHLFVGPRIGEGAHAKVYEGKY-----KNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQH-RNLVKFIGACKE 95 (317)
Q Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 95 (317)
.-++|+++++||+|+||+||+|++ +|+.||||++++...... ....+++.+|++++++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 347899999999999999999976 378999999865321100 0112347889999999976 899999999976
Q ss_pred C-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccCccc
Q 021127 96 P-VMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFGLAR 174 (317)
Q Consensus 96 ~-~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~ 174 (317)
. ..+++|||+.+|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+||+++.+ +.+||+|||+++
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSK 177 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred CCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchh
Confidence 5 89999999999999999987765 7899999999999999999999999999999999999998 799999999997
Q ss_pred cccc--ccccccccCccceecccccccccc-cccccccccCC-------------------------------CCCCCCC
Q 021127 175 EESL--TEMMTAETGTYRWMAPELYSTVTL-RQGEKKHYNHK-------------------------------NVRPSAE 220 (317)
Q Consensus 175 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~-------------------------------~~~~~~~ 220 (317)
.... ........|++.|+|||.+.+... .....++|+.+ ...+.+.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 5432 223345679999999999865432 22234444433 1233356
Q ss_pred CChHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 021127 221 NVPEELSIILTSCWKEDPNARP-----NFTQIIQM 250 (317)
Q Consensus 221 ~~~~~l~~li~~cl~~~p~~Rp-----s~~~~~~~ 250 (317)
.++.++.+||.+||+.||.+|| |++|+++|
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 7899999999999999999999 47899876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-36 Score=267.15 Aligned_cols=169 Identities=24% Similarity=0.316 Sum_probs=131.9
Q ss_pred CceeecceeccccceEEEEeEEC--CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-----------CCCeeeEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYK--NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-----------HRNLVKFI 90 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~ 90 (317)
++|+++++||+|+||+||+|++. |+.||||+++.... ....+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~------~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV------YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH------HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc------chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 57999999999999999999985 89999999975431 2335677888887774 58899999
Q ss_pred eeeec---CceEEEEEccCCCC-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEeeCCCC--
Q 021127 91 GACKE---PVMVIVTELLSGGT-LRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-HGIIHRDLKPENLLLTEDLK-- 163 (317)
Q Consensus 91 ~~~~~---~~~~lv~e~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~ivH~Dlkp~Nill~~~~~-- 163 (317)
+++.. ...+++|+++..+. ............+++..+..++.||+.||+|||+ .||+||||||+|||++.+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88753 35566666665544 3344444444569999999999999999999998 89999999999999986521
Q ss_pred ---ceEEcccCcccccccccccccccCccceecccccccc
Q 021127 164 ---TIKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 200 (317)
Q Consensus 164 ---~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 200 (317)
.++++|||.+..... .....+||+.|+|||++...
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhcccc
Confidence 389999999975433 23456799999999987653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.1e-26 Score=187.06 Aligned_cols=138 Identities=21% Similarity=0.216 Sum_probs=107.8
Q ss_pred eeecceeccccceEEEEeEEC-CeEEEEEEeecCCCh-------------HHHHHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 021127 26 LFVGPRIGEGAHAKVYEGKYK-NQTVAIKIVHKGETP-------------EEIAKKESRFAREVAMLSRVQHRNLVKFIG 91 (317)
Q Consensus 26 y~~~~~lG~G~~g~V~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 91 (317)
+.++++||+|+||+||+|++. |+.||||+++..... ............|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999875 899999987643211 011122334567889999999999999886
Q ss_pred eeecCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEeeCCCCceEEcccC
Q 021127 92 ACKEPVMVIVTELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHSHGIIHRDLKPENLLLTEDLKTIKLADFG 171 (317)
Q Consensus 92 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~ivH~Dlkp~Nill~~~~~~~kl~Dfg 171 (317)
+.. .+++|||+++..+.+ ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||
T Consensus 82 ~~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 82 WEG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred ecC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 542 379999998765432 4455567899999999999999999999999999999975 58999999
Q ss_pred cccccc
Q 021127 172 LAREES 177 (317)
Q Consensus 172 ~a~~~~ 177 (317)
+|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=2.6e-09 Score=88.29 Aligned_cols=140 Identities=15% Similarity=0.104 Sum_probs=94.0
Q ss_pred CceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEeeeec-CceEEE
Q 021127 24 KHLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ-HRNLVKFIGACKE-PVMVIV 101 (317)
Q Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-~~~~lv 101 (317)
+.|++.+..+-++.+.||+....++.++||+........ ...+.+|...+..+. +--+.+++.+..+ +..++|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc-----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 456666655555567899988778888999876543211 113567888877763 4446788877754 478999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021127 102 TELLSGGTLRKYLLNMRPRCLDVCVAIGFALDIARAMECLHS-------------------------------------- 143 (317)
Q Consensus 102 ~e~~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-------------------------------------- 143 (317)
|++++|.++.+..... .. ...++.+++..|+.||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9999998886654321 11 22234455555555553
Q ss_pred ---------------------CCccccCCCCCcEEeeCCCCceEEcccCccccc
Q 021127 144 ---------------------HGIIHRDLKPENLLLTEDLKTIKLADFGLAREE 176 (317)
Q Consensus 144 ---------------------~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~~ 176 (317)
..++|+|+.|.||+++.+ +.+.|+||+.+...
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGRA 214 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcccC
Confidence 127999999999999976 45569999988643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.49 E-value=2.6e-07 Score=75.55 Aligned_cols=71 Identities=18% Similarity=0.158 Sum_probs=48.5
Q ss_pred ecccc-ceEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeeEEeeeecC-ceEEEEEccC
Q 021127 32 IGEGA-HAKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQ--HRNLVKFIGACKEP-VMVIVTELLS 106 (317)
Q Consensus 32 lG~G~-~g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~-~~~lv~e~~~ 106 (317)
+..|. .+.||+.... +..+++|.-....... +..|...++.+. .-.+.+++++..++ ..++||++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~--------l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNE--------LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSC--------HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhH--------HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 34444 3689998876 5668899876554332 556777777663 33467788776654 7899999998
Q ss_pred CCCH
Q 021127 107 GGTL 110 (317)
Q Consensus 107 ~g~L 110 (317)
|.++
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=1.2e-06 Score=76.35 Aligned_cols=80 Identities=20% Similarity=0.098 Sum_probs=46.8
Q ss_pred cceeccccceEEEEeEEC--CeEEEEEEeecC--CChHHHHHHHHHHHHHHHHHHhc-C--CCCeeeEEeeeecCceEEE
Q 021127 29 GPRIGEGAHAKVYEGKYK--NQTVAIKIVHKG--ETPEEIAKKESRFAREVAMLSRV-Q--HRNLVKFIGACKEPVMVIV 101 (317)
Q Consensus 29 ~~~lG~G~~g~V~~~~~~--~~~vaiK~~~~~--~~~~~~~~~~~~~~~E~~~l~~l-~--h~niv~l~~~~~~~~~~lv 101 (317)
.+.||.|....||+.... ++.|+||.-... ...+.......+...|.+.|+.+ . ...+++++.+. ....++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-TEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-TTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-CCCCEEE
Confidence 456899999999998764 678999964321 00000000011244577777665 2 24567777654 3456789
Q ss_pred EEccCCCC
Q 021127 102 TELLSGGT 109 (317)
Q Consensus 102 ~e~~~~g~ 109 (317)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.55 E-value=0.00017 Score=60.70 Aligned_cols=65 Identities=9% Similarity=0.121 Sum_probs=40.7
Q ss_pred eEEEEeEEC-CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeeEEee------eecCceEEEEEccCCC
Q 021127 38 AKVYEGKYK-NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGA------CKEPVMVIVTELLSGG 108 (317)
Q Consensus 38 g~V~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~lv~e~~~~g 108 (317)
..||+++.. |+.|++|+.+...... ..+..|...+..|.... ++..+.. ..++..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 589999875 7889999987654322 23667777777763222 2222211 1245688899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.54 E-value=0.0001 Score=63.75 Aligned_cols=79 Identities=18% Similarity=0.276 Sum_probs=51.3
Q ss_pred ecCCceeecceeccccceEEEEeEEC---------CeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 021127 21 IDPKHLFVGPRIGEGAHAKVYEGKYK---------NQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRV-QHRNLVKFI 90 (317)
Q Consensus 21 i~~~~y~~~~~lG~G~~g~V~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 90 (317)
++.+++++ +.|+.|-.-.+|+.... .+.|++++.-.... .. ...+|..+++.+ .+.-.++++
T Consensus 40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~i------dr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ES------HLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HH------HHHHHHHHHHHHHHTTSSSCEE
T ss_pred CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hh------HHHHHHHHHHHHHhCCCCCeEE
Confidence 34455655 46777888899998764 24577777653222 11 234688888777 344456888
Q ss_pred eeeecCceEEEEEccCCCCH
Q 021127 91 GACKEPVMVIVTELLSGGTL 110 (317)
Q Consensus 91 ~~~~~~~~~lv~e~~~~g~L 110 (317)
+++.+ .+|+||++|..|
T Consensus 112 ~~~~~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG---GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT---EEEECCCCEEEC
T ss_pred EEcCC---ceEEEEeccccC
Confidence 88765 578999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.45 E-value=0.00033 Score=58.37 Aligned_cols=143 Identities=17% Similarity=0.134 Sum_probs=73.9
Q ss_pred ceeecceeccccceEEEEeEECCeEEEEEEeecCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeeEEee-------eec
Q 021127 25 HLFVGPRIGEGAHAKVYEGKYKNQTVAIKIVHKGETPEEIAKKESRFAREVAMLSRVQHRN--LVKFIGA-------CKE 95 (317)
Q Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-------~~~ 95 (317)
++.-.+.|..|.-.+.|+.+.++..+++|++....... .+..|++++..|...+ ++..+.. ..+
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~-------~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~ 91 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 91 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred CceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCHH-------HHHHHHHHHHhhhhccccccccceecCCCcceeee
Confidence 33444556677778899998887779999987543322 2344566666553211 2211111 123
Q ss_pred CceEEEEEccCCCCHHH-----------H---HHhcC-------CCCCCH------------------HHHHHHHHHHHH
Q 021127 96 PVMVIVTELLSGGTLRK-----------Y---LLNMR-------PRCLDV------------------CVAIGFALDIAR 136 (317)
Q Consensus 96 ~~~~lv~e~~~~g~L~~-----------~---l~~~~-------~~~l~~------------------~~~~~i~~~i~~ 136 (317)
.....++.+..+..... . +.... ...... ......+..+..
T Consensus 92 ~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 171 (316)
T d2ppqa1 92 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 171 (316)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred cccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHH
Confidence 45666777765543211 0 00000 000000 011122223333
Q ss_pred HHHHHHh----CCccccCCCCCcEEeeCCCCceEEcccCcccc
Q 021127 137 AMECLHS----HGIIHRDLKPENLLLTEDLKTIKLADFGLARE 175 (317)
Q Consensus 137 ~L~~lH~----~~ivH~Dlkp~Nill~~~~~~~kl~Dfg~a~~ 175 (317)
.+.-.+. .|+||+|+.++||+++.+ +..-|+||+.+..
T Consensus 172 ~~~~~~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 172 YLAAHWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hhhccCccccccccccCCcchhhhhcccc-cceeEeccccccc
Confidence 3333332 379999999999999987 4568999999874
|